Citrus Sinensis ID: 047020
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 266 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FX99 | 663 | Probable receptor-like pr | no | no | 0.962 | 0.386 | 0.391 | 9e-46 | |
| Q8VZJ9 | 411 | Calmodulin-binding recept | no | no | 0.808 | 0.523 | 0.433 | 6e-44 | |
| Q9LFV3 | 436 | Probable leucine-rich rep | no | no | 0.939 | 0.573 | 0.393 | 7e-44 | |
| Q9LX29 | 895 | Serine/threonine-protein | no | no | 0.966 | 0.287 | 0.382 | 2e-43 | |
| C0LGQ7 | 898 | Probable LRR receptor-lik | no | no | 0.973 | 0.288 | 0.390 | 4e-43 | |
| Q41328 | 354 | Pto-interacting protein 1 | N/A | no | 0.921 | 0.692 | 0.419 | 6e-43 | |
| Q6R2J8 | 703 | Protein STRUBBELIG-RECEPT | no | no | 0.947 | 0.358 | 0.372 | 3e-42 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.800 | 0.223 | 0.461 | 3e-42 | |
| Q8H1G6 | 361 | PTI1-like tyrosine-protei | no | no | 0.917 | 0.675 | 0.398 | 4e-42 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.827 | 0.305 | 0.412 | 4e-42 |
| >sp|Q9FX99|Y1497_ARATH Probable receptor-like protein kinase At1g49730 OS=Arabidopsis thaliana GN=At1g49730 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 183 bits (465), Expect = 9e-46, Method: Compositional matrix adjust.
Identities = 106/271 (39%), Positives = 159/271 (58%), Gaps = 15/271 (5%)
Query: 2 YALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL 61
++ +E+ ATNDF IG G VY AE DG AVK++ + + + F E+ +L
Sbjct: 317 FSYKEMTNATNDFNTVIGQGGFGTVYKAEFNDGLIAAVKKMNKVSEQAEQDFCREIGLLA 376
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
++ H NLV L GFC+ K E+ L+ +Y+ N SL D +H G+ SW R+ IA+D+A
Sbjct: 377 KLHHRNLVALKGFCINKKERFLVYDYMKNGSLKDHLHA-IGKPPP--SWGTRMKIAIDVA 433
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
ALEYLH DPP+ HRDIKSSNILL ++ AKL+DFGL T I+G+
Sbjct: 434 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLSDFGLAHSSRDGSVCFEPVNTDIRGT 493
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE--CRRNKNVEV 239
GYVD Y+ T ++ KSDVYS+GV+LLELITG +++ L E ++ ++K++E
Sbjct: 494 PGYVDPEYVVTQELTEKSDVYSYGVVLLELITGRRAVDEGRNLVEMSQRFLLAKSKHLE- 552
Query: 240 WAQMLDPKLN------GDANMEQLRVLIRIC 264
++DP++ G ++ + ++R+C
Sbjct: 553 ---LVDPRIKDSINDAGGKQLDAVVTVVRLC 580
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8VZJ9|CRCK2_ARATH Calmodulin-binding receptor-like cytoplasmic kinase 2 OS=Arabidopsis thaliana GN=CRCK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (450), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 97/224 (43%), Positives = 138/224 (61%), Gaps = 9/224 (4%)
Query: 2 YALEELKMATNDFR--IRIGVGATSFVYLAELGDGNFGAVKR----VMEERGGSRKIFLD 55
+ +E+ AT +F RIG G VY +L DG AVKR + ++R G+ F+
Sbjct: 107 FTFDEIYDATKNFSPSFRIGQGGFGTVYKVKLRDGKTFAVKRAKKSMHDDRQGADAEFMS 166
Query: 56 EVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS 115
E+ L +V+H +LV GF + E++L++EY+AN +L D + G++L + + RL
Sbjct: 167 EIQTLAQVTHLSLVKYYGFVVHNDEKILVVEYVANGTLRDHLDCKEGKTLDM---ATRLD 223
Query: 116 IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175
IA D+A A+ YLH PPIIHRDIKSSNILL ++ AK+ADFG +L P D
Sbjct: 224 IATDVAHAITYLHMYTQPPIIHRDIKSSNILLTENYRAKVADFGFARLAPDTDSGATHVS 283
Query: 176 TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQ 219
T +KG+ GY+D YL T ++ KSDVYSFGVLL+EL+TG + I+
Sbjct: 284 TQVKGTAGYLDPEYLTTYQLTEKSDVYSFGVLLVELLTGRRPIE 327
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFV3|Y5157_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730 OS=Arabidopsis thaliana GN=At5g15730 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (449), Expect = 7e-44, Method: Compositional matrix adjust.
Identities = 104/264 (39%), Positives = 160/264 (60%), Gaps = 14/264 (5%)
Query: 2 YALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL 61
Y ++++ AT +F +G G+ VY A + +G A K + F EVS+L
Sbjct: 104 YNYKDIQKATQNFTTVLGQGSFGPVYKAVMPNGELAAAKVHGSNSSQGDREFQTEVSLLG 163
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
R+ H NLV L G+C++K ++L+ E+++N SL + + Y G+ + VL+W RL IALDI+
Sbjct: 164 RLHHRNLVNLTGYCVDKSHRMLIYEFMSNGSLENLL--YGGEGMQVLNWEERLQIALDIS 221
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS-IKG 180
+EYLH A PP+IHRD+KS+NILL AK+ADFGL K + R TS +KG
Sbjct: 222 HGIEYLHEGAVPPVIHRDLKSANILLDHSMRAKVADFGLSKEMVLD------RMTSGLKG 275
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVW 240
+ GY+D Y++T + KSD+YSFGV++LELIT + Q L E+ + + +
Sbjct: 276 THGYMDPTYISTNKYTMKSDIYSFGVIILELITAIHPQQ---NLMEYINLA--SMSPDGI 330
Query: 241 AQMLDPKLNGDANMEQLRVLIRIC 264
++LD KL G+A++E++R+L +I
Sbjct: 331 DEILDQKLVGNASIEEVRLLAKIA 354
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LX29|ACR4_ARATH Serine/threonine-protein kinase-like protein ACR4 OS=Arabidopsis thaliana GN=ACR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (444), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 103/269 (38%), Positives = 160/269 (59%), Gaps = 12/269 (4%)
Query: 2 YALEELKMATNDFRIR--IGVGATSFVYLAELGDGNFGAVKRVM--EERGGSRKIFLDEV 57
+ EEL+ A + F+ +G G+ S VY L DG AVKR + ++ + F E+
Sbjct: 500 FTYEELEKAADGFKEESIVGKGSFSCVYKGVLRDGTTVAVKRAIMSSDKQKNSNEFRTEL 559
Query: 58 SVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIA 117
+L R++H +L+ LLG+C E GE+LL+ E++A+ SL + +H L W R++IA
Sbjct: 560 DLLSRLNHAHLLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKALKEQLDWVKRVTIA 619
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
+ AR +EYLH A PP+IHRDIKSSNIL+ ++++A++ADFGL LGP D P +
Sbjct: 620 VQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPV-DSGSPLAELP 678
Query: 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQ---GSATLAEWTEECRRN 234
G+ GY+D Y +++TKSDVYSFGVLLLE+++G K+I + EW +
Sbjct: 679 -AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMHYEEGNIVEWAVPLIKA 737
Query: 235 KNVEVWAQMLDPKLNGDANMEQLRVLIRI 263
++ +LDP L + +E L+ ++ +
Sbjct: 738 GDINA---LLDPVLKHPSEIEALKRIVSV 763
|
Controls formative cell division in meristems, including root tips and lateral root initiation zones of the pericycle, in response to CLE40 signal. Acts with CLE40p peptide as a ligand-receptor pair in a signal transduction pathway, coordinating movement of the root tip and organization of cell divisions in the root meristem. Required during embryogenesis and development, probably for the differentiation of protoderm and epidermal cells. Involved in the regulation of cellular organization during the development of sepal margins and ovule integument outgrowth. Can phosphorylate ALE2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ7|Y4245_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g20450 OS=Arabidopsis thaliana GN=At4g20450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (443), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 105/269 (39%), Positives = 150/269 (55%), Gaps = 10/269 (3%)
Query: 1 TYALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVL 60
+Y EE+ + TN+F +G G VY + D AVK + E K F EV +L
Sbjct: 580 SYTYEEVAVITNNFERPLGEGGFGVVYHGNVNDNEQVAVKVLSESSAQGYKQFKAEVDLL 639
Query: 61 LRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
LRV H NLV L+G+C E +L+ EY++N +L + H S LSW NRL IA +
Sbjct: 640 LRVHHINLVTLVGYCDEGQHLVLIYEYMSNGNL--KQHLSGENSRSPLSWENRLRIAAET 697
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
A+ LEYLH PP+IHRDIKS NILL ++ AKL DFGL + P + T++ G
Sbjct: 698 AQGLEYLHIGCKPPMIHRDIKSMNILLDNNFQAKLGDFGLSRSFPVG--SETHVSTNVAG 755
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS---ATLAEWTEECRRNKNV 237
S GY+D Y T +++ KSDV+SFGV+LLE+IT I + + + EW N ++
Sbjct: 756 SPGYLDPEYYRTNWLTEKSDVFSFGVVLLEIITSQPVIDQTREKSHIGEWVGFKLTNGDI 815
Query: 238 EVWAQMLDPKLNGDANMEQLRVLIRICMA 266
+ ++DP +NGD + L + + M+
Sbjct: 816 K---NIVDPSMNGDYDSSSLWKALELAMS 841
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 6e-43, Method: Compositional matrix adjust.
Identities = 110/262 (41%), Positives = 152/262 (58%), Gaps = 17/262 (6%)
Query: 1 TYALEELKMATNDF--RIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVS 58
+ A++ELK T++F + IG G+ VY L G A+K++ + R+ FL +VS
Sbjct: 55 SIAVDELKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDRE-FLAQVS 113
Query: 59 VLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYG----QSLGVLSWSNRL 114
++ R+ N+V LLG+C++ G ++L EY N SL D +H G Q VLSW+ R+
Sbjct: 114 MVSRLKDENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRV 173
Query: 115 SIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174
IA+ A+ LEYLH +A P IIHRDIKSSNILL DD+ AK+ADF L P D
Sbjct: 174 KIAVGAAKGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAP--DMAARLH 231
Query: 175 QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSI-----QGSATLAEWTE 229
T + G+FGY Y TG +S+KSDVYSFGV+LLEL+TG K + +G +L W
Sbjct: 232 STRVLGTFGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291
Query: 230 ECRRNKNVEVWAQMLDPKLNGD 251
V+ Q +D +LN D
Sbjct: 292 PRLSEDKVK---QCVDARLNTD 310
|
A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (435), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 105/282 (37%), Positives = 163/282 (57%), Gaps = 30/282 (10%)
Query: 2 YALEELKMATNDFRIR--IGVGATSFVYLAELGDGNFGAVKRV------MEERGGSRKIF 53
Y + L++ATN F IG G+ VY AE +G A+K++ ++E F
Sbjct: 383 YTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDN----F 438
Query: 54 LDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNR 113
L+ VS + R+ HPN+V L G+C E G++LL+ EY+ N +L D +HT +S+ L+W+ R
Sbjct: 439 LEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMN-LTWNAR 497
Query: 114 LSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173
+ +AL A+ALEYLH P I+HR+ KS+NILL ++ + L+D GL L P +
Sbjct: 498 VKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAALTPNTE----- 552
Query: 174 RQ--TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAE----- 226
RQ T + GSFGY + +G + KSDVY+FGV++LEL+TG K + S T AE
Sbjct: 553 RQVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVR 612
Query: 227 WTEECRRNKNVEVWAQMLDPKLNG---DANMEQLRVLIRICM 265
W + +++ ++M+DP LNG ++ + +I +C+
Sbjct: 613 WATP--QLHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCI 652
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 172 bits (435), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 103/223 (46%), Positives = 136/223 (60%), Gaps = 10/223 (4%)
Query: 1 TYALEELKMATNDFR--IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVS 58
TYA EL +AT++F +IG G VY LG G A+KR E K FL E+
Sbjct: 614 TYA--ELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIE 671
Query: 59 VLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL 118
+L R+ H NLV LLGFC E+GEQ+L+ EY+ N +L D + + L ++ RL IAL
Sbjct: 672 LLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEP---LDFAMRLRIAL 728
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ--- 175
A+ + YLH++A+PPI HRDIK+SNILL AK+ADFGL +L P D Q
Sbjct: 729 GSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVS 788
Query: 176 TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSI 218
T +KG+ GY+D Y T ++ KSDVYS GV+LLEL TG++ I
Sbjct: 789 TVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPI 831
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 104/261 (39%), Positives = 147/261 (56%), Gaps = 17/261 (6%)
Query: 3 ALEELKMATNDF--RIRIGVGATSFVYLAELGDGNFGAVKRV-MEERGGSRKIFLDEVSV 59
+L+E+K T +F + IG G+ VY A L DG A+K++ + + FL +VS+
Sbjct: 57 SLDEVKEKTENFGSKALIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTEFLSQVSM 116
Query: 60 LLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYG----QSLGVLSWSNRLS 115
+ R+ H NL+ LLGFC++ ++L E+ SL D +H G Q L W R+
Sbjct: 117 VSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRVK 176
Query: 116 IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175
IA++ AR LEYLH ++ PP+IHRDI+SSN+LL +D AK+ADF L P N
Sbjct: 177 IAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARL--HS 234
Query: 176 TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSI-----QGSATLAEWTEE 230
T + G+FGY Y TG ++ KSDVYSFGV+LLEL+TG K + +G +L W
Sbjct: 235 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 294
Query: 231 CRRNKNVEVWAQMLDPKLNGD 251
V+ Q +DPKL D
Sbjct: 295 RLSEDKVK---QCIDPKLKAD 312
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 96/233 (41%), Positives = 139/233 (59%), Gaps = 13/233 (5%)
Query: 2 YALEELKMATNDFRIR--IGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSV 59
++ EEL T F + +G G VY L DG AVK++ G + F EV +
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 60 LLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALD 119
+ RV H +LV L+G+C+ +LL+ EY++N++L +H G+ L VL WS R+ IA+
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLH---GKGLPVLEWSKRVRIAIG 475
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
A+ L YLH P IIHRDIKS+NILL D+ A++ADFGL +L ND + T +
Sbjct: 476 SAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARL---NDTTQTHVSTRVM 532
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQ-----GSATLAEW 227
G+FGY+ Y ++G ++ +SDV+SFGV+LLEL+TG K + G +L EW
Sbjct: 533 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEW 585
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 266 | ||||||
| 296085467 | 323 | unnamed protein product [Vitis vinifera] | 0.984 | 0.811 | 0.813 | 1e-121 | |
| 359474751 | 368 | PREDICTED: receptor-like serine/threonin | 0.984 | 0.711 | 0.813 | 1e-121 | |
| 255557811 | 367 | serine-threonine protein kinase, plant-t | 0.981 | 0.711 | 0.802 | 1e-119 | |
| 224129952 | 368 | predicted protein [Populus trichocarpa] | 0.988 | 0.714 | 0.774 | 1e-116 | |
| 157101270 | 842 | receptor-like kinase [Closterium ehrenbe | 0.977 | 0.308 | 0.462 | 2e-56 | |
| 157101308 | 442 | receptor-like kinase [Nitella axillaris] | 0.981 | 0.590 | 0.417 | 2e-51 | |
| 115461490 | 673 | Os04g0689400 [Oryza sativa Japonica Grou | 0.966 | 0.381 | 0.419 | 1e-49 | |
| 125592152 | 988 | hypothetical protein OsJ_16721 [Oryza sa | 0.966 | 0.260 | 0.419 | 1e-49 | |
| 116311987 | 975 | H0814G11.12 [Oryza sativa Indica Group] | 0.966 | 0.263 | 0.419 | 1e-49 | |
| 218195874 | 673 | hypothetical protein OsI_18023 [Oryza sa | 0.966 | 0.381 | 0.419 | 1e-49 |
| >gi|296085467|emb|CBI29199.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1133), Expect = e-121, Method: Compositional matrix adjust.
Identities = 214/263 (81%), Positives = 238/263 (90%), Gaps = 1/263 (0%)
Query: 1 TYALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVL 60
TYALEELKMAT DFRIRIGVGATSFVYLAELGDG GAVKRVMEERGGS+K+FLDEVSVL
Sbjct: 25 TYALEELKMATTDFRIRIGVGATSFVYLAELGDGRLGAVKRVMEERGGSKKMFLDEVSVL 84
Query: 61 LRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
LR+SHPNLVGL+GFCLEKGEQLLLLEY+ NKSLFDRMHT+ GQS G+LSWSNRL+IALDI
Sbjct: 85 LRISHPNLVGLMGFCLEKGEQLLLLEYVPNKSLFDRMHTFRGQSEGILSWSNRLNIALDI 144
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
ARAL+YLHSQADPPIIHRD+KSSNILLID++HAKLADFGLCKLG +ND + T +KG
Sbjct: 145 ARALDYLHSQADPPIIHRDVKSSNILLIDNDHAKLADFGLCKLG-YNDRYGSQSPTIVKG 203
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVW 240
SFGYVDTNYL TG VS+KSDVYSFGVLLLELITGL+SIQ S TLAEWTEE R+N ++EV
Sbjct: 204 SFGYVDTNYLKTGHVSSKSDVYSFGVLLLELITGLRSIQDSTTLAEWTEEARKNDSIEVL 263
Query: 241 AQMLDPKLNGDANMEQLRVLIRI 263
+LDPKLNGD N+EQLRVL+ +
Sbjct: 264 VGLLDPKLNGDVNVEQLRVLMEV 286
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474751|ref|XP_002269362.2| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 439 bits (1129), Expect = e-121, Method: Compositional matrix adjust.
Identities = 214/263 (81%), Positives = 238/263 (90%), Gaps = 1/263 (0%)
Query: 1 TYALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVL 60
TYALEELKMAT DFRIRIGVGATSFVYLAELGDG GAVKRVMEERGGS+K+FLDEVSVL
Sbjct: 70 TYALEELKMATTDFRIRIGVGATSFVYLAELGDGRLGAVKRVMEERGGSKKMFLDEVSVL 129
Query: 61 LRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
LR+SHPNLVGL+GFCLEKGEQLLLLEY+ NKSLFDRMHT+ GQS G+LSWSNRL+IALDI
Sbjct: 130 LRISHPNLVGLMGFCLEKGEQLLLLEYVPNKSLFDRMHTFRGQSEGILSWSNRLNIALDI 189
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
ARAL+YLHSQADPPIIHRD+KSSNILLID++HAKLADFGLCKLG +ND + T +KG
Sbjct: 190 ARALDYLHSQADPPIIHRDVKSSNILLIDNDHAKLADFGLCKLG-YNDRYGSQSPTIVKG 248
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVW 240
SFGYVDTNYL TG VS+KSDVYSFGVLLLELITGL+SIQ S TLAEWTEE R+N ++EV
Sbjct: 249 SFGYVDTNYLKTGHVSSKSDVYSFGVLLLELITGLRSIQDSTTLAEWTEEARKNDSIEVL 308
Query: 241 AQMLDPKLNGDANMEQLRVLIRI 263
+LDPKLNGD N+EQLRVL+ +
Sbjct: 309 VGLLDPKLNGDVNVEQLRVLMEV 331
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255557811|ref|XP_002519935.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223540981|gb|EEF42539.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 432 bits (1112), Expect = e-119, Method: Compositional matrix adjust.
Identities = 211/263 (80%), Positives = 239/263 (90%), Gaps = 2/263 (0%)
Query: 1 TYALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVL 60
TYALEELKMAT DFRIRIGVGATSFVYLAELGDG FGAVKRVME+RGGS+KIFLDEVSVL
Sbjct: 70 TYALEELKMATKDFRIRIGVGATSFVYLAELGDGRFGAVKRVMEDRGGSKKIFLDEVSVL 129
Query: 61 LRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
LR+SHPNLVG++GFCLEK EQLLLLEY+ N+SLFDRMHTY GQS G+L+WSNRL+IALDI
Sbjct: 130 LRISHPNLVGMMGFCLEKREQLLLLEYVPNRSLFDRMHTYSGQSSGILTWSNRLNIALDI 189
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
ARAL+YLHSQADPPIIHRD+KSSNILLIDD++AKLADFGLCKLG ++ P + T+IKG
Sbjct: 190 ARALDYLHSQADPPIIHRDVKSSNILLIDDDNAKLADFGLCKLG-YDKPG-SQSPTTIKG 247
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVW 240
S GYVDT YL TG VS KSDVYS+GVLLLELITGLKSIQGS TLAEWTEECR+N +++V
Sbjct: 248 SVGYVDTTYLRTGLVSPKSDVYSYGVLLLELITGLKSIQGSVTLAEWTEECRKNDDIQVL 307
Query: 241 AQMLDPKLNGDANMEQLRVLIRI 263
A++LDPKL G+AN+ QLRVLI +
Sbjct: 308 AKILDPKLRGEANLFQLRVLIDV 330
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224129952|ref|XP_002328844.1| predicted protein [Populus trichocarpa] gi|222839142|gb|EEE77493.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1090), Expect = e-116, Method: Compositional matrix adjust.
Identities = 209/270 (77%), Positives = 238/270 (88%), Gaps = 7/270 (2%)
Query: 1 TYALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVL 60
TYALEELKMAT DFRIRIGVGATSFVYLA+LGDG FGAVKRVME+RGGS+KIFLDEVSVL
Sbjct: 64 TYALEELKMATRDFRIRIGVGATSFVYLADLGDGRFGAVKRVMEDRGGSKKIFLDEVSVL 123
Query: 61 LRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
LR+SHPNL L+GFCLEKGEQLLLLEY+ NK+LFDR+HTY+GQS G+LSWS+RLSIALDI
Sbjct: 124 LRISHPNLARLMGFCLEKGEQLLLLEYVPNKTLFDRIHTYHGQSSGILSWSSRLSIALDI 183
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN------RPKR 174
ARAL+YLHS+ADP IIHRD+KSSNILL+DD+HAKLADFGLCKLG ++ P+
Sbjct: 184 ARALDYLHSRADPTIIHRDVKSSNILLVDDDHAKLADFGLCKLG-YDRPDSETSTTPSTS 242
Query: 175 QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN 234
TSIKGSFGY+D NYLNTG + K DVYS+GVLLLELITGLKSIQGS TLAEWTEE R++
Sbjct: 243 PTSIKGSFGYIDINYLNTGLATPKIDVYSYGVLLLELITGLKSIQGSVTLAEWTEEWRKS 302
Query: 235 KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264
+VEVWA +LDPKLNG+AN+EQL VLI +
Sbjct: 303 DDVEVWANLLDPKLNGNANLEQLSVLIHVA 332
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|157101270|dbj|BAF79966.1| receptor-like kinase [Closterium ehrenbergii] | Back alignment and taxonomy information |
|---|
Score = 225 bits (573), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 124/268 (46%), Positives = 168/268 (62%), Gaps = 8/268 (2%)
Query: 2 YALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL 61
+ L E+K AT +++ IG G VY A L DGN AVKR+ + F+ EV +L
Sbjct: 462 FTLSEMKQATQNWQTVIGKGGYGTVYKAVLKDGNPVAVKRLDQVSKQGDVEFIREVELLS 521
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
RV H +LV L+GFC EKGE+ L+ EY+A SL++ +H + LSW +R IA+ +A
Sbjct: 522 RVHHRHLVNLVGFCAEKGERALVYEYMAMGSLYEHLHGESAKEY-PLSWDSRTKIAIHVA 580
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ-----T 176
+EYLH ADPP+IHRDIKS+NILL DD ++K+ADFGLCK P Q T
Sbjct: 581 LGIEYLHYGADPPLIHRDIKSANILLSDDGYSKVADFGLCKEAPIGAGQDGTEQLVPTAT 640
Query: 177 SIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN 236
+++GSFGY+D Y+NT +S KSDVYS+GV+LLEL+TG KSI LA W EE ++
Sbjct: 641 AVRGSFGYLDPEYVNTSILSEKSDVYSYGVVLLELLTGHKSIHEWQPLAYWAEEYLADR- 699
Query: 237 VEVWAQMLDPKLNGDANMEQLRVLIRIC 264
E M+DPKL G+ ++++L L I
Sbjct: 700 -EKTPLMVDPKLEGNFDLDELYALCDIA 726
|
Source: Closterium ehrenbergii Species: Closterium ehrenbergii Genus: Closterium Family: Closteriaceae Order: Desmidiales Class: Zygnemophyceae Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|157101308|dbj|BAF79985.1| receptor-like kinase [Nitella axillaris] | Back alignment and taxonomy information |
|---|
Score = 208 bits (529), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 111/266 (41%), Positives = 165/266 (62%), Gaps = 5/266 (1%)
Query: 1 TYALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVL 60
T+ L+ L+ AT DF IG G VY A L DG A+KR+ + R + F EV +
Sbjct: 89 TFRLKALRDATCDFTTVIGKGGFGTVYKAYLTDGTIAAIKRMDKGRKEGDEEFRKEVLMP 148
Query: 61 LRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
R+ H +LV L+GFC EKGE++L+LEY+AN SL + +H G L W R+ IA+ +
Sbjct: 149 GRLHHRHLVNLIGFCAEKGERMLVLEYMANGSLKEHLHDKRGPPL---DWQKRMRIAVGV 205
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
A LEYLHS +DPP+IHRD+KSSN+LL ++ AK++DFGLCK+ P T + G
Sbjct: 206 AAGLEYLHSWSDPPVIHRDVKSSNVLLSENFTAKVSDFGLCKVAPAGSDVITSMTTDVMG 265
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVW 240
+ GY+D Y+N ++ KSDV+S+GV+LLELITG ++Q +L +W + +K E
Sbjct: 266 TPGYMDPEYVNKHVLTEKSDVFSYGVVLLELITGRHAVQEWRSLVDWAQIFFLDK--EKV 323
Query: 241 AQMLDPKLNGDANMEQLRVLIRICMA 266
M+DP L + ++++L V++ + +
Sbjct: 324 PGMVDPALGDNYDLQELYVVVEVAQS 349
|
Source: Nitella axillaris Species: Nitella axillaris Genus: Nitella Family: Characeae Order: Charales Class: Charophyceae Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115461490|ref|NP_001054345.1| Os04g0689400 [Oryza sativa Japonica Group] gi|38345516|emb|CAE01800.2| OSJNBa0039K24.19 [Oryza sativa Japonica Group] gi|113565916|dbj|BAF16259.1| Os04g0689400 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 202 bits (514), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 110/262 (41%), Positives = 162/262 (61%), Gaps = 5/262 (1%)
Query: 2 YALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL 61
Y+ +E ATN+F IG G VY A+ DG+ AVKR+ + + + F E+ +L
Sbjct: 320 YSYKETMKATNNFSTVIGKGGFGTVYKAQFSDGSIAAVKRMDKVSRQAEEEFCREMELLA 379
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
R+ H +LV L GFC+E+ E+ L+ EY+AN SL D +H+ LSW +RL IA+D+A
Sbjct: 380 RLHHRHLVTLKGFCIERKERFLVYEYMANGSLKDHLHS---SGRKALSWQSRLQIAMDVA 436
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
ALEYLH +PP+ HRDIKSSNILL ++ AK+ADFGL + T I+G+
Sbjct: 437 NALEYLHFFCNPPLCHRDIKSSNILLDENFVAKVADFGLAHASRTGAISFEAVNTDIRGT 496
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWA 241
GY+D Y+ T ++ KSD+YS+GVLLLEL+TG ++IQ S L EW + + ++
Sbjct: 497 PGYMDPEYVITQELTEKSDIYSYGVLLLELVTGRRAIQDSRNLVEWAQG--HLSSGKITP 554
Query: 242 QMLDPKLNGDANMEQLRVLIRI 263
+ +DP + G +M+QL +++ I
Sbjct: 555 EFVDPTIRGLVDMDQLHLVVSI 576
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|125592152|gb|EAZ32502.1| hypothetical protein OsJ_16721 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 202 bits (514), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 110/262 (41%), Positives = 162/262 (61%), Gaps = 5/262 (1%)
Query: 2 YALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL 61
Y+ +E ATN+F IG G VY A+ DG+ AVKR+ + + + F E+ +L
Sbjct: 320 YSYKETMKATNNFSTVIGKGGFGTVYKAQFSDGSIAAVKRMDKVSRQAEEEFCREMELLA 379
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
R+ H +LV L GFC+E+ E+ L+ EY+AN SL D +H+ LSW +RL IA+D+A
Sbjct: 380 RLHHRHLVTLKGFCIERKERFLVYEYMANGSLKDHLHS---SGRKALSWQSRLQIAMDVA 436
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
ALEYLH +PP+ HRDIKSSNILL ++ AK+ADFGL + T I+G+
Sbjct: 437 NALEYLHFFCNPPLCHRDIKSSNILLDENFVAKVADFGLAHASRTGAISFEAVNTDIRGT 496
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWA 241
GY+D Y+ T ++ KSD+YS+GVLLLEL+TG ++IQ S L EW + + ++
Sbjct: 497 PGYMDPEYVITQELTEKSDIYSYGVLLLELVTGRRAIQDSRNLVEWAQG--HLSSGKITP 554
Query: 242 QMLDPKLNGDANMEQLRVLIRI 263
+ +DP + G +M+QL +++ I
Sbjct: 555 EFVDPTIRGLVDMDQLHLVVSI 576
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116311987|emb|CAJ86345.1| H0814G11.12 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 202 bits (514), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 110/262 (41%), Positives = 162/262 (61%), Gaps = 5/262 (1%)
Query: 2 YALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL 61
Y+ +E ATN+F IG G VY A+ DG+ AVKR+ + + + F E+ +L
Sbjct: 320 YSYKETMKATNNFSTVIGKGGFGTVYKAQFSDGSIAAVKRMDKVSRQAEEEFCREMELLA 379
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
R+ H +LV L GFC+E+ E+ L+ EY+AN SL D +H+ LSW +RL IA+D+A
Sbjct: 380 RLHHRHLVTLKGFCIERKERFLVYEYMANGSLKDHLHS---SGRKALSWQSRLQIAMDVA 436
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
ALEYLH +PP+ HRDIKSSNILL ++ AK+ADFGL + T I+G+
Sbjct: 437 NALEYLHFFCNPPLCHRDIKSSNILLDENFVAKVADFGLAHASRTGAISFEAVNTDIRGT 496
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWA 241
GY+D Y+ T ++ KSD+YS+GVLLLEL+TG ++IQ S L EW + + ++
Sbjct: 497 PGYMDPEYVITQELTEKSDIYSYGVLLLELVTGRRAIQDSRNLVEWAQG--HLSSGKITP 554
Query: 242 QMLDPKLNGDANMEQLRVLIRI 263
+ +DP + G +M+QL +++ I
Sbjct: 555 EFVDPTIRGLVDMDQLHLVVSI 576
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218195874|gb|EEC78301.1| hypothetical protein OsI_18023 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 202 bits (514), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 110/262 (41%), Positives = 162/262 (61%), Gaps = 5/262 (1%)
Query: 2 YALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL 61
Y+ +E ATN+F IG G VY A+ DG+ AVKR+ + + + F E+ +L
Sbjct: 320 YSYKETMKATNNFSTVIGKGGFGTVYKAQFSDGSIAAVKRMDKVSRQAEEEFCREMELLA 379
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
R+ H +LV L GFC+E+ E+ L+ EY+AN SL D +H+ LSW +RL IA+D+A
Sbjct: 380 RLHHRHLVTLKGFCIERKERFLVYEYMANGSLKDHLHS---SGRKALSWQSRLQIAMDVA 436
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
ALEYLH +PP+ HRDIKSSNILL ++ AK+ADFGL + T I+G+
Sbjct: 437 NALEYLHFFCNPPLCHRDIKSSNILLDENFVAKVADFGLAHASRTGAISFEAVNTDIRGT 496
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWA 241
GY+D Y+ T ++ KSD+YS+GVLLLEL+TG ++IQ S L EW + + ++
Sbjct: 497 PGYMDPEYVITQELTEKSDIYSYGVLLLELVTGRRAIQDSRNLVEWAQG--HLSSGKITP 554
Query: 242 QMLDPKLNGDANMEQLRVLIRI 263
+ +DP + G +M+QL +++ I
Sbjct: 555 EFVDPTIRGLVDMDQLHLVVSI 576
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 266 | ||||||
| TAIR|locus:2012191 | 693 | AT1G49730 [Arabidopsis thalian | 0.973 | 0.373 | 0.399 | 1.1e-44 | |
| TAIR|locus:2090634 | 663 | AT3G19300 [Arabidopsis thalian | 0.966 | 0.387 | 0.393 | 2.4e-44 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.793 | 0.217 | 0.472 | 5.5e-44 | |
| TAIR|locus:2172149 | 440 | CRLK1 "calcium/calmodulin-regu | 0.921 | 0.556 | 0.416 | 6.4e-44 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.939 | 0.487 | 0.419 | 4.5e-43 | |
| UNIPROTKB|O24585 | 901 | CR4 "Putative receptor protein | 0.966 | 0.285 | 0.390 | 2.3e-42 | |
| TAIR|locus:2143166 | 436 | CRLK2 "calcium/calmodulin-regu | 0.928 | 0.566 | 0.4 | 3.2e-42 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.917 | 0.645 | 0.409 | 4e-42 | |
| TAIR|locus:2081227 | 895 | CR4 "crinkly4" [Arabidopsis th | 0.966 | 0.287 | 0.382 | 4.8e-42 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.887 | 0.247 | 0.428 | 7.4e-42 |
| TAIR|locus:2012191 AT1G49730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 1.1e-44, P = 1.1e-44
Identities = 107/268 (39%), Positives = 158/268 (58%)
Query: 2 YALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL 61
++ +E+ ATNDF IG G VY AE DG AVK++ + + + F E+ +L
Sbjct: 347 FSYKEMTNATNDFNTVIGQGGFGTVYKAEFNDGLIAAVKKMNKVSEQAEQDFCREIGLLA 406
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
++ H NLV L GFC+ K E+ L+ +Y+ N SL D +H G+ SW R+ IA+D+A
Sbjct: 407 KLHHRNLVALKGFCINKKERFLVYDYMKNGSLKDHLHAI-GKPPP--SWGTRMKIAIDVA 463
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNH-AKLADFGLCKLGPFNDPNRPKRQTSIKG 180
ALEYLH DPP+ HRDIKSSNILL D+N AKL+DFGL T I+G
Sbjct: 464 NALEYLHFYCDPPLCHRDIKSSNILL-DENFVAKLSDFGLAHSSRDGSVCFEPVNTDIRG 522
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE--CRRNKNVE 238
+ GYVD Y+ T ++ KSDVYS+GV+LLELITG +++ L E ++ ++K++E
Sbjct: 523 TPGYVDPEYVVTQELTEKSDVYSYGVVLLELITGRRAVDEGRNLVEMSQRFLLAKSKHLE 582
Query: 239 VWAQMLDPKLN--GDANMEQLRVLIRIC 264
+ + +N G ++ + ++R+C
Sbjct: 583 LVDPRIKDSINDAGGKQLDAVVTVVRLC 610
|
|
| TAIR|locus:2090634 AT3G19300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 467 (169.5 bits), Expect = 2.4e-44, P = 2.4e-44
Identities = 103/262 (39%), Positives = 154/262 (58%)
Query: 2 YALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL 61
++ +E++ AT DF IG G VY AE +G AVK++ + + F E+ +L
Sbjct: 316 FSYKEIRKATEDFNAVIGRGGFGTVYKAEFSNGLVAAVKKMNKSSEQAEDEFCREIELLA 375
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
R+ H +LV L GFC +K E+ L+ EY+ N SL D +H+ LSW +R+ IA+D+A
Sbjct: 376 RLHHRHLVALKGFCNKKNERFLVYEYMENGSLKDHLHS---TEKSPLSWESRMKIAIDVA 432
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
ALEYLH DPP+ HRDIKSSNILL + AKLADFGL T I+G+
Sbjct: 433 NALEYLHFYCDPPLCHRDIKSSNILLDEHFVAKLADFGLAHASRDGSICFEPVNTDIRGT 492
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWA 241
GYVD Y+ T ++ KSDVYS+GV+LLE+ITG +++ L E ++ +++ +
Sbjct: 493 PGYVDPEYVVTHELTEKSDVYSYGVVLLEIITGKRAVDEGRNLVELSQPLLVSESRRI-- 550
Query: 242 QMLDPKLNGDANMEQLRVLIRI 263
++DP++ + EQL ++ +
Sbjct: 551 DLVDPRIKDCIDGEQLETVVAV 572
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 5.5e-44, P = 5.5e-44
Identities = 105/222 (47%), Positives = 142/222 (63%)
Query: 2 YALEELKMATNDFRI--RIGVGATSFVYLAELGDGNFGAVKRVME--ERGGSRKIFLDEV 57
++ EELK TN+F + +G G VY L DG+ A+KR + +GG F E+
Sbjct: 626 FSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGGLE--FKTEI 683
Query: 58 SVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIA 117
+L RV H NLVGL+GFC E+GEQ+L+ EY++N SL D + G+S L W RL +A
Sbjct: 684 ELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLT---GRSGITLDWKRRLRVA 740
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
L AR L YLH ADPPIIHRD+KS+NILL ++ AK+ADFGL KL +D + T
Sbjct: 741 LGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKL--VSDCTKGHVSTQ 798
Query: 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQ 219
+KG+ GY+D Y T ++ KSDVYSFGV+++ELIT + I+
Sbjct: 799 VKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIE 840
|
|
| TAIR|locus:2172149 CRLK1 "calcium/calmodulin-regulated receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 463 (168.0 bits), Expect = 6.4e-44, P = 6.4e-44
Identities = 107/257 (41%), Positives = 151/257 (58%)
Query: 2 YALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL 61
Y+ +L+ AT +F IG GA VY A++ G AVK + + K F EV +L
Sbjct: 103 YSYRDLQKATCNFTTLIGQGAFGPVYKAQMSTGEIVAVKVLATDSKQGEKEFQTEVMLLG 162
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
R+ H NLV L+G+C EKG+ +L+ Y++ SL + Y + LSW R+ IALD+A
Sbjct: 163 RLHHRNLVNLIGYCAEKGQHMLIYVYMSKGSLASHL---YSEKHEPLSWDLRVYIALDVA 219
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
R LEYLH A PP+IHRDIKSSNILL A++ADFGL + + K +I+G+
Sbjct: 220 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGT 274
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEV-W 240
FGY+D Y++T + KSDVY FGVLL ELI G QG L E E N +V W
Sbjct: 275 FGYLDPEYISTRTFTKKSDVYGFGVLLFELIAGRNPQQG---LMELVELAAMNAEEKVGW 331
Query: 241 AQMLDPKLNGDANMEQL 257
+++D +L+G +++++
Sbjct: 332 EEIVDSRLDGRYDLQEV 348
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 455 (165.2 bits), Expect = 4.5e-43, P = 4.5e-43
Identities = 112/267 (41%), Positives = 151/267 (56%)
Query: 1 TYALEELKMATNDFRIR--IGVGATSFVYLAELGD-GNFGAVKRVMEERG--GSRKIFLD 55
T+ EL AT +FR +G G VY L G AVK+ ++ G G+R+ FL
Sbjct: 70 TFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQ-LDRNGLQGNRE-FLV 127
Query: 56 EVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS 115
EV +L + HPNLV L+G+C + ++LL+ EY+ SL D +H L WS R++
Sbjct: 128 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDK-EPLDWSTRMT 186
Query: 116 IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175
IA A+ LEYLH +A+PP+I+RD+KSSNILL D H KL+DFGL KLGP D
Sbjct: 187 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDKTHVS-- 244
Query: 176 TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQ-----GSATLAEWTEE 230
T + G++GY Y TG ++ KSDVYSFGV+ LELITG K+I G L W
Sbjct: 245 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVAWARP 304
Query: 231 CRRNKNVEVWAQMLDPKLNGDANMEQL 257
+++ + +M DP L G M L
Sbjct: 305 LFKDRRK--FPKMADPSLQGRYPMRGL 329
|
|
| UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 457 (165.9 bits), Expect = 2.3e-42, P = 2.3e-42
Identities = 105/269 (39%), Positives = 166/269 (61%)
Query: 2 YALEELKMATNDFR--IRIGVGATSFVYLAELGDGNFGAVKRVMEERG--GSRKIFLDEV 57
++ EEL+ AT F ++G G+ S V+ L DG AVKR ++ S K F +E+
Sbjct: 493 FSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKEFHNEL 552
Query: 58 SVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIA 117
+L R++H +L+ LLG+C + E+LL+ E++A+ SL+ +H L+W+ R++IA
Sbjct: 553 DLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWARRVTIA 612
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
+ AR +EYLH A PP+IHRDIKSSNIL+ +D++A++ADFGL LGP D P +
Sbjct: 613 VQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGPA-DSGTPLSELP 671
Query: 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQ---GSATLAEWTEECRRN 234
G+ GY+D Y +++TKSDVYSFGV+LLE+++G K+I + EW
Sbjct: 672 A-GTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQFEEGNIVEWAVPLI-- 728
Query: 235 KNVEVWAQMLDPKLNGDANMEQLRVLIRI 263
K +++A +LDP L+ +++E L+ + +
Sbjct: 729 KAGDIFA-ILDPVLSPPSDLEALKKIASV 756
|
|
| TAIR|locus:2143166 CRLK2 "calcium/calmodulin-regulated receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 447 (162.4 bits), Expect = 3.2e-42, P = 3.2e-42
Identities = 106/265 (40%), Positives = 163/265 (61%)
Query: 2 YALEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVK-RVMEERGGSRKIFLDEVSVL 60
Y ++++ AT +F +G G+ VY A + +G A K G R+ F EVS+L
Sbjct: 104 YNYKDIQKATQNFTTVLGQGSFGPVYKAVMPNGELAAAKVHGSNSSQGDRE-FQTEVSLL 162
Query: 61 LRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
R+ H NLV L G+C++K ++L+ E+++N SL + + Y G+ + VL+W RL IALDI
Sbjct: 163 GRLHHRNLVNLTGYCVDKSHRMLIYEFMSNGSLENLL--YGGEGMQVLNWEERLQIALDI 220
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS-IK 179
+ +EYLH A PP+IHRD+KS+NILL AK+ADFGL K + R TS +K
Sbjct: 221 SHGIEYLHEGAVPPVIHRDLKSANILLDHSMRAKVADFGLSKEMVLD------RMTSGLK 274
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-VE 238
G+ GY+D Y++T + KSD+YSFGV++LELIT + Q L E+ + + ++
Sbjct: 275 GTHGYMDPTYISTNKYTMKSDIYSFGVIILELITAIHPQQN---LMEYINLASMSPDGID 331
Query: 239 VWAQMLDPKLNGDANMEQLRVLIRI 263
++LD KL G+A++E++R+L +I
Sbjct: 332 ---EILDQKLVGNASIEEVRLLAKI 353
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 446 (162.1 bits), Expect = 4.0e-42, P = 4.0e-42
Identities = 106/259 (40%), Positives = 147/259 (56%)
Query: 1 TYALEELKMATNDFRIR--IGVGATSFVYLAELGDGNFGAVKRVMEERG--GSRKIFLDE 56
T+ EL AT +FR IG G VY L + A + ++ G G+R+ FL E
Sbjct: 60 TFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNRE-FLVE 118
Query: 57 VSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI 116
V +L + HPNLV L+G+C + ++LL+ EY+ SL D +H L W+ R+ I
Sbjct: 119 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDI-SPGKQPLDWNTRMKI 177
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT 176
A A+ LEYLH + PP+I+RD+K SNILL DD KL+DFGL KLGP D + T
Sbjct: 178 AAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVS--T 235
Query: 177 SIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAE-----WTEEC 231
+ G++GY Y TG ++ KSDVYSFGV+LLE+ITG K+I S + E W
Sbjct: 236 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPL 295
Query: 232 RRNKNVEVWAQMLDPKLNG 250
+++ ++QM DP L G
Sbjct: 296 FKDRRK--FSQMADPMLQG 312
|
|
| TAIR|locus:2081227 CR4 "crinkly4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 454 (164.9 bits), Expect = 4.8e-42, P = 4.8e-42
Identities = 103/269 (38%), Positives = 160/269 (59%)
Query: 2 YALEELKMATNDFRIR--IGVGATSFVYLAELGDGNFGAVKRVM--EERGGSRKIFLDEV 57
+ EEL+ A + F+ +G G+ S VY L DG AVKR + ++ + F E+
Sbjct: 500 FTYEELEKAADGFKEESIVGKGSFSCVYKGVLRDGTTVAVKRAIMSSDKQKNSNEFRTEL 559
Query: 58 SVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIA 117
+L R++H +L+ LLG+C E GE+LL+ E++A+ SL + +H L W R++IA
Sbjct: 560 DLLSRLNHAHLLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKALKEQLDWVKRVTIA 619
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
+ AR +EYLH A PP+IHRDIKSSNIL+ ++++A++ADFGL LGP D P +
Sbjct: 620 VQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPV-DSGSPLAELP 678
Query: 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQ---GSATLAEWTEECRRN 234
G+ GY+D Y +++TKSDVYSFGVLLLE+++G K+I + EW +
Sbjct: 679 A-GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMHYEEGNIVEWAVPLIKA 737
Query: 235 KNVEVWAQMLDPKLNGDANMEQLRVLIRI 263
++ +LDP L + +E L+ ++ +
Sbjct: 738 GDINA---LLDPVLKHPSEIEALKRIVSV 763
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 453 (164.5 bits), Expect = 7.4e-42, P = 7.4e-42
Identities = 107/250 (42%), Positives = 151/250 (60%)
Query: 2 YALEELKMATNDFRIRIGVGATSF--VYLAELGDGNFGAVKRVMEE--RGGSRKIFLDEV 57
+ EELK T++F VG + VY L +G A+KR + +GG F E+
Sbjct: 619 FTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLE--FKTEI 676
Query: 58 SVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGV-LSWSNRLSI 116
+L RV H N+V LLGFC ++ EQ+L+ EY++N SL D + G+S G+ L W+ RL I
Sbjct: 677 ELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLS---GKS-GIRLDWTRRLKI 732
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT 176
AL + L YLH ADPPIIHRDIKS+NILL ++ AK+ADFGL KL DP + T
Sbjct: 733 ALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKL--VGDPEKTHVTT 790
Query: 177 SIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQ-GSATLAEWTEECRRNK 235
+KG+ GY+D Y T ++ KSDVY FGV+LLEL+TG I+ G + E + +++
Sbjct: 791 QVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIERGKYVVREVKTKMNKSR 850
Query: 236 NVEVWAQMLD 245
++ ++LD
Sbjct: 851 SLYDLQELLD 860
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 266 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-46
Identities = 73/198 (36%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRVM-EERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+G G VYLA G A+K + E+ + L E+ +L +++HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
++ L++EY SL D + G+ LS L I L I LEYLHS I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK----LSEDEILRILLQILEGLEYLHSN---GI 113
Query: 136 IHRDIKSSNILL-IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL-NTG 193
IHRD+K NILL D+ KLADFGL KL +I G+ Y+ L G
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLL--KTIVGTPAYMAPEVLLGKG 169
Query: 194 FVSTKSDVYSFGVLLLEL 211
+ S KSD++S GV+L EL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-44
Identities = 74/202 (36%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGS--RKIFLDEVSVLLRVSHPNLVGLLG 73
++G G+ VY A G G AVK + + S + E+ +L R+SHPN+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+K L++EY LFD + G LS IAL I R LEYLHS
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG 193
IIHRD+K NILL ++ K+ADFGL K + + T+ G+ Y+ L G
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL----TTFVGTPWYMAPEVLLGG 173
Query: 194 -FVSTKSDVYSFGVLLLELITG 214
K DV+S GV+L EL+TG
Sbjct: 174 NGYGPKVDVWSLGVILYELLTG 195
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 9e-43
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+G G+ VYLA + G A+K + ++ R+ L E+ +L ++ HPN+V L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
++ + L++EY LFD + S I ALEYLHS+ I
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-----FYLRQILSALEYLHSK---GI 118
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV------DTNY 189
+HRD+K NILL +D H KLADFGL + + ++ T+ G+ Y+ Y
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQL-----DPGEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
D++S GV+L EL+TG
Sbjct: 174 ------GKAVDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-41
Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 48/218 (22%)
Query: 18 IGVGATSFVYLAELGDGNFG-----AVKRVMEERGGS-RKIFLDEVSVLLRVSHPNLVGL 71
+G GA VY +L AVK + E+ + FL E ++ ++ HPN+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
LG C E+ +++EY+ L +Y ++ LS S+ LS AL IAR +EYL S+
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDL----LSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY-- 189
IHRD+ + N L+ ++ K++DFGL + Y D Y
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSR-------------------DLYDDDYYRK 160
Query: 190 --------------LNTGFVSTKSDVYSFGVLLLELIT 213
L G ++KSDV+SFGVLL E+ T
Sbjct: 161 RGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 6e-40
Identities = 69/218 (31%), Positives = 100/218 (45%), Gaps = 47/218 (21%)
Query: 18 IGVGATSFVYLAELGDGNFG-----AVKRVMEERGGS-RKIFLDEVSVLLRVSHPNLVGL 71
+G GA VY L G AVK + E+ + FL E ++ ++ HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
LG C E+ ++++EY+ L D + LS S+ LS AL IAR +EYL S+
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY-- 189
IHRD+ + N L+ ++ K++DFGL + Y D Y
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSR-------------------DLYDDDYYKV 161
Query: 190 --------------LNTGFVSTKSDVYSFGVLLLELIT 213
L G ++KSDV+SFGVLL E+ T
Sbjct: 162 KGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-39
Identities = 71/215 (33%), Positives = 104/215 (48%), Gaps = 34/215 (15%)
Query: 18 IGVGATSFVYLAELGDGNFG----AVKRVMEE-RGGSRKIFLDEVSVLLRVSHPNLVGLL 72
+G GA VY +L + AVK + E+ RK FL E V+ ++ HPN+V LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 73 GFCLEKGEQLLLLEYLANKSLFD----RMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
G C E+ L+LEY+ L D + LS + LS A+ IA+ +EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT----------SI 178
S+ +HRD+ + N L+ +D K++DFGL + +D R K S+
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 179 KGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
K D + ++KSDV+SFGVLL E+ T
Sbjct: 180 K------DGIF------TSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-38
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 50/215 (23%)
Query: 30 ELGDGNFGAVKR-VMEERGGSRKI------------------FLDEVSVLLRVSHPNLVG 70
+LG+G FG V + ++ G + FL+E S++ ++SHPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
LLG C + ++ EY+ L D + + L+ + L +AL IA+ +EYL S+
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR----KHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT----------SIK- 179
+HRD+ + N L+ ++ K++DFGL + +D R + S+K
Sbjct: 122 ---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
G F ++KSDV+SFGVLL E+ T
Sbjct: 179 GKF-------------TSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-35
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 18 IGVGATSFVYLAELGD-GNFGAVKRVMEERGGSRKI--FLDEVSVLLRVSHPNLVGLLGF 74
+G G+ VYLA D G AVK V ++ E+ +L + HPN+V G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 75 CLEKGEQ--LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
++ + + LEY++ SL + + G L I L YLHS
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSNG- 121
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT 192
I+HRDIK +NIL+ D KLADFG K D + S++G+ ++ +
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAKR--LGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 193 GFVSTKSDVYSFGVLLLELITG 214
+D++S G ++E+ TG
Sbjct: 178 EEYGRAADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-32
Identities = 66/196 (33%), Positives = 100/196 (51%), Gaps = 28/196 (14%)
Query: 29 AELGDGNFGAVK-----------RVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE 77
A +G G FG V + +++ + + FL E SV+ + HPNLV LLG L+
Sbjct: 12 ATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLG--VLSWSNRLSIALDIARALEYLHSQADPPI 135
++ EY+A SL D Y +S G V++ + +L ALD+ +EYL +
Sbjct: 72 GNPLYIVTEYMAKGSLVD-----YLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---F 123
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV 195
+HRD+ + N+L+ +D AK++DFGL K + Q S K + L
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKF 176
Query: 196 STKSDVYSFGVLLLEL 211
STKSDV+SFG+LL E+
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-30
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 13 DFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
F I +IG G VY A G A+K + E ++ ++E+ +L + HPN+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
G L+K E +++E+ + SL D + + + L+ S + ++ + LEYLHS
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKS----TNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY----- 184
IIHRDIK++NILL D KL DFGL +D R T + G+ +
Sbjct: 117 NG---IIHRDIKAANILLTSDGEVKLIDFGLSA--QLSD--TKARNTMV-GTPYWMAPEV 168
Query: 185 -VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y K+D++S G+ +EL G
Sbjct: 169 INGKPY------DYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 6e-29
Identities = 77/219 (35%), Positives = 109/219 (49%), Gaps = 26/219 (11%)
Query: 24 SFVYLAELGDGNFGAVKRVMEERGGSRKI--------------FLDEVSVLLRVSHP-NL 68
S+ L +LG+G+FG V + + + K+ FL E+ +L ++HP N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
V L F ++G L++EY+ SL D + G LS S L I I ALEYLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIG--RKGPLSESEALFILAQILSALEYLH 118
Query: 129 SQADPPIIHRDIKSSNILL-IDDNHAKLADFGLCKLGPFNDPNRPKRQ--TSIKGSFGYV 185
S+ IIHRDIK NILL D KL DFGL KL P ++ G+ GY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 186 DTNYL---NTGFVSTKSDVYSFGVLLLELITGLKSIQGS 221
L + + S+ SD++S G+ L EL+TGL +G
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-27
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRV--MEERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
IG GA VY L G+F A+K++ + + + K + E+ +L + HPN+V +G
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTY--YGQSLGVLSWSNRLSIALDIA---RALEYLHS 129
++LEY N SL + + + +SL +A+ + + L YLH
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESL----------VAVYVYQVLQGLAYLHE 117
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
Q +IHRDIK++NIL D KLADFG+ + S+ G+ ++
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD----ASVVGTPYWMAPEV 170
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
+ ST SD++S G ++EL+TG
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 51/222 (22%)
Query: 13 DFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
+IG GA+ VY A + G A+K+ M R ++++ ++E+ ++ HPN+V
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKK-MRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSN-RLS------IALDIARAL 124
L E +++EY+ SL D +++ + R++ + ++ + L
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTD-----------IITQNFVRMNEPQIAYVCREVLQGL 129
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDPNRPKRQTS------ 177
EYLHSQ +IHRDIKS NILL D KLADFG +L + KR +
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT----KEKSKRNSVVGTPYW 182
Query: 178 -----IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
IK +Y K D++S G++ +E+ G
Sbjct: 183 MAPEVIKRK------DY------GPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 22 ATSFVYLAELGDGNFGAVK------------RVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
+ +L ELG G FG V +++ E S F++E V++++SHPNLV
Sbjct: 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L G C ++ ++ EY+AN L + Y + G L L + D+ A+EYL S
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLN----YLRERKGKLGTEWLLDMCSDVCEAMEYLES 118
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS---FGYVD 186
IHRD+ + N L+ +DN K++DFGL + +D + TS +G+ +
Sbjct: 119 NG---FIHRDLAARNCLVGEDNVVKVSDFGLARY-VLDD-----QYTSSQGTKFPVKWAP 169
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELITGLK 216
+ S+KSDV+SFGVL+ E+ + K
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-25
Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
IGVGAT+ VY A L + A+KR+ +E+ S EV + + +HPN+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
+ E L++ YL+ SL D M + Y G L + ++ ++ + LEYLHS
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN--TG 193
IHRDIK+ NILL +D K+ADFG+ K + + G+ ++ + G
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 194 FVSTKSDVYSFGVLLLELITG 214
+ K+D++SFG+ +EL TG
Sbjct: 184 Y-DFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 1e-24
Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAV----KRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
+G G+ V L + G A+ K+ + +R E ++L R++HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKLH 59
Query: 73 GFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLS-WSNRLSIALDIARALEYLHSQ 130
+ + E+L L+LEY LF + G S R A +I ALEYLHS
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHL-----SKEGRFSEERARFYAA-EIVLALEYLHSL 112
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
II+RD+K NILL D H KL DFGL K + R + G+ Y+ L
Sbjct: 113 G---IIYRDLKPENILLDADGHIKLTDFGLAKEL----SSEGSRTNTFCGTPEYLAPEVL 165
Query: 191 NTGFVSTKSDVYSFGVLLLELITGL 215
D +S GVLL E++TG
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 1e-23
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 37/213 (17%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRV----MEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
IG G+ VYL DG +K + M E+ R+ L+EV +L +++HPN++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK--EREDALNEVKILKKLNHPNIIKYY 65
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYY--GQSLG---VLSWSNRLSIALDIARALEYL 127
EKG+ +++EY L ++ G+ +L W + + AL+YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF------VQLCLALKYL 119
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV-- 185
HS+ I+HRDIK NI L + KL DFG+ K+ + +T + G+ Y+
Sbjct: 120 HSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSS-TVDLAKTVV-GTPYYLSP 172
Query: 186 ----DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ Y + KSD++S G +L EL T
Sbjct: 173 ELCQNKPY------NYKSDIWSLGCVLYELCTL 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-23
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKI-FLDEVSVLLRVSHPNLVGLLGFC 75
+IG G VY L AVK K FL E +L + HPN+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
++K +++E + SL T+ + L+ L ++LD A +EYL S+
Sbjct: 62 VQKQPIYIVMELVPGGSLL----TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKL--GPFNDPNRPKRQTSIKGSFGYVDTNYLNTG 193
IHRD+ + N L+ ++N K++DFG+ + G + +Q IK + LN G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK----WTAPEALNYG 170
Query: 194 FVSTKSDVYSFGVLLLELITG 214
+++SDV+S+G+LL E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-23
Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 28/203 (13%)
Query: 30 ELGDGNFGAVKRVMEERGGSRKI------------------FLDEVSVLLRVSHPNLVGL 71
+LGDG+FG V+R G + I FL E +++ + H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 72 LGFCLEKGEQLLLLEYLAN-KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
G L L+++ LA SL DR+ +LG S A+ IA + YL S+
Sbjct: 62 YGVVLTH--PLMMVTELAPLGSLLDRLRK---DALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
IHRD+ + NILL D+ K+ DFGL + P N+ + + +K F + L
Sbjct: 117 R---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY-VMEEHLKVPFAWCAPESL 172
Query: 191 NTGFVSTKSDVYSFGVLLLELIT 213
T S SDV+ FGV L E+ T
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-22
Identities = 67/222 (30%), Positives = 117/222 (52%), Gaps = 28/222 (12%)
Query: 29 AELGDGNFGAV--KRVMEERGGSRKI--------FLDEVSVLLRVSHPNLVGLLGFCLEK 78
+G+G FGAV ++ + I FL+E +V+ ++ H NLV LLG L
Sbjct: 12 EIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71
Query: 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHR 138
G +++ E ++ +L + + T G++L +S L +LD+A +EYL S+ ++HR
Sbjct: 72 GLYIVM-ELMSKGNLVNFLRTR-GRAL--VSVIQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 139 DIKSSNILLIDDNHAKLADFGLCKLGPFN-DPNR-PKRQTSIKGSFGYVDTNYLNTGFVS 196
D+ + NIL+ +D AK++DFGL ++G D ++ P + T+ + L S
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEA---------LKHKKFS 175
Query: 197 TKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVE 238
+KSDV+S+GVLL E+ + ++ +L E E + +E
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME 217
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 1e-22
Identities = 68/234 (29%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 12 NDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFL----------DEVS 58
+DF+ IG G+ S V LA E A+K + K L E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKIEKE 53
Query: 59 VLLRVS-HPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI 116
VL R++ HP ++ L + + E L +LEY N L + Y +
Sbjct: 54 VLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-----Y 107
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN------ 170
A +I ALEYLHS+ IIHRD+K NILL D H K+ DFG K+ N
Sbjct: 108 AAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 171 ------RPKRQTSIKGSF-G---YVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ ++ SF G YV LN SD+++ G ++ +++TG
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-22
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 24 SFVYLAELGDGNFG-------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVG 70
S +LG G FG AVK ++ S + FL E ++ ++ H LV
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVK-TLKPGTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
L C E+ ++ EY++ SL D + + G+ L + + +A IA + YL S+
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL---PQLVDMAAQIAEGMAYLESR 122
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS---IKGSFGYVDT 187
IHRD+ + NIL+ ++ K+ADFGL +L D R+ + IK +
Sbjct: 123 N---YIHRDLAARNILVGENLVCKIADFGLARL--IEDDEYTAREGAKFPIK----WTAP 173
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELIT 213
N G + KSDV+SFG+LL E++T
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-22
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 40/208 (19%)
Query: 30 ELGDGNFGAVKR-VMEERGGSR-----------------KIFLDEVSVLLRVSHPNLVGL 71
ELG GNFG+V + V + G K FL E SV+ ++ HP +V L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 72 LGFCLEKGEQLLLLEYLA-----NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
+G C KGE L+L+ LA K L R + A +A + Y
Sbjct: 62 IGVC--KGEPLMLVMELAPLGPLLKYLKKRREI---PVSDLKEL------AHQVAMGMAY 110
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK-LGPFNDPNRPKRQTSIKGSFGYV 185
L S+ +HRD+ + N+LL++ + AK++DFG+ + LG +D R T+ + +
Sbjct: 111 LESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA--TTAGRWPLKWY 165
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+N G S+KSDV+S+GV L E +
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-22
Identities = 68/193 (35%), Positives = 100/193 (51%), Gaps = 26/193 (13%)
Query: 31 LGDGNFGAVKRVMEERG-----------GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE-K 78
+G G FG V + + RG + + FL E SV+ ++ H NLV LLG +E K
Sbjct: 14 IGKGEFGDVM-LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHR 138
G ++ EY+A SL D + + G+S VL L +LD+ A+EYL + +HR
Sbjct: 73 GGLYIVTEYMAKGSLVDYLRSR-GRS--VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 139 DIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTK 198
D+ + N+L+ +DN AK++DFGL K Q + K + L STK
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 199 SDVYSFGVLLLEL 211
SDV+SFG+LL E+
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 7e-22
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 12 NDFRI--RIGVGATSFVYLAEL-GDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPN 67
+D +G G++ VY G A+K++ ++ RK L E+ L P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+V G ++GE ++LEY+ SL D + VL+ IA I + L+YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYL 115
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
H++ IIHRDIK SN+L+ K+ADFG+ K + + T + G+ Y+
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISK---VLENTLDQCNTFV-GTVTYMSP 169
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITG 214
+ S +D++S G+ LLE G
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALG 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-21
Identities = 58/205 (28%), Positives = 106/205 (51%), Gaps = 24/205 (11%)
Query: 16 IRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
++IG G+T V +A + G AVK++ + R++ +EV ++ HPN+V +
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 75 CLEKGEQLLLLEYLANKSLFD-----RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L E +++E+L +L D RM+ ++ L + +AL +LH+
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTRMNE-----------EQIATVCLAVLKALSFLHA 133
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
Q +IHRDIKS +ILL D KL+DFG C + P+R+ S+ G+ ++
Sbjct: 134 QG---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSK-EVPRRK-SLVGTPYWMAPEV 186
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
++ T+ D++S G++++E++ G
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-21
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 27 YLAELGDGNFG------------------AVKRVMEERGG-SRKIFLDEVSVLLRVSHPN 67
++ +LG+G+FG AVK + R F E+ +L + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 68 LVGLLGFCLEKGEQ--LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE 125
+V G C + G + L++EYL + SL D + + Q ++ L + I + ++
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQICKGMD 123
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP---NRPKRQTSIKGSF 182
YL SQ IHRD+ + NIL+ ++ K++DFGL K+ P + + ++ I F
Sbjct: 124 YLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---F 177
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
Y L T S+ SDV+SFGV L EL T
Sbjct: 178 WYA-PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 6e-21
Identities = 51/154 (33%), Positives = 73/154 (47%), Gaps = 28/154 (18%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGS----RKIFLD------------EVSVLLRVSHPNL 68
+ L +LG+G +G V + +++ G +KI LD E+S+L + HPN+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 69 VGLLGFCLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
V LL + + L+ EY K D+ G LS + SI + R L Y
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRP-------GPLSPNLIKSIMYQLLRGLAY 113
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160
HS I+HRD+K NIL+ D KLADFGL
Sbjct: 114 CHSHR---ILHRDLKPQNILINRDGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-20
Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 22/196 (11%)
Query: 30 ELGDGNFGAVK------------RVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE 77
E+G G FG V + + E S + F++E V++++SHP LV L G C E
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIH 137
+ L+ E++ + L D + G S L + LD+ + YL S +IH
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 138 RDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVST 197
RD+ + N L+ ++ K++DFG+ + F ++ T K + + S+
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTR---FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 198 KSDVYSFGVLLLELIT 213
KSDV+SFGVL+ E+ +
Sbjct: 181 KSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 5e-20
Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 26/205 (12%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+IG GA+ VY A ++ G A+K++ ++ +++ ++E+ V+ HPN+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
L E +++EYLA SL D + T G ++ ++ + +ALE+LHS +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIA-----AVCRECLQALEFLHSNQ---V 136
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV 195
IHRDIKS NILL D KL DFG C P + KR T V T Y V
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQ---ITPEQSKRST-------MVGTPYWMAPEV 186
Query: 196 ST------KSDVYSFGVLLLELITG 214
T K D++S G++ +E++ G
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-20
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 27 YLAELGDGNFGAVK------------RVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
++ ELG G FG V + + E S + F++E V++++SHP LV L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP 134
C ++ ++ E++ N L + Y Q G LS LS+ D+ +EYL +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLN----YLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--- 120
Query: 135 IIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGF 194
IHRD+ + N L+ K++DFG+ + + + + K + N
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTR---YVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 195 VSTKSDVYSFGVLLLELIT 213
S+KSDV+SFGVL+ E+ T
Sbjct: 178 YSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-20
Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 27 YLAELGDGNFG------------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNL 68
++ +LG GNFG AVK++ + F E+ +L + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 69 VGLLGFCLEKG--EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
V G C G L++EYL SL D Y + L L A I + +EY
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRD----YLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
L S+ +HRD+ + NIL+ +N K+ DFGL K+ P + R+ F Y
Sbjct: 124 LGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ + F S SDV+SFGV+L EL T
Sbjct: 181 ESLTESKF-SVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-19
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 30/227 (13%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVM--EERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
+IG G VY A + G A+K++ E G K L E+ +L ++HPN++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 74 FCLEKGEQLLLLEYL-ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
KG+ L+ E++ + + L S S + + L + HS
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQR------GLPESLIKSYLYQLLQGLAFCHSHG- 118
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY--- 189
I+HRD+K N+L+ + KLADFGL + F P RP YV T +
Sbjct: 119 --ILHRDLKPENLLINTEGVLKLADFGLARS--FGSPVRPYTH--------YVVTRWYRA 166
Query: 190 ----LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232
L ST D++S G + EL++ G + + + + R
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFR 213
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-19
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 43/214 (20%)
Query: 24 SFVYLAELGDGNFGAVKRVMEERGGS---------------RKIFLDEVSVLLRVSHPNL 68
YL ELG GN G V +V+ G +K L E+ +L + + P +
Sbjct: 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYI 61
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLG--VLSWSNRLSIALDIARALEY 126
VG G G+ + +EY+ SL D++ + +L IA+ + + L Y
Sbjct: 62 VGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILG-----KIAVAVLKGLTY 115
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
LH + IIHRD+K SNIL+ KL DFG+ + S+ +F V
Sbjct: 116 LHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSG----------QLVNSLAKTF--VG 161
Query: 187 TNY------LNTGFVSTKSDVYSFGVLLLELITG 214
T+ + S KSD++S G+ L+EL TG
Sbjct: 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 33/209 (15%)
Query: 23 TSFVYLAELGDGNFG-------------AVKRV----MEERGGSRKIFLDEVSVLLRVSH 65
TS L +LG G FG AVK + M+ K FL E ++ ++ H
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-----KDFLAEAQIMKKLRH 60
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE 125
P L+ L C + ++ E + SL + + G L + +A +A +
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMA 117
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN-RPKRQTSIKGSFGY 184
YL +Q IHRD+ + N+L+ ++N K+ADFGL ++ + R + IK +
Sbjct: 118 YLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK----W 170
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
S KSDV+SFG+LL E++T
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-19
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 27 YLAELGDGNFGAVK------------RVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
+L ELG G FG VK ++++E S F++E V++++SH LV L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP 134
C ++ ++ EY++N L Y + S L + D+ + YL S+
Sbjct: 68 CTKQRPIYIVTEYMSNGCLL----NYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--- 120
Query: 135 IIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS---FGYVDTNYLN 191
IHRD+ + N L+ D K++DFGL + +D TS GS + L
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRY-VLDD-----EYTSSVGSKFPVRWSPPEVLL 174
Query: 192 TGFVSTKSDVYSFGVLLLELIT 213
S+KSDV++FGVL+ E+ +
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-19
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 47/217 (21%)
Query: 31 LGDGNFGAVKRVMEERGGSR-----------------KIFLDEVSVLLRVS-HPNLVGLL 72
+G+GNFG V R M ++ G + + F E+ VL ++ HPN++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTY--------YGQSLGV---LSWSNRLSIALDIA 121
G C +G + +EY +L D + + + G L+ L A D+A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
++YL ++ IHRD+ + N+L+ ++ +K+ADFGL + + +K +
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----------GEEVYVKKT 176
Query: 182 FGYVDTNY-----LNTGFVSTKSDVYSFGVLLLELIT 213
G + + LN +TKSDV+SFGVLL E+++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-19
Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 16 IRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
I+IG G+T V +A E G AVK++ + R++ +EV ++ H N+V +
Sbjct: 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 75 CLEKGEQLLLLEYLANKSLFDRM-HTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
L E +++E+L +L D + HT + ++ L + RAL YLH+Q
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQG-- 138
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG 193
+IHRDIKS +ILL D KL+DFG C PKR+ S+ G+ ++ ++
Sbjct: 139 -VIHRDIKSDSILLTSDGRIKLSDFGFCAQ---VSKEVPKRK-SLVGTPYWMAPEVISRL 193
Query: 194 FVSTKSDVYSFGVLLLELITG 214
T+ D++S G++++E+I G
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-19
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 25 FVYLAELGDGNFG-------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
F +LG G FG A+K + + ++ F EV L R+ H +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
C ++ E + SL + + GQ L V ++ + +A +A + YL Q
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV---ASLIDMACQVAEGMAYLEEQN 124
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKL--GPF---NDPNRPKRQTSIKGSFGYVD 186
IHRD+ + NIL+ +D K+ADFGL +L +D P + T+ +
Sbjct: 125 ---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEA------ 175
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ G STKSDV+SFG+LL E+ T
Sbjct: 176 ---ASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-19
Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 22/196 (11%)
Query: 30 ELGDGNFGAV------------KRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE 77
+LG G FG V + +++ S + FL E +++ ++ HP LV L +
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIH 137
+ ++ EY+ N SL D + T G L + + + +A IA + ++ + IH
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTI---NKLIDMAAQIAEGMAFIERKN---YIH 125
Query: 138 RDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVST 197
RD++++NIL+ + K+ADFGL +L + N + K + +N G +
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL---IEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 198 KSDVYSFGVLLLELIT 213
KSDV+SFG+LL E++T
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-19
Identities = 67/211 (31%), Positives = 94/211 (44%), Gaps = 31/211 (14%)
Query: 30 ELGDGNFG------------------AVKRVMEERGGS-RKIFLDEVSVLLRVSHPNLVG 70
LG+G+FG AVK + E G + E+++L + H N+V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 71 LLGFCLEKGEQ--LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
G C E+G + L++EY+ SL D + + L+ + L A I + YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLH 124
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
SQ IHRD+ + N+LL +D K+ DFGL K P R+ F Y
Sbjct: 125 SQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-VE 180
Query: 189 YLNTGFVSTKSDVYSFGVLLLELITGLKSIQ 219
L S SDV+SFGV L EL+T S Q
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRVM------EERGGSRKIFLDEVSVLLRVSHPNLVG 70
+G G+ VY L DG+F AVK V + +++ E+++L ++ HPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE-QEIALLSKLQHPNIVQ 66
Query: 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
LG E+ + LE + SL + Y V+ R I LEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLHDR 121
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
+HRDIK +NIL+ + KLADFG+ K + S KGS ++ +
Sbjct: 122 N---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK-----SFKGSPYWMAPEVI 173
Query: 191 N-TGFVSTKSDVYSFGVLLLELITG 214
G +D++S G +LE+ TG
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATG 198
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 71/210 (33%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV-ME-ERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
RIG G VY A + G A+K+V M+ ER G L E+++LL + HPN+V L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 74 FCLEKGEQL----LLLEY----LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE 125
+ G+ L L++EY LA SL D M T S S + L + R L+
Sbjct: 74 VVV--GKHLDSIFLVMEYCEQDLA--SLLDNMPT-------PFSESQVKCLMLQLLRGLQ 122
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
YLH IIHRD+K SN+LL D K+ADFGL + + P +P + + Y
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVV--TLWYR 175
Query: 186 DTNYLNTGFVSTKS-DVYSFGVLLLELITG 214
L T + D+++ G +L EL+
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-18
Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 43/224 (19%)
Query: 17 RIGVGATSFVYLAE-LGDGNFGAVKRV-ME-ERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
+IG G VY A G A+K++ ME E+ G + E+ +L ++ HPN+V L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 74 FCLEK--GEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
K G ++ EY+ + L + + + + S + L+YLHS
Sbjct: 66 IVTSKGKGSIYMVFEYMDHDLTGL---LDSPEVK----FTESQIKCYMKQLLEGLQYLHS 118
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS------------ 177
I+HRDIK SNIL+ +D KLADFGL + P+ N T+
Sbjct: 119 NG---ILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSA-DYTNRVITLWYRPPEL 172
Query: 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS 221
+ G+ T Y + D++S G +L EL G QGS
Sbjct: 173 LLGA-----TRY------GPEVDMWSVGCILAELFLGKPIFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 2e-18
Identities = 61/199 (30%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+IG GA+ VY A ++ G A+K++ ++ +++ ++E+ V+ +PN+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
L E +++EYLA SL D + T G ++ ++ + +AL++LHS +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIA-----AVCRECLQALDFLHSNQ---V 136
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV 195
IHRDIKS NILL D KL DFG C P + KR T + G+ ++ +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQ---ITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 196 STKSDVYSFGVLLLELITG 214
K D++S G++ +E++ G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 47/217 (21%)
Query: 31 LGDGNFGAVKRVMEERGGSR-----------------KIFLDEVSVLLRVS-HPNLVGLL 72
+G+GNFG V + ++ G R + F E+ VL ++ HPN++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMH-----------TYYGQSLGVLSWSNRLSIALDIA 121
G C +G L +EY + +L D + + LS L A D+A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
R ++YL + IHRD+ + NIL+ ++ AK+ADFGL + ++ +K +
Sbjct: 135 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYVKKT 181
Query: 182 FGYVDTNY-----LNTGFVSTKSDVYSFGVLLLELIT 213
G + + LN +T SDV+S+GVLL E+++
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 2e-18
Identities = 57/199 (28%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+IG GA+ V+ A ++ G A+K++ ++ +++ ++E+ V+ + +PN+V L
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
L E +++EYLA SL D + + + + ++ + +ALE+LH+ +
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLHANQ---V 136
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV 195
IHRDIKS N+LL D KL DFG C P + KR T + G+ ++ +
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQ---ITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 196 STKSDVYSFGVLLLELITG 214
K D++S G++ +E++ G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-18
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 40/218 (18%)
Query: 27 YLAELGDGNFG-------------------AVKRVMEERGGS-RKIFLDEVSVLLRVSHP 66
+L ELG+G FG A+K + E ++ F E ++ + HP
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRM-----HTYYGQSLG------VLSWSNRLS 115
N+V LLG C ++ +L EYLA+ L + + H+ G G L S+ L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 116 IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR--PK 173
IA+ IA +EYL S +HRD+ + N L+ + K++DFGL + D R K
Sbjct: 129 IAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLEL 211
++ ++ + G +T+SD++SFGV+L E+
Sbjct: 186 SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-18
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 45/210 (21%)
Query: 31 LGDGNFGAVKR-----------------VMEERGG--SRKIFLDEVSVLLRVSHPNLVGL 71
LG G FG V + V+ E + K LDE V+ V HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 72 LGFCLEKGEQLLLL-EYLANKSLFD--RMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
LG CL Q+ L+ + + L D R H S +L+W + IA+ + YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSYLE 126
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
+ ++HRD+ + N+L+ H K+ DFGL KL ++ G V
Sbjct: 127 ---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE-------KEYHAEGGKVPIK 176
Query: 189 YL-----NTGFVSTKSDVYSFGVLLLELIT 213
++ + KSDV+S+GV + EL+T
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-18
Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 16 IRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
I+IG G+T V +A E G AVK + + R++ +EV ++ H N+V +
Sbjct: 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP 134
L E +L+E+L +L D + S L+ ++ + +AL YLHSQ
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIV------SQTRLNEEQIATVCESVLQALCYLHSQG--- 137
Query: 135 IIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGF 194
+IHRDIKS +ILL D KL+DFG C + PKR+ S+ G+ ++ ++
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQ---ISKDVPKRK-SLVGTPYWMAPEVISRTP 193
Query: 195 VSTKSDVYSFGVLLLELITG 214
T+ D++S G++++E++ G
Sbjct: 194 YGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-18
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 13 DFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
D I+IG G+T V +A + G AVK++ + R++ +EV ++ H N+V +
Sbjct: 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRM-HTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
L E +++E+L +L D + HT + ++ L + +AL LH+Q
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLKALSVLHAQ 135
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
+IHRDIKS +ILL D KL+DFG C P R+ S+ G+ ++ +
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP----RRKSLVGTPYWMAPELI 188
Query: 191 NTGFVSTKSDVYSFGVLLLELITG 214
+ + D++S G++++E++ G
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-18
Identities = 62/199 (31%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+IG GA+ VY A ++ G A++++ ++ +++ ++E+ V+ +PN+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
L E +++EYLA SL D + T G ++ ++ + +ALE+LHS +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIA-----AVCRECLQALEFLHSNQ---V 137
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV 195
IHRDIKS NILL D KL DFG C P + KR T + G+ ++ +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQ---ITPEQSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 196 STKSDVYSFGVLLLELITG 214
K D++S G++ +E+I G
Sbjct: 194 GPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 7e-18
Identities = 60/205 (29%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFL---DEVSVLLRVSHPNLVGLLG 73
IG G VY A L G AVK + + K DE+ VL + HPNLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+ + + + +EY + +L + + V+ L + L YLHS
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR-----VYTLQLLEGLAYLHSHG-- 119
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY----VDTNY 189
I+HRDIK +NI L + KL DFG N + S+ G+ Y V T
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
G +D++S G ++LE+ TG
Sbjct: 179 KGKGHGRA-ADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-17
Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 55/255 (21%)
Query: 31 LGDGNFGAVKRVMEERGGSR-----------------KIFLDEVSVLLRVSH-PNLVGLL 72
+G+GNFG V + ++ G R + F E+ VL ++ H PN++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTY--------YGQSLGV---LSWSNRLSIALDIA 121
G C +G L +EY + +L D + + + LS L A D+A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
R ++YL + IHRD+ + NIL+ ++ AK+ADFGL + ++ +K +
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYVKKT 169
Query: 182 FGYVDTNY-----LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE------- 229
G + + LN +T SDV+S+GVLL E+++ + T AE E
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229
Query: 230 -ECRRNKNVEVWAQM 243
E N + EV+ M
Sbjct: 230 LEKPLNCDDEVYDLM 244
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-17
Identities = 61/216 (28%), Positives = 89/216 (41%), Gaps = 51/216 (23%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGS---------------RKIFLDEVSVLLRVSHPNLV 69
V L+ LG+G G+V + + G +K L E+ + P +V
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62
Query: 70 GLLGFCLEKGEQLL--LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS------IALDIA 121
G L++ + +EY SL D + Y + V R+ IA +
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSL-DSI---YKK---VKKRGGRIGEKVLGKIAESVL 115
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
+ L YLHS+ IIHRDIK SNILL KL DFG+ G S+ G+
Sbjct: 116 KGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS--GEL--------VNSLAGT 162
Query: 182 FGYVDTNY------LNTGFVSTKSDVYSFGVLLLEL 211
F T++ + S SDV+S G+ LLE+
Sbjct: 163 F--TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 58/190 (30%), Positives = 92/190 (48%), Gaps = 18/190 (9%)
Query: 45 ERGGSRKIFLDEVSVLLRVSHPNLVGLL--GFCLEKGEQLLLLEYLANKSLFDRMHTYYG 102
E R F E ++ R+ HPN+V LL G G + EY+ ++L + +
Sbjct: 17 EEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVL----- 70
Query: 103 QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFG 159
+ G L + L + AL H+Q I+HRD+K NI++ HAK+ DFG
Sbjct: 71 AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFG 127
Query: 160 LCKLGP-FNDPNRPK--RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLK 216
+ L P D + R T + G+ Y L V+ SD+Y++G++ LE +TG +
Sbjct: 128 IGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
Query: 217 SIQGSATLAE 226
+QG A++AE
Sbjct: 188 VVQG-ASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 18 IGVGATSFVYLAEL------GDGNFGAVKRVMEERGGS-RKIFLDEVSVLLRVSHPNLVG 70
+G GA V+L E D AVK + E RK F E +L H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 71 LLGFCLEKGEQLLLLEYLANKSL--FDRMH-------TYYGQSLGVLSWSNRLSIALDIA 121
G C E +++ EY+ + L F R H +G L+ S L IA+ IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
+ YL SQ +HRD+ + N L+ D K+ DFG+ + D R + G
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR------VGGH 183
Query: 182 ----FGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
++ + +T+SDV+SFGV+L E+ T
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 60/207 (28%), Positives = 87/207 (42%), Gaps = 42/207 (20%)
Query: 30 ELGDGNFG--------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
ELGDG FG A K + E + F+ E+ +L HPN+VGL
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLG-VLSWSNRLSIALDIARALEYLHSQADPP 134
+ + +L+E+ +L M L L+ + + AL +LHS
Sbjct: 72 FYENKLWILIEFCDGGALDSIM-----LELERGLTEPQIRYVCRQMLEALNFLHSHK--- 123
Query: 135 IIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF----------GY 184
+IHRD+K+ NILL D KLADFG+ N KR T I + +
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAK---NKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLEL 211
D Y K+D++S G+ L+EL
Sbjct: 181 KDNPY------DYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 24/198 (12%)
Query: 30 ELGDGNFG--------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+LG G +G AVK + E+ + FL E +V+ + HPNLV LLG C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVC 71
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
+ ++ E++ +L D + Q + + L +A I+ A+EYL +
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLEKKN---F 125
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV 195
IHRD+ + N L+ +++ K+ADFGL +L + K + L
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 196 STKSDVYSFGVLLLELIT 213
S KSDV++FGVLL E+ T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-17
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGG----------------SRKIFLDEVSVLLRVSHPNL 68
F L ++G G+FG V +V+ + R+ +DE VL ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
+ L+KG+ +++EY N L + G+ L + I L +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL---PEDQVWRFFIQILLGLAHLH 118
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
S+ I+HRDIKS N+ L ++ K+ D G+ KL +D +I G+ Y+
Sbjct: 119 SKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFAN--TIVGTPYYLSPE 171
Query: 189 YLNTGFVSTKSDVYSFGVLLLELITG 214
+ KSDV++ GV+L E TG
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTG 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 18 IGVGATSFVYLAELG-DGNFGAVKRVMEERGGSRKIFLDEV----SVLLRVSHPNLVGLL 72
I GA V+LA+ G+ A+K V+++ RK +D+V +L + P +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIK-VIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL- 58
Query: 73 GFCLEKGEQLLLL--EYLANKSLFDRMHTYYGQSLGVLSWSN-RLSIALDIARALEYLHS 129
+ +G++ L L EYL L + ++G L R+ IA +I ALEYLHS
Sbjct: 59 -YYSFQGKKNLYLVMEYLPGGDLASLLE-----NVGSLDEDVARIYIA-EIVLALEYLHS 111
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG----PFNDPNRPKRQTSIKGSFGYV 185
IIHRD+K NIL+ + H KL DFGL K+G N + K I G+ Y+
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ S D +S G +L E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 24/224 (10%)
Query: 37 GAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDR 96
++ V++E I E++ + ++ HPN+V L+G C + L+ EY+ K+L
Sbjct: 714 NGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL--- 770
Query: 97 MHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLA 156
+ L LSW R IA+ IA+AL +LH + P ++ ++ I++ + L
Sbjct: 771 -----SEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL- 824
Query: 157 DFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLK 216
+L P T S YV T ++ KSD+Y FG++L+EL+TG
Sbjct: 825 -----RLSL---PGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKS 876
Query: 217 S----IQGSATLAEWTEECRRNKNVEVWAQMLDPKLNGDANMEQ 256
++ EW C + ++++W +DP + GD ++ Q
Sbjct: 877 PADAEFGVHGSIVEWARYCYSDCHLDMW---IDPSIRGDVSVNQ 917
|
Length = 968 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-17
Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 50/225 (22%)
Query: 31 LGDGNFG-------------------AVKRVMEERGGSR-KIFLDEVSVLLRVSHPNLVG 70
LG+G FG AVK + E S + L E ++L +V+HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 71 LLGFCLEKGEQLLLLEYLANKSL--FDRMHTYYGQSLGVLSWSNR--------------- 113
L G C + G LL++EY SL F R G S + S NR
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPS-YLGSDGNRNSSYLDNPDERALTM 126
Query: 114 ---LSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP- 169
+S A I+R ++YL A+ ++HRD+ + N+L+ + K++DFGL + D
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 170 -NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
R K + +K ++ L +T+SDV+SFGVLL E++T
Sbjct: 184 VKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-17
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEERGGS-----RKIFLD----EVSVLLRVSHPN 67
IG G+ VYL G AVK+V + ++ LD E+++L + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+V LG L+ + LEY+ S+ ++ Y G + + I + L YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYL 122
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK------LGPFNDPNRPKRQTSIKGS 181
H++ IIHRDIK +NIL+ + K++DFG+ K L + RP S++GS
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP----SLQGS 175
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
++ + + K+D++S G L++E++TG
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-17
Identities = 55/148 (37%), Positives = 72/148 (48%), Gaps = 16/148 (10%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
RIG G VY A ++ G A+K + E G +I E+S+L HPN+V G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR----ALEYLHSQA 131
L + + +++EY SL D + G LS L IA + R L YLH
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQ----VTRGPLS---ELQIAY-VCRETLKGLAYLHETG 121
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFG 159
IHRDIK +NILL +D KLADFG
Sbjct: 122 ---KIHRDIKGANILLTEDGDVKLADFG 146
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 8e-17
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSR------KIFLDEVSVLLRVSHPNLVG 70
+G GA S Y A ++ G AVK+V R S + E+ ++ R++HP+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
+LG E L +E++A S+ + Y G + ++ + R L YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH-- 120
Query: 131 ADPPIIHRDIKSSNILLIDD--NHAKLADFG--------LCKLGPFNDPNRPKRQTSIKG 180
+ IIHRD+K +N+ LID ++ADFG G F Q + G
Sbjct: 121 -ENQIIHRDVKGANL-LIDSTGQRLRIADFGAAARLAAKGTGAGEF--------QGQLLG 170
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ ++ L DV+S G +++E+ T
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-16
Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 30/197 (15%)
Query: 31 LGDGNFG-------------AVKRVMEERGGSRKI-FLDEVSVLLRVSHPNLVGLLGFCL 76
LG GNFG AVK E+ KI FL E +L + HPN+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPII 136
++ +++E + ++ + L + ALD A + YL S+ I
Sbjct: 63 QRQPIYIVMELVPGGDFL----SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115
Query: 137 HRDIKSSNILLIDDNHAKLADFGLCKL---GPFNDPNRPKRQTSIKGSFGYVDTNYLNTG 193
HRD+ + N L+ ++N K++DFG+ + G ++ +Q IK + LN G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL--KQIPIK----WTAPEALNYG 169
Query: 194 FVSTKSDVYSFGVLLLE 210
S++SDV+S+G+LL E
Sbjct: 170 RYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 53/218 (24%)
Query: 28 LAELGDGNFGAVKRVMEERGGSRKIF------------------LDEVSVLLRVSHPNLV 69
L +G G+FG V++V + G KI + EV++L + HPN+V
Sbjct: 5 LETIGKGSFGTVRKVRRKSDG--KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 70 GLLGFCLEKGEQLL--LLEYLANKSL------FDRMHTYYGQSLGVLSWSNRLSIALDIA 121
+++ Q L ++EY L + Y + I +
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF-------IWRILTQLL 115
Query: 122 RALEYLH--SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
AL H S ++HRD+K +NI L +N+ KL DFGL K+ +S
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG--------HDSSFA 167
Query: 180 GSFGYVDTNY------LNTGFVSTKSDVYSFGVLLLEL 211
+ YV T Y LN KSD++S G L+ EL
Sbjct: 168 KT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 33/213 (15%)
Query: 28 LAELGDGNFGAV---KRVMEERGGS-------RKIFLD---------EVSVLLRVSHPNL 68
L LG G+FG V +++ G +K L E +L V+HP +
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL-DIARALEYL 127
V L +G+ L+L++L LF R+ S V+ + L ++A AL++L
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDHL 114
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
HS II+RD+K NILL ++ H KL DFGL K + K+ S G+ Y+
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAP 167
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITGLKSIQG 220
+N + +D +SFGVL+ E++TG QG
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-16
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 31/211 (14%)
Query: 30 ELGDGNFGAVKRVMEERGGSRKI------------------FLDEVSVLLRVSHPNLVGL 71
ELG GNFG VK+ M + S K L E +V+ ++ +P +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
+G C + E +L+ LA ++ + ++ V N + ++ ++YL
Sbjct: 62 IGIC--EAESWMLVMELAE---LGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETN 115
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCK-LGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
+HRD+ + N+LL+ ++AK++DFGL K LG D N K +T K + +
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHGKWPVKWYAPECM 170
Query: 191 NTGFVSTKSDVYSFGVLLLELIT-GLKSIQG 220
N S+KSDV+SFGVL+ E + G K +G
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-16
Identities = 51/151 (33%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 13 DFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
DF + RIG G VY A + G A+K + E G + E+ ++ H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
G L + + + +E+ SL D H G LS S ++ + + L YLHS
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHS 124
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGL 160
+ +HRDIK +NILL D+ H KLADFG+
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 55/224 (24%)
Query: 31 LGDGNFG-------------------AVKRVMEERGGSRKIFLDEVS---VLLRV-SHPN 67
LG+G FG AVK + ++ + K D VS ++ + H N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKN 77
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSL--FDRMH----TYYGQSLGV-----LSWSNRLSI 116
++ LLG C ++G +++EY A+ +L F R Y L+ + +S
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR----- 171
A +AR +E+L S+ IHRD+ + N+L+ +D+ K+ADFGL + D R
Sbjct: 138 AYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 172 --PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
P + + + F V T +SDV+SFGVLL E+ T
Sbjct: 195 RLPVKWMAPEALFDRVYT---------HQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-16
Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 22/171 (12%)
Query: 53 FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY----------LANKSLFDRMHTYYG 102
F E+ + ++SH N+V LLG C E ++LEY A KS +++
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKL----- 109
Query: 103 QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162
LS ++++ IA +++L ++ +HRD+ + N L+ K++ L K
Sbjct: 110 -KPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
Query: 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+N R I ++ + STKSDV+SFGVL+ E+ T
Sbjct: 166 -DVYNSEYYKLRNALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-16
Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 18 IGVGATSFVYLAELGDGN----FGAVKRVMEERGGSRKIFLDEVSVLLR-------VSHP 66
IG G VY L D + AVK + +R L+EV L+ SHP
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL------NRITDLEEVEQFLKEGIIMKDFSHP 56
Query: 67 NLVGLLGFCLEK-GEQLLLLEYLANKSL--FDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
N++ LLG CL G L++L Y+ + L F R T+ + + + L +A+
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP------TVKDLIGFGLQVAKG 110
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
+EYL S+ +HRD+ + N +L + K+ADFGL + + T K
Sbjct: 111 MEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
++ L T +TKSDV+SFGVLL EL+T
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-16
Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 16/160 (10%)
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSL--FDRMHTYYGQSLGV---------LSWSNR 113
H N++ LLG C + G +L+EY + +L + R G L++ +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 114 LSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173
+S A +AR +EYL SQ IHRD+ + N+L+ +DN K+ADFGL + ++ + K
Sbjct: 137 VSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNIDYYK 191
Query: 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ T+ + ++ L + +SDV+SFGVLL E+ T
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-16
Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 52/217 (23%)
Query: 27 YLAELGDGNFG--------------AVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVG 70
L +G+G +G A+K+ E +K L EV VL ++ H N+V
Sbjct: 5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
L KG L+ EY+ ++L + + G G+ + R I + +A+ Y HS
Sbjct: 65 LKEAFRRKGRLYLVFEYV-ERTLLELLEASPG---GLPPDAVRSYI-WQLLQAIAYCHSH 119
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV----- 185
IIHRDIK NIL+ + KL DFG R R YV
Sbjct: 120 N---IIHRDIKPENILVSESGVLKLCDFGFA---------RALRARPASPLTDYVATRWY 167
Query: 186 --------DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
DTNY G DV++ G ++ EL+ G
Sbjct: 168 RAPELLVGDTNY---GK---PVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-16
Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRV-----MEERGGSR-----KIFLDEVSVLLRVSHP 66
IG G VYLA + G AVK+V + R SR K E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 67 NLVGLLGFCLEKGEQLL--LLEYLANKSLFD--RMHTYYGQSLGVLSWSNRLSIALDIAR 122
N+V LGF E E+ L LEY+ S+ R + + + L V ++ + +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL-VRFFTEQ------VLE 119
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP---FNDPNRPKRQTSIK 179
L YLHS+ I+HRD+K+ N+L+ D K++DFG+ K ND N S++
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN-----MSMQ 171
Query: 180 GSFGYVDTNYLNT---GFVSTKSDVYSFGVLLLELITG 214
GS ++ +++ G+ S K D++S G ++LE+ G
Sbjct: 172 GSVFWMAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-16
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 38/207 (18%)
Query: 28 LAELGDGNFGAVKRVMEERGGS---------------RKIFLDEVSVLLRVSHPNLVGLL 72
+++LG GN G+V +V G+ RK L E+ ++ P +V
Sbjct: 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQ-SLGVLSWSNRLSIALDIARALEYLHSQA 131
G L + + +E++ + DR++ G + +L IA+ + L YL++
Sbjct: 70 GAFLNENNICMCMEFM-DCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYNVH 123
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF----GYVDT 187
I+HRDIK SNIL+ KL DFG+ + SI +F Y+
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSG----------ELINSIADTFVGTSTYMSP 171
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITG 214
+ G + KSDV+S G+ ++EL G
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-15
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 23 TSFVYLAELGDGNFGAVKRVMEERGGSR---KIF---------LDEVSVLLRVSHPNLVG 70
F L +LG+G++G+V + + + G K+ + E+S+L + P +V
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 71 LLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLG-VLSWSNRLSIALDIARALEYLH 128
G K L +++EY S+ D M + L+ +I + LEYLH
Sbjct: 63 YYG-SYFKNTDLWIVMEYCGAGSVSDIM-----KITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
S IHRDIK+ NILL ++ AKLADFG+ G D KR T I F
Sbjct: 117 SNK---KIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMA-KRNTVIGTPFWMAPEV 170
Query: 189 YLNTGFVSTKSDVYSFGVLLLELITG 214
G+ + K+D++S G+ +E+ G
Sbjct: 171 IQEIGY-NNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 39/217 (17%)
Query: 31 LGDGNFGAVKRV-------------------MEERGGSRKIFLDEVSV--LLRV--SHPN 67
LG+G FG V R M + + K D +S L+++ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRM---------HTYYGQSL--GVLSWSNRLSI 116
++ LLG C ++G +++EY A +L + + +T+ + LS+ + +S
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT 176
A +AR +EYL S+ IHRD+ + N+L+ +DN K+ADFGL + +D + K+ +
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTS 194
Query: 177 SIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ + ++ L + +SDV+SFG+L+ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-15
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 18 IGVGATSFVY----LAELGDGNFG---AVKRVMEERGGSRKI-FLDEVSVLLRVSHPNLV 69
+G GA VY LG G+ AVK + + K FL E ++ +HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFD-----RMHTYYGQSLGVLSWSNRLSIALDIARAL 124
LLG CL Q +++E + L R+ + +L+ L I LD+A+
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPP---LLTLKELLDICLDVAKGC 119
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHA-----KLADFGLCKLGPFNDPNRPKRQTSIK 179
YL IHRD+ + N L+ + + K+ DFGL + +D R + + +
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL- 175
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
++ L G +T+SDV+SFGVL+ E++T
Sbjct: 176 -PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 36/206 (17%)
Query: 28 LAELGDGNFGAVKRVMEERGG----------SRKIFL-------DEVSVLLRVSHPNLVG 70
+ +G G FG V V + I L +E VL VSHP ++
Sbjct: 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65
Query: 71 LLGFCLEKGEQLL--LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
L F E ++ L L+EY+ LF Y ++ G S S L A +I ALEYLH
Sbjct: 66 L--FWTEHDQRFLYMLMEYVPGGELFS-----YLRNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
S+ I++RD+K NILL + H KL DFG K D R ++ G+ Y+
Sbjct: 119 SKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRD-----RTWTLCGTPEYLAPE 168
Query: 189 YLNTGFVSTKSDVYSFGVLLLELITG 214
+ + + D ++ G+L+ E++ G
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 44/213 (20%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGS----RKIFLD-----------EVSVLLRVSHPNLV 69
F L +G G+FG V + +++R + I L+ E+ L + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 70 GLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
G KG +L +++EY S D + G L + I ++ LEYLH
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLH 115
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
+ IHRDIK++NILL ++ KLADFG+ G KR T +V T
Sbjct: 116 EEGK---IHRDIKAANILLSEEGDVKLADFGVS--GQLTS-TMSKRNT-------FVGTP 162
Query: 189 Y-------LNTGFVSTKSDVYSFGVLLLELITG 214
+ +G+ K+D++S G+ +EL G
Sbjct: 163 FWMAPEVIKQSGY-DEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 48/235 (20%)
Query: 7 LKMATNDFRIR--IGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV 63
L T F + IG G VY A G A+K +M+ + +E ++L +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59
Query: 64 S-HPNLVGLLGFCLEKG-----EQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS- 115
S HPN+ G ++K +QL L++E S+ D + G+ RL
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVK-------GLRKKGKRLKE 112
Query: 116 -----IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDP 169
I + R L YLH +IHRDIK NILL + KL DFG+ +L D
Sbjct: 113 EWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DS 165
Query: 170 NRPKRQTSIKGSF----------GYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+R T I + D +Y +SDV+S G+ +EL G
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDA------RSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 68/238 (28%), Positives = 102/238 (42%), Gaps = 26/238 (10%)
Query: 14 FRIR--IGVGATSFVYLAELGD-GNFGAVKRVME----ERGGSRKIFLDEVSVLLRVSHP 66
F + IG GA V + + D A+K + + E+G R + +E +L ++HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL-NERRILQELNHP 60
Query: 67 NLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE 125
LV L + + E + L+++ L L R H S +I ALE
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDL--RYHL---SQKVKFSEEQVKFWICEIVLALE 114
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL-CKLGPFNDPNRPKRQTSIKGSFGY 184
YLHS+ IIHRDIK NILL + H + DF + K+ P TS G+ GY
Sbjct: 115 YLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP------DTLTTSTSGTPGY 165
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQG-SATLAEWTEECRRNKNVEVWA 241
+ L S D +S GV E + G + +G S T+ + + +V A
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPA 223
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-15
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 34/208 (16%)
Query: 31 LGDGNFG-------------------AVKRVMEE-RGGSRKIFLDEVSVLLRVSHPNLVG 70
LG G FG AVK + E FL E ++ + +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 71 LLGFCLEKGEQLLLLEYLANKSL--FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
L+G E+ + +LLE +A L F R + + L+ + L A D+A+ +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 129 SQADPPIIHRDIKSSNILLID---DNHAKLADFGLCKLGPFNDPNRP--KRQTSIKGSFG 183
IHRDI + N LL AK+ADFG+ + R + IK
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK---- 186
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLEL 211
++ G ++K+DV+SFGVLL E+
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-15
Identities = 53/197 (26%), Positives = 98/197 (49%), Gaps = 10/197 (5%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
++G G V++ + AVK ++ S + FL+E +++ + H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVK-TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPII 136
++ ++ EY+A SL D + + G G + + + IA + Y+ + I
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIERKN---YI 125
Query: 137 HRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVS 196
HRD++++N+L+ + K+ADFGL ++ D R+ + K + +N G +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGA-KFPIKWTAPEAINFGSFT 182
Query: 197 TKSDVYSFGVLLLELIT 213
KSDV+SFG+LL E++T
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-15
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 24 SFVYLAELGDGNFGAV------------KRVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
S + +LG+G FG V + ++ S + FL+E ++ ++ H LV L
Sbjct: 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL 66
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
E+ ++ EY++ SL D + G++L + N + +A +A + Y+
Sbjct: 67 YAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKL---PNLVDMAAQVAAGMAYIERMN 122
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
IHRD++S+NIL+ D K+ADFGL +L D RQ + K +
Sbjct: 123 ---YIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGA-KFPIKWTAPEAAL 176
Query: 192 TGFVSTKSDVYSFGVLLLELIT 213
G + KSDV+SFG+LL EL+T
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-15
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 36/205 (17%)
Query: 31 LGDGNFGAVKRVMEERGGSRKIFL------------DEVSVLL---RV-----SHPNLVG 70
LG G+FG V ++ E G+ +++ D+V + RV HP L
Sbjct: 3 LGKGSFGKV--LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 71 LLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L C + ++L ++EY+ L ++ Q G A +I L++LH
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLM-----FHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
+ II+RD+K N+LL + H K+ADFG+CK G ++ G+ Y+
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VTTSTFCGTPDYIAPEI 167
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
L+ D ++ GVLL E++ G
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-15
Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 63/229 (27%)
Query: 23 TSFVYLAELGDGNFG--------------AVKRV-MEERGGSRKIFLDEVSVLLRVSH-P 66
+ ELG G +G AVKR+ +K L ++ + +R P
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 67 NLVGLLGFCLEKGEQLLLLEYLAN------KSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
V G +G+ + +E + K ++D+ T LG IA+ I
Sbjct: 61 YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILG--------KIAVSI 112
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL---------------CKLGP 165
+ALEYLHS+ +IHRD+K SN+L+ + KL DFG+ CK P
Sbjct: 113 VKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCK--P 168
Query: 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ P R + + KG KSDV+S G+ ++EL TG
Sbjct: 169 YMAPERINPELNQKG--------------YDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 8e-15
Identities = 59/233 (25%), Positives = 87/233 (37%), Gaps = 80/233 (34%)
Query: 23 TSFVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVLLRV 63
F ++ LG G+FG V V + GS K + L+E +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHK--GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI 58
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI------A 117
HP LV L G + L++EY+ LF L S R A
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-----------LRKSGRFPEPVARFYA 107
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
+ ALEYLHS I++RD+K N+LL D + K+ DFG K
Sbjct: 108 AQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK--------------- 149
Query: 178 IKGSFGYVDTN---------YL------NTGFVSTKS-DVYSFGVLLLELITG 214
V YL + G+ K+ D ++ G+L+ E++ G
Sbjct: 150 ------RVKGRTYTLCGTPEYLAPEIILSKGY--GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 48/160 (30%), Positives = 83/160 (51%), Gaps = 16/160 (10%)
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSL-----------GVLSWSNR 113
H N++ LLG C + G +++EY + +L + + + LS+ +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 114 LSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173
+S A +AR +EYL S+ IHRD+ + N+L+ +DN K+ADFGL + + + K
Sbjct: 143 VSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYK 197
Query: 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ T+ + ++ L + +SDV+SFGVLL E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-14
Identities = 55/171 (32%), Positives = 80/171 (46%), Gaps = 38/171 (22%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLD--------EVSVLLRVSHPNL 68
+G G + VY A G A+K++ + G RK D E+ +L + HPN+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 69 VGLLGFCLEKGEQLLLLEYLA--------NKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
+GLL K L+ E++ +KS+ VL+ ++ S L
Sbjct: 65 IGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI-------------VLTPADIKSYMLMT 111
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171
R LEYLHS I+HRD+K +N+L+ D KLADFGL + F PNR
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNR 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-14
Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 17 RIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKI-FLDEVSVLLRVSHPNLVGLLGF 74
RIG G V+ L D AVK E K FL E +L + SHPN+V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP 134
C +K +++E + + T G L V + + + A +EYL S+
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRT-EGPRLKV---KELIQMVENAAAGMEYLESKH--- 114
Query: 135 IIHRDIKSSNILLIDDNHAKLADFGLCKL---GPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
IHRD+ + N L+ + N K++DFG+ + G + +Q +K + LN
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG-GMKQIPVK----WTAPEALN 169
Query: 192 TGFVSTKSDVYSFGVLLLE 210
G S++SDV+SFG+LL E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 52/165 (31%), Positives = 81/165 (49%), Gaps = 24/165 (14%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVK--RVMEERGGSRKIFLDEVSVLLRV---SHPNLVG 70
IG GA VY A +L G F A+K RV G L E+++L ++ HPN+V
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 71 LLGFC----LEKGEQLLL-LEYLANKSLFDR-MHTY--YGQSLGVLSWSNRLSIALDIAR 122
LL C ++ +L L E++ D+ + TY G+ + + + + R
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV------DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
+++LHS I+HRD+K NIL+ D K+ADFGL ++ F
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGS-RKIFLDEVSVLLRVSHPNLVGLLGF 74
RIG GA VY G A+K + + R+ E+ +L V+HPN+V
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP 134
GE +LLE++ SL + H Q L +A I + YLH +
Sbjct: 141 FDHNGEIQVLLEFMDGGSL-EGTHIADEQFLA--------DVARQILSGIAYLHRRH--- 188
Query: 135 IIHRDIKSSNILLIDDNHAKLADFGLCK-LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG 193
I+HRDIK SN+L+ + K+ADFG+ + L DP S G+ Y+ +NT
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC-----NSSVGTIAYMSPERINTD 243
Query: 194 FVSTK-----SDVYSFGVLLLELITG 214
D++S GV +LE G
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 62/237 (26%), Positives = 96/237 (40%), Gaps = 45/237 (18%)
Query: 13 DFR-IR-IGVGATSFVYLAEL-GDGNFGAVK----RVMEERGGSRKIFLDEVSVLLRVSH 65
F+ I+ +G G V+L L G G A+K + M +R +++ L E +L + H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRV-LTEQEILATLDH 60
Query: 66 PNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
P L L + L L+++Y LF + Q LS A ++ AL
Sbjct: 61 PFLPTLYA-SFQTETYLCLVMDYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLAL 116
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
EYLH I++RD+K NILL + H L+DF L K + P + KGS
Sbjct: 117 EYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQS--DVEPPPVSKALRKGSRRS 171
Query: 185 VDTNYLNTGFV---STKS------------------------DVYSFGVLLLELITG 214
+ + F S +S D ++ G+LL E++ G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 55/182 (30%), Positives = 95/182 (52%), Gaps = 21/182 (11%)
Query: 38 AVKRVMEERGGSRKI-FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDR 96
A+K + E G + F+DE ++ + HP+LV LLG CL QL+ + + + L D
Sbjct: 40 AIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLDY 98
Query: 97 MHTY---YGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHA 153
+H + G L +L+W + IA+ + YL + ++HRD+ + N+L+ NH
Sbjct: 99 VHEHKDNIGSQL-LLNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHV 148
Query: 154 KLADFGLCKL--GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLEL 211
K+ DFGL +L G + N + IK ++ ++ + +SDV+S+GV + EL
Sbjct: 149 KITDFGLARLLEGDEKEYNADGGKMPIK----WMALECIHYRKFTHQSDVWSYGVTIWEL 204
Query: 212 IT 213
+T
Sbjct: 205 MT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLR-VSHPNLVGLL 72
IG G+ V LA+ DG F AVK + ++ + +K + E +VLL+ V HP LVGL
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 73 GFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
+ + ++L +L+Y+ LF ++ Q A +IA AL YLHS
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELF-----FHLQRERSFPEPRARFYAAEIASALGYLHSLN 116
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
II+RD+K NILL H L DFGLCK K ++ G+ Y+ L
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 192 TGFVSTKSDVYSFGVLLLELITGL 215
D + G +L E++ GL
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 18 IGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLD--------EVSVL-LRVSHPN 67
+G G+ V+LAEL G F A+K + ++ + +D E VL L HP
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKD-----VVLMDDDVECTMVEKRVLSLAWEHPF 57
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
L L K ++EYL L ++ QS A +I L++L
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLM-----FHIQSCHKFDLPRATFYAAEIICGLQFL 112
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
HS+ I++RD+K NILL D H K+ADFG+CK D + + G+ Y+
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----AKTCTFCGTPDYIAP 165
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITGLKSIQG 220
L +T D +SFGVLL E++ G G
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 27/174 (15%)
Query: 53 FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS---LFDRMHTYYGQSLG-VL 108
L E +L +SH N++ +L C+E GE +L N LF + + L
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 109 SWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK------ 162
S + +A+ IA + YLH + +IH+DI + N ++ ++ K+ D L +
Sbjct: 115 STQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
Query: 163 ---LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
LG ++ NRP + +++ L S+ SDV+SFGVLL EL+T
Sbjct: 172 YHCLG--DNENRPVKWMALES---------LVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 49/217 (22%)
Query: 28 LAELGDGNFG--------------AVKRVMEERGG-SRKIFLDEVSVLLRVSH-PNLVGL 71
L E+G G FG AVKR+ +K L ++ V++R S P +V
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTY-YGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
G +G+ + +E L + SL D+ + Y Y V+ IA+ +AL YL +
Sbjct: 69 YGALFREGDCWICME-LMDISL-DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL--K 124
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLC-KL------------GPFNDPNRPKRQTS 177
+ IIHRD+K SNILL + + KL DFG+ +L P+ P R
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER------ 178
Query: 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+D + + G+ +SDV+S G+ L E+ TG
Sbjct: 179 -------IDPSARD-GY-DVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 71/265 (26%), Positives = 125/265 (47%), Gaps = 34/265 (12%)
Query: 13 DFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV-----MEERGGSRKIFLDEVSVLLRVS 64
+FRI +IG G S VY A L DG A+K+V M+ + +R + E+ +L +++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDLLKQLN 60
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
HPN++ +E E ++LE LA+ RM ++ + ++ + + AL
Sbjct: 61 HPNVIKYYASFIEDNELNIVLE-LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
E++HS+ ++HRDIK +N+ + KL D GL + F+ ++ S+ G+ Y
Sbjct: 120 EHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FS--SKTTAAHSLVGTPYY 172
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA----TLAEWTEECRRNKNVEVW 240
+ ++ + KSD++S G LL E+ G +L + E+C
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY------- 225
Query: 241 AQMLDPKLNGDANMEQLRVLIRICM 265
P L D E+LR L+ +C+
Sbjct: 226 -----PPLPSDHYSEELRQLVNMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 47/162 (29%), Positives = 85/162 (52%), Gaps = 20/162 (12%)
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGV-------------LSWS 111
H N++ LLG C + G +++EY + +L R + + G+ +++
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNL--REYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 112 NRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171
+ +S +AR +EYL SQ IHRD+ + N+L+ ++N K+ADFGL + N+ +
Sbjct: 138 DLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDY 192
Query: 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
K+ T+ + ++ L + +SDV+SFGVL+ E+ T
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-14
Identities = 50/152 (32%), Positives = 72/152 (47%), Gaps = 11/152 (7%)
Query: 12 NDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL 68
+D+ + R+G G VY A L G AVK + E G + E+ ++ H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
V G L + + + +EY SL D H G LS + + + L YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLH 123
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160
S+ +HRDIK +NILL D+ KLADFG+
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-14
Identities = 50/199 (25%), Positives = 100/199 (50%), Gaps = 28/199 (14%)
Query: 30 ELGDGNFGAVKRVM-----------------EERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
ELG GNFG VK+ + E R + E ++ ++ +P +V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
G C + E L+L+ +A+ ++ + ++ SN + + ++ ++YL +
Sbjct: 62 GVC--EAEALMLVMEMASGG---PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN- 115
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCK-LGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
+HRD+ + N+LL++ ++AK++DFGL K LG D + K +++ K + +N
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGA--DDSYYKARSAGKWPLKWYAPECIN 171
Query: 192 TGFVSTKSDVYSFGVLLLE 210
S++SDV+S+G+ + E
Sbjct: 172 FRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 18 IGVGATSFVYLAEL-GDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLR-VSHPNLVGLL 72
IG G+ V LA+ DG+F AVK + ++ + + + E +VLL+ + HP LVGL
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 73 GFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
+ + E+L +L+Y+ LF ++ Q A ++A A+ YLHS
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELF-----FHLQRERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS-IKGSFGYVDTNYL 190
II+RD+K NILL H L DFGLCK G P+ TS G+ Y+ L
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGV-----EPEETTSTFCGTPEYLAPEVL 168
Query: 191 NTGFVSTKSDVYSFGVLLLELITGL 215
D + G +L E++ GL
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-14
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 18 IGVGATSFVYLAELG--DGNFG--AVKRVMEERGGSRKI--FLDEVSVLLRVSHPNLVGL 71
+G G V +L DG+ AVK + + +I FL E + + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 72 LGFCLEKGEQ------LLLLEYLANKSLFDRMHTYYGQS-LGVLSW----SNRLSIALDI 120
+G C E +++L ++ + L H++ S LG L L +DI
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDL----HSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI-K 179
A +EYL ++ IHRD+ + N +L +D +ADFGL K D RQ I K
Sbjct: 123 ALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD---YYRQGRIAK 176
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
++ L ++KSDV++FGV + E+ T
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-14
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 32/207 (15%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSRKI-----------------FLDEVSVLLRVSHPN 67
F L ++G G+FG V + ++ R ++K+ E++VL + P
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNR--TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+ G L+ + +++EYL S D + G L + +I +I + L+YL
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYL 117
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
HS+ IHRDIK++N+LL + KLADFG+ G D + KR T + F ++
Sbjct: 118 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTD-TQIKRNTFVGTPF-WMAP 170
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITG 214
+ +K+D++S G+ +EL G
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-14
Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 18/181 (9%)
Query: 53 FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRM-----HTYYGQS--- 104
F E S++ + HPN+V LLG ++ +L EYL L + + H+ G S
Sbjct: 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113
Query: 105 ----LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160
L + L IA+ IA +EYL S +H+D+ + NIL+ + H K++D GL
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGL 170
Query: 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQ 219
+ D R + ++ + ++ + G S+ SD++SFGV+L E+ + GL+
Sbjct: 171 SREIYSADYYRVQPKSLL--PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228
Query: 220 G 220
G
Sbjct: 229 G 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-14
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 28/205 (13%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGS----RKIFLDE-----------VSVLLRVSHPNLV 69
F L +G G+FG V + ++ R + I L+E ++VL + P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
G L+ + +++EYL S D + G L + +I +I + L+YLHS
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHS 119
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
+ IHRDIK++N+LL + KLADFG+ G D + KR T + F ++
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTD-TQIKRNTFVGTPF-WMAPEV 172
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
+ K+D++S G+ +EL G
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-14
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 36/218 (16%)
Query: 11 TNDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV-----MEERGGSRKIFLDEVSVLLR 62
+F+I +IG G S VY A L DG A+K+V M+ + +R+ L E+ +L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK--ARQDCLKEIDLLKQ 58
Query: 63 VSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
+ HPN++ L +E E ++LE LA+ RM ++ + ++ + +
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLE-LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
ALE++HS+ I+HRDIK +N+ + KL D GL R S K +
Sbjct: 118 ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGL------------GRFFSSKTTA 162
Query: 183 GY--VDTNYL-------NTGFVSTKSDVYSFGVLLLEL 211
+ V T Y G+ + KSD++S G LL E+
Sbjct: 163 AHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-14
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 18 IGVGATSFVYLAE------LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
+G GA V+LAE D AVK + + +RK F E +L + H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 72 LGFCLEKGEQLLLLEYLANKSL--FDRMHTYYG---------QSLGVLSWSNRLSIALDI 120
G C + +++ EY+ + L F R H Q+ G L S L IA I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
A + YL SQ +HRD+ + N L+ + K+ DFG+ + D R T +
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-- 187
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
++ + +T+SDV+SFGV+L E+ T
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-14
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 29/205 (14%)
Query: 30 ELGDGNFG------------------AVKRVMEERGGSRKIFL-DEVSVLLRVSHPNLVG 70
+LG+G+FG AVK + E GG+ L E+ +L + H N+V
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 71 LLGFCLEKGEQ--LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
G C E G L++E+L + SL + Y ++ ++ +L A+ I + ++YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKE----YLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
S+ +HRD+ + N+L+ ++ K+ DFGL K + + F Y
Sbjct: 127 SRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 189 YLNTGFVSTKSDVYSFGVLLLELIT 213
+ + F SDV+SFGV L EL+T
Sbjct: 184 LIQSKFY-IASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-14
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 45/216 (20%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSRKIFL------------DEVSVLL----------R 62
F LA LG G+FG V ++ E + +++ DEV L+
Sbjct: 1 FRCLAVLGRGHFGKV--LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS 58
Query: 63 VSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
HP LV L C + + + ++EY A L +HT V S + A +
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVV 111
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK--LGPFNDPNRPKRQTSIK 179
L+YLH I++RD+K N+LL + K+ADFGLCK +G + R ++
Sbjct: 112 LGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD------RTSTFC 162
Query: 180 GSFGYVDTNYLNTGFVSTKS-DVYSFGVLLLELITG 214
G+ ++ L T T++ D + GVL+ E++ G
Sbjct: 163 GTPEFLAPEVL-TETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-14
Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 19/174 (10%)
Query: 48 GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGV 107
G + L E +L V+HP+++ + + ++L + ++ ++TY +
Sbjct: 99 GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD-----LYTYLTKRSRP 153
Query: 108 LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
L L I I L YLH+Q IIHRD+K+ NI + D + + D G + P
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVV 209
Query: 168 DPNRPKRQTSIKGSFGYVDTN---YLNTGFVSTKSDVYSFGVLLLELITGLKSI 218
P G G V+TN L ++K+D++S G++L E++ +I
Sbjct: 210 APA-------FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256
|
Length = 357 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-14
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVLLRVSH 65
F +L LG G+FG V ++ ER G+ +++ + E VL
Sbjct: 2 FNFLMVLGKGSFGKV--MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 66 PNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
P + L C + ++L ++EY+ L Y+ Q +G + + A +IA L
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLM-----YHIQQVGKFKEPHAVFYAAEIAIGL 114
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
+LHS+ II+RD+K N++L + H K+ADFG+CK F K + G+ Y
Sbjct: 115 FFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGTPDY 167
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ + D ++FGVLL E++ G
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-14
Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 20/173 (11%)
Query: 44 EERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYG- 102
+ER SRK EV+VL + HPN+V E G ++++Y L+ +++ G
Sbjct: 41 KEREESRK----EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGV 96
Query: 103 --QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160
+L W + I AL+++H D I+HRDIKS NI L D KL DFG+
Sbjct: 97 LFPEDQILDW------FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGI 147
Query: 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
++ N R T I G+ Y+ + KSD+++ G +L E+ T
Sbjct: 148 ARV--LNSTVELAR-TCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 42/225 (18%)
Query: 26 VYLAELGDGNFG-------------------AVKRVMEERGGSRKI-FLDEVSVLLRVSH 65
Y+ ++G G FG AVK + EE + F E +++ H
Sbjct: 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH 67
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLA----NKSLFDRMHTY-------------YGQSLGVL 108
PN+V LLG C LL EY+A N+ L R G + L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 109 SWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168
S + +L IA +A + YL ++ +HRD+ + N L+ ++ K+ADFGL + D
Sbjct: 128 SCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ +I + ++ + N +T+SDV+++GV+L E+ +
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 18 IGVGATSFVYLAELGDGN-FGAVK----RVMEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
+G G+ V LAEL N F A+K V+ E ++ + L HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 73 GFCLEKGEQLL--LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
FC + ++ L ++EYL L ++ QS G + A +I L++LH +
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGGDLM-----FHIQSSGRFDEARARFYAAEIICGLQFLHKK 115
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
II+RD+K N+LL D H K+ADFG+CK + N + ++ G+ Y+ L
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKE----NMNGEGKASTFCGTPDYIAPEIL 168
Query: 191 NTGFVSTKSDVYSFGVLLLELITGLKSIQG 220
+ D +SFGVLL E++ G G
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 12/159 (7%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLG 73
RIG GA V+ A + G A+K+V R GG L E+ L HP +V LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+L++EY+ + L + + L + S + + + Y+H+
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLR----DEERPLPEAQVKSYMRMLLKGVAYMHANG-- 119
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
I+HRD+K +N+L+ D K+ADFGL +L + R
Sbjct: 120 -IMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRL 156
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 50/178 (28%), Positives = 91/178 (51%), Gaps = 19/178 (10%)
Query: 49 SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYY------- 101
+R FL EV +L R+ PN++ LLG C+++ ++ EY+ N L + +++
Sbjct: 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 102 -------GQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAK 154
L +S+S+ L +AL IA ++YL S +HRD+ + N L+ ++ K
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIK 178
Query: 155 LADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELI 212
+ADFG+ + D R + + + ++ + G +T SDV++FGV L E++
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVL--PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-13
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGS----RKIFLDE-----------VSVLLRVSHPNLV 69
F L +G G+FG V + ++ R + I L+E ++VL + P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
G L+ + +++EYL S D + G ++ +I + L+YLHS
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHS 119
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
+ IHRDIK++N+LL + KLADFG+ G D + KR T + F ++
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTD-TQIKRNTFVGTPF-WMAPEV 172
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
+ +K+D++S G+ +EL G
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 64/235 (27%), Positives = 111/235 (47%), Gaps = 22/235 (9%)
Query: 18 IGVGATSFVYLAELGDGNFGAVKRVMEE-RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
+G GA F G AVK + + +R FL E+ ++ R+ +PN++ LLG C+
Sbjct: 33 LGEGAPEFD-----GQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV 87
Query: 77 EKGEQLLLLEYLANKSL--FDRMHTYYGQ-----SLGVLSWSNRLSIALDIARALEYLHS 129
++ EY+ N L F ++ +S +N L +A+ IA ++YL
Sbjct: 88 SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL-- 145
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
A +HRD+ + N L+ + K+ADFG+ + D R + + + + ++
Sbjct: 146 -ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL 204
Query: 190 LNTGFVSTKSDVYSFGVLLLELITGLK----SIQGSATLAEWTEECRRNKNVEVW 240
L G +T SDV++FGV L E+ T K S+ + E T E RN+ +++
Sbjct: 205 L--GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIY 257
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 52/219 (23%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIF--------LDEVSVLLRVS-HP 66
+IG G S V A G + A+K + +K F L E+ L R+S HP
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 67 NLVGLLGFCLEK--GEQLLLLEYLANKSLFDRM--HTYYGQSLGVLSWSNRLSIALDIAR 122
N++ L+ ++ G L+ E L + +L++ + V S+ +L +
Sbjct: 59 NILRLIEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQL------LK 111
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
+L+++H I HRDIK NIL I D+ KLADFG C R K +
Sbjct: 112 SLDHMHRNG---IFHRDIKPENIL-IKDDILKLADFGSC------------RGIYSKPPY 155
Query: 183 G-YVDTNY-------LNTGFVSTKSDVYSFGVLLLELIT 213
Y+ T + L G+ K D+++ G + E+++
Sbjct: 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 46/226 (20%)
Query: 23 TSFVYLAELGDGNFGAVK-----------------RVMEERGGSR--KIFLDEVSVLLRV 63
T F + LG G FG V + + E + K LDE V+ V
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 64 SHPNLVGLLGFCLEKGEQLL--------LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS 115
+P++ LLG CL QL+ LL+Y+ D + + Y +L+W
Sbjct: 67 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQY-----LLNW----- 114
Query: 116 IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175
+ IA+ + YL + ++HRD+ + N+L+ H K+ DFGL KL +
Sbjct: 115 -CVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGADEKEYHA 168
Query: 176 TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQG 220
K ++ + + +SDV+S+GV + EL+T G K G
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 31 LGDGNFGAV--------KRVMEERGGSRKI----------FLDEVSVLLRVSHPNLVGLL 72
LG+G FG+V +++ + KI FL E + HPN++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 73 GFCLEKGEQ------LLLLEYLANKSLFD-RMHTYYGQSLGVLSWSNRLSIALDIARALE 125
G CL+ E +++L ++ + L +++ G L + DIA +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
YL S++ IHRD+ + N +L ++ + +ADFGL K D R R K ++
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA--KMPVKWI 181
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELIT 213
L +TKSDV+SFGV + E+ T
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 18 IGVGATSFVYLAELGDGNFGAV-------KRVMEERGGSRKIFLDEVSVLLRVSHPNLVG 70
IG G+ +YLA+ + V K ++E+ S+K EV +L ++ HPN+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK----EVILLAKMKHPNIVT 63
Query: 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
E G +++EY L R++ G + S LS + I+ L+++H
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGV---LFSEDQILSWFVQISLGLKHIH-- 118
Query: 131 ADPPIIHRDIKSSNILLIDDNH-AKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
D I+HRDIKS NI L + AKL DFG+ + ND + G+ Y+
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAY--TCVGTPYYLSPEI 173
Query: 190 LNTGFVSTKSDVYSFGVLLLELIT 213
+ K+D++S G +L EL T
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-13
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 18 IGVGATSFVYLAEL------GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
+G GA V+LAE D AVK + + +RK F E +L + H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 72 LGFCLEKGEQLLLLEYLANKSL--FDRMH------TYYGQSLGVLSWSNRLSIALDIARA 123
G C+E +++ EY+ + L F R H G L+ S L IA IA
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
+ YL SQ +HRD+ + N L+ ++ K+ DFG+ + D R T +
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML--PIR 187
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
++ + +T+SDV+S GV+L E+ T
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-13
Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 22/182 (12%)
Query: 50 RKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLS 109
R+ L+E+ +L + HPN++ ++ L+ +EY +L+D++ GQ +
Sbjct: 43 RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ---LFE 99
Query: 110 WSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169
L I A+ Y+H I+HRDIK+ NI L KL DFG+ K
Sbjct: 100 EEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISK------- 149
Query: 170 NRPKRQTSIKGSFGYVDTNY-----LNTGF-VSTKSDVYSFGVLLLELITGLKSIQGSAT 223
+ + V T Y L G + KSD+++ G +L EL+T ++ +
Sbjct: 150 ---ILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
Query: 224 LA 225
L
Sbjct: 207 LN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-13
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 18 IGVGATSFVYLAELG------DGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
+G GA V+LAE D AVK + E +R+ F E +L + H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 72 LGFCLEKGEQLLLLEYLANKSL--FDRMH--------TYYGQSLGVLSWSNRLSIALDIA 121
G C E L++ EY+ + L F R H + G L+ L+IA IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
+ YL A +HRD+ + N L+ K+ DFG+ + D R +T +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--P 187
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
++ + +T+SD++SFGV+L E+ T
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-13
Identities = 68/265 (25%), Positives = 126/265 (47%), Gaps = 34/265 (12%)
Query: 13 DFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV-----MEERGGSRKIFLDEVSVLLRVS 64
+F+I +IG G S VY A L D A+K+V M+ + +R+ + E+ +L +++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK--ARQDCVKEIDLLKQLN 60
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
HPN++ L +E E ++LE LA+ +M Y+ + ++ + + A+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLE-LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
E++HS+ ++HRDIK +N+ + KL D GL + F+ ++ S+ G+ Y
Sbjct: 120 EHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FS--SKTTAAHSLVGTPYY 172
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA----TLAEWTEECRRNKNVEVW 240
+ ++ + KSD++S G LL E+ G +L + E+C
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY------- 225
Query: 241 AQMLDPKLNGDANMEQLRVLIRICM 265
P L + E+LR L+ +C+
Sbjct: 226 -----PPLPTEHYSEKLRELVSMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-13
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 22/196 (11%)
Query: 30 ELGDGNFGAVKR------------VMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE 77
+LG G FG V ++ S + FL E V+ ++ H LV L E
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIH 137
+ ++ EY++ SL D + G+ L + +A IA + Y+ +H
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVH 125
Query: 138 RDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVST 197
RD++++NIL+ ++ K+ADFGL +L D RQ + K + G +
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGA-KFPIKWTAPEAALYGRFTI 182
Query: 198 KSDVYSFGVLLLELIT 213
KSDV+SFG+LL EL T
Sbjct: 183 KSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 7e-13
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 18 IGVGATSFVYLAEL-GDGNFGAVKRV----MEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
+GVG V L ++ A+K V + E G IF E +L +HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKL- 58
Query: 73 GFCLEKGEQLL--LLEYLANKSLFDRMHTYYGQSLGVLS-WSNRLSIALDIARALEYLHS 129
+ K ++ + L+EY L+ + G+ ++ R IA + A EYLH+
Sbjct: 59 -YRTFKDKKYIYMLMEYCLGGELWTILR-----DRGLFDEYTARFYIAC-VVLAFEYLHN 111
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCK-LGPFNDPNRPKRQTSIKGSFGYV-DT 187
+ II+RD+K N+LL + + KL DFG K L ++ + G+ YV
Sbjct: 112 RG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK------SGQKTWTFCGTPEYVAPE 162
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITG 214
LN G+ D +S G+LL EL+TG
Sbjct: 163 IILNKGY-DFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 9e-13
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 18 IGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLD--------EVSVL-LRVSHPN 67
+G G+ V LAEL G G + AVK + ++ + +D E VL L +P
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKD-----VVLIDDDVECTMVEKRVLALAWENPF 57
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
L L K ++E+L L ++ Q G A +I L++L
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLM-----FHIQDKGRFDLYRATFYAAEIVCGLQFL 112
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
HS+ II+RD+K N++L D H K+ADFG+CK F D R ++ G+ Y+
Sbjct: 113 HSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----NRASTFCGTPDYIAP 165
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITGLKSIQG 220
L + D +SFGVLL E++ G G
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-13
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 28 LAELGDGNFG-------------------AVKRVME-ERGGSRKIFLDEVSVLLRVSHPN 67
+ ELG G+FG A+K V E R FL+E SV+ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFD-----RMHTYYGQSLGVLSWSNRLSIALDIAR 122
+V LLG L+++E +A L R LG + + +A +IA
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP--KRQTSIKG 180
+ YL ++ +HRD+ + N ++ +D K+ DFG+ + D R K ++
Sbjct: 131 GMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 186
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
++ L G +TKSDV+SFGV+L E+ T
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 62/215 (28%), Positives = 88/215 (40%), Gaps = 52/215 (24%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGS----RKI-------------FLDEVSVLLRVSHPN 67
F L E+G G+FGAV + R +K+ + EV L ++ HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 68 LVGLLGFCLEKGEQLLLLEY-LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
+ G L + L++EY L + S +H Q + + + I + L Y
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA------ICHGALQGLAY 130
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL-GPFNDPNRPKRQTSIKGSFGYV 185
LHS IHRDIK+ NILL + KLADFG L P N +V
Sbjct: 131 LHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS---------------FV 172
Query: 186 DTNY---------LNTGFVSTKSDVYSFGVLLLEL 211
T Y ++ G K DV+S G+ +EL
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-12
Identities = 50/183 (27%), Positives = 90/183 (49%), Gaps = 12/183 (6%)
Query: 38 AVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDR 96
AVK + E+ +R FL E+ ++ R+ PN++ LL C+ ++ EY+ N L
Sbjct: 50 AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109
Query: 97 MHTYYGQSLGV------LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD 150
+ + Q +S+S + +A IA ++YL S +HRD+ + N L+ +
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKN 166
Query: 151 NHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLE 210
K+ADFG+ + D R + + + ++ + G +T SDV++FGV L E
Sbjct: 167 YTIKIADFGMSRNLYSGDYYRIQGRAVL--PIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 211 LIT 213
++T
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 36/211 (17%)
Query: 23 TSFVYLAELGDGNFGAVKRVMEERGG---SRKI------------FLDEVSVLLRVSHPN 67
F L ELG GN G V +V+ G +RK+ + E+ VL + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYG----QSLGVLSWSNRLSIALDIARA 123
+VG G GE + +E++ SL D++ G LG ++SIA + R
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILG------KISIA--VLRG 111
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
L YL + I+HRD+K SNIL+ KL DFG+ G D S G+
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID----SMANSFVGTRS 163
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ L + +SD++S G+ L+E+ G
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 48/182 (26%), Positives = 87/182 (47%), Gaps = 18/182 (9%)
Query: 38 AVKRVMEE-RGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFD 95
AVK + R+ + E+ ++ + +H N+V LLG C G L++ EY L +
Sbjct: 69 AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN 128
Query: 96 RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKL 155
+ + L+ + LS + +A+ + +L S+ IHRD+ + N+LL K+
Sbjct: 129 FLRR---KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182
Query: 156 ADFGLCKLGPFNDPNRPKRQTSIKGS----FGYVDTNYLNTGFVSTKSDVYSFGVLLLEL 211
DFGL + ND N +KG+ ++ + + +SDV+S+G+LL E+
Sbjct: 183 CDFGLAR-DIMNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
Query: 212 IT 213
+
Sbjct: 237 FS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 11/208 (5%)
Query: 6 ELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH 65
E+ + ++G G V++A AVK M+ S + FL E +V+ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVK-TMKPGSMSVEAFLAEANVMKTLQH 60
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE 125
LV L + K ++ E++A SL D + + G + + + IA +
Sbjct: 61 DKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQIAEGMA 116
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
++ + IHRD++++NIL+ K+ADFGL ++ D R+ + K +
Sbjct: 117 FIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGA-KFPIKWT 170
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+N G + KSDV+SFG+LL+E++T
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-12
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+++G G V++ +G + ++ + FL E ++ ++ H LV L
Sbjct: 12 VKLGQGCFGEVWMGTW-NGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
E+ ++ E++ SL D + G+ L + + +A IA + Y+
Sbjct: 71 SEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKL---PQLVDMAAQIADGMAYIERMN---Y 123
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV 195
IHRD++++NIL+ D+ K+ADFGL +L D RQ + K + G
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGA-KFPIKWTAPEAALYGRF 180
Query: 196 STKSDVYSFGVLLLELIT 213
+ KSDV+SFG+LL EL+T
Sbjct: 181 TIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 40/211 (18%)
Query: 25 FVYLAELGDGNFGAVKRV---------------MEERGGSRKIFLDEVSVLLRVSHPNLV 69
F ++ELG GN G V +V +E + R + E+ VL + P +V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRL------SIALDIARA 123
G G GE + +E++ SL D+ VL + R+ +++ + R
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSL-DQ----------VLKEAKRIPEEILGKVSIAVLRG 115
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
L YL + I+HRD+K SNIL+ KL DFG+ G D S G+
Sbjct: 116 LAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID----SMANSFVGTRS 167
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ L S +SD++S G+ L+EL G
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 34/216 (15%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVLLRVSH 65
F +L LG G+FG V ++ ER G+ +++ + E VL
Sbjct: 2 FNFLMVLGKGSFGKV--MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 66 PNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
P + L C + ++L ++EY+ L Y Q +G + + A +IA L
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLM-----YQIQQVGRFKEPHAVFYAAEIAIGL 114
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
+LHS+ II+RD+K N++L + H K+ADFG+CK ++ + G+ Y
Sbjct: 115 FFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT----TKTFCGTPDY 167
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQG 220
+ + D ++FGVLL E++ G +G
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 51/212 (24%)
Query: 30 ELGDGNFG--------------AVKRVMEERGGSRK--IFLDEVSVLLRV-SHPNLVGLL 72
+LGDG FG A+K+ M+++ S + + L EV L ++ HPN+V L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKK-MKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
E E + EY+ +L+ M G+ S S SI I + L ++H
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGK---PFSESVIRSIIYQILQGLAHIHKHG- 119
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCK----LGPFNDPNRPKRQTSIKGSFGYVDTN 188
HRD+K N+L+ K+ADFGL + P+ D YV T
Sbjct: 120 --FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD---------------YVSTR 162
Query: 189 Y-------LNTGFVSTKSDVYSFGVLLLELIT 213
+ L + S+ D+++ G ++ EL T
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 48/151 (31%), Positives = 63/151 (41%), Gaps = 25/151 (16%)
Query: 31 LGDGNFGAVKRVMEERGGS-------RK---IFLDEVS-------VLLRVSHPNLVGLLG 73
LG G FG V V E+ G +K I DEV+ VL HP L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
++EY LF ++ V S +I AL YLHS
Sbjct: 63 SFQTHDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164
+++RD+K N++L D H K+ DFGLCK G
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 26/206 (12%)
Query: 24 SFVYLAELGDGNFGAVKRVMEERGGS----RKIFLD------------EVSVLLRVSHPN 67
+F + ++G+G +G V + + G +KI LD E+S+L ++HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+V LL + + L+ E+L ++ L M L + S + + L +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMD---ASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
HS ++HRD+K N+L+ + KLADFGL + F P R + + +
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEI 171
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELIT 213
L + ST D++S G + E++T
Sbjct: 172 -LLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-12
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 13 DFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV------MEERGGSRKIFLDEVSVLLRV 63
DF++ ++G G+ VY + L D F A+K V +ER + ++E+ +L V
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDA----VNEIRILASV 56
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVL-----SWSNRLSIAL 118
+HPN++ L+ + +++EY L + + L W I +
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISK--RKKKRKLIPEQEIW----RIFI 110
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
+ R L+ LH Q I+HRD+KS+NILL+ ++ K+ D G+ K+ N K Q
Sbjct: 111 QLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-- 162
Query: 179 KGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
G+ Y+ S KSD++S G LL E+ T
Sbjct: 163 -GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-12
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 35/212 (16%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSR-----KIFLDEVSVLLRVSHPNLVGL 71
+G GA VYL ++ G AVK+V + E+ +L + H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 72 LGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
G CL E L + +EY+ S+ D++ Y G L+ + I +EYLHS
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSN 123
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT---------SIKGS 181
I+HRDIK +NIL + KL DFG K + QT S+ G+
Sbjct: 124 M---IVHRDIKGANILRDSAGNVKLGDFGASK----------RLQTICSSGTGMKSVTGT 170
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
++ ++ K+DV+S G ++E++T
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-12
Identities = 65/240 (27%), Positives = 103/240 (42%), Gaps = 54/240 (22%)
Query: 30 ELGDGNFG-------------------AVKRVMEERGGSRKI-FLDEVSVLLRVSHPNLV 69
ELG G+FG A+K V E +I FL+E SV+ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 70 GLLGFCLEKGEQLLLLEYLAN-------KSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
LLG + L+++E + +SL M Q+ L + +A +IA
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK--KMIQMAGEIAD 130
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
+ YL++ +HRD+ + N ++ +D K+ DFG+ + D R KG
Sbjct: 131 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-------KGGK 180
Query: 183 GYVDTNY-----LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV 237
G + + L G +T SDV+SFGV+L E+ ATLAE + N+ V
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI----------ATLAEQPYQGMSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-12
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 56/223 (25%)
Query: 31 LGDGNFGAVKR-----------------VMEERGGSR--KIFLDEVSVLLRVSHPNLVGL 71
LG G FG V + V+ E + K LDE V+ V P + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 72 LGFCLEKGEQLL--------LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
LG CL QL+ LL+Y+ DR+ + +L+W + IA+
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENK--DRIGSQD-----LLNW------CVQIAKG 121
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
+ YL + ++HRD+ + N+L+ NH K+ DFGL +L + +T G
Sbjct: 122 MSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID-------ETEYHADGG 171
Query: 184 YVDTNYLNTGFV-----STKSDVYSFGVLLLELIT-GLKSIQG 220
V ++ + + +SDV+S+GV + EL+T G K G
Sbjct: 172 KVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-12
Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLR-VSHPNLVGLL 72
IG G+ V LA + F AVK + ++ + K + E +VLL+ V HP LVGL
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 73 GFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
F + ++L +L+Y+ LF Y+ Q A +IA AL YLHS
Sbjct: 62 HFSFQTADKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIASALGYLHSLN 116
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
I++RD+K NILL H L DFGLCK + N ++ G+ Y+ L+
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHN--GTTSTFCGTPEYLAPEVLH 169
Query: 192 TGFVSTKSDVYSFGVLLLELITGL 215
D + G +L E++ GL
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-12
Identities = 44/108 (40%), Positives = 60/108 (55%), Gaps = 10/108 (9%)
Query: 56 EVSVLLRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRL 114
E ++L V HP +V L+ + + G +L L+LEYL+ LF MH + G+
Sbjct: 50 ERNILEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELF--MHL---EREGIFMEDTAC 103
Query: 115 SIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162
+I+ ALE+LH Q II+RD+K NILL H KL DFGLCK
Sbjct: 104 FYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-12
Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 31 LGDGNFGAVKR-----------------VMEERGGSRKIF---LDEVSVLLRVSHPNLVG 70
LG G FG V + +++R G R+ F D + + + H +V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVR 73
Query: 71 LLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
LLG C G L L+ + SL D + Q L L+ + IA+ + YL
Sbjct: 74 LLGIC--PGASLQLVTQLSPLGSLLD----HVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
++HR++ + NILL D+ ++ADFG+ L +D + + K ++
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD--KKYFYSEHKTPIKWMALES 182
Query: 190 LNTGFVSTKSDVYSFGVLLLELIT 213
+ G + +SDV+S+GV + E+++
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-12
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 36/209 (17%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGG---SRKIF------------LDEVSVLLRVSHPNLV 69
F ++ELG GN G V +V + G +RK+ + E+ VL + P +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYG----QSLGVLSWSNRLSIALDIARALE 125
G G GE + +E++ SL D++ G Q LG ++SIA + + L
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILG------KVSIA--VIKGLT 117
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
YL + I+HRD+K SNIL+ KL DFG+ G D S G+ Y+
Sbjct: 118 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID----SMANSFVGTRSYM 169
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
L S +SD++S G+ L+E+ G
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 27/180 (15%)
Query: 48 GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGV 107
+R+ FL EV +L R+S PN+ LLG C +++EY+ N L + + ++ G+
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 108 ------LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHA-KLADFGL 160
LS+S L +A IA + YL S +HRD+ + N L+ N+ K+ADFG+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN-CLVGKNYTIKIADFGM 176
Query: 161 CKLGPFNDPNR-------PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ +D R P R + S L G +TKSDV++FGV L E++T
Sbjct: 177 SRNLYSSDYYRVQGRAPLPIRWMA-WESV------LL--GKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 18 IGVGATSFVYLAELG-DGNFGAVK----RVMEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
IG G+ V LA+ DG AVK +++ R + I + +L V HP LVGL
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 73 GFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
+ + E+L +L+++ LF ++ Q A +IA AL YLHS
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELF-----FHLQRERSFPEPRARFYAAEIASALGYLHSIN 116
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
I++RD+K NILL H L DFGLCK G + T+ G+ Y+ +
Sbjct: 117 ---IVYRDLKPENILLDSQGHVVLTDFGLCKEG----IAQSDTTTTFCGTPEYLAPEVIR 169
Query: 192 TGFVSTKSDVYSFGVLLLELITGL 215
D + G +L E++ GL
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 39/213 (18%)
Query: 31 LGDGNFGAVKRVM--EERGGSRKI-----------------FLDEVSVLLRVSHPNLVGL 71
LG G FG+V+ E G +K+ FL E + + HPN++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 72 LGFCLEKGEQ------LLLLEYLANKSLFDRMHTYY-----GQSLGVLSWSNRLSIALDI 120
+G L + +++L ++ + L HT+ G+ L + +DI
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDL----HTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
A +EYL S+ IHRD+ + N +L ++ +ADFGL K D R + + K
Sbjct: 123 ASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR--QGCASKL 177
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
++ L +T SDV++FGV + E++T
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 41/128 (32%), Positives = 59/128 (46%), Gaps = 10/128 (7%)
Query: 34 GNFGAVKRVME--ERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91
G A+K+ +E + +KI + E+ +L ++ H NLV L+ K L+ E++ +
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85
Query: 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN 151
L D G L S I R +E+ HS IIHRDIK NIL+
Sbjct: 86 VLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSG 137
Query: 152 HAKLADFG 159
KL DFG
Sbjct: 138 VVKLCDFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 37/98 (37%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT 176
A +I AL +LH + II+RD+K N+LL + H KLADFG+CK G FN K +
Sbjct: 102 AAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTS 154
Query: 177 SIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ G+ Y+ L D ++ GVLL E++ G
Sbjct: 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 13 DFRIRIGVGATSF--VYLAEL-GDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHP 66
DF + +G SF V +A+ G G + A+K + + + + E S+L+ +SHP
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS--IALDIARAL 124
+V ++ ++ LLE++ LF + + G + N ++ ++ A
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHL-----RKAG--RFPNDVAKFYHAELVLAF 131
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
EYLHS+ II+RD+K N+LL + H K+ DFG K P R ++ G+ Y
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-------KVPDRTFTLCGTPEY 181
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ + + D ++ GVLL E I G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 37/206 (17%)
Query: 31 LGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVLLRVSHPNLVGL 71
+G G+FG V +V + +++I+ L E +VL +V+ P +V L
Sbjct: 1 IGKGSFGKVMQV--RKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 72 LGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
F + E+L L+L ++ LF ++ Q G S ++ ALE LH
Sbjct: 59 -KFSFQSPEKLYLVLAFINGGELF-----HHLQREGRFDLSRARFYTAELLCALENLHKF 112
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
+I+RD+K NILL H L DFGLCKL +D + + G+ Y+ L
Sbjct: 113 N---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD----DKTNTFCGTPEYLAPELL 165
Query: 191 NTGFVSTKS-DVYSFGVLLLELITGL 215
G TK+ D ++ GVLL E++TGL
Sbjct: 166 -LGHGYTKAVDWWTLGVLLYEMLTGL 190
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 42/170 (24%), Positives = 82/170 (48%), Gaps = 27/170 (15%)
Query: 53 FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL--FDRMHTYYGQSLGVLSW 110
FL E S++ + HPN++ L G + +++ EY+ N SL F R + G +
Sbjct: 52 FLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND------GKFTV 105
Query: 111 SNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170
+ + IA ++YL ++ +HRD+ + NIL+ + K++DFGL + ++
Sbjct: 106 GQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162
Query: 171 R-------PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
P R T+ + + ++ SDV+SFG+++ E+++
Sbjct: 163 YTTKGGKIPIRWTAPEA---------IAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV-ME-ERGGSRKIFLDEVSVLLRVSHPNLVGL-- 71
RI G VY A + G A+K++ ME E+ G L E+++LL++ HPN+V +
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 72 --LGFCLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+G L+K +++EY+ + KSL + M + QS + L + + +L
Sbjct: 72 VVVGSNLDK--IYMVMEYVEHDLKSLMETMKQPFLQS-------EVKCLMLQLLSGVAHL 122
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
H I+HRD+K+SN+LL + K+ DFGL + + P K T + V T
Sbjct: 123 HDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSP--LKPYTQL------VVT 169
Query: 188 NY-------LNTGFVSTKSDVYSFGVLLLELITG 214
+ L ST D++S G + EL+T
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-11
Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 52/215 (24%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGS----RKI-------------FLDEVSVLLRVSHPN 67
F L E+G G+FGAV + R +K+ + EV L R+ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 68 LVGLLGFCLEKGEQLLLLEY-LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
+ G L + L++EY L + S +H Q + + + I + L Y
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------ITHGALQGLAY 140
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL-GPFNDPNRPKRQTSIKGSFGYV 185
LHS +IHRDIK+ NILL + KLADFG + P N +V
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS---------------FV 182
Query: 186 DTNY---------LNTGFVSTKSDVYSFGVLLLEL 211
T Y ++ G K DV+S G+ +EL
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 63/215 (29%), Positives = 90/215 (41%), Gaps = 52/215 (24%)
Query: 25 FVYLAELGDGNFGAVK-------------RVMEERGGSR----KIFLDEVSVLLRVSHPN 67
FV L E+G G+FGAV + M G + + EV L ++ HPN
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 68 LVGLLGFCLEKGEQLLLLEY-LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
+ G L++ L++EY L + S +H Q + + + I + L Y
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------ITHGALQGLAY 136
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFG-LCKLGPFNDPNRPKRQTSIKGSFGYV 185
LHS +IHRDIK+ NILL + KLADFG K P N +V
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS---------------FV 178
Query: 186 DTNY---------LNTGFVSTKSDVYSFGVLLLEL 211
T Y ++ G K DV+S G+ +EL
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 31/202 (15%)
Query: 31 LGDGNFGAVKRVMEERGGS-------RK---IFLDEVS-------VLLRVSHPNLVGLLG 73
LG G FG V V E+ G RK I DEV+ VL HP L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 61
Query: 74 FCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
+ + ++L ++EY LF ++ V + +I ALEYLHS+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELF-----FHLSRERVFTEERARFYGAEIVSALEYLHSRD- 115
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT 192
+++RDIK N++L D H K+ DFGLCK G + + G+ Y+ L
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLED 169
Query: 193 GFVSTKSDVYSFGVLLLELITG 214
D + GV++ E++ G
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-11
Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 38/231 (16%)
Query: 31 LGDGNFGAV------------------KRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
LG G FG V K+ +++R G ++ L+E +L +VS +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG-EQMALNEKKILEKVSSRFIVSL- 58
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
+ E + L L+ L N D + Y + + A I LE+LH +
Sbjct: 59 AYAFETKDDLCLVMTLMNGG--DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR- 115
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGL-CKLGPFNDPNRPKRQTSIK---GSFGYVDTN 188
I++RD+K N+LL D + +++D GL +L K IK G+ GY+
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVEL---------KGGKKIKGRAGTPGYMAPE 164
Query: 189 YLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEV 239
L D ++ G L E+I G + E E RR + V
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-11
Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 31 LGDGNFG--------------AVKRVMEERGGSRK---IFLDEVSVLLRVSHPNLVGLLG 73
LG G FG A K++ ++R RK + L+E +L +V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI--ALDIARALEYLHSQA 131
+ E + L L+ L N + H Y ++G + ++ A +I LE LH +
Sbjct: 67 YAYETKDALCLVLTLMNGGDL-KFHIY---NMGNPGFDEERAVFYAAEITCGLEDLHRER 122
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
I++RD+K NILL D H +++D GL P + R + G+ GY+ +
Sbjct: 123 ---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR-----VGTVGYMAPEVVK 174
Query: 192 TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVE 238
+ D + G L+ E+I G + + E RR K +
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-11
Identities = 56/163 (34%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 56 EVSVLLRV-SHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNR 113
E VL V P LV L + + +L L+L+Y+ LF T+ Q R
Sbjct: 54 ERQVLEAVRRCPFLVTLH-YAFQTDTKLHLILDYVNGGELF----THLYQREHFTESEVR 108
Query: 114 LSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173
+ IA +I AL++LH II+RDIK NILL + H L DFGL K F +
Sbjct: 109 VYIA-EIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE--FL-AEEEE 161
Query: 174 RQTSIKGSFGYVDTNYLNTGFVSTKS--DVYSFGVLLLELITG 214
R S G+ Y+ + G D +S GVL EL+TG
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-11
Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 11/150 (7%)
Query: 17 RIGVGATSFVYLAELGD-GNFGAVKRVM--EERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
+IG G+ V+ + G A+K+ + E+ +KI L E+ +L ++ HPNLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
K + L+ EY + L + GV + I +A+ + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVL----NELEKNPRGVPEHLIK-KIIWQTLQAVNFCHKHN-- 120
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKL 163
IHRD+K NIL+ KL DFG ++
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-11
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 44/218 (20%)
Query: 28 LAELGDGNFG-------------------AVKRVMEERGGSRKI-FLDEVSVLLRVSHPN 67
L ELG G+FG AVK V E +I FL+E SV+ + +
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70
Query: 68 LVGLLGFCLEKGEQLLLLEYLAN-------KSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
+V LLG + L+++E +A+ +SL G+ L + +A +I
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEI 128
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
A + YL+++ +HRD+ + N ++ D K+ DFG+ + D R KG
Sbjct: 129 ADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-------KG 178
Query: 181 SFGYVDTNY-----LNTGFVSTKSDVYSFGVLLLELIT 213
G + + L G +T SD++SFGV+L E+ +
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 38/111 (34%), Positives = 53/111 (47%), Gaps = 17/111 (15%)
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK-LGPFNDPNRPKRQTSIKG 180
+AL+Y+HS +IHRD+K SNILL D KLADFGL + L + T
Sbjct: 118 KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD--- 171
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGV-------LLLELITGLKSIQGSATL 224
YV T + + S Y+ GV +L E++ G G++TL
Sbjct: 172 ---YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-11
Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 26/172 (15%)
Query: 52 IFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL----LLLEYLANKSLFDRMHTYYGQSLGV 107
I +E+ L R+ N++ + GF ++ + L L+LEY L R + L
Sbjct: 64 ITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYL--REVLDKEKDL-- 119
Query: 108 LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL---G 164
S+ +L +A+D + L L+ + P ++++ S + L+ ++ K+ GL K+
Sbjct: 120 -SFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP 176
Query: 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGF--VSTKSDVYSFGVLLLELITG 214
PF + N Y LN F + K D+YS GV+L E+ TG
Sbjct: 177 PFKNVN----------FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-11
Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 18 IGVGATSFVYLAELGDGNFGAVKRVMEERGGS-------RKIFLDEVSVLLRVSHPNLVG 70
+G GA VY G AVK+V + K+ +EV +L + H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKL-QEEVDLLKSLKHVNIVQ 66
Query: 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
LG CL+ + +E++ S+ ++ + V + I + YLH
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-----QILDGVAYLH-- 119
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT--SIKGSFGYVDTN 188
+ ++HRDIK +N++L+ + KL DFG + + + S+ G+ ++
Sbjct: 120 -NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 189 YLNTGFVSTKSDVYSFGVLLLELITG 214
+N KSD++S G + E+ TG
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-11
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 6 ELKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS 64
E + N R+ +G G VY A +L A+K + E + +E+++ +
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK 63
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL---DIA 121
H N+V LG E G + +E + SL + + +G N +I I
Sbjct: 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLK-----DNEQTIIFYTKQIL 118
Query: 122 RALEYLHSQADPPIIHRDIKSSNILL-IDDNHAKLADFGLCK-LGPFNDPNRPKRQTSIK 179
L+YLH I+HRDIK N+L+ K++DFG K L N P +T
Sbjct: 119 EGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN----PCTET-FT 170
Query: 180 GSFGYVDTNYLNTGF--VSTKSDVYSFGVLLLELITG 214
G+ Y+ ++ G +D++S G ++E+ TG
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-11
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 52/214 (24%)
Query: 28 LAELGDGNFGAVKRVMEERGG---SRKI-----------FLDEVSVLLRVSHPNLVGLLG 73
+ ELGDG FG V + + G + K+ ++ E+ +L +HP +V LLG
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 74 FCLEKGEQLLLLEYLANKSL------FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
G+ +++E+ ++ DR L+ I + AL+YL
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRG----------LTEPQIQVICRQMLEALQYL 126
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV-- 185
HS IIHRD+K+ N+LL D KLADFG+ N +R + I +
Sbjct: 127 HSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAK---NVKTLQRRDSFIGTPYWMAPE 180
Query: 186 --------DTNYLNTGFVSTKSDVYSFGVLLLEL 211
DT Y K+D++S G+ L+E+
Sbjct: 181 VVMCETMKDTPY------DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 36/205 (17%)
Query: 31 LGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVL-LRVSHPNLVG 70
LG G+FG V ++ E G+ +++ + E +L L HP L
Sbjct: 3 LGKGSFGKV--MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 71 LLGFCLEKGEQLL-LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L C + ++L ++EY+ L ++ Q A ++ AL +LH
Sbjct: 61 LHC-CFQTKDRLFFVMEYVNGGDLMFQI-----QRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
+I+RD+K NILL + H KLADFG+CK G N T+ G+ Y+
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTTFCGTPDYIAPEI 167
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
L D ++ GVL+ E++ G
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 56/215 (26%)
Query: 31 LGDGNFGAVKR---VMEERGGSRKIF-LD-----------EVSVLLRVSH---PNLVGLL 72
+G G +GAV R V R + KI LD EV++L ++ PN+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS------IALDIARALEY 126
G KG +L ++ M G S+ L + ++ I ++ AL+Y
Sbjct: 69 G-SYLKGPRLWII-----------MEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
+H +IHRDIK++NIL+ + + KL DFG+ L N N KR T +V
Sbjct: 117 IHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQ-NSSKRST-------FVG 163
Query: 187 TNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
T Y + TK+D++S G+ + E+ TG
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 53/177 (29%), Positives = 80/177 (45%), Gaps = 46/177 (25%)
Query: 56 EVSVLLRVSHPNLVGLLG-FC----LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSW 110
E+ +L + H N++GLL F LE + + L+ +L G L +
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM------------GADLNNIVK 111
Query: 111 SNRLS------IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164
+LS + I R L+Y+HS A IIHRD+K SNI + +D K+ DFGL
Sbjct: 112 CQKLSDDHIQFLVYQILRGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLA--- 165
Query: 165 PFNDPNRPKRQTSIKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
R T + + GYV T + LN + D++S G ++ EL+TG
Sbjct: 166 ---------RHTDDEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 62/225 (27%)
Query: 31 LGDGNFG-----------------AVKRVMEERGGSRK-IFLDEVSVLLRVSHPNLVGLL 72
+G+G FG AVK S + FL E ++ + HP++V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 73 GFCLE-----------KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
G E GE L YL SL + S + + ++
Sbjct: 74 GVITENPVWIVMELAPLGE---LRSYL----------QVNKYSLDLASL---ILYSYQLS 117
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
AL YL S+ +HRDI + N+L+ + KL DFGL + D ++ K S
Sbjct: 118 TALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LED------ESYYKAS 166
Query: 182 FGYVDTNYL-----NTGFVSTKSDVYSFGVLLLE-LITGLKSIQG 220
G + ++ N ++ SDV+ FGV + E L+ G+K QG
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 64/237 (27%)
Query: 28 LAELGDGNFGAVKRVMEERGGSR----------------KIFLDEVSVLLRVSHPNLVGL 71
L ++G G +G V ++ R G++ K E+ +L + H N++GL
Sbjct: 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYY------GQSLGVLSWSNRLS------IALD 119
L + + SL DR H +Y G LG L +LS +
Sbjct: 80 LDV------------FTPDLSL-DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ 126
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
+ + L+Y+H+ IIHRD+K N+ + +D K+ DFGL RQT +
Sbjct: 127 MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA------------RQTDSE 171
Query: 180 GSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE 229
+ GYV T + LN + D++S G ++ E++TG +G L + E
Sbjct: 172 MT-GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 59/201 (29%), Positives = 82/201 (40%), Gaps = 29/201 (14%)
Query: 31 LGDGNFGAVKRVMEERGG---SRKIF--------------LDEVSVLLRVSHPNLVGLLG 73
LG G FG V V E+ G + KI L E VL HP L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
K ++EY+ LF ++ V S +I AL+YLHS
Sbjct: 63 SFQTKDRLCFVMEYVNGGELF-----FHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG 193
I++RD+K N++L D H K+ DFGLCK G D K + G+ Y+ L
Sbjct: 116 -IVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMK---TFCGTPEYLAPEVLEDN 170
Query: 194 FVSTKSDVYSFGVLLLELITG 214
D + GV++ E++ G
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 44/166 (26%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 50 RKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL--FDRMHTYYGQSLGV 107
R+ FL E S++ + HPN++ L G + +++ EY+ N SL F R H G
Sbjct: 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD------GQ 102
Query: 108 LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
+ + + IA ++YL +D +HRD+ + NIL+ + K++DFGL ++ +
Sbjct: 103 FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-D 158
Query: 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
DP K + + ++ SDV+S+G+++ E+++
Sbjct: 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
+HP LVGL + ++EY+ L ++ Q L + + +I+ A
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLM-----FHMQRQRKLPEEHARFYSAEISLA 108
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS-IKGSF 182
L YLH + II+RD+K N+LL + H KL D+G+CK G RP TS G+
Sbjct: 109 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-----RPGDTTSTFCGTP 160
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ L D ++ GVL+ E++ G
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 41/129 (31%), Positives = 70/129 (54%), Gaps = 7/129 (5%)
Query: 87 YLANKSLFDRMHTYYGQSLG--VLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSN 144
++ +KSL D G L L+ + +S + +AR +E+L S+ IHRD+ + N
Sbjct: 147 FIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARN 203
Query: 145 ILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSF 204
ILL ++N K+ DFGL + + DP+ R+ + ++ + +T+SDV+SF
Sbjct: 204 ILLSENNVVKICDFGLAR-DIYKDPDY-VRKGDARLPLKWMAPESIFDKVYTTQSDVWSF 261
Query: 205 GVLLLELIT 213
GVLL E+ +
Sbjct: 262 GVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 42/209 (20%)
Query: 28 LAELGDGNFGAVKRVMEERGG---SRKI-----------FLDEVSVLLRVSHPNLVGLLG 73
+ ELGDG FG V + + G + K+ ++ E+ +L HPN+V LL
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+ +L+E+ A ++ M + L+ + AL YLH +
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVML----ELERPLTEPQIRVVCKQTLEALNYLH---EN 122
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG 193
IIHRD+K+ NIL D KLADFG+ K +I+ ++ T Y
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGV----------SAKNTRTIQRRDSFIGTPYWMAP 172
Query: 194 FV-----------STKSDVYSFGVLLLEL 211
V K+DV+S G+ L+E+
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 30/202 (14%)
Query: 31 LGDGNFGAVKRVMEERGG---SRKIFLDEV--------------SVLLRVSHPNLVGLLG 73
LG G FG V V E+ G + KI EV VL HP L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-K 61
Query: 74 FCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
+ + ++L ++EY LF ++ V S +I AL+YLHS+ +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT 192
+++RD+K N++L D H K+ DFGLCK G D K + G+ Y+ L
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMK---TFCGTPEYLAPEVLED 170
Query: 193 GFVSTKSDVYSFGVLLLELITG 214
D + GV++ E++ G
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 29/152 (19%)
Query: 28 LAELGDGNFGAVKRVMEERGGS----RKIFLD------------EVSVLLRVSHPNLVGL 71
+ ++G+G +G V + ++ G +KI L+ E+S+L ++HPN+V L
Sbjct: 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLG---VLSWSNRLSIALDIARALEYLH 128
L + + L+ E+L + L M + L + S+ +L + + Y H
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQL------LQGIAYCH 116
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160
S ++HRD+K N+L+ + KLADFGL
Sbjct: 117 SHR---VLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 49/216 (22%), Positives = 92/216 (42%), Gaps = 34/216 (15%)
Query: 24 SFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSV------------------------ 59
+ L LG G FG V +V ++ G + L E++V
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 60 LLR--VSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIA 117
+++ + HPN+V LE ++++ + L + ++ + + +I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIF 119
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
+ + AL YLH + I+HRD+ +NI+L +D+ + DFGL K + TS
Sbjct: 120 VQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTS 172
Query: 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ G+ Y + K+DV++FG +L ++ T
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 70/232 (30%), Positives = 99/232 (42%), Gaps = 33/232 (14%)
Query: 13 DFRIRIGVGATSFVYLAELGD-GNFGAVKRVM--EERGGSRKIFLDEVSVLLRVSHPNLV 69
D +IG G VY A D G A+K+V E+ G + E+ +L +++H N+V
Sbjct: 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 70 GL----------LGFCLEKGEQLLLLEYLANKSLFDRMHTYYG---QSLGVLSWSNRLSI 116
L L F +KG L+ EY+ H G L S + S
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMD--------HDLMGLLESGLVHFSEDHIKSF 121
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN-DPNRPKRQ 175
+ L Y H + +HRDIK SNILL + KLADFGL +L +N + +RP
Sbjct: 122 MKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARL--YNSEESRPYTN 176
Query: 176 TSIKGSFGYVDTNYLNTGFVSTKS-DVYSFGVLLLELITGLKSIQGSATLAE 226
I + Y L + DV+S G +L EL T Q + LA+
Sbjct: 177 KVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 64 SHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
S+P LVGL C + +L L++EY+ L ++ Q L + A +I
Sbjct: 54 SNPFLVGLHS-CFQTTSRLFLVIEYVNGGDLM-----FHMQRQRKLPEEHARFYAAEICI 107
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS-IKGS 181
AL +LH + II+RD+K N+LL D H KL D+G+CK G P TS G+
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-----GPGDTTSTFCGT 159
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ L D ++ GVL+ E++ G
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 34/217 (15%)
Query: 24 SFVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVLLRVS 64
F +L LG G+FG V ++ ER G+ +++ + E VL
Sbjct: 1 DFNFLMVLGKGSFGKV--MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 65 HPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
P + L C + ++L ++EY+ L Y+ Q +G + A +I+
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLM-----YHIQQVGKFKEPQAVFYAAEISVG 113
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
L +LH + II+RD+K N++L + H K+ADFG+CK + + G+
Sbjct: 114 LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT----TRTFCGTPD 166
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQG 220
Y+ + D +++GVLL E++ G G
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 24 SFVYLAELGDGNFGAVKRVMEERGG----------------SRKIFLDEVSVLLRVSHPN 67
++ ++ +G G++G V V G RK E +L ++ HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 68 LVGLL-GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSL---GVLSWSNRLSIALDIARA 123
+V + E G +++ + L+ ++ G+ L V+ W + IA A
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMA 114
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
L+YLH + I+HRD+K+ N+ L N K+ D G+ ++ N+ +++ G+
Sbjct: 115 LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV----LENQCDMASTLIGTPY 167
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
Y+ + + KSDV++ G + E+ T
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-10
Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 29/169 (17%)
Query: 56 EVSVLLRVSHPNLVGLLGFCLEKGEQLL--LLEYLANKSLFDRMHTYYGQSLGVLSWSNR 113
E+ +L + H +V G ++ E+ L +EY+ S+ D++ Y G L+ S
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-----GALTESVT 108
Query: 114 LSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173
I + YLHS I+HRDIK +NIL + KL DFG K +
Sbjct: 109 RKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK----------R 155
Query: 174 RQT---------SIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
QT S+ G+ ++ ++ K+DV+S G ++E++T
Sbjct: 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-10
Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 16/153 (10%)
Query: 64 SHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
+HP LVGL C + +L ++E+++ L M Q L + + +I+
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHM-----QRQRKLPEEHARFYSAEISL 107
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS-IKGS 181
AL +LH + II+RD+K N+LL + H KL D+G+CK G RP TS G+
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-----RPGDTTSTFCGT 159
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ L D ++ GVL+ E++ G
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 24 SFVYLAE-LGDGNFGAVKR--------------VMEERGG----SRKIFLDEVSVLLRVS 64
S V + E +G G FG V R + + G R+ FL E S++ +
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 63
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
HPN++ L G + +++ E++ N +L ++ Q+ G + + + IA +
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGAL----DSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
+YL ++ +HRD+ + NIL+ + K++DFGL + +D + P +S+ G
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE-DDTSDPTYTSSLGGKIPI 175
Query: 185 VDTNYLNTGF--VSTKSDVYSFGVLLLELIT 213
T + ++ SDV+S+G+++ E+++
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 18/167 (10%)
Query: 18 IGVGATSFVYLA---ELGDGNFGAVKRV---MEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
IG G VY A DG A+K+ E+ G + E+++L + H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 72 LGFCLEKGEQL--LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
+ LE ++ LL +Y A L+ + + + S S+ I + YLHS
Sbjct: 68 VEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 130 QADPPIIHRDIKSSNILLIDDNHA----KLADFGLCKLGPFNDPNRP 172
++HRD+K +NIL++ + K+ D GL +L FN P +P
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL--FNAPLKP 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 64/234 (27%), Positives = 96/234 (41%), Gaps = 46/234 (19%)
Query: 22 ATSFVYLAELGDGNFGAV----KRV-----------MEERGGSRKIFLDEVSVLLRVSHP 66
ATS++ L +LG+G++ V R+ M+ G + E S+L + H
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHT----YYGQSLGVLSWSNRLSIALDIAR 122
N+V LL + E L + F+ MHT Y Q G L N + R
Sbjct: 64 NIV-LLHDIIHTKETLTFV--------FEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
L Y+H Q I+HRD+K N+L+ KLADFGL R K S S
Sbjct: 115 GLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLA---------RAKSIPSQTYSS 162
Query: 183 GYVDTNY------LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE 230
V Y L S+ D++ G + +E++ G + G + + E E+
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 28/225 (12%)
Query: 31 LGDGNFG--------------AVKRVMEERGGSRK---IFLDEVSVLLRVSHPNLVGLLG 73
LG G FG A KR+ ++R RK + L+E +L +V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+ E + L L+ + N + H Y + G L A +I LE LH +
Sbjct: 67 YAYETKDALCLVLTIMNGGDL-KFHIYNMGNPG-FEEERALFYAAEILCGLEDLHREN-- 122
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG 193
++RD+K NILL D H +++D GL P + R + G+ GY+ LN
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-----VGTVGYMAPEVLNNQ 176
Query: 194 FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVE 238
+ D + G L+ E+I G +G + E RR E
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 38/108 (35%), Positives = 53/108 (49%), Gaps = 19/108 (17%)
Query: 116 IALDIARALEYL---HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
+ + I +AL YL H +IHRD+K SNILL + KL DFG+ G D
Sbjct: 119 MTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD---S 168
Query: 173 KRQTSIKGSFGY-----VDTNYLNTGFVSTKSDVYSFGVLLLELITGL 215
K +T G Y +D N + ++DV+S G+ L+EL TG
Sbjct: 169 KAKTRSAGCAAYMAPERIDPPDPNPKY-DIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 17/102 (16%)
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
I R L+YLHS A+ +IHRD+K SNIL+ + K+ DFGL + D + T
Sbjct: 112 ILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGV-DPDEDEKGFLT--- 164
Query: 180 GSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
YV T + L++ + D++S G + EL+T
Sbjct: 165 ---EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 52/215 (24%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGS----RKI-------------FLDEVSVLLRVSHPN 67
F L E+G G+FGAV + R +K+ + EV L ++ HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 68 LVGLLGFCLEKGEQLLLLEY-LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
+ G L + L++EY L + S +H Q + + + + + L Y
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------VTHGALQGLAY 130
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL-GPFNDPNRPKRQTSIKGSFGYV 185
LHS +IHRD+K+ NILL + KL DFG + P N +V
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX---------------FV 172
Query: 186 DTNY---------LNTGFVSTKSDVYSFGVLLLEL 211
T Y ++ G K DV+S G+ +EL
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 26/201 (12%)
Query: 31 LGDGNFGAVKRVMEERGG------------------SRKIFLDEVSVLLRVSHPNLVGLL 72
+G G FG V R + + G R+ FL E S++ + SH N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
G + +++ EY+ N +L D+ Y G S + + IA ++YL +D
Sbjct: 73 GVVTKFKPAMIITEYMENGAL-DK---YLRDHDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT 192
+HRD+ + NIL+ + K++DFGL ++ +DP + K + +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 193 GFVSTKSDVYSFGVLLLELIT 213
++ SDV+SFG+++ E+++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 50/217 (23%)
Query: 31 LGDGNFGAVKRVMEERGGSRKI--FLD-----------EVSVLLRVS-HPNLVGLLGFCL 76
+G G +G V +V+ ++ GS+ LD E ++L +S HPN+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 77 EK----GEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS---IALDIARALEYLH 128
+K G+QL L+LE S+ D + G L R+ IA + AL L
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVK-------GFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGL-CKLGPFNDPNRPKRQTSIKGSF----- 182
IHRD+K +NILL + KL DFG+ +L R +R TS+ F
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL----TSTRLRRNTSVGTPFWMAPE 194
Query: 183 -----GYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+D+ Y + DV+S G+ +EL G
Sbjct: 195 VIACEQQLDSTY------DARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 55/216 (25%), Positives = 84/216 (38%), Gaps = 32/216 (14%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRVMEER--------GGSRKIFLDEVSVLLRVSHPNL 68
R G+ F L G G ++ + G R E +L ++HP++
Sbjct: 86 RAGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSI 145
Query: 69 VGLLG-FCLEKGEQLLLLEYLANKSLFDRMHTY-YGQSLGVLSWSNRLSIALDIARALEY 126
+ L G F K L+L Y + Y Y + ++ + L+I + RA++Y
Sbjct: 146 IQLKGTFTYNKFTCLILPRY--------KTDLYCYLAAKRNIAICDILAIERSVLRAIQY 197
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL-CKLGPFNDPNRPKRQTSIKGSFGYV 185
LH IIHRDIK+ NI + L DFG C N G G +
Sbjct: 198 LHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-------ANKYYGWAGTI 247
Query: 186 DTN---YLNTGFVSTKSDVYSFGVLLLELITGLKSI 218
TN L D++S G++L E+ T S+
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 11/110 (10%)
Query: 110 WSNRLSI------ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163
W + L++ + +AR +E+L S+ IHRD+ + NILL ++N K+ DFGL +
Sbjct: 167 WKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR- 222
Query: 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ DP+ R+ S + ++ + +T+SDV+SFGVLL E+ +
Sbjct: 223 DIYKDPDY-VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-09
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 15 RIRI-GVGATSFVYLAE-LGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVG 70
+IR+ G GA V+L D +K++ E+ R +E VL +SHPN++
Sbjct: 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
LE ++++EY +L + + + +L L + I AL ++H++
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQK---RCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 131 ADPPIIHRDIKSSNILLIDDNH---AKLADFGLCK-LGPFNDPNRPKRQTSIKGSFGYVD 186
I+HRD+K+ NILL D H K+ DFG+ K L ++ K T + G+ Y+
Sbjct: 121 L---ILHRDLKTQNILL--DKHKMVVKIGDFGISKILS-----SKSKAYTVV-GTPCYIS 169
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ KSD+++ G +L EL +
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 18/150 (12%)
Query: 107 VLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166
VL+ + + + +A+ +E+L S+ IHRD+ + NILL ++N K+ DFGL + +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR-DIY 230
Query: 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAE 226
DP+ R+ + ++ + + +SDV+SFGVLL E+ + S + E
Sbjct: 231 KDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289
Query: 227 WTEECRRNK-----------NVEVWAQMLD 245
E CRR K E++ MLD
Sbjct: 290 --EFCRRLKEGTRMRAPDYTTPEMYQTMLD 317
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 36/117 (30%), Positives = 46/117 (39%), Gaps = 28/117 (23%)
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND-------------- 168
AL+ +H IHRDIK NIL+ D H KLADFGLCK
Sbjct: 113 ALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 169 -----------PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
R R S G+ Y+ L + D +S GV+L E++ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 63/242 (26%), Positives = 100/242 (41%), Gaps = 72/242 (29%)
Query: 31 LGDGNFGAVKRVMEERGGS----RKIF------------LDEVSVLLRVSHPNLVGLLGF 74
LG+G FG V + + + G +KI L E+ +L ++ HPN+V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 75 CLEKGEQLLLLEYLANKSLFDR----MHTYYGQS--LGVLSWSN-RLS------IALDIA 121
+E+ + KS R M T Y G+L + +L+ L +
Sbjct: 76 AVERPD----------KSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHA--KLADFGLCKLGPFNDPNRPKRQTSIK 179
+ YLH I+HRDIK++NIL+ DN K+ADFGL + P++ P + K
Sbjct: 126 EGINYLHENH---ILHRDIKAANILI--DNQGILKIADFGLAR--PYDGP-----PPNPK 173
Query: 180 GSFGYVDTNYLNTGFVSTK-----------------SDVYSFGVLLLELITGLKSIQGSA 222
G G Y T V T+ D++ G + E+ T +QG +
Sbjct: 174 GGGGGGTRKY--TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231
Query: 223 TL 224
+
Sbjct: 232 DI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 31 LGDGNFG--------------AVKRVMEERGGSRK---IFLDEVSVLLRVSHPNLVGLLG 73
LG G FG A K++ ++R RK + L+E +L +V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+ E + L L+ L N + H Y+ G + A +I LE LH +
Sbjct: 67 YAYETKDALCLVLTLMNGGDL-KFHIYHMGEAG-FEEGRAVFYAAEICCGLEDLHQER-- 122
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK---GSFGYVDTNYL 190
I++RD+K NILL D H +++D GL + P+ QT IK G+ GY+ +
Sbjct: 123 -IVYRDLKPENILLDDHGHIRISDLGLAV-------HVPEGQT-IKGRVGTVGYMAPEVV 173
Query: 191 NTGFVSTKSDVYSFGVLLLELITGLKSIQ 219
+ D ++ G LL E+I G Q
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 32/207 (15%)
Query: 25 FVYLAELGD-GNFGAVKRV-MEERGGSRKIFL-DEVSVLLRVSHPNLVGLLGFCLEKGEQ 81
V+LA+ AVK++ ++ L E+ ++ HPN++ + + E
Sbjct: 15 IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSEL 74
Query: 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL---DIARALEYLHSQADPPIIHR 138
++ +A S D + T++ + L L+IA D+ AL+Y+HS+ IHR
Sbjct: 75 YVVSPLMAYGSCEDLLKTHFPEGL------PELAIAFILKDVLNALDYIHSKG---FIHR 125
Query: 139 DIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN------- 191
+K+S+ILL D L+ GL KRQ + F L
Sbjct: 126 SVKASHILLSGDGKVVLS--GLRYSVSMI--KHGKRQRVVHD-FPKSSVKNLPWLSPEVL 180
Query: 192 ----TGFVSTKSDVYSFGVLLLELITG 214
G+ + KSD+YS G+ EL G
Sbjct: 181 QQNLQGY-NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 26/218 (11%)
Query: 24 SFVYLAELGDG--------------NFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPNL 68
++V L +LG+G N A+K + +E G+ + EVS+L + H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
V L + L+ EYL + + Y ++S N + R L Y H
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDSD-----LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
+ I+HRD+K N+L+ + KLADFGL + P + + + D
Sbjct: 121 KRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV--PTKTYSNEVVTLWYRPPDVL 175
Query: 189 YLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAE 226
+T + ST D++ G +L E+ TG GS E
Sbjct: 176 LGSTEY-STPIDMWGVGCILYEMATGRPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 37/118 (31%), Positives = 57/118 (48%), Gaps = 19/118 (16%)
Query: 101 YGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG- 159
Y G L ++I + AL YLH + IIHRD+K+ NI L + +A L DFG
Sbjct: 175 YVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA 231
Query: 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVS------TKSDVYSFGVLLLEL 211
CKL P+ P+ +G+ T N+ + K+D++S G++L E+
Sbjct: 232 ACKLD--AHPDTPQ-------CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 5e-09
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 22 ATSFVYLAELGDGNFGAVKR---------------VMEERGGSRKIFLDEVSVLLRVSHP 66
A S+ L +LG+G++ V + ++E G+ + E S+L + H
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
N+V L K L+ EY+ + Y + G L N + R L Y
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTD-----LCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
+H + I+HRD+K N+L+ D KLADFGL + P+ + + D
Sbjct: 119 IHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRPPD 173
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE 229
+T + ST D++ G + +E+I G+ + G + + E
Sbjct: 174 VLLGSTEY-STCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE 215
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 65/250 (26%), Positives = 95/250 (38%), Gaps = 48/250 (19%)
Query: 12 NDFRI--RIGVGATSFVYLAELGD-GNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSH 65
DF+I ++G G V+LA+ D G A+KR+ + + + L E +L
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 66 PNLVGLLGFCLEKGEQLLL-LEY---------LANKSLFDRMHTYYGQSLGVLSWSNRLS 115
LV LL + + E L L +EY L N + H R
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA-------------RFY 106
Query: 116 IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175
+A ++ A++ LH IHRD+K N L+ H KL DFGL K
Sbjct: 107 MA-EMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYA 155
Query: 176 TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK 235
S+ GS Y+ L D +S G +L E + G GS W
Sbjct: 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE------- 208
Query: 236 NVEVWAQMLD 245
N++ W + L
Sbjct: 209 NLKYWKETLQ 218
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-09
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 43/212 (20%)
Query: 28 LAELGDGNFGAVKRVMEERGGSRKIFLD-----------------EVSVLLRVS---HPN 67
+AE+G+G +G V + + + G R + L EV+VL + HPN
Sbjct: 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 68 LVGLLGFCL-----EKGEQLLLLEYLANKSLFDRMHTYYGQSL---GVLSWSNRLSIALD 119
+V L C + + L+ E++ D+ T Y + GV + + + +
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLDKVPEPGVPTETIK-DMMFQ 118
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
+ R L++LHS ++HRD+K NIL+ KLADFGL ++ F TS+
Sbjct: 119 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-----MALTSVV 170
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLEL 211
+ Y L +T D++S G + E+
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-09
Identities = 44/177 (24%), Positives = 74/177 (41%), Gaps = 30/177 (16%)
Query: 54 LDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWS 111
L E+ ++ + H N++GL+ +E L+++ +A+ K + DR L+ S
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR--------LTES 119
Query: 112 NRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK-------LG 164
I L I L LH +HRD+ +NI + K+ADFGL +
Sbjct: 120 QVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 165 PFNDPNRPKRQ---TSIKGSFGYVDTNYLNTGFVSTK----SDVYSFGVLLLELITG 214
+ +R+ TS + Y L + K D++S G + EL+TG
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELL---MGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 5/91 (5%)
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
A+ ++HS+ +IHRDIKS+NILL + KL DFG K+ + R + G+
Sbjct: 155 AVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR--TFCGTP 209
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
YV S K+D++S GVLL EL+T
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 23/203 (11%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRV----MEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
I GA VYLA+ G++ A+K + M + + + ++++ P + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 73 GFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
+ + + L L++EYL + ++LG L ++ +E LH +
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
IIHRDIK N+L+ H KL DFGL + G N K+ G+ Y+ +
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----KK---FVGTPDYLAPETIL 166
Query: 192 TGFVSTKSDVYSFGVLLLELITG 214
SD +S G ++ E + G
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 52/218 (23%)
Query: 25 FVYLAELGDGNFGAVKRVMEERG--GSRKIFLDEVSV-----------------LLRVSH 65
++ LG G+FG V V +++ R L E+ V L ++ H
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTY--YGQSLG---VLSWSNRLSIALDI 120
P +V LE+ ++ EY + L ++ G++L V W +L + +
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH- 120
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL-------CKLGPFNDPNRPK 173
Y+H + I+HRD+K+ NI L +N K+ DFG+ C L
Sbjct: 121 -----YMHQRR---ILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLA--------- 162
Query: 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLEL 211
T+ G+ Y+ L +KSD++S G +L E+
Sbjct: 163 --TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 38/177 (21%)
Query: 49 SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSL--- 105
SRK E +L ++ HPN+V G +++EY L ++ G+
Sbjct: 45 SRK----EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED 100
Query: 106 GVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165
+L W ++ + + +++H + ++HRDIKS NI L + KL DFG +L
Sbjct: 101 TILQWFVQMCLGV------QHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL-- 149
Query: 166 FNDPNRPKRQTSIKGSFG--YVDTNYL-------NTGFVSTKSDVYSFGVLLLELIT 213
P G++ YV T Y N + + KSD++S G +L EL T
Sbjct: 150 LTSP----------GAYACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 32/84 (38%), Positives = 48/84 (57%), Gaps = 14/84 (16%)
Query: 83 LLLEYLAN---KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRD 139
L++EYL KSL ++ Y+ + + V S ++A AL+YLH IIHRD
Sbjct: 81 LVMEYLIGGDVKSLL-HIYGYFDEEMAVKYIS-------EVALALDYLHRHG---IIHRD 129
Query: 140 IKSSNILLIDDNHAKLADFGLCKL 163
+K N+L+ ++ H KL DFGL K+
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 56 EVSVLLRVSHPNLVGLLGFCLEKGEQLLLL-EYLANKSLFDRMHTYYGQSLGVLSWSNRL 114
E +L R+SHP ++ LL + G L+L +Y ++ ++TY G L L +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD------LYTYLGARLRPLGLAQVT 263
Query: 115 SIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174
++A + A++Y+H + IIHRDIK+ N+L+ L DFG R
Sbjct: 264 AVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA------RGSW 314
Query: 175 QTSIK-GSFGYVDTN---YLNTGFVSTKSDVYSFGVLLLE 210
T G G VDTN L + D++S G+++ E
Sbjct: 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 53 FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL--LLEYLANKSLFDRMHTYYGQSLGVLSW 110
F +E ++ + P +V L FC + ++ L ++EY+ L + M Y W
Sbjct: 90 FWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE----KW 143
Query: 111 SNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDP 169
+ + ++ AL+ +HS +IHRD+K N+LL H KLADFG C K+ D
Sbjct: 144 AKFYTA--EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM----DE 194
Query: 170 NRPKRQTSIKGSFGYVDTNYLNT----GFVSTKSDVYSFGVLLLELITG 214
R + G+ Y+ L + G+ + D +S GV L E++ G
Sbjct: 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 53/172 (30%), Positives = 76/172 (44%), Gaps = 34/172 (19%)
Query: 28 LAELGDGNFG--------------AVKRV-ME-ERGGSRKIFLDEVSVLLRVSHPNLVGL 71
LA++G G FG A+K+V ME E+ G L E+ +L + H N+V L
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSL-GVLSWSN---RLS----IALDIARA 123
+ C K Y K F + + L G+LS N LS + +
Sbjct: 77 IEICRTKATP-----YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175
L Y+H I+HRD+K++NIL+ D KLADFGL + F+ K
Sbjct: 132 LYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR--AFSLSKNSKPN 178
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 40/221 (18%)
Query: 24 SFVYLAELGDGNFGAV----KRVMEERGGSRKIFLD-----------EVSVLLRVSHPNL 68
+F L +LG+G + V R E ++I LD E+S++ + H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
V L + + +L+ EY+ +K L M T+ + G L + S + + + + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVR--GALDPNTVKSFTYQLLKGIAFCH 117
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK-LG-PFNDPNRPKRQTSIKGSFGYVD 186
+ ++HRD+K N+L+ KLADFGL + G P N S V
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-----------TFSNEVVT 163
Query: 187 TNY------LNTGFVSTKSDVYSFGVLLLELITGLKSIQGS 221
Y L + ST D++S G ++ E+ITG G+
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVK--RVMEERGGSRKIFLDEVSVLLRVS---HPNLVGL 71
IGVGA VY A + G+F A+K RV G + EV++L R+ HPN+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 72 LGFCL-----EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
+ C + + L+ E++ ++ L + L + + + L R L++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL---RGLDF 123
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163
LH+ I+HRD+K NIL+ KLADFGL ++
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 38/229 (16%)
Query: 4 LEELKMATNDFRIR--IGVGA-----------TSFVYLAELGDGNFGAVKRVMEERGGSR 50
+ +L+M D+ + IG GA T VY +L F +KR
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKR------SDS 87
Query: 51 KIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLS 109
F +E ++ + P +V L + + L +++EY+ L + M Y
Sbjct: 88 AFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE----K 142
Query: 110 WSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169
W+ R A ++ AL+ +HS IHRD+K N+LL H KLADFG C N
Sbjct: 143 WA-RFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKE 195
Query: 170 NRPKRQTSIKGSFGYVDTNYLNT----GFVSTKSDVYSFGVLLLELITG 214
+ T++ G+ Y+ L + G+ + D +S GV L E++ G
Sbjct: 196 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 19 GVGATSFVYLAELGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE 77
G AT F ++L + N A+K + +E G+ + EVS+L + H N+V L
Sbjct: 17 GTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 75
Query: 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIH 137
L+ EYL +K L Y ++S N I R L Y H + ++H
Sbjct: 76 DKSLTLVFEYL-DKDL----KQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLH 127
Query: 138 RDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVST 197
RD+K N+L+ + KLADFGL + P + + + D L + ST
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSV--PTKTYSNEVVTLWYRPPDV-LLGSSEYST 184
Query: 198 KSDVYSFGVLLLELITGLKSIQGS 221
+ D++ G + E+ +G GS
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGS 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 46/214 (21%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLG 73
+G+GA V A + G A+K++M+ +++ + E+ +L + H N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSD 76
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS------IALDIARALEYL 127
+ E + + L G L L S L I R L+Y+
Sbjct: 77 IFISPLEDIYFVTEL------------LGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYV 124
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
HS ++HRD+K SNIL+ ++ K+ DFGL ++ DP + T GYV T
Sbjct: 125 HSAG---VVHRDLKPSNILINENCDLKICDFGLARI---QDP----QMT------GYVST 168
Query: 188 NYLNTGFV-------STKSDVYSFGVLLLELITG 214
Y + + D++S G + E++ G
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 32/232 (13%)
Query: 24 SFVYLAELGDGNFG--------------AVKRVMEERGGSRK---IFLDEVSVLLRVSHP 66
+F + LG G FG A K++ ++R RK + L+E +L +V+
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI--ALDIARAL 124
+V L + E + L L+ + N + H Y ++G + + +I A ++ L
Sbjct: 61 FVVSL-AYAYETKDALCLVLTIMNGGDL-KFHIY---NMGNPGFDEQRAIFYAAELCCGL 115
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
E L + I++RD+K NILL D H +++D GL P + R + G+ GY
Sbjct: 116 EDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR-----VGTVGY 167
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN 236
+ +N + D + G L+ E+I G + + E RR K
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGS----RKIFLD------------EVSVLLRVSHPNL 68
+ + ++G+G +G V + ++ G +KI L+ E+S+L + HPN+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRL---SIALDIARALE 125
V L +++ L+ E+L+ D Y SL + + S I + +
Sbjct: 62 VCLQDVLMQESRLYLIFEFLS----MDLKK--YLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHA-KLADFGL 160
+ HS+ ++HRD+K N LLID+ KLADFGL
Sbjct: 116 FCHSRR---VLHRDLKPQN-LLIDNKGVIKLADFGL 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 17 RIGVGATSFVY--LAELGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
++G G + VY ++L D N A+K + +E G+ + EVS+L + H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+ L+ EYL +K L Y ++ N + R L Y H +
Sbjct: 72 IIHTEKSLTLVFEYL-DKDL----KQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK-- 124
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG 193
++HRD+K N+L+ + KLADFGL + P + + + D +T
Sbjct: 125 -VLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYSNEVVTLWYRPPDILLGSTD 181
Query: 194 FVSTKSDVYSFGVLLLELITGLKSIQGS 221
+ ST+ D++ G + E+ TG GS
Sbjct: 182 Y-STQIDMWGVGCIFYEMSTGRPLFPGS 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 45/160 (28%), Positives = 69/160 (43%), Gaps = 17/160 (10%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVM--EERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
+IG G V+ A A+KRV ++ G L E+ +L + H N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 74 FCLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
+ L+ EY K FD + + V S+ +L + L + HS
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI-VKSFMFQL------LKGLAFCHSHN 119
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171
++HRD+K N+L+ + KLADFGL + F P R
Sbjct: 120 ---VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVR 154
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 18 IGVGATSFVYLAELGD-GNFGAVKRVM---EERGGSRKI--FLDEVSVLLRVSHPNLVGL 71
+G GA VYL D G AVK+V E S+++ E+ +L + H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 72 LGFCLEKGEQLL--LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
G + E+ L +E++ S+ D++ +Y G L+ + I + YLHS
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHS 124
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT---------SIKG 180
I+HRDIK +NIL + KL DFG K + QT S+ G
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASK----------RLQTICLSGTGMKSVTG 171
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ ++ ++ K+D++S G ++E++T
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-08
Identities = 58/226 (25%), Positives = 88/226 (38%), Gaps = 65/226 (28%)
Query: 30 ELGDGNFGAV------------KRVMEERGGS-----RKIFLDEVSVLLRVSHPNLVGLL 72
E+G+G FG V + V++E S + +FL EV ++HPN++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
G C+E LL+LE+ L + + + G + +A ++A L +LH QAD
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD 120
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGL--CK------------------LGP-----FN 167
IH D+ N L D K+ D+GL + L P
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
PK QT KS+++S GV + EL T
Sbjct: 179 QDLLPKDQTK--------------------KSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-08
Identities = 37/129 (28%), Positives = 66/129 (51%), Gaps = 13/129 (10%)
Query: 97 MHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLA 156
+H + Q GV S + A +I LE++H++ +++RD+K +NILL + H +++
Sbjct: 84 LHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 139
Query: 157 DFGL-CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITG 214
D GL C D ++ K S+ G+ GY+ L G + +D +S G +L +L+ G
Sbjct: 140 DLGLAC------DFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
Query: 215 LKSIQGSAT 223
+ T
Sbjct: 193 HSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-08
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH-PNLVGLLGFC 75
+G G VY + G A+K VM+ G + E+++L + SH N+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 76 LEKG-----EQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
++K +QL L++E+ S+ D + G +L W I +I R L +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWI--AYICREILRGLSHLHQ 129
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGL-CKLGPFNDPNRPKRQTSIKGSFGYV--- 185
+IHRDIK N+LL ++ KL DFG+ +L D +R T I +
Sbjct: 130 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEV 182
Query: 186 ---DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
D N T KSD++S G+ +E+ G
Sbjct: 183 IACDENPDAT--YDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 58/197 (29%), Positives = 89/197 (45%), Gaps = 24/197 (12%)
Query: 56 EVSVLLRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRL 114
E +VL V + L + + +L L+L+Y++ +F H Y + S
Sbjct: 54 ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMF--THLYQRDNF---SEDEVR 108
Query: 115 SIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174
+ +I ALE+LH I++RDIK NILL + H L DFGL K F + +R
Sbjct: 109 FYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK--EFLSEEK-ER 162
Query: 175 QTSIKGSFGYVDTNYLNTGFVSTKS-DVYSFGVLLLELITGLKSIQGSATLAEWTEECRR 233
S G+ Y+ + K+ D +S G+L+ EL+TG + +T E R
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG---------ASPFTLEGER 213
Query: 234 NKNVEVWAQML--DPKL 248
N EV ++L DP
Sbjct: 214 NTQSEVSRRILKCDPPF 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 38/98 (38%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
+I ALE+LH II+RDIK NILL + H L DFGL K F++ + +R S
Sbjct: 113 EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK--EFHE-DEVERAYSF 166
Query: 179 KGSFGYVDTNYLNTGFVSTKS--DVYSFGVLLLELITG 214
G+ Y+ + + G D +S GVL+ EL+TG
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-08
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 37/214 (17%)
Query: 18 IGVGATSFVYLAELGD-GNFGAVKRV-----MEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
+G GA VYL D G AVK+V +E E+ +L + H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 72 LGFCLEKGEQ---LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
G CL E+ + +EY+ S+ D++ Y G L+ + I + + YLH
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH 123
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT---------SIK 179
S I+HRDIK +NIL + KL DFG K + QT S+
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASK----------RIQTICMSGTGIKSVT 170
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
G+ ++ ++ K+DV+S ++E++T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 30/221 (13%)
Query: 5 EELKMATNDFR-IR-IGVGATSFVYLAELGDGNFG--AVKRVMEERGGSRK----IFLDE 56
+ KM DF IR +G G+ V LA + +F A+KR + + +K +F E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SE 81
Query: 57 VSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFD--RMHTYYGQSLGVLSWSNRL 114
+L ++HP V L G ++ L+LE++ F R + + +G
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF------ 135
Query: 115 SIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174
A I EYL S I++RD+K N+LL D K+ DFG K+ R
Sbjct: 136 -YAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTR 184
Query: 175 QTSIKGSFGYVDTN-YLNTGFVSTKSDVYSFGVLLLELITG 214
++ G+ Y+ LN G +D ++ G+ + E++ G
Sbjct: 185 TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 3/45 (6%)
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
ALEYLH+ I+HRD+K N+L+ H KL DFGL K+G +
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 43/195 (22%)
Query: 59 VLLR-VSHPNLVGLLGF-----CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSN 112
VLL+ V+H N++ LL LE+ + + L+ L + +L +H
Sbjct: 72 VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHE-------- 123
Query: 113 RLSIAL-DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171
R+S L + +++LHS IIHRD+K SNI++ D K+ DFGL + N
Sbjct: 124 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMT 180
Query: 172 PKRQTSIKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL 224
P YV T Y L G+ D++S G ++ EL+ G QG+ +
Sbjct: 181 P-----------YVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHI 228
Query: 225 AEWTEECRRNKNVEV 239
+W NK +E
Sbjct: 229 DQW------NKVIEQ 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-08
Identities = 35/119 (29%), Positives = 62/119 (52%), Gaps = 11/119 (9%)
Query: 97 MHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLA 156
+H + Q GV S A +I LE++H++ +++RD+K +NILL + H +++
Sbjct: 84 LHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 139
Query: 157 DFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITG 214
D GL D ++ K S+ G+ GY+ L G + +D +S G +L +L+ G
Sbjct: 140 DLGLA-----CDFSKKKPHASV-GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 42/191 (21%)
Query: 40 KRVMEERGGSR-KIFLD-EVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRM 97
KRV + GSR I L+ E+ L R++H N++ K E++L AN + +
Sbjct: 198 KRV---KAGSRAAIQLENEILALGRLNHENIL--------KIEEIL--RSEANTYMITQK 244
Query: 98 HTYYGQSL---GVLSWSNR------LSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148
+ + S W +R +I + A+EY+H + +IHRDIK NI L
Sbjct: 245 YDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301
Query: 149 DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTK------SDVY 202
D L DFG PF +G+V T N+ + +D++
Sbjct: 302 CDGKIVLGDFGTAM--PFEKEREAF-------DYGWVGTVATNSPEILAGDGYCEITDIW 352
Query: 203 SFGVLLLELIT 213
S G++LL++++
Sbjct: 353 SCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 48/230 (20%)
Query: 31 LGDGNFGAVKRVMEERGG--------SRKIF---------LDEVSVLLRVSH---PNLVG 70
+G G FG V +V ++ S+K + E ++L+R P +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 71 LLGFCLEKGEQLLLL-EYLANKSLFDRMHTYYGQSLGVLSWSN-RLSIALDIARALEYLH 128
L F + L L+ +Y++ LF ++ Q G S + IA ++ ALE+LH
Sbjct: 61 L-KFSFQTDSDLYLVTDYMSGGELF-----WHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT--SIKGSFGYVD 186
I++RD+K NILL H L DFGL K N +T + G+ Y+
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSK------ANLTDNKTTNTFCGTTEYLA 164
Query: 187 TNYL--NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN 234
L G+ + D +S GVL+ E+ G S AE T++ RN
Sbjct: 165 PEVLLDEKGY-TKHVDFWSLGVLVFEMCCGW-----SPFYAEDTQQMYRN 208
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 49/217 (22%)
Query: 28 LAELGDGNFGAVKRVMEERGG----SRKIFLD-----------EVSVLLRVSHPNLVGLL 72
L ELG GN+G+V +V+ G ++I L+ E+ +L + P +V
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS-IALDIARALEYLHSQA 131
G +G + +EY+ SL D++ Y G + L I + + L++L +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKL--YAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGL--------------CKLGPFNDPNRPKRQTS 177
+ IIHRD+K +N+L+ + KL DFG+ C+ + P R
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQ--SYMAPER------ 172
Query: 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
IK + +SDV+S G+ +LE+ G
Sbjct: 173 IKSG------GPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 21/104 (20%)
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
I R L+Y+HS A+ ++HRD+K SN+LL + K+ DFGL ++ DP
Sbjct: 115 ILRGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARI---ADPE------HDH 162
Query: 180 GSF--GYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
F YV T + LN+ + D++S G +L E+++
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 4/49 (8%)
Query: 113 RLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161
R IA ++ A+E +H IHRDIK NIL+ D H KL DFGLC
Sbjct: 104 RFYIA-ELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-07
Identities = 35/153 (22%), Positives = 57/153 (37%), Gaps = 19/153 (12%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVL--LRVSHPNLV-GLLG 73
+ G T+ VYL D ++ +K + EV++L L V +L
Sbjct: 5 LLKGGLTNRVYLLGTKDEDY-VLK--INPSREKGADREREVAILQLLA-RKGLPVPKVLA 60
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
G LL+E++ G++L +S + IA +A L LH
Sbjct: 61 SGESDGWSYLLMEWIE------------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166
+ H D+ NIL+ D + D+ GP
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
I AL+ +HS+ ++HRD+KS+NI L+ KL DFG K ++D +S
Sbjct: 178 IVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFC 232
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQG 220
G+ Y+ S K+D++S GV+L EL+T + +G
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 52/226 (23%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 27 YLAELGDGNFG-------------------AVKRVMEERGGS-RKIFLDEVSVLLRVSHP 66
++ ELG+ FG A+K + ++ G R+ F E + R+ HP
Sbjct: 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRM-----HTYYGQS------LGVLSWSNRLS 115
N+V LLG ++ ++ Y ++ L + + H+ G + L ++ +
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 116 IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175
I IA +E+L S ++H+D+ + N+L+ D + K++D GL + D +
Sbjct: 129 IVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 176 TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQG 220
+ + ++ + G S SD++S+GV+L E+ + GL+ G
Sbjct: 186 SLL--PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 62/221 (28%)
Query: 28 LAELGDGNFGAVKRVMEERGGSR----------------KIFLDEVSVLLRVSHPNLVGL 71
L+ +G G +G+V + + G R K E+ +L + H N++GL
Sbjct: 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81
Query: 72 LGF-----CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS------IALDI 120
L LE+ + L+ +L G L + +L+ + I
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLM------------GADLNNIVKCQKLTDDHVQFLIYQI 129
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
R L+Y+HS AD IIHRD+K SN+ + +D K+ DFGL R T +
Sbjct: 130 LRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLA------------RHTDDEM 174
Query: 181 SFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
+ GYV T + LN + D++S G ++ EL+TG
Sbjct: 175 T-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 64/221 (28%), Positives = 90/221 (40%), Gaps = 58/221 (26%)
Query: 31 LGDGNFGAVKRVMEERGGSRKI--FLDEVS-----------VLLRVS-HPNLVGLLGFCL 76
+G G +G V +V ++ GS LD +S +L + HPN+V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 77 EK----GEQLLLLEYLAN--------KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
+ G QL L+ L N K L GQ L S L AL L
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGAL---LGL 141
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL-CKLGPFNDPNRPKRQTSIKGSFG 183
++LH+ IIHRD+K +NILL + KL DFG+ +L R +R TS+ F
Sbjct: 142 QHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL----TSTRLRRNTSVGTPFW 194
Query: 184 YV----------DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
D +Y + DV+S G+ +EL G
Sbjct: 195 MAPEVIACEQQYDYSY------DARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 35/155 (22%)
Query: 31 LGDGNFGAVKRVMEERGGSR----KI---F---------LDEVSVLLRVSHPNLVGLLGF 74
+G G +G V ++ R G + KI F L E+ +L H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNR-LSIAL------DIARALEYL 127
G + Y+ + D M + L + S++ L+ + R L+Y+
Sbjct: 73 LRPPGADFKDV-YV----VMDLMES----DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162
HS A+ +IHRD+K SN+L+ +D ++ DFG+ +
Sbjct: 124 HS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 37/103 (35%), Positives = 52/103 (50%), Gaps = 24/103 (23%)
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
+ R L+Y+HS A+ ++HRD+K SN+LL + K+ DFGL R TS K
Sbjct: 117 LLRGLKYIHS-AN--VLHRDLKPSNLLLNANCDLKICDFGLA------------RTTSEK 161
Query: 180 GSF--GYVDTNY-------LNTGFVSTKSDVYSFGVLLLELIT 213
G F YV T + LN +T DV+S G + EL+
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 53/209 (25%), Positives = 80/209 (38%), Gaps = 45/209 (21%)
Query: 27 YLAELGDGNFGAVKRVMEERGGS---------------RKIFLDEVSVLLRVSHPNLVGL 71
Y LG GN G V + +K + E+ +L + P ++G
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
G + + E++ SL D LG IA+ + + L YL S
Sbjct: 65 YGAFFVENRISICTEFMDGGSL-DVYRKIPEHVLG--------RIAVAVVKGLTYLWSLK 115
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN-YL 190
I+HRD+K SN+L+ KL DFG+ Q + YV TN Y+
Sbjct: 116 ---ILHRDVKPSNMLVNTRGQVKLCDFGV------------STQLVNSIAKTYVGTNAYM 160
Query: 191 NTGFVSTK-----SDVYSFGVLLLELITG 214
+S + SDV+S G+ +EL G
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-07
Identities = 33/117 (28%), Positives = 61/117 (52%), Gaps = 10/117 (8%)
Query: 53 FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSN 112
F + S++ ++SH +LV G C+ E +++ EY+ SL TY ++ +++ S
Sbjct: 46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSL----DTYLKKNKNLINISW 101
Query: 113 RLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169
+L +A +A AL +L D + H ++ + N+LLI + K + KL +DP
Sbjct: 102 KLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDP 152
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 56/195 (28%), Positives = 79/195 (40%), Gaps = 24/195 (12%)
Query: 34 GNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92
G A+K + +E G+ + E S+L + H N+V L K L+ EYL +
Sbjct: 30 GQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTD 88
Query: 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH 152
L Y G LS N + R L Y H + ++HRD+K N+L+ +
Sbjct: 89 L----KQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGE 141
Query: 153 AKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY------LNTGFVSTKSDVYSFGV 206
KLADFGL R K S S V Y L + ST D++ G
Sbjct: 142 LKLADFGLA---------RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGC 192
Query: 207 LLLELITGLKSIQGS 221
+ E+ TG GS
Sbjct: 193 IFYEMATGRPLFPGS 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 54/237 (22%)
Query: 4 LEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKI----------- 52
+ +L+M DF I V +G G FG V+ V + S+++
Sbjct: 35 ITKLRMKAEDFD-VIKV----------IGRGAFGEVQLVRHKS--SKQVYAMKLLSKFEM 81
Query: 53 --------FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL--LLEYLANKSLFDRMHTYYG 102
F +E ++ + +V L + ++ L ++EY+ L + M Y
Sbjct: 82 IKRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI 139
Query: 103 QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC- 161
W+ R A ++ AL+ +HS IHRD+K N+LL H KLADFG C
Sbjct: 140 PE----KWA-RFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190
Query: 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT----GFVSTKSDVYSFGVLLLELITG 214
K+ D N R + G+ Y+ L + G+ + D +S GV L E++ G
Sbjct: 191 KM----DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 17/27 (62%), Positives = 19/27 (70%)
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCK 162
IHRDIK N+LL H KL+DFGLC
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 30/202 (14%)
Query: 31 LGDGNFGAV------------------KRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
LG G FG V K+ ++++ G K+ L E +L +V+ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG-EKMALLEKEILEKVNSPFIVNL- 58
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
+ E L L+ L N + H Y G L + + I + +LHS
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDL-KYHIYNVGERG-LEMERVIHYSAQITCGILHLHSMD- 115
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT 192
I++RD+K N+LL D + +L+D GL K T G+ GY+ L
Sbjct: 116 --IVYRDMKPENVLLDDQGNCRLSDLGLAVELK-----DGKTITQRAGTNGYMAPEILKE 168
Query: 193 GFVSTKSDVYSFGVLLLELITG 214
S D ++ G + E++ G
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 51/191 (26%), Positives = 77/191 (40%), Gaps = 51/191 (26%)
Query: 59 VLLR-VSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIA 117
VL++ V+H N++GLL + KSL + Y L + + +
Sbjct: 67 VLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMD 114
Query: 118 LDIAR----------ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
LD R +++LHS IIHRD+K SNI++ D K+ DFGL
Sbjct: 115 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------ 165
Query: 168 DPNRPKRQTSIKGSF---GYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITGLKS 217
R SF YV T Y L G+ D++S G ++ E+I G
Sbjct: 166 ------RTAG--TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVL 216
Query: 218 IQGSATLAEWT 228
G+ + +W
Sbjct: 217 FPGTDHIDQWN 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-07
Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 17/135 (12%)
Query: 91 KSLFDRMHTYYGQSLGV------------LSWSNRLSIALDIARALEYLHSQADPPIIHR 138
+S +DR +Y G + L+ + LS +AR +E+L S+ +HR
Sbjct: 205 RSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHR 261
Query: 139 DIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTK 198
D+ + N+LL K+ DFGL + +D N + ++ ++ + +T
Sbjct: 262 DLAARNVLLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFL-PVKWMAPESIFDNLYTTL 319
Query: 199 SDVYSFGVLLLELIT 213
SDV+S+G+LL E+ +
Sbjct: 320 SDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 13/111 (11%)
Query: 107 VLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166
LS+ + + + +A +E+L S+ +HRD+ + N+L+ + K+ DFGL +
Sbjct: 235 ALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLAR---- 287
Query: 167 NDPNRPKRQTSIKGS----FGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
D R S KGS ++ + +T SDV+SFG+LL E+ T
Sbjct: 288 -DIMRDSNYIS-KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 17 RIGVGATSFVYLAELGDGNFG---AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
++G G VY A+ DG A+K++ E G E+++L + HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQK 65
Query: 74 FCLEKGEQ--LLLLEYLANKSL-----FDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
L ++ LL +Y A L F R + + L S S+ I + Y
Sbjct: 66 VFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQ-LPRSMVKSLLYQILDGIHY 123
Query: 127 LHSQADPPIIHRDIKSSNILLIDD----NHAKLADFGLCKLGPFNDPNRPKRQTS-IKGS 181
LH+ ++HRD+K +NIL++ + K+AD G +L FN P +P + +
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSPLKPLADLDPVVVT 178
Query: 182 FGYVDTNYLNTGFVSTKS-DVYSFGVLLLELIT 213
F Y L TK+ D+++ G + EL+T
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 20/157 (12%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV---MEERGGSRKIFLDEVSVLLRVSH-PNLVGL 71
+IG G VY A + G A+K+ M+E G L E+S+L +S +V L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA-LREISLLQMLSESIYIVRL 66
Query: 72 LGFCLEKGEQ-------LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
L +E E+ L+ EYL + L M + L S + + +
Sbjct: 67 L--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDD-NHAKLADFGL 160
+ H ++HRD+K N+L+ K+AD GL
Sbjct: 124 AHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH-PNLVGLLGFC 75
+G G VY + G A+K VM+ + E+++L + SH N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 76 LEKG-----EQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
++K +QL L++E+ S+ D + G +L W I +I R L +LH+
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWI--AYICREILRGLAHLHA 139
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGL-CKLGPFNDPNRPKRQTSIKGSFGYV--- 185
+IHRDIK N+LL ++ KL DFG+ +L D +R T I +
Sbjct: 140 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEV 192
Query: 186 ---DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
D N T +SD++S G+ +E+ G
Sbjct: 193 IACDENPDAT--YDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-06
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 17 RIGVGATSFVYLAELGDGNFG---AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
++G G VY A+ DG A+K++ E G E+++L + HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQK 65
Query: 74 FCLEKGEQ--LLLLEYLANKSLFD--RMHTYYGQSLGVLSWSNRL--SIALDIARALEYL 127
L ++ LL +Y A L+ + H + + + S+ I + YL
Sbjct: 66 VFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 128 HSQADPPIIHRDIKSSNILLIDD----NHAKLADFGLCKLGPFNDPNRPKRQTS-IKGSF 182
H+ ++HRD+K +NIL++ + K+AD G +L FN P +P + +F
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSPLKPLADLDPVVVTF 179
Query: 183 GYVDTNYLNTGFVSTKS-DVYSFGVLLLELIT 213
Y L TK+ D+++ G + EL+T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 31 LGDGNFGAVKRVM----EERGGSRKIFLD------EVSVLLRVSHPNLVGLLGF----CL 76
+G+G+FG V + E+ +K+ D E+ ++ ++H N++ L + C
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECF 133
Query: 77 EKGEQLLLL----EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
+K E+ + L E++ + +Y ++ L + + RAL Y+HS+
Sbjct: 134 KKNEKNIFLNVVMEFIPQT--VHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF- 190
Query: 133 PPIIHRDIKSSNILLIDDNHA-KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
I HRD+K N+L+ + H KL DFG K N + + I F L
Sbjct: 191 --ICHRDLKPQNLLIDPNTHTLKLCDFGSAK----NLLAGQRSVSYICSRFYRAPELMLG 244
Query: 192 TGFVSTKSDVYSFGVLLLELITGLKSIQGSATL 224
+T D++S G ++ E+I G G +++
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 19/102 (18%)
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
I R L+YLHS I+HRDIK N+L+ + K+ DFGL ++ +P+ K T
Sbjct: 112 ILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV---EEPDESKHMTQ-- 163
Query: 180 GSFGYVDTNY-----LNTG--FVSTKSDVYSFGVLLLELITG 214
V T Y + G ++ D++S G + EL+
Sbjct: 164 ----EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 51/205 (24%)
Query: 38 AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRM 97
AVK+++ S K L E+ ++ R+ H N+V + G L E + + + + +
Sbjct: 34 AVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD--LTEDVGSLTELNSV 91
Query: 98 HTYYGQS-----LGVLSWSNRLS------IALDIARALEYLHSQADPPIIHRDIKSSNIL 146
Y Q L + LS + R L+Y+HS ++HRD+K +N+
Sbjct: 92 --YIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVF 146
Query: 147 L-IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVS--------- 196
+ +D K+ DFGL ++ DP+ Y YL+ G V+
Sbjct: 147 INTEDLVLKIGDFGLARI---VDPH-------------YSHKGYLSEGLVTKWYRSPRLL 190
Query: 197 ------TKS-DVYSFGVLLLELITG 214
TK+ D+++ G + E++TG
Sbjct: 191 LSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 33/206 (16%)
Query: 28 LAELGDGNFGAV----KRVMEERGGSRKIFLD------------EVSVLLRVSHPNLVGL 71
+ ++G+G +G V RV E +KI L+ E+S+L + H N+V L
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRL--SIALDIARALEYLHS 129
+ L+ EYL + L M S + + RL + I R + Y HS
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHM-----DSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 130 QADPPIIHRDIKSSNILLID--DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
++HRD+K N LLID N KLADFGL + F P R + + +
Sbjct: 121 HR---VLHRDLKPQN-LLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEI 174
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELIT 213
L + ST D++S G + E++
Sbjct: 175 -LLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-06
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 23/100 (23%)
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
R L+Y+HS IIHRD+K SN+ + +D ++ DFGL RQ + +
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA------------RQADDEMT 173
Query: 182 FGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
GYV T + LN + D++S G ++ EL+ G
Sbjct: 174 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-06
Identities = 36/172 (20%), Positives = 74/172 (43%), Gaps = 26/172 (15%)
Query: 50 RKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL--FDRMHTYYGQSLGV 107
R+ FL E L + H N+V L G +++ EY++N +L F R H G
Sbjct: 50 RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE------GQ 103
Query: 108 LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
L + + +A ++YL ++ +H+ + + +L+ D K++ F
Sbjct: 104 LVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR-------- 152
Query: 168 DPNRPKRQTSIKGSFG------YVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ + +I + + + S+ SDV+SFG+++ E+++
Sbjct: 153 -RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 36/222 (16%)
Query: 12 NDFRIR--IGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRK---IFLDEVSVLLRVSH 65
DF ++ +G G V + E G+ A+K + + +++ F +E +L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE 125
P + L +K L++EY L ++ Y Q + +A +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF-------DEDMAQFYLAELVL 113
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG-----------LCKLGPFNDPN--RP 172
+HS +HRDIK N+L+ H KLADFG KL P P+ P
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL-PVGTPDYIAP 172
Query: 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ T++ G G + D +S GV+ E+I G
Sbjct: 173 EVLTTMNGDGK---------GTYGVECDWWSLGVIAYEMIYG 205
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 1e-05
Identities = 32/116 (27%), Positives = 46/116 (39%), Gaps = 22/116 (18%)
Query: 55 DEVSV-LLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNR 113
E V L +PN + L +L+++Y+ + LFD + +
Sbjct: 57 IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-----------EGK 105
Query: 114 LS------IALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADFGLCK 162
LS I + AL LH IIH DIK N+L + L D+GLCK
Sbjct: 106 LSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 21/118 (17%)
Query: 108 LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
L + L + +A+ +++L S+ IHRD+ + N+LL D AK+ DFGL + N
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR-DIMN 264
Query: 168 DPNR--------PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKS 217
D N P + + + F V T +SDV+S+G+LL E+ + KS
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYT---------VQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 16/102 (15%)
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
I L+Y+HS A+ ++HRD+K N+L+ D K+ DFGL + F+ N + +
Sbjct: 114 ILCGLKYIHS-AN--VLHRDLKPGNLLVNADCELKICDFGLAR--GFS-ENPGENAGFMT 167
Query: 180 GSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
YV T + L+ + DV+S G +L EL+
Sbjct: 168 ---EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 1e-05
Identities = 62/255 (24%), Positives = 101/255 (39%), Gaps = 51/255 (20%)
Query: 28 LAELGDGNFGAV-----KRVME-------------ERGGSRKIFLDEVSVLLRVSHPNLV 69
+ ++G+G FG V KR E ER S+ + EV+V+ + H N+V
Sbjct: 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI--EVNVMRELKHKNIV 75
Query: 70 GLLGFCLEKGEQLL--LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+ L K Q L L+E+ L + Y + G + + I + AL Y
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYC 134
Query: 128 HSQADPP----IIHRDIKSSNILL-----------IDDNH------AKLADFGLCKLGPF 166
H+ D P ++HRD+K NI L N+ AK+ DFGL K
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK---- 190
Query: 167 NDPNRPKRQTSIKGSFGYVDTNYL--NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL 224
+ S G+ Y L T KSD+++ G ++ EL +G +
Sbjct: 191 -NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 225 AEWTEECRRNKNVEV 239
++ E +R ++ +
Sbjct: 250 SQLISELKRGPDLPI 264
|
Length = 1021 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 54/239 (22%), Positives = 97/239 (40%), Gaps = 63/239 (26%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSR------------KIFLD----EVSVLLRVSHPNL 68
+ L ++G G +G+V +++R G + +IF E+++L + H N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYY----------GQSLGV-LSWSNRLSIA 117
+GLL + + D +Y + +G LS +
Sbjct: 77 IGLL-------------DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
+ L+Y+HS IIHRD+K N+ + +D K+ DFGL R
Sbjct: 124 YQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA------------RHAD 168
Query: 178 IKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE 229
+ + GYV T + LN + D++S G ++ E++TG +G L + T+
Sbjct: 169 AEMT-GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 226
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 4/49 (8%)
Query: 113 RLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161
R IA ++ A+E +H IHRDIK NIL+ D H KL DFGLC
Sbjct: 104 RFYIA-ELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 23/167 (13%)
Query: 53 FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSN 112
F + S++ +VSH ++V L G C+ E +++ E++ L MH + VL+
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH----RKSDVLTTPW 106
Query: 113 RLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL-CKLGPF---ND 168
+ +A +A AL YL D ++H ++ + NILL + G+ + GPF +D
Sbjct: 107 KFKVAKQLASALSYLE---DKDLVHGNVCTKNILLARE--------GIDGECGPFIKLSD 155
Query: 169 PNRP----KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLEL 211
P P RQ ++ ++ +S +D +SFG L E+
Sbjct: 156 PGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 21/108 (19%)
Query: 114 LSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR-- 171
LS + +A+ + +L S+ IHRD+ + NILL K+ DFGL + ND N
Sbjct: 217 LSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-DIRNDSNYVV 272
Query: 172 ------PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
P + + + F V T +SDV+S+G+LL E+ +
Sbjct: 273 KGNARLPVKWMAPESIFNCVYT---------FESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 21/39 (53%), Positives = 24/39 (61%), Gaps = 3/39 (7%)
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161
A+E +H IHRDIK NIL+ D H KL DFGLC
Sbjct: 113 AVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 27/169 (15%)
Query: 53 FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGV-LSWS 111
F + S++ ++SH +LV L G C+ ++ EY+ L +H + V L W
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHR---EKNNVSLHW- 102
Query: 112 NRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI--DDNH-----AKLADFGLCKLG 164
+L +A +A AL YL + ++H ++ NIL+ N KL+D G+
Sbjct: 103 -KLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI---- 154
Query: 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKS--DVYSFGVLLLEL 211
P +R +R I ++ + G S D +SFG LLE+
Sbjct: 155 PITVLSREERVERIP----WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 41/227 (18%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEERGGS---RKIFLDEVSVLLRVSHPNLVGLLG 73
IG G VYLA + A+K++ E+ + +K FL E + + HP +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 74 FCLEK-----------GEQL--LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
C + G L LL +SL + S+G LSI I
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE--KTSVGAF-----LSIFHKI 122
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP-------FNDPNRPK 173
+EY+HS+ ++HRD+K NILL + D+G D +
Sbjct: 123 CATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 174 RQTS-------IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
S I G+ Y+ L S +D+Y+ GV+L +++T
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 33/104 (31%), Positives = 49/104 (47%), Gaps = 24/104 (23%)
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND-----------PN 170
RAL+Y+H+ + HRD+K NIL D K+ DFGL ++ FND
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVAT 169
Query: 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
R R + GSF + Y + D++S G + E++TG
Sbjct: 170 RWYRAPELCGSFF---SKY------TPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-05
Identities = 49/189 (25%), Positives = 78/189 (41%), Gaps = 45/189 (23%)
Query: 59 VLLR-VSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIA 117
VL++ V+H N++GLL + KSL + Y L + + +
Sbjct: 75 VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 118 LDIAR----------ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
LD R +++LHS IIHRD+K SNI++ D K+ DFGL + +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 168 DPNRPKRQTSIKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITGLKSIQG 220
P YV T Y L G+ D++S G ++ E+I G G
Sbjct: 180 FMMTP-----------YVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 221 SATLAEWTE 229
+ + +W +
Sbjct: 228 TDHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 8e-05
Identities = 28/78 (35%), Positives = 38/78 (48%), Gaps = 8/78 (10%)
Query: 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKS 142
L++E+L L + Y S V R +A + A+E +H IHRDIK
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMA-ECVLAIEAVHKLG---FIHRDIKP 129
Query: 143 SNILLIDDNHAKLADFGL 160
NIL+ H KL+DFGL
Sbjct: 130 DNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 43/176 (24%), Positives = 79/176 (44%), Gaps = 41/176 (23%)
Query: 53 FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL-----FDRMHTYYGQSLGV 107
F + S++ +VSH +L + G C+ E +++ E++ + L ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVA----- 117
Query: 108 LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK-LGPF 166
W ++++A +A AL YL D ++H ++ + NIL LA GL + PF
Sbjct: 118 --W--KITVAQQLASALSYLE---DKNLVHGNVCAKNIL--------LARLGLAEGTSPF 162
Query: 167 ---NDP-------NRPKRQTSIKGSFGYVDTNYL-NTGFVSTKSDVYSFGVLLLEL 211
+DP +R +R I ++ + +ST +D +SFG LLE+
Sbjct: 163 IKLSDPGVSFTALSREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 19/150 (12%)
Query: 114 LSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173
+ IA+D L Y +HRDIK NIL+ + H +LADFG C L D
Sbjct: 111 MVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSC-LKLMEDGT--- 157
Query: 174 RQTSIK-GSFGYVDTNYLNT-----GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW 227
Q+S+ G+ Y+ L G + D +S GV + E++ G + + +
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
Query: 228 TEECRRNKNVEVWAQMLDPKLNGDANMEQL 257
+ + + AQ+ D + + +L
Sbjct: 218 GKIMNHKERFQFPAQVTDVSEDAKDLIRRL 247
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 8/100 (8%)
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
IA + +HS +HRDIK N+LL + H +LADFG C N + ++
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCL--KMNQDGTVQSSVAV- 164
Query: 180 GSFGYVDTNYLNT-----GFVSTKSDVYSFGVLLLELITG 214
G+ Y+ L G + D +S GV + E++ G
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 23/148 (15%)
Query: 31 LGDGNFGAV--------------KRVMEERGGSRKIF---LDEVSVLLRVSHPNLVGLLG 73
LG G FG V K++ ++R RK + + E +L +V H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTY-YGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
+ + L L+ + N R H Y + I LE+LH +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDL-RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR- 117
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGL 160
II+RD+K N+LL +D + +++D GL
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGL 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 26/85 (30%), Positives = 40/85 (47%), Gaps = 10/85 (11%)
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDPNRPKRQTSIKGSFGYVDTNYLN--- 191
+HRDIK N+LL + H +LADFG C +L + + G+ Y+ L
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRL----LADGTVQSNVAVGTPDYISPEILQAME 179
Query: 192 --TGFVSTKSDVYSFGVLLLELITG 214
G + D +S GV + E++ G
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 17/26 (65%), Positives = 19/26 (73%)
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLC 161
IHRDIK N+LL H KL+DFGLC
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 17/26 (65%), Positives = 19/26 (73%)
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLC 161
IHRDIK N+LL H KL+DFGLC
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 57/211 (27%), Positives = 83/211 (39%), Gaps = 28/211 (13%)
Query: 18 IGVGATSFVYLAELGDGNFGAVKRVMEERGGS----RKIFLDEVSVLLRVSHPNLVGLLG 73
IG G V L E+ G A V E R + + FL+E + H NL+ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
C E LL++E+ L + + L + +A +IA L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND----------PNR---PKRQTSIKG 180
IH D+ N LL D K+ D+GL D P R P+ + G
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLEL 211
+ VD + +S+V+S GV + EL
Sbjct: 180 NLLVVDQ--------TKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 44/183 (24%), Positives = 72/183 (39%), Gaps = 35/183 (19%)
Query: 44 EERGGSRKIFLDEVSVLLRVSHPNLV---------GLLGFCLEKGEQ--LLLLEYLANKS 92
EE ++ L E+ +L + N+V G L E E+ L LLE + N
Sbjct: 38 EENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV 97
Query: 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH 152
+++ +Y Q + + W ++ I+HRDIK N+L+ ++
Sbjct: 98 PPEKVRSYIYQLIKAIHWCHK-------------------NDIVHRDIKPENLLISHNDV 138
Query: 153 AKLADFGLCK-LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLEL 211
KL DFG + L ++ N T + Y L D++S G +L EL
Sbjct: 139 LKLCDFGFARNLSEGSNAN----YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
Query: 212 ITG 214
G
Sbjct: 195 SDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 33/137 (24%), Positives = 59/137 (43%), Gaps = 20/137 (14%)
Query: 81 QLLLLE--YLANKSLFDRMHTYYGQSLGVLSWSNRL--SIALDIARALEYLHSQADPPII 136
+ +LLE K +F R + + +L +I D+ LEY+H I
Sbjct: 102 RFILLEKLVENTKEIFKR----------IKCKNKKLIKNIMKDMLTTLEYIHEHG---IS 148
Query: 137 HRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN--RPKRQTSI-KGSFGYVDTNYLNTG 193
H DIK NI++ +N + D+G+ + + K Q + +G+ Y + N
Sbjct: 149 HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA 208
Query: 194 FVSTKSDVYSFGVLLLE 210
V+ + D+ S G +L+
Sbjct: 209 CVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 45/187 (24%), Positives = 79/187 (42%), Gaps = 36/187 (19%)
Query: 56 EVSVLLRVSHPNLVGLLGF-----CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSW 110
E+ ++ V+H N++ LL LE+ + + L+ L + +L +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHE------ 119
Query: 111 SNRLSIAL-DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169
R+S L + +++LHS IIHRD+K SNI++ D K+ DFGL + +
Sbjct: 120 --RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174
Query: 170 NRPKRQTSIKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA 222
P YV T Y L G+ D++S G ++ E++ G
Sbjct: 175 MTP-----------YVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRD 222
Query: 223 TLAEWTE 229
+ +W +
Sbjct: 223 YIDQWNK 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 0.004
Identities = 39/162 (24%), Positives = 69/162 (42%), Gaps = 31/162 (19%)
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLG-VLSWSNRLSIALDIARAL 124
PN+V L + + + L+L++ L+ + + V W+ + +ALD
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG- 183
LH + I+ RD+ +NILL D H +L F R + ++ S
Sbjct: 101 --LHREG---IVCRDLNPNNILLDDRGHIQLTYFS--------------RWSEVEDSCDG 141
Query: 184 -YVDTNYL--NTGFVSTKS---DVYSFGVLLLELITGLKSIQ 219
V+ Y G +S ++ D +S G +L EL+TG ++
Sbjct: 142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 266 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.29 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.14 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.1 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.99 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.94 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.8 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.72 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.48 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.48 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.47 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.35 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.22 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.21 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.15 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.06 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.05 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.05 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.0 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.89 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.68 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.68 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.61 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.59 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.55 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.55 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.47 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.45 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.43 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.39 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.37 | |
| PLN02236 | 344 | choline kinase | 97.34 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.04 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.96 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.95 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.93 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.79 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.78 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.77 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.77 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.31 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.22 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.07 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 96.01 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.9 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.53 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.5 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.47 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-50 Score=338.42 Aligned_cols=239 Identities=23% Similarity=0.374 Sum_probs=213.7
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeee---cccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVME---ERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
..+|.....||+|||..+|.+. +.+|+.+|+|.+.+ .+...++...+|+++.+.|+|||||+++++|++.++.|+|
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 3456666789999999999994 48999999998765 2445678899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
+|+|..++|.++++.. ++++|.+++.++.||+.|+.|||+++ |+|||||..|+|++++-++||+|||+|+..
T Consensus 97 LELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeee
Confidence 9999999999999864 78999999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch-------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV------- 237 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 237 (266)
..+ .....+..||+.|.|||++.....+..+||||+||++|.|+.|++||...+-.+.+.++....-..
T Consensus 169 e~~----~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~ 244 (592)
T KOG0575|consen 169 EYD----GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAE 244 (592)
T ss_pred cCc----ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHH
Confidence 432 245568899999999999999999999999999999999999999999887777777776655554
Q ss_pred --hhhhhhccCCCCCcchHHHHHH
Q 047020 238 --EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 --~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
++++++|+++|..||+.+++.+
T Consensus 245 A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 245 AKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 7899999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=309.50 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=204.1
Q ss_pred HHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccce-eEEecC-eEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLG-FCLEKG-EQL 82 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~-~~~ 82 (266)
-.+.+.+.++||+|.||.||++ .+.+|..++.|++.-.. ....+....|+.+|++|+||||+++++ .+.++. .++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 3455677789999999999999 78899999999876322 234567889999999999999999998 454444 489
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eecCCCCCCcEEEecCCceEEecccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP--IIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
+|||++.+|+|...++....+. ..+++..+|.++.|++.||..+|+. .++ +.||||||.|||++.+|.+||+|||+
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchh
Confidence 9999999999999998764443 7889999999999999999999994 444 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--ch-
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--NV- 237 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~- 237 (266)
++... .........+||+.||+||.+.+.+|+.++||||+||++|||+.-++||.|.+-.....++..... .+
T Consensus 175 ~r~l~----s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 175 GRFLS----SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred HhHhc----chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 98743 234556778999999999999999999999999999999999999999999966655555554432 22
Q ss_pred --------hhhhhhccCCCCCcch-HHHHHHHH
Q 047020 238 --------EVWAQMLDPKLNGDAN-MEQLRVLI 261 (266)
Q Consensus 238 --------~~~~~~l~~~~~~~~~-~~~l~~~~ 261 (266)
+++.-|+.+++..||+ ..-+.++.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 3567788888888886 44444433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=313.03 Aligned_cols=228 Identities=25% Similarity=0.346 Sum_probs=194.7
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.++.+.||+|+||.||.+ +..+++.+|+|.+.++.- .+.....+|..+|..++||+||+++..|++.+.+|+|+||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 344558999999999999 556788999987755332 3456778899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.||.|...+.+. +.+++..+..++.+|+.||.|||++| |+||||||+|||++..|+++|+|||+|....
T Consensus 107 ~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~-- 176 (357)
T KOG0598|consen 107 LNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL-- 176 (357)
T ss_pred cCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc--
Confidence 9999999999865 89999999999999999999999999 9999999999999999999999999998522
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-Cch---------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN-KNV--------- 237 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~--------- 237 (266)
..........||+.|||||++.+.+++..+|+||||+++|+|++|.+||.+++......++.... ..+
T Consensus 177 --~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 177 --KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEAR 254 (357)
T ss_pred --cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHH
Confidence 22334456899999999999999999999999999999999999999999999888887777755 111
Q ss_pred hhhhhhccCCCCCc
Q 047020 238 EVWAQMLDPKLNGD 251 (266)
Q Consensus 238 ~~~~~~l~~~~~~~ 251 (266)
+++++++..++..|
T Consensus 255 dll~~LL~rdp~~R 268 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQR 268 (357)
T ss_pred HHHHHHhccCHHHh
Confidence 34455555555554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=318.80 Aligned_cols=238 Identities=27% Similarity=0.381 Sum_probs=198.7
Q ss_pred HHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccccc-------HHHHHHHHHHHhcCCCCCccccceeEEecC
Q 047020 8 KMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGS-------RKIFLDEVSVLLRVSHPNLVGLLGFCLEKG 79 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 79 (266)
....|-..+.||+|+||.|-+| ...+|+.+|||.+....... .....+|+++|++|+||+||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3445556679999999999999 77789999999886543221 223568999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC---CceEEe
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD---NHAKLA 156 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~~~l~ 156 (266)
..|+||||+.||+|.+.+-.+ +.+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ -.+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence 999999999999999999875 77888888999999999999999999 9999999999999866 358999
Q ss_pred ccccccCCCCCCCCCCCcccccccCCCccCccccccccC---CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh
Q 047020 157 DFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV---STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (266)
|||+|... .....+.+.+||+.|.|||++.++.. ..++|+||+||++|.+++|.+||+++.....+.+.+.+
T Consensus 322 DFGlAK~~-----g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 322 DFGLAKVS-----GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred ccchhhcc-----ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 99999863 34667889999999999999976643 34789999999999999999999877665533333321
Q ss_pred c--------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 234 N--------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 ~--------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
. ...+++.+||.-+|..||+.++..
T Consensus 397 G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 397 GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 1 123678899999999999988764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=311.72 Aligned_cols=210 Identities=26% Similarity=0.384 Sum_probs=183.4
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.|.+..+||.|+|+.||++.+ .++..++||.+..+. ....+.+..|+.+|+.++|||||.+++++.+++..|+||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 456667899999999999955 457889999886652 33456678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC------CceEEeccccc
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD------NHAKLADFGLC 161 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~------~~~~l~dfg~~ 161 (266)
|.||+|.++++.. +.+++..++.++.|++.|+++||+++ |+||||||+|||++.. -.+||.|||+|
T Consensus 91 C~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 91 CNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999885 68999999999999999999999999 9999999999999764 34799999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (266)
+.+. ......+..|++-|||||++....|+.|+|+||+|+++|++++|..||+..+..+......+.
T Consensus 163 R~L~-----~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 163 RFLQ-----PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred hhCC-----chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc
Confidence 9643 345567899999999999999999999999999999999999999999877666655544333
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=319.48 Aligned_cols=241 Identities=27% Similarity=0.400 Sum_probs=211.5
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
...|.+.||.|+|++|++| +..++..+|||.+.++ +....+....|-+.|.+| .||.|++++..|+++..+|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 4567789999999999999 6678999999976432 122345566788999999 6999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||.++|+|.++++.. +.|++.-++.++.||+.|+.|||+.| |+||||||+|||++++++++|.|||.|..+.
T Consensus 154 e~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999987 89999999999999999999999999 9999999999999999999999999998876
Q ss_pred CCCCC---------CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc
Q 047020 166 FNDPN---------RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN 236 (266)
Q Consensus 166 ~~~~~---------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (266)
..... ........+||+.|.+||++.....+.++|+|+||||+|+|+.|.+||.+.++...+.+++.-...
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 54433 122235689999999999999999999999999999999999999999999999999998884333
Q ss_pred ---------hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 ---------VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ---------~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.++++++|..+|..|.+.++|.+
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 26889999999999999988865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=304.87 Aligned_cols=235 Identities=26% Similarity=0.328 Sum_probs=201.4
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecC-eEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG-EQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~ 87 (266)
..+....||+|+.|.|+++.+ .++...|+|.+....+ ...+++.+|+++++..+||+||++|+.|..+. ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 445556899999999999954 5688889998855433 34678899999999999999999999999988 59999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|++|||.+.++.. +.+++..+..++.++++||.|||. ++ |+||||||+|+|++..|++||+|||.+...
T Consensus 160 MDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~l-- 229 (364)
T KOG0581|consen 160 MDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGIL-- 229 (364)
T ss_pred cCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHh--
Confidence 9999999999875 779999999999999999999995 87 999999999999999999999999998753
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC-----chhHHHHHHHHhcCch----
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS-----ATLAEWTEECRRNKNV---- 237 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~---- 237 (266)
.+...++..||..|||||.+.+..|+.++||||||++++|++.|+.||... +.++.+..++...+..
T Consensus 230 ----vnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 230 ----VNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG 305 (364)
T ss_pred ----hhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 233678899999999999999999999999999999999999999999764 5556666666632221
Q ss_pred -------hhhhhhccCCCCCcchHHHHHH
Q 047020 238 -------EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 -------~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+..|++.+|..|+++.+|..
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 3466788899999998888753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=291.24 Aligned_cols=212 Identities=27% Similarity=0.378 Sum_probs=187.7
Q ss_pred hhchhhhhccccccceEEEEEcC-CCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG-DGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
...++...||.|+||.|.+++.+ +|.+.|+|.+....-. +.+...+|..+|+.+.||+++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 34456668999999999999544 5778888876543322 2344567999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||.+||.|.+++++. +.+++..++.++.|++.|+.|||+++ |++||+||+|||++++|.+||.|||.|...
T Consensus 124 eyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v- 194 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV- 194 (355)
T ss_pred eccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe-
Confidence 999999999999885 88999999999999999999999999 999999999999999999999999999852
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN 236 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (266)
.....+.+||+.|+|||.+..+++..++|+||||+++|||+.|.+||.+.+....+.+++.....
T Consensus 195 ------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~ 259 (355)
T KOG0616|consen 195 ------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK 259 (355)
T ss_pred ------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc
Confidence 33466889999999999999999999999999999999999999999999999999888886543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=307.99 Aligned_cols=234 Identities=23% Similarity=0.262 Sum_probs=194.0
Q ss_pred hhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 16 IRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 16 ~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
..||+|+||.||+| +..+|+.+|+|++.+.. ..+......|-.+|....+|+||+++..|++.+++||||||++||
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 48999999999999 66789999999886532 234556677999999999999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC----
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN---- 167 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~---- 167 (266)
++..++... +.+++..+..++.+++.|+..||+.| ++||||||+|+|++..|++||+|||++......
T Consensus 227 D~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 227 DMMTLLMRK-----DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred cHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 999999875 89999999999999999999999999 999999999999999999999999998542110
Q ss_pred ---------------CCCC------------------------CCcccccccCCCccCccccccccCCCcccchhHHHHH
Q 047020 168 ---------------DPNR------------------------PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLL 208 (266)
Q Consensus 168 ---------------~~~~------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~ 208 (266)
.+.. ........||+.|+|||++.+.+|+..+|+||||||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 0000 0111235899999999999999999999999999999
Q ss_pred HHHHhCCCCcCCCchhHHHHHHHHhcCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 209 LELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 209 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
|||+.|.+||.+++....|.++..-.. .+. .|...+...+-.++|.+|+
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~-------~l~-fP~~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRE-------TLK-FPEEVDLSDEAKDLITRLL 427 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhh-------hcc-CCCcCcccHHHHHHHHHHh
Confidence 999999999999988888887776432 222 2333333366788888776
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=303.86 Aligned_cols=239 Identities=49% Similarity=0.817 Sum_probs=197.7
Q ss_pred CCChHHHHHhhchhhh--hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEec
Q 047020 1 TYALEELKMATNDFRI--RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK 78 (266)
Q Consensus 1 ~~~~~~i~~~~~~~~~--~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 78 (266)
.|+..+|..+|++|.. .||+|+||.||++.+.+|..++||+...........|.+|++++.+++|||+++++++|.+.
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEG 143 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence 3889999999999996 89999999999999999999999977654433144599999999999999999999999998
Q ss_pred C-eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEec
Q 047020 79 G-EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLAD 157 (266)
Q Consensus 79 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~d 157 (266)
+ ..++|+||+++|+|.+.+...... +++|....+|+.+++.||.|||....++|+||||||.|||+|++.+.||+|
T Consensus 144 ~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 144 GEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred CceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 8 599999999999999998763111 889999999999999999999998888999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccc-ccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC-----chhHHHHHHH
Q 047020 158 FGLCKLGPFNDPNRPKRQTSI-KGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS-----ATLAEWTEEC 231 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~-----~~~~~~~~~~ 231 (266)
||+|...+.. ....... .||..|++||+......+.++||||||+++.|+++|+.|.+.. ..+..|.+..
T Consensus 221 FGLa~~~~~~----~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 221 FGLAKLGPEG----DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCcccCCcc----ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999753321 1111112 7999999999998888999999999999999999999888642 2355665444
Q ss_pred HhcCchhhhhhhccCCCC
Q 047020 232 RRNKNVEVWAQMLDPKLN 249 (266)
Q Consensus 232 ~~~~~~~~~~~~l~~~~~ 249 (266)
.... -+..++|+.+.
T Consensus 297 ~~~~---~~~eiiD~~l~ 311 (361)
T KOG1187|consen 297 LEEG---KLREIVDPRLK 311 (361)
T ss_pred HHCc---chhheeCCCcc
Confidence 4333 23355555544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=303.89 Aligned_cols=231 Identities=26% Similarity=0.416 Sum_probs=205.7
Q ss_pred hhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchh
Q 047020 16 IRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 16 ~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
++||+|+.|.||.+ +..+++.|+||++........+-+.+|+.+|+..+|+|||.+++.|...+.+|+||||++||+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 48999999999999 77889999999998887777888999999999999999999999998889999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCc
Q 047020 95 DRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174 (266)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 174 (266)
|.+.. ..+++.++..++.+++.||+|||.+| |+|||||.+||+++.+|.+||+|||+|..+.... ..
T Consensus 359 DvVt~------~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~----~K 425 (550)
T KOG0578|consen 359 DVVTK------TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ----SK 425 (550)
T ss_pred hhhhc------ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc----Cc
Confidence 99987 46899999999999999999999999 9999999999999999999999999998654332 24
Q ss_pred ccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch------------hhhhh
Q 047020 175 QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV------------EVWAQ 242 (266)
Q Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------~~~~~ 242 (266)
.....||+.|||||++..+.|++++||||||+|++||+.|.+||-.++.+.-.+.+..+.... +.+.+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 567899999999999999999999999999999999999999999887777776666543321 45677
Q ss_pred hccCCCCCcchHHHHHH
Q 047020 243 MLDPKLNGDANMEQLRV 259 (266)
Q Consensus 243 ~l~~~~~~~~~~~~l~~ 259 (266)
||..++..|++..+|.+
T Consensus 506 cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLE 522 (550)
T ss_pred HhhcchhcCCCHHHHhc
Confidence 88888888888888764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=297.01 Aligned_cols=246 Identities=30% Similarity=0.413 Sum_probs=200.6
Q ss_pred hchhhhhccccccceEEEEEcCCCcEEEEEEeeeccccc--HHHHHHHHHHHhcCCCCCccccceeEEecC-eEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGS--RKIFLDEVSVLLRVSHPNLVGLLGFCLEKG-EQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~ 87 (266)
.-.+...||+|+||.||.+.......++||.+....... ...|.+|+.+|.+++|||||++++.+.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 334455799999999999988554448999886543322 458999999999999999999999998887 79999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-ceEEeccccccCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLGPF 166 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~~~l~dfg~~~~~~~ 166 (266)
+++|+|.+++... ....++...+..++.||+.|+.|||+.+. |+||||||+|||++.++ ++||+|||+++....
T Consensus 122 ~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999763 34789999999999999999999999863 89999999999999997 999999999986332
Q ss_pred CCCCCCCcccccccCCCccCccccc--cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch-------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLN--TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV------- 237 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 237 (266)
.. ..+....||+.|||||+++ ...++.++||||||+++|||++|..||.+.....-......+...+
T Consensus 197 ~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~ 272 (362)
T KOG0192|consen 197 SK----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECP 272 (362)
T ss_pred cc----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 21 2334478999999999999 5699999999999999999999999998877644444443322221
Q ss_pred ----hhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 238 ----EVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 238 ----~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.++..+..++|..||+..++...++.+.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 3556788888888888888888777654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=301.85 Aligned_cols=239 Identities=26% Similarity=0.375 Sum_probs=204.4
Q ss_pred HHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeec----cc-ccHHHHHHHHHHHhcCC-CCCccccceeEEecCe
Q 047020 8 KMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEE----RG-GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGE 80 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~----~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 80 (266)
....|.+...||+|+||.|+.+ ...+|..+++|.+... .. ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3456777779999999999999 5667899999944332 12 23456678999999999 9999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC-CceEEeccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD-NHAKLADFG 159 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~~~l~dfg 159 (266)
.++||||+.||+|.+++... +.+.+..+..++.|+++|+.|+|++| |+||||||+|++++.+ +++||+|||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999874 78899999999999999999999999 9999999999999998 999999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCcccccccc-CC-CcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGF-VS-TKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN- 236 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 236 (266)
++.... .......+..||+.|+|||++.+.. |+ .++||||+|+++|.|++|..||++.+....+.++......
T Consensus 167 ~s~~~~----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~ 242 (370)
T KOG0583|consen 167 LSAISP----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI 242 (370)
T ss_pred cccccC----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC
Confidence 998642 2345667889999999999999877 75 7899999999999999999999998777777665553211
Q ss_pred ---------hhhhhhhccCCCCCcchHHHHH
Q 047020 237 ---------VEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 237 ---------~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..++++|+.++|..|++..++.
T Consensus 243 p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 243 PSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 2467899999999999888875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=289.56 Aligned_cols=242 Identities=27% Similarity=0.362 Sum_probs=194.0
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecC--eEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG--EQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~ 87 (266)
+....+.||+|+||.||++.. ++|...+||.+........+.+.+|+.+|++++|||||++++...... .++++|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 345556899999999999944 458999999987664444667899999999999999999999754444 68999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCceEEeccccccCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADFGLCKLGPF 166 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~~l~dfg~~~~~~~ 166 (266)
+.+|||.+++... . +.+++..+..+..|++.||.|||++| ++|+||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~~---g-~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 98 APGGSLSDLIKRY---G-GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred cCCCcHHHHHHHc---C-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999875 1 26999999999999999999999999 999999999999999 79999999999886432
Q ss_pred CCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCC-CchhHHHHHHHHhcC---------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQG-SATLAEWTEECRRNK--------- 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~-~~~~~~~~~~~~~~~--------- 235 (266)
............||+.|||||++.. ......+||||+||++.||+||..||.+ .........+.....
T Consensus 171 -~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 171 -KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred -ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence 1111233446789999999999985 3344599999999999999999999987 333333333333331
Q ss_pred --chhhhhhhccCCCCCcchHHHHHHH
Q 047020 236 --NVEVWAQMLDPKLNGDANMEQLRVL 260 (266)
Q Consensus 236 --~~~~~~~~l~~~~~~~~~~~~l~~~ 260 (266)
..+.+++++..+|..||+.+++..-
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 1256778888888899888887653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=278.04 Aligned_cols=210 Identities=23% Similarity=0.344 Sum_probs=179.5
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
|+-..++|+|+||.||.++ ..+|+.||||++....++ ..+...+|+.+|++++|+|+|.++++|......++|+||+
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 4444589999999999994 457999999999765442 3566789999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
+. ++.+-+..+ ...++.+.+..+++|++.|+.|+|+++ ++||||||+||+++.+|.+||||||.|+....+.
T Consensus 84 dh-TvL~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 84 DH-TVLHELERY----PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ch-HHHHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 76 444445443 356789999999999999999999999 9999999999999999999999999998654221
Q ss_pred CCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (266)
......+.|..|+|||.+-| ..|+..+||||+||++.||++|.+.|.|.+.+++.+.+...
T Consensus 156 ----d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~kt 217 (396)
T KOG0593|consen 156 ----DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKT 217 (396)
T ss_pred ----chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHH
Confidence 12234678889999999877 68999999999999999999999999999999998887664
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=294.24 Aligned_cols=213 Identities=24% Similarity=0.377 Sum_probs=186.8
Q ss_pred HHHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCC-CCCccccceeEEecC-eEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKG-EQL 82 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~~~ 82 (266)
+.+.+|...++||.|.||.||+| ...+|+.||||+++.+-.. +...-.+|+..|++++ ||||+++.+++.++. .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 56788999999999999999999 6678999999988665433 2333468999999999 999999999998887 999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||| ..+|+++++.. ...|++..++-|++||++||+|+|++| +.|||+||+|||+.....+||+|||+|+
T Consensus 87 fVfE~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeHHhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccc
Confidence 999999 56999998863 478999999999999999999999999 9999999999999988899999999999
Q ss_pred CCCCCCCCCCCcccccccCCCccCcccc-ccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYL-NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
..... .+....+.|..|+|||++ +...|+.+.|+||+|||++|+.+-++.|.|.++.++..+++.
T Consensus 159 ev~Sk-----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~ 224 (538)
T KOG0661|consen 159 EVRSK-----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE 224 (538)
T ss_pred ccccC-----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence 64332 333455678889999987 566899999999999999999999999999999999998876
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=298.69 Aligned_cols=235 Identities=27% Similarity=0.313 Sum_probs=200.7
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+|-+...||+|.||.||++ +.++.++|++|.+.+.... +...+.+|+++++.++||||+.++++|+...+.|+|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 4455568999999999999 6667899999987654433 356688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.| +|..++... +.++++.+..+++|+++||.|||+.+ |.|+|+||.||++...|.+|++|||+|+.+..+
T Consensus 83 a~g-~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 83 AVG-DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhh-hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 976 999999875 88999999999999999999999999 999999999999999999999999999976542
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch---------h
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV---------E 238 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------~ 238 (266)
........||+-|||||.+.+..|+..+|.||+||++||++.|++||-..+-......+...+..+ .
T Consensus 154 ----t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~n 229 (808)
T KOG0597|consen 154 ----TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVN 229 (808)
T ss_pred ----ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHH
Confidence 233456789999999999999999999999999999999999999997655444444444433322 4
Q ss_pred hhhhhccCCCCCcchHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~ 258 (266)
.+...+..+|..|.++.++.
T Consensus 230 fl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred HHHHHhhcChhhcccHHHHh
Confidence 56788889999998888775
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=286.72 Aligned_cols=245 Identities=26% Similarity=0.339 Sum_probs=208.8
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+.|++...||.|..+.||+| .+..++.|+||++-....+ ....+.+|+..++.++||||++++..|..+..+|+||+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 456777789999999999999 7778899999998654433 45888999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
||.+||+.+.++.... ..+++..+..++.+++.||.|||.+| .+|||||+.|||++.+|.++|+|||....+..
T Consensus 105 fMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999988644 34899999999999999999999999 99999999999999999999999998776655
Q ss_pred CCCCCCCcccccccCCCccCccccc--cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLN--TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
.........+...||+.|||||++. ..+|+.|+||||||++..||.+|+.||..-.....+...+.+.+.
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 4433333337789999999999953 347999999999999999999999999877666655555555442
Q ss_pred -----------hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 -----------VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 -----------~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+.+..|+..+|..||+.+++.+
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 14567899999999999988754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=300.72 Aligned_cols=229 Identities=24% Similarity=0.379 Sum_probs=196.5
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 85 (266)
...+...||+|.||.|+++ ..++++.+|||.+.+.. ..+.+....|-+++.... ||+++.++..|+..+++|+||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 3455668999999999999 45678899999776532 345677888999999886 999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||..||++...... +.+++..+..+++.++.||+|||++| |+|||||.+||+++.+|.+||+|||+|..
T Consensus 449 ey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe-- 517 (694)
T KOG0694|consen 449 EYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE-- 517 (694)
T ss_pred EecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc--
Confidence 99999995444332 78999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch--------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV-------- 237 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 237 (266)
........++..||+.|+|||++.+..|+.++|+||||+++|+|+.|.+||.|+++.+.+..++...+..
T Consensus 518 --~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea 595 (694)
T KOG0694|consen 518 --GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEA 595 (694)
T ss_pred --cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHH
Confidence 2223446788999999999999999999999999999999999999999999999999888887754443
Q ss_pred -hhhhhhccCCCCCcc
Q 047020 238 -EVWAQMLDPKLNGDA 252 (266)
Q Consensus 238 -~~~~~~l~~~~~~~~ 252 (266)
.++++++..+|..|-
T Consensus 596 ~~il~~ll~k~p~kRL 611 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRL 611 (694)
T ss_pred HHHHHHHhccCccccc
Confidence 455677777777663
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=290.80 Aligned_cols=248 Identities=29% Similarity=0.400 Sum_probs=198.9
Q ss_pred HHHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
+|......+.++||+|.||.|+++.+.....+++|.+... +-..+.|.+|+++|++|+|++||+++++|..++.+++||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 4556667778899999999999999877778899877654 334567889999999999999999999999998999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||++.|||.++++. ...+.++..+...++.||+.|++||++++ +|||||...||||+++..+||+|||+|+...
T Consensus 281 E~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999987 34477899999999999999999999999 9999999999999999999999999999533
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcCc--h-----
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNKN--V----- 237 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~--~----- 237 (266)
++. ........-...|.|||.+....++.++||||||+++||++| |+.||.+-+..+-....-++... +
T Consensus 355 d~~---Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 355 DDE---YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPD 431 (468)
T ss_pred CCc---eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCH
Confidence 222 222223334556999999999999999999999999999998 88898766544433333222111 1
Q ss_pred ---hhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 238 ---EVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 238 ---~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
++...|...+|..||+.+.++..++.
T Consensus 432 ~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 34556666666666666666665554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=288.36 Aligned_cols=212 Identities=28% Similarity=0.387 Sum_probs=184.5
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEec--CeEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQLLLL 85 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 85 (266)
.++-..+||+|.||.||+| +..+|+.||+|++.... .....-..+|+.+|++|.||||+++.+...+. +.+|+|+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 3444559999999999999 78899999999987644 44566678999999999999999999988766 6899999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
|||+. +|.-++.. ..-.|++.++..++.|++.||.|+|++| +.|||||..|||++++|.+||.|||+|++..
T Consensus 198 eYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred ecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 99965 88777654 2347999999999999999999999999 9999999999999999999999999999744
Q ss_pred CCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (266)
... .......+.|..|+|||.+.|. .|+.++|+||.|||+.||+.|++.|+|.+++++..++.+-
T Consensus 270 ~~~---~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl 335 (560)
T KOG0600|consen 270 PSG---SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL 335 (560)
T ss_pred CCC---CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence 322 2335567789999999998765 7999999999999999999999999999999999988873
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=280.13 Aligned_cols=236 Identities=25% Similarity=0.319 Sum_probs=196.2
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.+..+.||.|.-|.||++.+ +++..+|+|.+.+.. .....+++.|-+||+.+.||.++.+|..++.+...|++|||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 34556899999999999955 456889999775432 22356778899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
|+||+|..+++. ++.+.+++..++.++.+++.||.|||-.| |++|||||+|||+-++|+|.|+||+++......
T Consensus 159 CpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 159 CPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred CCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999988876 66788999999999999999999999999 999999999999999999999999986442110
Q ss_pred --------------------------------C-C-------------------CCCCcccccccCCCccCccccccccC
Q 047020 168 --------------------------------D-P-------------------NRPKRQTSIKGSFGYVDTNYLNTGFV 195 (266)
Q Consensus 168 --------------------------------~-~-------------------~~~~~~~~~~~t~~y~aPE~~~~~~~ 195 (266)
. . ......+..+||.+|.|||+++|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 00123345689999999999999999
Q ss_pred CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch-----------hhhhhhccCCCCCcch
Q 047020 196 STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV-----------EVWAQMLDPKLNGDAN 253 (266)
Q Consensus 196 ~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~~~~~~~~ 253 (266)
+.++|+|+||+.+|||++|..||.|.++.+.+..++.++... +++++.|-.+|..|.-
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence 999999999999999999999999999999888888765443 4555566666655543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=297.62 Aligned_cols=234 Identities=26% Similarity=0.343 Sum_probs=202.5
Q ss_pred hhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 13 DFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+..+.||.|+.|.|.+|+. .+|+..|||.+.+..+ .....+.+|+-+|+.++|||++.+++++.++.++|+|.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 4556899999999999954 5788889988765522 23456788999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
+||.|++++... +++++.++..+++||+.|+.|+|..+ |||||+||+|++++.+++|||+|||.|...
T Consensus 95 ~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe---- 162 (786)
T KOG0588|consen 95 PGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE---- 162 (786)
T ss_pred CCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc----
Confidence 999999999875 89999999999999999999999999 999999999999999999999999999862
Q ss_pred CCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------hh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------VE 238 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~ 238 (266)
.......+-+|+++|.+||++.|..| +.++||||.|+|+|.|++|..||+++|-...+.+...+.-. -+
T Consensus 163 -~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQd 241 (786)
T KOG0588|consen 163 -VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQD 241 (786)
T ss_pred -cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHH
Confidence 23445567899999999999999987 47899999999999999999999977766665554442211 26
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
++++|++-++..|.+.++|.+
T Consensus 242 LLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 242 LLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHHHHhccCccccccHHHHhh
Confidence 889999999999999999876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=270.27 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=204.6
Q ss_pred HHHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecC-----e
Q 047020 7 LKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG-----E 80 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 80 (266)
|..++|.+...||+|||++||++ .+.+++.+++|++........+...+|++..++++|||+++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 34567778889999999999999 46788999999998877777888999999999999999999998764333 4
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.|++++|...|+|.+.+..... .+..+++.++..++.+++.||.+||.. .+|++|+||||.||++++.+.+++.|||+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 8999999999999999987533 335789999999999999999999998 58999999999999999999999999999
Q ss_pred ccCCCCCCCCC-----CCcccccccCCCccCcccccc---ccCCCcccchhHHHHHHHHHhCCCCcCC-----C-chhHH
Q 047020 161 CKLGPFNDPNR-----PKRQTSIKGSFGYVDTNYLNT---GFVSTKSDVYSFGVLLLELITGLKSIQG-----S-ATLAE 226 (266)
Q Consensus 161 ~~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~i~~~l~~g~~pf~~-----~-~~~~~ 226 (266)
++..+..-.++ ...-.....|..|.|||.+.- ...+.++|||||||++|.|+.|..||.. . -.+.-
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 98643321111 112223568899999999854 4678899999999999999999999932 1 11111
Q ss_pred HHHHH--H-----hcCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 227 WTEEC--R-----RNKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 227 ~~~~~--~-----~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
....+ . .....+++++|+..+|..||+..++...+....
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 10000 0 111226788999999999999999998877643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=287.42 Aligned_cols=230 Identities=24% Similarity=0.306 Sum_probs=189.4
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||+|+||.||++ ...+|+.+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++||||+.+++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 5899999999999 44678899999876432 2234567789999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.+.+... +.+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++..... ..
T Consensus 82 L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~----~~ 149 (323)
T cd05571 82 LFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS----DG 149 (323)
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc----CC
Confidence 99988764 67899999999999999999999999 99999999999999999999999999874211 11
Q ss_pred CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------chhhhhhh
Q 047020 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------NVEVWAQM 243 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~~ 243 (266)
.......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+..... ..+++++|
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 229 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 223345789999999999998999999999999999999999999987665554444333221 12567788
Q ss_pred ccCCCCCcc-----hHHHHH
Q 047020 244 LDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 244 l~~~~~~~~-----~~~~l~ 258 (266)
+..+|..|+ +..++.
T Consensus 230 L~~dP~~R~~~~~~~~~~ll 249 (323)
T cd05571 230 LKKDPKQRLGGGPEDAKEIM 249 (323)
T ss_pred ccCCHHHcCCCCCCCHHHHH
Confidence 888888888 555553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=283.95 Aligned_cols=228 Identities=25% Similarity=0.316 Sum_probs=190.5
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+++...||+|+||.||++. ..+|+.+++|.+..... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 45667799999999999994 45788999998754321 234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... +.+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 82 YVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999998764 57899999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------ch
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------NV 237 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~ 237 (266)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+..... ..
T Consensus 154 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 226 (291)
T cd05612 154 -------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAK 226 (291)
T ss_pred -------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHH
Confidence 12235689999999999988899999999999999999999999988766555554443221 12
Q ss_pred hhhhhhccCCCCCcch
Q 047020 238 EVWAQMLDPKLNGDAN 253 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~ 253 (266)
+++++|+..+|..|++
T Consensus 227 ~li~~~l~~dp~~R~~ 242 (291)
T cd05612 227 DLIKKLLVVDRTRRLG 242 (291)
T ss_pred HHHHHHcCCCHHHccC
Confidence 5677888888888874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=285.78 Aligned_cols=231 Identities=24% Similarity=0.309 Sum_probs=189.3
Q ss_pred ccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCch
Q 047020 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 18 ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
||+|+||.||++. ..+++.+++|.+.... ......+.+|+.++++++||||+++++.+.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999994 4568889999875432 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCC
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 173 (266)
.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~----~~ 148 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD----DD 148 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC----CC
Confidence 9998763 57899999999999999999999999 999999999999999999999999998742211 12
Q ss_pred cccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------chhhhhhhc
Q 047020 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------NVEVWAQML 244 (266)
Q Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~~l 244 (266)
......||..|+|||++.+..++.++|+||+||++|+|++|..||.+.+....+........ ..+++.+|+
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 228 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLL 228 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence 23345789999999999998999999999999999999999999987766555544443221 125677888
Q ss_pred cCCCCCcchHHHHHHH
Q 047020 245 DPKLNGDANMEQLRVL 260 (266)
Q Consensus 245 ~~~~~~~~~~~~l~~~ 260 (266)
..+|..|++...+.++
T Consensus 229 ~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 229 SRDPTRRLGYNGAQEI 244 (312)
T ss_pred CCCHHHcCCCCCHHHH
Confidence 8888888754333333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=287.57 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=198.1
Q ss_pred HhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEec-C
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEK-G 79 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~ 79 (266)
..++++.+.||+|+||.||++.. .++..+++|.+..... .....+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45667777999999999999942 2346789988764322 2345688999999999 799999999987654 4
Q ss_pred eEEEEEEecCCCchhhhhhhhcCC--------------------------------------------------------
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQ-------------------------------------------------------- 103 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~-------------------------------------------------------- 103 (266)
..+++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 588999999999999998753210
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCC
Q 047020 104 -SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182 (266)
Q Consensus 104 -~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~ 182 (266)
....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........ ........++.
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~~ 240 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGSARLPL 240 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc--hhcccCCCCCc
Confidence 0134778889999999999999999999 99999999999999999999999999875322111 11223345667
Q ss_pred CccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc-----------CchhhhhhhccCCCCC
Q 047020 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN-----------KNVEVWAQMLDPKLNG 250 (266)
Q Consensus 183 ~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~~~~~ 250 (266)
.|+|||++.+..++.++||||||+++|+|++ |..||.+.............. ...+++.+|+.++|..
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 8999999988889999999999999999997 999998755433333333221 1225778999999999
Q ss_pred cchHHHHHHHHHHHh
Q 047020 251 DANMEQLRVLIRICM 265 (266)
Q Consensus 251 ~~~~~~l~~~~~~~~ 265 (266)
||+..++.+.++.++
T Consensus 321 RPs~~el~~~l~~~~ 335 (338)
T cd05102 321 RPTFSALVEILGDLL 335 (338)
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=288.91 Aligned_cols=231 Identities=24% Similarity=0.376 Sum_probs=192.8
Q ss_pred HHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
....+.+...||+|+||.||++.. .+|+.+++|.+.... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 345566777999999999999954 568899999875432 1234567899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+.+++|.+.+... +.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 96 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EEcCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 99999999999998764 57889999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-------- 235 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 235 (266)
... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+....+..+.....
T Consensus 168 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 240 (329)
T PTZ00263 168 VPD-------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240 (329)
T ss_pred cCC-------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCH
Confidence 321 12235689999999999998899999999999999999999999987766555544433221
Q ss_pred -chhhhhhhccCCCCCcch
Q 047020 236 -NVEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 236 -~~~~~~~~l~~~~~~~~~ 253 (266)
..+++++|+..+|..|++
T Consensus 241 ~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 241 RARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred HHHHHHHHHhhcCHHHcCC
Confidence 125677888888888875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=260.93 Aligned_cols=212 Identities=25% Similarity=0.349 Sum_probs=184.5
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeec--ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEE--RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+|.-..++|+|.||.||+| +..+|+.+|||++... .++-...+.+|++.|+.++|+||+.++++|.+.+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4555669999999999999 7789999999998653 223355678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+ ..+|+..++.. .-.++..++..++.+++.|+.|+|++. |.||||||+|++++.+|.+||.|||+|+....+
T Consensus 83 m-~tdLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 83 M-PTDLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred c-cccHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9 56999999863 256889999999999999999999999 999999999999999999999999999975433
Q ss_pred CCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN 234 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (266)
.. .....+-|..|+|||.+-| +.|+..+|+||.||++.||+-|.+.|.|.+.+++...+...-
T Consensus 155 ~~----~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~L 218 (318)
T KOG0659|consen 155 NR----IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRAL 218 (318)
T ss_pred Cc----ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHc
Confidence 32 1222377889999998754 589999999999999999999999999999999999888753
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=287.59 Aligned_cols=236 Identities=22% Similarity=0.308 Sum_probs=193.7
Q ss_pred HHhhchhhhhccccccceEEEEEc-CCC-cEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL-GDG-NFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~-~~g-~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
....+.+...||+|+||.||++.. .++ ..+++|.+.... ......+.+|+++++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 344566677999999999999953 333 578888775432 223456788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+.+++|.+++... +.+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++.
T Consensus 108 lv~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 999999999999998764 57899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------- 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 235 (266)
.... ......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+....+..+.....
T Consensus 180 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 252 (340)
T PTZ00426 180 VVDT-------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252 (340)
T ss_pred ecCC-------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence 5321 12345789999999999888899999999999999999999999988777665555544321
Q ss_pred --chhhhhhhccCCCCCcc-----hHHHHH
Q 047020 236 --NVEVWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 236 --~~~~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
..+++++|+..+|..|+ +.+++.
T Consensus 253 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 282 (340)
T PTZ00426 253 NNCKHLMKKLLSHDLTKRYGNLKKGAQNVK 282 (340)
T ss_pred HHHHHHHHHHcccCHHHcCCCCCCCHHHHH
Confidence 12567788888887774 555543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=287.01 Aligned_cols=241 Identities=24% Similarity=0.294 Sum_probs=211.0
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCe-EEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE-QLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv 84 (266)
+..|.+..++|+|+||.++++ ...++..+++|++..... ..+....+|+.++++++||||+.+.+.|..++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 457888889999999999999 445677889998865443 334567899999999999999999999988887 9999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|+|++||++.+.+.... +..++++.+..|+.|++.|+.|||++. |.|||||+.|||++.++.|+|+|||+|+.+
T Consensus 83 m~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhc
Confidence 99999999999998853 467999999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch-------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV------- 237 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 237 (266)
... ........||+.|++||.+.+.+|..++|||||||++|||++-+.+|.+.+......++......+
T Consensus 157 ~~~----~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~ 232 (426)
T KOG0589|consen 157 NPE----DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSS 232 (426)
T ss_pred CCc----hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccH
Confidence 322 235677899999999999999999999999999999999999999999999888888887754222
Q ss_pred ---hhhhhhccCCCCCcchHHHHHH
Q 047020 238 ---EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 ---~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.++..|+..+|..||++.+|..
T Consensus 233 el~~lv~~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 233 ELRSLVKSMLRKNPEHRPSALELLR 257 (426)
T ss_pred HHHHHHHHHhhcCCccCCCHHHHhh
Confidence 4678999999999999998865
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=282.55 Aligned_cols=224 Identities=24% Similarity=0.310 Sum_probs=183.7
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||+|+||.||++. ..+|..+++|.+.... ......+.+|+++++.++||||+++++.+...+..++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 58999999999994 5678899999876532 2234556789999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.+++... ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++..... ..
T Consensus 82 L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~----~~ 149 (323)
T cd05595 82 LFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS----DG 149 (323)
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC----CC
Confidence 98888653 57899999999999999999999999 99999999999999999999999999864211 11
Q ss_pred CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------chhhhhhh
Q 047020 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------NVEVWAQM 243 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~~ 243 (266)
.......||..|+|||++.+..++.++|+|||||++|+|++|..||.+.+............. ..+++.+|
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 229 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 222345689999999999988999999999999999999999999987665554444332211 12456677
Q ss_pred ccCCCCCcc
Q 047020 244 LDPKLNGDA 252 (266)
Q Consensus 244 l~~~~~~~~ 252 (266)
+..+|..|+
T Consensus 230 L~~dP~~R~ 238 (323)
T cd05595 230 LKKDPKQRL 238 (323)
T ss_pred ccCCHHHhC
Confidence 777777776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=302.32 Aligned_cols=247 Identities=26% Similarity=0.313 Sum_probs=201.5
Q ss_pred hhhhhccccccceEEEEEcCCC-cEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccce-eEEe------cCeEEE
Q 047020 13 DFRIRIGVGATSFVYLAELGDG-NFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLG-FCLE------KGEQLL 83 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~~g-~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~-~~~~------~~~~~l 83 (266)
.+++.|.+|||+.||+|.+..+ ..+|+|++............+|+++|++|+ |||||.|++ .... .-..++
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 4455899999999999965554 899999988876667788899999999998 999999999 3321 125689
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
+||||.||+|.|++...-. ..|++.++++|++|++.|+.+||.. .+||+|||||-||||++.+|++||||||+|+-
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred ehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 9999999999999986422 3499999999999999999999999 69999999999999999999999999999974
Q ss_pred CCCCCCCCCCcc------cccccCCCccCcccc---ccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc
Q 047020 164 GPFNDPNRPKRQ------TSIKGSFGYVDTNYL---NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN 234 (266)
Q Consensus 164 ~~~~~~~~~~~~------~~~~~t~~y~aPE~~---~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (266)
.-..-. ..... -....|+.|++||++ ++..++.|+|||||||+||-||....||.+...+........-+
T Consensus 196 ~~~~~~-~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~P 274 (738)
T KOG1989|consen 196 KILSPT-SAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSFP 274 (738)
T ss_pred ccCCCc-cHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccCC
Confidence 211110 01111 124689999999986 67889999999999999999999999998876666555554444
Q ss_pred Cch-------hhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 235 KNV-------EVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 235 ~~~-------~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
+.+ ++++.||.++|..||...++...+-+.
T Consensus 275 ~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 275 PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 432 678999999999999999888776554
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=282.57 Aligned_cols=224 Identities=25% Similarity=0.332 Sum_probs=185.3
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||+|+||.||++ ...+|..+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 5899999999999 45678899999876432 2234567889999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.+.+... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...... .
T Consensus 82 L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~----~ 149 (328)
T cd05593 82 LFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD----A 149 (328)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc----c
Confidence 98888653 57899999999999999999999999 999999999999999999999999998742111 1
Q ss_pred CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc---------Cchhhhhhh
Q 047020 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN---------KNVEVWAQM 243 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~~ 243 (266)
.......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+.... ...+++++|
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 229 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGL 229 (328)
T ss_pred cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHH
Confidence 22234568999999999988889999999999999999999999998766544443332221 122567788
Q ss_pred ccCCCCCcc
Q 047020 244 LDPKLNGDA 252 (266)
Q Consensus 244 l~~~~~~~~ 252 (266)
+..+|..|+
T Consensus 230 L~~dP~~R~ 238 (328)
T cd05593 230 LIKDPNKRL 238 (328)
T ss_pred cCCCHHHcC
Confidence 888888886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=276.61 Aligned_cols=238 Identities=25% Similarity=0.337 Sum_probs=206.1
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
.-+|++.++||+|.||.|-++ ....|..|+||.+++..- ...-.+.+|+++|+.|+||||+.++.+|++.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 446788889999999999999 557899999998765433 2344567899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||..+|.|+||+... +.+++..++.++.||.+|+.|+|+++ ++|||||.+||++++++++||.|||++...
T Consensus 132 MEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999885 88999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCC-CcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVS-TKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN------- 236 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------- 236 (266)
. ......+++|++-|.+||.+.|.+|. +.+|.||||+++|.|.+|..||+|.+.......+......
T Consensus 204 ~-----~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSd 278 (668)
T KOG0611|consen 204 A-----DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSD 278 (668)
T ss_pred c-----cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCch
Confidence 2 23455778999999999999998874 7899999999999999999999998877666555443111
Q ss_pred -hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 -VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 -~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.-++++|+.-+|.-|++.++|..
T Consensus 279 A~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 279 ASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred HHHHHHHHHhcCcccchhHHHHhh
Confidence 14789999999999999888754
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=284.08 Aligned_cols=204 Identities=27% Similarity=0.362 Sum_probs=175.9
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+.+...||+|+||.||++.. .+|+.+++|.+.... ......+.+|++++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 355667999999999999954 468899999876532 2234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 82 YVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999998763 57899999999999999999999999 99999999999999999999999999874221
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHH
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE 229 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~ 229 (266)
......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..
T Consensus 154 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 209 (333)
T cd05600 154 -------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209 (333)
T ss_pred -------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH
Confidence 23456789999999999988999999999999999999999999987765554433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=276.33 Aligned_cols=231 Identities=20% Similarity=0.253 Sum_probs=184.9
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+.....||+|+||.||++. ..+|+.+++|.+..... .....+.+|+++++.++|++|+++++.+.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 4455689999999999994 56789999998754321 2234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++++|.+.+... ....+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 82 ~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 82 MNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred cCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999998887642 2246889999999999999999999999 999999999999999999999999998753221
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHH---HHHHHHhc----------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAE---WTEECRRN---------- 234 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~---~~~~~~~~---------- 234 (266)
.......|+..|+|||++.+..++.++||||+||++|+|++|..||.+.+.... ........
T Consensus 156 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 230 (285)
T cd05631 156 -----ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSE 230 (285)
T ss_pred -----CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCH
Confidence 112345689999999999998999999999999999999999999987543221 11111110
Q ss_pred CchhhhhhhccCCCCCcch
Q 047020 235 KNVEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 235 ~~~~~~~~~l~~~~~~~~~ 253 (266)
...+++++|+..+|..|++
T Consensus 231 ~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05631 231 DAKSICRMLLTKNPKERLG 249 (285)
T ss_pred HHHHHHHHHhhcCHHHhcC
Confidence 1114667788888888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=280.20 Aligned_cols=231 Identities=25% Similarity=0.352 Sum_probs=188.9
Q ss_pred hhccccccceEEEEEc----CCCcEEEEEEeeecc----cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 16 IRIGVGATSFVYLAEL----GDGNFGAVKRVMEER----GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+.||+|+||.||++.. ..++.+++|.+.... ......+.+|+++++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4799999999999953 467889999875422 12234567899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+.+... +.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 152 (323)
T cd05584 82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH- 152 (323)
T ss_pred CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc-
Confidence 9999999988764 56788999999999999999999999 99999999999999999999999999864211
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------hh
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------VE 238 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~ 238 (266)
.........|+..|+|||++.+..++.++||||+|+++|+|++|..||.+.+.......+...... .+
T Consensus 153 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (323)
T cd05584 153 ---EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229 (323)
T ss_pred ---CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 112223456899999999998888899999999999999999999999887765555544433211 25
Q ss_pred hhhhhccCCCCCcc-----hHHHHH
Q 047020 239 VWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 239 ~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
++++|+..+|..|+ +.+++.
T Consensus 230 li~~~l~~~p~~R~~~~~~~~~~l~ 254 (323)
T cd05584 230 LLKKLLKRNPSSRLGAGPGDAAEVQ 254 (323)
T ss_pred HHHHHcccCHhHcCCCCCCCHHHHh
Confidence 67788888888887 566554
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=285.71 Aligned_cols=212 Identities=22% Similarity=0.283 Sum_probs=176.6
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+.+.+.||+|+||.||++ ...+|+.++||.+.... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 3556678999999999999 44578899999886432 2234557789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 82 YLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999998763 56899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCCCC----------------------------------CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHH
Q 047020 167 NDPNR----------------------------------PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELI 212 (266)
Q Consensus 167 ~~~~~----------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~ 212 (266)
..... ........||+.|+|||++.+..++.++|+||+||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11100 00112346899999999999889999999999999999999
Q ss_pred hCCCCcCCCchhHHHHHH
Q 047020 213 TGLKSIQGSATLAEWTEE 230 (266)
Q Consensus 213 ~g~~pf~~~~~~~~~~~~ 230 (266)
+|..||.+.+.......+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i 251 (364)
T cd05599 234 VGYPPFCSDNPQETYRKI 251 (364)
T ss_pred cCCCCCCCCCHHHHHHHH
Confidence 999999877655544443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.19 Aligned_cols=213 Identities=22% Similarity=0.272 Sum_probs=178.2
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+++.+.||+|+||.||++ ...+++.+++|.+.... ......+.+|+.++..++||+|+++++.+.+....++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 3556678999999999999 55578899999875432 2234567789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|++|++|.+++... +.+++..+..++.|++.||.|||++| |+||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 82 FLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999998764 67899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCC-------------------------------CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCC
Q 047020 167 NDPN-------------------------------RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGL 215 (266)
Q Consensus 167 ~~~~-------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~ 215 (266)
.... .........||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 000112357999999999999989999999999999999999999
Q ss_pred CCcCCCchhHHHHHHH
Q 047020 216 KSIQGSATLAEWTEEC 231 (266)
Q Consensus 216 ~pf~~~~~~~~~~~~~ 231 (266)
.||.+.+....+.++.
T Consensus 234 ~Pf~~~~~~~~~~~i~ 249 (363)
T cd05628 234 PPFCSETPQETYKKVM 249 (363)
T ss_pred CCCCCCCHHHHHHHHH
Confidence 9998877666555544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.00 Aligned_cols=241 Identities=22% Similarity=0.221 Sum_probs=196.3
Q ss_pred chhhhhccccccceEEEEE-cCC-CcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGD-GNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~-g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
|.+...||+|++|.||++. ..+ ++.+++|.+..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 4556689999999999994 334 56777776655444445567789999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++.... ....++++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 149 gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~- 223 (478)
T PTZ00267 149 GGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV- 223 (478)
T ss_pred CCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc-
Confidence 999999886532 12356899999999999999999999999 9999999999999999999999999987532211
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC----------chhh
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----------NVEV 239 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~~~ 239 (266)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+............. ..++
T Consensus 224 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 302 (478)
T PTZ00267 224 -SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKAL 302 (478)
T ss_pred -ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHH
Confidence 11223445689999999999988899999999999999999999999987766555544443221 1256
Q ss_pred hhhhccCCCCCcchHHHHH
Q 047020 240 WAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 240 ~~~~l~~~~~~~~~~~~l~ 258 (266)
+.+|+..+|..||+.+++.
T Consensus 303 i~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 303 LDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred HHHHhccChhhCcCHHHHH
Confidence 7899999999999988874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=277.17 Aligned_cols=242 Identities=24% Similarity=0.319 Sum_probs=196.1
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc--------------cHHHHHHHHHHHhcCCCCCccccce
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG--------------SRKIFLDEVSVLLRVSHPNLVGLLG 73 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~ 73 (266)
..+|.....||+|.||.|.+| +..+++.+|||.+.++.-. ..+...+|+.+|++++|||||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 346677779999999999999 6778999999987543211 1346789999999999999999999
Q ss_pred eEEec--CeEEEEEEecCCCchhhhhhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC
Q 047020 74 FCLEK--GEQLLLLEYLANKSLFDRMHTYYGQSLGV-LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD 150 (266)
Q Consensus 74 ~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~ 150 (266)
+..+. +.+|+|+||+..|.+.+.-- .++ +++.+++.++.++..||.|||.+| |+||||||.|+|++++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~------d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPP------DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCC------CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 98654 57999999998888765422 245 899999999999999999999999 9999999999999999
Q ss_pred CceEEeccccccCCCCCCC-CCCCcccccccCCCccCcccccccc----CCCcccchhHHHHHHHHHhCCCCcCCCchhH
Q 047020 151 NHAKLADFGLCKLGPFNDP-NRPKRQTSIKGSFGYVDTNYLNTGF----VSTKSDVYSFGVLLLELITGLKSIQGSATLA 225 (266)
Q Consensus 151 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~ 225 (266)
|++||+|||.+...+.... ..........||+.|+|||...+.. .+.+.||||+|+++|.|+.|+.||-+....+
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 9999999999875432211 1112223478999999999886632 3568999999999999999999999999999
Q ss_pred HHHHHHHhcCch-----------hhhhhhccCCCCCcchHHHHHH
Q 047020 226 EWTEECRRNKNV-----------EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 226 ~~~~~~~~~~~~-----------~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+.++...+-.. +++.++|..+|..|.+..+|..
T Consensus 327 l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 327 LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 888887743322 5678888888888887777653
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=278.87 Aligned_cols=224 Identities=25% Similarity=0.357 Sum_probs=185.6
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++. .++|+.+++|.+.... ......+..|.+++..+ +||||+++++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 58999999999994 4567899999876532 22345567788888866 6999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+.+... ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++......
T Consensus 82 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~---- 149 (321)
T cd05591 82 DLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN---- 149 (321)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC----
Confidence 999888764 56899999999999999999999999 999999999999999999999999998742111
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------chhhhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------NVEVWAQ 242 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~ 242 (266)
........||..|+|||++.+..++.++|+||+||++|+|++|..||.+.+....+..+..... ..+++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~ 229 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKA 229 (321)
T ss_pred CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 1223345689999999999988999999999999999999999999988877666655544321 1256778
Q ss_pred hccCCCCCcc
Q 047020 243 MLDPKLNGDA 252 (266)
Q Consensus 243 ~l~~~~~~~~ 252 (266)
|+..+|..|+
T Consensus 230 ~L~~dp~~R~ 239 (321)
T cd05591 230 FMTKNPNKRL 239 (321)
T ss_pred HhccCHHHcC
Confidence 8888888887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.40 Aligned_cols=211 Identities=22% Similarity=0.280 Sum_probs=175.0
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+.+...||+|+||.||++ ...++..+++|.+.... ......+.+|+++++.++||||+++++.+.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 455678999999999999 55678899999886532 22345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++++|.+++... +.+++..+..++.|++.||.|||+.| |+||||||+||+++.+++++|+|||++......
T Consensus 83 ~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 83 IPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999998764 56889999999999999999999999 999999999999999999999999987532110
Q ss_pred CCC-------------------------------------------CCCcccccccCCCccCccccccccCCCcccchhH
Q 047020 168 DPN-------------------------------------------RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSF 204 (266)
Q Consensus 168 ~~~-------------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 204 (266)
... .........||..|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 000 0001123579999999999988889999999999
Q ss_pred HHHHHHHHhCCCCcCCCchhHHHHHH
Q 047020 205 GVLLLELITGLKSIQGSATLAEWTEE 230 (266)
Q Consensus 205 G~i~~~l~~g~~pf~~~~~~~~~~~~ 230 (266)
||++|+|++|..||.+.+......++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i 260 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKV 260 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 99999999999999876654444433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=289.74 Aligned_cols=232 Identities=25% Similarity=0.377 Sum_probs=192.0
Q ss_pred hhhhhccccccceEEEE-EcCCCcEEEEE--Eee--ecccccHHHHHHHHHHHhcCCCCCccccceeEEecCe--EEEEE
Q 047020 13 DFRIRIGVGATSFVYLA-ELGDGNFGAVK--RVM--EERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE--QLLLL 85 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~-~~~~g~~~~vk--~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~lv~ 85 (266)
+|...||+|+|.+||+| +..+|-.||== ++. .++....++|..|+.+|+-|+||||+++++++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45568999999999999 44444443211 111 1333456889999999999999999999999877665 78999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCceEEeccccccCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADFGLCKLG 164 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~~l~dfg~~~~~ 164 (266)
|.+..|+|..|++.. +..+...+..|+.||+.||.|||++ +|||+|||||.+||||+. .|.+||+|+|+|+.+
T Consensus 123 EL~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999999999987 7788999999999999999999998 799999999999999985 589999999999863
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCchhhhhhhc
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQML 244 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (266)
+........||+.|||||++. ..|+..+||||||+++.||.|+.+||.......+.+++......+..+.+.=
T Consensus 197 ------r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 197 ------RKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred ------hccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence 234445589999999999997 7899999999999999999999999999999999998888777665443332
Q ss_pred cCCCCCcchHHHHHHHHHHHhC
Q 047020 245 DPKLNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 245 ~~~~~~~~~~~~l~~~~~~~~~ 266 (266)
+ .+++++|++|++
T Consensus 270 d---------Pevr~fIekCl~ 282 (632)
T KOG0584|consen 270 D---------PEVREFIEKCLA 282 (632)
T ss_pred C---------HHHHHHHHHHhc
Confidence 2 277888888864
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=288.57 Aligned_cols=214 Identities=24% Similarity=0.271 Sum_probs=185.8
Q ss_pred HHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-C-----CCccccceeEEecCe
Q 047020 8 KMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-H-----PNLVGLLGFCLEKGE 80 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~~~ 80 (266)
...+|.+.+.||+|.||.|.+| +.++++.||||.++.+.. ...+...|+.+|+.|+ | -|+|+++++|..+++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 3346667779999999999999 778899999998876543 4556778999999997 3 399999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC--ceEEecc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN--HAKLADF 158 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~--~~~l~df 158 (266)
.|+|+|.+ +.+|+++++.+ +...++...++.++.||+.+|.+||+.+ |+|+||||||||+.+.+ ++||+||
T Consensus 263 lciVfELL-~~NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred eeeeehhh-hhhHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 99999987 67999999984 5567999999999999999999999999 99999999999997654 6999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN 236 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (266)
|+++.. ......-..+..|+|||++.|..|+.+.||||||||++||++|.+.|.|+++.+++..+..-...
T Consensus 336 GSSc~~-------~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 336 GSSCFE-------SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred cccccc-------CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 999852 22222667888999999999999999999999999999999999999999999999888775433
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=278.16 Aligned_cols=228 Identities=24% Similarity=0.344 Sum_probs=185.6
Q ss_pred hhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHH---hcCCCCCccccceeEEecCeEEEEE
Q 047020 13 DFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVL---LRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
++...||+|+||.||++ ...+|+.++||.+.... ......+.+|..++ +.++||||+++++++.+.+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45668999999999999 45578899999876432 22344566666655 4567999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+.+++|...+.. +.+++..+..++.|++.|+.|||+.| ++|+||||+||+++.++.++|+|||++....
T Consensus 82 E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 82 EYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred cCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999887754 57899999999999999999999999 9999999999999999999999999886421
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------c
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------N 236 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~ 236 (266)
. .........|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+..... .
T Consensus 153 ~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 228 (324)
T cd05589 153 G----FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREA 228 (324)
T ss_pred C----CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1 11223446789999999999988999999999999999999999999988766555544443221 1
Q ss_pred hhhhhhhccCCCCCcch
Q 047020 237 VEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~ 253 (266)
.+++.+|+..+|..|++
T Consensus 229 ~~li~~~L~~dP~~R~~ 245 (324)
T cd05589 229 ISIMRRLLRRNPERRLG 245 (324)
T ss_pred HHHHHHHhhcCHhHcCC
Confidence 25678888888888873
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=284.45 Aligned_cols=239 Identities=24% Similarity=0.334 Sum_probs=192.9
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
+|.+...||+|+||.||++.. .+|+.+++|.+.... ......+.+|++++..++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 455667999999999999954 478899999876432 2345667889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... +.+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 82 YMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999998764 67899999999999999999999999 99999999999999999999999999876433
Q ss_pred CC-------------------------CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC
Q 047020 167 ND-------------------------PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS 221 (266)
Q Consensus 167 ~~-------------------------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~ 221 (266)
.. ...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 00012234567899999999999999999999999999999999999999887
Q ss_pred chhHHHHHHHHh--c-----------CchhhhhhhccCCCCCcch-HHHHH
Q 047020 222 ATLAEWTEECRR--N-----------KNVEVWAQMLDPKLNGDAN-MEQLR 258 (266)
Q Consensus 222 ~~~~~~~~~~~~--~-----------~~~~~~~~~l~~~~~~~~~-~~~l~ 258 (266)
+....+..+... . ...+++.+|+. ++..|++ .+++.
T Consensus 234 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred CHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 765555544431 0 01144556664 6666666 55553
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=271.68 Aligned_cols=239 Identities=19% Similarity=0.227 Sum_probs=194.2
Q ss_pred Hhhchhh--hhccccccceEEEEEcCCCcEEEEEEeeeccccc---HHHHHHHHHHHhcCCCCCccccceeEEe----cC
Q 047020 9 MATNDFR--IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGS---RKIFLDEVSVLLRVSHPNLVGLLGFCLE----KG 79 (266)
Q Consensus 9 ~~~~~~~--~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 79 (266)
....+.. ..|++|+++.||++.. +|+.++||.+....... .+.+.+|+.++++++||||+++++++.+ ..
T Consensus 17 ~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 17 SDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred HHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 3334444 3799999999999977 68899999886543333 4667799999999999999999998876 34
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ-ADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
..++||||+++|+|.+++... ..+++.....++.|++.|+.+||+. + ++|+||||+||++++++.+||+||
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~df 167 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICH 167 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEccc
Confidence 688999999999999998763 5688899999999999999999984 7 899999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCcccccc--ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT--GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK- 235 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~- 235 (266)
|++...... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.............
T Consensus 168 g~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 240 (283)
T PHA02988 168 GLEKILSSP-------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS 240 (283)
T ss_pred chHhhhccc-------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence 998743211 123457889999999976 6789999999999999999999999987765544444322211
Q ss_pred ----------chhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 236 ----------NVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 236 ----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
..+++.+|+..+|..||+.+++...++.
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1156788999999999999999888764
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=284.52 Aligned_cols=213 Identities=23% Similarity=0.260 Sum_probs=175.8
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.|.+...||.|+||.||++ ...+|+.+++|.+.... ......+.+|+++++.++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 3456678999999999999 55678899999875432 2234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... +.+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||+++....
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 82 FLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999998764 67899999999999999999999999 99999999999999999999999999863211
Q ss_pred CCCC------------C-------------------------------CCcccccccCCCccCccccccccCCCcccchh
Q 047020 167 NDPN------------R-------------------------------PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYS 203 (266)
Q Consensus 167 ~~~~------------~-------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s 203 (266)
.... . ........||+.|+|||++.+..++.++|+||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0 00001246899999999999889999999999
Q ss_pred HHHHHHHHHhCCCCcCCCchhHHHHHHH
Q 047020 204 FGVLLLELITGLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 204 lG~i~~~l~~g~~pf~~~~~~~~~~~~~ 231 (266)
+||++|+|++|..||.+.+....+..+.
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999999998776655554443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=278.30 Aligned_cols=231 Identities=25% Similarity=0.360 Sum_probs=188.4
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCC-CCccccceeEEecCeEEEEEE
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSH-PNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 86 (266)
+.+...||+|+||.||++ ..++++.+++|.+.... ......+..|.+++..++| ++|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456678999999999999 45567889999876432 2334567789999999975 568889999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 82 YVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999988764 56899999999999999999999999 99999999999999999999999998863211
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------h
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------V 237 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~ 237 (266)
.........||..|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+...... .
T Consensus 154 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T cd05587 154 ----GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAV 229 (324)
T ss_pred ----CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 112233457899999999999988999999999999999999999999887766655554443221 1
Q ss_pred hhhhhhccCCCCCcchH
Q 047020 238 EVWAQMLDPKLNGDANM 254 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~ 254 (266)
+++++|+..+|..|++.
T Consensus 230 ~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 230 SICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHHhhcCHHHcCCC
Confidence 46677888888888754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=276.39 Aligned_cols=229 Identities=25% Similarity=0.383 Sum_probs=185.3
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++. .++++.+++|.+.... .........|..++... +||||+++++++...+..++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 68999999999994 4568889999876532 22334455667777654 7999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... +.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 82 ~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~---- 149 (316)
T cd05592 82 DLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG---- 149 (316)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC----
Confidence 999888763 57899999999999999999999999 999999999999999999999999998742111
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------chhhhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------NVEVWAQ 242 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~ 242 (266)
........||..|+|||++.+..++.++|+||+||++|+|++|..||.+.+............+ ..+++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~ 229 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSK 229 (316)
T ss_pred CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 1223445789999999999988899999999999999999999999988766554444333221 1256778
Q ss_pred hccCCCCCcchH-HHH
Q 047020 243 MLDPKLNGDANM-EQL 257 (266)
Q Consensus 243 ~l~~~~~~~~~~-~~l 257 (266)
|+..+|..|++. +++
T Consensus 230 ~l~~~P~~R~~~~~~l 245 (316)
T cd05592 230 LFERDPTKRLGVDGDI 245 (316)
T ss_pred HccCCHHHcCCChHHH
Confidence 888888888864 344
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=280.00 Aligned_cols=224 Identities=24% Similarity=0.314 Sum_probs=183.2
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||+|+||.||++ ...+|+.+++|.+.... ......+.+|+++++.++||||+++++.+..++..++||||+.+++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 5899999999999 45678899999876532 1234566789999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
|.+++... ..+++..+..++.|++.||.|||+ .| ++||||||+||+++.++.++|+|||++......
T Consensus 82 L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~---- 149 (325)
T cd05594 82 LFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---- 149 (325)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC----
Confidence 98887653 568999999999999999999997 78 999999999999999999999999998642111
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------chhhhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------NVEVWAQ 242 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~ 242 (266)
........||..|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+..... ..+++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 229 (325)
T cd05594 150 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSG 229 (325)
T ss_pred CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 1122345689999999999988999999999999999999999999987765544443332211 1256677
Q ss_pred hccCCCCCcc
Q 047020 243 MLDPKLNGDA 252 (266)
Q Consensus 243 ~l~~~~~~~~ 252 (266)
|+..+|..|+
T Consensus 230 ~L~~dP~~R~ 239 (325)
T cd05594 230 LLKKDPKQRL 239 (325)
T ss_pred HhhcCHHHhC
Confidence 8888888775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=270.66 Aligned_cols=205 Identities=28% Similarity=0.403 Sum_probs=171.6
Q ss_pred hhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecC-----eEEEEEEec
Q 047020 15 RIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG-----EQLLLLEYL 88 (266)
Q Consensus 15 ~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~ 88 (266)
.+.+|+|+||.||.+.. .+++.+|||++...... -.+|+++|+.+.|||||++..+|.... ...+||||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 34799999999999954 45799999998665432 246999999999999999988775432 345899999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC-CceEEeccccccCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD-NHAKLADFGLCKLGPFN 167 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~~~l~dfg~~~~~~~~ 167 (266)
+ .+|.+.++.. ......++...+.-+.+||+.|+.|||+.| ||||||||.|++++.+ |.+||+|||+|......
T Consensus 105 P-~tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 105 P-ETLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred h-HHHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 5 4899998863 233367888889999999999999999999 9999999999999965 88999999999976544
Q ss_pred CCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (266)
.++ ..-..|..|+|||.+.|. .|+.+.||||.||++.||+-|++.|.|++..++...+++.
T Consensus 180 epn-----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~ 241 (364)
T KOG0658|consen 180 EPN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV 241 (364)
T ss_pred CCc-----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH
Confidence 433 345577889999988654 7999999999999999999999999999999999888774
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=273.83 Aligned_cols=237 Identities=25% Similarity=0.314 Sum_probs=189.0
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..|.+...||.|+||.||++ ...++..+++|.+..... .....+.+|++++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45667779999999999999 455788999998764332 2345677899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+ +|.+++... ...+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LDS-DLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCc-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 965 898887652 135788999999999999999999999 999999999999999999999999998743211
Q ss_pred CCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh-------------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR------------- 233 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~------------- 233 (266)
........++..|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+...........
T Consensus 157 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 157 ----TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred ----CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 112234567889999998865 56889999999999999999999999876544433222110
Q ss_pred --------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 --------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 --------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++++|+..+|..|++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 0112567788888888888887765
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=271.60 Aligned_cols=205 Identities=21% Similarity=0.276 Sum_probs=169.9
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+|.+...||+|+||.||++.. .++..+++|++.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 356667899999999999955 467888998876432 22346678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
++++.+..+... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 82 VEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred CCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 988666544322 256899999999999999999999999 999999999999999999999999998754221
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHH
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAE 226 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~ 226 (266)
. ........++..|+|||++.+..++.++|+||+||++|+|++|..||.+.+....
T Consensus 154 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~ 209 (287)
T cd07848 154 S---NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209 (287)
T ss_pred c---cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1 1122345688999999999888899999999999999999999999987655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=281.33 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=198.8
Q ss_pred HhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeecc-cccHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
...+.+.+.||+|+||.||++.. +++..++||.+.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34566777999999999999842 345678898775432 23456788999999999 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCC---------------------------------------------------------
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQ--------------------------------------------------------- 103 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~--------------------------------------------------------- 103 (266)
.++||||+++|+|.+++......
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999998653210
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 104 -------------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 104 -------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN- 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence 1124778889999999999999999999 99999999999999999999999999875432211
Q ss_pred CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc-----------Cchh
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN-----------KNVE 238 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~-----------~~~~ 238 (266)
....+...++..|+|||++.+..++.++|+||||+++|+|++ |..||.+........+..... ...+
T Consensus 270 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (375)
T cd05104 270 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD 348 (375)
T ss_pred -ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence 112223345667999999998899999999999999999998 899997654444333333321 1126
Q ss_pred hhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
++.+|+.++|..||+..++.+.+++.
T Consensus 349 li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 349 IMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHccCChhHCcCHHHHHHHHHhh
Confidence 78899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=283.93 Aligned_cols=212 Identities=23% Similarity=0.302 Sum_probs=175.8
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+...+.||+|+||.||++ ...+++.+++|.+.... ......+.+|++++++++||||+++++.+.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 456678999999999999 55678899999876432 12345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++......
T Consensus 83 ~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 83 IPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999998763 56889999999999999999999999 999999999999999999999999997532100
Q ss_pred CC-------------------------------------------CCCCcccccccCCCccCccccccccCCCcccchhH
Q 047020 168 DP-------------------------------------------NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSF 204 (266)
Q Consensus 168 ~~-------------------------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 204 (266)
.. ..........||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 00 00001123468999999999998899999999999
Q ss_pred HHHHHHHHhCCCCcCCCchhHHHHHHH
Q 047020 205 GVLLLELITGLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 205 G~i~~~l~~g~~pf~~~~~~~~~~~~~ 231 (266)
||++|+|++|..||.+.+.......+.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~ 261 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVI 261 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999999998876655554443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=277.44 Aligned_cols=226 Identities=24% Similarity=0.364 Sum_probs=186.1
Q ss_pred hccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++.. .+++.+++|.+.... ......+..|..++..+ +||||+++++++...+..++||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 589999999999954 567889999876432 23345667788888876 5999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~----~ 149 (320)
T cd05590 82 DLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF----N 149 (320)
T ss_pred hHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc----C
Confidence 999888764 57899999999999999999999999 99999999999999999999999999864211 1
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------hhhhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------VEVWAQ 242 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~ 242 (266)
........||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+....+..+...... .+++++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKA 229 (320)
T ss_pred CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 12233457899999999999888999999999999999999999999887766555544432211 256778
Q ss_pred hccCCCCCcchH
Q 047020 243 MLDPKLNGDANM 254 (266)
Q Consensus 243 ~l~~~~~~~~~~ 254 (266)
|+..+|..|++.
T Consensus 230 ~L~~dP~~R~~~ 241 (320)
T cd05590 230 FMTKNPTMRLGS 241 (320)
T ss_pred HcccCHHHCCCC
Confidence 888888888776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=270.39 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=201.9
Q ss_pred HHHhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCe
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 80 (266)
|+...+.+...||+|+||.||++.. .++..+++|.+..........+.+|+++++.++||||+++++++...+.
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3445566677999999999999953 2345577777655444456678899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcC--------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYG--------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH 152 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~ 152 (266)
.+++|||+++++|.+++..... .....+++..+..++.|++.|+.+||+.| ++|+||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999999875421 12245899999999999999999999999 999999999999999999
Q ss_pred eEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHH
Q 047020 153 AKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 153 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~ 231 (266)
++|+|||.+........ ........++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+.........
T Consensus 159 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 159 VKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred EEeccCCccccccCCce--eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999875432211 112233445778999999988889999999999999999998 899997665444333332
Q ss_pred Hhc----------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 232 RRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 232 ~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
... ...+++.+|+.++|..||+.+++...++..
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 221 112578899999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=275.48 Aligned_cols=230 Identities=26% Similarity=0.397 Sum_probs=186.6
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++. ..+|+.+++|.+.... .........|..++... +||+|+++++++.+.+..++||||+.++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 68999999999994 4578899999876532 23345566778887754 7999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~ 149 (316)
T cd05620 82 DLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF----G 149 (316)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc----C
Confidence 999888653 56899999999999999999999999 99999999999999999999999998863211 1
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------hhhhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------VEVWAQ 242 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~ 242 (266)
........||..|+|||++.+..++.++|+||+||++|+|++|..||.+.+....+.......+. .+++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEK 229 (316)
T ss_pred CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 12234466899999999999989999999999999999999999999877665444433322221 256778
Q ss_pred hccCCCCCcchH-HHHH
Q 047020 243 MLDPKLNGDANM-EQLR 258 (266)
Q Consensus 243 ~l~~~~~~~~~~-~~l~ 258 (266)
|+..+|..|++. ++++
T Consensus 230 ~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 230 LFERDPTRRLGVVGNIR 246 (316)
T ss_pred HccCCHHHcCCChHHHH
Confidence 888888888875 3443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=282.14 Aligned_cols=237 Identities=21% Similarity=0.301 Sum_probs=188.7
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
..+.+...||+|+||.||++. ..+++.+++|.+.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 445555689999999999994 4568889999875421 223455778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++....
T Consensus 123 Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 123 EYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred cCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999998865 45788999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCCCCCcccccccCCCccCccccccc----cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-----
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTG----FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN----- 236 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 236 (266)
... ........||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+....+..+......
T Consensus 194 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 194 ANG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred CCC---cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence 211 1122345789999999998653 4788999999999999999999999888776666555432111
Q ss_pred --------hhhhhhhccCCCCC--cchHHHHH
Q 047020 237 --------VEVWAQMLDPKLNG--DANMEQLR 258 (266)
Q Consensus 237 --------~~~~~~~l~~~~~~--~~~~~~l~ 258 (266)
.+++.+|+..++.. |++.+++.
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell 302 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIK 302 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHh
Confidence 13466677655544 66666653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=274.84 Aligned_cols=230 Identities=27% Similarity=0.394 Sum_probs=186.8
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++. ..+++.+++|.+.... .........|..+++.. +||||+++++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 68999999999995 4567889999876542 23345566778888764 8999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... ..+++..+..++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++..... .
T Consensus 82 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~----~ 149 (316)
T cd05619 82 DLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML----G 149 (316)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCC----C
Confidence 999988763 56889999999999999999999999 99999999999999999999999998864211 1
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------hhhhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------VEVWAQ 242 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~ 242 (266)
........||..|+|||++.+..++.++|+||+||++|+|++|..||.+.+............+. .+++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVK 229 (316)
T ss_pred CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 12223456899999999999888999999999999999999999999877655444433322211 257788
Q ss_pred hccCCCCCcchHH-HHH
Q 047020 243 MLDPKLNGDANME-QLR 258 (266)
Q Consensus 243 ~l~~~~~~~~~~~-~l~ 258 (266)
|+..+|..|++.. +++
T Consensus 230 ~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 230 LFVREPERRLGVKGDIR 246 (316)
T ss_pred HhccCHhhcCCChHHHH
Confidence 8889999998774 543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=281.73 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=198.5
Q ss_pred HhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeecc-cccHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
...+++...||+|+||.||++.. .++..+++|.+.... ......+.+|+++++.+ +||||+++++.+.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 44566777999999999999842 223578888775433 22345678999999999 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcC----------------------------------------------------------
Q 047020 81 QLLLLEYLANKSLFDRMHTYYG---------------------------------------------------------- 102 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~---------------------------------------------------------- 102 (266)
.++||||+++++|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998864311
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcc
Q 047020 103 -------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175 (266)
Q Consensus 103 -------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 175 (266)
....++++..+..++.|++.||.|||++| ++||||||+||++++++.++|+|||++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~--~~~~ 271 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--YVVK 271 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc--eeec
Confidence 01134788889999999999999999999 99999999999999999999999999875322211 1122
Q ss_pred cccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc-----------Cchhhhhhh
Q 047020 176 TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN-----------KNVEVWAQM 243 (266)
Q Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~-----------~~~~~~~~~ 243 (266)
....++..|+|||++.+..++.++|||||||++|+|++ |..||................ ...+++.+|
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 23345667999999988889999999999999999997 999997654433333333221 112567899
Q ss_pred ccCCCCCcchHHHHHHHHHHHh
Q 047020 244 LDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 244 l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+..+|..||+.+++.++++..+
T Consensus 352 l~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 352 WNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=273.90 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=192.9
Q ss_pred HhhchhhhhccccccceEEEEEcC-----------------CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccc
Q 047020 9 MATNDFRIRIGVGATSFVYLAELG-----------------DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVG 70 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~-----------------~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~ 70 (266)
...+.+..+||+|+||.||++... ++..+++|.+..... .....+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 345677789999999999999542 234688887754332 23456889999999999999999
Q ss_pred cceeEEecCeEEEEEEecCCCchhhhhhhhcC--------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 047020 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYG--------------QSLGVLSWSNRLSIALDIARALEYLHSQADPPII 136 (266)
Q Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~ 136 (266)
+++++.+.+..++||||+.+++|.+++..... .....+++..+..++.|++.|+.|||+.| ++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999998865321 11134678889999999999999999999 99
Q ss_pred cCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh--C
Q 047020 137 HRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT--G 214 (266)
Q Consensus 137 H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~--g 214 (266)
|+||||+||+++.++.++|+|||++........ ........++..|+|||++.+..++.++|+||||+++|+|++ +
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY--YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce--eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999875322211 112233455788999999988889999999999999999986 5
Q ss_pred CCCcCCCchhHHHHHHH---Hh--------------cCchhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 215 LKSIQGSATLAEWTEEC---RR--------------NKNVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 215 ~~pf~~~~~~~~~~~~~---~~--------------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
..||.+.+......... .. ....+++.+|+..+|..||+.++|.++++
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 67886543322221110 00 01126788999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=269.35 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=200.9
Q ss_pred HHhhchhhhhccccccceEEEEEcC------CCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCe
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 80 (266)
...++.+...||+|+||.||++... ++..+++|.+...... ....+.+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 4566778889999999999999542 3467888877654433 35678899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC
Q 047020 81 QLLLLEYLANKSLFDRMHTYYG---------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN 151 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~ 151 (266)
.+++|||+++++|.+++..... .....+++..+..++.|++.++.+||+++ ++|+||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence 9999999999999999976421 12245788999999999999999999999 99999999999999999
Q ss_pred ceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHH
Q 047020 152 HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEE 230 (266)
Q Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~ 230 (266)
.++|+|||++........ ........++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+........
T Consensus 160 ~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred eEEECCcccceecccCcc--eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 999999999864322111 111223345678999999999899999999999999999998 99999766554433332
Q ss_pred HHhc----------CchhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 231 CRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 231 ~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
.... ...+++++|+..+|..||+.+++.+.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2211 1125788999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=281.38 Aligned_cols=235 Identities=27% Similarity=0.348 Sum_probs=192.2
Q ss_pred hhccccccceEEEEEc----CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 16 IRIGVGATSFVYLAEL----GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+.||+|+||.||++.. .+|+.+++|.+..... .....+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999843 4678899998765322 234556789999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-- 151 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-- 151 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--
Confidence 99999988653 56899999999999999999999999 999999999999999999999999998743211
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------chhhh
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------NVEVW 240 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~ 240 (266)
........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+..... ..+++
T Consensus 152 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 229 (318)
T cd05582 152 --EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 229 (318)
T ss_pred --CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 1222345789999999999888889999999999999999999999988766555544433211 12577
Q ss_pred hhhccCCCCCcchHHH--HHHHHH
Q 047020 241 AQMLDPKLNGDANMEQ--LRVLIR 262 (266)
Q Consensus 241 ~~~l~~~~~~~~~~~~--l~~~~~ 262 (266)
++|+..+|..|++..+ +.++++
T Consensus 230 ~~~l~~~P~~R~~a~~~~~~~~~~ 253 (318)
T cd05582 230 RALFKRNPANRLGAGPDGVEEIKR 253 (318)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhC
Confidence 8999999999998555 454443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=276.87 Aligned_cols=201 Identities=26% Similarity=0.334 Sum_probs=171.9
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
....++....||+|+||.||++. ..+|..+++|.+..... .....+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 34556667799999999999994 45677888887755432 23467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ-ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
||+++++|.+++... ..+++..+..++.|++.|+.|||++ + ++|+||||+||+++.++.++|+|||++...
T Consensus 83 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 83 EHMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 999999999998764 5688999999999999999999985 6 999999999999999999999999998743
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
.. .......++..|+|||++.+..++.++|+|||||++|+|++|..||...+
T Consensus 155 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 155 ID------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred cc------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 12234568999999999998889999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=277.63 Aligned_cols=226 Identities=29% Similarity=0.380 Sum_probs=182.9
Q ss_pred hccccccceEEEEEc-CCCcEEEEEEeeeccc---ccHHHHHHHHH-HHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAEL-GDGNFGAVKRVMEERG---GSRKIFLDEVS-VLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~---~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++.. .+|+.+++|.+..... .....+..|.. +++.++||||+++++.+.+.+..++||||+.++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 589999999999944 5788999998764321 22233444444 567889999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~----~ 149 (323)
T cd05575 82 ELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE----H 149 (323)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc----C
Confidence 999888653 57899999999999999999999999 99999999999999999999999999864211 1
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------hhhhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------VEVWAQ 242 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~ 242 (266)
........||..|+|||++.+..++.++|+|||||++|+|++|..||.+.+....+..+...... .+++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEG 229 (323)
T ss_pred CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 12233456899999999999889999999999999999999999999877665555444432211 256778
Q ss_pred hccCCCCCcchH
Q 047020 243 MLDPKLNGDANM 254 (266)
Q Consensus 243 ~l~~~~~~~~~~ 254 (266)
|+..+|..|++.
T Consensus 230 ~l~~~p~~R~~~ 241 (323)
T cd05575 230 LLQKDRTKRLGA 241 (323)
T ss_pred HhhcCHHhCCCC
Confidence 888888888776
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=267.74 Aligned_cols=249 Identities=16% Similarity=0.196 Sum_probs=198.0
Q ss_pred HHHhhchhhhhccccccceEEEEEc----CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL----GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
|...++++...||+|+||.||++.. ..+..+++|.+..... .....+.+|+..+++++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 4556777888999999999999953 3456788887765432 2345688999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+++++|.+++... ...+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.++++|||.+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccc
Confidence 9999999999999988752 246899999999999999999999999 999999999999999999999999987
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN------ 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~------ 234 (266)
....... ........++..|+|||.+.+..++.++|+||+||++|++++ |..||.+.+............
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd05064 155 QEDKSEA---IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR 231 (266)
T ss_pred ccccccc---hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC
Confidence 6421111 111112334567999999988899999999999999999775 999997665444333222211
Q ss_pred ----CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 235 ----KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 235 ----~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...+++.+|+.++|..||+.++|.+.+++.+
T Consensus 232 ~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~ 266 (266)
T cd05064 232 NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266 (266)
T ss_pred CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence 1114678899999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=272.80 Aligned_cols=202 Identities=26% Similarity=0.375 Sum_probs=167.2
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.+|++..+||+|+||.||++.. .+|+.+++|.+..... .....+.+|+++++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 3566677999999999999954 4688999998754332 2334677899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+. ++|.+++... .+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 85 VH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 95 6888777642 256889999999999999999999999 999999999999999999999999998642211
Q ss_pred CCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCch
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSAT 223 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~ 223 (266)
........++..|+|||++.+ ..++.++|+||+||++|+|++|..||.+...
T Consensus 157 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 157 ----SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred ----CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 112234567899999998865 4578899999999999999999999976533
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=276.15 Aligned_cols=203 Identities=23% Similarity=0.358 Sum_probs=166.6
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEec-----CeEEE
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK-----GEQLL 83 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 83 (266)
|.+...||+|+||.||++ +..+|..+++|++..... .....+.+|+++++.++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 556678999999999999 456789999998764322 2345678999999999999999999987543 24799
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+ +++|.+.+... ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++..
T Consensus 82 v~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 82 VFELM-ESDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEecC-CCCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 99999 46898888653 56899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCcccccc--ccCCCcccchhHHHHHHHHHhCCCCcCCCchh
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNT--GFVSTKSDVYSFGVLLLELITGLKSIQGSATL 224 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~ 224 (266)
....... ........++..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..
T Consensus 153 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~ 214 (338)
T cd07859 153 AFNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214 (338)
T ss_pred cccccCc-cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH
Confidence 3221111 112234568999999999865 57889999999999999999999999776543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=280.26 Aligned_cols=210 Identities=23% Similarity=0.327 Sum_probs=174.7
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+++...||+|+||.||++.. .+++.+++|.+.... ......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 445556899999999999954 567888988775421 1234557789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 124 y~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 124 YMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999998865 45789999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCCCCCcccccccCCCccCccccccc----cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTG----FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
.. ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+....+..+..
T Consensus 195 ~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 195 TG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred CC---ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 11 1223456799999999998654 377899999999999999999999988776665555543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=264.60 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=200.4
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
....+.+..+||+|++|.||++. .+.++.+++|..... ......+.+|+++++.++||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 34556677799999999999994 445788888876532 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... ....+++..+..++.|++.++.+||+++ ++|+||||+||++++++.++|+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 83 FMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred eCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 99999999988653 2246889999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------C
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------K 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~ 235 (266)
.. .........+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+....+....... .
T Consensus 157 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (263)
T cd05052 157 DT---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPK 233 (263)
T ss_pred ce---eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence 11 111122334567999999988889999999999999999998 999998765544333322211 1
Q ss_pred chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++.+.++..+
T Consensus 234 ~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 234 VYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 124788999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=263.64 Aligned_cols=241 Identities=27% Similarity=0.385 Sum_probs=197.0
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+.+.+.+.||+|+||.||++..+++..+++|.+... ......+.+|+++++.++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 456667789999999999998877778888876533 3335678889999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++... .+.+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 83 NGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999988652 145889999999999999999999999 99999999999999999999999998875322111
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------chh
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------NVE 238 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~~~ 238 (266)
.......++..|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+.......+..... ..+
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE 232 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 11122335567999999988889999999999999999999 8999987766555444433211 125
Q ss_pred hhhhhccCCCCCcchHHHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
++++|+.++|..||+.+++...+
T Consensus 233 li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHccCCcccCcCHHHHHHhh
Confidence 67889999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=273.78 Aligned_cols=226 Identities=25% Similarity=0.375 Sum_probs=185.4
Q ss_pred hccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++.. .+++.+++|.+.... ......+..|.+++..+ +||||+++++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 589999999999944 567889999876532 23345667888898888 5999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+.+... +.+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++..... .
T Consensus 82 ~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----~ 149 (318)
T cd05570 82 DLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL----G 149 (318)
T ss_pred CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc----C
Confidence 999888763 57899999999999999999999999 99999999999999999999999998863211 1
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------hhhhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------VEVWAQ 242 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~ 242 (266)
........|+..|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+...... .+++++
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKS 229 (318)
T ss_pred CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 12223456899999999999999999999999999999999999999877655544443332211 256778
Q ss_pred hccCCCCCcchH
Q 047020 243 MLDPKLNGDANM 254 (266)
Q Consensus 243 ~l~~~~~~~~~~ 254 (266)
|+..+|..||+.
T Consensus 230 ~l~~dP~~R~s~ 241 (318)
T cd05570 230 FLTKNPEKRLGC 241 (318)
T ss_pred HccCCHHHcCCC
Confidence 888888888877
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=264.02 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=203.0
Q ss_pred HhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
...+.+.++||.|++|.||++....++.+++|.+..........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34567778999999999999977678899999876655545677889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++... ....+++..+..++.|++.|+.+||++| ++|+||+|+||++++++.++|+|||.+.......
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 85 EKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999763 2356899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------Cch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------KNV 237 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~~~ 237 (266)
. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+............ ...
T Consensus 159 ~----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05148 159 Y----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY 234 (261)
T ss_pred c----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHH
Confidence 1 1123345667999999988889999999999999999998 899997765444443333211 122
Q ss_pred hhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
+++.+|+..+|..||+..++.+.|+.
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 235 KIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 56789999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=264.97 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=200.1
Q ss_pred HHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
....+++.++||+|++|.||++...++..+++|..... ....+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 34566777899999999999998777788888876542 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 83 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 83 MAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999998753 2356788899999999999999999999 999999999999999999999999999754322
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh----------cCc
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR----------NKN 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~----------~~~ 236 (266)
.. .......++..|+|||+..+..++.++|+||||+++|+|++ |..||.+............. ...
T Consensus 157 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05072 157 EY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL 233 (261)
T ss_pred ce---eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 11 11223345678999999988888999999999999999998 99999765443333222211 112
Q ss_pred hhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
.+++.+|+.++|..||+.+++.++++.
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 256889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=278.84 Aligned_cols=211 Identities=23% Similarity=0.299 Sum_probs=175.1
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.++.+...||+|+||.||++.. .+++.+++|.+.... ......+.+|..+++.++||||+++++.+.+....++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4455556899999999999944 567888888775322 123455778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 123 Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 123 EYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred cCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 99999999998865 45788999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCCCCCcccccccCCCccCcccccccc----CCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGF----VSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
... ........||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+.+....+..+..
T Consensus 194 ~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 261 (371)
T cd05622 194 KEG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261 (371)
T ss_pred cCC---cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 211 12234567999999999986543 78899999999999999999999988777666655543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=261.01 Aligned_cols=219 Identities=27% Similarity=0.351 Sum_probs=183.5
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCC-ccccceeEEecC-----
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPN-LVGLLGFCLEKG----- 79 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~----- 79 (266)
...+....+||+|+||.||.| ...+|+.||+|++..... +.-....+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 344555668999999999999 566789999999977644 34456789999999999999 999999987766
Q ss_pred -eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 80 -EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 80 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
..++|+||+ ..+|..++....... ..++...+..+++|++.|+.|||+++ |+||||||+|+++++.|.+||+||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeecc
Confidence 788999998 569999887742111 35666889999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN 236 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (266)
|+|+-...+ ........+|..|+|||++.+. .|+...||||+|||++||++++..|.|.++.++..++.+.-..
T Consensus 165 GlAra~~ip----~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 165 GLARAFSIP----MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred chHHHhcCC----cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 999842211 1224456788889999998776 7999999999999999999999999999999999888875333
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=281.51 Aligned_cols=210 Identities=22% Similarity=0.300 Sum_probs=174.5
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.|.+...||+|+||.||++ ...+++.+++|.+.... ......+.+|+++++.++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 3566679999999999999 45678899999875432 2234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... +.+++..+..++.|++.||.|||+.| |+||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 82 YIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999998764 56889999999999999999999999 99999999999999999999999999752210
Q ss_pred CCC---------------------------------------CCCCcccccccCCCccCccccccccCCCcccchhHHHH
Q 047020 167 NDP---------------------------------------NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVL 207 (266)
Q Consensus 167 ~~~---------------------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 207 (266)
... ..........||+.|+|||++.+..++.++||||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 000 00011123469999999999999999999999999999
Q ss_pred HHHHHhCCCCcCCCchhHHHH
Q 047020 208 LLELITGLKSIQGSATLAEWT 228 (266)
Q Consensus 208 ~~~l~~g~~pf~~~~~~~~~~ 228 (266)
+|+|++|..||.+.+......
T Consensus 234 lyell~G~~Pf~~~~~~~~~~ 254 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQL 254 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHH
Confidence 999999999998876554443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=275.47 Aligned_cols=201 Identities=26% Similarity=0.358 Sum_probs=172.0
Q ss_pred HHHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
|...+|+...+||+|+||.||++.. .+|..+++|.+..... .....+.+|+++++.++||||+++++++.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 4566778888999999999999954 4677778876654322 2346688999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
|||+++++|.+++... +.+++..+..++.|++.++.|||+ .+ ++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 82 MEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 9999999999998763 568899999999999999999997 47 99999999999999999999999999864
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS 221 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~ 221 (266)
... .......++..|+|||++.+..++.++|+|||||++|+|++|..||...
T Consensus 154 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 154 LID------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhh------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 321 1223456889999999998888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=273.24 Aligned_cols=230 Identities=22% Similarity=0.339 Sum_probs=186.5
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEE
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 86 (266)
+++...||+|+||.||++ ...+|+.+++|.+.... ......+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 466778999999999999 45678899999876432 223455677888888886 5788889999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... +.+++..+..++.|++.|+.|||++| ++||||||+||+++.++.++|+|||++.....
T Consensus 82 y~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 82 YVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999988764 67899999999999999999999999 99999999999999999999999999874211
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------h
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------V 237 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~ 237 (266)
. ........||..|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+...... .
T Consensus 154 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 229 (323)
T cd05615 154 D----GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAV 229 (323)
T ss_pred C----CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence 1 11223456899999999999888999999999999999999999999887665555544442211 1
Q ss_pred hhhhhhccCCCCCcch
Q 047020 238 EVWAQMLDPKLNGDAN 253 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~ 253 (266)
+++.+|+..+|..|++
T Consensus 230 ~li~~~l~~~p~~R~~ 245 (323)
T cd05615 230 SICKGLMTKHPSKRLG 245 (323)
T ss_pred HHHHHHcccCHhhCCC
Confidence 4566777777777765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=273.54 Aligned_cols=230 Identities=23% Similarity=0.350 Sum_probs=186.0
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEE
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
+++...||+|+||.||++ ..++++.+++|.+..... ........|..++..+ +|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456678999999999999 455678899998765321 2234456677887777 48999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+.+... +.+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 82 YVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999888764 56899999999999999999999999 99999999999999999999999999864211
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------h
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------V 237 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~ 237 (266)
. ........||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+...... .
T Consensus 154 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 229 (323)
T cd05616 154 D----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 229 (323)
T ss_pred C----CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHH
Confidence 1 12223456899999999999999999999999999999999999999887766555544443221 1
Q ss_pred hhhhhhccCCCCCcch
Q 047020 238 EVWAQMLDPKLNGDAN 253 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~ 253 (266)
+++.+|+..+|..|++
T Consensus 230 ~li~~~l~~~p~~R~~ 245 (323)
T cd05616 230 AICKGLMTKHPGKRLG 245 (323)
T ss_pred HHHHHHcccCHHhcCC
Confidence 4567777777777765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=274.82 Aligned_cols=227 Identities=26% Similarity=0.344 Sum_probs=182.1
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHH-HHHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDE-VSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e-~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++. ..+++.+++|.+..... .....+..| ..+++.++||||+++++++...+..++||||+.++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 68999999999994 45677889987754321 122233334 34567889999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... +.+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~----~ 149 (325)
T cd05602 82 ELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE----H 149 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc----C
Confidence 999988763 56888999999999999999999999 99999999999999999999999999864211 1
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------hhhhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------VEVWAQ 242 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~ 242 (266)
........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..+...... .+++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 229 (325)
T ss_pred CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHH
Confidence 12233456899999999999989999999999999999999999999887766655554433211 146677
Q ss_pred hccCCCCCcchHH
Q 047020 243 MLDPKLNGDANME 255 (266)
Q Consensus 243 ~l~~~~~~~~~~~ 255 (266)
|+..++..|++..
T Consensus 230 ~l~~~p~~R~~~~ 242 (325)
T cd05602 230 LLQKDRTKRLGAK 242 (325)
T ss_pred HcccCHHHCCCCC
Confidence 8888888887654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=263.05 Aligned_cols=247 Identities=22% Similarity=0.305 Sum_probs=200.4
Q ss_pred HHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
+...++++.+.||+|++|.||++....++.+++|.+... ......+.+|++++++++||||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 445667778899999999999997777788888876543 2345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... ....+++..+..++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999998763 2346899999999999999999999999 99999999999999999999999999876432
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------C
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------K 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~ 235 (266)
... ........+..|+|||+..+..++.++|+||||+++|+|++ |..||.+.+............ .
T Consensus 156 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05068 156 DIY---EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE 232 (261)
T ss_pred Ccc---cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 111 11111223457999999988889999999999999999999 999997765444333322211 1
Q ss_pred chhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
..+++.+|+..+|..||+.++|...++.
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1256789999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=276.72 Aligned_cols=227 Identities=26% Similarity=0.354 Sum_probs=183.6
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeeccc---ccHHHHHHHHH-HHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERG---GSRKIFLDEVS-VLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~---~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++ ...+|+.+++|.+..... .....+..|.. +++.++||||+++++.+...+..++||||+.++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5899999999999 455788999998765321 22334444544 567789999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+.+... ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~----~ 149 (325)
T cd05604 82 ELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA----Q 149 (325)
T ss_pred CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC----C
Confidence 998888653 67899999999999999999999999 99999999999999999999999999864211 1
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------chhhhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------NVEVWAQ 242 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~ 242 (266)
........||..|+|||++.+..++.++|+||+||++|+|++|..||.+.+....+........ ..+++++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 229 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEE 229 (325)
T ss_pred CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHH
Confidence 1222345689999999999998999999999999999999999999987766555544443221 1156778
Q ss_pred hccCCCCCcchHH
Q 047020 243 MLDPKLNGDANME 255 (266)
Q Consensus 243 ~l~~~~~~~~~~~ 255 (266)
|+..++..|++..
T Consensus 230 ll~~~p~~R~~~~ 242 (325)
T cd05604 230 LLEKDRQRRLGAK 242 (325)
T ss_pred HhccCHHhcCCCC
Confidence 8888888887653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=265.04 Aligned_cols=208 Identities=27% Similarity=0.342 Sum_probs=180.3
Q ss_pred hhhccccccceEEEE-EcCCCcEEEEEEee--ecccccHHHHHHHHHHHhcCCCCCccccceeEEe-----cCeEEEEEE
Q 047020 15 RIRIGVGATSFVYLA-ELGDGNFGAVKRVM--EERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE-----KGEQLLLLE 86 (266)
Q Consensus 15 ~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e 86 (266)
...||+|++|.|..+ +..+|+.||+|++. -......++..+|+.+|+.++|+||+.+.+.+.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 357999999999999 66789999999987 3444567888999999999999999999998865 236899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
+| +.+|...++.. ..+++..+...++|++.|++|+|+.+ ++|||+||.|++++.+-.+||+|||+|+....
T Consensus 107 lM-etDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred HH-hhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccc
Confidence 98 77999999873 44999999999999999999999999 99999999999999999999999999996543
Q ss_pred CCCCCCCcccccccCCCccCcccc-ccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYL-NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (266)
. .....+..-+.|..|.|||.+ ....|+.+.||||.|||+.||++|+..|.|.+.+.+...++.-
T Consensus 178 ~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 178 F--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred c--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 3 234455667889999999987 4568999999999999999999999999999999887666553
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=273.00 Aligned_cols=225 Identities=24% Similarity=0.322 Sum_probs=180.2
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++. ..++..+++|.+..... .....+..|..+++.+ +||||+++++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 58999999999994 45688899998765321 2345577899999988 5999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----~ 149 (329)
T cd05588 82 DLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR----P 149 (329)
T ss_pred CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc----C
Confidence 998888653 67899999999999999999999999 99999999999999999999999998863111 1
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc--------hhHHHHH-HHHhcC-------
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA--------TLAEWTE-ECRRNK------- 235 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~--------~~~~~~~-~~~~~~------- 235 (266)
........||..|+|||++.+..++.++|+||+||++|+|++|..||.... ....... ......
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 229 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCC
Confidence 122334578999999999999899999999999999999999999995311 1111111 111110
Q ss_pred --chhhhhhhccCCCCCcch
Q 047020 236 --NVEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 236 --~~~~~~~~l~~~~~~~~~ 253 (266)
..+++++|+..+|..|++
T Consensus 230 ~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred HHHHHHHHHHhccCHHHcCC
Confidence 124677888888888876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=266.24 Aligned_cols=249 Identities=27% Similarity=0.370 Sum_probs=197.8
Q ss_pred hhchhhhhccccccceEEEEEcCC-C-----cEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGD-G-----NFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~-g-----~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
..+++.+.||+|+||.||++.... + ..+++|....... .....+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 456677899999999999995432 2 4677877654332 23456889999999999999999999999888999
Q ss_pred EEEEecCCCchhhhhhhhcCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSL-----------GVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN 151 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~ 151 (266)
++|||+++++|.+++........ ..+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999876422211 56788999999999999999999999 99999999999999999
Q ss_pred ceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHH
Q 047020 152 HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEE 230 (266)
Q Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~ 230 (266)
.++|+|||++........ ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+.......+
T Consensus 162 ~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred cEEECCCcceeecccccc--ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999875322211 112233456788999999988889999999999999999998 99999876554433332
Q ss_pred HHhc----------CchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 231 CRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 231 ~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
.... ...+++.+|+..+|..||+..+|.+.++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2211 11267889999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=278.49 Aligned_cols=212 Identities=22% Similarity=0.281 Sum_probs=176.7
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
++..+.||+|+||.||++ ...+++.+++|.+.... ......+.+|+.++..++||+|+++++.+.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 455668999999999999 44578899999875432 22345677899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
++|++|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 83 LPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred CCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999998763 67899999999999999999999999 999999999999999999999999998743221
Q ss_pred CCC-------------------------------CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCC
Q 047020 168 DPN-------------------------------RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLK 216 (266)
Q Consensus 168 ~~~-------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~ 216 (266)
... .........||+.|+|||++.+..++.++|+||+||++|+|++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 0011123568999999999999999999999999999999999999
Q ss_pred CcCCCchhHHHHHHH
Q 047020 217 SIQGSATLAEWTEEC 231 (266)
Q Consensus 217 pf~~~~~~~~~~~~~ 231 (266)
||.+.+....+..+.
T Consensus 235 Pf~~~~~~~~~~~i~ 249 (360)
T cd05627 235 PFCSETPQETYRKVM 249 (360)
T ss_pred CCCCCCHHHHHHHHH
Confidence 998776655554443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=266.88 Aligned_cols=227 Identities=19% Similarity=0.214 Sum_probs=180.5
Q ss_pred ccccccceEEEEE-cCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCch
Q 047020 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 18 ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
||+|+||.||++. ..+|+.+++|.+...... ....+..|+++++.++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999994 457889999987643222 234567899999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCC
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 173 (266)
.+.+.... .....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+....... .
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~----~ 152 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ----S 152 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC----c
Confidence 88775421 22357899999999999999999999999 9999999999999999999999999987532211 1
Q ss_pred cccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH---Hhc----------Cchhhh
Q 047020 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC---RRN----------KNVEVW 240 (266)
Q Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~---~~~----------~~~~~~ 240 (266)
......|+..|+|||++.+..++.++|+||+|+++|+|++|..||............. ... ...+++
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFC 232 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHH
Confidence 2234568899999999999999999999999999999999999997654322111111 110 112466
Q ss_pred hhhccCCCCCcc
Q 047020 241 AQMLDPKLNGDA 252 (266)
Q Consensus 241 ~~~l~~~~~~~~ 252 (266)
.+|+..+|..|+
T Consensus 233 ~~~l~~~P~~R~ 244 (280)
T cd05608 233 EALLAKDPEKRL 244 (280)
T ss_pred HHHhcCCHHHhc
Confidence 788888888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=266.12 Aligned_cols=236 Identities=25% Similarity=0.352 Sum_probs=184.5
Q ss_pred hchhhhhccccccceEEEEEc-C-CCcEEEEEEeeeccc--ccHHHHHHHHHHHhcC---CCCCccccceeEE-----ec
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-G-DGNFGAVKRVMEERG--GSRKIFLDEVSVLLRV---SHPNLVGLLGFCL-----EK 78 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~-~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~~ 78 (266)
+|++...||+|+||.||++.. . .|..+++|.+..... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 466777999999999999954 3 357788887754332 2234566777777766 5999999999875 34
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
...++||||+. ++|.+++... ....+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 56899999985 5898888653 2245889999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--- 235 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 235 (266)
|++...... .......++..|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+.....
T Consensus 155 g~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred cceEeccCC-----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 998753221 223445689999999999888899999999999999999999999988776655544432110
Q ss_pred ---------------------------------chhhhhhhccCCCCCcchHHHHH
Q 047020 236 ---------------------------------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 ---------------------------------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++.+|+..+|..||+..++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 02456778888888888777664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=261.49 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=200.9
Q ss_pred HHHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
+|...++++..+||+|+||.||++...+++.+++|.+.... .....+.+|+++++.++||||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 45677888889999999999999988788899999875433 34567889999999999999999998864 45789999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+.+++|.+++... ....+++..+..++.|++.++.+||+.| ++|+||+|+||++++++.++|+|||++....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 80 EYMENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EcCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 999999999988653 2356889999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN---------- 234 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~---------- 234 (266)
... ........++..|+|||++....++.++|+||||+++|++++ |..||.+.+............
T Consensus 154 ~~~---~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd05067 154 DNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPE 230 (260)
T ss_pred CCC---cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCH
Confidence 111 111123345678999999988888999999999999999998 999997765444332222111
Q ss_pred CchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 235 KNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 235 ~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
...+++.+|+..+|..||+.+++..+++.
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 12357789999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=273.98 Aligned_cols=204 Identities=25% Similarity=0.312 Sum_probs=168.5
Q ss_pred HHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecC-----
Q 047020 8 KMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG----- 79 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 79 (266)
...+|.....||+|+||.||++ +..+|..+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3456677779999999999999 45678899999875432 223456778999999999999999999886543
Q ss_pred -eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 80 -EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 80 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
..++||||+.+ ++.+.+. ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence 47999999965 6666553 34788999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHH
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW 227 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~ 227 (266)
|++..... ........+|..|+|||++.+..++.++|+||+||++|+|++|..||.+.+....+
T Consensus 168 g~a~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~ 231 (359)
T cd07876 168 GLARTACT-----NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW 231 (359)
T ss_pred CCcccccc-----CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99874221 12223457889999999999999999999999999999999999999877655544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=272.08 Aligned_cols=236 Identities=28% Similarity=0.382 Sum_probs=204.5
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 84 (266)
..|++...||+|.||.||++ ...+|+.+++|.+.+.... ......+|+++|+++. ||||+.+++.|++....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 45677789999999999999 4556999999988665443 3467899999999998 99999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC----CceEEecccc
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD----NHAKLADFGL 160 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~----~~~~l~dfg~ 160 (266)
||++.||.|.+.+... .+++..+..++.|++.+++|||+.| ++|+|+||+|+++... +.++++|||+
T Consensus 115 mEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 9999999999999874 3999999999999999999999999 9999999999999643 4799999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch---
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV--- 237 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--- 237 (266)
+..... ........||+.|+|||++....++..+|+||+|+++|.|++|.+||.+.++......+.......
T Consensus 186 a~~~~~-----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~ 260 (382)
T KOG0032|consen 186 AKFIKP-----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSE 260 (382)
T ss_pred ceEccC-----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCC
Confidence 986321 445678899999999999999999999999999999999999999999998888777766654432
Q ss_pred ----------hhhhhhccCCCCCcchHHHHHH
Q 047020 238 ----------EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 ----------~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
+.++.++..++..|.+..++.+
T Consensus 261 ~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 261 PWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 5677889999999988877653
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=266.66 Aligned_cols=237 Identities=21% Similarity=0.258 Sum_probs=187.8
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
+++....||+|+||.||++. ..+++.+++|++..... .....+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 35566789999999999995 45688999998754321 123456789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+.+... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999887652 2246899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHH---HHHHHh----------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW---TEECRR---------- 233 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~---~~~~~~---------- 233 (266)
.. ......|+..|+|||++.+..++.++|+||+|+++|+|++|..||.+.+..... ......
T Consensus 155 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd05605 155 GE-----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS 229 (285)
T ss_pred CC-----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccC
Confidence 11 123346889999999998888999999999999999999999999875443222 111111
Q ss_pred cCchhhhhhhccCCCCCcc-----hHHHHH
Q 047020 234 NKNVEVWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 234 ~~~~~~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
....+++.+|+..+|..|+ +.+++.
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05605 230 EAARSICRQLLTKDPGFRLGCRGEGAEEVK 259 (285)
T ss_pred HHHHHHHHHHccCCHHHhcCCCCCCHHHHh
Confidence 0012456777888888887 565553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=276.32 Aligned_cols=237 Identities=21% Similarity=0.268 Sum_probs=191.2
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
++.+...||+|+||.||++ ...+|+.+++|.+..... .....+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 4566779999999999999 455788999998765322 234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... ...+++..+..++.|++.||.+||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 82 YQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999998763 246899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCCCCCcccccccCCCccCccccc------cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-----
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLN------TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----- 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----- 235 (266)
.. ........||..|+|||++. +..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 155 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 231 (330)
T cd05601 155 NK---MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP 231 (330)
T ss_pred CC---ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC
Confidence 21 11223456899999999986 45677899999999999999999999988776665554433211
Q ss_pred --------chhhhhhhccCCCCCcchHHHHH
Q 047020 236 --------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 --------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++..|+. ++..|++.+++.
T Consensus 232 ~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 232 EDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 1245566776 778888777654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=271.45 Aligned_cols=226 Identities=26% Similarity=0.361 Sum_probs=181.2
Q ss_pred hccccccceEEEEEc-CCCcEEEEEEeeeccc---ccHHHHHHHH-HHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAEL-GDGNFGAVKRVMEERG---GSRKIFLDEV-SVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~---~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++.. .+|+.+++|.+..... .....+..|. .+++.++||||+++++.+.+.+..++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 689999999999954 5678899998754321 2233344444 4678899999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+.+... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 82 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 149 (321)
T cd05603 82 ELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP---- 149 (321)
T ss_pred CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC----
Confidence 998887653 56889999999999999999999999 999999999999999999999999998742111
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------chhhhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------NVEVWAQ 242 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~ 242 (266)
........||..|+|||++.+..++.++|+||+||++|+|++|..||.+.+............. ..+++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVG 229 (321)
T ss_pred CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 1222345689999999999888899999999999999999999999988765544444333221 1256778
Q ss_pred hccCCCCCcchH
Q 047020 243 MLDPKLNGDANM 254 (266)
Q Consensus 243 ~l~~~~~~~~~~ 254 (266)
|+..++..|++.
T Consensus 230 ~l~~~p~~R~~~ 241 (321)
T cd05603 230 LLHKDQRRRLGA 241 (321)
T ss_pred HccCCHhhcCCC
Confidence 888888888754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=260.90 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=199.4
Q ss_pred HHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
...++.+.++||+|++|.||++...+...+++|...... .....+.+|+++++.++||||+++++.+. ....++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 456678888999999999999976666678888775422 33467889999999999999999998764 4568999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++++|.+++... ....+++..+..++.|++.|+.+||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 82 MSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999998753 2245789999999999999999999999 999999999999999999999999998754322
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh----------cCc
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR----------NKN 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~----------~~~ 236 (266)
.. .......++..|+|||+..+..++.++|+||||+++|+|++ |..||.+............. ...
T Consensus 156 ~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (262)
T cd05071 156 EY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 232 (262)
T ss_pred cc---ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHH
Confidence 11 11223446678999999988889999999999999999999 88899766544433322221 112
Q ss_pred hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.+++.+|+..+|..||+..++.++++.++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 233 HDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 26788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=265.21 Aligned_cols=251 Identities=23% Similarity=0.293 Sum_probs=199.3
Q ss_pred HHHhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCe
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 80 (266)
|+..+..+..+||+|+||.||++.. .++..+++|............+.+|+++++.++|+||+++++++.+...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 3455667778999999999999842 3456777877665544556778999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC
Q 047020 81 QLLLLEYLANKSLFDRMHTYYG----------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD 150 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~ 150 (266)
.+++|||+++++|.+++..... .....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCC
Confidence 9999999999999999876421 11135788999999999999999999999 9999999999999999
Q ss_pred CceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHH
Q 047020 151 NHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTE 229 (266)
Q Consensus 151 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~ 229 (266)
+.++|+|||++........ ........++..|+|||++.+..++.++|+|||||++|+|++ |..||...........
T Consensus 159 ~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCEEECCCCceeEcCCCce--eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 9999999999874322111 111223345678999999988889999999999999999998 8999966554443333
Q ss_pred HHHhc----------CchhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 230 ECRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 230 ~~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
..... ...+++.+|+..+|..||+.++|...++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 32221 1126778999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=259.87 Aligned_cols=246 Identities=25% Similarity=0.331 Sum_probs=198.3
Q ss_pred HHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
+....+++..+||+|++|.||++...++..+++|.+.... .....+.+|+.++++++||+++++++++. ....+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 3456778888999999999999987777888888775433 24567889999999999999999998875 456899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 81 YMSKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred ecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 99999999998752 2246899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------C
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------K 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~ 235 (266)
.. ........++..|+|||...+..++.++|+||||+++|+|++ |..||.+.+............ .
T Consensus 155 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05070 155 NE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231 (260)
T ss_pred cc---cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 11 111122234567999999988888999999999999999999 899997765544333332211 1
Q ss_pred chhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
..+++.+|+..+|..||+..++.++++.
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1267789999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=264.72 Aligned_cols=251 Identities=24% Similarity=0.298 Sum_probs=199.0
Q ss_pred HhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
...+.+...||+|+||.||++.. .++..+++|..........+.+.+|+++++.++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 34455666899999999999953 234456777765544444567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC
Q 047020 83 LLLEYLANKSLFDRMHTYYG-----------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN 151 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~ 151 (266)
+||||+++++|.+++..... ...+.+++..++.++.|++.|+.+||+++ ++|+||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 99999999999999876321 12245889999999999999999999999 99999999999999999
Q ss_pred ceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHH
Q 047020 152 HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEE 230 (266)
Q Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~ 230 (266)
.++|+|||++........ ........++..|+|||++.+..++.++|+||||+++|+|++ |..||...+....+...
T Consensus 161 ~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred cEEECCCCcccccCCCce--eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999875332211 112234456788999999988889999999999999999998 99999665544333222
Q ss_pred HHhc----------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 231 CRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 231 ~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
.... ...+++.+|+.++|..||+..++.+.++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 2211 112577899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=270.12 Aligned_cols=191 Identities=28% Similarity=0.405 Sum_probs=163.7
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++. ..+++.+++|.+.... ......+..|..++.++ +||||+++++++...+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 58999999999995 4567889999876532 22345567888888776 7999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... +.+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~----~ 149 (329)
T cd05618 82 DLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR----P 149 (329)
T ss_pred CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC----C
Confidence 998887653 57899999999999999999999999 99999999999999999999999999864211 1
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcC
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQ 219 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~ 219 (266)
........||..|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 122234578999999999999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=276.79 Aligned_cols=195 Identities=23% Similarity=0.299 Sum_probs=165.5
Q ss_pred HHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
...+|.+.+.||+|+||.||++ +..+++.+++|... ...+.+|+++++.++||||+++++++......++++|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3445677779999999999999 55678888998542 2346789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
++ +++|.+++... ..+++..+..++.|++.||.|||+.| |+||||||+||+++..+.++|+|||++.....
T Consensus 164 ~~-~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 164 RY-KTDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred cC-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 98 46888887653 56889999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCC
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQG 220 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~ 220 (266)
.. ........||+.|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 235 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 235 IN---ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cc---ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 11 1222345789999999999888899999999999999999999987743
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=268.91 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=196.4
Q ss_pred hhchhhhhccccccceEEEEEc------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEec-Ce
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEK-GE 80 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~ 80 (266)
.++++.+.||+|+||.||++.. .+++.+++|++..... .....+.+|+++++++ +||||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4667777999999999999932 2346789987754322 2345677899999999 799999999987654 56
Q ss_pred EEEEEEecCCCchhhhhhhhcCC--------------------------------------------------------C
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQ--------------------------------------------------------S 104 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~--------------------------------------------------------~ 104 (266)
.++++||+++++|.+++...... .
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999988653211 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCc
Q 047020 105 LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184 (266)
Q Consensus 105 ~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y 184 (266)
...+++..+..++.|++.|+.|||+++ ++||||||+||++++++.++|+|||++........ ........++..|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~--~~~~~~~~~~~~y 241 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLPLKW 241 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc--hhhccCCCCCccc
Confidence 136788999999999999999999999 99999999999999999999999999976432211 1223344566789
Q ss_pred cCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc-----------CchhhhhhhccCCCCCcc
Q 047020 185 VDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN-----------KNVEVWAQMLDPKLNGDA 252 (266)
Q Consensus 185 ~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~~~~~~~ 252 (266)
+|||++.+..++.++||||+||++|+|++ |..||.+..........+... ...+++.+|+..+|..||
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999999999999998 999997644333332222211 112567789999999999
Q ss_pred hHHHHHHHHHHHh
Q 047020 253 NMEQLRVLIRICM 265 (266)
Q Consensus 253 ~~~~l~~~~~~~~ 265 (266)
+.+++.+.++.++
T Consensus 322 s~~ell~~l~~~~ 334 (337)
T cd05054 322 TFSELVEILGDLL 334 (337)
T ss_pred CHHHHHHHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=263.87 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=196.5
Q ss_pred HHhhchhhhhccccccceEEEEEc-----CCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL-----GDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~-----~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
.....++...||+|+||.||++.. .++..+++|.+...... ....+.+|+++++.++||||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 345677888999999999999953 35577888887643332 335688899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec
Q 047020 82 LLLLEYLANKSLFDRMHTYYG------------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID 149 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~ 149 (266)
+++|||+.+++|.+++..... .....+++..+..++.|++.|+.|||+++ ++|+||||+||++++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcC
Confidence 999999999999998854211 11235788889999999999999999999 999999999999999
Q ss_pred CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHH
Q 047020 150 DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWT 228 (266)
Q Consensus 150 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~ 228 (266)
++.++|+|||++........ ........++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 160 QLHVKISDLGLSREIYSADY--YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCcEEeccccccccccCCcc--eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999875432211 111223345677999999988889999999999999999998 999997654432222
Q ss_pred HHHHhc----------CchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 229 EECRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 229 ~~~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
...... ...+++.+|+.++|..||+..+|.+.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 211111 01156789999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=283.05 Aligned_cols=244 Identities=25% Similarity=0.258 Sum_probs=195.6
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecC-------
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------- 79 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 79 (266)
.+|.+...||+|+||.||++ ...+|+.++||.+.... ......+.+|+..+..++|+||++++..+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 45556668999999999999 45678999999875532 223456788999999999999999887664332
Q ss_pred -eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 80 -EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 80 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
..++||||+.+++|.+++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEec
Confidence 3679999999999999987532 22357899999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--- 235 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 235 (266)
|+++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.............
T Consensus 188 Gls~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 265 (496)
T PTZ00283 188 GFSKMYAATVS--DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265 (496)
T ss_pred ccCeecccccc--ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 99875332111 1223456789999999999998999999999999999999999999987765544444333211
Q ss_pred -------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 -------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 -------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+..++..
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 125678999999999999988764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=270.76 Aligned_cols=230 Identities=25% Similarity=0.302 Sum_probs=182.3
Q ss_pred chhhhhccccccceEEEEEc----CCCcEEEEEEeeecc----cccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEE
Q 047020 12 NDFRIRIGVGATSFVYLAEL----GDGNFGAVKRVMEER----GGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 82 (266)
+++.+.||+|+||.||++.. .+|..+++|.+.... ......+..|+++++.++ ||+|+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 45667899999999999843 367889999775422 123456778999999995 899999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+.+++|.+++... ..+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++.
T Consensus 82 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999998763 56899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCc---hhHHHHHHHH-hcC--
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSA---TLAEWTEECR-RNK-- 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~---~~~~~~~~~~-~~~-- 235 (266)
...... ........||..|+|||++.+. .++.++|||||||++|+|++|..||.... .......... ..+
T Consensus 154 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd05614 154 EFLSEE---KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF 230 (332)
T ss_pred cccccC---CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 432111 1122345789999999998765 47889999999999999999999996432 2222222221 111
Q ss_pred -------chhhhhhhccCCCCCcc
Q 047020 236 -------NVEVWAQMLDPKLNGDA 252 (266)
Q Consensus 236 -------~~~~~~~~l~~~~~~~~ 252 (266)
..+++.+|+..+|..|+
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~ 254 (332)
T cd05614 231 PSFIGPEAQDLLHKLLRKDPKKRL 254 (332)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcC
Confidence 12567788888888888
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=269.41 Aligned_cols=211 Identities=21% Similarity=0.298 Sum_probs=174.2
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.|++...||+|+||.||++. ..+++.+++|.+... .......+.+|..+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 45667799999999999995 456889999987542 12234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 82 YYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred cCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999998652 246899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCCCCCcccccccCCCccCcccccc-----ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNT-----GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~ 231 (266)
.. ........||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+....+..+.
T Consensus 155 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05597 155 DG---TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred CC---CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 11 112233568999999999863 356789999999999999999999998776655554443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=247.64 Aligned_cols=235 Identities=21% Similarity=0.346 Sum_probs=198.2
Q ss_pred chhhhhccccccceEEEEEcCC-CcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAELGD-GNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~~-g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.++.+.||+|-||.||++..++ +--+++|.+.+. ..+...++.+|+++.+.|+||||++++++|-++...|+++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 4556689999999999996555 455666655432 234457788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
..+|+++..+.. +..+.+++...+.++.|++.|+.|+|.++ ++||||||+|++++..|.+|+.|||.+..
T Consensus 104 a~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~---- 173 (281)
T KOG0580|consen 104 APRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVH---- 173 (281)
T ss_pred cCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceee----
Confidence 999999998875 34478999999999999999999999999 99999999999999999999999998764
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------hh
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------VE 238 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~ 238 (266)
.......+..||..|.|||...+...+..+|+|++|++.|+++.|..||...+..+.+.++.+.... .+
T Consensus 174 --~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 174 --APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD 251 (281)
T ss_pred --cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence 1244556789999999999999999999999999999999999999999888877777666653222 26
Q ss_pred hhhhhccCCCCCcchHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~ 258 (266)
++..++..+|..|....++.
T Consensus 252 lI~~ll~~~p~~r~~l~~v~ 271 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVM 271 (281)
T ss_pred HHHHHhccCccccccHHHHh
Confidence 77888888888887766654
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=259.84 Aligned_cols=238 Identities=25% Similarity=0.335 Sum_probs=191.0
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.++.+...||+|+||.||++. ..++..+++|............+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 466777799999999999994 5678888888776554444556788999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++... +.+++..+..++.|++.++.|||+.| ++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd06645 89 GGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT- 159 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-
Confidence 999999988654 57899999999999999999999999 999999999999999999999999998653221
Q ss_pred CCCCCcccccccCCCccCccccc---cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-----------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLN---TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----------- 234 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 234 (266)
........|+..|+|||++. ...++.++|+||+||++|+|++|..||................
T Consensus 160 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06645 160 ---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236 (267)
T ss_pred ---ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence 12223456889999999874 4457889999999999999999999996544322222111110
Q ss_pred ---CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ---KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ---~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.++|..
T Consensus 237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 237 WSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0114677888888888888877653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=260.35 Aligned_cols=228 Identities=21% Similarity=0.266 Sum_probs=180.8
Q ss_pred ccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCch
Q 047020 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 18 ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
||+|+||.||++. ..+|+.+++|.+..... .....+..|+++++.++||||+++++.+......++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999994 45688999998754221 1234456799999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCC
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 173 (266)
.+.+... ....+++..+..++.|++.|+.|||+.| ++|+||||+||+++.++.++|+|||++...... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-----~ 149 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-----K 149 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC-----c
Confidence 8887653 2245788999999999999999999999 999999999999999999999999998753221 1
Q ss_pred cccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH---HHHHHHHh-----------cCchhh
Q 047020 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA---EWTEECRR-----------NKNVEV 239 (266)
Q Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~---~~~~~~~~-----------~~~~~~ 239 (266)
......++..|+|||++.+..++.++|+||+||++|+|++|..||.+..... ........ ....++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDI 229 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHH
Confidence 2234568899999999988889999999999999999999999997543211 11111110 111356
Q ss_pred hhhhccCCCCCcchHHH
Q 047020 240 WAQMLDPKLNGDANMEQ 256 (266)
Q Consensus 240 ~~~~l~~~~~~~~~~~~ 256 (266)
+++|+..+|..||+..+
T Consensus 230 i~~~L~~~P~~R~~~~~ 246 (277)
T cd05607 230 CRLFLAKKPEDRLGSRE 246 (277)
T ss_pred HHHHhccCHhhCCCCcc
Confidence 77888888888887744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=288.73 Aligned_cols=213 Identities=31% Similarity=0.444 Sum_probs=182.4
Q ss_pred HHHHhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEec
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEK 78 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 78 (266)
+|......|+.+||+|+||.||++.. .+...|+||.++...+. .+.+|.+|++++..++|||||+++++|...
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 45556667888999999999999943 23457899998887776 788999999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQS---------LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID 149 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~ 149 (266)
+..++|+||+..|||.++++...... ..+++..+...++.||+.|+.||-++. ++||||-..|++|++
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 99999999999999999998754322 234889999999999999999999999 999999999999999
Q ss_pred CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCch
Q 047020 150 DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSAT 223 (266)
Q Consensus 150 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~ 223 (266)
+-.|||+|||+++-.+..+..+ ..+...-..+|||||.+..+.+++.+||||+|+++||+++ |..||-+-+.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk--~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn 711 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYK--VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN 711 (774)
T ss_pred ceEEEecccccchhhhhhhhhc--ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence 9999999999998655444322 2224455678999999999999999999999999999997 8999976543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=268.08 Aligned_cols=226 Identities=26% Similarity=0.319 Sum_probs=179.6
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++. ..++..+++|.+..... .....+..|..++.++ +||+|+++++++...+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 58999999999995 45678889988765322 2345577899999888 5999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... +.+++..+..++.|++.|+.|||++| ++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~----~ 149 (327)
T cd05617 82 DLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG----P 149 (327)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC----C
Confidence 999888653 57899999999999999999999999 99999999999999999999999998864211 1
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc------hhHHHHHHHHhcC----------
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA------TLAEWTEECRRNK---------- 235 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~------~~~~~~~~~~~~~---------- 235 (266)
........||+.|+|||++.+..++.++|+||+|+++|+|++|..||.... ............+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 229 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK 229 (327)
T ss_pred CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 122234578999999999999999999999999999999999999995321 1111112111111
Q ss_pred chhhhhhhccCCCCCcchH
Q 047020 236 NVEVWAQMLDPKLNGDANM 254 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~ 254 (266)
..+++.+|+..+|..|++.
T Consensus 230 ~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHhccCHHHcCCC
Confidence 1245677777777777653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=262.07 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=198.7
Q ss_pred HHHhhchhhhhccccccceEEEEEcC------CCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecC
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG 79 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 79 (266)
|...++++...||+|+||.||++... .+..+++|.+...... ....+.+|..+++.++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 44567788889999999999999542 3467888887644332 2456788999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYG-----------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~ 148 (266)
..+++++|+.+++|.+++..... .....+++..+..++.|++.|+.|||+.| ++|+||||+||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence 99999999999999998853210 11235788889999999999999999999 99999999999999
Q ss_pred cCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHH
Q 047020 149 DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEW 227 (266)
Q Consensus 149 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~ 227 (266)
+++.++|+|||++........ ........+++.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADY--YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred CCCceEecccccccccccchh--eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999999875432211 122234456778999999988889999999999999999998 88899776554444
Q ss_pred HHHHHhcC----------chhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 228 TEECRRNK----------NVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 228 ~~~~~~~~----------~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
..+..... ..+++.+|+..+|..||+..+|...|+
T Consensus 237 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 237 EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 33333221 125678899999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=273.44 Aligned_cols=235 Identities=23% Similarity=0.270 Sum_probs=187.7
Q ss_pred hhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecC-----eEEEE
Q 047020 13 DFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG-----EQLLL 84 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv 84 (266)
+..+.||+|+||.||++. ..+|+.+++|++..... ....++.+|+++++.++||||+++++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 345689999999999994 46789999998754322 23456789999999999999999999988776 78999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
+||+. ++|.+.+... ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++...
T Consensus 83 ~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 83 TELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred eeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99985 5788777543 57899999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh----------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR---------- 233 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~---------- 233 (266)
.... ........++..|+|||++.+. .++.++|+||+||++|+|++|..||.+.+...+...+...
T Consensus 154 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDE---SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCc---cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 2211 1223344678899999998764 5788999999999999999999999877655444332210
Q ss_pred -------------------------------cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 -------------------------------NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 -------------------------------~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..||+.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 01125677899999999998887753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=258.68 Aligned_cols=242 Identities=24% Similarity=0.322 Sum_probs=195.1
Q ss_pred HhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
...+.+...||+|++|.||.+....+..+++|.+... ......+.+|+.+++.++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 3456777899999999999997766667899877543 233567889999999999999999999999888999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+++... ...+++..++.++.|++.|+.|||+.+ ++|+||||.||+++.++.++|+|||.+.......
T Consensus 82 ~~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 82 SNGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 999999988753 136899999999999999999999999 9999999999999999999999999887532221
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------ch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------NV 237 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~~ 237 (266)
. .......++..|+|||+..+..++.++|+||||+++|+|++ |..||...+............. ..
T Consensus 155 ~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05113 155 Y---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY 231 (256)
T ss_pred e---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1 11122335667999999988888999999999999999998 9999976554443333322211 12
Q ss_pred hhhhhhccCCCCCcchHHHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
+++.+|+.++|..||+..+|...+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHhh
Confidence 567789999999999998887765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=254.20 Aligned_cols=238 Identities=23% Similarity=0.279 Sum_probs=198.8
Q ss_pred HHHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeee--cccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVME--ERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
+....|+....||+|.|+.|+++ ...+|..+++|.+.. -+....+.+.+|+.+.+.|+||||+++.+...+.+..++
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 34556777789999999999999 556777777765422 122356778899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC---CceEEecccc
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD---NHAKLADFGL 160 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~~~l~dfg~ 160 (266)
|+|++.|++|..-|-.. .-+++..+..++.||+.++.|+|.++ |+|||+||+|+++-.. .-+||+|||+
T Consensus 88 vFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred EEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccce
Confidence 99999999997766543 56799999999999999999999999 9999999999999643 3489999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc----
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---- 236 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---- 236 (266)
|.... .........||+.|+|||+++...++..+|||+.|+++|-|+.|++||.+.+.-..+..+......
T Consensus 160 Ai~l~-----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~ 234 (355)
T KOG0033|consen 160 AIEVN-----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSP 234 (355)
T ss_pred EEEeC-----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCc
Confidence 98533 233445688999999999999999999999999999999999999999998887777777664222
Q ss_pred ---------hhhhhhhccCCCCCcchHHHH
Q 047020 237 ---------VEVWAQMLDPKLNGDANMEQL 257 (266)
Q Consensus 237 ---------~~~~~~~l~~~~~~~~~~~~l 257 (266)
.+++++|+.-+|.+|.+..+-
T Consensus 235 ~w~~is~~Ak~LvrrML~~dP~kRIta~EA 264 (355)
T KOG0033|consen 235 EWDTVTPEAKSLIRRMLTVNPKKRITADEA 264 (355)
T ss_pred ccCcCCHHHHHHHHHHhccChhhhccHHHH
Confidence 157889999999999887764
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=263.15 Aligned_cols=236 Identities=25% Similarity=0.379 Sum_probs=194.7
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
++.....||+|++|.||++. ..+++.+++|.+..........+.+|+.+++.++|||++++++.+......++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 44555589999999999994 56788999998876555556778899999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++.. ..+++..+..++.|++.|+.+||+.| ++|+||||+||+++.++.++|+|||.+.......
T Consensus 101 ~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 101 GGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred CCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 9999998865 45789999999999999999999999 9999999999999999999999999887432211
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------------Cch
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------------KNV 237 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------------~~~ 237 (266)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+....+....... ...
T Consensus 171 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (296)
T cd06654 171 ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (296)
T ss_pred ---cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHH
Confidence 11233468889999999988888999999999999999999999998766544333222111 112
Q ss_pred hhhhhhccCCCCCcchHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
+++.+|+..+|..||+.+++..
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhh
Confidence 4677899999999999888764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=269.64 Aligned_cols=211 Identities=20% Similarity=0.267 Sum_probs=173.7
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+.+...||+|+||.||++. ..+++.+++|.+.... ......+.+|..++..++|++|+++++++.+.+..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 35666789999999999995 4567888988775421 1234457789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.|++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 y~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 82 YYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred CCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999998752 246889999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCCCCcccccccCCCccCcccccc-----ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNT-----GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~ 231 (266)
.. ........|++.|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.+....+..+.
T Consensus 155 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05624 155 DG---TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred CC---ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH
Confidence 11 112234568999999999865 457889999999999999999999998776655554443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=258.20 Aligned_cols=238 Identities=20% Similarity=0.267 Sum_probs=194.7
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeec-ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEE-RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+++...||.|+||.||++. ..+++.+++|.+... .....+.+.+|+.+++.++||||+++++.+.+++..+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 4567799999999999994 456888899877543 23345677889999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++... ....+++..+..++.|++.|+.+||+++ ++|+||+|+||++++++.++++|||.+......
T Consensus 82 ~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 82 GGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred CCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 99999988653 2345789999999999999999999999 999999999999999999999999998753221
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC----------chhh
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----------NVEV 239 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~~~ 239 (266)
........++..|+|||++.+..++.++|+||+|+++|+|++|..||...+............. ..++
T Consensus 154 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (255)
T cd08219 154 --GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSL 231 (255)
T ss_pred --ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHH
Confidence 1122345688889999999888899999999999999999999999987665444433322211 1256
Q ss_pred hhhhccCCCCCcchHHHHHH
Q 047020 240 WAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 240 ~~~~l~~~~~~~~~~~~l~~ 259 (266)
+.+|+..+|..||+..++..
T Consensus 232 i~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HHHHHhCCcccCCCHHHHhh
Confidence 78899999999998887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=271.85 Aligned_cols=207 Identities=23% Similarity=0.297 Sum_probs=170.2
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEec------C
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK------G 79 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 79 (266)
..+|.+...||+|+||.||.+ +...++.++||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 456666679999999999999 45568889999876432 22345678899999999999999999887543 3
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
..++||||+++ ++.+.+.. .+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 57999999954 77776643 4788899999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~ 231 (266)
++..... ........+|..|+|||++.+..++.++|+|||||++|+|++|..||.+.+....+.+.+
T Consensus 172 ~a~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 238 (364)
T cd07875 172 LARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238 (364)
T ss_pred CccccCC-----CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9875321 122234568899999999999999999999999999999999999998877666554443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=257.67 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=199.6
Q ss_pred HHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
|...++.+...||+|+||.||++....+..+++|..... ......+.+|+++++.++|+||+++++.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 456677888899999999999998777778888876543 2345678899999999999999999998877 77899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... ....+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++..+.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999998763 2346788899999999999999999999 99999999999999999999999999875332
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------C
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------K 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~ 235 (266)
.. ........++..|+|||++....++.++|+||||+++|++++ |..||.+.+............ .
T Consensus 155 ~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05073 155 NE---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE 231 (260)
T ss_pred CC---cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHH
Confidence 11 111222345677999999988888999999999999999998 999998765544443322211 1
Q ss_pred chhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
..+++.+|+.++|..||+.+++..+|+.
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2257789999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=264.72 Aligned_cols=252 Identities=29% Similarity=0.407 Sum_probs=195.3
Q ss_pred HHHHhhchhhhhccccccceEEEEEc-CCCcE--EEEEEeeecc-cccHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAEL-GDGNF--GAVKRVMEER-GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~--~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
.|.-..+.+...||+|+||.||++.. .++.. +++|...... ......+.+|++++.++ +||||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 34556677888999999999999954 34443 4555544322 22345678899999999 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec
Q 047020 81 QLLLLEYLANKSLFDRMHTYYG-----------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID 149 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~ 149 (266)
.++||||+++++|.+++..... .....+++..+..++.|++.|+.+||++| ++|+||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecC
Confidence 9999999999999999876422 11236789999999999999999999999 999999999999999
Q ss_pred CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHH
Q 047020 150 DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWT 228 (266)
Q Consensus 150 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~ 228 (266)
++.++|+|||++..... ........++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+......
T Consensus 160 ~~~~kl~dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 160 NYVAKIADFGLSRGQEV-----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred CCcEEeCccccCcccch-----hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 99999999998863110 111112234567999999988888999999999999999998 999997655443332
Q ss_pred HHHHh----------cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 229 EECRR----------NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 229 ~~~~~----------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..... ....+++.+|+..+|..||+.+++...++..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 235 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22111 01125788999999999999999988877644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=263.07 Aligned_cols=248 Identities=22% Similarity=0.322 Sum_probs=198.3
Q ss_pred HhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeecc-cccHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
..++.+...||+|+||.||++.. ..+..+++|...... ......+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 34455666899999999999853 234467887665432 22345688999999999 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.+++|||+.+++|.+++... ....+++.++..++.|++.++.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999998753 1234899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK---- 235 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~---- 235 (266)
+........ ........++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+........+......
T Consensus 188 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 188 ARDIMNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccCCCc--eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 875322211 112223456778999999988889999999999999999998 9999987665554444433211
Q ss_pred -------chhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 236 -------NVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 236 -------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
..+++.+|+.++|..||+..++...+++.
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 12578899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=261.49 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=195.2
Q ss_pred HHhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCe
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 80 (266)
...++++...||+|++|.||++.. ..+..+++|+...... .....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 455677777999999999999843 2346788887643222 234567889999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEE
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQS-----LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKL 155 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l 155 (266)
.++||||+++++|.+++....... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999987643211 134577888999999999999999999 999999999999999999999
Q ss_pred eccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc
Q 047020 156 ADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN 234 (266)
Q Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~ 234 (266)
+|||++........ ........++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+............
T Consensus 161 ~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 161 GDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred CCCCCccccCCcce--eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999875322111 111122345678999999988889999999999999999999 789997765443333222211
Q ss_pred C----------chhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 235 K----------NVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 235 ~----------~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
. ..+++.+|+..+|..||+..++...++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1 124778999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=260.27 Aligned_cols=235 Identities=29% Similarity=0.406 Sum_probs=193.0
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHH--HHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRK--IFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~--~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
|++.+.||+|+||.||++ ..++++.+++|.+......... ...+|+.+++.++||||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456778999999999999 4556668899887665433222 2355999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+++... ..+++..+..++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||.+...
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~---- 148 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL---- 148 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES----
T ss_pred cccccccccccc-----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc----
Confidence 999999999843 77899999999999999999999999 999999999999999999999999998642
Q ss_pred CCCCCcccccccCCCccCccccc-cccCCCcccchhHHHHHHHHHhCCCCcCCC---chhHHHHHHHHh-----------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLN-TGFVSTKSDVYSFGVLLLELITGLKSIQGS---ATLAEWTEECRR----------- 233 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~i~~~l~~g~~pf~~~---~~~~~~~~~~~~----------- 233 (266)
...........++..|+|||++. +..++.++|+||+|+++|+|++|..||... +...........
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (260)
T PF00069_consen 149 SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSRE 228 (260)
T ss_dssp TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccch
Confidence 11233445667888999999998 788999999999999999999999999876 233332222220
Q ss_pred --cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 --NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 --~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+..+|..||+++++.
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~ 255 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELL 255 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHH
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1223677899999999999988765
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=257.26 Aligned_cols=245 Identities=23% Similarity=0.320 Sum_probs=196.6
Q ss_pred HHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
...++++...||+|++|.||++....+..+++|..... ......+.+|+++++.++||+++++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 34567777899999999999997766667888876443 234567889999999999999999998875 4568999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+++... ....+++..+..++.|++.|+.|||+.| ++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 82 MGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999998763 2245789999999999999999999999 999999999999999999999999998754322
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------c
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------N 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~ 236 (266)
. ........++..|+|||...+..++.++|+||||+++|+|++ |..||.+............... .
T Consensus 156 ~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05069 156 E---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL 232 (260)
T ss_pred c---ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 1 111122345677999999988889999999999999999999 8999987655444433322211 1
Q ss_pred hhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
.+++++|+..+|..||+.+++.++++.
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 257789999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=271.49 Aligned_cols=204 Identities=22% Similarity=0.273 Sum_probs=167.8
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecC------
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------ 79 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 79 (266)
..+|...+.||+|+||.||++. ...++.+++|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 4456666789999999999994 45688899998764322 23456778999999999999999999876433
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
..++||||+++ ++.+.+.. .+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 57999999964 67666543 4788999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHH
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT 228 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~ 228 (266)
++..... ........+|..|+|||++.+..++.++|+||+||++|+|++|..||.+.+....+.
T Consensus 165 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 165 LARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred ccccCCC-----ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9875321 122234568899999999998899999999999999999999999998876555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=271.69 Aligned_cols=224 Identities=24% Similarity=0.300 Sum_probs=178.8
Q ss_pred ccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcC---CCCCccccceeEEecCeEEEEEEecCC
Q 047020 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRV---SHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 18 ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
||+|+||.||++. ..+|+.+++|.+..... ........|..++... +||+|+++++.+......++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999994 45688999998754321 1223344566666655 699999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
++|.+.+... +.+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~---- 148 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT---- 148 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC----
Confidence 9999888653 67899999999999999999999999 99999999999999999999999999864211
Q ss_pred CCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc----------Cchhh
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----------KNVEV 239 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~ 239 (266)
.........||..|+|||++.+. .++.++|+||+||++|+|++|..||.+.+....+..+.... ...++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 228 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQF 228 (330)
T ss_pred CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 11223456789999999998654 57899999999999999999999998776555444333211 11256
Q ss_pred hhhhccCCCCCcch
Q 047020 240 WAQMLDPKLNGDAN 253 (266)
Q Consensus 240 ~~~~l~~~~~~~~~ 253 (266)
+++|+..+|..|++
T Consensus 229 i~~~L~~~P~~R~~ 242 (330)
T cd05586 229 VKGLLNRNPQHRLG 242 (330)
T ss_pred HHHHcCCCHHHCCC
Confidence 78899999999873
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=258.21 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=201.4
Q ss_pred HHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
|....+.+...||.|++|.||++...++..+++|.+... ......+.+|++++++++||||+++++++......+++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 445667777899999999999997777778888876543 3345678899999999999999999999998889999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... ....+++..+..++.|++.|+.+||+++ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 82 ~~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999998763 2246899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------C
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------K 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~ 235 (266)
.. .........+..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+............ .
T Consensus 156 ~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05034 156 DE---YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE 232 (261)
T ss_pred hh---hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 11 111122334567999999988889999999999999999998 999997765544444433221 1
Q ss_pred chhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
..+++.+|+..+|..||+.+++..+++.
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1256789999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=261.95 Aligned_cols=235 Identities=25% Similarity=0.340 Sum_probs=184.5
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcC---CCCCccccceeEEe-----cCe
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRV---SHPNLVGLLGFCLE-----KGE 80 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~~~ 80 (266)
|++...||+|+||.||++ ...+|+.+++|.+..... .......+|+++++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 556678999999999999 555788899998754322 2233456777777765 69999999998754 245
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.+++||++. ++|.+++... ....+++..+..++.|++.|+.|||+.| ++|+||||+||+++.++.++|+|||+
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred EEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 789999996 4888887652 2245899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------ 234 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------ 234 (266)
+..... ........++..|+|||++.+..++.++|+||+||++|+|++|..||.+.+......++....
T Consensus 155 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 155 ARIYSC-----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred cccccC-----cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 875321 112233567889999999988889999999999999999999999998766554443332210
Q ss_pred ------------------------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 ------------------------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 ------------------------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+..++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 012567889999999999888765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=272.24 Aligned_cols=250 Identities=21% Similarity=0.304 Sum_probs=196.3
Q ss_pred hchhhhhccccccceEEEEEcC------CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEE
Q 047020 11 TNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 82 (266)
++.+...||+|+||.||.+... .+..++||++..... ...+.+.+|+++++.+. ||||+++++++.+.+..+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 3445568999999999998531 234688988754322 23467889999999996 999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCC-----------------------------------------------------------
Q 047020 83 LLLEYLANKSLFDRMHTYYGQ----------------------------------------------------------- 103 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~----------------------------------------------------------- 103 (266)
+||||+++|+|.+++......
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 999999999999988653210
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC
Q 047020 104 --------------------------------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN 151 (266)
Q Consensus 104 --------------------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~ 151 (266)
....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCC
Confidence 0124778888999999999999999999 99999999999999999
Q ss_pred ceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHH
Q 047020 152 HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEE 230 (266)
Q Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~ 230 (266)
.++|+|||++........ ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..........
T Consensus 275 ~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 275 IVKICDFGLARDIMHDSN--YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred EEEEEeCCcceecccccc--ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 999999999875322111 112233456778999999988889999999999999999997 99999765433333332
Q ss_pred HHhc-----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 231 CRRN-----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 231 ~~~~-----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.... ...+++.+|+..+|..||+..+|.++++.++
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 2221 1135778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=268.68 Aligned_cols=235 Identities=25% Similarity=0.305 Sum_probs=201.2
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
|+..+.||+|.|..|-++ ..-+|+.|+||.+.+.+-. ....+.+|+..|+.++|||||++|++...+..+|+|+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 566779999999999999 4568999999988654332 3567889999999999999999999999999999999998
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe-cCCceEEeccccccCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI-DDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~~~l~dfg~~~~~~~~ 167 (266)
++|+|+|||+++ ...++++.+.+++.||+.|+.|+|+.. ++||||||+||.+. +-|-+||.|||+...
T Consensus 100 D~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNk---- 168 (864)
T KOG4717|consen 100 DGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNK---- 168 (864)
T ss_pred CCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecccccc----
Confidence 899999999975 356899999999999999999999999 99999999998876 457899999998763
Q ss_pred CCCCCCcccccccCCCccCccccccccCC-CcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------h
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVS-TKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------V 237 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~ 237 (266)
........+..|+..|.|||.+.|..|+ +++||||||+|+|.|.+|+.||+..+.-+.+..++.-... .
T Consensus 169 -f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCr 247 (864)
T KOG4717|consen 169 -FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECR 247 (864)
T ss_pred -CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHH
Confidence 2223445678899999999999998876 6899999999999999999999988777777666653222 2
Q ss_pred hhhhhhccCCCCCcchHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~ 258 (266)
+++.+|+-.+|..|++.++|.
T Consensus 248 dLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 248 DLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred HHHHHHHhcCchhhccHHHHh
Confidence 688899999999999888764
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=277.85 Aligned_cols=207 Identities=23% Similarity=0.325 Sum_probs=164.2
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEec--------CeE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--------GEQ 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~ 81 (266)
.|.+...||+|+||.||++. ..+++.++||++.... ....+|+.+++.++||||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 45556689999999999994 4678899999875432 2345799999999999999998876432 246
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-ceEEecccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGL 160 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~~~l~dfg~ 160 (266)
++||||+++ ++.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence 799999964 7777765431 22367899999999999999999999999 99999999999998664 699999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~ 231 (266)
+...... .......+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+.
T Consensus 218 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 218 AKNLLAG-----QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred chhccCC-----CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9753221 122235678999999998654 68999999999999999999999998877665554443
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=265.10 Aligned_cols=238 Identities=25% Similarity=0.323 Sum_probs=187.5
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.+|....+||+|+||.||++. ..+++.+++|.+..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 456667799999999999994 45678899998764332 2344677899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+ +|.+++... ...+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++......
T Consensus 86 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LDK-DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCC-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 964 888777542 245788999999999999999999999 999999999999999999999999998742211
Q ss_pred CCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh-------------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR------------- 233 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~------------- 233 (266)
........++..|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.+..+........
T Consensus 158 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 158 ----TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ----ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 112233467889999998865 46788999999999999999999999776544332222110
Q ss_pred --------------------------cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 --------------------------NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 --------------------------~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..|++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 01125677888888888888877653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=256.90 Aligned_cols=247 Identities=20% Similarity=0.257 Sum_probs=196.9
Q ss_pred hhchhhhhccccccceEEEEEcC----CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG----DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
..+.+...||+|+||.||++... +...+++|....... .....+.+|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 45666779999999999999553 235678887654332 2345678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+++++|.+++... .+.+++..+..++.|++.|+.+||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999998653 247899999999999999999999999 999999999999999999999999998864
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh----------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR---------- 233 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~---------- 233 (266)
..... ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||...............
T Consensus 157 ~~~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd05033 157 EDSEA--TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCP 234 (266)
T ss_pred ccccc--ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 31111 111112334568999999988889999999999999999998 99999655433333322221
Q ss_pred cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 234 NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 234 ~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
....+++.+|+..+|..||+.+++.+.++..+
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11125778999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=257.19 Aligned_cols=241 Identities=26% Similarity=0.376 Sum_probs=193.0
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
....+...||+|++|.||++....+..+++|..... ......+.+|+++++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 446677799999999999997766778888876432 2334568889999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++... .+.+++..+..++.|++.++.+||+.+ ++|+||||+||++++++.++|+|||.++......
T Consensus 83 ~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~- 154 (256)
T cd05059 83 NGCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ- 154 (256)
T ss_pred CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc-
Confidence 99999998753 136899999999999999999999999 9999999999999999999999999887532111
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh----------cCchh
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR----------NKNVE 238 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~----------~~~~~ 238 (266)
........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+........... ....+
T Consensus 155 --~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05059 155 --YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYT 232 (256)
T ss_pred --ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 111112234457999999988889999999999999999998 89999766544443332221 11225
Q ss_pred hhhhhccCCCCCcchHHHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
++.+|+..+|..||+.+++.+.+
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHHh
Confidence 67788888999999888887765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=254.92 Aligned_cols=237 Identities=25% Similarity=0.293 Sum_probs=192.6
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeec--ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEE--RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+.+...||+|++|.+|++.. .+|+.+++|.+... .......+.+|+++++.++|||++++++.+...+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 45567899999999999954 56888898877543 2234567888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++... ....+++..++.++.|++.|+.|||+.| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 82 ENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999998763 2356889999999999999999999999 9999999999999999999999999887543221
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc----------Cchh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----------KNVE 238 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~ 238 (266)
.......++..|+|||+..+..++.++|+||||+++|+|++|..||...+......+..... ...+
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd08529 156 ----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQ 231 (256)
T ss_pred ----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHH
Confidence 12234467888999999988889999999999999999999999998776544443332211 1125
Q ss_pred hhhhhccCCCCCcchHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~ 258 (266)
++.+|+..+|..||+..++.
T Consensus 232 ~i~~~l~~~p~~Rp~~~~ll 251 (256)
T cd08529 232 LIDQCLTKDYRQRPDTFQLL 251 (256)
T ss_pred HHHHHccCCcccCcCHHHHh
Confidence 66788888888888877764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=254.75 Aligned_cols=237 Identities=24% Similarity=0.332 Sum_probs=188.6
Q ss_pred hccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchh
Q 047020 17 RIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
.||+|+||.||++.. .+++.+++|....... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 689999999999954 5788888887654322 23467889999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCc
Q 047020 95 DRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174 (266)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 174 (266)
+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 82 ~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~ 152 (252)
T cd05084 82 TFLRTE----GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--AST 152 (252)
T ss_pred HHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc--ccc
Confidence 988642 245789999999999999999999999 99999999999999999999999999875322111 111
Q ss_pred ccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh----------cCchhhhhhh
Q 047020 175 QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR----------NKNVEVWAQM 243 (266)
Q Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~----------~~~~~~~~~~ 243 (266)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+........... ....+++.+|
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 232 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERC 232 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHH
Confidence 112233457999999988889999999999999999997 88999654433222211111 1112577899
Q ss_pred ccCCCCCcchHHHHHHHHH
Q 047020 244 LDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 244 l~~~~~~~~~~~~l~~~~~ 262 (266)
+..+|..||+.+++.+.++
T Consensus 233 l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 233 WEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCChhhCcCHHHHHHHHh
Confidence 9999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=268.08 Aligned_cols=232 Identities=21% Similarity=0.267 Sum_probs=184.9
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEec------Ce
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK------GE 80 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 80 (266)
.+|.....||+|+||.||++ ...+++.++||++..... .....+.+|+++++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 35566668999999999999 456788999998754322 2345577899999999999999999887543 35
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.+++++++ +++|.+.+.. ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||+
T Consensus 95 ~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred EEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 68999987 7789887754 56899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-----
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----- 234 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----- 234 (266)
+..... ......+|..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+............
T Consensus 165 ~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 165 ARQADD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred ceecCC-------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 875321 1234568899999999876 568899999999999999999999998765544333222100
Q ss_pred -----------------------------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 -----------------------------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 -----------------------------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 012567788888999998887765
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=291.34 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=197.4
Q ss_pred CChHHHHHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEe-
Q 047020 2 YALEELKMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE- 77 (266)
Q Consensus 2 ~~~~~i~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 77 (266)
|...++....|.+...||.|+||.||++. ..++..+++|.+.... ......+..|+.++++++||||++++++|.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 44566777788888899999999999994 4556777887765432 2235678899999999999999999998854
Q ss_pred -cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeecCCCCCCcEEEecC--
Q 047020 78 -KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD----PPIIHRDIKSSNILLIDD-- 150 (266)
Q Consensus 78 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~----~~i~H~dikp~nil~~~~-- 150 (266)
...+++||||+++++|.+++..... ..+.+++..++.++.||+.||.|||+.+. .+|+|+||||+|||++..
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 3568999999999999999875322 22578999999999999999999998431 239999999999999642
Q ss_pred ---------------CceEEeccccccCCCCCCCCCCCcccccccCCCccCcccccc--ccCCCcccchhHHHHHHHHHh
Q 047020 151 ---------------NHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT--GFVSTKSDVYSFGVLLLELIT 213 (266)
Q Consensus 151 ---------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~i~~~l~~ 213 (266)
+.++|+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-----s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-----SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccc-----ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 34899999998753221 12234578999999999854 457889999999999999999
Q ss_pred CCCCcCCCchhHHHHHHHHhcCc----------hhhhhhhccCCCCCcchHHHHH
Q 047020 214 GLKSIQGSATLAEWTEECRRNKN----------VEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 214 g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
|..||...+....+...+...+. .+++..|+..+|..||+..++.
T Consensus 239 Gk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 239 GKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 99999877766666555543221 2567889999999999988876
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=271.84 Aligned_cols=233 Identities=25% Similarity=0.306 Sum_probs=195.6
Q ss_pred hhhccccccceEEEE-EcCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 15 RIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 15 ~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
...||+|.||.||++ +..+++.+++|.+.... .......++|+.++.+++++||.++|+.+..+..++++|||+.||+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 358999999999999 66788999999886543 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
+.+.++.. ..+++..+..++.+++.|+.|||+.+ .+|+|||+.||++...|.++|.|||.+-.+.. ..
T Consensus 98 v~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~----~~ 165 (467)
T KOG0201|consen 98 VLDLLKSG-----NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN----TV 165 (467)
T ss_pred hhhhhccC-----CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec----hh
Confidence 99999772 34488889999999999999999999 99999999999999999999999999876432 23
Q ss_pred CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc----------Cchhhhhh
Q 047020 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----------KNVEVWAQ 242 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~~ 242 (266)
....+..||+.|||||++....|+.++||||||++.+||++|.+|+.+-+...-...+-+.. +.-+.+..
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHH
Confidence 34478999999999999998899999999999999999999999997654321111111111 11256778
Q ss_pred hccCCCCCcchHHHHHH
Q 047020 243 MLDPKLNGDANMEQLRV 259 (266)
Q Consensus 243 ~l~~~~~~~~~~~~l~~ 259 (266)
|++.+|..||++.++.+
T Consensus 246 CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLK 262 (467)
T ss_pred HhhcCcccCcCHHHHhh
Confidence 99999999999988764
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=255.09 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=199.7
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+.+...||+|++|.||++. ..+|+.++||.+..... .....+.+|+.+++.++||||+++++++...+..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 56677799999999999995 56788999997754322 234577889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++.... .....+++..++.++.|++.++.|||++| ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 83 LADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999887532 22356899999999999999999999999 99999999999999999999999998875322
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh-HHHHHHHHh---c--------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL-AEWTEECRR---N-------- 234 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~-~~~~~~~~~---~-------- 234 (266)
.. .......++..|+|||+..+..++.++|+||+|+++|+|++|..||.+.... ......... .
T Consensus 159 ~~----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 159 KT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred CC----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 11 1122346788999999998888899999999999999999999999654321 122111111 0
Q ss_pred -CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 235 -KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 235 -~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...+++.+|+..+|..||+.++|.+.++++=
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1125678899999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=287.40 Aligned_cols=250 Identities=21% Similarity=0.270 Sum_probs=194.0
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
+|++..+||+|+||.||++ +..+|+.+++|++...... ...++.+|+++++.++||||+++++++.+.+..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 4566779999999999999 4557889999988653222 24578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 87 YLANKSLFDRMHTYYGQ------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
|++|++|.+++...... .....+...+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999988753211 1134566778899999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCC--------------CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHH
Q 047020 161 CKLGPFNDP--------------NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAE 226 (266)
Q Consensus 161 ~~~~~~~~~--------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~ 226 (266)
+........ ..........||+.|+|||++.+..++.++|+||+||++|+|++|..||.+......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 976421110 001112235699999999999999999999999999999999999999976443222
Q ss_pred HHHHHHh------------cCchhhhhhhccCCCCCc-chHHHHHHHHHH
Q 047020 227 WTEECRR------------NKNVEVWAQMLDPKLNGD-ANMEQLRVLIRI 263 (266)
Q Consensus 227 ~~~~~~~------------~~~~~~~~~~l~~~~~~~-~~~~~l~~~~~~ 263 (266)
....... ....+++.+|+..+|..| ++.+++.+-++.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2111110 011256778999999999 456666665554
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=260.56 Aligned_cols=235 Identities=24% Similarity=0.399 Sum_probs=194.8
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCC
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
+.+...||.|++|.||++ +..+|+.+++|.+..........+.+|+.+++.++|||++++++++......++|+||+.+
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 455568999999999999 5577899999988765555667788999999999999999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
++|.+++.. ..+++..+..++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 101 ~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 169 (296)
T cd06655 101 GSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-- 169 (296)
T ss_pred CcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc--
Confidence 999998865 46899999999999999999999999 9999999999999999999999999887432211
Q ss_pred CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC------------chh
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------------NVE 238 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------------~~~ 238 (266)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+............. ..+
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred --ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 122334678899999999888889999999999999999999999988766554433322110 114
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
++.+|+..+|..||+.+++..
T Consensus 248 li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhh
Confidence 567888888888888877653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=253.77 Aligned_cols=208 Identities=27% Similarity=0.365 Sum_probs=178.4
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEe--cCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE--KGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 91 (266)
+|++|.||.||++ +..+++.||+|++.-... +.--...+|+.+|.+.+|||||.+-.+... -+..|+||||++.
T Consensus 83 rI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh- 161 (419)
T KOG0663|consen 83 RIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH- 161 (419)
T ss_pred hcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-
Confidence 8999999999999 556788999998865433 334456799999999999999999887654 3479999999965
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|..++... ..+|...++..++.|++.|++|||.+. |+||||||.|++++..|.+||+|||+|+....+
T Consensus 162 DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp---- 230 (419)
T KOG0663|consen 162 DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP---- 230 (419)
T ss_pred hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC----
Confidence 888777653 258999999999999999999999998 999999999999999999999999999964322
Q ss_pred CCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc
Q 047020 172 PKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN 236 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (266)
........-|..|+|||.+.+ ..|++++|+||+|||+.||+++.+.|.|.++.++..++...-..
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt 296 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT 296 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC
Confidence 445667788999999998865 47999999999999999999999999999999999998885333
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=269.54 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=200.7
Q ss_pred HHHhhchhhhhccccccceEEEEEcC------CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCC-CCCccccceeEEec
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEK 78 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 78 (266)
|...++....+||+|+||.||++... .+..+++|++..... .....+.+|++++.++. ||||+++++.+...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33444555569999999999999642 345789998865322 23456889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcC--------------------------------------------------------
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYG-------------------------------------------------------- 102 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~-------------------------------------------------------- 102 (266)
+..++||||+.+|+|.+++.....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999865321
Q ss_pred -------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcE
Q 047020 103 -------------------------------------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNI 145 (266)
Q Consensus 103 -------------------------------------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 145 (266)
.....+++..+..++.|++.|+.|||+.+ ++|+||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 01124577788899999999999999999 99999999999
Q ss_pred EEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchh
Q 047020 146 LLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATL 224 (266)
Q Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~ 224 (266)
++++++.++|+|||++........ ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSN--YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EEeCCCEEEEEecCcceecccccc--cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999999999999999875322111 112223456788999999988889999999999999999998 89999765544
Q ss_pred HHHHHHHHhcC-----------chhhhhhhccCCCCCcchHHHHHHHHHHHhC
Q 047020 225 AEWTEECRRNK-----------NVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 225 ~~~~~~~~~~~-----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~~ 266 (266)
........... ..+++.+|+..+|..||+..+|...++.+++
T Consensus 349 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~~ 401 (401)
T cd05107 349 EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLLT 401 (401)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhC
Confidence 44433333211 1157889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=254.59 Aligned_cols=240 Identities=31% Similarity=0.441 Sum_probs=196.0
Q ss_pred hccccccceEEEEEcCC----CcEEEEEEeeeccccc-HHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAELGD----GNFGAVKRVMEERGGS-RKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~----g~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++.... +..+++|......... ...+.+|++.++.++|+|++++++++.+....+++|||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 68999999999995433 7788888776544332 677889999999999999999999999999999999999999
Q ss_pred chhhhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 92 SLFDRMHTYYGQ----SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 92 ~L~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+|.+++...... ....+++..++.++.|++.|+.+||+++ ++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999998763111 1367899999999999999999999999 999999999999999999999999999865433
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh----------cCc
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR----------NKN 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~----------~~~ 236 (266)
.. ........++..|+|||.+....++.++|+||+|+++|+|++ |..||.+......+...... ...
T Consensus 159 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd00192 159 DY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL 236 (262)
T ss_pred cc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHH
Confidence 21 122334567888999999988889999999999999999999 69999877544444333321 112
Q ss_pred hhhhhhhccCCCCCcchHHHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
.+++.+|+.+++..||+.+++...+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhh
Confidence 2567899999999999999998775
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=254.33 Aligned_cols=240 Identities=23% Similarity=0.286 Sum_probs=192.5
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc-----cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG-----SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
++.....||+|++|.||.+. ..++..+++|.+...... ....+.+|++++++++||||+++++++..+...+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 35556699999999999994 456889999877543221 234678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
+||+++++|.+.+... +.+++..+..++.|++.|+.+||+.+ ++|+||+|+||++++++.++|+|||.+...
T Consensus 83 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 83 MEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999988764 56889999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--------- 235 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 235 (266)
..... .........++..|+|||+..+..++.++|+||+|+++|+|++|..||...+.............
T Consensus 155 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (263)
T cd06625 155 QTICS-SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVS 233 (263)
T ss_pred ccccc-ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCC
Confidence 22111 11111334577889999999888899999999999999999999999977655544433322211
Q ss_pred --chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 --NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 --~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+..++..
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 234 PDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 125677888888888988777654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=268.39 Aligned_cols=234 Identities=26% Similarity=0.338 Sum_probs=181.3
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..+++.++||+|+||.||++. ..+|+.+++|.+..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 344566689999999999994 45788999998754332 2346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+. ...++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 154 ~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 154 MDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999988643 23467788899999999999999999 999999999999999999999999998753221
Q ss_pred CCCCCCcccccccCCCccCcccccc-----ccCCCcccchhHHHHHHHHHhCCCCcCCCchh--HHHH-HHHHh------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-----GFVSTKSDVYSFGVLLLELITGLKSIQGSATL--AEWT-EECRR------ 233 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~--~~~~-~~~~~------ 233 (266)
........||..|+|||++.. ...+.++|||||||++|+|++|..||...... .... .....
T Consensus 222 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 297 (353)
T PLN00034 222 ----MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP 297 (353)
T ss_pred ----cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCC
Confidence 112234578999999998743 23456899999999999999999999633211 1111 11110
Q ss_pred ----cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 ----NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 ----~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..++..||+.+++.+
T Consensus 298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 298 ATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01125677888888888888877653
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=266.24 Aligned_cols=212 Identities=21% Similarity=0.280 Sum_probs=173.5
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+.+...||+|+||.||++.. .+++.+++|.+.... ......+.+|..++..++|++|+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 456667999999999999954 457778888764321 2233457789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... ...+++..+..++.|++.|+.+||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 y~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 82 YYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred ccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999752 246889999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCCCCCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
.. ........||..|+|||++. ...++.++|+|||||++|+|++|..||.+.+....+..+..
T Consensus 155 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~ 222 (332)
T cd05623 155 DG---TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (332)
T ss_pred CC---cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence 11 11223457899999999985 34578899999999999999999999988776665555443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=256.29 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=191.6
Q ss_pred hhhhccccccceEEEEEcCCCc---EEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEec------CeEE
Q 047020 14 FRIRIGVGATSFVYLAELGDGN---FGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK------GEQL 82 (266)
Q Consensus 14 ~~~~ig~g~~~~v~~~~~~~g~---~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~ 82 (266)
+...||+|+||.||++.....+ .+++|...... ......+.+|+++++.++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 4568999999999999654433 46777664432 23356688899999999999999999876422 2468
Q ss_pred EEEEecCCCchhhhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYG-QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++|||+.+++|.+++..... .....+++..+..++.|++.|+.|||+++ ++|+||||+||++++++.++|+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988754321 22346899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-----
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----- 235 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----- 235 (266)
......... .......++..|++||+..+..++.++|+||||+++|+|++ |..||.+......+........
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd05075 160 KKIYNGDYY--RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237 (272)
T ss_pred cccCcccce--ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 864332211 11223345678999999998889999999999999999999 8899977654443332222111
Q ss_pred -----chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 -----NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 -----~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+.++|..||+.+++.+.++.++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 124678999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=259.94 Aligned_cols=247 Identities=27% Similarity=0.380 Sum_probs=192.7
Q ss_pred hchhhhhccccccceEEEEEcC-CCc--EEEEEEeeecc-cccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAELG-DGN--FGAVKRVMEER-GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~-~g~--~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.+.+...||+|+||.||++... ++. .+++|.+.... ....+.+.+|++++.++ +||||+++++++...+..++++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 4567779999999999999553 333 35666654322 22345688899999999 6999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceE
Q 047020 86 EYLANKSLFDRMHTYYGQ-----------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAK 154 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~ 154 (266)
||+++++|.+++...... ....+++..+..++.|++.|+.+||+.| ++|+||||+||++++++.++
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEE
Confidence 999999999998753211 1235888999999999999999999999 99999999999999999999
Q ss_pred EeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh
Q 047020 155 LADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~ 233 (266)
|+|||++..... .........+..|+|||+..+..++.++||||||+++|+|++ |..||.+.+....+......
T Consensus 160 l~dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 160 IADFGLSRGEEV-----YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred ECCcCCCccccc-----eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 999998763111 011111223457999999988889999999999999999997 99999876655444333221
Q ss_pred c----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 234 N----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 234 ~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
. ...+++.+|+..+|..||+.+++.+.++..+
T Consensus 235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1126788999999999999999987776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=257.84 Aligned_cols=240 Identities=25% Similarity=0.318 Sum_probs=190.9
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
....+++...||+|+||.||++. ..+|+.+++|............+.+|+.++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 34567778899999999999995 46778889988765544445667889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... +.+++..+..++.|++.++.|||+.+ ++|+|++|+||+++.++.++|+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 87 YCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999988653 57899999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCCCCCcccccccCCCccCccccc---cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH---h-------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLN---TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR---R------- 233 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~---~------- 233 (266)
. ........++..|+|||.+. ...++.++|+||+|+++|+|++|..||...+.......... .
T Consensus 159 ~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 159 T----IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234 (267)
T ss_pred c----ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccc
Confidence 1 11223456788999999874 33467899999999999999999999964432221111000 0
Q ss_pred ----cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 ----NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 ----~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++++|+..+|..||+.+++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 01125677888888888988887654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=259.56 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=197.5
Q ss_pred HhhchhhhhccccccceEEEEEcC------CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 9 MATNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
...+++...||+|++|.||++... ....+++|....... .....+.+|+++++++ +||||+++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 344555668999999999999542 235678887654322 2345678899999999 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec
Q 047020 81 QLLLLEYLANKSLFDRMHTYYG-----------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID 149 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~ 149 (266)
.+++|||+++++|.+++..... .....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 9999999999999999875321 23357889999999999999999999999 999999999999999
Q ss_pred CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHH
Q 047020 150 DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWT 228 (266)
Q Consensus 150 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~ 228 (266)
++.++|+|||.+........ ........++..|+|||++.+..++.++|+|||||++|+|++ |..||.+........
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDY--YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCeEEeCccccccccccccc--eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 99999999999875432211 111122334567999999988889999999999999999997 999997765444333
Q ss_pred HHHHhc----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 229 EECRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 229 ~~~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...... ...+++.+|+.++|..||+..++.+-++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 222211 1125788999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=260.91 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=196.0
Q ss_pred HhhchhhhhccccccceEEEEEcCC-----------------CcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccc
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGD-----------------GNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVG 70 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~-----------------g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~ 70 (266)
...+++...||+|+||.||++.... +..+++|.+..... .....+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4567777899999999999985432 23467776654332 23567888999999999999999
Q ss_pred cceeEEecCeEEEEEEecCCCchhhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCc
Q 047020 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQS------LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSN 144 (266)
Q Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~n 144 (266)
+++++...+..+++||++.+++|.+++....... ...+++..++.++.|++.|+.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999899999999999999999987753222 236899999999999999999999999 9999999999
Q ss_pred EEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh--CCCCcCCCc
Q 047020 145 ILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT--GLKSIQGSA 222 (266)
Q Consensus 145 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~--g~~pf~~~~ 222 (266)
|+++.++.++|+|||.+........ ........++..|+|||++.+..++.++||||||+++|+|++ +..||...+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY--YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcc--eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 9999999999999999875322211 122234456778999999988889999999999999999998 678886544
Q ss_pred hhHHHHHHHHh-----------------cCchhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 223 TLAEWTEECRR-----------------NKNVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 223 ~~~~~~~~~~~-----------------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
....+...... ....+++.+|+..+|..||+..+|.+.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 33332222211 11236778999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=254.95 Aligned_cols=240 Identities=25% Similarity=0.375 Sum_probs=192.3
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeeccccc---------HHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGS---------RKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
+.+...||.|++|.||++. ..++..+++|.+....... ...+.+|++++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 3455689999999999994 4567888998775543321 24577899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++++||+++++|.+++... +.+++..+..++.|++.|+.+||+.+ ++|+||+|+||++++++.++|+|||.+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999764 56889999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCC--CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh-c----
Q 047020 162 KLGPFNDPNR--PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR-N---- 234 (266)
Q Consensus 162 ~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~-~---- 234 (266)
.......... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+........... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIP 233 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCC
Confidence 7654221111 11122345788899999998888899999999999999999999999876555444332221 0
Q ss_pred -----CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 -----KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 -----~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+.++|..||+.+++.+
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0125677888888888888877653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=262.35 Aligned_cols=243 Identities=24% Similarity=0.319 Sum_probs=195.1
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
+++....||+|++|.||++.. .+++.+++|........ ....+.+|+++++.++||||+++++.+.+....+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 345566899999999999944 46889999987654322 34568889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... ....+++..+..++.|++.+|.|||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 82 YCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred ecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999988652 2356899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCCCC-------------------------CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC
Q 047020 167 NDPNR-------------------------PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS 221 (266)
Q Consensus 167 ~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~ 221 (266)
..... ........|+..|+|||++.+..++.++|+||||+++|+|++|..||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 11100 01122346788999999998888999999999999999999999999887
Q ss_pred chhHHHHHHHHhcC-----------chhhhhhhccCCCCCcch----HHHHHH
Q 047020 222 ATLAEWTEECRRNK-----------NVEVWAQMLDPKLNGDAN----MEQLRV 259 (266)
Q Consensus 222 ~~~~~~~~~~~~~~-----------~~~~~~~~l~~~~~~~~~----~~~l~~ 259 (266)
+....+........ ..+++.+|+..++..||+ .+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 76666655443221 125677888888888887 555543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=254.36 Aligned_cols=240 Identities=29% Similarity=0.413 Sum_probs=197.3
Q ss_pred HhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
...+.+...||.|++|.||.+... |+.+++|....... ..+++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 456677779999999999999754 78889998866543 4677889999999999999999999999889999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++... ....+++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 83 AKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999998763 2236899999999999999999999999 9999999999999999999999999987542111
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh----------cCch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR----------NKNV 237 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~----------~~~~ 237 (266)
.....+..|+|||++....++.++|+||+|+++|++++ |..||............... ....
T Consensus 157 -------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05039 157 -------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVY 229 (256)
T ss_pred -------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHH
Confidence 12334567999999988888999999999999999997 99999765433322221111 1122
Q ss_pred hhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
+++++|+..+|..||+.+++.+.++.
T Consensus 230 ~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 230 KVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHhccChhhCcCHHHHHHHHhc
Confidence 67889999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=254.15 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=196.4
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
++.+...||+|+||.||++. ..+++.+++|.+.... ......+.+|+++++.++||||+++++++.+.+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 45667799999999999994 4578899999765422 1234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++..... ....+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 83 LADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988865322 2256789999999999999999999999 99999999999999999999999998875322
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc-hhHHHHHHHHh------------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA-TLAEWTEECRR------------ 233 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~-~~~~~~~~~~~------------ 233 (266)
.. .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.... ....+......
T Consensus 159 ~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 159 KT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred hh----HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 11 11223467888999999988888999999999999999999999996442 22222222211
Q ss_pred cCchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 234 NKNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 234 ~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
....+++.+|+..+|..||+.+++.+.++.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 112356788999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=256.43 Aligned_cols=236 Identities=24% Similarity=0.301 Sum_probs=187.6
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCC
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
++....||+|+||.||++.. .++..+++|............+.+|+++++.++|||++++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 45667899999999999954 45667777766544444456788899999999999999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
++|.+++... ..++++..+..++.|++.+|.+||+.| ++|+||+|+||+++.+++++|+|||++......
T Consensus 87 ~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--- 156 (282)
T cd06643 87 GAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--- 156 (282)
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc---
Confidence 9998876542 256899999999999999999999999 999999999999999999999999998653211
Q ss_pred CCCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-----------
Q 047020 171 RPKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----------- 234 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 234 (266)
........++..|+|||++. +..++.++|+||+||++|+|++|..||...+............
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd06643 157 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 235 (282)
T ss_pred -ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccC
Confidence 12223456888999999873 3457789999999999999999999998766544443333211
Q ss_pred -CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 -KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 -~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+.+++.
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 236 SEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHh
Confidence 112566778888888888777654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=274.41 Aligned_cols=227 Identities=26% Similarity=0.401 Sum_probs=192.8
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchhhh
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDR 96 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 96 (266)
=||.|+.|.||++++ .++.|+||++..-. ..+++-|++|+||||+.+.++|...--+|+||||+..|-|.+.
T Consensus 131 WlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 499999999999988 57899999885432 2479999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCccc
Q 047020 97 MHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT 176 (266)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 176 (266)
++.. ..+....+..|..+|+.|+.|||.+. |+|||||.-||||..+..+||+|||-.+... ....+.
T Consensus 203 Lka~-----~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~-----~~STkM 269 (904)
T KOG4721|consen 203 LKAG-----RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELS-----DKSTKM 269 (904)
T ss_pred Hhcc-----CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhh-----hhhhhh
Confidence 9874 67899999999999999999999999 9999999999999999999999999877422 123345
Q ss_pred ccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-------h----hhhhhhcc
Q 047020 177 SIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------V----EVWAQMLD 245 (266)
Q Consensus 177 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------~----~~~~~~l~ 245 (266)
.+.||..|||||++++.+.+.++||||||+++|||+||..||.+-+.-......-.+.-. + -++++++.
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 678999999999999999999999999999999999999999776555544332221111 1 25689999
Q ss_pred CCCCCcchHHHHHHHHHHH
Q 047020 246 PKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 246 ~~~~~~~~~~~l~~~~~~~ 264 (266)
.++++||+..+++.-+..+
T Consensus 350 sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cCCCCCccHHHHHHHHhhc
Confidence 9999999999998877643
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=261.69 Aligned_cols=237 Identities=24% Similarity=0.375 Sum_probs=195.1
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+|.+...||+|++|.||++. ..+++.+++|.+..........+.+|+.+++.++||||+++++.+......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 445555689999999999994 5678999999886655555667888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++.. ..+++..+..++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 99 ~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999998865 46788999999999999999999999 9999999999999999999999999887432221
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------------Cc
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------------KN 236 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------------~~ 236 (266)
.......++..|+|||.+.+..++.++|+||+|+++|++++|..||.+.+............ ..
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T cd06656 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF 245 (297)
T ss_pred ----cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHH
Confidence 11234567888999999988888999999999999999999999997765433322221110 11
Q ss_pred hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++.+|+..+|..||+.+++..
T Consensus 246 ~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 246 RDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 25678899999999999888765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=255.87 Aligned_cols=249 Identities=20% Similarity=0.262 Sum_probs=196.0
Q ss_pred HhhchhhhhccccccceEEEEEcC-CCc---EEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAELG-DGN---FGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~-~g~---~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
...+.....||+|++|.||++... +++ .+++|...... ......+.+|+++++.++|||++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 345566679999999999999553 333 57777765432 2235678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+++++|.+++... .+.+++..+..++.|++.|+.+||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999988652 256899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK------- 235 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~------- 235 (266)
....... .........+..|+|||++.+..++.++|+||||+++|+|++ |..||...+.......+.....
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 235 (268)
T cd05063 157 LEDDPEG-TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDC 235 (268)
T ss_pred ccccccc-ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCC
Confidence 3321111 111111223457999999988888999999999999999997 9999976654443333322111
Q ss_pred ---chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 ---NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ---~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+.+++...+++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 125678999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=258.60 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=195.4
Q ss_pred chhhhhccccccceEEEEEcC------CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 12 NDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
+.+...||+|+||.||++... ....+++|....... .....+.+|+++++.++||||+++++.+..++..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 345668999999999999432 224567766654332 2345788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcE
Q 047020 85 LEYLANKSLFDRMHTYYG-------------------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNI 145 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 145 (266)
+||+.+++|.+++..... .....+++..+..++.|++.++.+||+.+ ++|+||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheE
Confidence 999999999998875321 11245788999999999999999999999 99999999999
Q ss_pred EEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchh
Q 047020 146 LLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATL 224 (266)
Q Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~ 224 (266)
++++++.++|+|||++........ ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDS--YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEcCCCcEEeccccccccccCccc--hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999875322211 111223345678999999988889999999999999999998 99999766543
Q ss_pred HHHHHHHHh----------cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 225 AEWTEECRR----------NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 225 ~~~~~~~~~----------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+...... ....+++.+|+.++|..||+..++.+.++..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 333222211 11226788999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.38 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=198.5
Q ss_pred HHHhhchhhhhccccccceEEEEEc--------CCCcEEEEEEeeecc-cccHHHHHHHHHHHhcC-CCCCccccceeEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL--------GDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCL 76 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~--------~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 76 (266)
+....+.+...||+|+||.||++.. .++..+++|...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4455566667999999999999952 123467777665432 23346788999999999 7999999999999
Q ss_pred ecCeEEEEEEecCCCchhhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcE
Q 047020 77 EKGEQLLLLEYLANKSLFDRMHTYYGQ-----------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNI 145 (266)
Q Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 145 (266)
.....+++|||+.+++|.+++...... ....+++..+..++.|++.|+.|||++| ++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 999999999999999999998764221 1235788889999999999999999999 99999999999
Q ss_pred EEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchh
Q 047020 146 LLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATL 224 (266)
Q Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~ 224 (266)
++++++.++|+|||.+........ ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccc--cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 999999999999999875432211 111223345677999999988889999999999999999998 78899766544
Q ss_pred HHHHHHHHhc----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 225 AEWTEECRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 225 ~~~~~~~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.......... ...+++.+|+.++|..||+..++.+.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 4333222211 1125678999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=261.74 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=193.1
Q ss_pred HHHhhchhhhhccccccceEEEEEc-CCCcE----EEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCe
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL-GDGNF----GAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~----~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 80 (266)
+....++....||+|+||.||++.. .+|+. +++|.+..... .....+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 3445566667899999999999954 33443 67777654322 3356788899999999999999999988764 5
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.+++++|+.+|+|.+++... ...++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccc
Confidence 67999999999999998763 245788899999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK---- 235 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~---- 235 (266)
+........ ........++..|+|||++.+..++.++|+||||+++|+|++ |..||.+..... .........
T Consensus 156 a~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~ 232 (316)
T cd05108 156 AKLLGADEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQ 232 (316)
T ss_pred cccccCCCc--ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCC
Confidence 986432221 111122334667999999998899999999999999999997 999997654332 222222211
Q ss_pred -------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 -------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 -------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++...+....
T Consensus 233 ~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 233 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 124667899999999999999988877653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=273.65 Aligned_cols=240 Identities=28% Similarity=0.400 Sum_probs=187.4
Q ss_pred hhhhhccccccceEEEEEcCC--C--cE-EEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 13 DFRIRIGVGATSFVYLAELGD--G--NF-GAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~~--g--~~-~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
.+.++||+|+||.||.+.+.. + .. ||||...... ......+.+|++++++++||||++++|++..+..+++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 344699999999999995533 2 22 7888776522 23467789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
||++.||+|.++++.+ .+.++..+...++++.+.||+|||+++ ++||||-..|+|++.++.+||+|||+++..
T Consensus 240 mEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 9999999999999985 225899999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcCch------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNKNV------ 237 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~------ 237 (266)
.... ...........|+|||.+....++.++||||||+++||+++ |..||.+-....-..++.......
T Consensus 313 ~~~~----~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~ 388 (474)
T KOG0194|consen 313 SQYV----MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKT 388 (474)
T ss_pred ccee----eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCC
Confidence 2111 11112245678999999999999999999999999999998 888998876655444442321110
Q ss_pred -----hhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 238 -----EVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 238 -----~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
.+..++...++..||+..++.+.++.
T Consensus 389 p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~ 419 (474)
T KOG0194|consen 389 PKELAKVMKQCWKKDPEDRPTMSTIKKKLEA 419 (474)
T ss_pred HHHHHHHHHHhccCChhhccCHHHHHHHHHH
Confidence 23345555566666666655555443
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=260.06 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=193.9
Q ss_pred HHhhchhhhhccccccceEEEEEcCC---------------CcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCcccc
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELGD---------------GNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGL 71 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~~---------------g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~ 71 (266)
...++++..+||+|+||.||++.... ...+++|....... .....+.+|++++++++|||++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34567788899999999999985422 23477887754322 234568899999999999999999
Q ss_pred ceeEEecCeEEEEEEecCCCchhhhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCc
Q 047020 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQ-------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSN 144 (266)
Q Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~n 144 (266)
++++...+..++||||+++++|.+++...... ....+++..+..++.|++.|+.|||+.+ ++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 99999999999999999999999988653111 1124678889999999999999999999 9999999999
Q ss_pred EEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh--CCCCcCCCc
Q 047020 145 ILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT--GLKSIQGSA 222 (266)
Q Consensus 145 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~--g~~pf~~~~ 222 (266)
|++++++.++|+|||++........ ........++..|+|||+..+..++.++|+||||+++|+|++ +..||...+
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EEEcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9999999999999999875332211 112233455678999999988889999999999999999988 678886544
Q ss_pred hhHHHHHHHH---h--------------cCchhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 223 TLAEWTEECR---R--------------NKNVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 223 ~~~~~~~~~~---~--------------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
.......... . ....+++++|+..+|..||+.+++.+.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 3222211110 0 11236788999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=254.11 Aligned_cols=238 Identities=25% Similarity=0.328 Sum_probs=192.9
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.++++...||.|++|.+|++.. .+++.+++|............+.+|++++++++||||+++++.+......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 3566777999999999999954 567788888876655456678899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+++... ...+++..+..++.|++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 83 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~- 154 (262)
T cd06613 83 GGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT- 154 (262)
T ss_pred CCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh-
Confidence 999999987652 246899999999999999999999999 999999999999999999999999998753211
Q ss_pred CCCCCcccccccCCCccCccccccc---cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh------------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTG---FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR------------ 233 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~------------ 233 (266)
........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+...........
T Consensus 155 ---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 155 ---IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred ---hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 1122345678889999998776 7888999999999999999999999776543333222221
Q ss_pred --cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 --NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 --~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++++|+..+|..||+.+++.
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il 258 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLL 258 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 1112567788888888888877765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=252.91 Aligned_cols=238 Identities=21% Similarity=0.294 Sum_probs=188.6
Q ss_pred hccccccceEEEEE---cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAE---LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~---~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
+||+|+||.||++. .+++..+++|....... ...+.+.+|+.+++.++||||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 58999999999984 34677888887654332 234568889999999999999999998754 4678999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... ..+++..+..++.|++.|+.+||++| ++|+||||.||++++++.++|+|||.+..........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 999988653 56899999999999999999999999 9999999999999999999999999987543222110
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------Cchhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------KNVEVW 240 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~~~~~~ 240 (266)
.......++..|+|||.+....++.++|+||||+++|+|++ |..||.+.+.......+.... ...+++
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 231 (257)
T cd05116 153 -KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLM 231 (257)
T ss_pred -eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 11112234578999999988888999999999999999998 999997654433322222211 111678
Q ss_pred hhhccCCCCCcchHHHHHHHHHHH
Q 047020 241 AQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 241 ~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
.+|+.++|..||+.++|.+.++.|
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 232 KLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHhccCchhCcCHHHHHHHHhcc
Confidence 899999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=257.10 Aligned_cols=251 Identities=23% Similarity=0.295 Sum_probs=197.2
Q ss_pred HHHhhchhhhhccccccceEEEEEcC------CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecC
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG 79 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 79 (266)
|....+.+...||+|+||.||++... ++..+++|....... .....+.+|+++++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 45566777779999999999998542 346788887654322 23456778999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceE
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQ-----SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAK 154 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~ 154 (266)
..++||||+++++|.+++...... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 999999999999999998764321 1235788899999999999999999999 99999999999999999999
Q ss_pred EeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh
Q 047020 155 LADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~ 233 (266)
|+|||++........ ........++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.+...........
T Consensus 160 l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 160 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred ECCcccchhhccCcc--cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 999999875332211 112233456778999999988889999999999999999998 99999765543333222211
Q ss_pred c----------CchhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 234 N----------KNVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 234 ~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
. ...+++.+|+..+|..||+..++...++
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1 1125778999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=259.63 Aligned_cols=239 Identities=24% Similarity=0.311 Sum_probs=188.5
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
..+|.+..+||.|+||.||++. ..+++.+++|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 3456677799999999999994 4578899999876433 2334567789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|++ ++|.+++... ...+++..+..++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 996 5888877652 245789999999999999999999999 99999999999999999999999999874321
Q ss_pred CCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh------------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR------------ 233 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~------------ 233 (266)
. ........++..|+|||++.+. .++.++|+||+|+++|+|++|..||.+.+....+......
T Consensus 157 ~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 157 P----TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred C----CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 1 1112234568899999988654 5788999999999999999999999876554333221110
Q ss_pred ---------------------------cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 ---------------------------NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 ---------------------------~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00125678888888888888877653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=250.03 Aligned_cols=233 Identities=22% Similarity=0.299 Sum_probs=190.7
Q ss_pred hhhhhccccccceEEEE-EcCCCcEEEEEEeeeccccc--------HHHHHHHHHHHhcCC-CCCccccceeEEecCeEE
Q 047020 13 DFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGS--------RKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~--------~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 82 (266)
.-++.||+|..+.|.++ ...+|+..++|++....+.. .+.-.+|+++|+++. ||+|+++.++++.+...+
T Consensus 20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F 99 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF 99 (411)
T ss_pred ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence 33457999999999988 44567788888775543321 234567999999997 999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+|+|.++-|.|.|++.+. -.+++...+.++.|++.++.|||.++ |+|||+||+||+++++.+++|+|||.++
T Consensus 100 lVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred hhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceee
Confidence 999999999999999875 67899999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccc------cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc--
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLN------TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN-- 234 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~-- 234 (266)
.+.. .......+||++|+|||.+. ..+|+..+|+||.|+|+|.|+.|.+||-......+...+..+.
T Consensus 172 ~l~~-----GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 172 QLEP-----GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred ccCC-----chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 6432 23345689999999999984 3467888999999999999999999996555555444444422
Q ss_pred -----------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 -----------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 -----------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..-+++++++.-+|..|.+.++..
T Consensus 247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred cCCcchhhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 222577788888888887777643
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=253.21 Aligned_cols=240 Identities=32% Similarity=0.409 Sum_probs=192.0
Q ss_pred HHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeE-EecCeEEEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC-LEKGEQLLLLE 86 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e 86 (266)
....+.+...||+|++|.||++.. .|..+++|..... ...+.+.+|+.++++++|++++++++++ ...+..++++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 455677778999999999999965 4777888876432 3356788999999999999999999875 45567899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... ....+++..+..++.|++.++.+||++| ++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 81 YMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999998763 2235789999999999999999999999 99999999999999999999999998874221
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh----------cC
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR----------NK 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~----------~~ 235 (266)
. ......+..|+|||++.+..++.++|+|||||++|+|++ |..||...+........... ..
T Consensus 155 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05082 155 T-------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPV 227 (256)
T ss_pred c-------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence 1 122334567999999988889999999999999999997 99999765433222222111 11
Q ss_pred chhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
..+++.+|+..+|..||+..++.+.++.
T Consensus 228 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 228 VYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 2356789999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=256.25 Aligned_cols=248 Identities=24% Similarity=0.289 Sum_probs=191.5
Q ss_pred hhchhhhhccccccceEEEEEcC------CCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
..+.+...||+|++|.||++... .+..+++|........ ....+.+|+.+++.++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 34455568999999999999553 3556777766433322 2356888999999999999999999999888999
Q ss_pred EEEEecCCCchhhhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC---ceEEec
Q 047020 83 LLLEYLANKSLFDRMHTYYGQ--SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN---HAKLAD 157 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~~~l~d 157 (266)
++|||+++++|.+++...... ....+++..+..++.|++.++.|||+++ ++|+||||+||+++.++ .++|+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEecc
Confidence 999999999999998765321 2236889999999999999999999999 99999999999998655 589999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc--
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN-- 234 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~-- 234 (266)
||++........ .........+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+............
T Consensus 163 fg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 163 FGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred CccccccCCccc--eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 999875421111 111222334567999999988889999999999999999997 999998765443332222111
Q ss_pred --------CchhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 235 --------KNVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 235 --------~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
...+++.+|+..+|..||+..++.+.+.
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1126778999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=256.39 Aligned_cols=239 Identities=24% Similarity=0.296 Sum_probs=191.7
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
..|++..+||.|+||.||++.. .++..+++|............+.+|+++++.++||||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 3466777999999999999954 457888888876555455677888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|..++.+. ...+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 92 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~-- 162 (292)
T cd06644 92 PGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK-- 162 (292)
T ss_pred CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccc--
Confidence 999998877542 246899999999999999999999999 99999999999999999999999998764211
Q ss_pred CCCCCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-------- 235 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 235 (266)
.........++..|+|||++. ...++.++|+||||+++|+|++|..||.+.+.............
T Consensus 163 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06644 163 --TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240 (292)
T ss_pred --cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcc
Confidence 112223456788999999984 33467889999999999999999999977654433333222111
Q ss_pred ----chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 124678899999999998887754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=254.10 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=193.8
Q ss_pred hhhhhccccccceEEEEEcC----CCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCe------
Q 047020 13 DFRIRIGVGATSFVYLAELG----DGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE------ 80 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------ 80 (266)
.+...||+|+||.||.+... .+..+++|++..... .....+.+|++.++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 34568999999999999543 246789998764332 234568899999999999999999998765443
Q ss_pred EEEEEEecCCCchhhhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYG-QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
.++++||+++++|.+++..... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcc
Confidence 7999999999999988865422 12246899999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN---- 234 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~---- 234 (266)
++......... ........+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+..............
T Consensus 159 ~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05035 159 LSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236 (273)
T ss_pred ceeeccccccc--cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 98754332211 11122334667999999988889999999999999999999 889997765544333322211
Q ss_pred ------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 235 ------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 235 ------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...+++.+|+..+|..||+..++.+.++..
T Consensus 237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 113678899999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=288.86 Aligned_cols=235 Identities=23% Similarity=0.306 Sum_probs=194.7
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeee---cccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVME---ERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+.+.+.||+|+||.|.++.. .+++.+|+|++.+ -.......|..|-.+|.--..+.|+.++..|++..++|+||+|
T Consensus 77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY 156 (1317)
T KOG0612|consen 77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY 156 (1317)
T ss_pred hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence 34445899999999999954 5678888887644 2334567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
++||+|..++... ..+++..+..++.+|..||..||+.| +|||||||+|||++..|++||.|||.|-.+...
T Consensus 157 ~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 157 MPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999875 57999999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCCCCcccccccCCCccCccccc----c-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCchhhhhh
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLN----T-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQ 242 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~----~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (266)
. ...+...+|||.|.+||++. + +.|+..+|+||+|+++|||++|..||..++-...|-+++.......
T Consensus 229 G---~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~---- 301 (1317)
T KOG0612|consen 229 G---TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS---- 301 (1317)
T ss_pred C---cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC----
Confidence 3 45667889999999999983 3 4688899999999999999999999988888888877776532221
Q ss_pred hccCCCCCcchHHHHHHHHHHHh
Q 047020 243 MLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 243 ~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.| ..--..++.+.+|++.+
T Consensus 302 --FP--~~~~VSeeakdLI~~ll 320 (1317)
T KOG0612|consen 302 --FP--DETDVSEEAKDLIEALL 320 (1317)
T ss_pred --CC--cccccCHHHHHHHHHHh
Confidence 12 11125556666666543
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=251.15 Aligned_cols=238 Identities=22% Similarity=0.300 Sum_probs=195.2
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
|++.+.||.|+||.++.+ ...+++.+++|.+.... ......+.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 566779999999999999 45668888999875432 334567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+.+... ....+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 82 NGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred CCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999998763 2356899999999999999999999999 9999999999999999999999999987543222
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC----------chh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----------NVE 238 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~~ 238 (266)
.......++..|+|||...+..++.++|+||+|+++|+|++|..||...+............. ..+
T Consensus 156 ----~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd08221 156 ----SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELIS 231 (256)
T ss_pred ----ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHH
Confidence 123445688999999999888889999999999999999999999987665554444332211 124
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
++.+|+.++|..||+.+++.+
T Consensus 232 ~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 232 LVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred HHHHHcccCcccCCCHHHHhh
Confidence 567888888888888777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=256.93 Aligned_cols=230 Identities=23% Similarity=0.267 Sum_probs=183.6
Q ss_pred hhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 13 DFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
...+.||+|+||.||.+ ...+++.+++|.+..... .....+.+|+++++.++|++|+++.+.+..++..+++|||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 34457999999999999 445788999998754321 12345678999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+.+... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05632 83 NGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG- 155 (285)
T ss_pred cCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence 999998887652 2246899999999999999999999999 999999999999999999999999988643211
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH---h----------cC
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR---R----------NK 235 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~---~----------~~ 235 (266)
.......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.+............ . ..
T Consensus 156 ----~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd05632 156 ----ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEE 231 (285)
T ss_pred ----CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHH
Confidence 112345689999999999888899999999999999999999999987654332221111 0 00
Q ss_pred chhhhhhhccCCCCCcch
Q 047020 236 NVEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~ 253 (266)
..+++..|+..+|..|++
T Consensus 232 ~~~li~~~l~~~P~~R~~ 249 (285)
T cd05632 232 AKSICKMLLTKDPKQRLG 249 (285)
T ss_pred HHHHHHHHccCCHhHcCC
Confidence 124567788888888877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=258.50 Aligned_cols=237 Identities=21% Similarity=0.244 Sum_probs=186.9
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
++....||+|+||.||++ ...+++.+++|.+...... ....+.+|+.+++.++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 344568999999999999 5567889999987543222 234567899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999888652 2245899999999999999999999999 999999999999999999999999998753211
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh---HHHHHHHH----------hc
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL---AEWTEECR----------RN 234 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~---~~~~~~~~----------~~ 234 (266)
. ......|+..|+|||++.+..++.++|+||+|+++|+|++|..||.+.... ........ ..
T Consensus 156 ~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd05630 156 Q-----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSP 230 (285)
T ss_pred c-----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCH
Confidence 1 122346899999999998888999999999999999999999999764321 11111111 01
Q ss_pred CchhhhhhhccCCCCCcch-----HHHHHH
Q 047020 235 KNVEVWAQMLDPKLNGDAN-----MEQLRV 259 (266)
Q Consensus 235 ~~~~~~~~~l~~~~~~~~~-----~~~l~~ 259 (266)
...+++.+|+..+|..|++ .+++..
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1125677888888888887 555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=256.62 Aligned_cols=237 Identities=24% Similarity=0.307 Sum_probs=192.7
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
++.+...||.|++|.||++.. .++..+++|............+.+|+++++.++||||+++++.+..+...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 466777999999999999954 5688889988765554556678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++... ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 86 ~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 86 GGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred CCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 99999988653 246899999999999999999999999 999999999999999999999999987643211
Q ss_pred CCCCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc----------
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN---------- 234 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 234 (266)
........++..|+|||.+. ...++.++|+||+|+++|+|++|..||.+.+............
T Consensus 157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (280)
T cd06611 157 --LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW 234 (280)
T ss_pred --ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccC
Confidence 12223456888999999874 3456779999999999999999999997765444333333221
Q ss_pred --CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 --KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 --~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+.+++.
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 235 SSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHh
Confidence 112467889999999999887764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=260.26 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=195.1
Q ss_pred HhhchhhhhccccccceEEEEEcC--------CCcEEEEEEeeecc-cccHHHHHHHHHHHhcC-CCCCccccceeEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAELG--------DGNFGAVKRVMEER-GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEK 78 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~--------~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 78 (266)
...+.+...||+|+||.||++... ++..+++|...... ......+.+|+++++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 355666779999999999999531 22457887765432 22345678899999999 699999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQ-----------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL 147 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~ 147 (266)
+..++||||+++++|.+++...... ....+++..+..++.|++.|+.|||+.| ++|+||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 9999999999999999999764221 1235788999999999999999999999 9999999999999
Q ss_pred ecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHH
Q 047020 148 IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAE 226 (266)
Q Consensus 148 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~ 226 (266)
+.++.++|+|||.+......... .......++..|+|||++.+..++.++|+||+|+++|+|++ |..||.+.... .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-~ 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-E 250 (307)
T ss_pred cCCCcEEECCCcccccccccchh--hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-H
Confidence 99999999999998753221110 11112234467999999988889999999999999999998 88999765433 3
Q ss_pred HHHHHHhcCc-----------hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 227 WTEECRRNKN-----------VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 227 ~~~~~~~~~~-----------~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
....+..... .+++.+|+..+|..||+..++.+.++..+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 2222222111 15678999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=252.07 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=198.1
Q ss_pred hchhhhhccccccceEEEEEcC-CCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAELG-DGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
++.+...||+|++|.||++... +|+.+++|.+.... ......+.+|++++++++|++++++++.+......+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 5667779999999999999554 78899998775322 2235678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++.... .....+++..+..++.+++.++.+||+.| ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 83 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 83 LADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999887532 22356899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCch-hHHHHHHHH------------h
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT-LAEWTEECR------------R 233 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~-~~~~~~~~~------------~ 233 (266)
.. .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......... .
T Consensus 159 ~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 159 KT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred CC----cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 11 112334678889999999888899999999999999999999999965432 112211111 0
Q ss_pred cCchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 234 NKNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 234 ~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
....+++.+|+.++|..||+..+|.+.++.
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 122357789999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=252.61 Aligned_cols=240 Identities=20% Similarity=0.300 Sum_probs=187.4
Q ss_pred hccccccceEEEEEc---CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLAEL---GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~---~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||+|+||.||++.. +.+..+++|....... ...+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 589999999999844 2345678887654432 234568899999999999999999998754 57899999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.+++... ...+++..+..++.|++.|+.+||++| ++|+||||+||+++.++.++|+|||++......... .
T Consensus 81 L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~-~ 152 (257)
T cd05115 81 LNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-Y 152 (257)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc-e
Confidence 99988642 256899999999999999999999999 999999999999999999999999998753322211 1
Q ss_pred CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------Cchhhhh
Q 047020 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------KNVEVWA 241 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~ 241 (266)
.......++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.............. ...+++.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMK 232 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11112233568999999988888999999999999999996 999997654433322221111 1125678
Q ss_pred hhccCCCCCcchHHHHHHHHHHHh
Q 047020 242 QMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 242 ~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+|+..++..||+..+|.+.|+.-|
T Consensus 233 ~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 233 DCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHcCCChhhCcCHHHHHHHHhhhc
Confidence 999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=253.52 Aligned_cols=240 Identities=23% Similarity=0.338 Sum_probs=193.3
Q ss_pred chhhhhccccccceEEEEEcCCCcEEEEEEeeecccc------cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 12 NDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGG------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
+.....||.|+||.||++...+|+.+++|.+...... ....+.+|+++++.++|+||+++++++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 4456689999999999997778889999987643321 2355788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+++++|.+++... +++++..++.++.|++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+....
T Consensus 82 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 82 EFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999998764 56889999999999999999999999 9999999999999999999999999887532
Q ss_pred CCCCC--CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-C-------
Q 047020 166 FNDPN--RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN-K------- 235 (266)
Q Consensus 166 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~-~------- 235 (266)
..... .........++..|+|||++.+..++.++|+||+|+++|+|++|..||...+.......+.... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS 233 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCC
Confidence 21110 1112234568889999999988888999999999999999999999997765554443322220 0
Q ss_pred ----chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++++|+.++|..||+.+++..
T Consensus 234 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 234 FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 114577888888888888877653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=257.56 Aligned_cols=239 Identities=32% Similarity=0.449 Sum_probs=183.4
Q ss_pred hhhhccccccceEEEEEcC-----CCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 14 FRIRIGVGATSFVYLAELG-----DGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 14 ~~~~ig~g~~~~v~~~~~~-----~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
....||.|.||.||+|... .+..++||.+...... ....+.+|++.+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3458999999999999654 3567888877443332 367899999999999999999999999988889999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++++|.+++... ....+++..+..++.|++.||.|||+++ ++|++|++.||++++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999873 3357899999999999999999999999 999999999999999999999999998753111
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------c
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------N 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~ 236 (266)
. .............|+|||.+....++.++||||||+++||+++ |..||.+.+............. .
T Consensus 157 ~--~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (259)
T PF07714_consen 157 S--KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDI 234 (259)
T ss_dssp S--SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHH
T ss_pred c--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHH
Confidence 1 1122233456778999999988889999999999999999999 7899977644443333322111 1
Q ss_pred hhhhhhhccCCCCCcchHHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVL 260 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~ 260 (266)
.+++.+|+..+|..||+..++.+.
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~~ 258 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQE 258 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHhc
Confidence 146678888888888888877654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=251.27 Aligned_cols=238 Identities=28% Similarity=0.371 Sum_probs=191.9
Q ss_pred hccccccceEEEEEcCC--C--cEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAELGD--G--NFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~--g--~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|++|.||++...+ + ..+++|....... ...+.+.+|++++++++||||+++++.+.. ...++++||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 68999999999995432 2 2578887765544 456678899999999999999999999888 8899999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+.+..... ..+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 153 (257)
T cd05040 81 SLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH- 153 (257)
T ss_pred cHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc-
Confidence 99999877421 46899999999999999999999999 999999999999999999999999998764332211
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc-----------Cchhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN-----------KNVEV 239 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~-----------~~~~~ 239 (266)
........++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+............ ...++
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence 111123456778999999988889999999999999999998 999997665554443333211 11256
Q ss_pred hhhhccCCCCCcchHHHHHHHHH
Q 047020 240 WAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 240 ~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
+.+|+..+|..||+..++...+.
T Consensus 234 i~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 234 MLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHCCCCcccCCCHHHHHHHhc
Confidence 78899999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=256.18 Aligned_cols=237 Identities=22% Similarity=0.299 Sum_probs=187.4
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+.+...||+|++|.||++.. .+|..+++|++..... .....+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 45566899999999999954 5688999998754322 23466788999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
. ++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 82 S-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred C-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 6 5888877653 22356899999999999999999999999 999999999999999999999999998743221
Q ss_pred CCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh--------------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR-------------- 233 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~-------------- 233 (266)
........++..|+|||++.+. .++.++|+||+|+++|+|++|..||.+.............
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 ---VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 1112234567889999988654 4688999999999999999999999876554433222110
Q ss_pred ------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 ------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 ------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++++|+..+|..||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll 280 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 0111577888999999998887764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=258.71 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=195.4
Q ss_pred hhchhhhhccccccceEEEEEc--------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEecC
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL--------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKG 79 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~--------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 79 (266)
.++.+..+||+|+||.||++.. .....+++|.+..... .....+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 4555667999999999999953 1234677777654322 2345678899999999 5999999999999989
Q ss_pred eEEEEEEecCCCchhhhhhhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYG-----------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~ 148 (266)
..+++|||+++++|.+++..... .....+++..+..++.|++.|+.|||++| ++|+||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999976421 12245888999999999999999999999 99999999999999
Q ss_pred cCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHH
Q 047020 149 DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEW 227 (266)
Q Consensus 149 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~ 227 (266)
+++.++|+|||.+......... .......++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYY--KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred CCCcEEEccccccccccccccc--cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999998753321111 11112234457999999988889999999999999999999 89999765443333
Q ss_pred HHHHHhc----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 228 TEECRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 228 ~~~~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
....... ...+++.+|+..+|..||+..++.+.++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 2222211 1225778999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=258.91 Aligned_cols=199 Identities=23% Similarity=0.349 Sum_probs=158.5
Q ss_pred hhccccccceEEEEEcC---CCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEe--cCeEEEEEEecCC
Q 047020 16 IRIGVGATSFVYLAELG---DGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE--KGEQLLLLEYLAN 90 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~---~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 90 (266)
.+||+|+||.||++... ++..+++|.+... .....+.+|+.+++.++||||+++++++.. +...+++|||+ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~ 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-E 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-C
Confidence 48999999999999543 5677888877543 234557789999999999999999998854 44678999998 4
Q ss_pred CchhhhhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe----cCCceEEecccccc
Q 047020 91 KSLFDRMHTYYG----QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI----DDNHAKLADFGLCK 162 (266)
Q Consensus 91 ~~L~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~----~~~~~~l~dfg~~~ 162 (266)
++|.+++..... .....+++..+..++.|++.||.|||++| ++||||||+||++. ..+.+||+|||++.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 588887764321 12235899999999999999999999999 99999999999994 55789999999997
Q ss_pred CCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCC
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGS 221 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~ 221 (266)
....... .........+|..|+|||++.+ ..++.++|+||+||++|+|++|..||.+.
T Consensus 161 ~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCc-cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 5432211 1122334678999999999876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=250.80 Aligned_cols=238 Identities=24% Similarity=0.323 Sum_probs=188.3
Q ss_pred hhccccccceEEEEEc-C---CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCC
Q 047020 16 IRIGVGATSFVYLAEL-G---DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~-~---~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
++||+|+||.||++.. . .+..+++|....... .....+.+|+++++.+.||||+++++++. ....++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 3699999999999842 2 236788887764433 24567889999999999999999999876 4468999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
++|.+++... ..+++..+..++.|++.++.+||..+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999764 46899999999999999999999999 999999999999999999999999998754322211
Q ss_pred CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------Cchhh
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------KNVEV 239 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~~~~~ 239 (266)
........++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+............ ...++
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 230 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSI 230 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 111112233467999999988889999999999999999998 999997655433222221111 11267
Q ss_pred hhhhccCCCCCcchHHHHHHHHHH
Q 047020 240 WAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 240 ~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
+.+|+.++|..||+..+|.+.++.
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~~l~~ 254 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELESTFRR 254 (257)
T ss_pred HHHHhcCChhhCcCHHHHHHHHHh
Confidence 889999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=256.12 Aligned_cols=243 Identities=28% Similarity=0.329 Sum_probs=189.7
Q ss_pred hhhhhccccccceEEEEE-----cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEec--CeEEEE
Q 047020 13 DFRIRIGVGATSFVYLAE-----LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQLLL 84 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~-----~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 84 (266)
.+...||+|+||.||++. ..++..+++|....... .....+.+|+++++.++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 566789999999998753 34677889987755432 2356678899999999999999999987653 357899
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+.+++|.+++.. ..+++..+..++.|++.|+.+||+++ ++|+||||+||++++++.++|+|||++...
T Consensus 87 ~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 87 MEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999875 46899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH--------------HHHHH
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA--------------EWTEE 230 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~--------------~~~~~ 230 (266)
...... ........++..|+|||...+..++.++|+||||+++|+|++|..||....... .+...
T Consensus 158 ~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchh-hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 322110 011122345567999999988888999999999999999999999985432110 01100
Q ss_pred HHh-----------cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 231 CRR-----------NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 231 ~~~-----------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
... ....+++.+|+.++|..||+.+++...++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000 11125678999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=253.97 Aligned_cols=248 Identities=20% Similarity=0.259 Sum_probs=195.6
Q ss_pred HhhchhhhhccccccceEEEEEcC----CCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAELG----DGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
..++++...||+|+||.||++... ++..+++|.+.... ......+.+|+.+++.++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 345667779999999999999542 23367887765432 2234678889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
+|||+++++|.+++... .+.+++..+..++.|++.|+.+||+++ ++|+||||+||+++.++.++|+|||.+..
T Consensus 83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 99999999999998753 246799999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc--------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN-------- 234 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~-------- 234 (266)
....... ........++..|+|||++.+..++.++|+||||+++|++++ |..||.+.+............
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd05066 156 LEDDPEA-AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDC 234 (267)
T ss_pred cccccce-eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCC
Confidence 4322111 011111223467999999988889999999999999999886 999997665443333322211
Q ss_pred --CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 235 --KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 235 --~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...+++.+|+..+|..||+.+++.++++..
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 112577899999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=256.51 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=195.9
Q ss_pred HHHhhchhhhhccccccceEEEEEcC------CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecC
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG 79 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 79 (266)
+...++.+...||+|+||.||++... .+..+++|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34556777779999999999998432 244678886543322 22345778999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceE
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQ-----SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAK 154 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~ 154 (266)
..++||||+++++|.+++...... ....++...+..++.|++.|+.|||+++ ++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 999999999999999999764221 1134466788899999999999999999 99999999999999999999
Q ss_pred EeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh
Q 047020 155 LADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~ 233 (266)
|+|||+++....... ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+...........
T Consensus 160 L~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 160 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred ECcCCcccccccccc--ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999875332221 111222345677999999988889999999999999999998 78899765543322222211
Q ss_pred ----------cCchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 234 ----------NKNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 234 ----------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
....+++.+|+..+|..||+..++.+.++..
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1122678899999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=252.77 Aligned_cols=241 Identities=29% Similarity=0.407 Sum_probs=188.6
Q ss_pred hccccccceEEEEEcCC-Cc--EEEEEEeeecc-cccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAELGD-GN--FGAVKRVMEER-GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~-g~--~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++...+ |. .+++|...... ......+.+|++++.++ +||||+++++++...+..+++|||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999996543 33 34666554322 22345788899999999 6999999999999999999999999999
Q ss_pred chhhhhhhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 92 SLFDRMHTYYG-----------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 92 ~L~~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
+|.+++..... .....+++..+..++.|++.|+.|||+.| ++|+||||+||++++++.++|+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 99999876431 11235789999999999999999999999 99999999999999999999999998
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc-----
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----- 234 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----- 234 (266)
+..... .........+..|+|||++....++.++|+||||+++|+|++ |..||.+.+....+.......
T Consensus 159 ~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 233 (270)
T cd05047 159 SRGQEV-----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 233 (270)
T ss_pred ccccch-----hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC
Confidence 752110 111112233567999999988889999999999999999997 999997655443333221110
Q ss_pred -----CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 235 -----KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 235 -----~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...+++.+|+..+|..||+.+++...++..|
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 234 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1125678999999999999999999887765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=250.12 Aligned_cols=236 Identities=25% Similarity=0.350 Sum_probs=189.4
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchhh
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFD 95 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
.||+|++|.||++...++..+++|........ ....+.+|+++++.++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 68999999999998777888898876544322 23467889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcc
Q 047020 96 RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175 (266)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 175 (266)
++... ...+++..+..++.|++.++.++|++| ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 ~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---~~~~ 151 (250)
T cd05085 82 FLRKK----KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---YSSS 151 (250)
T ss_pred HHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc---cccC
Confidence 88652 245789999999999999999999999 9999999999999999999999999986432111 1111
Q ss_pred cccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------Cchhhhhhhc
Q 047020 176 TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------KNVEVWAQML 244 (266)
Q Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~~~l 244 (266)
....++..|+|||++.+..++.++|+||||+++|++++ |..||.+.+............ ...+++.+|+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 22344567999999988888999999999999999998 999997664443322222111 1125678999
Q ss_pred cCCCCCcchHHHHHHHHH
Q 047020 245 DPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 245 ~~~~~~~~~~~~l~~~~~ 262 (266)
..+|..||+.+++.+.+.
T Consensus 232 ~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 232 DYKPENRPKFSELQKELA 249 (250)
T ss_pred ccCcccCCCHHHHHHHhc
Confidence 999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=253.73 Aligned_cols=235 Identities=22% Similarity=0.282 Sum_probs=192.2
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
++++...||.|++|.||++. ..+++.+++|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 45667799999999999994 4568888998775443 233456788999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++.. ..+++..+..++.|++.++.+||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 82 GGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred CCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999998875 37899999999999999999999999 9999999999999999999999999987643321
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh-----------cCch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR-----------NKNV 237 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~-----------~~~~ 237 (266)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||...+........... ....
T Consensus 153 ----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
T cd06609 153 ----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFK 228 (274)
T ss_pred ----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHH
Confidence 1223456788899999998888999999999999999999999999765543332222221 1122
Q ss_pred hhhhhhccCCCCCcchHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~ 258 (266)
+++.+|+..+|..||+.+++.
T Consensus 229 ~~l~~~l~~~p~~Rpt~~~il 249 (274)
T cd06609 229 DFVSLCLNKDPKERPSAKELL 249 (274)
T ss_pred HHHHHHhhCChhhCcCHHHHh
Confidence 566778888888888887764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=251.02 Aligned_cols=237 Identities=21% Similarity=0.286 Sum_probs=190.8
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEe-cCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE-KGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~ 87 (266)
|.+.+.||.|++|.||++. ..+++.+++|++..... .....+.+|++++++++|+|++++++.+.. +...++++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 5677899999999999994 45678889998754332 234567889999999999999999988764 4467899999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++++|.+.+... ....+++.++..++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 82 CEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999988763 2246899999999999999999999999 999999999999999999999999998754221
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC----------ch
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----------NV 237 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~ 237 (266)
. .......+++.|+|||+..+..++.++|+||+|+++|+|++|..||...+............. ..
T Consensus 156 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd08223 156 C----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELG 231 (257)
T ss_pred C----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHH
Confidence 1 122345678899999999888899999999999999999999999987654443333222111 12
Q ss_pred hhhhhhccCCCCCcchHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~ 258 (266)
+++.+|+.++|..||+..++.
T Consensus 232 ~li~~~l~~~p~~Rp~~~~~l 252 (257)
T cd08223 232 ELIATMLSKRPEKRPSVKSIL 252 (257)
T ss_pred HHHHHHhccCcccCCCHHHHh
Confidence 567889999999999877765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=256.90 Aligned_cols=231 Identities=26% Similarity=0.385 Sum_probs=191.6
Q ss_pred hhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchh
Q 047020 16 IRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
.+||+|+||.||.+. ..++..+++|.+..........+.+|+.+++.++|||++++++.+...+..++++||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 389999999999994 4578899999876554455667889999999999999999999999999999999999999998
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCc
Q 047020 95 DRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174 (266)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 174 (266)
+.+.. ..+++..++.++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 107 ~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~----~~ 173 (297)
T cd06659 107 DIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----PK 173 (297)
T ss_pred HHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc----cc
Confidence 87754 56899999999999999999999999 9999999999999999999999999986432211 12
Q ss_pred ccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------------Cchhhhhh
Q 047020 175 QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------------KNVEVWAQ 242 (266)
Q Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------------~~~~~~~~ 242 (266)
.....++..|+|||++.+..++.++|+||+|+++|+|++|..||...+............ ...+.+++
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence 234568889999999988888999999999999999999999997665444333222111 11356788
Q ss_pred hccCCCCCcchHHHHHH
Q 047020 243 MLDPKLNGDANMEQLRV 259 (266)
Q Consensus 243 ~l~~~~~~~~~~~~l~~ 259 (266)
|+..+|..||+.+++..
T Consensus 254 ~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 254 MLTREPQERATAQELLD 270 (297)
T ss_pred HhcCCcccCcCHHHHhh
Confidence 99999999999888765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=253.72 Aligned_cols=240 Identities=23% Similarity=0.327 Sum_probs=191.3
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc------cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
+.....||+|++|.+|++. ..+++.+++|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 3445689999999999994 567888999877543321 245678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-ceEEeccccccC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKL 163 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~~~l~dfg~~~~ 163 (266)
+||+.+++|.+++... +++++..+..++.|++.|+.+||++| ++|+||+|+||+++.++ .++|+|||.+..
T Consensus 82 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 82 VEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999998764 57889999999999999999999999 99999999999998776 589999999876
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHH---HHh-------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE---CRR------- 233 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~---~~~------- 233 (266)
................++..|+|||.+.+..++.++|+||+|+++|+|++|..||............ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc
Confidence 5433222222233456888999999998888899999999999999999999999654432222111 110
Q ss_pred ----cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 ----NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 ----~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..||+..++..
T Consensus 234 ~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 234 EHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11124667899999999998888753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=257.54 Aligned_cols=231 Identities=27% Similarity=0.397 Sum_probs=190.2
Q ss_pred hhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchh
Q 047020 16 IRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
..||+|+||.||++. ..+++.+++|.+..........+.+|+.+++.++||||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 479999999999994 4568899999876554445667889999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCc
Q 047020 95 DRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174 (266)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 174 (266)
+++.. +.+++..+..++.|++.++.|||+++ ++|+||+|+||++++++.++|+|||++...... ...
T Consensus 108 ~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~ 174 (292)
T cd06658 108 DIVTH------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----VPK 174 (292)
T ss_pred HHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccc----ccc
Confidence 88754 46889999999999999999999999 999999999999999999999999998753221 112
Q ss_pred ccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------------Cchhhhhh
Q 047020 175 QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------------KNVEVWAQ 242 (266)
Q Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------------~~~~~~~~ 242 (266)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+............ ...+++.+
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 234567889999999988888999999999999999999999998765544333221110 01145678
Q ss_pred hccCCCCCcchHHHHHH
Q 047020 243 MLDPKLNGDANMEQLRV 259 (266)
Q Consensus 243 ~l~~~~~~~~~~~~l~~ 259 (266)
|+..+|..||+.+++.+
T Consensus 255 ~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 255 MLVREPSQRATAQELLQ 271 (292)
T ss_pred HccCChhHCcCHHHHhh
Confidence 88899999999887764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=269.29 Aligned_cols=199 Identities=23% Similarity=0.298 Sum_probs=166.4
Q ss_pred HHHhhchhhhhccccccceEEEEEc---CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL---GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~---~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
+...++.+...||+|+||.||++.. ..+..+++|.+... ....+|++++++++||||+++++.+......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 4445677777999999999999843 23566777765432 234679999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
+||++. ++|.+++... ..+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++..
T Consensus 164 v~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EehhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 999984 6888888442 67899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS 221 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~ 221 (266)
...... ........||..|+|||++.+..++.++||||+||++|+|++|..||.+.
T Consensus 235 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 235 LDAHPD--TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cCcccc--cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 332211 12223467899999999999889999999999999999999999999654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=258.81 Aligned_cols=197 Identities=26% Similarity=0.341 Sum_probs=167.2
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+++..+||+|+||.||++.. .+|..+++|.+..... .....+.+|++++++++||||+++++.+.+++..+++|||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 45666899999999999954 4677777776654322 234567889999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
+++|.+++... +.+++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-- 152 (308)
T cd06615 83 GGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 152 (308)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccc--
Confidence 99999998764 668999999999999999999997 58 99999999999999999999999998864321
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
.......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 153 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 153 ----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred ----cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 12234568889999999988888999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=260.47 Aligned_cols=254 Identities=26% Similarity=0.339 Sum_probs=197.8
Q ss_pred HHHhhchhhhhccccccceEEEEEc-C-------CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL-G-------DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCL 76 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~-~-------~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 76 (266)
+...++.+.+.||+|+||.||++.. + .+..+++|....... .....+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 3445677778999999999999942 1 122567776654322 2346788999999999 7999999999999
Q ss_pred ecCeEEEEEEecCCCchhhhhhhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcE
Q 047020 77 EKGEQLLLLEYLANKSLFDRMHTYYG-----------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNI 145 (266)
Q Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 145 (266)
..+..++++||+++++|.+++..... .....++...+..++.|++.|+.|||++| ++|+||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence 99999999999999999999876421 12245788889999999999999999999 99999999999
Q ss_pred EEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchh
Q 047020 146 LLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATL 224 (266)
Q Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~ 224 (266)
+++.++.++|+|||+++....... ........++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred EEcCCCcEEECCcccceecccccc--cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999875322111 111122334567999999988889999999999999999998 88999776544
Q ss_pred HHHHHHHHhcC----------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 225 AEWTEECRRNK----------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 225 ~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
........... ..+++.+|+..+|..||+..++...++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 44333222111 114678999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=253.90 Aligned_cols=248 Identities=20% Similarity=0.302 Sum_probs=195.1
Q ss_pred HhhchhhhhccccccceEEEEEcC-CC---cEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAELG-DG---NFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~-~g---~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
...+++...||+|+||.||++... ++ ..+++|...... ......+..|+.+++.++||||+++++++.+....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 345677789999999999999543 33 357888765432 2245678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+++++|.+++... .+.+++..+..++.|++.|+.+||++| ++|+||||+||+++.++.++|+|||.+..
T Consensus 83 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 83 ITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccc
Confidence 99999999999988753 246889999999999999999999999 99999999999999999999999998875
Q ss_pred CCCCCCCCCCcccccc--cCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc------
Q 047020 164 GPFNDPNRPKRQTSIK--GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN------ 234 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~------ 234 (266)
....... ........ .+..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+............
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 234 (269)
T cd05065 156 LEDDTSD-PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPM 234 (269)
T ss_pred cccCccc-cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcc
Confidence 3322111 11111111 2457999999988889999999999999999886 999997665443333222110
Q ss_pred ----CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 235 ----KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 235 ----~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...+++.+++.++|..||+.+++...++.+
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 112467889999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=253.02 Aligned_cols=239 Identities=23% Similarity=0.266 Sum_probs=179.7
Q ss_pred hccccccceEEEEEcCC---CcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLAELGD---GNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~---g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
+||+|+||.||++.... ...+++|........ ....+.+|++.++.++||||+++++.+......++||||+.+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999995433 235566655433222 23567889999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.+++...........++..+..++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~ 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--Y 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh--e
Confidence 999998754333344567888999999999999999999 99999999999999999999999999864322111 1
Q ss_pred CcccccccCCCccCcccccc-------ccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC---------
Q 047020 173 KRQTSIKGSFGYVDTNYLNT-------GFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK--------- 235 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~--------- 235 (266)
.......++..|+|||++.. ..++.++|+||+||++|+|++ |..||.................
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 11133445677999998743 356789999999999999999 7889976655444333322211
Q ss_pred --ch----hhhhhhccCCCCCcchHHHHHHHH
Q 047020 236 --NV----EVWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 236 --~~----~~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
.. +++..+. .+|..||+.++|.+++
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00 1222333 5889999999988876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=252.99 Aligned_cols=247 Identities=21% Similarity=0.270 Sum_probs=195.1
Q ss_pred HHHhhchhhhhccccccceEEEEEcCC----CcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELGD----GNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~~----g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
+...++.+...||+|++|.||++...+ ...+++|...... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 344566777799999999999995422 2357777765544 2345678899999999999999999998875 457
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
+++|||+++++|.+++... ...+++..+..++.|++.|+.+||+.+ ++|+||||+||+++..+.++|+|||++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 82 WIVMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred EEEEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCcee
Confidence 8999999999999998753 135799999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN------ 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~------ 234 (266)
........ .......++..|+|||.+....++.++|+||||+++|++++ |..||.+.+............
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (270)
T cd05056 155 RYLEDESY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP 231 (270)
T ss_pred eecccccc---eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 75432211 11122234567999999988889999999999999999986 999998776554443332211
Q ss_pred ----CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 235 ----KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 235 ----~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...+++.+|+.++|..||+..++...++..
T Consensus 232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112567899999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=254.64 Aligned_cols=240 Identities=23% Similarity=0.267 Sum_probs=194.6
Q ss_pred HHHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
|....+++.+.||+|++|.||++.. .+|..+++|...... ......+.+|+++++.++||||+++++.+......++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 4556778888999999999999954 457788888765433 23356788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
|||+++++|.+++... +.+++..+..++.+++.++.|||+ .+ ++|+||+|+||++++++.++|+|||++..
T Consensus 82 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 82 MEFMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred EecCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 9999999999988663 568999999999999999999997 57 99999999999999999999999998764
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh-----------HHHHHHHH
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL-----------AEWTEECR 232 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~-----------~~~~~~~~ 232 (266)
... .......++..|+|||++.+..++.++|+||+||++|+|++|..||...... ........
T Consensus 154 ~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd06620 154 LIN------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227 (284)
T ss_pred hhh------hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh
Confidence 211 1123456889999999998888899999999999999999999999764431 11111111
Q ss_pred h-----------cCchhhhhhhccCCCCCcchHHHHHHH
Q 047020 233 R-----------NKNVEVWAQMLDPKLNGDANMEQLRVL 260 (266)
Q Consensus 233 ~-----------~~~~~~~~~~l~~~~~~~~~~~~l~~~ 260 (266)
. ....+++.+|+..+|..||+++++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1 011256788999999999999988763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=253.08 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=193.4
Q ss_pred HHHhhchhhhhccccccceEEEEE-cCCCc----EEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCe
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAE-LGDGN----FGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~-~~~g~----~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 80 (266)
+.....++...||+|+||.||++. ..+|. .+++|....... .....+.+|+.+++.++||||+++++++... .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 344556667799999999999995 34454 367777654333 2345678899999999999999999988654 5
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.+++++|+++|+|.+++... .+.+++..+..++.|++.|+.|||+++ ++|+||||+||++++++.++|+|||+
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCc
Confidence 78999999999999998752 246899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK---- 235 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~---- 235 (266)
+........ ........++..|+|||...+..++.++|+|||||++|+|++ |..||......... .......
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~ 232 (279)
T cd05109 156 ARLLDIDET--EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQ 232 (279)
T ss_pred eeecccccc--eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCC
Confidence 875432211 111222345678999999988889999999999999999998 89999764432222 2222111
Q ss_pred -------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 -------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 -------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++...++.+.
T Consensus 233 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 233 PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 115778999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=254.35 Aligned_cols=253 Identities=21% Similarity=0.211 Sum_probs=198.1
Q ss_pred HHHhhchhhhhccccccceEEEEEcCC-----CcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEe-cC
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELGD-----GNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE-KG 79 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~~-----g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 79 (266)
|...++.+...||+|+||.||.+.... +..+++|++..... .....+.+|+.+++.++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 445667777899999999999996544 67778877654322 235667889999999999999999998765 46
Q ss_pred eEEEEEEecCCCchhhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEe
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQ---SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLA 156 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~ 156 (266)
..+++++|+++++|.+++...... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998664211 1246899999999999999999999999 9999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc-
Q 047020 157 DFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN- 234 (266)
Q Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~- 234 (266)
|||+++.+..... ........++..|+|||++.+..++.++||||||+++|++++ |..||.+.+............
T Consensus 160 d~g~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 237 (280)
T cd05043 160 DNALSRDLFPMDY--HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237 (280)
T ss_pred CCCCcccccCCce--EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC
Confidence 9999875322211 111123345677999999988889999999999999999998 999997665433322211111
Q ss_pred ---------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 235 ---------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 235 ---------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...+++.+|+..+|..||+..++...++..
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 122577889999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=255.35 Aligned_cols=227 Identities=24% Similarity=0.368 Sum_probs=185.6
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.|.+...||+|++|.||++. ...++.+++|.+.... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 45667789999999999994 4568889998775432 1234667889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... +.+++..+..++.|++.+|.+||+.| ++|+||+|.||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 82 YVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred cCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999998764 67899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------h
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------V 237 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~ 237 (266)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.............. .
T Consensus 154 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 226 (290)
T cd05580 154 R-------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAK 226 (290)
T ss_pred C-------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHH
Confidence 1 23446788999999998888889999999999999999999999876644444333321111 1
Q ss_pred hhhhhhccCCCCCcc
Q 047020 238 EVWAQMLDPKLNGDA 252 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~ 252 (266)
+++.+|+..+|..|+
T Consensus 227 ~li~~~l~~~p~~R~ 241 (290)
T cd05580 227 DLIRNLLQVDLTKRL 241 (290)
T ss_pred HHHHHHccCCHHHcc
Confidence 455666666666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=259.71 Aligned_cols=203 Identities=22% Similarity=0.247 Sum_probs=164.2
Q ss_pred hhhhcccc--ccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 14 FRIRIGVG--ATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 14 ~~~~ig~g--~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+...||+| +|+.||++ ...+|+.+++|++..... .....+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 67889999 556789999998765432 23456778999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999986531 245889999999999999999999999 9999999999999999999999998654321111
Q ss_pred CCC---CCcccccccCCCccCcccccc--ccCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 169 PNR---PKRQTSIKGSFGYVDTNYLNT--GFVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 169 ~~~---~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
... ........++..|+|||++.+ ..++.++|+||+||++|+|++|..||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 100 011122346677999999875 458899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=271.18 Aligned_cols=234 Identities=26% Similarity=0.356 Sum_probs=185.6
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeec--ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCch
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEE--RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
..||+|.||+||++.+. +.||||.+.-. .+...+.|++|+.++++-+|.||+-+.+++..... .+|+.+++|.+|
T Consensus 398 ~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSL 474 (678)
T KOG0193|consen 398 ERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSL 474 (678)
T ss_pred ceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchh
Confidence 48999999999999773 46788876443 33356789999999999999999999999988876 899999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCC
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 173 (266)
+.++... ..+|.......|+.|++.|+.|||.++ |+|+|||..|||+.++++|||+|||+++..... ....
T Consensus 475 Y~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w--~g~~ 545 (678)
T KOG0193|consen 475 YTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW--SGEQ 545 (678)
T ss_pred hhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee--cccc
Confidence 9988753 267888999999999999999999999 999999999999999999999999999863332 2334
Q ss_pred cccccccCCCccCcccccc---ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc--------------Cc
Q 047020 174 RQTSIKGSFGYVDTNYLNT---GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN--------------KN 236 (266)
Q Consensus 174 ~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~--------------~~ 236 (266)
......|...|||||+++. .++++.+||||||+++|||++|..||...+............ ..
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~m 625 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAM 625 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHH
Confidence 4556778889999999854 478999999999999999999999998554444322221110 11
Q ss_pred hhhhhhhccCCCCCcchHHHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
.+++..|+..++..||...+|...|
T Consensus 626 k~Ll~~C~~~~~~eRP~F~~il~~l 650 (678)
T KOG0193|consen 626 KRLLSDCWKFDREERPLFPQLLSKL 650 (678)
T ss_pred HHHHHHHHhcCcccCccHHHHHHHH
Confidence 1345566666666666666665533
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=250.34 Aligned_cols=243 Identities=28% Similarity=0.357 Sum_probs=187.0
Q ss_pred hccccccceEEEEEcC----CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEE-ecCeEEEEEEecCC
Q 047020 17 RIGVGATSFVYLAELG----DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCL-EKGEQLLLLEYLAN 90 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~~ 90 (266)
.||+|+||.||++... .+..+++|....... .....+.+|+.+++.++||||+++++++. .++..++++||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5899999999999532 234678887643322 23567788999999999999999999765 45568899999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
++|.+++... ....+...+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 82 GDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999998652 134567778889999999999999999 999999999999999999999999998754322111
Q ss_pred CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhC-CCCcCCCchhHHHHHHHHh----------cCchhh
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG-LKSIQGSATLAEWTEECRR----------NKNVEV 239 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g-~~pf~~~~~~~~~~~~~~~----------~~~~~~ 239 (266)
.........++..|+|||.+.+..++.++||||||+++|+|++| ..||...+........... ....++
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 11112234456789999999888899999999999999999995 6667655443333222211 112257
Q ss_pred hhhhccCCCCCcchHHHHHHHHHHHhC
Q 047020 240 WAQMLDPKLNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 240 ~~~~l~~~~~~~~~~~~l~~~~~~~~~ 266 (266)
+.+|+.++|..||+..++...++..++
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 789999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=251.09 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=198.7
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
+...+|.+.||+|.||.|.++ ...+|+..++|.+++..-- +...-..|-.+|+..+||++..+-..|+.++.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 345577789999999999999 5567999999987664432 334455688999999999999998899999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||..||.|.-.+... ..+++...+.+..+|++||.|||+++ |++||+|.+|.+++.+|++||.|||+|..
T Consensus 247 MeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE- 317 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKE- 317 (516)
T ss_pred EEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchh-
Confidence 9999999998777653 67999999999999999999999999 99999999999999999999999999984
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh----cCc----
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR----NKN---- 236 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~----~~~---- 236 (266)
.......+.+..||+.|+|||++....|+.++|+|.+|+++|+|++|+.||...+....+.-++-. +..
T Consensus 318 ---~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~e 394 (516)
T KOG0690|consen 318 ---EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPE 394 (516)
T ss_pred ---cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHH
Confidence 222234567889999999999999999999999999999999999999999877665555444332 111
Q ss_pred -hhhhhhhccCCCCCc--chHHHHHHHHH
Q 047020 237 -VEVWAQMLDPKLNGD--ANMEQLRVLIR 262 (266)
Q Consensus 237 -~~~~~~~l~~~~~~~--~~~~~l~~~~~ 262 (266)
..++...+..+|..| ..+++.+++++
T Consensus 395 AktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 395 AKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 145667777777766 45566666554
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=251.96 Aligned_cols=244 Identities=21% Similarity=0.272 Sum_probs=187.5
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcE----EEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNF----GAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~----~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
..+++...||+|+||.||++.. .+|.. +++|....... .....+..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 3455566899999999999954 34443 55555533221 123456778888899999999999998754 45788
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
++||+++++|.+++... .+.+++..+..++.|++.|+.|||+++ ++|+||||+||++++++.++|+|||.+..
T Consensus 86 i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 99999999999998652 246899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK------- 235 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~------- 235 (266)
...... ........++..|+|||++.+..++.++|+||||+++|++++ |..||.+...... ........
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (279)
T cd05111 159 LYPDDK--KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQI 235 (279)
T ss_pred ccCCCc--ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCC
Confidence 432211 112233456678999999988889999999999999999998 9999976543221 12222111
Q ss_pred ----chhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
..+++.+|+..+|..||+.+++.+.+...
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11356789999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=257.63 Aligned_cols=247 Identities=20% Similarity=0.257 Sum_probs=194.5
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
++.+.+.||+|+||.||++. ..+++.+++|.+..... .....+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 35566789999999999994 45678899997754321 234567789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|++|++|.+++... +.+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 82 YVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999998764 56899999999999999999999999 99999999999999999999999998763211
Q ss_pred CCCC-----------CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-
Q 047020 167 NDPN-----------RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN- 234 (266)
Q Consensus 167 ~~~~-----------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~- 234 (266)
.... .........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+..............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~ 233 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 233 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 1000 0011122457888999999988889999999999999999999999998765443333332211
Q ss_pred -----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 235 -----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 235 -----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...+++.+|+..+|..||+...+.++++..|
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 0125677888888888888766666666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=248.91 Aligned_cols=237 Identities=24% Similarity=0.343 Sum_probs=191.2
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchhh
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFD 95 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
+||.|++|.||++....++.+++|........ ....+.+|++++++++||||+++++++.+....+++|||+.+++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 68999999999997666899999987654443 45678899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcc
Q 047020 96 RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175 (266)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 175 (266)
++... ...++...+..++.+++.++.+||+++ ++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 82 ~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~ 152 (251)
T cd05041 82 FLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--TVSD 152 (251)
T ss_pred HHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc--eecc
Confidence 88652 245788999999999999999999999 99999999999999999999999999875321111 1111
Q ss_pred cccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh----------cCchhhhhhhc
Q 047020 176 TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR----------NKNVEVWAQML 244 (266)
Q Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~----------~~~~~~~~~~l 244 (266)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+............. ....+++.+|+
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 232 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCW 232 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHh
Confidence 22334567999999988889999999999999999998 88999765433322222111 11125678999
Q ss_pred cCCCCCcchHHHHHHHHH
Q 047020 245 DPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 245 ~~~~~~~~~~~~l~~~~~ 262 (266)
..+|..||+.+++.+.++
T Consensus 233 ~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 233 AYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccChhhCcCHHHHHHHhh
Confidence 999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=259.87 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=195.0
Q ss_pred HhhchhhhhccccccceEEEEE------cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEec-C
Q 047020 9 MATNDFRIRIGVGATSFVYLAE------LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEK-G 79 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~------~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~ 79 (266)
..++++.+.||+|+||.||++. ..+++.++||.+..... .....+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 4567788899999999999994 23567899998765332 2345678899999999 589999999987654 4
Q ss_pred eEEEEEEecCCCchhhhhhhhcCC--------------------------------------------------------
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQ-------------------------------------------------------- 103 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~-------------------------------------------------------- 103 (266)
..+++|||+++++|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998753210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccc
Q 047020 104 ------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177 (266)
Q Consensus 104 ------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 177 (266)
....+++..+..++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~ 240 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGD 240 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc--hhhcCC
Confidence 0124677888899999999999999999 99999999999999999999999999875322111 112223
Q ss_pred cccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc-----------Cchhhhhhhcc
Q 047020 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN-----------KNVEVWAQMLD 245 (266)
Q Consensus 178 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~ 245 (266)
..++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.............. ...+++.+|+.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 345677999999988889999999999999999997 999997654333332222211 11245678999
Q ss_pred CCCCCcchHHHHHHHHHHHh
Q 047020 246 PKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 246 ~~~~~~~~~~~l~~~~~~~~ 265 (266)
++|..||+..+|.+.++.++
T Consensus 321 ~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 321 GEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CChhhCcCHHHHHHHHHHHH
Confidence 99999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=254.91 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=191.9
Q ss_pred hhchhhhhccccccceEEEEEcC-----------------CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCcccc
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG-----------------DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGL 71 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~-----------------~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~ 71 (266)
.++.+..+||+|+||.||++... ++..+++|....... .....+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 45677779999999999997421 233567777654322 234678899999999999999999
Q ss_pred ceeEEecCeEEEEEEecCCCchhhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcE
Q 047020 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQS------LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNI 145 (266)
Q Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 145 (266)
++++...+..+++|||+.+++|.+++....... ...+++..+..++.|++.|+.+||+.| ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999987643211 134678889999999999999999999 99999999999
Q ss_pred EEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh--CCCCcCCCch
Q 047020 146 LLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT--GLKSIQGSAT 223 (266)
Q Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~--g~~pf~~~~~ 223 (266)
+++.++.++|+|||++........ ........++..|++||...+..++.++|+|||||++|+|++ |..||...+.
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc--eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999875322211 111223344678999998888889999999999999999998 7789865543
Q ss_pred hHHHHHHHH------------h-----cCchhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 224 LAEWTEECR------------R-----NKNVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 224 ~~~~~~~~~------------~-----~~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
......... . ....+++.+|+..+|..||+.+++.+.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 332221110 0 01125778999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=256.47 Aligned_cols=250 Identities=24% Similarity=0.291 Sum_probs=195.9
Q ss_pred HhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
...+++...||+|+||.||++.. .+++.+++|.+..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 34566667999999999999954 2567888887764432 2345688899999999999999999999998899
Q ss_pred EEEEEecCCCchhhhhhhhcC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCc
Q 047020 82 LLLLEYLANKSLFDRMHTYYG-----------------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSN 144 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~n 144 (266)
++++||+++++|.+++..... .....+++..++.++.|++.|+.+||+++ ++|+||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999875321 11235788889999999999999999999 9999999999
Q ss_pred EEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCch
Q 047020 145 ILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSAT 223 (266)
Q Consensus 145 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~ 223 (266)
|++++++.++|+|||.+........ .........+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY--YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred eEecCCCceEECccccceecccCcc--ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999998864322111 111122234567999999988889999999999999999997 8889976554
Q ss_pred hHHHHHHHHh----------cCchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 224 LAEWTEECRR----------NKNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 224 ~~~~~~~~~~----------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
.......... ....+++.+|+..+|..||+.+++.+.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 4333222211 112267889999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=261.32 Aligned_cols=205 Identities=25% Similarity=0.307 Sum_probs=176.5
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||+|+||.|+-+ .-.+|+..+.|++.++ +........+|-.+|++++.++||.+-..|++.+.+++|+..|.||+
T Consensus 192 vlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGD 271 (591)
T KOG0986|consen 192 VLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGD 271 (591)
T ss_pred EEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCc
Confidence 7999999999988 4567888888876432 22334556789999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.-.|.+. ....+++..+..++.+|+.||.+||+.+ |++||+||+||++|+.|+++|+|+|+|..++..+
T Consensus 272 LkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~---- 341 (591)
T KOG0986|consen 272 LKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK---- 341 (591)
T ss_pred eeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCC----
Confidence 98888764 2258999999999999999999999999 9999999999999999999999999998654433
Q ss_pred CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
......||.+|||||++.++.|+...|+||+||++|+|+.|+.||...-+...+...-+
T Consensus 342 -~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr 400 (591)
T KOG0986|consen 342 -PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR 400 (591)
T ss_pred -ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH
Confidence 33445899999999999999999999999999999999999999987666555544333
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=252.98 Aligned_cols=204 Identities=25% Similarity=0.349 Sum_probs=169.1
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+|++...||+|++|.||++.. .+|+.+++|....... ...+.+.+|++++++++|||++++++.+......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 466777999999999999954 4688999998754332 2345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
++++++....... ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 82 CDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred cCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9887777665432 46899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHH
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAE 226 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~ 226 (266)
.. ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+.
T Consensus 154 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~ 209 (286)
T cd07847 154 GD----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ 209 (286)
T ss_pred cc----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 11 1223456788999999865 4578899999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=271.51 Aligned_cols=198 Identities=21% Similarity=0.259 Sum_probs=159.4
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCC------CCccccceeEEec-CeEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH------PNLVGLLGFCLEK-GEQL 82 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~-~~~~ 82 (266)
+|.+...||+|+||.||++. ...++.++||.+.... ........|+++++.++| ++++++++++... ...+
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 34455589999999999994 4568889999875432 223445667777777654 4588888887654 4788
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCC----------
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDN---------- 151 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~---------- 151 (266)
+||+++ +++|.+++... +.+++..+..++.|++.||.|||+ .| |+||||||+||+++..+
T Consensus 209 iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccc
Confidence 999987 77898888764 678999999999999999999997 58 99999999999998765
Q ss_pred ------ceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH
Q 047020 152 ------HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA 225 (266)
Q Consensus 152 ------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~ 225 (266)
.+||+|||.+... ........||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 280 ~~~~~~~vkl~DfG~~~~~-------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE-------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cCCCCceEEECCCCccccC-------ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4899999987531 122335678999999999999999999999999999999999999998766544
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=252.73 Aligned_cols=236 Identities=24% Similarity=0.342 Sum_probs=190.0
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
|.+...||.|++|.+|++. ..+|..+++|++.... ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 5566789999999999995 4568899999876543 223467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
+++|.+++... ...+++..++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 -~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 82 -PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred -CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 99999988653 156899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh--------------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR-------------- 233 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~-------------- 233 (266)
. .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+....+......
T Consensus 154 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 P---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred C---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 1 122345688899999998654 4688999999999999999999888776654444332221
Q ss_pred -------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 -------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 -------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+..+|..||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l 280 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL 280 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHh
Confidence 1112567788888888888877664
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=254.05 Aligned_cols=230 Identities=23% Similarity=0.275 Sum_probs=184.6
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+++.+.||+|++|.||++ ...+++.+++|.+..... .....+.+|++++++++||||+++++.+......+++|||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 456678999999999999 456788899998754432 234568899999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|..+ ..+++..+..++.|++.|+.|||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~--- 147 (279)
T cd06619 83 GGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN--- 147 (279)
T ss_pred CCChHHh---------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc---
Confidence 9988543 34688899999999999999999999 99999999999999999999999999874321
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh------HHH-HHHHHh---------
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL------AEW-TEECRR--------- 233 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~------~~~-~~~~~~--------- 233 (266)
.......++..|+|||++.+..++.++|+||+|+++|+|++|..||...... ... ......
T Consensus 148 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (279)
T cd06619 148 ---SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224 (279)
T ss_pred ---ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCc
Confidence 1223457888999999998888999999999999999999999999542211 011 111100
Q ss_pred --cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 --NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 --~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..||+.+++..
T Consensus 225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 225 FSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 01125677889999999998887654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=248.77 Aligned_cols=241 Identities=24% Similarity=0.380 Sum_probs=194.2
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
..+.+...||+|++|.||++....+..+++|.+... ......+.+|++++++++||+++++++++......++++||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 356677799999999999997766788888876533 2335678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++... .+.+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999988652 245789999999999999999999999 99999999999999999999999998874322111
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh----------cCchh
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR----------NKNVE 238 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~----------~~~~~ 238 (266)
.......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+........... ....+
T Consensus 156 ---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05112 156 ---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYE 232 (256)
T ss_pred ---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 11122334568999999988889999999999999999998 99999766544433332211 11125
Q ss_pred hhhhhccCCCCCcchHHHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
++.+|+..+|..||+.+++.+.+
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHhh
Confidence 77899999999999999887765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=248.56 Aligned_cols=239 Identities=25% Similarity=0.338 Sum_probs=191.2
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
|.....||+|++|.+|++. ..++..+++|........ ....+..|+++++.++|+||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 5566789999999999995 456888888887654432 4667889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++... ..+++..+..++.|++.++.+||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 82 SGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999988753 45788999999999999999999999 9999999999999999999999999988654333
Q ss_pred CCCCCcccccccCCCccCcccccccc---CCCcccchhHHHHHHHHHhCCCCcCCCchhHHH-HHHHHh-----------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGF---VSTKSDVYSFGVLLLELITGLKSIQGSATLAEW-TEECRR----------- 233 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~-~~~~~~----------- 233 (266)
...........++..|+|||++.+.. .+.++|+||||+++|++++|..||...+..... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL 233 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccccc
Confidence 22111122356788999999987765 788999999999999999999999754322221 111111
Q ss_pred -cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 -NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 -~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+..+|..||+.+++.
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 234 SPEGKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1112567888888999998887764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=250.98 Aligned_cols=236 Identities=22% Similarity=0.280 Sum_probs=191.1
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+.....||.|+||.+|.+.. .+++.+++|...... ......+.+|+.+++.++||||+++++.+.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 345556899999999999954 567888888765432 234567888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++.. +++++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 85 GGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999998865 46888999999999999999999999 9999999999999999999999999987532211
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh----------cCchh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR----------NKNVE 238 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~ 238 (266)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||.+.+........... ....+
T Consensus 156 ----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06640 156 ----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKE 231 (277)
T ss_pred ----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHH
Confidence 1223346788899999998888899999999999999999999999765443322221111 11225
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
++.+|+..+|..||+.+++..
T Consensus 232 li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 232 FIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred HHHHHcccCcccCcCHHHHHh
Confidence 678899999999998888743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=251.26 Aligned_cols=236 Identities=23% Similarity=0.284 Sum_probs=190.8
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+.....||+|++|.||++. ..++..+++|...... ......+.+|+++++.++||||+++++.+..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 34455689999999999994 4567788888765332 234567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++.. ..+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~- 154 (277)
T cd06642 85 GGGSALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT- 154 (277)
T ss_pred CCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc-
Confidence 99999988764 56889999999999999999999999 999999999999999999999999998753321
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh----------cCchh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR----------NKNVE 238 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~ 238 (266)
........++..|+|||++.+..++.++|+||||+++|+|++|..||............... ....+
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06642 155 ---QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKE 231 (277)
T ss_pred ---chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHH
Confidence 11223346788899999998888899999999999999999999999654332222111111 11235
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
++.+|+..+|..||+..++..
T Consensus 232 li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 232 FVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 678899999999999988876
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=250.83 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=192.0
Q ss_pred hhchhhhhccccccceEEEEE-----cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEec--CeE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-----LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQ 81 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-----~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 81 (266)
.++.....||+|+||.||++. ..++..+++|.+..... .....+.+|+++++.++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 445666689999999999985 34577889998754432 2346788999999999999999999988765 568
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+++++|.+++... ...+++..+..++.|++.|+.+||++| ++|+||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccc
Confidence 9999999999999988652 135799999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC--------------chhHHH
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS--------------ATLAEW 227 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~--------------~~~~~~ 227 (266)
......... ........++..|+|||+..+..++.++|+||||+++|+|+++..|+... ......
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 157 KAIETDKEY-YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccccCccc-eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 754322211 11122345677899999998888999999999999999999977654221 111111
Q ss_pred HHHHHh-----------cCchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 228 TEECRR-----------NKNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 228 ~~~~~~-----------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...... ....+++.+|+..+|..||+.+++.+.++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111 1122678899999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=254.73 Aligned_cols=247 Identities=25% Similarity=0.345 Sum_probs=191.2
Q ss_pred hhchhhhhccccccceEEEEEc-----CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEe--cCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-----GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE--KGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-----~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 82 (266)
..+.+...||+|+||.||.+.. .++..+++|++..........+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 3456667899999999999853 4578899998765554456678899999999999999999987643 34689
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+|+||+++++|.+++... ...+++..+..++.|++.||.|||++| ++|+||||+||++++++.++|+|||++.
T Consensus 84 lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 999999999999998652 245889999999999999999999999 9999999999999999999999999988
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH---------------HH
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA---------------EW 227 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~---------------~~ 227 (266)
......... .......++..|+|||+..+..++.++|+||||+++|+|++|..|+....... ..
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 157 VLPQDKEYY-KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cccCCCcce-eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 643322110 01111223446999999988889999999999999999999877764322110 00
Q ss_pred HHHHHh-----------cCchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 228 TEECRR-----------NKNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 228 ~~~~~~-----------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...... ....+++.+|+.++|..||+.+++.+.++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111 1123577899999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=247.30 Aligned_cols=238 Identities=30% Similarity=0.420 Sum_probs=191.0
Q ss_pred hhhhccccccceEEEEEcCC-----CcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 14 FRIRIGVGATSFVYLAELGD-----GNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 14 ~~~~ig~g~~~~v~~~~~~~-----g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+...||.|+||.||++.... +..+++|........ ....+.+|+++++.++|+||+++++++.+.+..+++||+
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 55689999999999995433 377888887554333 567888999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++++|.+++.... ...+++..+..++.|++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 83 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 83 MEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred cCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999987631 112899999999999999999999999 999999999999999999999999998764332
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------c
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------N 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~ 236 (266)
... ......++..|+|||...+..++.++|+||+|+++|+|++ |..||...+............. .
T Consensus 157 ~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T smart00219 157 DYY---KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEI 233 (258)
T ss_pred ccc---ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHH
Confidence 111 1112336788999999988889999999999999999998 7888876544443333222111 1
Q ss_pred hhhhhhhccCCCCCcchHHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVL 260 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~ 260 (266)
.+++.+|+..+|..||+..++.+.
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHhh
Confidence 246778999999999999888764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=247.97 Aligned_cols=238 Identities=22% Similarity=0.289 Sum_probs=193.1
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
|.+...||+|+||.+|.+ ...+|+.+++|.+.... ......+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 556679999999999999 44567888999875432 233457889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+.+... ....+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~- 154 (256)
T cd08218 82 EGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST- 154 (256)
T ss_pred CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc-
Confidence 999999988753 2235788999999999999999999999 999999999999999999999999988753221
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC----------chh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----------NVE 238 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~~ 238 (266)
........++..|+|||+..+..++.++|+||||+++|+|++|..||...+............. ..+
T Consensus 155 ---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd08218 155 ---VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRN 231 (256)
T ss_pred ---hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHH
Confidence 1112234578889999999888889999999999999999999999987665555444433221 125
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
++.+|+..+|..||+..++.+
T Consensus 232 li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 232 LVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHhhCChhhCcCHHHHhh
Confidence 677888888999988877653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=248.80 Aligned_cols=244 Identities=28% Similarity=0.357 Sum_probs=195.4
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
++++...||.|++|.||++. ..++..+++|...... ......+.+|++.++.++|+|++++++.+......++++|++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 45667789999999999995 4567788888765432 234567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+++..... ...+++..+..++.|++.|+.+||+.| ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 82 SGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred CCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999876321 256899999999999999999999999 9999999999999999999999999987654433
Q ss_pred CCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC------------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------------ 235 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 235 (266)
...........++..|+|||++... .++.++|+||+|+++|+|++|..||...+......+.....+
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence 2211223445688899999998766 788999999999999999999999977655444443333211
Q ss_pred ---chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ---NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ---~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++..
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 125677888888888888777653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=247.97 Aligned_cols=234 Identities=27% Similarity=0.308 Sum_probs=190.0
Q ss_pred chhhhhccccccceEEEEEcC-CCcEEEEEEeeeccc-----ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 12 NDFRIRIGVGATSFVYLAELG-DGNFGAVKRVMEERG-----GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
+.....||+|++|.||++... +++.+++|....... .....+.+|+++++.++||||+++++++......++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 455568999999999999554 788999997754332 13456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+++++|.+++... +.+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 82 ELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999998763 56889999999999999999999999 9999999999999999999999999887532
Q ss_pred CCCCCCCCcccccccCCCccCcccccccc-CCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGF-VSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--------- 235 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 235 (266)
... ......++..|++||.+.... ++.++|+||+|+++|+|++|..||.................
T Consensus 154 ~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (258)
T cd06632 154 EFS-----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS 228 (258)
T ss_pred ccc-----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcC
Confidence 211 223456788899999987766 88999999999999999999999976654444433332110
Q ss_pred --chhhhhhhccCCCCCcchHHHHH
Q 047020 236 --NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 --~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++.+|+..+|..||+.+++.
T Consensus 229 ~~~~~li~~~l~~~p~~Rp~~~~~l 253 (258)
T cd06632 229 DEAKDFILKCLQRDPSLRPTAAELL 253 (258)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHh
Confidence 11456788888888888877764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=247.65 Aligned_cols=197 Identities=26% Similarity=0.408 Sum_probs=172.9
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecCCCchh
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
.||+|+++.|-.+ .+.+|..++||.+.+...-.+.+..+|++++.+.+ |+||+.++++|++++.+|+|||-+.||+|.
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplL 164 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLL 164 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHH
Confidence 7999999999988 78899999999887776667889999999999997 999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc---eEEeccccccCCCCCCCCC
Q 047020 95 DRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH---AKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---~~l~dfg~~~~~~~~~~~~ 171 (266)
..|.+. ..|++.++.++..+|++||.|||.+| |.|||+||+||+-.+.+. +||+||++..-+..+..-.
T Consensus 165 shI~~~-----~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 165 SHIQKR-----KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHh-----hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999875 78999999999999999999999999 999999999999876554 7999999887654443221
Q ss_pred ---CCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhCCCCcCCC
Q 047020 172 ---PKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITGLKSIQGS 221 (266)
Q Consensus 172 ---~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g~~pf~~~ 221 (266)
.....++.|+..|||||++. ...|+.++|.||||+++|-|++|+.||.|.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 23345678999999999873 235788999999999999999999999664
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=251.04 Aligned_cols=238 Identities=21% Similarity=0.270 Sum_probs=188.5
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
++++...||+|+||.||++.. .+|..+++|.+..... .....+.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 467778999999999999954 4788999997765422 23457889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
++++|.+++... .....+++..+..++.|++.++.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~- 155 (286)
T cd06622 82 DAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA- 155 (286)
T ss_pred CCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC-
Confidence 999998887652 122478999999999999999999996 58 99999999999999999999999998864321
Q ss_pred CCCCCCcccccccCCCccCccccccc------cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHH---HHHHHhcC---
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTG------FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW---TEECRRNK--- 235 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~---~~~~~~~~--- 235 (266)
.......++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+..... ........
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 156 -----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred -----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 122334577889999998544 3478999999999999999999999654332221 11111111
Q ss_pred -------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 -------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 -------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++..
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 124678899999999999887764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=251.16 Aligned_cols=248 Identities=21% Similarity=0.263 Sum_probs=194.3
Q ss_pred HhhchhhhhccccccceEEEEEcC------CCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 9 MATNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
...+.....||.|+||.||++... ..+.+++|........ ....+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 345556668999999999999642 3456777766543332 356788999999999999999999999998999
Q ss_pred EEEEEecCCCchhhhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEec
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQS----LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLAD 157 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~d 157 (266)
++||||+++++|.+++....... ...+++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999987653211 126899999999999999999999999 99999999999999999999999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc--
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN-- 234 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~-- 234 (266)
||++...... .........++..|+|||.+.+..++.++|+||||+++|++++ |..||.+......+.......
T Consensus 161 ~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd05046 161 LSLSKDVYNS---EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE 237 (275)
T ss_pred cccccccCcc---cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC
Confidence 9987642111 1122233456778999999888888899999999999999998 788996654433333222111
Q ss_pred ---------CchhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 235 ---------KNVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 235 ---------~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
...+++.+|+..+|..||+.+++...++
T Consensus 238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1125678999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=248.52 Aligned_cols=238 Identities=22% Similarity=0.266 Sum_probs=184.1
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-----ccHHHHHHHHHHHhcCCCCCccccceeEEec--CeEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-----GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQL 82 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 82 (266)
.+.....||+|+||.||.+. ..+|..+++|.+..... .....+.+|+++++.++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 34556689999999999994 45688999998753221 1235678899999999999999999987653 4678
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
++|||+++++|.+++... ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 83 ~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 999999999999988763 45788999999999999999999999 9999999999999999999999999887
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------- 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 235 (266)
........ ........++..|+|||++.+..++.++|+||||+++|+|++|..||.+.+.............
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06652 155 RLQTICLS-GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233 (265)
T ss_pred cccccccc-ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchh
Confidence 53221110 1122334588899999999888889999999999999999999999977655544433322111
Q ss_pred ----chhhhhhhccCCCCCcchHHHHH
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+.+++|+ .++..||+.+++.
T Consensus 234 ~~~~~~~~i~~~l-~~p~~Rp~~~~il 259 (265)
T cd06652 234 VSDHCRDFLKRIF-VEAKLRPSADELL 259 (265)
T ss_pred hCHHHHHHHHHHh-cChhhCCCHHHHh
Confidence 113445555 3677788776654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=247.97 Aligned_cols=240 Identities=23% Similarity=0.253 Sum_probs=180.2
Q ss_pred hccccccceEEEEEcC---CCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLAELG---DGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~---~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||+|+||.||++... ++..+++|++...... ....+.+|+.+++.++||||+++++.+.+....++||||+++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999543 3346778876544332 33467889999999999999999999999889999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.+++...........++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--~ 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--Y 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce--e
Confidence 999987643323345677788899999999999999999 99999999999999999999999999874322111 1
Q ss_pred CcccccccCCCccCccccccc-------cCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc------C---
Q 047020 173 KRQTSIKGSFGYVDTNYLNTG-------FVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN------K--- 235 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~~-------~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~------~--- 235 (266)
.......++..|+|||++.+. .++.++|+||||+++|+|++ |..||................ +
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence 112234567889999998542 35789999999999999996 999997654433322221110 0
Q ss_pred --c----hhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 236 --N----VEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 236 --~----~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
. .+++..|. .+|..||+.++|...++
T Consensus 237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0 02344454 56888888888877653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=253.09 Aligned_cols=236 Identities=25% Similarity=0.331 Sum_probs=187.7
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc-----cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG-----SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
+++...||+|++|.||++. ..+|+.+++|++...... ....+.+|+++++.++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 4556689999999999995 457889999988654322 2345678999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+ +++|.+++... ...+++..+..++.|++.||.+||+.| ++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 82 EFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred ccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 999 88999998753 136899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc----------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN---------- 234 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 234 (266)
... .......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+......+.....
T Consensus 154 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPN----RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCC----ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 211 11223355778999998854 467889999999999999999988887766555443332210
Q ss_pred ---------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ---------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ---------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+.++|..||+..++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 1113567788888888888777654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=245.54 Aligned_cols=237 Identities=23% Similarity=0.313 Sum_probs=192.5
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
|+....||+|++|.+|++ ...+++.+++|.+.... ......+.+|+++++.++|||++++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 556678999999999999 44578888998875432 224567889999999999999999999999889999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-ceEEeccccccCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLGPFN 167 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~~~l~dfg~~~~~~~~ 167 (266)
++++|.+++... ....+++..+..++.+++.++.+||+++ ++|+||+|+||++++++ .++|+|||.+......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 82 PGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999763 2245789999999999999999999999 99999999999998654 5799999998754322
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC----------ch
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----------NV 237 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~ 237 (266)
.......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+............. ..
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 230 (256)
T cd08220 156 -----SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLR 230 (256)
T ss_pred -----ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHH
Confidence 122335678899999999888889999999999999999999999987765554444433211 12
Q ss_pred hhhhhhccCCCCCcchHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
+++.+|+.++|..||+..++..
T Consensus 231 ~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 231 QLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHHccCChhhCCCHHHHhh
Confidence 4677888899999998887753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=250.02 Aligned_cols=230 Identities=25% Similarity=0.316 Sum_probs=187.6
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+++...||.|+||.||++.. .+++.+++|.+..... .....+.+|++++++++||||+++++.+......++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 56677999999999999954 4688899998764332 2356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+++... .++++..+..++.|++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 82 LLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999998763 57899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCch--hHHHHHHHHh----------cC
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT--LAEWTEECRR----------NK 235 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~--~~~~~~~~~~----------~~ 235 (266)
.......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+. .......... ..
T Consensus 154 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (258)
T cd05578 154 -----TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTE 228 (258)
T ss_pred -----ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHH
Confidence 122345678889999999888899999999999999999999999987653 2332222221 11
Q ss_pred chhhhhhhccCCCCCcchH
Q 047020 236 NVEVWAQMLDPKLNGDANM 254 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~ 254 (266)
..+++.+|+..+|..|++.
T Consensus 229 ~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 229 AIDAINKLLERDPQKRLGD 247 (258)
T ss_pred HHHHHHHHccCChhHcCCc
Confidence 1245667777777777776
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=249.60 Aligned_cols=230 Identities=26% Similarity=0.416 Sum_probs=189.4
Q ss_pred hhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchh
Q 047020 16 IRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
..||+|++|.+|++. ..++..+++|++..........+.+|+.+++.++||||+++++++...+..++++||+.+++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 489999999999995 4578889999876544445566889999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCc
Q 047020 95 DRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174 (266)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 174 (266)
+++.. +.+++..+..++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 105 ~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~----~~~ 171 (285)
T cd06648 105 DIVTH------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----VPR 171 (285)
T ss_pred HHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC----Ccc
Confidence 98875 46889999999999999999999999 999999999999999999999999987643221 112
Q ss_pred ccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------------Cchhhhhh
Q 047020 175 QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------------KNVEVWAQ 242 (266)
Q Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------------~~~~~~~~ 242 (266)
.....++..|+|||...+..++.++|+||+|+++|+|++|..||.+.+............ ...+++.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 233567889999999988889999999999999999999999997765544433322211 11256778
Q ss_pred hccCCCCCcchHHHHH
Q 047020 243 MLDPKLNGDANMEQLR 258 (266)
Q Consensus 243 ~l~~~~~~~~~~~~l~ 258 (266)
|+..+|..||+.+++.
T Consensus 252 ~l~~~p~~Rpt~~~il 267 (285)
T cd06648 252 MLVRDPAQRATAAELL 267 (285)
T ss_pred HcccChhhCcCHHHHc
Confidence 8888888888887765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=247.68 Aligned_cols=238 Identities=24% Similarity=0.289 Sum_probs=186.8
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc-----ccHHHHHHHHHHHhcCCCCCccccceeEEe--cCeEEE
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG-----GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE--KGEQLL 83 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 83 (266)
+.....||+|++|.||++ ...++..+++|++..... .....+.+|+.+++.++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 455668999999999999 456788999998754321 123567889999999999999999998765 356789
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
++||+++++|.+.+... ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 84 FMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 99999999999998763 46889999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV------ 237 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 237 (266)
....... ........++..|+|||++.+..++.++|+||+||++|+|++|..||...+..............+
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd06651 156 LQTICMS-GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHI 234 (266)
T ss_pred ccccccc-CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhc
Confidence 3221111 111123457888999999988889999999999999999999999998765555444333221111
Q ss_pred -----hhhhhhccCCCCCcchHHHHHH
Q 047020 238 -----EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 -----~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
+++ +++..+|..||+.+++..
T Consensus 235 ~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 235 SEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 123 466678999998888753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=253.02 Aligned_cols=237 Identities=25% Similarity=0.379 Sum_probs=191.6
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.++.+.+.||+|+||.||++. ..+++.+++|.+..........+.+|+.+++.++|||++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 455666689999999999994 4578889999876544445667889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++.. ..+++..+..++.|++.++.+||++| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999998875 45788999999999999999999999 9999999999999999999999999876432211
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh-c-----------Cc
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR-N-----------KN 236 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~-~-----------~~ 236 (266)
.......++..|++||.+.+..++.++|+||||+++|++++|..||...+........... . ..
T Consensus 170 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (293)
T cd06647 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 245 (293)
T ss_pred ----cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHH
Confidence 1123346788899999998888899999999999999999999999776554433222111 0 11
Q ss_pred hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++++|+..+|..||+.+++..
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 246 RDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 24567788888888887776643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=247.31 Aligned_cols=237 Identities=27% Similarity=0.389 Sum_probs=190.3
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
..+.+...||+|+||.||.+.. .++.+++|..... .....+.+|+.+++.++|||++++++++... ..+++|||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4566777999999999999864 6778888877543 2346788999999999999999999988654 5799999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++... ....+++..+..++.|++.|+.+||+.| ++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 82 KGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 99999998763 2246789999999999999999999999 999999999999999999999999998742211
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------Cchh
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------KNVE 238 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~~~~ 238 (266)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+............ ...+
T Consensus 154 -----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (254)
T cd05083 154 -----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV 228 (254)
T ss_pred -----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHH
Confidence 112234567999999988889999999999999999997 999997665433222221110 1125
Q ss_pred hhhhhccCCCCCcchHHHHHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
++.+|+..+|..||+.+++...+++
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHcc
Confidence 7789999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=252.79 Aligned_cols=207 Identities=26% Similarity=0.351 Sum_probs=170.5
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
++++...||+|++|.||++.. .+++.+++|+....... ....+.+|+++++.++||||+++++++......++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 456677999999999999955 46888999876543322 345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
++++++.+..... ..+++..+..++.|++.++.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 82 VDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred CCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9988887765442 45899999999999999999999999 999999999999999999999999998753222
Q ss_pred CCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHH
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE 229 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~ 229 (266)
. .......++..|+|||++.+ ..++.++|+||||+++|+|++|..||........+..
T Consensus 154 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 154 G----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred c----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 1 12223457888999998865 3467889999999999999999999987665554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=247.16 Aligned_cols=237 Identities=24% Similarity=0.299 Sum_probs=193.5
Q ss_pred hhchhhhhccccccceEEEEEcC-CCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG-DGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
..+.+...||+|++|.+|++... ++..+++|.+..... ...+.+|++++++++||||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 34666779999999999999654 478888887755432 678899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+++... ...+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 81 GAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999988642 256899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh------------cCc
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR------------NKN 236 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~------------~~~ 236 (266)
.......++..|+|||++.+..++.++|+||+|+++|+|++|..||...+........... ...
T Consensus 154 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd06612 154 ----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEF 229 (256)
T ss_pred ----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHH
Confidence 1223455788899999998888999999999999999999999999765443333221111 112
Q ss_pred hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++.+|+..+|..||+.+++..
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhc
Confidence 35677888899999998887653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=248.07 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=194.0
Q ss_pred HHhhchhhhhccccccceEEEEEc-CCCc----EEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL-GDGN----FGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~-~~g~----~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
....+++.+.||+|+||.||++.. .+|+ .+++|....... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 345566777999999999999954 2333 466665544332 234567889999999999999999998877 788
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++++||+.+++|.+++... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 84 ~~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred EEEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccc
Confidence 9999999999999998753 245899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-----
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----- 235 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----- 235 (266)
........ ........++..|+|||.+....++.++|+||+|+++|++++ |..||.+...............
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T cd05057 157 KLLDVDEK--EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234 (279)
T ss_pred ccccCccc--ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Confidence 76432211 111112223567999999988888999999999999999998 9999977654333322222111
Q ss_pred -----chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 -----NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 -----~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..++..||+..++.+.++.+.
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 114567899999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=248.51 Aligned_cols=241 Identities=25% Similarity=0.370 Sum_probs=189.9
Q ss_pred hccccccceEEEEEcCC-------CcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 17 RIGVGATSFVYLAELGD-------GNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~-------g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.||+|++|.||++...+ +..+++|...... ......+.+|+++++.++||||+++++++..+...+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999995432 2467777664432 234567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-----ceEEeccccc
Q 047020 89 ANKSLFDRMHTYYGQ--SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-----HAKLADFGLC 161 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-----~~~l~dfg~~ 161 (266)
++++|.+++...... ....+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999754221 2245788999999999999999999999 99999999999999877 8999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh-------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR------- 233 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~------- 233 (266)
........ ........++..|+|||++.+..++.++|+||||+++|+|++ |..||...+.......+...
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05044 159 RDIYKSDY--YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236 (269)
T ss_pred cccccccc--cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcc
Confidence 75322211 112223445678999999988889999999999999999998 99999765544433222111
Q ss_pred ---cCchhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 234 ---NKNVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 234 ---~~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
....+++.+|+.++|..||+.+++.+.++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 237 NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11236778999999999999999988775
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=256.05 Aligned_cols=198 Identities=24% Similarity=0.346 Sum_probs=157.4
Q ss_pred hccccccceEEEEEcC---CCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEe--cCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAELG---DGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE--KGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~---~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 91 (266)
+||+|+||.||++... ++..+++|.+... .....+.+|+++++.++||||+++++++.. +...++++||+. +
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07867 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H 84 (317)
T ss_pred EeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence 7999999999999643 4567888876543 234567889999999999999999998853 457889999985 5
Q ss_pred chhhhhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE----ecCCceEEeccccccC
Q 047020 92 SLFDRMHTYYG----QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL----IDDNHAKLADFGLCKL 163 (266)
Q Consensus 92 ~L~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~----~~~~~~~l~dfg~~~~ 163 (266)
+|.+++..... .....+++..++.++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 88887754321 12246889999999999999999999999 9999999999999 4567899999999975
Q ss_pred CCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCC
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGS 221 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~ 221 (266)
...... .........+|..|+|||++.+ ..++.++||||+||++|+|++|..||...
T Consensus 162 ~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcc-cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 432211 1122334578899999999866 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=250.80 Aligned_cols=205 Identities=27% Similarity=0.345 Sum_probs=170.0
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
++++...||+|++|.+|++.. .+++.+++|.+.... ......+.+|+++++.++|+||+++++++...+..++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 456677999999999999954 467889998765432 22356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
++++.+..+.... ..+++..+..++.|++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 82 VERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9876665554432 45899999999999999999999999 999999999999999999999999998764322
Q ss_pred CCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHH
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAE 226 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~ 226 (266)
.. .......++..|+|||++.+. .++.++|+||+|+++|+|++|..||.+.+..+.
T Consensus 154 ~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~ 210 (288)
T cd07833 154 PA---SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ 210 (288)
T ss_pred cc---ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 21 122335677889999999877 788999999999999999999999987655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=247.42 Aligned_cols=237 Identities=23% Similarity=0.304 Sum_probs=183.7
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEec------CeEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEK------GEQL 82 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------~~~~ 82 (266)
.++....||+|+||.||.+. ..+++.+++|..... ......+.+|+.+++++ +||||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 35556689999999999994 456778888876543 33456788899999998 699999999988653 4688
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
++|||+++++|.+++... ....+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++.
T Consensus 86 iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 999999999999988763 2246889999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc---
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN--- 234 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~--- 234 (266)
..... ........|+..|+|||++. +..++.++|+||+||++|+|++|..||................
T Consensus 160 ~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06637 160 QLDRT----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 235 (272)
T ss_pred ecccc----cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence 53211 11223456888999999985 3357889999999999999999999997654444333222211
Q ss_pred --------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 --------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 --------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+.+++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 112456677777777777766654
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=250.59 Aligned_cols=201 Identities=28% Similarity=0.377 Sum_probs=165.9
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..+.+...||+|++|.||++.. .+++.+++|.+..... .....+.+|++++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 4566777999999999999954 4678899998765432 2234567899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+ +|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~-~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LDT-DLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 974 898887653 246789999999999999999999999 999999999999999999999999998642211
Q ss_pred CCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
........++..|+|||++.+ ..++.++|+||+|+++|+|++|..||.+..
T Consensus 157 ----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 157 ----SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ----CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 111122346788999998865 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=247.18 Aligned_cols=242 Identities=21% Similarity=0.319 Sum_probs=187.6
Q ss_pred HHHhhchhh--hhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 7 LKMATNDFR--IRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 7 i~~~~~~~~--~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
++.+++++. ..||+|+||.||++. ..++..+++|.+..........+.+|+++++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 344455554 389999999999995 45677888887765555556678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCceEEecccc
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVL--SWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADFGL 160 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~~l~dfg~ 160 (266)
++||+++++|.+.+.... ..+ ++..+..++.|++.|+.|||+.+ ++|+||||+||+++. .+.++|+|||.
T Consensus 83 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence 999999999999887531 234 78888899999999999999999 999999999999976 67899999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccc--cCCCcccchhHHHHHHHHHhCCCCcCCCchhH--HHHHHH-Hhc-
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG--FVSTKSDVYSFGVLLLELITGLKSIQGSATLA--EWTEEC-RRN- 234 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~--~~~~~~-~~~- 234 (266)
+....... .......++..|+|||++.+. .++.++|+||+|+++|+|++|..||....... .+.... ...
T Consensus 156 ~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (268)
T cd06624 156 SKRLAGIN----PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP 231 (268)
T ss_pred heecccCC----CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCC
Confidence 87532211 112234578899999998654 47889999999999999999999996533221 111111 001
Q ss_pred --------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 --------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 --------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+.++|..||+.+++..
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1124678899999999998887653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=248.77 Aligned_cols=247 Identities=25% Similarity=0.333 Sum_probs=195.4
Q ss_pred hhchhhhhccccccceEEEEEc-----CCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEe--cCeE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-----GDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLE--KGEQ 81 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-----~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 81 (266)
..+.+...||+|+||.||++.. ++++.+++|.+...... ....+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 4556667899999999999953 34678899887654443 45678999999999999999999998877 5578
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
+++|||+++++|.+++... ...+++..+..++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||.+
T Consensus 84 ~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccc
Confidence 9999999999999998763 135899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh--------------HHH
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL--------------AEW 227 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~--------------~~~ 227 (266)
......... ........++..|++||...+..++.++|+||||+++|+|++|..||...... ..+
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKDY-YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccccCCcc-eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 864322111 11112234456799999998888899999999999999999999998653221 111
Q ss_pred HHHHHhc-----------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 228 TEECRRN-----------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 228 ~~~~~~~-----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...+... ...+++.+|+.++|..||+..++.+.++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2222111 112567899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=249.25 Aligned_cols=231 Identities=25% Similarity=0.395 Sum_probs=190.1
Q ss_pred hhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchh
Q 047020 16 IRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
.+||+|++|.||++.. .+|+.+++|++..........+.+|+.+++.++|+|++++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4799999999999944 578899999876544445667889999999999999999999999999999999999999998
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCc
Q 047020 95 DRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174 (266)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 174 (266)
+.+.. ..+++..+..++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 106 ~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~----~~~ 172 (292)
T cd06657 106 DIVTH------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPR 172 (292)
T ss_pred HHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccc----ccc
Confidence 87754 46789999999999999999999999 999999999999999999999999987643221 112
Q ss_pred ccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh------------cCchhhhhh
Q 047020 175 QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR------------NKNVEVWAQ 242 (266)
Q Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~------------~~~~~~~~~ 242 (266)
.....++..|+|||...+..++.++|+||+|+++|+|++|..||.+.+........... ....+.+.+
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR 252 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence 23456788999999998888899999999999999999999999876544332222111 111245788
Q ss_pred hccCCCCCcchHHHHHH
Q 047020 243 MLDPKLNGDANMEQLRV 259 (266)
Q Consensus 243 ~l~~~~~~~~~~~~l~~ 259 (266)
|+..+|..||+.+++..
T Consensus 253 ~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 253 LLVRDPAQRATAAELLK 269 (292)
T ss_pred HHhCCcccCcCHHHHhc
Confidence 99999999999888764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=248.44 Aligned_cols=237 Identities=27% Similarity=0.386 Sum_probs=190.9
Q ss_pred ccccccceEEEEEcC-CCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCch
Q 047020 18 IGVGATSFVYLAELG-DGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 18 ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
||.|++|.||++... +|+.+++|.+..... .....+.+|++++++++||||+++++.+......++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999654 588999997754332 3456788899999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC---
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN--- 170 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 170 (266)
.+++... +.+++..+..++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9998764 47899999999999999999999999 999999999999999999999999998753222110
Q ss_pred -CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH-----------hcCchh
Q 047020 171 -RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR-----------RNKNVE 238 (266)
Q Consensus 171 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~-----------~~~~~~ 238 (266)
.........++..|++||...+...+.++|+||||+++|++++|..||.............. .....+
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAID 232 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHH
Confidence 01122345678889999999888889999999999999999999999976654443333221 111235
Q ss_pred hhhhhccCCCCCcchHHHHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
++.+|+..+|..||+...+.++++
T Consensus 233 ~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 233 LISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHhcCCHhhcCCCccHHHHhc
Confidence 677888889999998866666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=251.45 Aligned_cols=196 Identities=24% Similarity=0.330 Sum_probs=162.3
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
|.+...||+|++|.||++. ..+|+.+++|.+..... .....+.+|++++++++||||+++++++.+....++++||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 5566789999999999994 45788999998754322 22355778999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
. ++|.+++... .+.+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 82 D-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred C-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 6 5787776542 256899999999999999999999999 9999999999999999999999999987432211
Q ss_pred CCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcC
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQ 219 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~ 219 (266)
.......++..|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus 154 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 154 ----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred ----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 112334568889999988664 46889999999999999999988864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=263.99 Aligned_cols=192 Identities=22% Similarity=0.296 Sum_probs=159.8
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
++.+...||+|+||.||++. ...+..++||... ...+.+|++++++++|+||+++++++...+..++||+++
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~- 242 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY- 242 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence 34555589999999999994 4567788888532 223568999999999999999999999999999999998
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
.++|.+++... ...+++..+..++.|++.||.|||++| |+|+||||+||+++.++.++|+|||++........
T Consensus 243 ~~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 RSDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 46888887642 246899999999999999999999999 99999999999999999999999999875322111
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCc
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSI 218 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf 218 (266)
........||..|+|||++.+..++.++|||||||++|+|++|..|+
T Consensus 316 --~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 --TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred --cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 11223456899999999999989999999999999999999987554
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=245.32 Aligned_cols=240 Identities=23% Similarity=0.282 Sum_probs=191.1
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEe--cCeEEEEEE
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE--KGEQLLLLE 86 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 86 (266)
|++...||.|++|.||++ ...+|+.+++|.+.... ....+++.+|+++++.++||||+++++.+.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 456678999999999999 45677888888765432 2234567889999999999999999997753 446789999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH-----SQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-----~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
|+++++|.+++..... ....+++..++.++.|++.++.+|| +.+ ++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 82 YCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999876422 2367899999999999999999999 888 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------- 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------- 234 (266)
....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+............
T Consensus 158 ~~~~~~~----~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd08217 158 KILGHDS----SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYR 233 (265)
T ss_pred ccccCCc----ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccc
Confidence 8643221 11233468889999999988888999999999999999999999998765333222222111
Q ss_pred ---CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ---KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ---~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++.+
T Consensus 234 ~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 234 YSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1125678899999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=245.83 Aligned_cols=223 Identities=24% Similarity=0.330 Sum_probs=182.5
Q ss_pred ccccccceEEEEEc-CCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCch
Q 047020 18 IGVGATSFVYLAEL-GDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 18 ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
||.|++|.||++.. .+++.+++|.+..... ...+.+.+|+.+++.++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999954 4588899998754332 2346788999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCC
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 173 (266)
.+++... ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----- 147 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----- 147 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----
Confidence 9998763 45889999999999999999999999 9999999999999999999999999987543221
Q ss_pred cccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc--hhHHHHHHHHh-----------cCchhhh
Q 047020 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA--TLAEWTEECRR-----------NKNVEVW 240 (266)
Q Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~--~~~~~~~~~~~-----------~~~~~~~ 240 (266)
......++..|++||.+.+..++.++|+||+|+++|+|++|..||.... ........... ....+++
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 227 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLI 227 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence 2234567889999999988888999999999999999999999997665 33333333311 1112456
Q ss_pred hhhccCCCCCcch
Q 047020 241 AQMLDPKLNGDAN 253 (266)
Q Consensus 241 ~~~l~~~~~~~~~ 253 (266)
.+|+..+|..|++
T Consensus 228 ~~~l~~~p~~R~~ 240 (262)
T cd05572 228 KQLLRRNPEERLG 240 (262)
T ss_pred HHHccCChhhCcC
Confidence 6777777777777
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=246.70 Aligned_cols=236 Identities=25% Similarity=0.345 Sum_probs=187.3
Q ss_pred hhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc----------cHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 13 DFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG----------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
.....||.|++|.||++ ...+|+.+++|.+...... ..+.+.+|+++++.++|||++++++++...+..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34458999999999999 4456889999977432111 123567899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+++++|.+++... +.+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred EEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999998764 57899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCcccccccc--CCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-----
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGF--VSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----- 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----- 234 (266)
...... ..........++..|+|||.+.... ++.++|+||+|+++|++++|..||................
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06629 156 KKSDDI--YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233 (272)
T ss_pred cccccc--ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence 753211 1112233456788999999986654 7889999999999999999999997655544333322111
Q ss_pred ----------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 ----------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 ----------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+.++|..||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 267 (272)
T cd06629 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267 (272)
T ss_pred CccccccCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 112456678888888998877764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=256.45 Aligned_cols=205 Identities=24% Similarity=0.327 Sum_probs=168.6
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEec------C
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK------G 79 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 79 (266)
..+++....||+|+||.||++ ...+|+.+++|.+.... ......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 455666679999999999999 45578899999875422 22345677899999999999999999987644 3
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
..++||||+. ++|.+.+.. .+++..+..++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 5799999995 588877653 2788999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHH
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE 229 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~ 229 (266)
++...... .......++..|+|||.+.+..++.++|+||+||++|+|++|..||...+....+.+
T Consensus 164 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~ 228 (353)
T cd07850 164 LARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK 228 (353)
T ss_pred cceeCCCC-----CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 98753221 112334678899999999999999999999999999999999999987765554443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=246.01 Aligned_cols=229 Identities=20% Similarity=0.276 Sum_probs=176.1
Q ss_pred hccccccceEEEEEcCC-------------CcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 17 RIGVGATSFVYLAELGD-------------GNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~-------------g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
.||+|+||.||.+.... ...+++|............+.+|+.+++.++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999995422 12356665544333445577889999999999999999999999889999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc-------eEEe
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH-------AKLA 156 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~-------~~l~ 156 (266)
+|||+++++|..++... ...+++..+..++.|++.|++|||+++ ++|+||||+||+++.++. ++++
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 82 VEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999998877542 246899999999999999999999999 999999999999986654 8999
Q ss_pred ccccccCCCCCCCCCCCcccccccCCCccCccccc-cccCCCcccchhHHHHHHHHH-hCCCCcCCCchhHHHHHHHHh-
Q 047020 157 DFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN-TGFVSTKSDVYSFGVLLLELI-TGLKSIQGSATLAEWTEECRR- 233 (266)
Q Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~i~~~l~-~g~~pf~~~~~~~~~~~~~~~- 233 (266)
|||++.... ......++..|+|||.+. +..++.++||||||+++|+|+ .|..||....... .......
T Consensus 155 d~g~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~ 225 (262)
T cd05077 155 DPGIPITVL--------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KERFYEGQ 225 (262)
T ss_pred CCCCCcccc--------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-HHHHHhcC
Confidence 999876421 122345677899999886 567889999999999999997 5888886543221 1111111
Q ss_pred --------cCchhhhhhhccCCCCCcchHHHHHHHH
Q 047020 234 --------NKNVEVWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 234 --------~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
....+++.+|+..+|..||+..+|..-+
T Consensus 226 ~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0112567888888899999888876644
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=258.49 Aligned_cols=190 Identities=22% Similarity=0.319 Sum_probs=158.0
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+|.+...||+|+||.||++. ..++..+++|..... ....|+.+++.++||||+++++++......++|+|++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 345666699999999999994 456677888753222 2356899999999999999999999999999999998
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
. ++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++..+.++|+|||++.....
T Consensus 140 ~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 209 (357)
T PHA03209 140 S-SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-- 209 (357)
T ss_pred C-CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc--
Confidence 4 5888887642 256899999999999999999999999 99999999999999999999999999874211
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCc
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSI 218 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf 218 (266)
........||..|+|||++.+..++.++|+|||||++|+|+++..|+
T Consensus 210 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 ---APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 11223456899999999999888999999999999999999854444
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=245.71 Aligned_cols=227 Identities=20% Similarity=0.289 Sum_probs=177.7
Q ss_pred hccccccceEEEEEcCCCc-----------EEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 17 RIGVGATSFVYLAELGDGN-----------FGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~-----------~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.||+|+||.||++...... .+++|....... ....+.+|+.+++.++||||+++++++.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchh-hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 6899999999999654332 345554433222 26778899999999999999999999887 7789999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-------ceEEecc
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-------HAKLADF 158 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-------~~~l~df 158 (266)
||+++++|.+++... ...++...+..++.|++.||.|||+++ ++|+||||+||+++.++ .++|+||
T Consensus 80 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 80 EYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999998764 126889999999999999999999999 99999999999999877 7999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccc--cCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc-
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG--FVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN- 234 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~- 234 (266)
|++..... .....++..|+|||++.+. .++.++|+||+|+++|+|++ |..||...+... ........
T Consensus 153 g~a~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~~~~~~~ 223 (259)
T cd05037 153 GIPITVLS--------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQDQH 223 (259)
T ss_pred Cccccccc--------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-HHHHHhcCC
Confidence 99875321 2234466779999999776 78899999999999999999 578886553222 21111111
Q ss_pred --------CchhhhhhhccCCCCCcchHHHHHHHH
Q 047020 235 --------KNVEVWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 235 --------~~~~~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
...+++.+|+..+|..||+..++.+.+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112567889999999999888877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=243.50 Aligned_cols=211 Identities=25% Similarity=0.302 Sum_probs=171.9
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc-----cccHHHHHHHHHHHhcCCCCCccccceeEEec--CeEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER-----GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQL 82 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 82 (266)
.+.+...||+|++|.+|++. ..+|..+++|.+.... ......+.+|++++++++||||+++++.+.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 45566799999999999994 4568899999764321 12345678899999999999999999988654 4588
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+++||+++++|.+++... +.+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 83 ~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 999999999999998763 56789999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHH
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE 230 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~ 230 (266)
........ ........++..|+|||++.+..++.++|+||||+++|+|++|..||.+..........
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 221 (264)
T cd06653 155 RIQTICMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI 221 (264)
T ss_pred cccccccc-CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH
Confidence 54221111 11122345788999999998888899999999999999999999999876555544433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=247.96 Aligned_cols=236 Identities=25% Similarity=0.345 Sum_probs=186.0
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
++....||.|++|.||++. ..+|+.+++|++..... .....+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 4556689999999999994 45788999997754332 23356889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
. ++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 82 H-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred c-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 5 5888877652 2356899999999999999999999999 9999999999999999999999999987432211
Q ss_pred CCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh--------------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR-------------- 233 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~-------------- 233 (266)
.......++..|+|||++.+. .++.++|+||||+++|+|++|..||.+.+......+....
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 ----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred ----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 112233467889999988654 4578899999999999999999999776554433332211
Q ss_pred ------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 ------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 ------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+..+|..||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 0011467788888888888877764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=253.03 Aligned_cols=206 Identities=24% Similarity=0.328 Sum_probs=168.4
Q ss_pred chhhhhccccccceEEEEEcC---CCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEec--CeEEE
Q 047020 12 NDFRIRIGVGATSFVYLAELG---DGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQLL 83 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~---~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 83 (266)
+.+...||+|++|.||++... .+..+++|.+.... ......+.+|+.+++.++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 456678999999999999543 57889999887633 33456678899999999999999999999888 78999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec----CCceEEeccc
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID----DNHAKLADFG 159 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~----~~~~~l~dfg 159 (266)
||||++ +++.+.+..........+++..++.++.|++.|+.|||+.+ ++|+||||+||+++. ++.++|+|||
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 999985 47777776543333357899999999999999999999999 999999999999998 8899999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
++......... ........++..|+|||++.+ ..++.++|+||||+++|+|++|..||.+..
T Consensus 158 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 158 LARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 98764332211 122234567888999998765 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=262.35 Aligned_cols=239 Identities=25% Similarity=0.331 Sum_probs=199.7
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
|....+||+|.|+.|.++ ...+|..|++|.+.+..-. ....+.+|+++++.++|||||+++.+...+..+|+||||.
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 344458999999999999 5678999999966443222 2344789999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+|.+++++.++ +...+..+..++.|+.+|++|+|+++ |+|||||.+|++++.+..+||+|||+.+....
T Consensus 138 ~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 138 SGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred cCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--
Confidence 999999999886 67778999999999999999999999 99999999999999999999999999886432
Q ss_pred CCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------chh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------NVE 238 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~ 238 (266)
.......+|++.|.|||++.+..+ ++.+|+||+|+++|.|.+|..||+|.+-...-.+.+...- ..+
T Consensus 208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~ 284 (596)
T KOG0586|consen 208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCED 284 (596)
T ss_pred ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHH
Confidence 334567899999999999988765 5789999999999999999999998765554433333211 126
Q ss_pred hhhhhccCCCCCcchHHHHHHHHHHHhC
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~~~~~~ 266 (266)
+++++|-.+|..|++.++ +++.||.
T Consensus 285 lLrk~lvl~Pskr~~~dq---im~~~W~ 309 (596)
T KOG0586|consen 285 LLRKFLVLNPSKRGPCDQ---IMKDRWR 309 (596)
T ss_pred HHHHhhccCccccCCHHH---hhhhccc
Confidence 788999999999996655 6677773
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=246.29 Aligned_cols=236 Identities=25% Similarity=0.362 Sum_probs=193.7
Q ss_pred hchhhhhccccccceEEEEEcC-CCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 11 TNDFRIRIGVGATSFVYLAELG-DGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
++.+...||+|++|.+|.+... ++..+++|.+..... ....+.+|+++++.++|+|++++++.+......++++||++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 3455568999999999999554 688889988765433 45678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++.... ..+++..+..++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 99 ~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 99 GGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999998741 37899999999999999999999999 9999999999999999999999999876432211
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------------Cch
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------------KNV 237 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------------~~~ 237 (266)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+.... ...
T Consensus 171 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 171 ---SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred ---hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence 12233457788999999988888999999999999999999999998766554443332211 122
Q ss_pred hhhhhhccCCCCCcchHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~ 258 (266)
+++.+|+..+|..||+..++.
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred HHHHHHhccChhhCcCHHHHh
Confidence 467889999999999988885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=247.74 Aligned_cols=230 Identities=20% Similarity=0.287 Sum_probs=176.0
Q ss_pred hccccccceEEEEEcCC-------------------------CcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCcccc
Q 047020 17 RIGVGATSFVYLAELGD-------------------------GNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~-------------------------g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 71 (266)
.||+|+||.||++.... ...+++|............+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999985311 12356665544333334567889999999999999999
Q ss_pred ceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC
Q 047020 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN 151 (266)
Q Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~ 151 (266)
++++.+....++||||+++++|.+++... .+.+++..+..++.|++.|+.|||+++ ++|+||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 99999999999999999999998888642 256789999999999999999999999 99999999999997643
Q ss_pred -------ceEEeccccccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHH-hCCCCcCCCc
Q 047020 152 -------HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELI-TGLKSIQGSA 222 (266)
Q Consensus 152 -------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~-~g~~pf~~~~ 222 (266)
.++++|||.+.... ......++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~--------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTAL--------SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccc--------cccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 37999999875311 1122346778999998865 56789999999999999985 6899997654
Q ss_pred hhHH--HHHHHHhc------CchhhhhhhccCCCCCcchHHHHHHHH
Q 047020 223 TLAE--WTEECRRN------KNVEVWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 223 ~~~~--~~~~~~~~------~~~~~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
.... +....... ...+++.+|+..+|..||+.+++.+-+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 227 PSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 3221 11111111 123567889999999999888877654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.13 Aligned_cols=195 Identities=30% Similarity=0.411 Sum_probs=168.6
Q ss_pred hhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEec------CeEEEEEE
Q 047020 15 RIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK------GEQLLLLE 86 (266)
Q Consensus 15 ~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e 86 (266)
...||+||||.||++. ..+|..+|||.+..... ..+++..+|++++++++|+|||+++++=++. ....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4489999999999996 67899999998876443 3467778999999999999999999875443 35789999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe--cCCc--eEEecccccc
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI--DDNH--AKLADFGLCK 162 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~--~~~~--~~l~dfg~~~ 162 (266)
|+.||||...+..- .+...+++.++..++.++..|+.|||.+| |+||||||+||++- .+|+ .||+|||.|+
T Consensus 98 yC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred ecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999764 55578999999999999999999999999 99999999999974 3344 5999999999
Q ss_pred CCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcC
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQ 219 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~ 219 (266)
... .........||..|.+||.+.. +.++.-+|.|||||++|++.||..||.
T Consensus 173 el~-----d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 173 ELD-----DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cCC-----CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 543 3446778999999999999985 788899999999999999999999994
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=250.68 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=190.2
Q ss_pred hhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhc--CCCCCccccceeEEec----CeEEEEEE
Q 047020 13 DFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLR--VSHPNLVGLLGFCLEK----GEQLLLLE 86 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~----~~~~lv~e 86 (266)
...+.||+|.||.||++.+ .|+.||||.+... +.....+|.++++. |+|+||+.++..-..+ .++++|++
T Consensus 214 ~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 4445899999999999988 6899999988543 33456667777665 5899999999765332 27899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH-----SQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-----~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
|-+.|||+|++.. ..++......++..+++||.+|| ++|+|+|.|||||..||++.++|...|.|+|+|
T Consensus 290 YHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 290 YHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred cccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 9999999999987 57899999999999999999999 567899999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccC------CCcccchhHHHHHHHHHhC----------CCCcCCCchhH
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV------STKSDVYSFGVLLLELITG----------LKSIQGSATLA 225 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~------~~~~Di~slG~i~~~l~~g----------~~pf~~~~~~~ 225 (266)
-........-....+...||.+|||||++..... -..+||||||+++||++.. +.||.+--.-+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 8765555555667788999999999999865422 2369999999999999764 47774321111
Q ss_pred HHHHHHHhcCchhhhhhhccCCCCCcchHHHHHHHHHHHhC
Q 047020 226 EWTEECRRNKNVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~~ 266 (266)
.-...++.-...+-++--++..+.+.|....+.++|+.||.
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~ 484 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWY 484 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhc
Confidence 11112222222233334456777788999999999999994
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=244.72 Aligned_cols=242 Identities=23% Similarity=0.348 Sum_probs=192.2
Q ss_pred chhhhhccccccceEEEEEcC--CCcEEEEEEeeecc----------cccHHHHHHHHHHHhc-CCCCCccccceeEEec
Q 047020 12 NDFRIRIGVGATSFVYLAELG--DGNFGAVKRVMEER----------GGSRKIFLDEVSVLLR-VSHPNLVGLLGFCLEK 78 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~--~g~~~~vk~~~~~~----------~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~ 78 (266)
+.+...||+|+||.||.+... .++.+++|.+.... ......+.+|+.++.+ ++||||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 456678999999999999654 36788888764321 1123456778888865 7899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEec
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLAD 157 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~d 157 (266)
+..+++|||+++++|.+++..... ....+++..++.++.|++.++.+||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999998865322 22568999999999999999999995 77 99999999999999999999999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh----
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR---- 233 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~---- 233 (266)
||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||...+...........
T Consensus 158 fg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 158 FGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred ccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence 99987532211 233456788999999998888899999999999999999999999765544333222221
Q ss_pred -------cCchhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 234 -------NKNVEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 234 -------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
....+++.+|+..+|..||+..++...++
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11124677899999999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=245.76 Aligned_cols=241 Identities=24% Similarity=0.293 Sum_probs=189.1
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEecC------eE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKG------EQ 81 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~------~~ 81 (266)
.+|.+...||+|++|.+|++.. .++..+++|..... ......+.+|+++++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC-chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 4556667999999999999955 46777888765443 33456788999999999 6999999999986544 48
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+++++|.+++..... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccc
Confidence 999999999999998865321 1357899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCcccccc-----ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc--
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-----GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN-- 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~-- 234 (266)
...... ........++..|+|||++.. ..++.++|+||+|+++|+|++|..||.+.+............
T Consensus 161 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 161 AQLDST----LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred eecccc----hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 753221 122234568889999998753 346778999999999999999999997655444443333221
Q ss_pred ----------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ----------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ----------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1125678889999999998887653
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=247.20 Aligned_cols=230 Identities=22% Similarity=0.273 Sum_probs=183.5
Q ss_pred ccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCch
Q 047020 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 18 ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
||+|+||.||++ ...+|+.+++|.+.... ......+.+|++++++++||||+++++.+...+..++||||+.+++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999 45568899998775432 22344567899999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCC
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 173 (266)
.+++... ....+++..+..++.|++.++.+||+.| ++|+||+|+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-----~~ 149 (277)
T cd05577 81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG-----GK 149 (277)
T ss_pred HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc-----CC
Confidence 9988764 1136899999999999999999999999 99999999999999999999999998875322 11
Q ss_pred cccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH-------------hcCchhhh
Q 047020 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR-------------RNKNVEVW 240 (266)
Q Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~-------------~~~~~~~~ 240 (266)
......++..|+|||++.+..++.++|+||+|+++|+|++|..||.............. .....+++
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 229 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC 229 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHH
Confidence 22334677889999999888889999999999999999999999976543211111111 01123567
Q ss_pred hhhccCCCCCcc-----hHHHHH
Q 047020 241 AQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 241 ~~~l~~~~~~~~-----~~~~l~ 258 (266)
.+|+..+|..|| +.+++.
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 230 EALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred HHHccCChhHccCCCcccHHHHH
Confidence 888888888888 666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=246.55 Aligned_cols=235 Identities=24% Similarity=0.336 Sum_probs=188.1
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCC---CCCccccceeEEecCeEEEEEE
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVS---HPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e 86 (266)
|+....||.|+||.+|++. ..+++.+++|.+.... ......+.+|+.+++.++ |||++++++++......+++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 4556689999999999995 4678888998775432 234567888999999997 9999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++.. +.+++..+..++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 83 YAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred cCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999998865 47899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh-----------c
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR-----------N 234 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~-----------~ 234 (266)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+........... .
T Consensus 154 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06917 154 NS----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSK 229 (277)
T ss_pred Cc----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCH
Confidence 22 12233468889999998864 45688999999999999999999999766543322211110 0
Q ss_pred CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+.+.+|+..+|..||+..++..
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1124567888888888888877653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=243.86 Aligned_cols=236 Identities=25% Similarity=0.356 Sum_probs=193.5
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+++...||.|++|.+|++.. .+++.+++|++..... .....+.+|++.+..++|+|++++++++......++++||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 45667899999999999955 4589999998765443 345778899999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
+++|.+++... ..+++..+..++.|++.++.+||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 83 GGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999764 678999999999999999999999 99 9999999999999999999999999987532211
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc--hhHHHHHHHHhc------------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA--TLAEWTEECRRN------------ 234 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~--~~~~~~~~~~~~------------ 234 (266)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ...+........
T Consensus 155 ----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (264)
T cd06623 155 ----DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230 (264)
T ss_pred ----CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCH
Confidence 11234567889999999988888999999999999999999999997664 222222222211
Q ss_pred CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+.+++..||+.+++.+
T Consensus 231 ~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 231 EFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHh
Confidence 1224677888889999998877654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=247.49 Aligned_cols=229 Identities=20% Similarity=0.288 Sum_probs=177.9
Q ss_pred hccccccceEEEEEcC-CCc-------EEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 17 RIGVGATSFVYLAELG-DGN-------FGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~-~g~-------~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.||+|+||.||++... .+. .+++|..........+.+.+|..+++.++||||+++++++......++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 6899999999999442 222 35555554333334466788999999999999999999999988999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc--------eEEecccc
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH--------AKLADFGL 160 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~--------~~l~dfg~ 160 (266)
++++|.+++... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++. ++++|||.
T Consensus 82 ~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 82 KFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999998753 135788999999999999999999999 999999999999987664 68999998
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCC-CCcCCCchhHHHHHHHHhc----
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGL-KSIQGSATLAEWTEECRRN---- 234 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~-~pf~~~~~~~~~~~~~~~~---- 234 (266)
+.... ......++..|+|||++.+ ..++.++|+||||+++|+|++|. .||...+...... .....
T Consensus 155 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (258)
T cd05078 155 SITVL--------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLP 225 (258)
T ss_pred ccccC--------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCC
Confidence 76421 1223457788999999876 45788999999999999999985 6665543332221 11111
Q ss_pred -----CchhhhhhhccCCCCCcchHHHHHHHH
Q 047020 235 -----KNVEVWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 235 -----~~~~~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
...+++.+|+..+|..||+.+++.+.+
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112578899999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=248.65 Aligned_cols=246 Identities=24% Similarity=0.275 Sum_probs=189.2
Q ss_pred HHHHHhhchhh--hhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEec--
Q 047020 5 EELKMATNDFR--IRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEK-- 78 (266)
Q Consensus 5 ~~i~~~~~~~~--~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-- 78 (266)
++|...+.+|. ..||+|+||.||++.. .+++.+++|.+... ......+.+|+.+++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 44444444554 4899999999999954 56788888876432 22345677899999998 699999999988653
Q ss_pred ---CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEE
Q 047020 79 ---GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKL 155 (266)
Q Consensus 79 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l 155 (266)
+..++||||+++++|.+++..... ....+++..++.++.|++.|+.+||+.+ ++|+||||+||+++.++.++|
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 358999999999999998864321 2256899999999999999999999999 999999999999999999999
Q ss_pred eccccccCCCCCCCCCCCcccccccCCCccCccccccc-----cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHH
Q 047020 156 ADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-----FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE 230 (266)
Q Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~ 230 (266)
+|||++....... .......++..|+|||.+... .++.++|+||+|+++|+|++|..||...+........
T Consensus 170 ~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 170 VDFGVSAQLTSTR----LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245 (291)
T ss_pred eecccchhccccc----ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence 9999987533211 112334678889999987543 3678999999999999999999999876554444333
Q ss_pred HHhcC------------chhhhhhhccCCCCCcchHHHHHH
Q 047020 231 CRRNK------------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 231 ~~~~~------------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..... ..+++.+|+..+|..||+.+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 246 PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 22211 124678899999999998887753
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=248.24 Aligned_cols=201 Identities=25% Similarity=0.337 Sum_probs=164.5
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.|.+.+.||+|+||.||++ ...+|+.+++|.+..... .....+.+|+++++.++|+||+++++++......++|+||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 3555668999999999999 456788999998765432 22346778999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
. +++.+.+... ...+++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 86 H-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred c-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 5 6777766542 245678889999999999999999999 9999999999999999999999999987432211
Q ss_pred CCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSAT 223 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~ 223 (266)
.......++..|+|||++.+. .++.++|+||+|+++|+|++|..||.+.+.
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 158 ----QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred ----CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 112334568899999998654 578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=243.45 Aligned_cols=238 Identities=20% Similarity=0.225 Sum_probs=176.2
Q ss_pred hccccccceEEEEEcCCCc---EEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLAELGDGN---FGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~---~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||+|+||.||++...++. ..++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999543332 34455444322 2245678899999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.+++...... ....+...+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~--~~ 155 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED--YI 155 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch--hh
Confidence 99998764222 245677778899999999999999999 9999999999999999999999999875321111 01
Q ss_pred CcccccccCCCccCcccccc-------ccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 173 KRQTSIKGSFGYVDTNYLNT-------GFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
.......++..|+|||++.. ..++.++|+||||+++|+|++ +..||...+....+.........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 11234567888999998743 235678999999999999997 57788765554444433322110
Q ss_pred -------hhhhhhhccCCCCCcchHHHHHHHH
Q 047020 237 -------VEVWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 237 -------~~~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
.+++..|+ .+|..||+.+++.+.+
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 02344455 5688888888887665
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=246.36 Aligned_cols=235 Identities=25% Similarity=0.331 Sum_probs=189.3
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+++...||.|++|.||++.. .+++.+++|.+..... .....+.+|+++++.++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 356777999999999999955 4688889987765432 34567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
++++|.+++.... ..+++..+..++.|++.++.+||+ .+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 82 DGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred CCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999887531 578899999999999999999999 98 999999999999999999999999988643211
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc----hhHHHHHHHHhc---------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA----TLAEWTEECRRN--------- 234 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~----~~~~~~~~~~~~--------- 234 (266)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+ ............
T Consensus 155 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd06605 155 ------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGK 228 (265)
T ss_pred ------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhh
Confidence 1112667888999999988889999999999999999999999996542 222222211111
Q ss_pred ---CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 ---KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 ---~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+..++.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 122456778888888888877764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=246.54 Aligned_cols=209 Identities=23% Similarity=0.341 Sum_probs=171.2
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+++..+||.|++|.+|++.. .+|..+++|.+..... .....+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 45567899999999999954 4688899998765432 234567789999999999999999999999999999999997
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+ +|.+++.... ....+++..+..++.|++.|+.+||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~-~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~-- 153 (284)
T cd07836 82 K-DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP-- 153 (284)
T ss_pred c-cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--
Confidence 5 8888876532 2346899999999999999999999999 999999999999999999999999998743211
Q ss_pred CCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHH
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE 230 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~ 230 (266)
........++..|++||.+.+ ..++.++|+||+|+++|+|++|..||.+.+......++
T Consensus 154 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 213 (284)
T cd07836 154 --VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213 (284)
T ss_pred --ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 111223456788999998755 45788999999999999999999999887765554443
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=247.29 Aligned_cols=237 Identities=21% Similarity=0.279 Sum_probs=183.2
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEe------cCeEE
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLE------KGEQL 82 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~~~~ 82 (266)
.+.+...||.|+||.||++.. .+++.+++|..... ......+..|+.+++++ +||||+++++++.. ....+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 344445899999999999944 56778888876443 23345678899999998 59999999998743 45789
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
++|||+++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+.
T Consensus 96 iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 9999999999999987632 245788889999999999999999999 9999999999999999999999999887
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-- 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 235 (266)
..... ........++..|+|||++. ...++.++|+||||+++|+|++|..||.+...............
T Consensus 170 ~~~~~----~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 245 (282)
T cd06636 170 QLDRT----VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 245 (282)
T ss_pred hhhcc----ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence 43211 11223456888999999875 34678899999999999999999999976544333332222111
Q ss_pred ---------chhhhhhhccCCCCCcchHHHHH
Q 047020 236 ---------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 ---------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++++|+..+|..||+..+|.
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred CcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 12567778888888888877664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=277.61 Aligned_cols=220 Identities=30% Similarity=0.450 Sum_probs=180.5
Q ss_pred hHHHHHhhchhhhhccccccceEEEEEc--CCCc----EEEEEEeeec-ccccHHHHHHHHHHHhcCCCCCccccceeEE
Q 047020 4 LEELKMATNDFRIRIGVGATSFVYLAEL--GDGN----FGAVKRVMEE-RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76 (266)
Q Consensus 4 ~~~i~~~~~~~~~~ig~g~~~~v~~~~~--~~g~----~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 76 (266)
+.++..++-.+...||+|+||.||.+.. ..|. .+++|.+... +..+...|.+|..+|+.++||||+++++++.
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 3345556666777899999999999943 2333 3677776543 3345678999999999999999999999999
Q ss_pred ecCeEEEEEEecCCCchhhhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceE
Q 047020 77 EKGEQLLLLEYLANKSLFDRMHTYYGQS--LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAK 154 (266)
Q Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~ 154 (266)
+.+..++++|||.||+|..++++.+... ...++..++..++.|++.|+.||+++. ++||||...|+|++....+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEE
Confidence 9999999999999999999999853322 356788999999999999999999999 99999999999999999999
Q ss_pred EeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHH
Q 047020 155 LADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWT 228 (266)
Q Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~ 228 (266)
|+|||+|+-+......+.. ....-...|||||.+....++.++||||||+++||+++ |..||.+.+..+-..
T Consensus 843 IaDFGlArDiy~~~yyr~~--~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~ 915 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKH--GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL 915 (1025)
T ss_pred EcccchhHhhhhchheecc--CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH
Confidence 9999999854433322211 11234567999999999999999999999999999998 899998877666554
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=260.84 Aligned_cols=199 Identities=22% Similarity=0.317 Sum_probs=163.9
Q ss_pred hchhhhhccccccceEEEEEcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.|+..++||+||.+.||++.-.+.+-+++|++..... ....-+.+|+..|.+|+ |.+|+.++||-..++.+|+|||+
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 3445569999999999999776677778887755333 23566889999999997 89999999999999999999996
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
...+|...+++.. ..++...+..++.||+.++.++|..| |||.||||+|+++. .|.+||+|||+|..+...
T Consensus 442 -Gd~DL~kiL~k~~----~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 442 -GDIDLNKILKKKK----SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred -ccccHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 4679999988741 23333478899999999999999999 99999999999985 468999999999876554
Q ss_pred CCCCCCcccccccCCCccCccccccc-----------cCCCcccchhHHHHHHHHHhCCCCcCC
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTG-----------FVSTKSDVYSFGVLLLELITGLKSIQG 220 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~Di~slG~i~~~l~~g~~pf~~ 220 (266)
++ ........||..||+||.+... ..+.++||||+|||+|+|++|+.||..
T Consensus 513 TT--sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 513 TT--SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred cc--ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 43 4455567899999999998432 246789999999999999999999964
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=247.23 Aligned_cols=240 Identities=21% Similarity=0.253 Sum_probs=186.2
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEE-----ecCeEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCL-----EKGEQLL 83 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~~~~~l 83 (266)
++++...||+|+||.||++ ...++..+++|..... ......+.+|+.+++.+ +||||+++++++. .....++
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 4455568999999999999 4456778888865432 22345677899999999 6999999999873 3457899
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+++++|.+++.... .....+++..+..++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 98 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 98 VLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceee
Confidence 999999999999876432 22356889999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCcccccc-----ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc----
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNT-----GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN---- 234 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~---- 234 (266)
.... ........++..|+|||++.. ..++.++|+||+||++|+|++|..||.+.+............
T Consensus 174 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd06638 174 LTST----RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249 (286)
T ss_pred cccC----CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence 4221 112234468899999998753 347889999999999999999999997765544433221111
Q ss_pred --------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 --------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 --------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++.+
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1224678899999999998888754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=244.70 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=191.5
Q ss_pred hhhhhccccccceEEEEEc----CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecC------e
Q 047020 13 DFRIRIGVGATSFVYLAEL----GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------E 80 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~ 80 (266)
.+...||+|+||.||++.. +++..+++|.+..... ...+.+.+|+++++.++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 4556899999999999953 3467889998765432 23456788999999999999999999875432 2
Q ss_pred EEEEEEecCCCchhhhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYY-GQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
.+++++|+.+++|.+++.... ......++...+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccc
Confidence 478899999999988775432 122245788999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN---- 234 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~---- 234 (266)
+++....... ........++..|++||...+..++.++|+|||||++|+|++ |..||.+.+.......+....
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05074 159 LSKKIYSGDY--YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236 (273)
T ss_pred ccccccCCcc--eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 9875432211 111122345567999999988888999999999999999998 889997665544333222211
Q ss_pred ------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 235 ------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 235 ------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...+++.+|+.++|..||+..++...++..|
T Consensus 237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 1135678899999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=246.33 Aligned_cols=238 Identities=25% Similarity=0.247 Sum_probs=187.1
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEec--CeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~ 87 (266)
++...+||.|++|.||++.. .+++.+++|.+..... .....+.+|+++++.++||||+++++++.+. +..++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 45566899999999999954 5678888887754332 2456788999999999999999999988543 468999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++++|.+++..... ....+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 83 CEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred cCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999999988765322 2356889999999999999999999999 999999999999999999999999998753211
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc----hhHHHHHHHHh--------c-
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA----TLAEWTEECRR--------N- 234 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~----~~~~~~~~~~~--------~- 234 (266)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.... ...+....... .
T Consensus 159 ------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 159 ------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred ------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence 1123456788999999988889999999999999999999999997652 11121111111 0
Q ss_pred --------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 --------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 --------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+..++.+
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1125677888888888888877654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=243.83 Aligned_cols=231 Identities=23% Similarity=0.285 Sum_probs=182.9
Q ss_pred hhccccccceEEEEE-cCCCcEEEEEEeeecccc---cHHHHHHHHHHH-hcCCCCCccccceeEEecCeEEEEEEecCC
Q 047020 16 IRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG---SRKIFLDEVSVL-LRVSHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
+.||.|++|.||++. ..+|+.+++|.+...... ....+..|..++ ...+|||++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 468999999999994 456889999977543211 112234444443 445799999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
++|.+++... +.+++..+..++.|++.||.+||+.+ ++|+||+|.||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999998764 56899999999999999999999999 99999999999999999999999998764211
Q ss_pred CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-------------Cch
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN-------------KNV 237 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~-------------~~~ 237 (266)
.....++..|++||.+.+..++.++|+||+|+++|+|++|..||...+....+....... ...
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAV 225 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHH
Confidence 234457888999999988888999999999999999999999997766554443332221 112
Q ss_pred hhhhhhccCCCCCcchHHHHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
+++.+|+..+|..||+...+.++++
T Consensus 226 ~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 226 DLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHccCCHHHccCCCcHHHHHc
Confidence 4577888888888887766666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=244.44 Aligned_cols=236 Identities=23% Similarity=0.293 Sum_probs=191.0
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+.....||.|+||.||++. ..+++.+++|...... ......+.+|+.+++.++||||+++++.+......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 34556689999999999994 4567888998764332 233456888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++.. ..+++..+..++.|++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+......
T Consensus 85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~- 154 (277)
T cd06641 85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT- 154 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccc-
Confidence 99999988864 56899999999999999999999999 999999999999999999999999988643221
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc----------Cchh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----------KNVE 238 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~ 238 (266)
........++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+............ ...+
T Consensus 155 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06641 155 ---QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE 231 (277)
T ss_pred ---hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHH
Confidence 112233567888999999988888899999999999999999999997655443333222111 1224
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+.+|+..+|..||+..++..
T Consensus 232 ~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 232 FVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred HHHHHccCChhhCcCHHHHHh
Confidence 677899999999999888776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=247.03 Aligned_cols=211 Identities=24% Similarity=0.267 Sum_probs=168.7
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCC-CCCccccceeEEecCe-----E
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGE-----Q 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~-----~ 81 (266)
+++....||+|+||.||++. ..+|+.+++|....... .....+.+|+.+++.++ ||||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 34556689999999999994 45788999997654332 23456788999999996 6999999998876655 8
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCceEEecccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADFGL 160 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~~l~dfg~ 160 (266)
+++|||+++ +|.+++..........+++..++.++.|++.||.|||+++ ++|+||+|+||+++. ++.++|+|||.
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999975 8888887643333357899999999999999999999999 999999999999998 88999999998
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHH
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE 229 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~ 229 (266)
+....... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+......+
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~ 223 (295)
T cd07837 158 GRAFSIPV----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH 223 (295)
T ss_pred ceecCCCc----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 87432211 11122356788999998754 4578899999999999999999999987766554443
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=249.17 Aligned_cols=237 Identities=27% Similarity=0.348 Sum_probs=186.6
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEec--CeEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 84 (266)
.+++....||+|++|.||++.. .+|+.+++|.+...... ......+|+.++++++|+||+++++++... +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 4566667899999999999954 56889999987644322 233456799999999999999999988655 468999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+. ++|.+++... ...+++..+..++.|++.|+.+||+.| ++|+||+|+||+++.++.++|+|||.+...
T Consensus 87 ~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 87 MEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99985 4788877652 156899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh----------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR---------- 233 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~---------- 233 (266)
.... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+...........
T Consensus 159 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPA----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CCcc----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 3221 11222345778999998865 56789999999999999999999999877655544333221
Q ss_pred -----------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 -----------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 -----------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+..+|..||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 1112467889999999999888765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=247.66 Aligned_cols=240 Identities=25% Similarity=0.283 Sum_probs=184.4
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.......||+|+||.||++ ...+|+.+++|++..... .....+.+|+.++.++. ||||+++++++......+++||+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4445568999999999999 456788999998764332 34556788999999996 99999999999888899999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ-ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
+. +++.++...........+++..+..++.|++.|++|||+. + ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 74 4665544332222236789999999999999999999974 8 99999999999999999999999999864321
Q ss_pred CCCCCCCcccccccCCCccCccccccc---cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHH-HHhc--------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTG---FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE-CRRN-------- 234 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~-~~~~-------- 234 (266)
. .......++..|+|||++.+. .++.++|+||+|+++|+|++|..||...+...+.... ....
T Consensus 161 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd06616 161 S-----IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235 (288)
T ss_pred C-----CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence 1 112234578889999998765 6889999999999999999999999765432222111 1110
Q ss_pred ------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++..
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0125678888999999998888754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=247.69 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=187.9
Q ss_pred HhhchhhhhccccccceEEEEEc-CCCc----EEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL-GDGN----FGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~-~~g~----~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
....+..+.||+|+||.||++.. .+|+ .+++|....... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 34445556899999999999954 3444 346665543222 2234678899999999999999999988654 467
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
++++|+++|+|.+++... ...+++..+..++.|++.|+.|||+++ ++|+||||+||++++++.++|+|||++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence 899999999999988653 245788999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK------ 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~------ 235 (266)
....... ........++..|+|||++.+..++.++|+||||+++|+|++ |..||.+..... .........
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 234 (303)
T cd05110 158 LLEGDEK--EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPP 234 (303)
T ss_pred cccCccc--ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCC
Confidence 5432211 111223345678999999988889999999999999999997 899997653221 222222111
Q ss_pred -----chhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 236 -----NVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 236 -----~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
..+++.+|+..+|..||+..++.+.++.+
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 12456789999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=252.09 Aligned_cols=207 Identities=21% Similarity=0.292 Sum_probs=168.2
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEe----cCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE----KGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~ 82 (266)
..+.....||.|++|.||++ ...+|+.+++|++..... .....+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 44556668999999999999 456789999998765322 234567789999999999999999988753 34689
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+|+||+. ++|.+.+... +.+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.+.
T Consensus 85 lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 9999995 5888887543 56899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhH
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLA 225 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~ 225 (266)
.................++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~ 219 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH
Confidence 543322222222234578889999998755 457899999999999999999999997765443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=247.76 Aligned_cols=205 Identities=26% Similarity=0.365 Sum_probs=165.1
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecC--------
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG-------- 79 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 79 (266)
+|.....||+|++|.||++. ..+++.+++|.+..... .....+.+|+++++.++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 46667799999999999994 45788999998754332 22345678999999999999999999876543
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
..++||||+. +++.+.+... ...+++..++.++.|++.|+.|||++| ++|+||+|+||+++.++.++|+|||
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999985 5787777542 246899999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCch
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSAT 223 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~ 223 (266)
.+..................++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9876443322211222345678889999988654 468899999999999999999999976654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=245.37 Aligned_cols=238 Identities=25% Similarity=0.337 Sum_probs=182.1
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHH-HhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSV-LLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+.+...||+|+||.||++. ..+|+.+++|++..... .....+..|+.. ++.++||||+++++++..++..+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 4556689999999999994 45789999998765432 223445556665 56678999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ-ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+ ++|.+++....... ..+++..++.++.|++.|+.|||++ + ++|+||||+||+++.++.++|+|||.+......
T Consensus 83 ~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 83 D-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred c-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 5 68888876543222 5789999999999999999999997 8 999999999999999999999999998753211
Q ss_pred CCCCCCcccccccCCCccCcccccc----ccCCCcccchhHHHHHHHHHhCCCCcCCC-chhHHHHHHHHhc--------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT----GFVSTKSDVYSFGVLLLELITGLKSIQGS-ATLAEWTEECRRN-------- 234 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~i~~~l~~g~~pf~~~-~~~~~~~~~~~~~-------- 234 (266)
.......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||... .............
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd06617 158 -----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232 (283)
T ss_pred -----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence 11223467888999998865 34688999999999999999999999643 2223222222211
Q ss_pred ---CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ---KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ---~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++..
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0124567888888888888877754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=252.62 Aligned_cols=203 Identities=25% Similarity=0.339 Sum_probs=164.6
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecC-----eEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG-----EQLL 83 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l 83 (266)
++.+...||+|++|.||++ ...+|+.+++|++.... ......+.+|+.+++.++||||+++++++.... ..++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 4556668999999999999 45678899999875322 223456778999999999999999998765443 5799
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
++||+. +++.+.+.. ..+++..++.++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++..
T Consensus 86 v~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 86 VQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred Eehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999985 588777654 57899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchh
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATL 224 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~ 224 (266)
....... ........++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+..
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~ 216 (336)
T cd07849 156 ADPEHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216 (336)
T ss_pred ccccccc-cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4322211 112233567889999998654 56888999999999999999999999776543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=265.75 Aligned_cols=231 Identities=23% Similarity=0.317 Sum_probs=192.3
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchhh
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFD 95 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
.||+|.||.||-+ +..+....+||-+..+.+...+-+.+|+.+.+.++|+|||++++.+..++.+-++||-.+||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999 455566788998888877788889999999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCceEEeccccccCCCCCCCCCC
Q 047020 96 RMHTYYGQSLGVL--SWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 96 ~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
+++.. . +++ ++.++..+..||+.||.|||.+. |+|||||-+||+++. .|-+||+|||-+.+...- .
T Consensus 662 LLrsk--W--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi----n 730 (1226)
T KOG4279|consen 662 LLRSK--W--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI----N 730 (1226)
T ss_pred HHHhc--c--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC----C
Confidence 99874 2 455 89999999999999999999999 999999999999984 678999999988764322 3
Q ss_pred CcccccccCCCccCcccccc--ccCCCcccchhHHHHHHHHHhCCCCcC--CCchhHHHHHHHH-h-cCch--------h
Q 047020 173 KRQTSIKGSFGYVDTNYLNT--GFVSTKSDVYSFGVLLLELITGLKSIQ--GSATLAEWTEECR-R-NKNV--------E 238 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~i~~~l~~g~~pf~--~~~~~~~~~~~~~-~-~~~~--------~ 238 (266)
.-..+..||..|||||++.. ++|+.++|||||||++.||.||++||. |.....++..-+- . ++.+ .
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~ 810 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKN 810 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHH
Confidence 44567899999999999854 478999999999999999999999994 3333333322111 1 1111 3
Q ss_pred hhhhhccCCCCCcchHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~ 258 (266)
.+.+++.|++..||+..++.
T Consensus 811 FilrcFepd~~~R~sA~~LL 830 (1226)
T KOG4279|consen 811 FILRCFEPDPCDRPSAKDLL 830 (1226)
T ss_pred HHHHHcCCCcccCccHHHhc
Confidence 56689999999999988764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=244.81 Aligned_cols=235 Identities=24% Similarity=0.326 Sum_probs=185.5
Q ss_pred hhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 13 DFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
++...||.|++|.||++. ..+|..+++|++..... .....+.+|+++++.++|||++++++++.+.+..++++||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 456789999999999994 45788999998764432 233567889999999999999999999999999999999994
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
++|.+++... ....+++..+..++.|++.+|.+||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 -~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~- 153 (283)
T cd07835 82 -LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV- 153 (283)
T ss_pred -cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence 6898888653 1136899999999999999999999999 9999999999999999999999999987432211
Q ss_pred CCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh---------------
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR--------------- 233 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~--------------- 233 (266)
.......++..|+|||++.+. .++.++|+||+|+++|+|++|..||.+.+......+....
T Consensus 154 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 ---RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred ---cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 111223467889999987654 5688999999999999999999999876654443332211
Q ss_pred -----------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 -----------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 -----------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+.++|..||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 0112466788888888888877764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=245.28 Aligned_cols=205 Identities=27% Similarity=0.356 Sum_probs=167.8
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEec--CeEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 84 (266)
.++.+...||.|++|.||++.. .++..+++|++..... .....+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 3567777999999999999954 4678889988764332 2234567899999999999999999988777 789999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
+||++ ++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99996 4888887653 136899999999999999999999999 999999999999999999999999988754
Q ss_pred CCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHH
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAE 226 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~ 226 (266)
.... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+....
T Consensus 157 ~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~ 215 (293)
T cd07843 157 GSPL----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ 215 (293)
T ss_pred cCCc----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 3221 122334567889999988654 468899999999999999999999976654443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=259.87 Aligned_cols=227 Identities=26% Similarity=0.342 Sum_probs=192.7
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||.|+||.||-+ +....+.|+||++.-.... ....+..|+.+|++++|||++.|-++|......|+|||||-| |
T Consensus 33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-S 111 (948)
T KOG0577|consen 33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-S 111 (948)
T ss_pred HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-c
Confidence 6999999999999 5567788999987543333 346788999999999999999999999999999999999954 7
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
-.|++.-. .+++.+..+..+..+.+.||+|||+.+ .+|||||..||++++.|.+||+|||+|.. -
T Consensus 112 AsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi--------~ 176 (948)
T KOG0577|consen 112 ASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASI--------M 176 (948)
T ss_pred HHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhh--------c
Confidence 77766543 267899999999999999999999999 99999999999999999999999999875 4
Q ss_pred CcccccccCCCccCcccc---ccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-h----------h
Q 047020 173 KRQTSIKGSFGYVDTNYL---NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-V----------E 238 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~---~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~----------~ 238 (266)
.+.+.+.||+.|||||++ ..+.|+-++||||||+++.+|...++|...-|...-++.+..+... + +
T Consensus 177 ~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~ 256 (948)
T KOG0577|consen 177 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 256 (948)
T ss_pred CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHH
Confidence 567789999999999997 4567899999999999999999999999877777767666654322 1 3
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+..|+..-|..||+.+++.+
T Consensus 257 Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 257 FVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHhhCcccCCcHHHHhh
Confidence 456788888889998888754
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=265.79 Aligned_cols=204 Identities=19% Similarity=0.208 Sum_probs=156.7
Q ss_pred HHhhchhhhhccccccceEEEEEcCC--CcEEEEEE--------------e---eecccccHHHHHHHHHHHhcCCCCCc
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELGD--GNFGAVKR--------------V---MEERGGSRKIFLDEVSVLLRVSHPNL 68 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~~--g~~~~vk~--------------~---~~~~~~~~~~~~~e~~~l~~l~~~~i 68 (266)
....|++...||+|+||.||++.... +...+.+. + ..........+.+|+++++.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34567777799999999999985422 11111110 0 01111234557889999999999999
Q ss_pred cccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe
Q 047020 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~ 148 (266)
+++++++...+..+++++++ ++++.+++...............+..++.|++.||.|||++| |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 99999999999999999988 457877765432221233456678889999999999999999 99999999999999
Q ss_pred cCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCc
Q 047020 149 DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSI 218 (266)
Q Consensus 149 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf 218 (266)
.++.++|+|||++....... ........||..|+|||++.+..++.++|||||||++|+|++|..++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKER---EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCccc---ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999997543221 12223457899999999999999999999999999999999987544
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=245.21 Aligned_cols=237 Identities=24% Similarity=0.283 Sum_probs=184.1
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
++++...||+|++|.+|++.. .+|+.+++|++..... .....+.+|+++++.++||||+++++++.+....++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 456677999999999999954 5788899998754322 2345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCceEEeccccccCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADFGLCKLGPF 166 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~~l~dfg~~~~~~~ 166 (266)
++ +++.+.+... ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++. ++.++|+|||++.....
T Consensus 83 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 83 LD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 95 5787777542 2234678889999999999999999999 999999999999985 55799999999874321
Q ss_pred CCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh------------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR------------ 233 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~------------ 233 (266)
. ........++..|+|||++.+ ..++.++|+||+|+++|+|++|..||.+........+....
T Consensus 156 ~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 156 P----VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred C----ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 1 111223456788999998865 45788999999999999999999999776554444332210
Q ss_pred --------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 --------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 --------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+..+|..||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l 282 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh
Confidence 0012466788888888888877764
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=248.54 Aligned_cols=233 Identities=23% Similarity=0.274 Sum_probs=190.0
Q ss_pred hhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 13 DFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
++..+||+|+||.||.+ ...+|..+++|++.-. ...+.+..|+.++++...|++|++|+.+.....+++|||||..|
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 34458999999999999 5567999999987543 45678899999999999999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
|+.|.++.. ..++++.++..++...+.+|.|||... -+|||||..||+++.+|..||.|||.|....+ .
T Consensus 114 SiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD----T 182 (502)
T KOG0574|consen 114 SISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD----T 182 (502)
T ss_pred cHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh----h
Confidence 999988763 368999999999999999999999998 99999999999999999999999999875322 2
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH------------HhcCchhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC------------RRNKNVEV 239 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~------------~~~~~~~~ 239 (266)
-...++..||+.|||||++..-.|..++||||||++..+|..|++||.+.+..--..-+- ....-.+.
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDF 262 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHH
Confidence 234567889999999999999999999999999999999999999997653221110000 01111145
Q ss_pred hhhhccCCCCCcchHHHHH
Q 047020 240 WAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 240 ~~~~l~~~~~~~~~~~~l~ 258 (266)
+++|+-..|..|.+..+|.
T Consensus 263 i~~CLiK~PE~R~TA~~L~ 281 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLC 281 (502)
T ss_pred HHHHhcCCHHHHHHHHHHh
Confidence 5667766666666655543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=251.37 Aligned_cols=238 Identities=23% Similarity=0.276 Sum_probs=190.5
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecC-----eEEE
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG-----EQLL 83 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l 83 (266)
+.+...||.|++|.||++.. .+|+.+++|++.... ....+.+.+|+++++.++||||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 56677999999999999954 458899999876543 334567889999999999999999999887765 7899
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
+|+|+. ++|.+.+... ..+++..+..++.|++.|+.+||+.| ++|+||||+||+++.++.++|+|||.+..
T Consensus 82 v~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 82 VTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred Eecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 999986 5888887653 47899999999999999999999999 99999999999999999999999999886
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh---------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR--------- 233 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~--------- 233 (266)
....... ........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+.......+...
T Consensus 153 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 153 VDPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred ecccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 4332210 1122344678889999999877 7899999999999999999999999877655444333221
Q ss_pred -------------------------------cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 -------------------------------NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 -------------------------------~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..||+.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 01124677788888888888777654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=239.55 Aligned_cols=235 Identities=28% Similarity=0.377 Sum_probs=192.0
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+.+...||+|++|.+|++. ..+++.+++|....... .....+.+|++++++++|||++++++++.+....++++|++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 4556789999999999994 45678899988765543 34567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+++... +.+++..+..++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 82 ENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999998764 67899999999999999999999999 9999999999999999999999999988643222
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh----------cCchh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR----------NKNVE 238 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~ 238 (266)
. ......++..|+|||...+..++.++|+||+|+++|+|++|..||...+........... ....+
T Consensus 154 ~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (254)
T cd06627 154 K----DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD 229 (254)
T ss_pred c----cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence 1 123456788899999998877889999999999999999999999766544444332211 11124
Q ss_pred hhhhhccCCCCCcchHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~ 258 (266)
.+.+|+.++|..||+.+++.
T Consensus 230 ~i~~~l~~~p~~R~~~~~~l 249 (254)
T cd06627 230 FLMQCFQKDPNLRPTAKQLL 249 (254)
T ss_pred HHHHHHhCChhhCcCHHHHh
Confidence 56778888888888877664
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=239.40 Aligned_cols=240 Identities=25% Similarity=0.349 Sum_probs=194.1
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+.+...||.|++|.+|++.. .++..+++|.+..... .....+.+|+++++.++|||++++.+.+......++++|++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 45566899999999999944 4688889988765433 34567889999999999999999999999989999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+.+..... ....+++..+..++.+++.++.+||+.| ++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 82 DGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred CCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999998876421 2367899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh----------cCchh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR----------NKNVE 238 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~ 238 (266)
.......++..|+|||...+..++.++|+||+|+++++|++|..||...+........... ....+
T Consensus 158 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd08215 158 ----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRN 233 (258)
T ss_pred ----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 2334456888999999998888999999999999999999999999776533333222221 11124
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+.+|+..+|..||+..++..
T Consensus 234 ~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 234 LVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHHcCCChhhCcCHHHHhc
Confidence 667888888888888887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=244.92 Aligned_cols=240 Identities=29% Similarity=0.402 Sum_probs=194.6
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.|.+...||+|++|.||++.. .+|+.+++|...... ......+.+|.+++++++ ||||+++++++.+.+..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 355667899999999999944 578888888765421 123456788999999998 999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
|++.+++|.+++... +.+++..++.++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 82 EYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999764 57999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCCC----------------CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHH
Q 047020 166 FNDPNR----------------PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE 229 (266)
Q Consensus 166 ~~~~~~----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~ 229 (266)
...... ........++..|+|||+..+..++.++|+||+|++++++++|..||...+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 322110 1222345678899999999888889999999999999999999999987765444443
Q ss_pred HHHhc---------CchhhhhhhccCCCCCcchH----HHHH
Q 047020 230 ECRRN---------KNVEVWAQMLDPKLNGDANM----EQLR 258 (266)
Q Consensus 230 ~~~~~---------~~~~~~~~~l~~~~~~~~~~----~~l~ 258 (266)
..... ...+++.+|+..+|..||+. +++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 234 ILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 33221 11267789999999999988 6654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=245.99 Aligned_cols=248 Identities=17% Similarity=0.183 Sum_probs=172.8
Q ss_pred HHHHHhhchhhhhccccccceEEEEEcCCC----cEEEEEEeeeccccc-H----------HHHHHHHHHHhcCCCCCcc
Q 047020 5 EELKMATNDFRIRIGVGATSFVYLAELGDG----NFGAVKRVMEERGGS-R----------KIFLDEVSVLLRVSHPNLV 69 (266)
Q Consensus 5 ~~i~~~~~~~~~~ig~g~~~~v~~~~~~~g----~~~~vk~~~~~~~~~-~----------~~~~~e~~~l~~l~~~~i~ 69 (266)
.++...++.+.+.||+|+||.||++...++ ..+++|......... . .....+...+..+.|++++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 455566778888999999999999965433 344444322211110 0 1112333445567899999
Q ss_pred ccceeEEecC----eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcE
Q 047020 70 GLLGFCLEKG----EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNI 145 (266)
Q Consensus 70 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 145 (266)
++++.+.... ..+++++++ ..++.+.+... ...++..+..++.|++.|+.|||+.+ ++||||||+||
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Ni 157 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENI 157 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 9998765443 346777766 34666666542 34578888999999999999999999 99999999999
Q ss_pred EEecCCceEEeccccccCCCCCCCC---CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 146 LLIDDNHAKLADFGLCKLGPFNDPN---RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
+++.++.++|+|||+++........ .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999998754322111 1122234579999999999999999999999999999999999999997663
Q ss_pred hhHH--------HHHHHHhcC---------chhhhhhhccCCCCCcchHHHHHHHH
Q 047020 223 TLAE--------WTEECRRNK---------NVEVWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 223 ~~~~--------~~~~~~~~~---------~~~~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
.... +.+.+.... ..+.+..++..++..||+.++|.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 3221 111111110 11455667777777777777777654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=250.09 Aligned_cols=234 Identities=24% Similarity=0.343 Sum_probs=195.4
Q ss_pred HHHHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCC-CCCccccceeEEecCe
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGE 80 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 80 (266)
-|.....+|...||+|+||.|.++ ..++.+.++||.+.+.. +...+--..|-++|.... -|.++.++..|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 355566788889999999999999 66778888998765432 122333445666766664 6899999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
+|+||||+.||+|--.+++. +.+.+..+..++.+|+-||-+||++| |++||||.+||+++.+|++||.|||.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred eeeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccc
Confidence 99999999999999888876 88999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch---
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV--- 237 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--- 237 (266)
+.. +........+..||+.|+|||.+...+|+.++|+||+|+++|||+.|+.||+|+++...+..+...+...
T Consensus 497 cKE----ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs 572 (683)
T KOG0696|consen 497 CKE----NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS 572 (683)
T ss_pred ccc----cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc
Confidence 874 3333455677899999999999999999999999999999999999999999999999998888765443
Q ss_pred ------hhhhhhccCCCCCc
Q 047020 238 ------EVWAQMLDPKLNGD 251 (266)
Q Consensus 238 ------~~~~~~l~~~~~~~ 251 (266)
.+...++...|.+|
T Consensus 573 lSkEAv~ickg~ltK~P~kR 592 (683)
T KOG0696|consen 573 LSKEAVAICKGLLTKHPGKR 592 (683)
T ss_pred ccHHHHHHHHHHhhcCCccc
Confidence 23344555555544
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=244.03 Aligned_cols=205 Identities=30% Similarity=0.400 Sum_probs=168.6
Q ss_pred hhhhhccccccceEEEEEc-CCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEec--CeEEEEEEe
Q 047020 13 DFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQLLLLEY 87 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~ 87 (266)
++...||.|++|.||++.. .+|+.+++|.+.... ......+.+|+++++.++|||++++++++... +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 4556899999999999954 458889999887653 33456678899999999999999999999887 789999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++ +|.+++... ...+++..+..++.|++.|+.+||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~~~-~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 82 MDH-DLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-cHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 964 888877542 147899999999999999999999999 999999999999999999999999998754332
Q ss_pred CCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHH
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT 228 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~ 228 (266)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+......
T Consensus 154 ~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~ 212 (287)
T cd07840 154 NS---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212 (287)
T ss_pred Cc---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 21 12233456788999998765 357889999999999999999999998766544433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=239.71 Aligned_cols=237 Identities=24% Similarity=0.346 Sum_probs=188.4
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+.+...||.|++|.||++.. .+|+.+++|.+.... ......+.+|+++++.++|+||+++++.+.+.+..++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 45566899999999999944 567888888775432 123456789999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc-eEEeccccccCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH-AKLADFGLCKLGPFN 167 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~-~~l~dfg~~~~~~~~ 167 (266)
.+++|.+++... ....+++..+..++.|++.++.+||+.+ ++|+||+|+||++++++. ++|+|||.+......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 82 DGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999988753 2235789999999999999999999999 999999999999988764 699999988754321
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc----------Cch
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----------KNV 237 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~ 237 (266)
. .......++..|+|||+..+..++.++|+||+|+++|+|++|..||...+............ ...
T Consensus 156 ~----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd08225 156 M----ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLR 231 (257)
T ss_pred c----ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHH
Confidence 1 11223457888999999988888999999999999999999999997665444443332211 112
Q ss_pred hhhhhhccCCCCCcchHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~ 258 (266)
+++.+|+..+|..||+.+++.
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~ll 252 (257)
T cd08225 232 SLISQLFKVSPRDRPSITSIL 252 (257)
T ss_pred HHHHHHhccChhhCcCHHHHh
Confidence 456788888888888877764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=244.63 Aligned_cols=232 Identities=25% Similarity=0.320 Sum_probs=186.6
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+.....||+|+||.+|++. ..+|..+++|.+..... .....+.+|+++++.++|||++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 4555689999999999995 45688889987754322 2234678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.| ++.+.+... ..++++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 107 ~~g-~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~-- 176 (317)
T cd06635 107 CLG-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS-- 176 (317)
T ss_pred CCC-CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC--
Confidence 964 777776542 256899999999999999999999999 9999999999999999999999999876422
Q ss_pred CCCCCCcccccccCCCccCccccc---cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLN---TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--------- 235 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 235 (266)
......++..|+|||++. ...++.++|+||+|+++|+|++|..||.+.+.............
T Consensus 177 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (317)
T cd06635 177 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS 250 (317)
T ss_pred ------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCcccc
Confidence 122346788899999873 45678899999999999999999999977655544443333211
Q ss_pred --chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 --NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 --~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+..++..
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHh
Confidence 125677899999999999888775
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=237.61 Aligned_cols=235 Identities=27% Similarity=0.383 Sum_probs=191.8
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCC
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
|.....||+|++|.+|++.. .++..+++|+...........+.+|++++++++||+++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 34556899999999999955 46788899887665544567889999999999999999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
++|.+++... ...+++..+..++.|++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 82 GSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 9999988763 157899999999999999999999999 99999999999999999999999999875332211
Q ss_pred CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh------------cCchh
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR------------NKNVE 238 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~------------~~~~~ 238 (266)
.....++..|+|||.+.+...+.++|+||+|+++|+|++|..||...+........... ....+
T Consensus 154 ----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229 (253)
T ss_pred ----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHH
Confidence 34567888999999998888899999999999999999999999766433322222111 11135
Q ss_pred hhhhhccCCCCCcchHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~ 258 (266)
++.+|+..+|..||+..++.
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l 249 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLL 249 (253)
T ss_pred HHHHHccCChhhCCCHHHHh
Confidence 66788888888888877764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=242.12 Aligned_cols=232 Identities=24% Similarity=0.344 Sum_probs=180.6
Q ss_pred hhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCC-CCCccccceeEEec--CeEEEEEEe
Q 047020 13 DFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEK--GEQLLLLEY 87 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~e~ 87 (266)
.+..+||+|++|.||++. ..++..+++|+...... .......+|+..+.++. |||++++++++.+. +..++||||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 456689999999999994 45788899998765322 22334457888888886 99999999999887 889999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+. +++.+.+... ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++. +.++|+|||.+......
T Consensus 82 ~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 82 MD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred CC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 96 5888877652 146899999999999999999999999 999999999999999 99999999998753221
Q ss_pred CCCCCCcccccccCCCccCccccc-cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh-------------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLN-TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR------------- 233 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~------------- 233 (266)
. ......++..|+|||++. +..++.++|+||+||++|+|++|..||.+.+..+........
T Consensus 153 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 P-----PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred C-----CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 1 112345788899999764 445688999999999999999999999877654433222110
Q ss_pred -------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 -------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 -------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+.++|..||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l 277 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHh
Confidence 1112456778888888888877764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=239.98 Aligned_cols=225 Identities=22% Similarity=0.298 Sum_probs=178.9
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEe----cCeEEEEEEecCC
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLE----KGEQLLLLEYLAN 90 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----~~~~~lv~e~~~~ 90 (266)
+||-|-.|.|..+ ...+|+.+++|.+.. .....+|+++.=..+ |||||.++++|.+ ..-+.+|||.++|
T Consensus 69 vLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 69 VLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 7999999999999 455788888886633 344667888877775 9999999998753 3456799999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC---CceEEeccccccCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD---NHAKLADFGLCKLGPFN 167 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~~~l~dfg~~~~~~~~ 167 (266)
|.|++.+... ....|++.++.+++.||+.|+.|||+.+ |.||||||+|+|...+ ..+||+|||+|..
T Consensus 144 GeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~---- 213 (400)
T KOG0604|consen 144 GELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE---- 213 (400)
T ss_pred hHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccc----
Confidence 9999999884 3356999999999999999999999999 9999999999999754 4589999999985
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh----HHHHHHH------------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL----AEWTEEC------------ 231 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~----~~~~~~~------------ 231 (266)
+.......+..-|+.|.|||++....|+..+|+||+|+++|-|++|.+||-...-. ..-.++.
T Consensus 214 -t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs 292 (400)
T KOG0604|consen 214 -TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS 292 (400)
T ss_pred -cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh
Confidence 22345566788999999999999999999999999999999999999999322111 1111111
Q ss_pred -HhcCchhhhhhhccCCCCCcchHHHH
Q 047020 232 -RRNKNVEVWAQMLDPKLNGDANMEQL 257 (266)
Q Consensus 232 -~~~~~~~~~~~~l~~~~~~~~~~~~l 257 (266)
.....-++++.++..+|..|-+.+++
T Consensus 293 ~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 293 CVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred HHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 11122357778888888888777665
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=240.84 Aligned_cols=228 Identities=21% Similarity=0.287 Sum_probs=174.9
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeecccc---cHHHHHHHHH---HHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG---SRKIFLDEVS---VLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~---~~~~~~~e~~---~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.||+|+||.||++. ..+|+.+++|.+...... ....+..|.. .++...||+|+++++.+.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999994 456889999987653221 1222333433 3444579999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
|++|.+++... +.+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-- 150 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--
Confidence 99999888653 57899999999999999999999999 999999999999999999999999988643211
Q ss_pred CCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCch---hHHHHHHHHh---------cCc
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSAT---LAEWTEECRR---------NKN 236 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~---~~~~~~~~~~---------~~~ 236 (266)
......|+..|+|||++.+. .++.++|+||+|+++|+|++|..||.+... .......... ...
T Consensus 151 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 226 (278)
T cd05606 151 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226 (278)
T ss_pred ----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHH
Confidence 12334688999999998644 688999999999999999999999976522 1111111110 112
Q ss_pred hhhhhhhccCCCCCcc-----hHHHHH
Q 047020 237 VEVWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
.+++.+|+..++..|+ +.+++.
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~ll 253 (278)
T cd05606 227 RSLLEGLLQRDVNRRLGCLGRGAQEVK 253 (278)
T ss_pred HHHHHHHhhcCHHhccCCCCCCHHHHH
Confidence 2567778888888887 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=243.04 Aligned_cols=228 Identities=21% Similarity=0.288 Sum_probs=173.5
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeecccc---cHHHHHHHHHHHhc---CCCCCccccceeEEecCeEEEEEEecC
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLR---VSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~---l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.||+|+||.||++. ..+|..+++|.+...... ....+.+|..+++. .+||+|+.+++.+...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999994 456889999977543221 12233444444443 468999999999998889999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++... +.+++..+..++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~--- 149 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK--- 149 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccc---
Confidence 99999988764 57899999999999999999999999 99999999999999999999999998864221
Q ss_pred CCCCcccccccCCCccCccccc-cccCCCcccchhHHHHHHHHHhCCCCcCCCchh--HHHHHHHH----------hcCc
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLN-TGFVSTKSDVYSFGVLLLELITGLKSIQGSATL--AEWTEECR----------RNKN 236 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~--~~~~~~~~----------~~~~ 236 (266)
.......++..|+|||... +..++.++|+||+||++|+|++|..||.+.... ........ ....
T Consensus 150 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (279)
T cd05633 150 ---KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPEL 226 (279)
T ss_pred ---cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHH
Confidence 1122346889999999886 456789999999999999999999999653221 11111110 0111
Q ss_pred hhhhhhhccCCCCCcc-----hHHHHH
Q 047020 237 VEVWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
.+++.+|+..+|..|+ +.+++.
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~~~ 253 (279)
T cd05633 227 KSLLEGLLQRDVSKRLGCLGRGAQEVK 253 (279)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 2567788888888887 355554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=250.24 Aligned_cols=238 Identities=21% Similarity=0.275 Sum_probs=184.8
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEec----------
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK---------- 78 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---------- 78 (266)
.++.+...||.|+||.||++ ...+|+.+++|++..........+.+|+++++.++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 45666679999999999999 4567889999988666555567788999999999999999999766543
Q ss_pred ----CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCce
Q 047020 79 ----GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHA 153 (266)
Q Consensus 79 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~ 153 (266)
...++++||+. ++|.+.+.. ..+++..++.++.|++.|+.|||+.| ++|+||||+||+++. ++.+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999996 588877754 46899999999999999999999999 999999999999974 4578
Q ss_pred EEeccccccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 154 KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 154 ~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
+|+|||.+......... ........++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..........
T Consensus 155 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 155 KIGDFGLARIVDPHYSH-KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EECCcccceecCCcccc-ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999998753221111 111123356888999997643 5678899999999999999999999987665544433222
Q ss_pred hc---------------------------------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 233 RN---------------------------------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 233 ~~---------------------------------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
.. ...+++.+|+.++|..||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 10 011467788888888888888765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=244.84 Aligned_cols=234 Identities=25% Similarity=0.285 Sum_probs=186.2
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
..++....||+|++|.||++.. .+|+.+++|.+...... ....+.+|+++++.++||||+++++++.+....++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 3456667899999999999954 56888999977543222 2356788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+. +++.+.+... ...+++..+..++.|++.++.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9986 5777766532 146899999999999999999999999 9999999999999999999999999886432
Q ss_pred CCCCCCCCcccccccCCCccCccccc---cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh---------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLN---TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR--------- 233 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~--------- 233 (266)
......++..|+|||++. ...++.++|+||||+++|+|++|..||.+.+...........
T Consensus 167 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (307)
T cd06607 167 --------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSND 238 (307)
T ss_pred --------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchh
Confidence 122345778899999873 456788999999999999999999999776554433322211
Q ss_pred --cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 --NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 --~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..||+..++..
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11235678899999999998877754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=248.31 Aligned_cols=235 Identities=22% Similarity=0.262 Sum_probs=183.9
Q ss_pred hhhccccccceEEEEE-cCCCcEEEEEEeeeccccc--------------HHHHHHHHHHHhcCCCCCccccceeEEecC
Q 047020 15 RIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGS--------------RKIFLDEVSVLLRVSHPNLVGLLGFCLEKG 79 (266)
Q Consensus 15 ~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~--------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 79 (266)
...||.|+||.||++. ..+++.+++|.+....... ...+.+|+++++.++||||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 3469999999999994 5578899999875432221 124678999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
..+++|||+. ++|.+++... ..+++..+..++.|++.|+.+||+.| ++|+||+|+||+++.++.++|+|||
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcc
Confidence 9999999996 5898888653 56899999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCCCC----------CCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHH
Q 047020 160 LCKLGPFNDP----------NRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT 228 (266)
Q Consensus 160 ~~~~~~~~~~----------~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~ 228 (266)
.+........ ..........++..|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9875431110 001111233467889999998654 46889999999999999999999998776554443
Q ss_pred HHHHh-------------------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 229 EECRR-------------------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 229 ~~~~~-------------------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
.+... ....+++.+|+..+|..||+.+++.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 32210 1112567788888888888877765
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=246.96 Aligned_cols=204 Identities=25% Similarity=0.271 Sum_probs=162.0
Q ss_pred hhcccc--ccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCC
Q 047020 16 IRIGVG--ATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 16 ~~ig~g--~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
..||+| +|+.||++. ..+|+.+++|....... ...+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 889999995 45789999998754322 2346778899999999999999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
+++.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999998876422 35889999999999999999999999 999999999999999999999999765322111110
Q ss_pred CC---CcccccccCCCccCccccccc--cCCCcccchhHHHHHHHHHhCCCCcCCCchhH
Q 047020 171 RP---KRQTSIKGSFGYVDTNYLNTG--FVSTKSDVYSFGVLLLELITGLKSIQGSATLA 225 (266)
Q Consensus 171 ~~---~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~ 225 (266)
.. .......++..|+|||++.+. .++.++|+||+||++|+|++|..||.+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 217 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH
Confidence 00 001122345679999998764 47889999999999999999999997655433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=239.58 Aligned_cols=220 Identities=22% Similarity=0.289 Sum_probs=171.5
Q ss_pred ccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCCchhh
Q 047020 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFD 95 (266)
Q Consensus 18 ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
||+|+||.||++. ..++..+++|......... .|......+ +||||+++++.+...+..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 5999999999994 4567777777664332111 133333333 69999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-ceEEeccccccCCCCCCCCCCCc
Q 047020 96 RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLGPFNDPNRPKR 174 (266)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~ 174 (266)
++... ..+++..+..++.|++.|+.+||+.| ++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 99 ~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~-------- 162 (267)
T PHA03390 99 LLKKE-----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT-------- 162 (267)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCC--------
Confidence 98763 47899999999999999999999999 99999999999999888 999999998875321
Q ss_pred ccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh----HHHHHHHHh---------cCchhhhh
Q 047020 175 QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL----AEWTEECRR---------NKNVEVWA 241 (266)
Q Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~----~~~~~~~~~---------~~~~~~~~ 241 (266)
.....++..|+|||++.+..++.++|+||+|+++|+|++|..||.+.... ..+...... ....+++.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (267)
T PHA03390 163 PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ 242 (267)
T ss_pred CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHH
Confidence 12345788999999998888999999999999999999999999754322 122111111 11124678
Q ss_pred hhccCCCCCcch-HHHHH
Q 047020 242 QMLDPKLNGDAN-MEQLR 258 (266)
Q Consensus 242 ~~l~~~~~~~~~-~~~l~ 258 (266)
+|+.++|..|++ .+++.
T Consensus 243 ~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 243 SMLKYNINYRLTNYNEII 260 (267)
T ss_pred HHhccChhhCCchHHHHh
Confidence 889999999985 36654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=238.42 Aligned_cols=238 Identities=25% Similarity=0.322 Sum_probs=192.7
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
++....||.|++|.+|++ ...+++.+++|...... ......+.+|+++++.++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 455668999999999999 45577888998875432 233456778999999999999999999999989999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++.... .....+++..++.++.|++.|+.+||+.| ++|+||+|.||++++++.++|+|||++......
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 82 PFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred CCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999886632 22256899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC----------chh
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----------NVE 238 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~~ 238 (266)
......++..|+|||...+..++.++|+||+|+++|+|++|..||...+............. ..+
T Consensus 157 -----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd08530 157 -----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQN 231 (256)
T ss_pred -----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHH
Confidence 22234578889999999888889999999999999999999999987654433222222111 125
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
++.+|+..++..||+.+++..
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhc
Confidence 677899999999999888753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=236.42 Aligned_cols=226 Identities=28% Similarity=0.349 Sum_probs=185.2
Q ss_pred ccccccceEEEEEc-CCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCch
Q 047020 18 IGVGATSFVYLAEL-GDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 18 ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
||+|++|.+|++.. .+++.+++|........ ....+..|++++++++||||+++++.+......+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999954 46888899877554322 345788899999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCC
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 173 (266)
.+++... ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----~ 148 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----S 148 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC----C
Confidence 9998764 46899999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred cccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc---------Cchhhhhhhc
Q 047020 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN---------KNVEVWAQML 244 (266)
Q Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~~l 244 (266)
......++..|++||...+...+.++|+||||+++|++++|..||...+............ ...+++.+|+
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 228 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLL 228 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence 2344567888999999988888999999999999999999999997766533333322211 1125667888
Q ss_pred cCCCCCcchHH
Q 047020 245 DPKLNGDANME 255 (266)
Q Consensus 245 ~~~~~~~~~~~ 255 (266)
..+|..||+..
T Consensus 229 ~~~p~~R~~~~ 239 (250)
T cd05123 229 QKDPTKRLGSG 239 (250)
T ss_pred cCCHhhCCCcc
Confidence 88888888883
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=247.02 Aligned_cols=204 Identities=24% Similarity=0.269 Sum_probs=162.7
Q ss_pred chhhhhccccccceEEEEEc-CC--CcEEEEEEeeeccc--ccHHHHHHHHHHHhcCC-CCCccccceeEEe----cCeE
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GD--GNFGAVKRVMEERG--GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLE----KGEQ 81 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~--g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----~~~~ 81 (266)
+.+...||+|+||.||++.. .+ +..+++|++..... ...+.+.+|++++++++ ||||+++++.+.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 45667899999999999954 34 77889998754322 23456778999999995 9999999986432 2457
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
+++++++. ++|.+.+... ..+++..+..++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||.+
T Consensus 82 ~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 82 YLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 88899874 6888887653 57899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchh
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATL 224 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~ 224 (266)
..................++..|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~ 216 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV 216 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH
Confidence 7543322211222334578899999998755 46889999999999999999999999776543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=245.90 Aligned_cols=210 Identities=27% Similarity=0.391 Sum_probs=168.5
Q ss_pred HHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeec--ccccHHHHHHHHHHHhcC-CCCCccccceeEEec--CeE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEE--RGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEK--GEQ 81 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~ 81 (266)
....+.+...||+|+||.+|++.. .+|+.+++|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 345677778999999999999954 46788999987542 222345677899999999 899999999987643 368
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+. ++|.+++.. +.+++..+..++.|++.||.+||+.| ++|+||+|+||+++.++.++|+|||.+
T Consensus 85 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999996 588888765 36788889999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCC-CCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHH
Q 047020 162 KLGPFNDPNR-PKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW 227 (266)
Q Consensus 162 ~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~ 227 (266)
.......... ........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~ 222 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL 222 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 7643322110 112233467889999998754 45788999999999999999999999876655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=247.05 Aligned_cols=199 Identities=24% Similarity=0.300 Sum_probs=163.8
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeec--ccccHHHHHHHHHHHhcCCCCCccccceeEEec-----CeEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEE--RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK-----GEQL 82 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 82 (266)
.|.....||+|+||.||++ +..+|+.+++|++... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 3455568999999999999 4567899999987543 222345677899999999999999999987544 3579
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+++||+. ++|.+++... +.+++..+..++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 86 lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 86 IVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 9999985 6888887653 67899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+
T Consensus 157 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 157 TTSEKG----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred ccCCCc----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 532211 22234467888999998754 468899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=242.91 Aligned_cols=201 Identities=21% Similarity=0.225 Sum_probs=159.9
Q ss_pred ccccccceEEEEEcCCCcEEEEEEeeec--ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchhh
Q 047020 18 IGVGATSFVYLAELGDGNFGAVKRVMEE--RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFD 95 (266)
Q Consensus 18 ig~g~~~~v~~~~~~~g~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
+|.|+++.++.... +|+.+++|++... .......+.+|+++++.++||||+++++++.+++..+++|||+++++|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 34444444444433 7899999987654 22345678899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC---CC
Q 047020 96 RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN---RP 172 (266)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~ 172 (266)
++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+||+.+......... ..
T Consensus 89 ~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 89 LLKTHF---PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 987642 245789999999999999999999999 999999999999999999999999988643221111 11
Q ss_pred CcccccccCCCccCcccccc--ccCCCcccchhHHHHHHHHHhCCCCcCCCchhH
Q 047020 173 KRQTSIKGSFGYVDTNYLNT--GFVSTKSDVYSFGVLLLELITGLKSIQGSATLA 225 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~ 225 (266)
.......++..|+|||++.. ..++.++|+||+|+++|+|++|..||.+.....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~ 217 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 11233456778999999865 357889999999999999999999997654433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=241.30 Aligned_cols=206 Identities=26% Similarity=0.340 Sum_probs=171.0
Q ss_pred hhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 13 DFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.+...||.|++|.+|++.. .+|+.+++|++...... ....+.+|+++++.++|+||+++++++...+..++++||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 4556899999999999954 56888899877544322 35677889999999999999999999999999999999986
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+ ++.+.+... ...+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~-~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 82 T-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred C-CHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 5 888777652 157899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHH
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE 230 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~ 230 (266)
.......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+...+..+.
T Consensus 153 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 153 ---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred ---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 112234577889999998766 7889999999999999999999999887776655443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=236.21 Aligned_cols=236 Identities=25% Similarity=0.309 Sum_probs=190.9
Q ss_pred hhhhhccccccceEEEEEcC-CCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEec--CeEEEEEEe
Q 047020 13 DFRIRIGVGATSFVYLAELG-DGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQLLLLEY 87 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~ 87 (266)
.....||+|++|.+|.+... ++..+++|....... ...+.+.+|++.+++++||||+++++.+... ...++++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34568999999999999554 688888887755432 3467788999999999999999999999888 889999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+++... ..+++..++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 83 VSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999998764 47899999999999999999999999 999999999999999999999999998754332
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh------------cC
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR------------NK 235 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~------------~~ 235 (266)
... .......++..|+|||...+...+.++|+||||+++|+|++|..||...+........... ..
T Consensus 155 ~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd06606 155 ETG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEE 232 (260)
T ss_pred ccc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHH
Confidence 210 1134466888999999998888999999999999999999999999776522222221111 11
Q ss_pred chhhhhhhccCCCCCcchHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++.+|+..+|..||+..++.
T Consensus 233 l~~~i~~~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 233 AKDFLRKCLRRDPKKRPTADELL 255 (260)
T ss_pred HHHHHHHhCcCChhhCCCHHHHh
Confidence 22567788888888888777654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=247.62 Aligned_cols=204 Identities=25% Similarity=0.346 Sum_probs=164.5
Q ss_pred HHHHHhhchhh--hhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEec-
Q 047020 5 EELKMATNDFR--IRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK- 78 (266)
Q Consensus 5 ~~i~~~~~~~~--~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 78 (266)
+++...+.+|. ..||+|+||.||++ ...+|+.+++|++..... .....+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44444555555 48999999999999 456788999998754321 2245677899999999999999999987543
Q ss_pred -----CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCce
Q 047020 79 -----GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHA 153 (266)
Q Consensus 79 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~ 153 (266)
...+++++++ +++|.+.+.. ..+++..++.++.|++.|+.|||+.| ++|+||||+||++++++.+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3467888876 7789887754 46899999999999999999999999 9999999999999999999
Q ss_pred EEeccccccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhH
Q 047020 154 KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLA 225 (266)
Q Consensus 154 ~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~ 225 (266)
+|+|||++.... .......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+...
T Consensus 160 kl~dfg~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 225 (345)
T cd07877 160 KILDFGLARHTD-------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225 (345)
T ss_pred EEeccccccccc-------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999987421 12233467888999998866 467889999999999999999999997655433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=247.34 Aligned_cols=231 Identities=23% Similarity=0.288 Sum_probs=183.7
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecC------eE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------EQ 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~ 81 (266)
+|.....||+|++|.||++ ...+|..++||++..... .....+.+|+++++.++||||+++++++.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 3445558999999999999 456788999998754322 22456788999999999999999999886553 45
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||+++ +++|.+++.. ..+++..+..++.|++.|+.+||+.| ++|+||||+||+++.++.++|+|||.+
T Consensus 96 ~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 8999998 7788887754 56899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------ 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------ 234 (266)
..... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+......+.....
T Consensus 166 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 166 RQTDS-------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccc-------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 75321 1223456888999998865 457889999999999999999999998776544443322210
Q ss_pred ----------------------------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 ----------------------------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 ----------------------------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+..++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 012566788888899998888765
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=240.44 Aligned_cols=228 Identities=25% Similarity=0.308 Sum_probs=183.0
Q ss_pred hhccccccceEEEEE-cCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 16 IRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.+||+|++|.||++. ..+|..+++|.+...... ....+.+|+++++.++|||++++++++.+....++||||+. +
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 469999999999995 456888888877543222 23457789999999999999999999999999999999995 5
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
++.+.+... ..++++..+..++.|++.++.|||+.| ++|+||+|+||+++.++.++|+|||++...
T Consensus 106 ~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~------- 171 (313)
T cd06633 106 SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS------- 171 (313)
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc-------
Confidence 777776542 246889999999999999999999999 999999999999999999999999987631
Q ss_pred CCcccccccCCCccCccccc---cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-----------ch
Q 047020 172 PKRQTSIKGSFGYVDTNYLN---TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-----------NV 237 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------~~ 237 (266)
.......++..|+|||++. +..++.++|+||||+++|+|++|..||.+.+............. ..
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
T cd06633 172 -SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR 250 (313)
T ss_pred -CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHH
Confidence 1223456788999999974 45678899999999999999999999977655444443332211 12
Q ss_pred hhhhhhccCCCCCcchHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
+++.+|+..+|..||+..++..
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 4667888899999988887653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=238.95 Aligned_cols=234 Identities=25% Similarity=0.338 Sum_probs=183.5
Q ss_pred hhhhhccccccceEEEEEcC-CCcEEEEEEeeecccc--cHHHHHHHHHHHhcC---CCCCccccceeEEecCe-----E
Q 047020 13 DFRIRIGVGATSFVYLAELG-DGNFGAVKRVMEERGG--SRKIFLDEVSVLLRV---SHPNLVGLLGFCLEKGE-----Q 81 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~-----~ 81 (266)
++...||+|++|.||++... +++.+++|.+...... ....+.+|+.+++++ +|||++++++++..... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45568999999999999654 5889999987643222 234456787777666 59999999999987776 8
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
+++||++. ++|.+++... ....+++..++.++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 82 ~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred EEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 99999986 4888887653 2235899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------- 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------- 234 (266)
....... ......++..|+|||++.+..++.++|+||+|+++|+|++|..||.+.+......+.....
T Consensus 155 ~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEM-----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCc-----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 7532221 1123346888999999988889999999999999999999999998877665554443311
Q ss_pred -----------------------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 -----------------------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 -----------------------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+.++|..||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 112456678888888888777654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=238.90 Aligned_cols=199 Identities=29% Similarity=0.344 Sum_probs=165.5
Q ss_pred chhhhhccccccceEEEEEc----CCCcEEEEEEeeeccc----ccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEE
Q 047020 12 NDFRIRIGVGATSFVYLAEL----GDGNFGAVKRVMEERG----GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 82 (266)
+++...||.|+||.||++.. .+|..+++|.+..... .....+.+|+.++++++ |++|+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 45567899999999999954 4688899988754321 23456778999999995 899999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+|+||+++++|.+++... ..+++..+..++.|++.|+.+||+.| ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 82 LILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999998763 56889999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccc--cCCCcccchhHHHHHHHHHhCCCCcCCC
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG--FVSTKSDVYSFGVLLLELITGLKSIQGS 221 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~i~~~l~~g~~pf~~~ 221 (266)
...... ........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...
T Consensus 154 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 154 EFHEDE---VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred eccccc---ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 532211 1122345678899999998653 4678899999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.82 Aligned_cols=235 Identities=23% Similarity=0.283 Sum_probs=184.8
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
..++.....||+|++|.||++. ..+++.+++|.+.... ......+.+|+++++.++|+|++++.+++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 3445555689999999999995 4567888898775421 12234677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
+||+. +++.+.+... ..++++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 94 ~e~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 94 MEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred EEccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceee
Confidence 99996 5777776532 245889999999999999999999999 999999999999999999999999988642
Q ss_pred CCCCCCCCCcccccccCCCccCccccc---cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLN---TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------- 234 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------- 234 (266)
. ......++..|+|||.+. ...++.++|+||+|+++|+|++|..||.+.+............
T Consensus 166 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06634 166 A--------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237 (308)
T ss_pred c--------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcc
Confidence 2 122345788899999874 3457889999999999999999999997654433332222211
Q ss_pred ----CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ----KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ----~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++..
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 1125677899999999998887764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=238.37 Aligned_cols=204 Identities=26% Similarity=0.346 Sum_probs=167.7
Q ss_pred hhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecC
Q 047020 13 DFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.+...||+|++|.||++.. .+++.+++|+....... ......+|+..+++++ |||++++++++.+++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 4567899999999999965 45788899887554332 2334567899999999 999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+.+... ....+++..+..++.|++.++.+||+++ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-- 152 (283)
T cd07830 81 EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-- 152 (283)
T ss_pred CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC--
Confidence 78998888763 1246899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCCCcccccccCCCccCccccc-cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHH
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLN-TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT 228 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~ 228 (266)
.......++..|+|||++. +..++.++|+||||+++++|++|..||.+.+..+...
T Consensus 153 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 153 ---PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred ---CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 1122345778899999874 4457889999999999999999999997776555443
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=245.50 Aligned_cols=228 Identities=23% Similarity=0.310 Sum_probs=178.3
Q ss_pred hhhhhccccccceEEEEE-cCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecC------eEEE
Q 047020 13 DFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------EQLL 83 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~~l 83 (266)
.....||+|++|.||++. ..+|+.+++|++.... ......+.+|+++++.++||||+++++++.... ..++
T Consensus 18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 333489999999999994 5678999999875432 223456788999999999999999999886543 4689
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
|+||+. .++.+... ..+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 98 v~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 98 VMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred Eecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 999985 46655432 35889999999999999999999999 99999999999999999999999999874
Q ss_pred CCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh---------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR--------- 233 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~--------- 233 (266)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+....+......
T Consensus 167 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 167 ADA-------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCC-------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 211 1223456788999999865 46788999999999999999999999877654444332221
Q ss_pred -------------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 -------------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 -------------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+..+|..||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0112567778888888888877765
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=236.55 Aligned_cols=239 Identities=21% Similarity=0.271 Sum_probs=184.3
Q ss_pred chhhhhccccccceEEEEEcC-CCcEEEEEEeeec-----ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 12 NDFRIRIGVGATSFVYLAELG-DGNFGAVKRVMEE-----RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
|.+...||+|++|.||++... .+....+|.+... .......+..|+.+++.++||||+++++++.+....++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 556678999999999999543 3333444433321 1123345677999999999999999999999889999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+++++|.+++..... ....+++..+..++.|++.|+.+||+.| ++|+||+|+||++++ +.++|+|||.+....
T Consensus 82 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 82 EYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999988865322 2357899999999999999999999999 999999999999975 569999999887532
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc----------C
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----------K 235 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----------~ 235 (266)
.. ........++..|+|||...+..++.++|+||+|+++|+|++|..||.+.............. .
T Consensus 157 ~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd08222 157 GS----CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ 232 (260)
T ss_pred CC----cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHH
Confidence 21 112234567888999999988888899999999999999999999997665544433332211 1
Q ss_pred chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++..
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhh
Confidence 124677888888888888877653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=244.67 Aligned_cols=201 Identities=24% Similarity=0.350 Sum_probs=165.1
Q ss_pred HHHHhhchhh--hhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEe-cC
Q 047020 6 ELKMATNDFR--IRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE-KG 79 (266)
Q Consensus 6 ~i~~~~~~~~--~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 79 (266)
++...+++|. ..||.|+||.||++ +..+|+.+++|++.... ......+.+|+++++.++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 4444455554 58999999999999 56688999999875432 2245667889999999999999999998865 55
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
..++++||+ +++|.+.++. ..+++..+..++.|++.|+.+||+.+ ++|+||+|.||++++++.++|+|||
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg 153 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFG 153 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccc
Confidence 789999998 5688887764 46788889999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCch
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSAT 223 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~ 223 (266)
.+..... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.
T Consensus 154 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 154 LARIQDP-------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred cccccCC-------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8874211 1123456778999998765 5688999999999999999999999976654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=244.25 Aligned_cols=246 Identities=25% Similarity=0.327 Sum_probs=188.2
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc-------cHHHHHHHHHHHhcCCCCCccccceeEE-ecC
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG-------SRKIFLDEVSVLLRVSHPNLVGLLGFCL-EKG 79 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~ 79 (266)
..+|-....||+|||+.||.+ ++....+++||.-....+. ..+...+|..+.+.|.||-||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 344555568999999999999 7778889999865433322 2345678999999999999999999985 556
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec---CCceEEe
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID---DNHAKLA 156 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~~~l~ 156 (266)
.+|-|+||++|.+|.-+++.+ ..+++..++.|+.||+.||.||... .+||+|-||||.||++.+ -|.+||.
T Consensus 542 sFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 788999999999999999886 7789999999999999999999988 699999999999999964 3689999
Q ss_pred ccccccCCCCCCCCCC---CcccccccCCCccCcccccc----ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHH
Q 047020 157 DFGLCKLGPFNDPNRP---KRQTSIKGSFGYVDTNYLNT----GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE 229 (266)
Q Consensus 157 dfg~~~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~ 229 (266)
|||++..+........ .......||..|++||.+-. ...+.++||||+|+|+|.+++|+-||...-.-. .
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---d 692 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---D 692 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---H
Confidence 9999998876554322 23355679999999998732 356889999999999999999999996542211 1
Q ss_pred HHHhcCchhhhhhhccCCCCCcchHHHHHHHHHHHhC
Q 047020 230 ECRRNKNVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 230 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~~ 266 (266)
++..+..+. .-=-.-|.+.-...+-..+|++|||
T Consensus 693 ILqeNTIlk---AtEVqFP~KPvVsseAkaFIRRCLa 726 (775)
T KOG1151|consen 693 ILQENTILK---ATEVQFPPKPVVSSEAKAFIRRCLA 726 (775)
T ss_pred HHhhhchhc---ceeccCCCCCccCHHHHHHHHHHHH
Confidence 122122111 1001222233344567899999986
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=239.80 Aligned_cols=210 Identities=29% Similarity=0.363 Sum_probs=168.0
Q ss_pred HHHHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecC---
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG--- 79 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 79 (266)
+.....+.+...||.|++|.||++.. .+|+.+++|.+..... .....+.+|+++++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 34556677778999999999999955 4678889988754332 23456778999999999999999999886544
Q ss_pred -------eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc
Q 047020 80 -------EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH 152 (266)
Q Consensus 80 -------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~ 152 (266)
..++++||+++ ++.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCc
Confidence 78999999965 676666542 246899999999999999999999999 999999999999999999
Q ss_pred eEEeccccccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHH
Q 047020 153 AKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAE 226 (266)
Q Consensus 153 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~ 226 (266)
++|+|||.+........ .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+....
T Consensus 155 ~kl~dfg~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~ 226 (302)
T cd07864 155 IKLADFGLARLYNSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226 (302)
T ss_pred EEeCcccccccccCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99999999875432221 11222345778999998864 3568899999999999999999999976654443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=253.71 Aligned_cols=234 Identities=24% Similarity=0.360 Sum_probs=189.9
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||-|+||.|.++ +.++...+++|.+.+..- ......+.|-.||.....+.||++|..|++.+.+|+||+|++||+
T Consensus 636 ~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGD 715 (1034)
T KOG0608|consen 636 TIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD 715 (1034)
T ss_pred eecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCcc
Confidence 6999999999999 666677778887755432 233445679999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC-----
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN----- 167 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~----- 167 (266)
+-.++... +-|.+..++.++.++..|+...|+.| ++||||||+||||+.+|+|||.|||+|+-.-..
T Consensus 716 mMSLLIrm-----gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 716 MMSLLIRM-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred HHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99998775 88999999999999999999999999 999999999999999999999999999641100
Q ss_pred ----CC-----------------------------CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhC
Q 047020 168 ----DP-----------------------------NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214 (266)
Q Consensus 168 ----~~-----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g 214 (266)
+. .+.......+||..|+|||++....++..+|+||.|+|+|+|+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 00 111223356899999999999999999999999999999999999
Q ss_pred CCCcCCCchhHHHHHHHHhcCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 215 LKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 215 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+.||.+......-.+ ..-|+..|+--+....+++.+..+.+-|.
T Consensus 868 ~~pf~~~tp~~tq~k-------v~nw~~~l~~~~~~~ls~e~~~li~kLc~ 911 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYK-------VINWRNFLHIPYQGNLSKEALDLIQKLCC 911 (1034)
T ss_pred CCCccCCCCCcceee-------eeehhhccccccccccCHHHHHHHHHHhc
Confidence 999976644332221 12355777777777777777666666664
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=240.74 Aligned_cols=211 Identities=25% Similarity=0.376 Sum_probs=165.8
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecC-------
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------- 79 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 79 (266)
.++.+...||.|++|.||++. ..+++.+++|++...... ....+.+|+++++.++||||+++++++....
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 456666789999999999994 456888999987654322 2345678999999999999999998774433
Q ss_pred -eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 80 -EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 80 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
..+++++|+.+ ++.+.+... ...+++..+..++.|++.||.|||++| ++|+||||+||++++++.++|+||
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 46999999854 676665431 256899999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCCCC-------CCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHH
Q 047020 159 GLCKLGPFNDPNR-------PKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT 228 (266)
Q Consensus 159 g~~~~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~ 228 (266)
|++.......... ........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+......
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~ 237 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9987543222111 111123456788999998755 357889999999999999999999998776654433
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=247.55 Aligned_cols=230 Identities=23% Similarity=0.279 Sum_probs=182.9
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCe------EE
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE------QL 82 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------~~ 82 (266)
|.+...||+|++|.+|++.. .+++.+++|.+.... ......+.+|+.++++++|||++++.+++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 44455899999999999954 567889999765422 2234567789999999999999999988766554 89
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+|+||+ +++|.+++.. ..+++..++.++.|++.|+.+||+.| ++|+||+|+||++++++.++|+|||.+.
T Consensus 97 lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 97 LVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccc
Confidence 999998 6799888865 56899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh--------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR-------- 233 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~-------- 233 (266)
.... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+....+..+...
T Consensus 167 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 167 HTDD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccc-------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 5321 1233456788999998755 36788999999999999999999999876655444332221
Q ss_pred --------------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 --------------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 --------------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+.++|..||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 1112567788888888888888764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=250.52 Aligned_cols=249 Identities=26% Similarity=0.311 Sum_probs=196.1
Q ss_pred hHHHHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeeccccc-HHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 4 LEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGS-RKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 4 ~~~i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
+.|.-.....++++||+|-||.|.++....+..+|||.++...... +..|..|+++|.+++||||+.++++|..++.++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 4555566677888999999999999988778999999987765543 578999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+|+||++.|+|.+++..+.... +.......++.||++|++||.+.+ ++|||+.+.|++++.++++||+|||.++
T Consensus 612 mI~EYmEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccc
Confidence 9999999999999998852222 344556679999999999999999 9999999999999999999999999988
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh--CCCCcCCCchhHHHH--HHHHhcCchh
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT--GLKSIQGSATLAEWT--EECRRNKNVE 238 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~--g~~pf~~~~~~~~~~--~~~~~~~~~~ 238 (266)
-.+.... ....+......+|||||.+.-..+++++|+|+||+++||+++ ...||..-...+-.. ..+...+...
T Consensus 686 ~lysg~y--y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 686 NLYSGDY--YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred ccccCCc--eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc
Confidence 5443332 233345567789999999999999999999999999999865 678996433222211 1111111111
Q ss_pred hhhhhccCCCCCcchHHHHHHHHHHHhC
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~~~~~~ 266 (266)
.--++.+..+..|.++|.+||.
T Consensus 764 ------~~l~~P~~cp~~lyelml~Cw~ 785 (807)
T KOG1094|consen 764 ------VVLSRPPACPQGLYELMLRCWR 785 (807)
T ss_pred ------eeccCCCcCcHHHHHHHHHHhc
Confidence 1123345677788888888883
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=239.97 Aligned_cols=241 Identities=25% Similarity=0.298 Sum_probs=187.3
Q ss_pred chhhhhccccccceEEEEEc----CCCcEEEEEEeeecc----cccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEE
Q 047020 12 NDFRIRIGVGATSFVYLAEL----GDGNFGAVKRVMEER----GGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 82 (266)
+.+...||.|++|.||++.. .++..+++|.+.... ......+.+|++++++++ ||+|+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 44566899999999999843 356788998775422 123456788999999995 999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+.+++|.+.+... ..+++..+..++.|++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++.
T Consensus 82 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 82 LILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999888653 56889999999999999999999999 9999999999999999999999999887
Q ss_pred CCCCCCCCCCCcccccccCCCccCcccccccc--CCCcccchhHHHHHHHHHhCCCCcCCCchh---HHHHHHH-Hh---
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGF--VSTKSDVYSFGVLLLELITGLKSIQGSATL---AEWTEEC-RR--- 233 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~i~~~l~~g~~pf~~~~~~---~~~~~~~-~~--- 233 (266)
...... ........++..|++||.+.+.. .+.++|+||+|+++|+|++|..||...... ....... ..
T Consensus 154 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd05583 154 EFLAEE---EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230 (288)
T ss_pred cccccc---ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC
Confidence 532211 11222345788999999986654 678999999999999999999999643221 1111111 11
Q ss_pred ------cCchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 234 ------NKNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 234 ------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
....+++.+|+..++..||+..++.++++.
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111256678899999999988877776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=255.16 Aligned_cols=236 Identities=23% Similarity=0.301 Sum_probs=193.2
Q ss_pred hhhhhccccccceEEEEEcCCCc-EEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 13 DFRIRIGVGATSFVYLAELGDGN-FGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~~g~-~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
+++..||-|+||.||.+..++-+ .-+.|.+..+...+...+.-|+++|....||+|+++++.|...+.++++.|||.||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 45568999999999999655444 44555555555667788999999999999999999999888889999999999998
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
-+...+-.. +..+.+.++..+++|++.||.|||++. |+|||||..||++.-+|.++|.|||.+.. ....
T Consensus 115 AVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK----n~~t 183 (1187)
T KOG0579|consen 115 AVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK----NKST 183 (1187)
T ss_pred hHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc----chhH
Confidence 887666543 467899999999999999999999999 99999999999999999999999998763 2333
Q ss_pred CCcccccccCCCccCcccc-----ccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc----------
Q 047020 172 PKRQTSIKGSFGYVDTNYL-----NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------- 236 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 236 (266)
......+.||+.|||||++ ...+|+.++||||||+++.+|..+.+|-..-+..--+.++.+..+.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~ 263 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR 263 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence 4455678999999999986 4558999999999999999999999998765554444444443222
Q ss_pred --hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 --VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 --~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+.+..++..+|..||+..+|.+
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhh
Confidence 15677899999999998887653
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=236.24 Aligned_cols=204 Identities=30% Similarity=0.400 Sum_probs=169.2
Q ss_pred hhhhhccccccceEEEEEc-CCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 13 DFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.+...||+|++|.+|++.. .+++.+++|...... ......+..|+++++.++|+|++++++++.+.+..++|+|+++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 3456899999999999954 458899998876543 2334667889999999999999999999999999999999986
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
++|.+++.... ..+++..+..++.|++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 -~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 152 (282)
T cd07829 82 -MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL- 152 (282)
T ss_pred -cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc-
Confidence 58999887631 46899999999999999999999999 9999999999999999999999999987532211
Q ss_pred CCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHH
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT 228 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~ 228 (266)
.......++..|+|||.+.+. .++.++|+||+|+++|++++|..||.+.+......
T Consensus 153 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 209 (282)
T cd07829 153 ---RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF 209 (282)
T ss_pred ---cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 122233456789999998766 78899999999999999999999998776555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=275.21 Aligned_cols=210 Identities=27% Similarity=0.338 Sum_probs=174.4
Q ss_pred hhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 13 DFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.....||.|.||.||.+ ...+|+..++|-+..... .......+|..+++.++|||+|+++++=.+++..+++||||+
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred ccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence 33448999999999999 777898889986644322 234567789999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+|+|.+.+..- +..++.....+..|++.|+.|||+.| |+||||||+||+++.+|-+|++|||.|..+..+..
T Consensus 1318 ~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1318 GGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred cCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999998762 45677777788999999999999999 99999999999999999999999999987654433
Q ss_pred CCCCcccccccCCCccCccccccc---cCCCcccchhHHHHHHHHHhCCCCcCC-CchhHHHHHH
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTG---FVSTKSDVYSFGVLLLELITGLKSIQG-SATLAEWTEE 230 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i~~~l~~g~~pf~~-~~~~~~~~~~ 230 (266)
..........||+.|||||++.+. +...+.||||+||+..||+||+.||.. +++....++.
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V 1454 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV 1454 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH
Confidence 334455677899999999999654 456789999999999999999999964 3444444433
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=242.20 Aligned_cols=209 Identities=22% Similarity=0.312 Sum_probs=176.7
Q ss_pred CChHHHHHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC--CC----Ccccccee
Q 047020 2 YALEELKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS--HP----NLVGLLGF 74 (266)
Q Consensus 2 ~~~~~i~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~--~~----~i~~~~~~ 74 (266)
|.+.|++..+|.....+|+|.||.|-.+ +...+..+++|.++.. +...+...-|+++++++. .| -++.+.++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 5677888888888889999999999999 5566788888866543 334566677999999994 33 45677788
Q ss_pred EEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-----
Q 047020 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID----- 149 (266)
Q Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~----- 149 (266)
|...++.|+|+|.+ |-|++|++++ ++..+++...++.|++|++.++.+||+.+ ++|.||||+||++.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence 99999999999977 7799999987 45678999999999999999999999999 999999999999832
Q ss_pred ---------------CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhC
Q 047020 150 ---------------DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214 (266)
Q Consensus 150 ---------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g 214 (266)
+..|+|+|||+|+.. .........|.+|.|||++.+.+|+.++||||+|||++|+.+|
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~-------~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFD-------HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCccee-------ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 124899999999852 2233678899999999999999999999999999999999999
Q ss_pred CCCcCCCchhH
Q 047020 215 LKSIQGSATLA 225 (266)
Q Consensus 215 ~~pf~~~~~~~ 225 (266)
...|++.+..+
T Consensus 306 ~~LFqtHen~E 316 (415)
T KOG0671|consen 306 ETLFQTHENLE 316 (415)
T ss_pred ceecccCCcHH
Confidence 99998876555
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=249.35 Aligned_cols=230 Identities=25% Similarity=0.320 Sum_probs=188.4
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..|.+...+|.|+|+.|-.+ ...++...++|.+.... ....+|+.++... +||||+++.+.+.+..+.++|||.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 34566778999999999888 55677888998876552 2234578777766 499999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE-ecCCceEEeccccccCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL-IDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~-~~~~~~~l~dfg~~~~~~~ 166 (266)
+.|+-+.+.+... +.....+..|+.+|+.|+.|||.+| ++|||+||+|||+ ++.++++|+|||.+....
T Consensus 398 l~g~ell~ri~~~------~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~- 467 (612)
T KOG0603|consen 398 LDGGELLRRIRSK------PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE- 467 (612)
T ss_pred ccccHHHHHHHhc------chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc-
Confidence 9998888877763 2333778889999999999999999 9999999999999 688999999999987421
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc--------Cchh
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN--------KNVE 238 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~--------~~~~ 238 (266)
.......-|..|.|||+.....++.++||||||+++|+|++|+.||.......+....+... ...+
T Consensus 468 ------~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKd 541 (612)
T KOG0603|consen 468 ------RSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKD 541 (612)
T ss_pred ------hhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHH
Confidence 12456678899999999999999999999999999999999999997665554444444433 1126
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
++++++..+|..|++.+++..
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHhccCChhhCcChhhhcc
Confidence 889999999999999998753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=238.24 Aligned_cols=245 Identities=27% Similarity=0.388 Sum_probs=184.4
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcC--CCCCccccceeEEecC----eEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV--SHPNLVGLLGFCLEKG----EQLL 83 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~----~~~l 83 (266)
..-++...||+|.||.||.+++ .++.||||.+.. .+.+.+++|-++++.. +|+||+++++.-.... .+++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3345666899999999999988 458999998854 3457788888888875 6999999998765444 8999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeecCCCCCCcEEEecCCceEEec
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA------DPPIIHRDIKSSNILLIDDNHAKLAD 157 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------~~~i~H~dikp~nil~~~~~~~~l~d 157 (266)
|++|-+.|||.++++. ..+++....+++..++.||+|||+.- +++|+|||||..|||+.++++..|+|
T Consensus 286 Vt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999999998 57899999999999999999999643 46899999999999999999999999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccccCC------CcccchhHHHHHHHHHhCCCCcC-CC-chhH-HHH
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVS------TKSDVYSFGVLLLELITGLKSIQ-GS-ATLA-EWT 228 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~------~~~Di~slG~i~~~l~~g~~pf~-~~-~~~~-~~~ 228 (266)
||+|........ ........||.+|||||++.+...- .++||||+|+++||+++...-++ +. .+.. -+.
T Consensus 360 FGLAl~~~p~~~--~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 360 FGLALRLEPGKP--QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred cceeEEecCCCC--CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999987654433 2233348899999999999775322 36999999999999998754442 11 0000 111
Q ss_pred HHHHhcCchh-----hhhhh----ccCCCCCcchHHHHHHHHHHHhC
Q 047020 229 EECRRNKNVE-----VWAQM----LDPKLNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 229 ~~~~~~~~~~-----~~~~~----l~~~~~~~~~~~~l~~~~~~~~~ 266 (266)
..+...+..+ ++++- +...+.+-+.+..+++.++.||+
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWD 484 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWD 484 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcC
Confidence 1222222221 11122 22333355888899999999995
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=234.63 Aligned_cols=237 Identities=23% Similarity=0.319 Sum_probs=181.0
Q ss_pred hhchhhhhccccccceEEEEEcC-CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG-DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 86 (266)
..+.+...||+|++|.||++... ++..++||.+..... .....+..|+.++.+.. ||||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 44566679999999999999665 488899998764332 23445666777776665 9999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
|+. +++.+++... ...+++..+..++.|++.++.|||+ .+ ++|+||+|+||++++++.++|+|||.+....
T Consensus 95 ~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 95 LMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred ccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 984 5777766542 2478899999999999999999997 58 9999999999999999999999999987532
Q ss_pred CCCCCCCCcccccccCCCccCcccccccc----CCCcccchhHHHHHHHHHhCCCCcCCCchh-HHHHHHHHhc------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGF----VSTKSDVYSFGVLLLELITGLKSIQGSATL-AEWTEECRRN------ 234 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~i~~~l~~g~~pf~~~~~~-~~~~~~~~~~------ 234 (266)
... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...... ..........
T Consensus 167 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 167 DSK-----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241 (296)
T ss_pred CCC-----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence 211 112335678899999986553 788999999999999999999999653322 2222221111
Q ss_pred ------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++..
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0125677888888888888877753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=246.47 Aligned_cols=209 Identities=21% Similarity=0.270 Sum_probs=182.9
Q ss_pred hhhhhccccccceEEEEEcCCCcE-EEEEEeee---cccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 13 DFRIRIGVGATSFVYLAELGDGNF-GAVKRVME---ERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~~g~~-~~vk~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+....||-|+||.|-++..+.... +++|.+.+ ..+.+.+....|-.+|...+.|+||++|-.|.++.+.|++||-|
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 344489999999999997665543 55554433 33445566778999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
-||.+|..++.. +.|++..+..++.-++.|+.|||++| |++|||||+|++++.+|-+||.|||.|..+.
T Consensus 503 lGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--- 571 (732)
T KOG0614|consen 503 LGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--- 571 (732)
T ss_pred cCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc---
Confidence 999999999885 88999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN 234 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (266)
......+..||+.|.|||.+.++..+.++|.||||+++|||++|.+||++.+....+.-+++.-
T Consensus 572 --~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 572 --SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred --cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 3455678999999999999999999999999999999999999999999999888887777653
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=248.40 Aligned_cols=234 Identities=26% Similarity=0.365 Sum_probs=191.4
Q ss_pred hhhhccccccceEEEEEc--CCCcE--EEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 14 FRIRIGVGATSFVYLAEL--GDGNF--GAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 14 ~~~~ig~g~~~~v~~~~~--~~g~~--~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.-+.||+|.||.|+++.+ ..|+. |+||.+...... ....|.+|+.+|.+|+|+|++++|++..+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 345899999999999943 34554 577766554443 56889999999999999999999999887 5788999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
+.|||.+.+++ -....|....+-.++.||+.|+.||.+++ ++|||+...|+++-....+||+|||+.+-+..+.
T Consensus 193 plGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 193 PLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred ccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999987 23367888889999999999999999999 9999999999999998899999999998765544
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcCchhhhhhhccCC
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPK 247 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 247 (266)
.. ........-...|+|||.++...++.++|+|++|+++|||++ |..||.|..-...+.++-.+. --
T Consensus 267 d~-Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-----------rL 334 (1039)
T KOG0199|consen 267 DM-YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-----------RL 334 (1039)
T ss_pred cc-eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-----------cC
Confidence 32 233344566778999999999999999999999999999998 899999987776665544221 22
Q ss_pred CCCcchHHHHHHHHHHHhC
Q 047020 248 LNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 248 ~~~~~~~~~l~~~~~~~~~ 266 (266)
++..+++++|.++|+.||+
T Consensus 335 pRPk~csedIY~imk~cWa 353 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWA 353 (1039)
T ss_pred CCCCCChHHHHHHHHHhcc
Confidence 3345778888888888886
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=231.76 Aligned_cols=206 Identities=26% Similarity=0.341 Sum_probs=171.3
Q ss_pred hchhhhhccccccceEEEE-EcCC----CcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEe-cCeEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGD----GNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE-KGEQL 82 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~----g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 82 (266)
.|+....||+|.+|.||+| ..++ .+..++|++...++ +......+|+.+++.++|||++.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 3455568999999999999 3322 23678888866543 456778899999999999999999998866 77899
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC----CceEEecc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD----NHAKLADF 158 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~----~~~~l~df 158 (266)
+++||.+. +|+..|+-++......++...+..+++||+.|+.|||++= +.||||||.||++..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999855 9999999877766678999999999999999999999996 9999999999999876 89999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCC
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGS 221 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~ 221 (266)
|+++....+-. ........+-|..|+|||.+.|. .|+.+.|+||+|||+.||++-.+.|.+.
T Consensus 181 GlaR~~~~plk-pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 181 GLARLFNNPLK-PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cHHHHhhcccc-ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99987433221 12344567788999999988664 7999999999999999999999888654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=228.22 Aligned_cols=214 Identities=18% Similarity=0.202 Sum_probs=167.7
Q ss_pred cccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchhhhhhh
Q 047020 21 GATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHT 99 (266)
Q Consensus 21 g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 99 (266)
|.++.||++ +..+|+.+++|.+..... ...|...+....||||+++++++.+....+++|||+.+++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999 556788999998765432 23344444555699999999999999999999999999999999876
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccc
Q 047020 100 YYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179 (266)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 179 (266)
. ..+++..+..++.|++.|+.+||+++ ++|+||||+||+++.++.++++|||.+..... ......
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-------~~~~~~ 143 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-------SCDGEA 143 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc-------ccccCC
Confidence 4 45899999999999999999999999 99999999999999999999999998764321 112234
Q ss_pred cCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH-----hcCchhhhhhhccCCCCCcchH
Q 047020 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR-----RNKNVEVWAQMLDPKLNGDANM 254 (266)
Q Consensus 180 ~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~~~~~~~~ 254 (266)
++..|+|||...+..++.++|+||+|+++|+|++|..||.............. .....+++.+|+..+|..|++.
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 56679999999888889999999999999999999988854322111000000 0112246778888888888875
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=242.86 Aligned_cols=239 Identities=26% Similarity=0.366 Sum_probs=190.5
Q ss_pred hhhhhccccccceEEEEEcCC-CcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 13 DFRIRIGVGATSFVYLAELGD-GNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~~-g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
-+..+||-|.||.||.+.++. ...++||.+.. .+-....|..|+.+|+.++|||+|+++++|.....+|+|.|||..|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 344599999999999996654 56778887654 3446788999999999999999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.||++.. +...++.-.+.+|+.||.+|+.||.++. ++||||...|+|++++..+|+.|||++++|.......
T Consensus 349 NLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 349 NLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred cHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 999999983 3456777888999999999999999999 9999999999999999999999999999876554322
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcCc-----------hhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNKN-----------VEV 239 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~-----------~~~ 239 (266)
. ....-..-|.|||-+....++.++|||+||+++||+.| |-.||.|.+ +.+.+..+++... .++
T Consensus 423 H---AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-lSqVY~LLEkgyRM~~PeGCPpkVYeL 498 (1157)
T KOG4278|consen 423 H---AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYGLLEKGYRMDGPEGCPPKVYEL 498 (1157)
T ss_pred c---cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHHHHhccccccCCCCCCHHHHHH
Confidence 2 22233456999999999999999999999999999987 889998865 3455555553221 134
Q ss_pred hhhhccCCCCCcchHHHHHHHHH
Q 047020 240 WAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 240 ~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
.+.|....|.+||+..++-..++
T Consensus 499 MraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 499 MRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred HHHHhcCCcccCccHHHHHHHHH
Confidence 45555555555555555544443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=208.07 Aligned_cols=207 Identities=26% Similarity=0.325 Sum_probs=176.4
Q ss_pred hhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 16 IRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 16 ~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
++||+|.+|+||.+ ...+++-+++|+++...+ +.-....+|+-+++.++|+|||++++....+..+.+|+||+. .+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HH
Confidence 48999999999999 556789999999876544 345678899999999999999999999999999999999994 47
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|..++... .+.++.+.+..++.|++.++.|+|+.. +.|||+||+|.+++.+|++|+.|||+++-...+ -
T Consensus 87 lkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip----v 155 (292)
T KOG0662|consen 87 LKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP----V 155 (292)
T ss_pred HHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc----e
Confidence 77776553 377899999999999999999999999 999999999999999999999999998742111 1
Q ss_pred CcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc
Q 047020 173 KRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN 234 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~ 234 (266)
.-.+...-|..|.+|.++.+. .|++..|+||-||++.|+.. |.+.|.|.+..++..++.+.-
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l 219 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh
Confidence 122445678889999998654 78999999999999999986 788899999999999888753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=252.03 Aligned_cols=145 Identities=30% Similarity=0.397 Sum_probs=127.4
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
..|.+..+||+|+||.||++.. .+++.+++|.+..... .....+..|+.++..++||||+++++.+......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 4566677999999999999954 4788999998764322 12366788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
||+.+++|.+++... +.+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998764 56889999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=220.71 Aligned_cols=208 Identities=25% Similarity=0.374 Sum_probs=167.8
Q ss_pred hhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecC
Q 047020 13 DFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.+...||.|..|.|+.+.. .+|...+||++....+. +.+++.+.+.++.+-+ +|+||+.+++|..+...++.||.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 3445799999999999954 45888899998765543 4567788888877765 899999999999999999999987
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+..+..+++.. .+++++..+..+...+++||.||-.+.+ ++|||+||.||++++.|.+||+|||++.++.+..
T Consensus 174 s~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 174 STCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred HHHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeeccc-
Confidence 55777766653 3678999999999999999999976433 9999999999999999999999999988654322
Q ss_pred CCCCcccccccCCCccCccccccc---cCCCcccchhHHHHHHHHHhCCCCcCCCch-hHHHHHHHH
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTG---FVSTKSDVYSFGVLLLELITGLKSIQGSAT-LAEWTEECR 232 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i~~~l~~g~~pf~~~~~-~~~~~~~~~ 232 (266)
....-.|-+.|||||.+... .|+.++||||||++++||.||+.||.+.+. ++...+++.
T Consensus 247 ----AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln 309 (391)
T KOG0983|consen 247 ----AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN 309 (391)
T ss_pred ----ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence 23344577889999998544 688999999999999999999999988644 444444444
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=240.03 Aligned_cols=195 Identities=24% Similarity=0.328 Sum_probs=167.5
Q ss_pred hhccccccceEEEE-EcCCCcEEEEEEeeec--ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 16 IRIGVGATSFVYLA-ELGDGNFGAVKRVMEE--RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 16 ~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
+.||+|.||.||-+ .-++|+.|+||.+.+. .+.....+.+|+.+|+.++||.||.+-.-|+..+..|+|||-+.| +
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence 38999999999999 4467999999987542 233457789999999999999999999999999999999999855 5
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC---CceEEeccccccCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD---NHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~~~l~dfg~~~~~~~~~~ 169 (266)
..+.|-. ...+.+++.....++.||+.||+|||-++ |+|+||||+||++... -.+||+|||.|+.+..
T Consensus 649 MLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--- 719 (888)
T KOG4236|consen 649 MLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--- 719 (888)
T ss_pred HHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch---
Confidence 5555544 34478999999999999999999999999 9999999999999754 3689999999997543
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
........||+.|+|||+++++.|....|+||.|+|+|.-++|..||-.+.
T Consensus 720 --ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 720 --KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred --hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 445567899999999999999999999999999999999999999995443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=259.31 Aligned_cols=229 Identities=24% Similarity=0.422 Sum_probs=177.6
Q ss_pred hhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCch
Q 047020 15 RIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 15 ~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
...||+|+||.||++.. .+|..++||++..... ....|++.+++++||||+++++++.+....++||||+++++|
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L 770 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL 770 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence 34799999999999954 6788999998754322 123568899999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCC
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 173 (266)
.++++. +++..+..++.|++.|++|||....++++||||||+||+++.++..++. ++..... .
T Consensus 771 ~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~--------~ 833 (968)
T PLN00113 771 SEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL--------C 833 (968)
T ss_pred HHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc--------c
Confidence 999853 6889999999999999999994422339999999999999988877665 4443321 1
Q ss_pred cccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC----chhHHHHHHHHh--------------c-
Q 047020 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS----ATLAEWTEECRR--------------N- 234 (266)
Q Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~----~~~~~~~~~~~~--------------~- 234 (266)
......++..|+|||++.+..++.++||||||+++|||++|+.||... .....|.+.... .
T Consensus 834 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 834 TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 112235788999999999889999999999999999999999998532 122222221100 0
Q ss_pred --------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 235 --------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 235 --------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...++..+|+..+|..||+.+++.+.++..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 011345678999999999999998888764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=253.42 Aligned_cols=236 Identities=26% Similarity=0.320 Sum_probs=178.7
Q ss_pred chhhh--hccccccceEEEE-EcCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEec---------
Q 047020 12 NDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--------- 78 (266)
Q Consensus 12 ~~~~~--~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------- 78 (266)
.+|.+ .||+||||.|+++ ..-+|..+|||++..+.+ .......+|+..+.+|+|||||+|+..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 35555 7999999999999 445899999999987642 2345678899999999999999998432110
Q ss_pred --------------------------------------------------------------------------------
Q 047020 79 -------------------------------------------------------------------------------- 78 (266)
Q Consensus 79 -------------------------------------------------------------------------------- 78 (266)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CeEEEEEEecCCCchhhhhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHH
Q 047020 79 ------------------------------GEQLLLLEYLANKSLFDRMHTYYGQSLGVL--SWSNRLSIALDIARALEY 126 (266)
Q Consensus 79 ------------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~ 126 (266)
..+|+-||||+...+.+++..+ .+ ....+|+++.+|+.||.|
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N------~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN------HFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc------ccchhhHHHHHHHHHHHHHHHH
Confidence 1234556666555555555442 22 367789999999999999
Q ss_pred HhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC----------CCC----CCCCCcccccccCCCccCcccccc
Q 047020 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP----------FND----PNRPKRQTSIKGSFGYVDTNYLNT 192 (266)
Q Consensus 127 Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~----------~~~----~~~~~~~~~~~~t~~y~aPE~~~~ 192 (266)
+|+.| ++||||||.|||+++++.|||+|||+|+... ... ...........||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999998611 000 011123345789999999999966
Q ss_pred cc---CCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch--------------hhhhhhccCCCCCcchHH
Q 047020 193 GF---VSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV--------------EVWAQMLDPKLNGDANME 255 (266)
Q Consensus 193 ~~---~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~~l~~~~~~~~~~~ 255 (266)
.. |+.++|+||+|++++||+. ||...++-......++....+ .++++|++.+|..||++.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 54 9999999999999999976 487777666665555533222 357899999999999999
Q ss_pred HHHH
Q 047020 256 QLRV 259 (266)
Q Consensus 256 ~l~~ 259 (266)
+|..
T Consensus 867 eLL~ 870 (1351)
T KOG1035|consen 867 ELLN 870 (1351)
T ss_pred HHhh
Confidence 8753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=238.17 Aligned_cols=199 Identities=28% Similarity=0.424 Sum_probs=167.5
Q ss_pred hhhhhccccccceEEEEE---cCCCc--EEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 13 DFRIRIGVGATSFVYLAE---LGDGN--FGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~---~~~g~--~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.....||.|.||.||.+. .++|+ .|+||.++...+ ...+.|..|..+++.++||||++++++|.++ ..|+|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 344589999999999992 33454 467776655333 3577899999999999999999999998875 7899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
.++-|.|.+++..+ ...++...+..+++|++.||.|||+.. ++||||...||++....-+||+|||+++.+.+
T Consensus 471 L~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 471 LAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred cccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999864 356888889999999999999999999 99999999999999998999999999998766
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCc
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSA 222 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~ 222 (266)
....... ......-|||||.+.-+.++.++|||-||+++||++. |.-||++-.
T Consensus 544 ~~yYkaS---~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk 597 (974)
T KOG4257|consen 544 DAYYKAS---RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK 597 (974)
T ss_pred cchhhcc---ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence 5543332 3344566999999999999999999999999999987 999998753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=221.88 Aligned_cols=192 Identities=27% Similarity=0.394 Sum_probs=166.6
Q ss_pred hhccccccceEEEEEcC-CCcEEEEEEeeecc---cccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecCC
Q 047020 16 IRIGVGATSFVYLAELG-DGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
..||+|+|..|.++.+. +.+-+++|.+++.. +......+.|-.++.+.+ ||++|.++.+|+..+.+++|.||.+|
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g 335 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG 335 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence 37999999999999654 45667777665432 334566778888998885 99999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
|+|.-..... .+++++.++.+..+|+.||.|||++| |++||+|.+|++++..|++||.|+|.+.. ...
T Consensus 336 gdlmfhmqrq-----rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke----~l~ 403 (593)
T KOG0695|consen 336 GDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE----GLG 403 (593)
T ss_pred cceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc----CCC
Confidence 9996555443 78999999999999999999999999 99999999999999999999999999874 222
Q ss_pred CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcC
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQ 219 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~ 219 (266)
.....++..||+.|.|||.+++..|+..+|+|++|+++++|+.|+.||+
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 3345567899999999999999999999999999999999999999994
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=223.39 Aligned_cols=208 Identities=27% Similarity=0.357 Sum_probs=168.0
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecCCCch
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
.||.|+||.|+.- ...+|+.-+||+++.... .+.+++..|.+...+-+ .|+||++++.+..++.-|+-||.| +.|+
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~Sl 149 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISL 149 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhH
Confidence 7999999999998 445788999999976554 46678888988777664 899999999999999999999988 6677
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCC
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 173 (266)
..+-+..+......+++.-+..+..-...||.||-..- .|+|||+||.||+++..|.+||+|||++... ..+.
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL-----v~Si 222 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL-----VDSI 222 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH-----HHHH
Confidence 66655544455578899988899999999999997633 2999999999999999999999999998632 2233
Q ss_pred cccccccCCCccCcccccc--ccCCCcccchhHHHHHHHHHhCCCCcCCCch-hHHHHHHHH
Q 047020 174 RQTSIKGSFGYVDTNYLNT--GFVSTKSDVYSFGVLLLELITGLKSIQGSAT-LAEWTEECR 232 (266)
Q Consensus 174 ~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~-~~~~~~~~~ 232 (266)
....-.|-..|||||.+.. ..|+.++|+||||+++||+.||..|+.+=++ +++......
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~ 284 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI 284 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence 3445667888999999854 3689999999999999999999999987444 344443333
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=214.54 Aligned_cols=225 Identities=33% Similarity=0.445 Sum_probs=184.1
Q ss_pred ccceEEEEEcC-CCcEEEEEEeeeccccc-HHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchhhhhhh
Q 047020 22 ATSFVYLAELG-DGNFGAVKRVMEERGGS-RKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHT 99 (266)
Q Consensus 22 ~~~~v~~~~~~-~g~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 99 (266)
+||.+|++... +|+.+++|......... ...+.+|++.+++++|+|++++++++......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57899999654 58899999876654444 67889999999999999999999999998999999999998899998876
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccc
Q 047020 100 YYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179 (266)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 179 (266)
. ..++...++.++.+++.++.+||+.+ ++|+||+|.||++++++.++|+|||.+....... ......
T Consensus 81 ~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~ 147 (244)
T smart00220 81 R-----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LLTTFV 147 (244)
T ss_pred c-----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-----cccccc
Confidence 3 33889999999999999999999999 9999999999999999999999999987533221 234456
Q ss_pred cCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-------------CchhhhhhhccC
Q 047020 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN-------------KNVEVWAQMLDP 246 (266)
Q Consensus 180 ~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~ 246 (266)
++..|++||...+..++.++|+||+|++++++++|..||................ ...+++.+|+..
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 227 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVK 227 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccC
Confidence 7888999999988888899999999999999999999997733333333322211 112567788888
Q ss_pred CCCCcchHHHHHH
Q 047020 247 KLNGDANMEQLRV 259 (266)
Q Consensus 247 ~~~~~~~~~~l~~ 259 (266)
+|..||+..++.+
T Consensus 228 ~p~~Rp~~~~~~~ 240 (244)
T smart00220 228 DPEKRLTAEEALQ 240 (244)
T ss_pred CchhccCHHHHhh
Confidence 8888988877654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=245.05 Aligned_cols=209 Identities=22% Similarity=0.329 Sum_probs=175.9
Q ss_pred HHHHhhchhhhhccccccceEEEEEcC----CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCe
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAELG----DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 80 (266)
||..+.....+.||.|.||.|+.+.++ ....|+||.++.-.+ .++..|..|+.+|.+++||||+++.++......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 455555556668999999999999654 345789998865443 346679999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
..+|.|||++|+|..+++.+ .+.|...++..|++.|++|++||-..+ ++||||...|||++.+-..|++|||+
T Consensus 705 vMIiTEyMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccc
Confidence 99999999999999999975 367999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCc
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSA 222 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~ 222 (266)
++.+.+... .......-....+|.|||.+..+.++.++||||+|+++||.++ |..||=+-+
T Consensus 778 SRvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 778 SRVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred eeecccCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 997655442 1222222334578999999999999999999999999999775 999985443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-33 Score=233.06 Aligned_cols=190 Identities=24% Similarity=0.327 Sum_probs=160.3
Q ss_pred hhccccccceEEEEEcCCCc-EEEEEEeeeccc--------ccHHHHHHHHHHHhcCC---CCCccccceeEEecCeEEE
Q 047020 16 IRIGVGATSFVYLAELGDGN-FGAVKRVMEERG--------GSRKIFLDEVSVLLRVS---HPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~-~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 83 (266)
..+|.|+||.|++|..++.. .|++|.+.+.+- ......-.|+++|..++ |+||++++++|++++++|+
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 47999999999999666554 455554433211 11122346999999997 9999999999999999999
Q ss_pred EEEec-CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 84 LLEYL-ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 84 v~e~~-~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||-- +|.+|+++|... ..+++.++..++.|+..|+++||++| |+|||||-+||.++.+|-+||+|||++.
T Consensus 647 ~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred EecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchh
Confidence 99964 457999999764 77999999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcC
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQ 219 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~ 219 (266)
. .+..+.....||..|.|||++.|..| +..-|||++|+++|.+.....||-
T Consensus 719 ~------~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 Y------TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred h------hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 4 33566778999999999999999877 466899999999999999999884
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=239.14 Aligned_cols=249 Identities=27% Similarity=0.364 Sum_probs=190.9
Q ss_pred hchhhhhccccccceEEEEEcC---C-----CcEEEEEEeeeccc-ccHHHHHHHHHHHhcCC-CCCccccceeEEecCe
Q 047020 11 TNDFRIRIGVGATSFVYLAELG---D-----GNFGAVKRVMEERG-GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGE 80 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~---~-----g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 80 (266)
...+...||+|+||.|+++... . ...++||.+..... .+.+.+..|+++++.+. ||||+.+++.+...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3345558999999999999432 1 34578887765433 35678899999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhc---CCCC------C--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec
Q 047020 81 QLLLLEYLANKSLFDRMHTYY---GQSL------G--VLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID 149 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~---~~~~------~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~ 149 (266)
.++|+||+..|+|.++++..+ .... . .++...+..+++||+.|+.||++.. ++|||+-..||++.+
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecC
Confidence 999999999999999999876 1111 1 3888999999999999999999999 999999999999999
Q ss_pred CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHH
Q 047020 150 DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWT 228 (266)
Q Consensus 150 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~ 228 (266)
+..+||+|||+++................ ....|||||.+....++.++||||+|+++||+++ |..||.+-.......
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 99999999999985333222211111111 4556999999999999999999999999999998 889998733122222
Q ss_pred HHHHhcC---ch--------hhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 229 EECRRNK---NV--------EVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 229 ~~~~~~~---~~--------~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
+.++... .+ ++.+.+...+|..||+..++.+.+..
T Consensus 533 ~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 533 EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 2222211 11 33567777788888888777777665
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=236.55 Aligned_cols=237 Identities=22% Similarity=0.265 Sum_probs=185.8
Q ss_pred chhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEE-----ecCeEEEEE
Q 047020 12 NDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCL-----EKGEQLLLL 85 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-----~~~~~~lv~ 85 (266)
..+...||.|.+|.||+++..+.+..++.++.............|.++++.+. |||++.+++++. ..+++|+||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 45566899999999999955444444444444544555677788999999986 999999999874 346899999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
|||.|||.-|+++... +..+.|+.+..|++.++.|+.+||.+. ++|||||-.||+++.++.+||.|||.....+
T Consensus 101 EfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 9999999999999864 578999999999999999999999999 9999999999999999999999999976532
Q ss_pred CCCCCCCCcccccccCCCccCcccccc-----ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-----
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNT-----GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----- 235 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----- 235 (266)
......++..||+.|||||++.. ..|+.++|+||||++..||.-|.+|+-+-+..--+..+.++++
T Consensus 175 ----sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 175 ----STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR 250 (953)
T ss_pred ----cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence 33455677899999999999843 2577899999999999999999999966544333322222211
Q ss_pred -------chhhhhhhccCCCCCcchHHHHH
Q 047020 236 -------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 -------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
-.+.+..++-.+...||+..++.
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 12445567777777777666553
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=201.80 Aligned_cols=208 Identities=26% Similarity=0.366 Sum_probs=164.9
Q ss_pred hhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 16 IRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
..||+|++|.|-... ..+|...++|++....+ ...+++.+|+.+..+- .+|++|.+++........++.||.| ..|
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tS 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTS 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhh
Confidence 379999999987774 45678889998866544 3456777888876665 4899999999988889999999988 568
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|..+-++- -..++.+++..+-+++..+.+||.|||++-. ++|||+||.|||++..|++|++|||++.... .+
T Consensus 131 ldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~-----dS 202 (282)
T KOG0984|consen 131 LDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLV-----DS 202 (282)
T ss_pred HHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeeh-----hh
Confidence 87655543 2344788999999999999999999998644 9999999999999999999999999976421 12
Q ss_pred CcccccccCCCccCcccccc----ccCCCcccchhHHHHHHHHHhCCCCcCC-CchhHHHHHHHH
Q 047020 173 KRQTSIKGSFGYVDTNYLNT----GFVSTKSDVYSFGVLLLELITGLKSIQG-SATLAEWTEECR 232 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~i~~~l~~g~~pf~~-~~~~~~~~~~~~ 232 (266)
.......|-..|+|||.+.. ..|+.++||||||+++.||.+++.||.. ...+.++....+
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 22233567888999999843 3788999999999999999999999965 444555544444
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-33 Score=212.72 Aligned_cols=212 Identities=24% Similarity=0.335 Sum_probs=172.2
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEee--ecccccHHHHHHHHHHHhcCCCCCccccceeEEe--------cC
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVM--EERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE--------KG 79 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~~ 79 (266)
+|.-..+||+|.||.||+| .-++|+.|++|++. .+..+.-....+|+.+|..++|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3444458999999999999 44567777887653 3445556678899999999999999999887642 33
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
.+++||.+++. +|.-++.+ ..-.++...+..++.++..||.|+|... |+|||+||+|++++.+|.++|.|||
T Consensus 98 t~ylVf~~ceh-DLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 58999999854 77776654 2256899999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHH
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE 230 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~ 230 (266)
+++.................-|..|++||.+.| +.++++.|+|+-||++.+|+++.+.|++..+..+..-+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 997654444443444455667999999998755 58999999999999999999999999998877765443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=238.76 Aligned_cols=230 Identities=26% Similarity=0.332 Sum_probs=181.8
Q ss_pred hccccccce-EEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecCCCchh
Q 047020 17 RIGVGATSF-VYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 17 ~ig~g~~~~-v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
.+|.|..|+ ||++.. +|..||||++... .-..+.+|+..|+.-+ ||||+++++.-.++...|+..|.| ..+|.
T Consensus 516 ilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~ 590 (903)
T KOG1027|consen 516 ILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ 590 (903)
T ss_pred HcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence 688999977 788865 6789999987553 2356788999998885 999999999989999999999999 46999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec---CC--ceEEeccccccCCCCCCC
Q 047020 95 DRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID---DN--HAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~--~~~l~dfg~~~~~~~~~~ 169 (266)
|++... ............+..+.|+++|+++||+.+ |+||||||+||+|+. ++ +++|+|||++........
T Consensus 591 dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 591 DLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 999873 111111122456788999999999999999 999999999999975 34 578999999998766554
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhC-CCCcCCCchhHHHHHHHHhc------------Cc
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG-LKSIQGSATLAEWTEECRRN------------KN 236 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g-~~pf~~~~~~~~~~~~~~~~------------~~ 236 (266)
. ........||.+|+|||++.....+.++||||+||++|+.++| ..||.+...-+-. ++... ..
T Consensus 667 S-~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 667 S-FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--ILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred h-hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--hhcCccceeeeccCchHHH
Confidence 3 2336678899999999999988888899999999999999885 8999654332111 11111 23
Q ss_pred hhhhhhhccCCCCCcchHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
.+++.+|+.++|..||+.+++.
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHh
Confidence 4688999999999999998874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=203.07 Aligned_cols=205 Identities=20% Similarity=0.321 Sum_probs=169.1
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecC--eEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKG--EQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~~~lv 84 (266)
+..|+...++|+|-++.||.+ ...+.+.++||.+.. ...+.+.+|+.+|+-|. +|||+++++...+.. .+.+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 345667779999999999999 566777888887643 23467889999999998 999999999886654 56799
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC-CceEEeccccccC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD-NHAKLADFGLCKL 163 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~~~l~dfg~~~~ 163 (266)
+||..+.+...+. ..++...++.++++++.||.|+|+.| |.|||+||.|++++.. -+++|+|+|+|.+
T Consensus 114 FE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 9999887765543 45788999999999999999999999 9999999999999965 4699999999986
Q ss_pred CCCCCCCCCCcccccccCCCccCccccc-cccCCCcccchhHHHHHHHHHhCCCCc-CCCchhHHHHHHHH
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLN-TGFVSTKSDVYSFGVLLLELITGLKSI-QGSATLAEWTEECR 232 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~i~~~l~~g~~pf-~~~~~~~~~~~~~~ 232 (266)
. .....-+....+..|-.||.+- -..|+.+.|+|||||++..|+..+.|| .|.+..++..++.+
T Consensus 183 Y-----Hp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 183 Y-----HPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred c-----CCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence 3 2344556778888999999874 457889999999999999999887776 67777787766554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=232.34 Aligned_cols=237 Identities=19% Similarity=0.174 Sum_probs=156.6
Q ss_pred hchhhhhccccccceEEEEEc-CC----CcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCcccccee------EEecC
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GD----GNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGF------CLEKG 79 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~----g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------~~~~~ 79 (266)
.+.+...||+|+||.||++.. .+ +..+++|++..... .+....+ .+....+.++..+... .....
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 344555899999999999954 44 68899997643321 1111111 1111122222222221 23556
Q ss_pred eEEEEEEecCCCchhhhhhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQ---------------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSN 144 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~n 144 (266)
..++|++|+.+++|.+++...... .........+..++.|++.||.|||+++ |+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHH
Confidence 789999999999999988652100 0011123456789999999999999999 9999999999
Q ss_pred EEEec-CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccc----------------------cCCCcccc
Q 047020 145 ILLID-DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG----------------------FVSTKSDV 201 (266)
Q Consensus 145 il~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~Di 201 (266)
||++. ++.+||+|||++....... ........+++.|+|||.+... .++.++||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~---~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGI---NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred EEEeCCCCcEEEEeCCCcccccccc---ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99985 5789999999997532221 1223345788999999965322 23345699
Q ss_pred hhHHHHHHHHHhCCCCcCCCchhHHHHHHH--------------HhcCc-----------------hhhhhhhccCCCCC
Q 047020 202 YSFGVLLLELITGLKSIQGSATLAEWTEEC--------------RRNKN-----------------VEVWAQMLDPKLNG 250 (266)
Q Consensus 202 ~slG~i~~~l~~g~~pf~~~~~~~~~~~~~--------------~~~~~-----------------~~~~~~~l~~~~~~ 250 (266)
||+||++|+|+++..|+.. ...++.+.+ ..... .+++.+|+..+|..
T Consensus 363 wSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999997766532 222222111 11100 15888999999999
Q ss_pred cchHHHHHH
Q 047020 251 DANMEQLRV 259 (266)
Q Consensus 251 ~~~~~~l~~ 259 (266)
||+.+++.+
T Consensus 441 R~ta~e~L~ 449 (566)
T PLN03225 441 RISAKAALA 449 (566)
T ss_pred CCCHHHHhC
Confidence 999988754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=213.58 Aligned_cols=205 Identities=24% Similarity=0.306 Sum_probs=170.7
Q ss_pred hhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecC-----eEEEEEEe
Q 047020 16 IRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG-----EQLLLLEY 87 (266)
Q Consensus 16 ~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~ 87 (266)
.-||-|+||.||.+ +-.+|+.+++|++...-. ...+++.+|+.++.-++|.|++..++..+... ..|++.|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 47999999999999 667899999998754322 23567889999999999999999998876543 45678887
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
++ .+|...+-. ..+++.+.+.-.++||+.||+|||+.+ |.||||||.|.+++.+-.+||+|||+++.-
T Consensus 139 mQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve--- 206 (449)
T KOG0664|consen 139 MQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW--- 206 (449)
T ss_pred HH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc---
Confidence 74 477776644 378899999999999999999999999 999999999999999999999999999852
Q ss_pred CCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
.......+....-|..|.|||.+-| +.|+.+.||||.|||+.||+..+..|+..+.+.+..-+..
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd 272 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID 272 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence 2233445566788999999998855 5799999999999999999999999999988887765544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=202.49 Aligned_cols=209 Identities=33% Similarity=0.469 Sum_probs=173.6
Q ss_pred hhhhhccccccceEEEEEcCC-CcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCC
Q 047020 13 DFRIRIGVGATSFVYLAELGD-GNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~~-g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
.+...||.|+++.+|++.... ++.+++|........ ..+.+.+|++.++.++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 455689999999999996554 788899987655444 567888999999999999999999999988999999999999
Q ss_pred CchhhhhhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGV-LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
++|.+++... .. +++..+..++.+++.++.+||+.+ ++|+|++|.||+++.++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 82 GDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999998764 23 789999999999999999999999 99999999999999999999999998875432210
Q ss_pred CCCCcccccccCCCccCcccc-ccccCCCcccchhHHHHHHHHHhCCCCcCC-CchhHHHHHHHH
Q 047020 170 NRPKRQTSIKGSFGYVDTNYL-NTGFVSTKSDVYSFGVLLLELITGLKSIQG-SATLAEWTEECR 232 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~i~~~l~~g~~pf~~-~~~~~~~~~~~~ 232 (266)
.......++..|++||.. ....++.++|+|++|+++++|++|+.||.. .+........+.
T Consensus 154 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 154 ---ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ---ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 122345677889999998 666778899999999999999999999977 444444444444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=210.02 Aligned_cols=204 Identities=25% Similarity=0.316 Sum_probs=173.3
Q ss_pred hccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecC------eEEEEEEe
Q 047020 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------EQLLLLEY 87 (266)
Q Consensus 17 ~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~~lv~e~ 87 (266)
.+|.|+- .|-.+ +.-.+..+++|+...+- ....++..+|+.++..++|+||++++.+|..+. ..|+|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 5777777 44445 55678899999876542 234577889999999999999999999987654 56899999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+ ..+|...+.. .++...+..+++|++.|+++||+.| |+||||||+||++..+..+||.|||+|+.
T Consensus 103 m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~---- 167 (369)
T KOG0665|consen 103 M-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART---- 167 (369)
T ss_pred h-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc----
Confidence 8 5688887763 3688899999999999999999999 99999999999999999999999999984
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV 237 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (266)
......+.....|..|.|||++.+..+...+||||+||++.||++|...|.|.+..++|.++.....++
T Consensus 168 -e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 168 -EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred -cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence 222345566788999999999999889999999999999999999999999999999999988875554
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=222.99 Aligned_cols=213 Identities=24% Similarity=0.214 Sum_probs=177.4
Q ss_pred CChHHHHHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC------CCCcccccee
Q 047020 2 YALEELKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS------HPNLVGLLGF 74 (266)
Q Consensus 2 ~~~~~i~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~ 74 (266)
|-+.|++-.+|.+....|+|.|+.|.+| +...|..||||.+..... -.+.=..|+++|++|+ .-|++.++-.
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3467899999999999999999999999 666788999998866422 1122357999999996 2489999999
Q ss_pred EEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-ce
Q 047020 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-HA 153 (266)
Q Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~~ 153 (266)
|...+++|+|+|.+ ..+|.+.++.+. ..-.+....+..+++|++.||..|-+.| ++|.||||+|||+++.. .+
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 99999999999977 679999999862 2256788899999999999999999999 99999999999999765 47
Q ss_pred EEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHH
Q 047020 154 KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW 227 (266)
Q Consensus 154 ~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~ 227 (266)
||||||+|.....+. -...+-+..|.|||.+.|..|+...|+||.||++|||.||...|.|...-.++
T Consensus 577 KLCDfGSA~~~~ene------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 577 KLCDFGSASFASENE------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred eeccCcccccccccc------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 999999998533222 22344566799999999999999999999999999999999999887655543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=200.41 Aligned_cols=238 Identities=18% Similarity=0.311 Sum_probs=178.5
Q ss_pred hhchhhhhccccccceEEEEEcCCC-cEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCcccccee-EEecCeEEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDG-NFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGF-CLEKGEQLLLLE 86 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g-~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~~~~~~~lv~e 86 (266)
..|++.+.+|+|.||.+-++.+... ..+++|-+ ...-.....|.+|...--.|. |.||+.-++. |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKav-p~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAV-PRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeecc-CcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 4567778999999999999976554 44555544 433445677888887766665 8999988874 677788899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec--CCceEEeccccccCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID--DNHAKLADFGLCKLG 164 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~--~~~~~l~dfg~~~~~ 164 (266)
|++-|+|.+-+.. ..+-+.....++.|+++|+.|||+++ ++|||||.+||++-. ..++||+|||..+..
T Consensus 103 ~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred cCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999876655 56778888999999999999999999 999999999999953 458999999987631
Q ss_pred CCCCCCCCCcccccccCCCccCccccccc-----cCCCcccchhHHHHHHHHHhCCCCcCCCchhHH-------HHHHHH
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTG-----FVSTKSDVYSFGVLLLELITGLKSIQGSATLAE-------WTEECR 232 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~-------~~~~~~ 232 (266)
.........+..|.+||..... ...+.+|+|.||+++|.+++|..||+.....+. |.+..
T Consensus 174 -------g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk- 245 (378)
T KOG1345|consen 174 -------GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK- 245 (378)
T ss_pred -------CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc-
Confidence 1122234456678999976322 346789999999999999999999975433332 21111
Q ss_pred hcCch-----------hhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 233 RNKNV-----------EVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 233 ~~~~~-----------~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
....+ ..+++.+.+++..|+-..+..++.+..|
T Consensus 246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 11111 3567888999999988888777776655
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=219.40 Aligned_cols=204 Identities=21% Similarity=0.225 Sum_probs=145.5
Q ss_pred hchhhhhccccccceEEEEEc-----------------CCCcEEEEEEeeecccccHHH--------------HHHHHHH
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-----------------GDGNFGAVKRVMEERGGSRKI--------------FLDEVSV 59 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-----------------~~g~~~~vk~~~~~~~~~~~~--------------~~~e~~~ 59 (266)
.+....+||+|+||.||++.. ..+..++||++.......... ...|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 344445899999999999842 234578999875433222222 3346667
Q ss_pred HhcCCCCCc-----cccceeEEe--------cCeEEEEEEecCCCchhhhhhhhcCC-------------------CCCC
Q 047020 60 LLRVSHPNL-----VGLLGFCLE--------KGEQLLLLEYLANKSLFDRMHTYYGQ-------------------SLGV 107 (266)
Q Consensus 60 l~~l~~~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~-------------------~~~~ 107 (266)
+.+++|.++ ++++++|.. .+..++|+||+.+++|.+++....+. ....
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777765543 566666542 35689999999999999988642111 1123
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCc
Q 047020 108 LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187 (266)
Q Consensus 108 ~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aP 187 (266)
+++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.++|+|||++....... ........+++.|+||
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~---~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI---NFNPLYGMLDPRYSPP 379 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC---ccCccccCCCcceeCh
Confidence 466778899999999999999999 9999999999999999999999999986432211 1111123347899999
Q ss_pred ccccccc----------------------CCCcccchhHHHHHHHHHhCCC-CcCC
Q 047020 188 NYLNTGF----------------------VSTKSDVYSFGVLLLELITGLK-SIQG 220 (266)
Q Consensus 188 E~~~~~~----------------------~~~~~Di~slG~i~~~l~~g~~-pf~~ 220 (266)
|.+.... ...+.|+||+||++|+|+++.. ||.+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 9875321 1124799999999999999875 7754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=225.20 Aligned_cols=198 Identities=29% Similarity=0.442 Sum_probs=163.7
Q ss_pred hhccccccceEEEE-EcCCCcE----EEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 16 IRIGVGATSFVYLA-ELGDGNF----GAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 16 ~~ig~g~~~~v~~~-~~~~g~~----~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
++||+|+||+||++ ..-+|+. |++|.+.... ......+..|+-.|..++|||++++++++.... .-+|++|++
T Consensus 702 kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP 780 (1177)
T KOG1025|consen 702 KVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMP 780 (1177)
T ss_pred ceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcc
Confidence 38999999999999 4445664 4555544332 234677899999999999999999999998775 788999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+|+|.|+++.+ ..++......-|.+||++|+.|||.++ ++||||-..|||+.....+|+.|||++........
T Consensus 781 ~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 781 LGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999985 356778889999999999999999999 99999999999999999999999999987554433
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCch
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSAT 223 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~ 223 (266)
.-.. ....-..-|+|-|.++...++..+||||||+++||++| |..|+++...
T Consensus 854 ey~~--~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 854 EYSA--PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred cccc--cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 2221 22223445889999999999999999999999999998 8999987644
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=192.07 Aligned_cols=209 Identities=35% Similarity=0.500 Sum_probs=175.2
Q ss_pred ccccccceEEEEEcC-CCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchhh
Q 047020 18 IGVGATSFVYLAELG-DGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFD 95 (266)
Q Consensus 18 ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
||+|.+|.+|++... +|+.+++|........ ....+.+|++.++.++|++++++++++......++++|+..+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999654 4888888877554332 34678899999999999999999999999899999999999899999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCceEEeccccccCCCCCCCCCCCc
Q 047020 96 RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADFGLCKLGPFNDPNRPKR 174 (266)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~ 174 (266)
++.... ..++...+..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+||+.+........ .
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----~ 149 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----L 149 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----h
Confidence 887621 36889999999999999999999999 999999999999998 89999999999875322111 2
Q ss_pred ccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCchhhhhhhccCCCCCcch
Q 047020 175 QTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 175 ~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 253 (266)
.....+...|++||..... ..+.+.|+|++|++++++ ....+++.+++..++..||+
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------HHHHHHHHHHhhCCcccCcC
Confidence 3345678889999998777 788999999999999999 23345667899999999999
Q ss_pred HHHHHH
Q 047020 254 MEQLRV 259 (266)
Q Consensus 254 ~~~l~~ 259 (266)
..++.+
T Consensus 208 ~~~l~~ 213 (215)
T cd00180 208 AKEILE 213 (215)
T ss_pred HHHHhh
Confidence 888764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=197.92 Aligned_cols=136 Identities=26% Similarity=0.350 Sum_probs=110.0
Q ss_pred HHHHH-hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC--------CCCcccccee
Q 047020 5 EELKM-ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS--------HPNLVGLLGF 74 (266)
Q Consensus 5 ~~i~~-~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~ 74 (266)
+|... .+|-+..+||.|-|++||++ +.....+||+|.++. .....+....|+.+|++++ ..+||++++.
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 34444 56666679999999999999 666677888876543 3334566788999999984 2489999999
Q ss_pred EEec----CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE
Q 047020 75 CLEK----GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL 147 (266)
Q Consensus 75 ~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~ 147 (266)
|... .+.|+|+|++ |.+|..+|... +...++...+.+|++|++.||.|||..- +|+|.||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 8654 4889999988 77999999873 4467899999999999999999999843 49999999999998
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=186.68 Aligned_cols=245 Identities=20% Similarity=0.244 Sum_probs=188.6
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+++.++||+|+||.+|++ .+-.+++||||.=. ......++.-|....+.|. .++|...+.+....-+-.+|+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 4556669999999999999 67789999998432 3345677888999999996 789988887777777888999977
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-----ceEEeccccccC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-----HAKLADFGLCKL 163 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-----~~~l~dfg~~~~ 163 (266)
|.||+|++.-. +..|+..++..++.|+++-+.++|++. +++|||||+|+||+..+ .|.++|||+|..
T Consensus 107 -GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 107 -GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred -CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 88999887642 257999999999999999999999999 99999999999997543 388999999987
Q ss_pred CCCCCCCCC---CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC---chhHHHHHHHHh--cC
Q 047020 164 GPFNDPNRP---KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS---ATLAEWTEECRR--NK 235 (266)
Q Consensus 164 ~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~---~~~~~~~~~~~~--~~ 235 (266)
.-++.+.+. .+.....||++||+-....|+..+.+.|.-|||.++.+.+.|..||+|- +....+.++-.. ..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 666555443 3446688999999999999999999999999999999999999999763 333344443332 11
Q ss_pred chhhhh------------hhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 NVEVWA------------QMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ~~~~~~------------~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.++.+. =.-+-+....|+-+-++.++...+
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 111111 111233445566777777776654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=209.01 Aligned_cols=233 Identities=27% Similarity=0.345 Sum_probs=191.1
Q ss_pred hhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 14 FRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 14 ~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
...++|.|.+|.||++ +..+++..++|.+........+..++|+-+++..+||||+.+++.+...+..++.|||+.||+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 3348999999999999 667899999999988888788888999999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.|.-... +++++.++.....+.+.++.|||+.| =+|||||-.||++++.|.+|+.|||.+..+.. ..
T Consensus 99 lQdiy~~T-----gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita----ti 166 (829)
T KOG0576|consen 99 LQDIYHVT-----GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA----TI 166 (829)
T ss_pred ccceeeec-----ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh----hh
Confidence 99865443 88999999999999999999999999 99999999999999999999999998764321 12
Q ss_pred CcccccccCCCccCcccc---ccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH---hcCc----------
Q 047020 173 KRQTSIKGSFGYVDTNYL---NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR---RNKN---------- 236 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~---~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~---~~~~---------- 236 (266)
.....+.||+.|||||+. +...|...+|+|+.|+...++..-+.|-.+-+......-..+ +++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 344567899999999987 455789999999999999999887777644322221111111 1111
Q ss_pred -hhhhhhhccCCCCCcchHHHHH
Q 047020 237 -VEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 237 -~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
-+.++..+...|.+||+++.+.
T Consensus 247 fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhhe
Confidence 1466788999999999988764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=178.93 Aligned_cols=220 Identities=24% Similarity=0.274 Sum_probs=175.8
Q ss_pred ChHHH-HHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCC-CCccccceeEEecC
Q 047020 3 ALEEL-KMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH-PNLVGLLGFCLEKG 79 (266)
Q Consensus 3 ~~~~i-~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~ 79 (266)
|++++ ....|.+.++||+|+||.+|++ .+.+|+.||+|.=..+ ....++.-|..+.+.|++ ..|+.+..+..+..
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 44443 3445677779999999999999 7889999999854332 234567889999999984 67777788888888
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec---CCceEEe
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID---DNHAKLA 156 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~~~l~ 156 (266)
+-.+||+.+ |.||++++.-- ...++..++.-++-|++.-+.|+|.++ ++||||||+|++++- -.++.++
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred cceeeeecc-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEE
Confidence 999999977 88999988642 156899999999999999999999999 999999999999963 3468999
Q ss_pred ccccccCCCCCCCCCC---CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC---chhHHHHHH
Q 047020 157 DFGLCKLGPFNDPNRP---KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS---ATLAEWTEE 230 (266)
Q Consensus 157 dfg~~~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~---~~~~~~~~~ 230 (266)
|||++....+..+... .......||.+|.+-....+...+.+.|+-|+|.++.++-.|..||+|- +....+.++
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 9999987555444333 2334578999999999888888899999999999999999999999874 333344444
Q ss_pred HH
Q 047020 231 CR 232 (266)
Q Consensus 231 ~~ 232 (266)
.+
T Consensus 237 ~E 238 (341)
T KOG1163|consen 237 SE 238 (341)
T ss_pred HH
Confidence 44
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-27 Score=189.06 Aligned_cols=234 Identities=23% Similarity=0.258 Sum_probs=174.9
Q ss_pred hccccccceEEEEEc------CCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEE-ecCeEEEEEEec
Q 047020 17 RIGVGATSFVYLAEL------GDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCL-EKGEQLLLLEYL 88 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~ 88 (266)
.+-+|.||.+|.+-+ .+.+.+-+|.+.....+ +...+..|.-++.-+.|||+.++.+++. +...+++++++.
T Consensus 291 llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~ 370 (563)
T KOG1024|consen 291 LLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPAT 370 (563)
T ss_pred hhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEecc
Confidence 688999999999933 23344455555443332 3456677887888889999999999875 445788999999
Q ss_pred CCCchhhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 89 ANKSLFDRMHTYYGQ---SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
.-|+|..++..-++. ....++-.++.-++.|++.|+.|||+.| ++|.||...|.++++.-++||+|=.+++-.-
T Consensus 371 ~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLF 447 (563)
T KOG1024|consen 371 GVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLF 447 (563)
T ss_pred CcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccC
Confidence 889999999854322 2245677788889999999999999999 9999999999999999999999988876422
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcCchhhhhhhc
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNKNVEVWAQML 244 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (266)
..+ ..+.....-....||+||.+.+..++.++|+||||+++|||++ |+.|+...+..+...-...+...-
T Consensus 448 P~D--YhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla------- 518 (563)
T KOG1024|consen 448 PGD--YHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA------- 518 (563)
T ss_pred ccc--ccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec-------
Confidence 111 1333334445667999999999999999999999999999998 899998877666554333322111
Q ss_pred cCCCCCcchHHHHHHHHHHHhC
Q 047020 245 DPKLNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 245 ~~~~~~~~~~~~l~~~~~~~~~ 266 (266)
+.-.+|+++..+|--|||
T Consensus 519 ----QP~NCPDeLf~vMacCWa 536 (563)
T KOG1024|consen 519 ----QPFNCPDELFTVMACCWA 536 (563)
T ss_pred ----CCCCCcHHHHHHHHHHHh
Confidence 122456677777777775
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=191.87 Aligned_cols=193 Identities=27% Similarity=0.376 Sum_probs=159.6
Q ss_pred hhhhccccccceEEEEEc-C---CCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEec
Q 047020 14 FRIRIGVGATSFVYLAEL-G---DGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 14 ~~~~ig~g~~~~v~~~~~-~---~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
...+||.|.|+.||.+.+ . +...+++|.+..... -.+...|+++|..+. +.||+++.+.+..++...+|+||+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 334899999999999933 3 577889998866544 466889999999997 899999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCceEEeccccccCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~~l~dfg~~~~~~~~ 167 (266)
+.....++.+. ++...+..+++.++.||.++|++| |+||||||.|++.+. .++-.|+|||+|......
T Consensus 118 ~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 118 EHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred CccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 99888888765 678999999999999999999999 999999999999984 567899999998721000
Q ss_pred ----------------------------------------CCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHH
Q 047020 168 ----------------------------------------DPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGV 206 (266)
Q Consensus 168 ----------------------------------------~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~ 206 (266)
...+........||++|.|||++.. ...++++||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0011112224579999999999854 46788999999999
Q ss_pred HHHHHHhCCCCcC
Q 047020 207 LLLELITGLKSIQ 219 (266)
Q Consensus 207 i~~~l~~g~~pf~ 219 (266)
|+..++++..||-
T Consensus 267 I~Lslls~~~PFf 279 (418)
T KOG1167|consen 267 ILLSLLSRRYPFF 279 (418)
T ss_pred eeehhhccccccc
Confidence 9999999999994
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=188.15 Aligned_cols=248 Identities=24% Similarity=0.279 Sum_probs=182.0
Q ss_pred hchhhhhccccccceEEEEEcCCC--cEEEEEEeeecccccHHHHHHHHHHHhcCC----CCCccccceeE-EecCeEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDG--NFGAVKRVMEERGGSRKIFLDEVSVLLRVS----HPNLVGLLGFC-LEKGEQLL 83 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g--~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~l 83 (266)
++....+||+|+||.||.+...+. ...++|.-..........+..|..++..+. .+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 566667999999999999954443 355665444432332337888999999987 26889999888 47778999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC-----CceEEecc
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD-----NHAKLADF 158 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-----~~~~l~df 158 (266)
||+.+ |.||.++.+... .+.++..++..++.|++.+|.+||+.| ++||||||+|+.++.. ..++|.||
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99976 889999886642 478999999999999999999999999 9999999999999865 35899999
Q ss_pred cccc--CCCCCCCC--CCC-c-ccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh---HHHHH
Q 047020 159 GLCK--LGPFNDPN--RPK-R-QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL---AEWTE 229 (266)
Q Consensus 159 g~~~--~~~~~~~~--~~~-~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~---~~~~~ 229 (266)
|+++ ........ ... . .....||..|+++....+...+.+.|+||++.++.++..|..||.+.... .....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998 32222211 111 1 23456999999999999999999999999999999999999999665432 22222
Q ss_pred HHHhcC-------c---hhhhhhhcc-CCCCCcchHHHHHHHHHHHh
Q 047020 230 ECRRNK-------N---VEVWAQMLD-PKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 230 ~~~~~~-------~---~~~~~~~l~-~~~~~~~~~~~l~~~~~~~~ 265 (266)
...... . ...+...++ .+...+|....+..+++.++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 111110 0 111223333 56777788888777776654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=214.74 Aligned_cols=191 Identities=20% Similarity=0.227 Sum_probs=133.0
Q ss_pred hcCCC-CCccccceeE-------EecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 047020 61 LRVSH-PNLVGLLGFC-------LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132 (266)
Q Consensus 61 ~~l~~-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 132 (266)
+.++| +||+.++++| .....++.++|++ +++|.+++... ...+++..+..++.||+.||.|||++|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 34455 5777777776 2234567788876 67999998642 256899999999999999999999999
Q ss_pred CCeecCCCCCCcEEEecCCceEE-------------------eccccccCCCCCCCC------C------CCcccccccC
Q 047020 133 PPIIHRDIKSSNILLIDDNHAKL-------------------ADFGLCKLGPFNDPN------R------PKRQTSIKGS 181 (266)
Q Consensus 133 ~~i~H~dikp~nil~~~~~~~~l-------------------~dfg~~~~~~~~~~~------~------~~~~~~~~~t 181 (266)
|+||||||+|||++..+.+++ +|||+++........ . ........+|
T Consensus 101 --IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 101 --IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred --eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 999999999999976555554 455544321100000 0 0001123578
Q ss_pred CCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh-HHHHHHHHh-------cCchhhhhhhccCCCCCcch
Q 047020 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL-AEWTEECRR-------NKNVEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 182 ~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~-~~~~~~~~~-------~~~~~~~~~~l~~~~~~~~~ 253 (266)
+.|+|||++.+..++.++|||||||++|||++|..|+...... ......... .....++.+|+.++|..||+
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence 8899999998889999999999999999999999888643221 111111100 11124456789999999999
Q ss_pred HHHHHH
Q 047020 254 MEQLRV 259 (266)
Q Consensus 254 ~~~l~~ 259 (266)
..++.+
T Consensus 259 ~~eil~ 264 (793)
T PLN00181 259 MSELLQ 264 (793)
T ss_pred hHHHhh
Confidence 998754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=184.57 Aligned_cols=169 Identities=20% Similarity=0.107 Sum_probs=125.6
Q ss_pred HHHhhchhhhhccccccceEEEEEcC--CCcEEEEEEeeecc-----cccHHHHHHHHHHHhcCCCCCccccceeEEecC
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELG--DGNFGAVKRVMEER-----GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG 79 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~--~g~~~~vk~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 79 (266)
.....|.+...||+|+||.||++... ++..++||+..... ......+.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34556777889999999999999543 46667888765331 1234568899999999999999853322 24
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCC-CCCcEEEecCCceEEecc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDI-KSSNILLIDDNHAKLADF 158 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di-kp~nil~~~~~~~~l~df 158 (266)
..++||||++|++|.. ... .. ...++.|++.+|.+||+.| |+|||| ||+||+++.+++++|+||
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 5799999999998862 211 11 1457889999999999999 999999 999999998899999999
Q ss_pred ccccCCCCCCCCCC----CcccccccCCCccCccccccc
Q 047020 159 GLCKLGPFNDPNRP----KRQTSIKGSFGYVDTNYLNTG 193 (266)
Q Consensus 159 g~~~~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~ 193 (266)
|++........... .......+++.|.+||.+...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99986543322111 111345678889999998543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-26 Score=204.67 Aligned_cols=238 Identities=21% Similarity=0.240 Sum_probs=187.6
Q ss_pred hchhhhhccccccceEEEEEcCCCcEEEEEEeeecccc-cH---HHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGG-SR---KIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~-~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
...+.+.||++.|=.+.+++..+|. ++||.+.++.+. .. .+...|++ ...+++||++++.-+...+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4567779999999999999887776 888988776643 22 23334455 556689999999988888888899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|... +|+|.+... ..+...+...++.|++.|+..+|+.| +||||||.+|||++.-+-+.|.||...+..+.
T Consensus 102 yvkh-nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHhh-hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 9855 999998763 55677888899999999999999999 99999999999999999999999998866444
Q ss_pred CCCCCCCc---ccccccCCCccCccccccc----------c-CCCcccchhHHHHHHHHHh-CCCCc---------CC-C
Q 047020 167 NDPNRPKR---QTSIKGSFGYVDTNYLNTG----------F-VSTKSDVYSFGVLLLELIT-GLKSI---------QG-S 221 (266)
Q Consensus 167 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~-~~~~~Di~slG~i~~~l~~-g~~pf---------~~-~ 221 (266)
+..+.... ..+...-..|.|||.+-.. . .+++.||||+||+++||++ |++|| .+ .
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~ 252 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNA 252 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCc
Confidence 43333222 1223334469999987331 1 5678999999999999987 78888 22 5
Q ss_pred chhHHHHHHHHhcCchhhhhhhccCCCCCcchHHHHHH
Q 047020 222 ATLAEWTEECRRNKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+..+.++.....+++..||+-+|..|-+.++..+
T Consensus 253 ~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHH
Confidence 66667777777777778999999999999999988654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=165.82 Aligned_cols=149 Identities=21% Similarity=0.158 Sum_probs=117.1
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
|+|.+++... ...+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc---
Confidence 5788888753 256999999999999999999999875 999999999999999 9988753221
Q ss_pred CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh----c------------
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR----N------------ 234 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~----~------------ 234 (266)
...||..|+|||++.+..++.++||||+||++|+|++|..||............... .
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVS 136 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHH
Confidence 125789999999999999999999999999999999999999765443322222111 0
Q ss_pred ---CchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 235 ---KNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 235 ---~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
...+++.+|+..+|..||+..++.+....
T Consensus 137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 137 AARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred hhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 13356778888888999888887766543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-24 Score=165.72 Aligned_cols=173 Identities=16% Similarity=0.157 Sum_probs=131.6
Q ss_pred HHHHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHH---H------HHHHHHHHhcCCCCCccccceeE
Q 047020 5 EELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRK---I------FLDEVSVLLRVSHPNLVGLLGFC 75 (266)
Q Consensus 5 ~~i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~---~------~~~e~~~l~~l~~~~i~~~~~~~ 75 (266)
+++...+++..+.+|.|+||.||+++. +++.+++|.+......... . +.+|+..+.+++|++|..+.+++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 567777888888999999999999876 5668899988654333222 2 57899999999999999998886
Q ss_pred Eec--------CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE
Q 047020 76 LEK--------GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL 147 (266)
Q Consensus 76 ~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~ 147 (266)
... +..+++|||++|.+|.+... +++ ....+++.++..+|+.| ++|+|++|+||++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili 168 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIV 168 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEE
Confidence 543 35789999999999977531 232 24569999999999999 9999999999999
Q ss_pred ecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHH
Q 047020 148 IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLEL 211 (266)
Q Consensus 148 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l 211 (266)
+++| ++|+|||......... . ....+....+..++|+||||+++..+
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~------a----------~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRK------A----------KDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred eCCC-EEEEECCCcccccchh------h----------HHHHHHHhHhcccccccceeEeehHH
Confidence 9888 9999999776321100 0 01133344566799999999987655
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-21 Score=162.77 Aligned_cols=205 Identities=37% Similarity=0.541 Sum_probs=167.2
Q ss_pred chhhhhccccccceEEEEEcCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCC-CccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHP-NLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+.....||.|+|+.||.+... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 345568999999999999654 66777766554333 366788999999999987 799999999777778999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-ceEEeccccccCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLGPF 166 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~~~l~dfg~~~~~~~ 166 (266)
+.++++.+.+...... ..++......+..|++.++.++|+.+ ++|||+||+||+++..+ .++++|||.+.....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999766653111 36889999999999999999999999 99999999999999888 799999999874333
Q ss_pred CCCCCC--CcccccccCCCccCcccccc---ccCCCcccchhHHHHHHHHHhCCCCcCCCch
Q 047020 167 NDPNRP--KRQTSIKGSFGYVDTNYLNT---GFVSTKSDVYSFGVLLLELITGLKSIQGSAT 223 (266)
Q Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~ 223 (266)
...... .......++..|++||...+ .......|+||+|+++++++.|..||.....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 222111 13567889999999999987 5788899999999999999999999877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=191.01 Aligned_cols=236 Identities=22% Similarity=0.240 Sum_probs=178.3
Q ss_pred hhhccccccceEEEE-EcCCCcEEEEEEeee---ccccc---HHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 15 RIRIGVGATSFVYLA-ELGDGNFGAVKRVME---ERGGS---RKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 15 ~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~---~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
...+|.|++|.++.+ .....+....+..+. ..... ...+..|+.+-..++|||++..+..+.+.....-.|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 347999999977777 333333344443221 11111 12255677777888999998888777666655556999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++ +|+.++... +.+....+-.++.|++.|++|+|+.| +.|||+||+|+++..+|.+||+|||.+......
T Consensus 403 ~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred ccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 998 999999873 57888999999999999999999999 999999999999999999999999999875555
Q ss_pred CCCCCCcccccccCCCccCccccccccCCC-cccchhHHHHHHHHHhCCCCcCCCchhHH----------------HHHH
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVST-KSDVYSFGVLLLELITGLKSIQGSATLAE----------------WTEE 230 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~i~~~l~~g~~pf~~~~~~~~----------------~~~~ 230 (266)
............|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||.-....++ ...+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 444446667789999999999999998876 59999999999999999999943322211 0111
Q ss_pred HH--hcCchhhhhhhccCCCCCcchHHHHHH
Q 047020 231 CR--RNKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 231 ~~--~~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.. ......++.+|++++|..|.+.++|.+
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11 111225678999999999999988764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=157.59 Aligned_cols=137 Identities=19% Similarity=0.184 Sum_probs=106.5
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeeccccc--------------------------HHHHHHHHHHHhcCCCCCcc
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGS--------------------------RKIFLDEVSVLLRVSHPNLV 69 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~--------------------------~~~~~~e~~~l~~l~~~~i~ 69 (266)
..||+|++|.||++...+|+.++||......... ......|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4799999999999977789999999876532210 11223599999999887765
Q ss_pred ccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeecCCCCCCcEEEe
Q 047020 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL-HSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~~~~i~H~dikp~nil~~ 148 (266)
....+... ..++||||++|+++....... ..++...+..++.|++.++.++ |+.| ++|+||||+||+++
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~ 152 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH 152 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence 44333222 238999999887665443221 5688999999999999999999 7999 99999999999998
Q ss_pred cCCceEEeccccccC
Q 047020 149 DDNHAKLADFGLCKL 163 (266)
Q Consensus 149 ~~~~~~l~dfg~~~~ 163 (266)
++.++|+|||++..
T Consensus 153 -~~~v~LiDFG~a~~ 166 (190)
T cd05147 153 -DGKLYIIDVSQSVE 166 (190)
T ss_pred -CCcEEEEEcccccc
Confidence 47899999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-21 Score=149.17 Aligned_cols=136 Identities=19% Similarity=0.169 Sum_probs=107.4
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeeccccc--------------------------HHHHHHHHHHHhcCCCCCcc
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGS--------------------------RKIFLDEVSVLLRVSHPNLV 69 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~--------------------------~~~~~~e~~~l~~l~~~~i~ 69 (266)
..||+|++|.||++...+|+.++||......... ...+..|.+.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 4799999999999977689999999876532110 12245789999999988875
Q ss_pred ccceeEEecCeEEEEEEecCCCchhhh-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEE
Q 047020 70 GLLGFCLEKGEQLLLLEYLANKSLFDR-MHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILL 147 (266)
Q Consensus 70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~ 147 (266)
....+... ..++||||++|+++... +.. ..++...+..++.|++.++.++|+ .| ++|+||||+||++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 44443332 24899999988755433 322 457888999999999999999999 99 9999999999999
Q ss_pred ecCCceEEeccccccC
Q 047020 148 IDDNHAKLADFGLCKL 163 (266)
Q Consensus 148 ~~~~~~~l~dfg~~~~ 163 (266)
+ +++++|+|||++..
T Consensus 152 ~-~~~~~liDFG~a~~ 166 (190)
T cd05145 152 H-DGKPYIIDVSQAVE 166 (190)
T ss_pred E-CCCEEEEEccccee
Confidence 8 78999999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-22 Score=180.63 Aligned_cols=238 Identities=19% Similarity=0.215 Sum_probs=173.9
Q ss_pred hhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC---CCCccccceeEEecCeEEEEEEecC
Q 047020 13 DFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS---HPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
-+.+.||+|+||.||+|...+|+.+|+|.=......+.- -=.+++.+|+ -+.|..+...+..++..++|++|.+
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~ 777 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP 777 (974)
T ss_pred EEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence 344589999999999998777999999864433332211 0123333343 3567777777788888899999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-------CCceEEecccccc
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-------DNHAKLADFGLCK 162 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-------~~~~~l~dfg~~~ 162 (266)
.|+|.|++... +.+++..+..+..|++..+..||..+ ||||||||+|+++.. ...++|+|||.+-
T Consensus 778 ~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 778 YGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred cccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 99999999743 77899999999999999999999999 999999999999942 2348999999875
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCC-c-CCCchhHHHHHHHHhcCchh--
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKS-I-QGSATLAEWTEECRRNKNVE-- 238 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~p-f-~~~~~~~~~~~~~~~~~~~~-- 238 (266)
-|..-.. ........+|-.+-++|...|+.|+..+|.|.++.+++.|+.|.+- + .|......- .+++.+..+
T Consensus 850 Dm~lfp~--~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~~~--~~~Ry~~~~~W 925 (974)
T KOG1166|consen 850 DMKLFPD--GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMVKT--NFPRYWKRDMW 925 (974)
T ss_pred eeeEcCC--CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceeccc--cchhhhhHHHH
Confidence 4332221 2344567788889999999999999999999999999999998422 1 111110000 012222222
Q ss_pred --hhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 239 --VWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 239 --~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
++..+|.++...-|...+|+..|+..|
T Consensus 926 ~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 926 NKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred HHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 344667777777788889998888766
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=145.54 Aligned_cols=186 Identities=16% Similarity=0.093 Sum_probs=130.0
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeecccc----cHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecCC
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGG----SRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
..|++|+||.|+++.- .+..++.+.+...... ....+.+|+++|++++ ++++++++++ +..+++|+|+.|
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 4799999999998865 4444444433222111 1235788999999996 5889998886 446999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCC-CCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDI-KSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di-kp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
.+|...... + ...++.|++.++.++|+.| ++|+|| ||+||+++.++.++|+|||++........
T Consensus 83 ~~L~~~~~~------~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 83 AAMYQRPPR------G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ccHHhhhhh------h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 888643211 1 1346789999999999999 999999 79999999999999999999984221110
Q ss_pred C----C-C----CcccccccCCCccCccccccc-cCC-CcccchhHHHHHHHHHhCCCCcCCC
Q 047020 170 N----R-P----KRQTSIKGSFGYVDTNYLNTG-FVS-TKSDVYSFGVLLLELITGLKSIQGS 221 (266)
Q Consensus 170 ~----~-~----~~~~~~~~t~~y~aPE~~~~~-~~~-~~~Di~slG~i~~~l~~g~~pf~~~ 221 (266)
- . . ........++.++.|+.-.-. ..+ .+.++++.|+.+|.+.|+..|+-++
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 0 001122356667777654222 122 4678889999999999999887544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=152.52 Aligned_cols=195 Identities=21% Similarity=0.264 Sum_probs=123.0
Q ss_pred hhccccccceEEEE-EcCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCC----------CCccccceeE------
Q 047020 16 IRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSH----------PNLVGLLGFC------ 75 (266)
Q Consensus 16 ~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~----------~~i~~~~~~~------ 75 (266)
..||.|+++.||.+ +-.+|+..+||.+...... ..+.+.+|.-....+.+ -.++..++..
T Consensus 18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~ 97 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKP 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-
T ss_pred cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCC
Confidence 47999999999999 6677999999988654432 23444444433333221 1222222221
Q ss_pred ---Eec---C-----eEEEEEEecCCCchhhhhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCC
Q 047020 76 ---LEK---G-----EQLLLLEYLANKSLFDRMHTYYGQSL--GVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKS 142 (266)
Q Consensus 76 ---~~~---~-----~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp 142 (266)
... + +.+++|+-+ .+||.+++........ ..+.......+..|++..+++||+.| ++|+||+|
T Consensus 98 ~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~ 173 (288)
T PF14531_consen 98 PFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKP 173 (288)
T ss_dssp SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SG
T ss_pred cceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccce
Confidence 111 1 336788866 5688887664322211 22333444567789999999999999 99999999
Q ss_pred CcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccc--------cCCCcccchhHHHHHHHHHhC
Q 047020 143 SNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG--------FVSTKSDVYSFGVLLLELITG 214 (266)
Q Consensus 143 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~Di~slG~i~~~l~~g 214 (266)
+|++++.+|.++|+||+...... .... ....+..|.|||..... .++.+.|.|++|+++|.|+++
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g-----~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAG-----TRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETT-----EEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeEEEcCCCCEEEcChHHHeecC-----ceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999876411 1111 13455778999976432 467889999999999999999
Q ss_pred CCCcCCC
Q 047020 215 LKSIQGS 221 (266)
Q Consensus 215 ~~pf~~~ 221 (266)
..||...
T Consensus 247 ~lPf~~~ 253 (288)
T PF14531_consen 247 RLPFGLS 253 (288)
T ss_dssp S-STCCC
T ss_pred cCCCCCC
Confidence 9999654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=144.86 Aligned_cols=131 Identities=15% Similarity=0.163 Sum_probs=102.2
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-----CCCCccccceeEEecC---eEE-EEEE
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-----SHPNLVGLLGFCLEKG---EQL-LLLE 86 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~~~-lv~e 86 (266)
..||+|++|.||. ...++.. +||+...........+.+|+.+++.+ .||||+++++++.++. ..+ +|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 3799999999996 4444444 68877655444567789999999999 5799999999998864 333 7899
Q ss_pred e--cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeecCCCCCCcEEEecC----CceEEeccc
Q 047020 87 Y--LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL-EYLHSQADPPIIHRDIKSSNILLIDD----NHAKLADFG 159 (266)
Q Consensus 87 ~--~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~Lh~~~~~~i~H~dikp~nil~~~~----~~~~l~dfg 159 (266)
| ..+++|.+++++ +.+++. ..++.|++.++ .|||+++ |+|+||||+||+++.. ++++|+|++
T Consensus 86 ~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 86 FDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred CCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 9 446899999965 335555 35577778777 8999999 9999999999999743 379999944
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9e-22 Score=169.07 Aligned_cols=186 Identities=30% Similarity=0.398 Sum_probs=153.5
Q ss_pred hccccccceEEEEEc----CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecC
Q 047020 17 RIGVGATSFVYLAEL----GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.+|+|.+|.|+++.. ..|...++|....... ........|..++...+ ||++++++..++..+..++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999999832 2344455554433221 11225566888888887 9999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
|+.+...+... ..+.+.....+...++.++.++|+.+ ++|+|+|++||+++.+|++++.|||.....
T Consensus 81 gg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~----- 147 (612)
T KOG0603|consen 81 GGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEA----- 147 (612)
T ss_pred cchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHh-----
Confidence 99998777653 67888899999999999999999999 999999999999999999999999987642
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCC
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQG 220 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~ 220 (266)
.......||..|||||.+. ....+.|+||+|++.++|++|..||.+
T Consensus 148 ---v~~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 148 ---VKEKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---HhhhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 2222238899999999987 567899999999999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-21 Score=149.17 Aligned_cols=244 Identities=18% Similarity=0.252 Sum_probs=176.2
Q ss_pred HHHHhhchhhhhccccccceEEEEEcCCCcEEEEEEe--eecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRV--MEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
.|..+..++.-+|.....|..|++++..+ -+++|.+ ..-.+.-...|..|...++.+.||||+++++.|....++.+
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 45556667777999999999999987543 3344432 22233345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
+..|++-|||+..+.. +..--.+..++.+.+.+++.++.|||+.. +-|.---++..+++++++-+.+|+- +-+.+
T Consensus 265 isq~mp~gslynvlhe---~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf 339 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF 339 (448)
T ss_pred eeeeccchHHHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee
Confidence 9999999999999876 33344677889999999999999999984 3333447888999999887766542 11111
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCC---CcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc---Cch
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVS---TKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN---KNV 237 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~---~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~ 237 (266)
+.......-++.|++||.+..++-+ .++|+|||++++|||-|...||.+-+..+-=.++.... ..+
T Consensus 340 --------sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip 411 (448)
T KOG0195|consen 340 --------SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP 411 (448)
T ss_pred --------eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC
Confidence 0111223446779999999766433 46999999999999999999997654433222222111 111
Q ss_pred --------hhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 238 --------EVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 238 --------~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
.++.-+...+|..||-.+++..++++
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 34456788888888888888887776
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-18 Score=136.30 Aligned_cols=134 Identities=25% Similarity=0.393 Sum_probs=111.0
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeecccc--------cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGG--------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..||+|++|.||++.. .|..+++|+....... ...++.+|++++..+++++++....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 3689999999999976 5667788865543221 124577899999999999888777777777788999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
++|++|.+.+... .. ....++.+++.++.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887652 12 77889999999999999999 99999999999998 78899999998874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-18 Score=135.86 Aligned_cols=130 Identities=25% Similarity=0.390 Sum_probs=104.7
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccc--------cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGG--------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.||+|++|.||++.. +|..+++|........ ...++.+|++++..++++++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999974 5678888875443211 1255678999999999887665555556666779999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
+|++|.+.+... .. .++.+++.++.+||+.| ++|+|++|.||+++ +++++++|||.+..
T Consensus 80 ~g~~l~~~~~~~------~~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG------ND------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc------HH------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998876541 11 78899999999999999 99999999999998 78999999998774
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-18 Score=136.73 Aligned_cols=140 Identities=19% Similarity=0.182 Sum_probs=106.2
Q ss_pred chhhhhccccccceEEEEE--cCCCcEEEEEEeeecccc------------------------cHHHHHHHHHHHhcCCC
Q 047020 12 NDFRIRIGVGATSFVYLAE--LGDGNFGAVKRVMEERGG------------------------SRKIFLDEVSVLLRVSH 65 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~--~~~g~~~~vk~~~~~~~~------------------------~~~~~~~e~~~l~~l~~ 65 (266)
+.+...||+|++|.||+|. ..+|..+++|........ ....+..|++.++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3444589999999999997 678999999987643210 01235679999999975
Q ss_pred C--CccccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCC
Q 047020 66 P--NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSS 143 (266)
Q Consensus 66 ~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ 143 (266)
. .+++.+.. ...++||||++|.++....... ..+....+..++.|++.++.+||+.|. ++|+||||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChh
Confidence 3 33344432 2358999999988876654221 345666778999999999999998763 999999999
Q ss_pred cEEEecCCceEEeccccccC
Q 047020 144 NILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 144 nil~~~~~~~~l~dfg~~~~ 163 (266)
||+++ +++++|+|||.+..
T Consensus 179 NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hEEEE-CCCEEEEEChhhhc
Confidence 99998 88999999998873
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.4e-18 Score=131.66 Aligned_cols=141 Identities=24% Similarity=0.238 Sum_probs=107.5
Q ss_pred HHHHHhh--chhhhhccccccceEEEEEcCCCcEEEEEEeeecccc----------------------cHHHHHHHHHHH
Q 047020 5 EELKMAT--NDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGG----------------------SRKIFLDEVSVL 60 (266)
Q Consensus 5 ~~i~~~~--~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~----------------------~~~~~~~e~~~l 60 (266)
.++.... +.+...||+|++|.||++...+|+.++||........ .......|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3455555 4556689999999999998778999999976542211 012356788888
Q ss_pred hcCCCCC--ccccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecC
Q 047020 61 LRVSHPN--LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHR 138 (266)
Q Consensus 61 ~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~ 138 (266)
..+.+++ ++..++ ....+++|||++|++|.+... ......++.+++.++.++|+.| ++|+
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~~g---i~H~ 149 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYKHG---IIHG 149 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHHCC---CCcC
Confidence 8887763 444433 245689999999988865432 1345678899999999999999 9999
Q ss_pred CCCCCcEEEecCCceEEeccccccC
Q 047020 139 DIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 139 dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||+|+||++++++.++|+|||.+..
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCcccc
Confidence 9999999999999999999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=7e-18 Score=150.57 Aligned_cols=131 Identities=21% Similarity=0.296 Sum_probs=105.1
Q ss_pred hhhccccccceEEEEEcCCCcEEEEEEeeeccc--------ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 15 RIRIGVGATSFVYLAELGDGNFGAVKRVMEERG--------GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 15 ~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
...||+|+||.||++..... .+++|+...+.. ....++.+|+++++.++|++++....++......++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 45899999999999865433 334443322111 123567889999999999999887777777777899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
|++|++|.+++. ....++.+++.++.+||+.+ ++|||+||+||++ +++.++|+|||++..
T Consensus 417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999988774 24678899999999999999 9999999999999 677899999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-18 Score=155.40 Aligned_cols=133 Identities=26% Similarity=0.400 Sum_probs=99.4
Q ss_pred HHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC-----------CCCCcccccccCCCccCccc
Q 047020 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP-----------NRPKRQTSIKGSFGYVDTNY 189 (266)
Q Consensus 121 ~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~t~~y~aPE~ 189 (266)
+.++.|||+.| |+|+|+||+|.+|..-|++|+.|||+....--... ..........||+.|.|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 88999999999 99999999999999999999999999764211110 01112235689999999999
Q ss_pred cccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 190 LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 190 ~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+....|+..+|+|++|+|+|+.+-|..||.++...+.+-..+.-.... ++- ..+.+.+.+.+++..+
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w--------pE~-dea~p~Ea~dli~~LL 296 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW--------PEE-DEALPPEAQDLIEQLL 296 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc--------ccc-CcCCCHHHHHHHHHHH
Confidence 999999999999999999999999999999876555543333322111 111 4455566677766654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=136.13 Aligned_cols=188 Identities=20% Similarity=0.264 Sum_probs=131.1
Q ss_pred CCCCccccceeEEe---------------------------cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHH
Q 047020 64 SHPNLVGLLGFCLE---------------------------KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI 116 (266)
Q Consensus 64 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~ 116 (266)
+||||+.+++.|.+ ....|+||... ..+|.+++-. ...+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc------CCCchHHHHHH
Confidence 59999999876643 23568888866 4578888765 45677788889
Q ss_pred HHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe--cCC--ceEEeccccccCCCCCCCCC--CCcccccccCCCccCcccc
Q 047020 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLI--DDN--HAKLADFGLCKLGPFNDPNR--PKRQTSIKGSFGYVDTNYL 190 (266)
Q Consensus 117 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~--~~~--~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~ 190 (266)
+.|++.|+.|||++| +.|||+|.+||++. +++ .++|.|||+|--.......- .+..-...|....||||+.
T Consensus 347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 999999999999999 99999999999985 333 36899999875321111111 1122345677788999998
Q ss_pred ccccC------CCcccchhHHHHHHHHHhCCCCcCCCc--hhH--HHHHHHH-------hcCchhhhhhhccCCCCCcch
Q 047020 191 NTGFV------STKSDVYSFGVLLLELITGLKSIQGSA--TLA--EWTEECR-------RNKNVEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 191 ~~~~~------~~~~Di~slG~i~~~l~~g~~pf~~~~--~~~--~~~~~~~-------~~~~~~~~~~~l~~~~~~~~~ 253 (266)
...+- -.++|.|+.|.+.||++....||-+.. .++ .+.+.-. .+...+++..++.+++.+|++
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvs 503 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVS 503 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCC
Confidence 54321 247999999999999999999996532 221 1211110 011126778899999999988
Q ss_pred HHHHHHHH
Q 047020 254 MEQLRVLI 261 (266)
Q Consensus 254 ~~~l~~~~ 261 (266)
+.--..++
T Consensus 504 p~iAANvl 511 (598)
T KOG4158|consen 504 PNIAANVL 511 (598)
T ss_pred ccHHHhHH
Confidence 86544443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=141.48 Aligned_cols=153 Identities=29% Similarity=0.436 Sum_probs=124.2
Q ss_pred HhcCCCCCccccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-ecC
Q 047020 60 LLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI-IHR 138 (266)
Q Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i-~H~ 138 (266)
|+.+.|.|+.++++.+.++...+.|.+|+.-|+|.|.+... .-.+++.-...++.+++.|+.|||+.. | .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSP---IGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCc---ceeee
Confidence 46788999999999999999999999999999999999862 245666677788999999999999987 6 999
Q ss_pred CCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCcccccccc-------CCCcccchhHHHHHHHH
Q 047020 139 DIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGF-------VSTKSDVYSFGVLLLEL 211 (266)
Q Consensus 139 dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~i~~~l 211 (266)
.++..|.+++..-.+||.|||+........ .........-..-|.|||.+++.. .+.+.|+||+|++++|+
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~--~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETA--EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccc--cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 999999999999899999999987653311 111112223445589999987641 46679999999999999
Q ss_pred HhCCCCcCCC
Q 047020 212 ITGLKSIQGS 221 (266)
Q Consensus 212 ~~g~~pf~~~ 221 (266)
++...||...
T Consensus 152 ~~r~~~~~~~ 161 (484)
T KOG1023|consen 152 LFRSGPFDLR 161 (484)
T ss_pred HhccCccccc
Confidence 9999999653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-16 Score=125.98 Aligned_cols=133 Identities=19% Similarity=0.237 Sum_probs=100.7
Q ss_pred hcc-ccccceEEEEEcCCCcEEEEEEeeecc-------------cccHHHHHHHHHHHhcCCCCCc--cccceeEEecC-
Q 047020 17 RIG-VGATSFVYLAELGDGNFGAVKRVMEER-------------GGSRKIFLDEVSVLLRVSHPNL--VGLLGFCLEKG- 79 (266)
Q Consensus 17 ~ig-~g~~~~v~~~~~~~g~~~~vk~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~- 79 (266)
.|| .|+.|.+|.+... ++.++||...... .....++.+|++++..++++++ +..+.+.....
T Consensus 38 ~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred eeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 577 8888999998774 6677887664311 1123567889999999998775 55665543322
Q ss_pred ---eEEEEEEecCC-CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEE
Q 047020 80 ---EQLLLLEYLAN-KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKL 155 (266)
Q Consensus 80 ---~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l 155 (266)
..++|||+++| .+|.+++.. ..+++. .+.+++.++.+||+.| |+|+||||+||+++.++.++|
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 23599999987 688887754 344543 3568999999999999 999999999999998889999
Q ss_pred eccccccC
Q 047020 156 ADFGLCKL 163 (266)
Q Consensus 156 ~dfg~~~~ 163 (266)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=118.11 Aligned_cols=133 Identities=23% Similarity=0.196 Sum_probs=107.9
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCC--CCccccceeEEecCeEEEEEEecCCCch
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH--PNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
..||.|.++.+|++...+ ..+++|....... ...+.+|+..++.+++ .++++++.+...++..++++||+++.++
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 469999999999997644 6778877644332 4678899999999976 5888988888887889999999988766
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
..+ +......+..+++.++..+|.....+++|+|++|+||++++.+.++++||+.+..
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 432 4456677889999999999985323399999999999999989999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.3e-16 Score=121.19 Aligned_cols=134 Identities=23% Similarity=0.254 Sum_probs=95.2
Q ss_pred hhhccccccceEEEEEcCCCcEEEEEEeeeccccc--HHH----------------------HHHHHHHHhcCCCC--Cc
Q 047020 15 RIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGS--RKI----------------------FLDEVSVLLRVSHP--NL 68 (266)
Q Consensus 15 ~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~--~~~----------------------~~~e~~~l~~l~~~--~i 68 (266)
...||+|+||.||++...+|+.++||......... ... ...|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999977789999999765432211 011 13455556555433 23
Q ss_pred cccceeEEecCeEEEEEEecCCCchhh-hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEE
Q 047020 69 VGLLGFCLEKGEQLLLLEYLANKSLFD-RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNIL 146 (266)
Q Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil 146 (266)
.+.+.. ...+++|||++++.+.. .+... . ....+..++.+++.++.++|+ .+ ++|+||||+||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~-~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------R-LLEDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh------h-hcccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 344432 24689999998854432 12211 0 116678899999999999999 98 999999999999
Q ss_pred EecCCceEEeccccccC
Q 047020 147 LIDDNHAKLADFGLCKL 163 (266)
Q Consensus 147 ~~~~~~~~l~dfg~~~~ 163 (266)
++ ++.++|+|||.+..
T Consensus 148 i~-~~~~~liDfg~a~~ 163 (187)
T cd05119 148 VD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EE-CCcEEEEECccccc
Confidence 99 88999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-17 Score=138.91 Aligned_cols=165 Identities=27% Similarity=0.360 Sum_probs=125.3
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
.+++.|+++.-.+|.+.+... ......+......+..|+..++.| ++ .+|+|+||.||+...+..++|+|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr--~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR--RTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC--CcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 578999999999999999754 333556777888999999999999 78 9999999999999999999999999
Q ss_pred cccCCCCCCCC--CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhH-----HHHHHH
Q 047020 160 LCKLGPFNDPN--RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLA-----EWTEEC 231 (266)
Q Consensus 160 ~~~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~-----~~~~~~ 231 (266)
+.+.+...... ....+....||..||+||++.+..|+.++||||||++++|++. -...|....... ++..+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEF 481 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHH
Confidence 98864433211 1223456789999999999999999999999999999999998 444442211111 111111
Q ss_pred H-h-cCchhhhhhhccCCCCCcc
Q 047020 232 R-R-NKNVEVWAQMLDPKLNGDA 252 (266)
Q Consensus 232 ~-~-~~~~~~~~~~l~~~~~~~~ 252 (266)
. . +...+++.+++.+.|..||
T Consensus 482 ~~d~p~e~~ll~~lls~~p~~RP 504 (516)
T KOG1033|consen 482 LQDYPEEYTLLQQLLSPSPEERP 504 (516)
T ss_pred hhcCcHHHHHHHHhcCCCcccCc
Confidence 1 1 2222677899999999999
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.1e-14 Score=125.18 Aligned_cols=167 Identities=19% Similarity=0.237 Sum_probs=127.9
Q ss_pred EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCC
Q 047020 30 ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLS 109 (266)
Q Consensus 30 ~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 109 (266)
...+++++.|...............+.++.++.++||+|+++++.++..+..|+|+|.+. .|..++++. .
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~ 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------G 102 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------H
Confidence 445688888876655443345667788999999999999999999999999999999874 677777763 3
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccc
Q 047020 110 WSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189 (266)
Q Consensus 110 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 189 (266)
...+...++||+.||.|||..+. ++|++|....||++..|++||++|..+..-.... ........-..|..|+.
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~----~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN----APAKSLYLIESFDDPEE 176 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC----cccccchhhhcccChhh
Confidence 66677788999999999985333 9999999999999999999999999876421111 11222333344666765
Q ss_pred cccccCCCcccchhHHHHHHHHHhC
Q 047020 190 LNTGFVSTKSDVYSFGVLLLELITG 214 (266)
Q Consensus 190 ~~~~~~~~~~Di~slG~i~~~l~~g 214 (266)
+.... ...|.|.|||++++++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 43322 467999999999999999
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.4e-16 Score=140.92 Aligned_cols=207 Identities=26% Similarity=0.286 Sum_probs=160.2
Q ss_pred hhchhhhhccccccceEEEEEcCC--CcEEEEEEeeec--ccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGD--GNFGAVKRVMEE--RGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~--g~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 84 (266)
..+++...||+|+++.+-.+.... ...++++.+... ..........|..+-+.+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345666689999999999884422 333444433222 1223344556888888887 99999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeecCCCCCCcEEEecCC-ceEEecccccc
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH-SQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCK 162 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~~~~i~H~dikp~nil~~~~~-~~~l~dfg~~~ 162 (266)
+++..|+++.+.+.. ......+...+..++.|+..++.|+| ..+ ++|+|+||+|.+++..+ .+++.|||+|+
T Consensus 100 ~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999999887732 11125677788999999999999999 998 99999999999999999 99999999998
Q ss_pred CCCCCCCCCCCccccccc-CCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCch
Q 047020 163 LGPFNDPNRPKRQTSIKG-SFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSAT 223 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~-t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~ 223 (266)
..... ...........| ++.|.|||...+. ......|+||.|+++..+++|..|+.....
T Consensus 174 ~~~~~-~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 174 AYRNK-NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccc-CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 64431 222333445667 9999999999874 556789999999999999999999965433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.6e-14 Score=116.03 Aligned_cols=197 Identities=22% Similarity=0.276 Sum_probs=138.6
Q ss_pred HhcCCCCCccccceeEEecC-----eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 047020 60 LLRVSHPNLVGLLGFCLEKG-----EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP 134 (266)
Q Consensus 60 l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~ 134 (266)
+-++.|.||++++.++.+.. ...++.+|+..|++..+++..... ...++.....+|+-||++||.|||+. +||
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 34455899999998875543 467889999999999999875322 25678888899999999999999998 799
Q ss_pred eecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhC
Q 047020 135 IIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214 (266)
Q Consensus 135 i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g 214 (266)
++|+++..+.|++..+|-+|++--.-...-+..............+.++|.+||.-.....+.++|||+||+...+|.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999888888763211110001111112233455678889999987666677899999999999999887
Q ss_pred CCCcCCC-chhH------HHHHHHHhcCchhhhhhhccCCCCCcchHHHHH
Q 047020 215 LKSIQGS-ATLA------EWTEECRRNKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 215 ~~pf~~~-~~~~------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..--... ++.. +..--+.+....+.+.+++.++|++||++.++.
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred eeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhh
Confidence 5443222 2211 111111122223567789999999999887754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=3e-13 Score=117.46 Aligned_cols=136 Identities=21% Similarity=0.239 Sum_probs=93.5
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeeccccc----------------------------------------HHHHHHH
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGS----------------------------------------RKIFLDE 56 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~----------------------------------------~~~~~~e 56 (266)
.||.|++|.||+|.+.+|+.|+||......... .-.+.+|
T Consensus 124 plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~E 203 (437)
T TIGR01982 124 PLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRRE 203 (437)
T ss_pred ceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHH
Confidence 699999999999999999999999764321100 0013345
Q ss_pred HHHHhcCC-----CCCc--cccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 047020 57 VSVLLRVS-----HPNL--VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR-ALEYLH 128 (266)
Q Consensus 57 ~~~l~~l~-----~~~i--~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~Lh 128 (266)
+..+.+++ ++++ ++++ ....+..++||||++|+++.+...... ...+ ...++.+++. .+..+|
T Consensus 204 a~n~~~~~~~~~~~~~v~vP~v~--~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 204 AANASELGENFKNDPGVYVPEVY--WDRTSERVLTMEWIDGIPLSDIAALDE----AGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHhcCCCCCEEeCCEe--hhhcCCceEEEEeECCcccccHHHHHh----cCCC---HHHHHHHHHHHHHHHHH
Confidence 55444442 2332 2222 222345799999999999988765321 1112 2345555544 467899
Q ss_pred hCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 129 ~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
..| ++|+|++|.||++.++++++++|||++...
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999 999999999999999999999999998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.9e-13 Score=100.52 Aligned_cols=128 Identities=20% Similarity=0.151 Sum_probs=92.0
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCcc-ccceeEEecCeEEEEEEecCCCchhh
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV-GLLGFCLEKGEQLLLLEYLANKSLFD 95 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
.++.|.++.+|++... |+.+++|....... ....+..|+.+++.+.+.+++ +++.+. .+..++||||++|.++.+
T Consensus 5 ~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 5 PLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred ecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 5788999999999764 67788876543321 223457899999988754444 444432 234589999999987754
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 96 RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA--DPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
. . ......+.+++.++..||+.+ ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 81 ~--~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 E--D-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred c--c-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 2 0 111345678999999999987 11249999999999998 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.3e-13 Score=117.43 Aligned_cols=244 Identities=24% Similarity=0.213 Sum_probs=172.8
Q ss_pred HHHhhchhhhhccc--cccceEEEEEc---CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCC-CCCccccceeEEec
Q 047020 7 LKMATNDFRIRIGV--GATSFVYLAEL---GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEK 78 (266)
Q Consensus 7 i~~~~~~~~~~ig~--g~~~~v~~~~~---~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 78 (266)
....+-.....+|. |.+|.+|.+.- .++..+++|+-..... ....+-.+|+.-..+++ |++.++.+..+...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 34455566668999 99999999843 5677778876333222 33444557788888886 99999988889999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeecCCCCCCcEEEecC-Cce
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR----ALEYLHSQADPPIIHRDIKSSNILLIDD-NHA 153 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~----~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~~ 153 (266)
+..++-+|.+ +.++.++.... ...++...++..+.+... |+.++|+.. ++|-|++|+|+++..+ ...
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred Ccceeeeccc-cchhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccccee
Confidence 9999999987 56777766543 234677788888888888 999999999 9999999999999988 778
Q ss_pred EEeccccccCCCCCCCCCCCcc-cccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC--chhHHHHH-
Q 047020 154 KLADFGLCKLGPFNDPNRPKRQ-TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS--ATLAEWTE- 229 (266)
Q Consensus 154 ~l~dfg~~~~~~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~--~~~~~~~~- 229 (266)
+++|||+...+........... ....+...|++||.. ...++...|++++|.++.+-..+..++... +.-.+...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 9999999887665553333222 223788889999986 446688999999999999988886555332 11111100
Q ss_pred -----HHHh--cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 230 -----ECRR--NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 230 -----~~~~--~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+.. ......+..|+++++.-+++.+.+..
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000 00112456778887777776666543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.8e-11 Score=91.50 Aligned_cols=130 Identities=25% Similarity=0.402 Sum_probs=98.3
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccc--------cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGG--------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+++|+-+.++.+... |..+++|....+.-. ...+..+|+.++.+++.-.|....-+..+.....++|||.
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4788999999999663 334555544333221 1455678999999987555555555566777788999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
+|..|.+.+... ...++..+-.-+.-||..| |+|+|+.+.||++..++ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999888888762 2456777778888899999 99999999999997664 99999999874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.1e-12 Score=112.71 Aligned_cols=138 Identities=16% Similarity=0.157 Sum_probs=87.1
Q ss_pred hccccccceEEEEEcCC-CcEEEEEEeeecccc----------------------------------cHHH------HHH
Q 047020 17 RIGVGATSFVYLAELGD-GNFGAVKRVMEERGG----------------------------------SRKI------FLD 55 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~-g~~~~vk~~~~~~~~----------------------------------~~~~------~~~ 55 (266)
.||+|++|.|++|.+.+ |+.|+||........ .... +.+
T Consensus 126 PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~ 205 (537)
T PRK04750 126 PLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMR 205 (537)
T ss_pred hhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHH
Confidence 79999999999998877 999999987543110 0111 233
Q ss_pred HHHHHhcCC----CCCccccceeE-EecCeEEEEEEecCCCchhhhhhhh-cCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 047020 56 EVSVLLRVS----HPNLVGLLGFC-LEKGEQLLLLEYLANKSLFDRMHTY-YGQSLGVLSWSNRLSIALDIARALEYLHS 129 (266)
Q Consensus 56 e~~~l~~l~----~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 129 (266)
|+..+.+++ +...+.+-.++ .-.+..++||||+.|+++.+.-... .+.....+.+..+..++.|+ ..
T Consensus 206 Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~ 278 (537)
T PRK04750 206 EAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FR 278 (537)
T ss_pred HHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------Hh
Confidence 444444442 22222222222 2244578999999999997743211 01111123333333444444 45
Q ss_pred CCCCCeecCCCCCCcEEEecCC----ceEEeccccccCC
Q 047020 130 QADPPIIHRDIKSSNILLIDDN----HAKLADFGLCKLG 164 (266)
Q Consensus 130 ~~~~~i~H~dikp~nil~~~~~----~~~l~dfg~~~~~ 164 (266)
.| ++|+|++|.||+++.+| +++++|||++...
T Consensus 279 ~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 279 DG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred CC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 78 99999999999999887 8999999998753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.8e-11 Score=92.47 Aligned_cols=133 Identities=17% Similarity=0.204 Sum_probs=93.5
Q ss_pred hhccccccceEEEEEcCC-------CcEEEEEEeeecccc----------------------cHHH----HHHHHHHHhc
Q 047020 16 IRIGVGATSFVYLAELGD-------GNFGAVKRVMEERGG----------------------SRKI----FLDEVSVLLR 62 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~-------g~~~~vk~~~~~~~~----------------------~~~~----~~~e~~~l~~ 62 (266)
..||.|-=+.||.+...+ +..++||..+..... .... ..+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368888899999995432 468888854321100 0112 2379999999
Q ss_pred CCC--CCccccceeEEecCeEEEEEEecCCCchhh-hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeecC
Q 047020 63 VSH--PNLVGLLGFCLEKGEQLLLLEYLANKSLFD-RMHTYYGQSLGVLSWSNRLSIALDIARALEYL-HSQADPPIIHR 138 (266)
Q Consensus 63 l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~~~~i~H~ 138 (266)
+.. -+++..+++ ...++||||+.+..+.. .++. ..++...+..+..+++.++..| |+.| ++||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 863 355555653 45689999997644421 2222 2345566777889999999988 8999 9999
Q ss_pred CCCCCcEEEecCCceEEecccccc
Q 047020 139 DIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 139 dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
|+++.||++. ++.+.|+|||.+.
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav 172 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSV 172 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCce
Confidence 9999999996 4689999999775
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4e-11 Score=89.44 Aligned_cols=141 Identities=23% Similarity=0.269 Sum_probs=104.4
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeecccc--------cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGG--------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..+.+|+-+.|+++.. .|+...||....+.-. ...+..+|+..+.+++--.|.-..-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 3688999999999966 5777777754333221 246677899999988744554444456666677899999
Q ss_pred cCC-CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc---eEEeccccccC
Q 047020 88 LAN-KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH---AKLADFGLCKL 163 (266)
Q Consensus 88 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---~~l~dfg~~~~ 163 (266)
++| .++.+++..... ...........+.++-..+.-||.++ |+||||..+||++..++. +.++|||+...
T Consensus 92 ~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 977 578888876422 22333444788899999999999999 999999999999986653 48999998763
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.6e-11 Score=94.22 Aligned_cols=141 Identities=24% Similarity=0.344 Sum_probs=101.5
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCC--CccccceeEEec---CeEEEEEEecCC
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHP--NLVGLLGFCLEK---GEQLLLLEYLAN 90 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~---~~~~lv~e~~~~ 90 (266)
.|+.|..+.+|++...+|+.+++|....... .....+..|.++++.+++. .+++++.+.... +..++||||++|
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G 84 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG 84 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence 5889999999999776667788886543222 1345678999999999753 456666665543 256899999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA--------------------------------------- 131 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--------------------------------------- 131 (266)
.++.+.+.. ..++......++.+++..+..||+..
T Consensus 85 ~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 85 RVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 888765431 23566666666777777777776421
Q ss_pred --------------CCCeecCCCCCCcEEEec--CCceEEeccccccC
Q 047020 132 --------------DPPIIHRDIKSSNILLID--DNHAKLADFGLCKL 163 (266)
Q Consensus 132 --------------~~~i~H~dikp~nil~~~--~~~~~l~dfg~~~~ 163 (266)
...++|+|++|.||++++ ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999988 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.8e-10 Score=87.36 Aligned_cols=123 Identities=25% Similarity=0.277 Sum_probs=80.6
Q ss_pred eEEEEEcCCCcEEEEEEeeecccc--------------------------cHHHHHHHHHHHhcCCCC--CccccceeEE
Q 047020 25 FVYLAELGDGNFGAVKRVMEERGG--------------------------SRKIFLDEVSVLLRVSHP--NLVGLLGFCL 76 (266)
Q Consensus 25 ~v~~~~~~~g~~~~vk~~~~~~~~--------------------------~~~~~~~e~~~l~~l~~~--~i~~~~~~~~ 76 (266)
.||.|...+|+.++||.-+..... ......+|.+.|.++..- ++++.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 378887778889999865432111 123466899999999854 45666644
Q ss_pred ecCeEEEEEEecC--CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeecCCCCCCcEEEecCCce
Q 047020 77 EKGEQLLLLEYLA--NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY-LHSQADPPIIHRDIKSSNILLIDDNHA 153 (266)
Q Consensus 77 ~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-Lh~~~~~~i~H~dikp~nil~~~~~~~ 153 (266)
...++||||++ |..+.. +.. ..++......++.+++..+.. +|+.| ++|||+.+.||+++++ .+
T Consensus 79 --~~~~ivME~I~~~G~~~~~-l~~------~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPR-LKD------VDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp --ETTEEEEE--EETTEEGGC-HHH------CGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred --eCCEEEEEecCCCccchhh-HHh------ccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 23479999998 655543 333 122345567778888885554 68999 9999999999999877 89
Q ss_pred EEecccccc
Q 047020 154 KLADFGLCK 162 (266)
Q Consensus 154 ~l~dfg~~~ 162 (266)
.++|||.+.
T Consensus 146 ~iIDf~qav 154 (188)
T PF01163_consen 146 YIIDFGQAV 154 (188)
T ss_dssp EE--GTTEE
T ss_pred EEEecCcce
Confidence 999999876
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1e-09 Score=93.86 Aligned_cols=169 Identities=21% Similarity=0.239 Sum_probs=124.5
Q ss_pred cceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEE----ecCeEEEEEEecCC-Cchhhh
Q 047020 23 TSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL----EKGEQLLLLEYLAN-KSLFDR 96 (266)
Q Consensus 23 ~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~ 96 (266)
....|++ .--+|..+++|++.............-.+.++++.|+|+|++.++|. .+..+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3557788 44578888888884444433333445688999999999999998775 34578999999876 577775
Q ss_pred hhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 97 MHTYYGQ----------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 97 ~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
--..... .+...++..+|.++.|+..||.++|+.| +..+-+.|.+|+++.+-+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4332211 1235678999999999999999999999 99999999999999888999998777654221
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCC
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGL 215 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~ 215 (266)
+. . +.+.+ -.+-|.=.||.++..|.+|.
T Consensus 446 d~----------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 446 DP----------------T--EPLES---QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CC----------------C--cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence 11 0 11111 24578889999999999994
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.1e-09 Score=87.31 Aligned_cols=131 Identities=18% Similarity=0.088 Sum_probs=91.7
Q ss_pred eEEEEEcCCCcEEEEEEeeecccc-----------cHHHHHHHHHHHhcCCCCCc--cccceeEEe-----cCeEEEEEE
Q 047020 25 FVYLAELGDGNFGAVKRVMEERGG-----------SRKIFLDEVSVLLRVSHPNL--VGLLGFCLE-----KGEQLLLLE 86 (266)
Q Consensus 25 ~v~~~~~~~g~~~~vk~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~-----~~~~~lv~e 86 (266)
.|.++.. .|+.+.||+....... -...+.+|...+.++...+| +..+.+.+. ....++|+|
T Consensus 37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 3555555 5677888865332211 01136788888888753322 233334332 234789999
Q ss_pred ecCCC-chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-------CCceEEecc
Q 047020 87 YLANK-SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-------DNHAKLADF 158 (266)
Q Consensus 87 ~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-------~~~~~l~df 158 (266)
++++. +|.+++.... ..+.+......++.+++..+..||..| ++|+|+++.||+++. ...+.++||
T Consensus 116 ~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 116 DLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred eCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 99885 8888876421 134566777899999999999999999 999999999999975 357899999
Q ss_pred cccc
Q 047020 159 GLCK 162 (266)
Q Consensus 159 g~~~ 162 (266)
+.+.
T Consensus 190 ~r~~ 193 (268)
T PRK15123 190 HRAQ 193 (268)
T ss_pred Cccc
Confidence 9775
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.3e-09 Score=85.06 Aligned_cols=131 Identities=25% Similarity=0.281 Sum_probs=99.6
Q ss_pred hhhccccccceEEEEEcCCCcEEEEEEeeecccc----------------------cHHHHHHHHHHHhcCCCC--Cccc
Q 047020 15 RIRIGVGATSFVYLAELGDGNFGAVKRVMEERGG----------------------SRKIFLDEVSVLLRVSHP--NLVG 70 (266)
Q Consensus 15 ~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~----------------------~~~~~~~e~~~l~~l~~~--~i~~ 70 (266)
..+||-|--+.||.+...+|..++||.-+.-.+. .+..+.+|.+.|++|... .+++
T Consensus 96 G~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~ 175 (304)
T COG0478 96 GTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPK 175 (304)
T ss_pred ccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 3489999999999998889999999853322111 133467899999999855 7777
Q ss_pred cceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC
Q 047020 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD 150 (266)
Q Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~ 150 (266)
.+++ +...+|||++.|..|...- ++.+....++..|+.-+..+-..| ++|||+++-||+++++
T Consensus 176 P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 176 PIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred cccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 7765 4567999999886664321 234445566777777777777888 9999999999999999
Q ss_pred CceEEecccccc
Q 047020 151 NHAKLADFGLCK 162 (266)
Q Consensus 151 ~~~~l~dfg~~~ 162 (266)
|.++++||--+.
T Consensus 239 g~~~vIDwPQ~v 250 (304)
T COG0478 239 GDIVVIDWPQAV 250 (304)
T ss_pred CCEEEEeCcccc
Confidence 999999997654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.2e-09 Score=80.57 Aligned_cols=139 Identities=21% Similarity=0.144 Sum_probs=102.0
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecc------cccHHHHHHHHHHHhcCCCC--CccccceeEE-ec----CeEEE
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEER------GGSRKIFLDEVSVLLRVSHP--NLVGLLGFCL-EK----GEQLL 83 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~------~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~-~~----~~~~l 83 (266)
--|+||-+.|++...+ |..+.+|+-.... +.....+.+|+..+.++..- .+++.. ++. .. -..++
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 3577999999999764 3467777654221 22457789999999998632 244444 322 11 14679
Q ss_pred EEEecCC-CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc--eEEecccc
Q 047020 84 LLEYLAN-KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH--AKLADFGL 160 (266)
Q Consensus 84 v~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~--~~l~dfg~ 160 (266)
|+|-++| .+|.+++.+. ...+.+......++.+++..++-||..| +.|+|+.+.||+++..|. +.++||..
T Consensus 103 VTe~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 9998765 5888877552 2245577778899999999999999999 999999999999986666 89999987
Q ss_pred ccC
Q 047020 161 CKL 163 (266)
Q Consensus 161 ~~~ 163 (266)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 663
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.7e-10 Score=99.85 Aligned_cols=185 Identities=26% Similarity=0.238 Sum_probs=134.1
Q ss_pred hhccccccceEEEEEc--CCCcEEEEEEeeecccccHHH--HHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecCC
Q 047020 16 IRIGVGATSFVYLAEL--GDGNFGAVKRVMEERGGSRKI--FLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~--~~g~~~~vk~~~~~~~~~~~~--~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
..||.|.|+.++.+.. ..+..+++|-..........+ -..|+.+...+. |.+++.++..+....+.++-.||+.+
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 4799999999998843 345556666554433332222 234555555554 88888888877777777889999988
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC-CceEEeccccccCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD-NHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~~~l~dfg~~~~~~~~~~ 169 (266)
+++...+... ..+++...+.+..|++.++.++|+.. ++|.|++|.||++..+ +.-+++||+.++.+..
T Consensus 351 ~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~--- 419 (524)
T KOG0601|consen 351 GSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF--- 419 (524)
T ss_pred cchhhhhHHH-----HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccce---
Confidence 8776555322 45788889999999999999999999 9999999999999876 5668999998864221
Q ss_pred CCCCcccccccCCCcc--CccccccccCCCcccchhHHHHHHHHHhCC
Q 047020 170 NRPKRQTSIKGSFGYV--DTNYLNTGFVSTKSDVYSFGVLLLELITGL 215 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~--aPE~~~~~~~~~~~Di~slG~i~~~l~~g~ 215 (266)
.........++. +++......+..+.|++|||.-+.+..++.
T Consensus 420 ----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~ 463 (524)
T KOG0601|consen 420 ----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS 463 (524)
T ss_pred ----ecccccccccccccchhhccccccccccccccccccccccccCc
Confidence 112222333333 555566667888999999999999988875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.4e-10 Score=106.02 Aligned_cols=209 Identities=23% Similarity=0.286 Sum_probs=143.2
Q ss_pred hccccccceEEEEEc-CCCcEEEEEEeee---cccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLAEL-GDGNFGAVKRVME---ERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~-~~g~~~~vk~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
-+-+|.++.++.+.- ..|.....+.... -.....+....+-.++-..++|.++...-.+......+++++|+.+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 466788888887732 3343333322111 111111111122222222345666655555566778899999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC----
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND---- 168 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~---- 168 (266)
|...+.+. +..+++.++.....+..+..+||+.. +.|+|++|.|.+....+..++.||+.........
T Consensus 891 ~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 891 LPSKLHNS-----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred chhhhhcC-----CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 98887663 55677777888899999999999998 9999999999999999999999997432211000
Q ss_pred ---------------------CC--CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH
Q 047020 169 ---------------------PN--RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA 225 (266)
Q Consensus 169 ---------------------~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~ 225 (266)
.. .........+|+.|.+||...+......+|+|+.|+++++.++|..||.....-.
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 00 0112345679999999999999999999999999999999999999997765555
Q ss_pred HHHHHHHh
Q 047020 226 EWTEECRR 233 (266)
Q Consensus 226 ~~~~~~~~ 233 (266)
.+..+..+
T Consensus 1043 ~f~ni~~~ 1050 (1205)
T KOG0606|consen 1043 IFENILNR 1050 (1205)
T ss_pred hhhccccC
Confidence 55444443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=8.9e-09 Score=80.79 Aligned_cols=106 Identities=25% Similarity=0.297 Sum_probs=81.6
Q ss_pred HHHHHHHHHHHhcCCCC--CccccceeEEecC----eEEEEEEecCC-CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHH
Q 047020 50 RKIFLDEVSVLLRVSHP--NLVGLLGFCLEKG----EQLLLLEYLAN-KSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122 (266)
Q Consensus 50 ~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~----~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 122 (266)
..+..+|...+..+..- ..++.+.+..... ..++|+|++++ .+|.+++... ...+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHH
Confidence 45677888888877532 2334444444322 45899999987 4788888763 22566777889999999
Q ss_pred HHHHHhhCCCCCeecCCCCCCcEEEecCC---ceEEeccccccC
Q 047020 123 ALEYLHSQADPPIIHRDIKSSNILLIDDN---HAKLADFGLCKL 163 (266)
Q Consensus 123 ~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~~~l~dfg~~~~ 163 (266)
.+.-||..| ++|+|+++.|||++.++ ++.++||+.+..
T Consensus 130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999 99999999999999887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.2e-09 Score=87.23 Aligned_cols=193 Identities=17% Similarity=0.216 Sum_probs=125.7
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCcccccee-----E-EecC-eEEEEEEe
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGF-----C-LEKG-EQLLLLEY 87 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~-----~-~~~~-~~~lv~e~ 87 (266)
..||+|+-+.+|..---.+ .|-|+....+...+ .+-...|... .||-+-.-+-| + -+.+ ..-++|+.
T Consensus 17 r~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 17 RPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred ccccCCccceeeecchhhc---hhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 3699999999996621111 23333333322111 1122333333 35532221111 1 1222 25577887
Q ss_pred cCCC-chhhhhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 88 LANK-SLFDRMH-TYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 88 ~~~~-~L~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
+.|. .+.++.+ ..+.++...+++.-+.+....++.+...||..| .+-||++++|+++++++.++|.|=++....
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~- 167 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN- 167 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec-
Confidence 7653 2333222 222345567789999999999999999999999 999999999999999999999986654431
Q ss_pred CCCCCCCCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhC-CCCcCCC
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITG-LKSIQGS 221 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g-~~pf~~~ 221 (266)
..........|..+|.+||..+ +..-+...|.|.||+++++++.| +.||.|.
T Consensus 168 ----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 168 ----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 1233445678999999999864 33456779999999999999875 9999663
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.80 E-value=1e-07 Score=74.18 Aligned_cols=140 Identities=17% Similarity=0.184 Sum_probs=86.7
Q ss_pred HHHHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHH---------HHHHHHHHHhcCCC---CCccccc
Q 047020 5 EELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRK---------IFLDEVSVLLRVSH---PNLVGLL 72 (266)
Q Consensus 5 ~~i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~---------~~~~e~~~l~~l~~---~~i~~~~ 72 (266)
+++....+...+.+.......|.+.... |+...+|....+...... ...+.+..+..++. .....++
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 4455555555566666666777777663 466677755443222111 12344444444432 2222322
Q ss_pred eeE-----EecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE
Q 047020 73 GFC-----LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL 147 (266)
Q Consensus 73 ~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~ 147 (266)
-.. ......+++|||++|..|.+... +++ .+...+..++.-||+.| +.|||.+|.|+++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv 168 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLV 168 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEE
Confidence 221 22235678999999988866432 222 24456777899999999 9999999999998
Q ss_pred ecCCceEEecccccc
Q 047020 148 IDDNHAKLADFGLCK 162 (266)
Q Consensus 148 ~~~~~~~l~dfg~~~ 162 (266)
.++ .++++|++...
T Consensus 169 ~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 169 SNN-GIRIIDTQGKR 182 (229)
T ss_pred ECC-cEEEEECcccc
Confidence 754 59999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.1e-07 Score=72.38 Aligned_cols=142 Identities=13% Similarity=0.133 Sum_probs=82.6
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCC--CccccceeEEecCeEEEEEEecCCCc-
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHP--NLVGLLGFCLEKGEQLLLLEYLANKS- 92 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~lv~e~~~~~~- 92 (266)
..||.|..+.+|+.. |+..++|.... ........+|.++++.+..- .+++.+.+..+.+...+||++++|.+
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~--~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNP--GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCC--CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 368999999999842 44555665433 22345578899999998633 34667777777777789999998863
Q ss_pred hhh------------------hhhhhcCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhh-CCCCCeecCCCC
Q 047020 93 LFD------------------RMHTYYGQSLGVLSWSNRLS-IAL----------DIAR-ALEYLHS-QADPPIIHRDIK 141 (266)
Q Consensus 93 L~~------------------~~~~~~~~~~~~~~~~~~~~-~~~----------~i~~-~l~~Lh~-~~~~~i~H~dik 141 (266)
+.+ .++..+.............. +.. ++.. ...+|.. ...+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 111 11112211111111111000 000 0011 1112211 112357999999
Q ss_pred CCcEEEecCCceEEeccccccC
Q 047020 142 SSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 142 p~nil~~~~~~~~l~dfg~~~~ 163 (266)
|.||++++++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999887 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.8e-07 Score=80.38 Aligned_cols=143 Identities=19% Similarity=0.155 Sum_probs=92.5
Q ss_pred hhhh-hccccccceEEEEEcCCCcEEEEEEeeeccccc----------------------------------HH------
Q 047020 13 DFRI-RIGVGATSFVYLAELGDGNFGAVKRVMEERGGS----------------------------------RK------ 51 (266)
Q Consensus 13 ~~~~-~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~----------------------------------~~------ 51 (266)
+|.. -|+.++-|.|+.|.+.+|+.|+||..+...... .+
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 3443 688999999999999999999999764422110 01
Q ss_pred HHHHHHHHHhcCC-----CCCccccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 047020 52 IFLDEVSVLLRVS-----HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126 (266)
Q Consensus 52 ~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 126 (266)
.+.+|..-+.+++ .+.+.----+.+-.+...++|||++|..+.+...... ..++...+.....++.- ..
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k~ia~~~~~~f~--~q 280 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRKELAELLVRAFL--RQ 280 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHHHHHHHHHHHHH--HH
Confidence 1223444444442 2332211112233456789999999988888753321 33454444444443333 23
Q ss_pred HhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 127 Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
+-..| +.|+|.+|.||++..+|++.+.|||.....
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 33357 999999999999999999999999998753
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2e-08 Score=88.75 Aligned_cols=103 Identities=24% Similarity=0.417 Sum_probs=76.2
Q ss_pred HHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC-----CCCcccccccCCCccCccccc
Q 047020 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN-----RPKRQTSIKGSFGYVDTNYLN 191 (266)
Q Consensus 117 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~ 191 (266)
+.+...|+.|+|..-+ ++|++|.|++|+++..+.+||+.|+.+.-...+... .............|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445599999998655 999999999999999999999999987532221110 011111234456799999999
Q ss_pred cccCCCcccchhHHHHHHHHHh-CCCCcCCC
Q 047020 192 TGFVSTKSDVYSFGVLLLELIT-GLKSIQGS 221 (266)
Q Consensus 192 ~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~ 221 (266)
+...+.++|++|+|+++|.+.. |..-+...
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc
Confidence 8888999999999999999984 55555443
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.2e-06 Score=68.13 Aligned_cols=141 Identities=12% Similarity=0.074 Sum_probs=81.7
Q ss_pred cccccc-ceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecCCCchhh
Q 047020 18 IGVGAT-SFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLANKSLFD 95 (266)
Q Consensus 18 ig~g~~-~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
|..|.+ ..||++... ++...+|...... ...+.+|+++++.+. +-.+++++.+....+..++||++++|.++.+
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 678998654 3566666553322 334677999988885 4445677777766667899999999877653
Q ss_pred hh----------------hhhcCCCCC--CCCHH--H-HHHHHH-------------------HHHHHHHHHhh----CC
Q 047020 96 RM----------------HTYYGQSLG--VLSWS--N-RLSIAL-------------------DIARALEYLHS----QA 131 (266)
Q Consensus 96 ~~----------------~~~~~~~~~--~~~~~--~-~~~~~~-------------------~i~~~l~~Lh~----~~ 131 (266)
.. ...+..... ++... . ...... .....+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 31 122222111 11100 0 000000 01111222211 11
Q ss_pred CCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 132 ~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
.+.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2459999999999999987767899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.8e-06 Score=64.59 Aligned_cols=129 Identities=21% Similarity=0.269 Sum_probs=90.2
Q ss_pred hhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCch
Q 047020 14 FRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 14 ~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
....|++|.+|.||++... |..+++|..... ..+..+..|+++++.+..-++.+=+-.+.. -++.|||..|.+|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcch
Confidence 3347999999999999774 557777755443 346778999999999986555543322222 2345999988788
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCC-CCcEEEecCCceEEeccccccC
Q 047020 94 FDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIK-SSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dik-p~nil~~~~~~~~l~dfg~~~~ 163 (266)
.+.... . + .+.+..++.+.--|...| |-|+.|. |...++.+++.+.|+||..|+.
T Consensus 100 ~~~~~~------~--~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIG------G--D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhc------c--c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 654432 1 1 334455666667788888 9999886 5556666666999999999884
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.47 E-value=4.2e-06 Score=66.14 Aligned_cols=133 Identities=23% Similarity=0.282 Sum_probs=89.9
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeeccccc------------------------HHHHHHHHHHHhcCC--CCCccc
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGS------------------------RKIFLDEVSVLLRVS--HPNLVG 70 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~------------------------~~~~~~e~~~l~~l~--~~~i~~ 70 (266)
.|++|--+.||+|..+++..++||......... ......|+.-|+++. +=.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 466677777999988888999999764432211 112335777777764 223334
Q ss_pred cceeEEecCeEEEEEEecCCC-chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEe
Q 047020 71 LLGFCLEKGEQLLLLEYLANK-SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 71 ~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~ 148 (266)
-+.+. .-.+||||+... .-.-.++. -++....+..+..+++..+.-|.. .+ ++|+||..-|||+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~ 201 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH 201 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE
Confidence 44432 346999998543 11111211 233333677888899999998888 77 99999999999998
Q ss_pred cCCceEEeccccccC
Q 047020 149 DDNHAKLADFGLCKL 163 (266)
Q Consensus 149 ~~~~~~l~dfg~~~~ 163 (266)
++.+.++|++-+..
T Consensus 202 -~~~p~iID~~QaV~ 215 (268)
T COG1718 202 -DGEPYIIDVSQAVT 215 (268)
T ss_pred -CCeEEEEECccccc
Confidence 88999999997763
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.7e-06 Score=66.94 Aligned_cols=143 Identities=21% Similarity=0.234 Sum_probs=79.6
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCC--CccccceeE---EecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHP--NLVGLLGFC---LEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~---~~~~~~~lv~e~~~~~ 91 (266)
.++.|..+.+|.+...+ +.+++|..... .....+.+|..+++.+... .+++++... ......+++|++++|.
T Consensus 4 ~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 4 PLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred cCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 57889999999998766 57777765333 3456677888998888532 355666533 2333578999999998
Q ss_pred chhh----------------hhhhhcCC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHhh--
Q 047020 92 SLFD----------------RMHTYYGQ--SLGVLSWSN---------RLSI------------ALDIAR-ALEYLHS-- 129 (266)
Q Consensus 92 ~L~~----------------~~~~~~~~--~~~~~~~~~---------~~~~------------~~~i~~-~l~~Lh~-- 129 (266)
.+.+ .+...+.. ....+.... .... ...+.. .+..+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7776 22222111 001111000 0000 011111 2223321
Q ss_pred --CCCCCeecCCCCCCcEEEe-cCCceEEecccccc
Q 047020 130 --QADPPIIHRDIKSSNILLI-DDNHAKLADFGLCK 162 (266)
Q Consensus 130 --~~~~~i~H~dikp~nil~~-~~~~~~l~dfg~~~ 162 (266)
.....++|+|+.|.||+++ +++++.|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1123499999999999999 66777899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.6e-05 Score=61.66 Aligned_cols=129 Identities=19% Similarity=0.219 Sum_probs=87.0
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecc----------------cccHHHHHHHHHHHhcCC------CCCcccccee
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEER----------------GGSRKIFLDEVSVLLRVS------HPNLVGLLGF 74 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~----------------~~~~~~~~~e~~~l~~l~------~~~i~~~~~~ 74 (266)
.||+|+...||..-. .....||...... .....+..+|+.....+. +.+|.+++++
T Consensus 8 ~i~~G~~R~cy~HP~--dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 8 LIAQGGERDCYQHPD--DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred ccccCCCceEEECCC--CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 699999999997743 2344555544333 112345566766666555 7899999999
Q ss_pred EEecCeEEEEEEecCC------CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe
Q 047020 75 CLEKGEQLLLLEYLAN------KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 75 ~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~ 148 (266)
.+++-..-+|+|...+ .+|.++++. +.++. .+ ...+-.-..+|-... |+.+|++|.||++.
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~~---~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE------GGLTE-EL---RQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc------CCccH-HH---HHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 9999888899987643 346666654 44554 33 333444556777777 99999999999996
Q ss_pred cCC----ceEEec-ccc
Q 047020 149 DDN----HAKLAD-FGL 160 (266)
Q Consensus 149 ~~~----~~~l~d-fg~ 160 (266)
..+ ++.|+| ||.
T Consensus 153 ~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ecCCCceEEEEEeCCCC
Confidence 432 477887 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.3e-05 Score=72.97 Aligned_cols=77 Identities=21% Similarity=0.415 Sum_probs=52.2
Q ss_pred hccccccceEEEEEcCCC---cEEEEEEeeecc-cccHHHHHHHHHHHhcCC-CCCc--cccceeEEec---CeEEEEEE
Q 047020 17 RIGVGATSFVYLAELGDG---NFGAVKRVMEER-GGSRKIFLDEVSVLLRVS-HPNL--VGLLGFCLEK---GEQLLLLE 86 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g---~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~lv~e 86 (266)
.++.|.+..+|+.+...+ ..+++++..... ......+.+|+++++.+. |+++ ++++.++.+. +..|+|||
T Consensus 45 ~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME 124 (822)
T PLN02876 45 QFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIME 124 (822)
T ss_pred EeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEE
Confidence 688888999999866554 244555432211 123456789999999996 6554 6767776654 46789999
Q ss_pred ecCCCch
Q 047020 87 YLANKSL 93 (266)
Q Consensus 87 ~~~~~~L 93 (266)
+++|..+
T Consensus 125 ~v~G~~~ 131 (822)
T PLN02876 125 YLEGRIF 131 (822)
T ss_pred ecCCccc
Confidence 9988643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.7e-05 Score=68.78 Aligned_cols=138 Identities=21% Similarity=0.181 Sum_probs=88.2
Q ss_pred hhhh-hccccccceEEEEEcCCCcEEEEEEeeeccccc-------------------------------HHH------HH
Q 047020 13 DFRI-RIGVGATSFVYLAELGDGNFGAVKRVMEERGGS-------------------------------RKI------FL 54 (266)
Q Consensus 13 ~~~~-~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~-------------------------------~~~------~~ 54 (266)
.|.. .||..+.+.|++|++..|+.|+||.=+..-... .+. |.
T Consensus 163 ~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~ 242 (538)
T KOG1235|consen 163 EFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFT 242 (538)
T ss_pred hcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchH
Confidence 3443 699999999999999999999998533211110 011 22
Q ss_pred HHHHHHhcC----CCCC------ccccceeEEecCeEEEEEEecCCCchhhh--hhhhcCCCCCCCCHHHHHHHHHHHHH
Q 047020 55 DEVSVLLRV----SHPN------LVGLLGFCLEKGEQLLLLEYLANKSLFDR--MHTYYGQSLGVLSWSNRLSIALDIAR 122 (266)
Q Consensus 55 ~e~~~l~~l----~~~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~ 122 (266)
+|++-.++. .|-+ |++++- .-.+...++|||++|..+.|. +.+ ..++...+..-+.+...
T Consensus 243 ~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~------~gi~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 243 KEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK------RGISPHDILNKLVEAYL 314 (538)
T ss_pred HHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH------cCCCHHHHHHHHHHHHH
Confidence 333333332 2333 334432 223457899999999766554 333 34566655555555444
Q ss_pred HHHHHhhCCCCCeecCCCCCCcEEEec----CCceEEeccccccC
Q 047020 123 ALEYLHSQADPPIIHRDIKSSNILLID----DNHAKLADFGLCKL 163 (266)
Q Consensus 123 ~l~~Lh~~~~~~i~H~dikp~nil~~~----~~~~~l~dfg~~~~ 163 (266)
-+-+- .| ++|+|-+|.||++.. ++++.+.|||+...
T Consensus 315 ~qIf~--~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 315 EQIFK--TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred HHHHh--cC---CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 33333 46 999999999999984 56799999999874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.6e-06 Score=62.79 Aligned_cols=104 Identities=24% Similarity=0.296 Sum_probs=80.0
Q ss_pred HHHHHHHhcCCC-CCccccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 047020 54 LDEVSVLLRVSH-PNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132 (266)
Q Consensus 54 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 132 (266)
..|.-+++.+++ +++++++++|.+ +++.|+...+++.+.-... ......++..+..++.+++..+.+++..-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357888888875 699999998743 6788998766664320000 001345899999999999999999998544
Q ss_pred CCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 133 ~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
..+.-+|++|+|+-++++++++++|.+.+..
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 4489999999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.15 E-value=6.2e-05 Score=60.24 Aligned_cols=72 Identities=14% Similarity=0.042 Sum_probs=44.1
Q ss_pred hccccccceEEEEEcCC--CcEEEEEEeeecccccHHHHHHHHHHHhcCCCCC-ccccceeEEecCeEEEEEEecCCCch
Q 047020 17 RIGVGATSFVYLAELGD--GNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPN-LVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~--g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
.|..|-...+|++..++ ++.+++|... ..+.......+|+.+++.+...+ .++++.... + .++|||++|.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~-~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYG-NKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEcc-CCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence 46777778999997664 5666666433 22222223357888888886333 334443322 2 379999988665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.15 E-value=4e-05 Score=61.42 Aligned_cols=72 Identities=14% Similarity=0.051 Sum_probs=42.5
Q ss_pred hccccccc-eEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCC---CccccceeEEec---CeEEEEEEecC
Q 047020 17 RIGVGATS-FVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHP---NLVGLLGFCLEK---GEQLLLLEYLA 89 (266)
Q Consensus 17 ~ig~g~~~-~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv~e~~~ 89 (266)
.|+.|+.. .+|+.. ...++|.... ......+.+|.+++..+... .+.+.+...... ...+++|++++
T Consensus 4 ~~~~gG~~n~vy~~~----~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 4 PVDSGGTDNATFRLG----DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eccCCCcccceEEcC----CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 46666665 488762 2345553222 22345788899999888632 334444433322 24588999998
Q ss_pred CCchh
Q 047020 90 NKSLF 94 (266)
Q Consensus 90 ~~~L~ 94 (266)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 86664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00018 Score=59.76 Aligned_cols=74 Identities=18% Similarity=0.126 Sum_probs=53.2
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCC---CCccccceeEEe---cCeEEEEEEecCC
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH---PNLVGLLGFCLE---KGEQLLLLEYLAN 90 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~~~lv~e~~~~ 90 (266)
.||.|..+.+|.....++. +.+|. ... ......+..|.+.++.+.. -.++++++++.. .+..++|||+++|
T Consensus 21 ~i~~G~~~~vy~~~~~~~~-~~~k~-~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 21 CISEQPYAALWALYDSQGN-PMPLM-ARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred ecCCccceeEEEEEcCCCC-EEEEE-ecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 6999999999999776664 34443 222 1133578899999998863 367788877654 3568999999988
Q ss_pred Cch
Q 047020 91 KSL 93 (266)
Q Consensus 91 ~~L 93 (266)
.++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00017 Score=61.92 Aligned_cols=74 Identities=15% Similarity=0.122 Sum_probs=52.4
Q ss_pred hccccccceEEEEEcCCC-cEEEEEEeeec-------ccccHHHHHHHHHHHhcCC---CCCccccceeEEecCeEEEEE
Q 047020 17 RIGVGATSFVYLAELGDG-NFGAVKRVMEE-------RGGSRKIFLDEVSVLLRVS---HPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g-~~~~vk~~~~~-------~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.||.|....||++...+| +.+.||+.... ..-...+...|.+.|+.+. ..++++++.+ +.+..++||
T Consensus 33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVM 110 (401)
T PRK09550 33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVM 110 (401)
T ss_pred EcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEE
Confidence 689999999999987776 47888875321 1223566778888888874 2456666655 445678999
Q ss_pred EecCCCc
Q 047020 86 EYLANKS 92 (266)
Q Consensus 86 e~~~~~~ 92 (266)
|++++..
T Consensus 111 E~L~~~~ 117 (401)
T PRK09550 111 EDLSDHK 117 (401)
T ss_pred ecCCCcc
Confidence 9987643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00013 Score=59.15 Aligned_cols=141 Identities=18% Similarity=0.113 Sum_probs=76.0
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCc-cccceeEEecCeEEEEEEecCCCchhh
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL-VGLLGFCLEKGEQLLLLEYLANKSLFD 95 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
.+..|-...+|+.+. .|+.+++|..........-...+|.++++.+....+ ++++... . .++|++|++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 356677788998873 455556654322211111235779999998864333 3333332 2 368999998865432
Q ss_pred --------------hhhhhcCCCC--CCCCHH-HHHHHHHHH---------HHHHHHHhhCC-----CCCeecCCCCCCc
Q 047020 96 --------------RMHTYYGQSL--GVLSWS-NRLSIALDI---------ARALEYLHSQA-----DPPIIHRDIKSSN 144 (266)
Q Consensus 96 --------------~~~~~~~~~~--~~~~~~-~~~~~~~~i---------~~~l~~Lh~~~-----~~~i~H~dikp~n 144 (266)
.+...+..+. .+++.. .+..+..++ ...+..+-... ...++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2222222211 112211 111211111 11122222110 1248999999999
Q ss_pred EEEecCCceEEeccccccC
Q 047020 145 ILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 145 il~~~~~~~~l~dfg~~~~ 163 (266)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9998876 89999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.4e-06 Score=74.54 Aligned_cols=180 Identities=19% Similarity=0.087 Sum_probs=122.2
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCC-ccccceeEEecCeEEEEEEecCCC-chh
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPN-LVGLLGFCLEKGEQLLLLEYLANK-SLF 94 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~ 94 (266)
..++++++.+++...-..+....+.+... ....-++++|.+++||| .+.+++.++.+...++.+++..++ +..
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 57778888888774333333334333222 33456899999999999 777777777888889999988665 222
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCc
Q 047020 95 DRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174 (266)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 174 (266)
.... .....+...+...+...-..++.++|+.. =+|+| ||+. .++..+..||+....... ...
T Consensus 324 ~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~-s~~~~~~~~~~v~~~L~~-----~~~ 386 (829)
T KOG0576|consen 324 LEMT----VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILG-SEEEVKLLDFAVPPQLTR-----TMK 386 (829)
T ss_pred ccCC----hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccc-cccccccccccCCcccCc-----ccc
Confidence 2111 11123344445556677778888999875 57877 6654 446789999998764322 113
Q ss_pred ccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCc
Q 047020 175 QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSI 218 (266)
Q Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf 218 (266)
.....+++.++|||+.....+..+.|.|+++.=..++.-|..|-
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 45678999999999999999999999999997666666664443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.89 E-value=2e-05 Score=64.77 Aligned_cols=132 Identities=20% Similarity=0.235 Sum_probs=94.8
Q ss_pred hhhhhccccccceEEEEEcCCCcEEEEEEeeecccc----------------------cHHHHHHHHHHHhcCC-CC-Cc
Q 047020 13 DFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGG----------------------SRKIFLDEVSVLLRVS-HP-NL 68 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~----------------------~~~~~~~e~~~l~~l~-~~-~i 68 (266)
.+..+||-|--+.+|.+....|...++|.-+.-.+. .+-...+|+..|+.|. |. .+
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 344589999999999998888988887743221111 1223457999999996 33 34
Q ss_pred cccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe
Q 047020 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~ 148 (266)
++.+++ +..++||+++.|..|...-. ......+...+...+.-|-.+| ++|||.+--||++.
T Consensus 175 PkpiD~----~RH~Vvmelv~g~Pl~~v~~-----------v~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 175 PKPIDH----NRHCVVMELVDGYPLRQVRH-----------VEDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCcccc----cceeeHHHhhcccceeeeee-----------cCChHHHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 555654 45689999998877753321 1223455666777778889999 99999999999999
Q ss_pred cCCceEEecccccc
Q 047020 149 DDNHAKLADFGLCK 162 (266)
Q Consensus 149 ~~~~~~l~dfg~~~ 162 (266)
+++.++++||--+-
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997554
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.003 Score=52.97 Aligned_cols=29 Identities=28% Similarity=0.415 Sum_probs=24.8
Q ss_pred eecCCCCCCcEEEecCCceEEeccccccC
Q 047020 135 IIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 135 i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
+||+|+.|.||+++++...-|+||+.+..
T Consensus 189 liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 189 VIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCCCCCCCcEEEECCceEEEEecccccC
Confidence 99999999999998655457999998763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.0011 Score=54.97 Aligned_cols=143 Identities=17% Similarity=0.153 Sum_probs=79.2
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCC--Cccccce------eEEecCeEEEEEEec
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHP--NLVGLLG------FCLEKGEQLLLLEYL 88 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~------~~~~~~~~~lv~e~~ 88 (266)
.+..|....+|++...++ .+++|.... ........|++++..+... .+++++. +....+..+++++++
T Consensus 21 ~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 21 GISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred cccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 577787788999876444 556665433 2345567788888887532 2344432 123345678999999
Q ss_pred CCCchhh-----------hhhhhcCCC----CC-----CCCHHHH----------HHHHHHHHHHHHHHhhC----CCCC
Q 047020 89 ANKSLFD-----------RMHTYYGQS----LG-----VLSWSNR----------LSIALDIARALEYLHSQ----ADPP 134 (266)
Q Consensus 89 ~~~~L~~-----------~~~~~~~~~----~~-----~~~~~~~----------~~~~~~i~~~l~~Lh~~----~~~~ 134 (266)
+|..+.. .+...+... .. ...+... ......+..++..+.+. ....
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 8866432 111111100 00 0000000 00111122333444321 0123
Q ss_pred eecCCCCCCcEEEecCCceEEeccccccC
Q 047020 135 IIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 135 i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
+||+|+.|.|+++++++.+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999999876678999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0024 Score=53.31 Aligned_cols=141 Identities=16% Similarity=0.145 Sum_probs=76.8
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCC--Ccccccee------EEecCeEEEEEEec
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHP--NLVGLLGF------CLEKGEQLLLLEYL 88 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~------~~~~~~~~lv~e~~ 88 (266)
.++.|....+|+++..+| ..++|..... ........|.+++..|... .+++++.. ....+..+++++|+
T Consensus 29 ~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 29 GIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred ccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 466777788999876555 4456644322 1234455677777776421 23444331 12245678999999
Q ss_pred CCCchh-----------hhhhhhcCCCCC---C----CCHHHHH---------------HHHHHHHHHHHHHhh------
Q 047020 89 ANKSLF-----------DRMHTYYGQSLG---V----LSWSNRL---------------SIALDIARALEYLHS------ 129 (266)
Q Consensus 89 ~~~~L~-----------~~~~~~~~~~~~---~----~~~~~~~---------------~~~~~i~~~l~~Lh~------ 129 (266)
+|.++. ..+...+....+ + ....... .....+...+.++..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 885432 111111111000 0 0000000 001112234444432
Q ss_pred -CCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 130 -QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 130 -~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
.+ +||+|+++.|+++++++...|+||+.+..
T Consensus 186 ~~~---l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRG---VIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCc---cCCCCCCcCcEEEECCceEEEeecccccC
Confidence 44 99999999999998887668999998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00018 Score=68.11 Aligned_cols=193 Identities=20% Similarity=0.198 Sum_probs=116.6
Q ss_pred HHHHHHHhcCCCCCccccceeEEecCe----EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 047020 54 LDEVSVLLRVSHPNLVGLLGFCLEKGE----QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129 (266)
Q Consensus 54 ~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 129 (266)
.-|++.+.++.|+|++.++.+...... ..+..+++...++.+.+... +..+...++.+..+...++.++|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHHHHHH
Confidence 346777788899999999987644322 12344566666776666553 678899999999999999999999
Q ss_pred CCCCCeecCCCCCC---cEEEecCCceEEe--ccccccCCCCCCCCCCCcccccccCCCccCccccccccCCC--cccch
Q 047020 130 QADPPIIHRDIKSS---NILLIDDNHAKLA--DFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVST--KSDVY 202 (266)
Q Consensus 130 ~~~~~i~H~dikp~---nil~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~Di~ 202 (266)
.. +.|.-+... +--++..+.+..+ ||+......... .......+..+.++|.......+. ..|+|
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-----~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE-----KSFSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcc-----cchhhcCccccccccccccccchhhhhhHHH
Confidence 86 655544333 2222334445555 887766432221 222333444567777776665554 47999
Q ss_pred hHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCchhhhhhhccCCCCCcchHHHHHH
Q 047020 203 SFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 203 slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+|.....+..|..+-........+..........+...++++.+...|....++..
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHHHHhhhhhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 999999999888644422222222211111111223344666666666666555543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0019 Score=53.71 Aligned_cols=73 Identities=23% Similarity=0.195 Sum_probs=43.8
Q ss_pred hccccccceEEEEEcCC-------CcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCc-cccceeEEecCeEEEEEEec
Q 047020 17 RIGVGATSFVYLAELGD-------GNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL-VGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~-------g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+..|-.-.+|++...+ ++.+++|.. ...........+|.++++.+....+ ++++..+. + ..|++|+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~-~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVY-GQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEe-cCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 45566667899887654 456666653 3322333456788888888863333 34444433 2 3589998
Q ss_pred CCCchh
Q 047020 89 ANKSLF 94 (266)
Q Consensus 89 ~~~~L~ 94 (266)
+|..+.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0017 Score=53.29 Aligned_cols=30 Identities=27% Similarity=0.512 Sum_probs=25.5
Q ss_pred CeecCCCCCCcEEEecCCce-EEeccccccC
Q 047020 134 PIIHRDIKSSNILLIDDNHA-KLADFGLCKL 163 (266)
Q Consensus 134 ~i~H~dikp~nil~~~~~~~-~l~dfg~~~~ 163 (266)
.++|+|++|.||++++++++ -|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999875665 5999998874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0016 Score=53.64 Aligned_cols=71 Identities=21% Similarity=0.245 Sum_probs=45.4
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC---CCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS---HPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.++.|.-..+|+.+ .+++.+-||.-. ......+..|.+-|+.|. .-.+++.+.+...++..+++|||++.+
T Consensus 24 ~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 24 PVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred ecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 68888889999988 456677777554 233467888999888884 346778888887777789999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0026 Score=53.76 Aligned_cols=72 Identities=18% Similarity=0.209 Sum_probs=48.0
Q ss_pred hccccccceEEEEEcCCC-cEEEEEEeeec-------ccccHHHHHHHHHHHhcCC--CC-CccccceeEEecCeEEEEE
Q 047020 17 RIGVGATSFVYLAELGDG-NFGAVKRVMEE-------RGGSRKIFLDEVSVLLRVS--HP-NLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g-~~~~vk~~~~~-------~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv~ 85 (266)
.||-|..-.||++...+| +.+.||+.... .+-...+..-|.+.|+... .| ++++++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999976554 57888875321 1223456667888887764 35 4444443 3445667999
Q ss_pred EecCC
Q 047020 86 EYLAN 90 (266)
Q Consensus 86 e~~~~ 90 (266)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0038 Score=52.00 Aligned_cols=119 Identities=19% Similarity=0.281 Sum_probs=72.9
Q ss_pred CcEEEEEEee--ecccccHHHHHHHHHHHhcCCC--CCccccceeEEecC--eEEEEEEecCCCchhhhhhhhcCCCCCC
Q 047020 34 GNFGAVKRVM--EERGGSRKIFLDEVSVLLRVSH--PNLVGLLGFCLEKG--EQLLLLEYLANKSLFDRMHTYYGQSLGV 107 (266)
Q Consensus 34 g~~~~vk~~~--~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 107 (266)
++..++. .. ...........+|+.+++.+.. -.+...++.|.++. ..|.||+|.+|..+.+..... .
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~------~ 120 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE------S 120 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc------c
Confidence 5565665 22 1222234566788988888753 33445566666655 679999999885443322110 0
Q ss_pred CCHHHHHHHHH-HHHHHHHHHhh--------------------------------------------------CC-----
Q 047020 108 LSWSNRLSIAL-DIARALEYLHS--------------------------------------------------QA----- 131 (266)
Q Consensus 108 ~~~~~~~~~~~-~i~~~l~~Lh~--------------------------------------------------~~----- 131 (266)
.. .+.+. .+...|..||+ +.
T Consensus 121 ~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~ 196 (321)
T COG3173 121 LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAG 196 (321)
T ss_pred ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCC
Confidence 00 11112 44444444442 11
Q ss_pred CCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 132 ~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
.+.++|||..+.|+++++.+.+-|+||+.+..
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 24699999999999999988889999999875
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0025 Score=49.33 Aligned_cols=125 Identities=23% Similarity=0.328 Sum_probs=82.1
Q ss_pred hhchhhhhcccccc-ceEEEEEcCCCcEEEEEEeee---ccc------------------ccHHHHHHHHHHHhcCC---
Q 047020 10 ATNDFRIRIGVGAT-SFVYLAELGDGNFGAVKRVME---ERG------------------GSRKIFLDEVSVLLRVS--- 64 (266)
Q Consensus 10 ~~~~~~~~ig~g~~-~~v~~~~~~~g~~~~vk~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 64 (266)
...+|.+.||.|.- |.||+++++ |..+++|.+.. ..+ ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 45567778999999 999999984 56889998321 111 01234667888777775
Q ss_pred CCCc--cccceeEEec---C---------------eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 047020 65 HPNL--VGLLGFCLEK---G---------------EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124 (266)
Q Consensus 65 ~~~i--~~~~~~~~~~---~---------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 124 (266)
+.++ +++++|..-. . ..-+|-||.+... .+ ...-+.+|.+-+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~----~~~~~~~~~~dl 177 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PL----QIRDIPQMLRDL 177 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------cc----chhHHHHHHHHH
Confidence 4466 7888876211 0 1134555443221 12 233456677788
Q ss_pred HHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 125 ~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
..+|+.| |+-+|+++.|.. .=+|+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8899999 999999999986 2388999853
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0044 Score=53.39 Aligned_cols=71 Identities=17% Similarity=0.190 Sum_probs=48.0
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeeccc-------ccHHHHHHHHHHHhcCC---CCCccccceeEEecCeEEEEEE
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERG-------GSRKIFLDEVSVLLRVS---HPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~-------~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.||.|..-.||++..+ ++.++||+...... -...+...|.+.|+.+. ..++++++.++. +..+++||
T Consensus 39 eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME 115 (418)
T PLN02756 39 EVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMR 115 (418)
T ss_pred EcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEe
Confidence 6899999999999764 45678887542111 13445556677777664 246777787766 44678899
Q ss_pred ecCC
Q 047020 87 YLAN 90 (266)
Q Consensus 87 ~~~~ 90 (266)
++++
T Consensus 116 ~L~~ 119 (418)
T PLN02756 116 YLEP 119 (418)
T ss_pred ecCC
Confidence 9966
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0036 Score=53.19 Aligned_cols=142 Identities=17% Similarity=0.228 Sum_probs=74.7
Q ss_pred hccccccceEEEEEcCC-----CcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCcc-ccceeEEecCeEEEEEEecCC
Q 047020 17 RIGVGATSFVYLAELGD-----GNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV-GLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~-----g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~ 90 (266)
.+..|-.-.+|++...+ ++.+.++ +....+...-...+|..+++.+..-++. ++++.+. .+ .|.+|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~R-i~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVR-IYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFP-NG---RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEE-EccCCCCeeechHHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEEeeCC
Confidence 45567777899886432 2345554 3333333222336789999888643333 4444442 22 57889877
Q ss_pred Cchhh--------------hhhhhcCCCC-C---CCCHHHHHHHHHHH-----------------HHHHHH----Hhh-C
Q 047020 91 KSLFD--------------RMHTYYGQSL-G---VLSWSNRLSIALDI-----------------ARALEY----LHS-Q 130 (266)
Q Consensus 91 ~~L~~--------------~~~~~~~~~~-~---~~~~~~~~~~~~~i-----------------~~~l~~----Lh~-~ 130 (266)
.++.. .++..+.... . ......+..+..++ ...+.. +.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 55431 1122222110 0 11122222222111 111111 121 1
Q ss_pred CCCCeecCCCCCCcEEEec-CCceEEeccccccC
Q 047020 131 ADPPIIHRDIKSSNILLID-DNHAKLADFGLCKL 163 (266)
Q Consensus 131 ~~~~i~H~dikp~nil~~~-~~~~~l~dfg~~~~ 163 (266)
....+||+|+++.||++++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1224899999999999986 46799999998763
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.013 Score=49.54 Aligned_cols=134 Identities=21% Similarity=0.262 Sum_probs=89.6
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeec-----c-c----c----------------cHHHHHHHHHHHhcCCCCCccc
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEE-----R-G----G----------------SRKIFLDEVSVLLRVSHPNLVG 70 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~-----~-~----~----------------~~~~~~~e~~~l~~l~~~~i~~ 70 (266)
-|..|--.-||.|.-.+|..++||..... . . + ..-.+..|+.-|++++.-.|+-
T Consensus 151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 46677777899998888988998854221 0 0 0 0223456888888876433321
Q ss_pred cceeEEecCeEEEEEEecCCCchhh--hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe
Q 047020 71 LLGFCLEKGEQLLLLEYLANKSLFD--RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~ 148 (266)
.--+.. ....|||+|+. .+-+- .++. ..++...+..+-.+++.-+.-|.+ .++++|.||.--|+++
T Consensus 231 PePIlL--k~hVLVM~FlG-rdgw~aPkLKd------~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 231 PEPILL--KNHVLVMEFLG-RDGWAAPKLKD------ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY- 298 (520)
T ss_pred CCceee--ecceEeeeecc-CCCCcCccccc------ccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE-
Confidence 111111 23579999984 33322 2222 467777888899999999998887 4459999999999987
Q ss_pred cCCceEEecccccc
Q 047020 149 DDNHAKLADFGLCK 162 (266)
Q Consensus 149 ~~~~~~l~dfg~~~ 162 (266)
.+|.+.++|-+-+.
T Consensus 299 hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSV 312 (520)
T ss_pred ECCEEEEEEccccc
Confidence 56789999987543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.01 Score=50.14 Aligned_cols=30 Identities=23% Similarity=0.408 Sum_probs=26.0
Q ss_pred CeecCCCCCCcEEEec-CCceEEeccccccC
Q 047020 134 PIIHRDIKSSNILLID-DNHAKLADFGLCKL 163 (266)
Q Consensus 134 ~i~H~dikp~nil~~~-~~~~~l~dfg~~~~ 163 (266)
.+||+|+.+.||++++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4799999999999975 57899999998764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0054 Score=48.20 Aligned_cols=29 Identities=34% Similarity=0.554 Sum_probs=20.7
Q ss_pred CeecCCCCCCcEEE-ecCCceEEecccccc
Q 047020 134 PIIHRDIKSSNILL-IDDNHAKLADFGLCK 162 (266)
Q Consensus 134 ~i~H~dikp~nil~-~~~~~~~l~dfg~~~ 162 (266)
.++|+|+.|.||++ ..++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 788999999999775
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0048 Score=52.87 Aligned_cols=72 Identities=18% Similarity=0.081 Sum_probs=49.1
Q ss_pred hccccccceEEEEEcCC-CcEEEEEEeeec------ccccHHHHHHHHHHHhcCC--CC-CccccceeEEecCeEEEEEE
Q 047020 17 RIGVGATSFVYLAELGD-GNFGAVKRVMEE------RGGSRKIFLDEVSVLLRVS--HP-NLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~-g~~~~vk~~~~~------~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv~e 86 (266)
.||-|.-..||++...+ ++.+.||+.... .+-...+..-|.+.|+... .| ++++++. .+.....+|||
T Consensus 36 eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~vME 113 (409)
T PRK12396 36 EIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCVME 113 (409)
T ss_pred EcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHHHH
Confidence 68999999999997643 567888875321 1234567778888888775 45 4445553 34445678888
Q ss_pred ecCC
Q 047020 87 YLAN 90 (266)
Q Consensus 87 ~~~~ 90 (266)
+++.
T Consensus 114 dL~~ 117 (409)
T PRK12396 114 DLSD 117 (409)
T ss_pred hCcc
Confidence 8854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.017 Score=49.67 Aligned_cols=29 Identities=24% Similarity=0.353 Sum_probs=24.1
Q ss_pred CeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 134 ~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
.+||.|+.+.||+.. ++.+.++||..|..
T Consensus 228 VfCHNDL~~gNIL~~-~~~l~lID~EYA~~ 256 (383)
T PTZ00384 228 LFCHNDLFFTNILDF-NQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeccCCcccEEec-CCCEEEEEeccccC
Confidence 389999999999865 45699999988763
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.023 Score=47.78 Aligned_cols=138 Identities=23% Similarity=0.339 Sum_probs=78.2
Q ss_pred ccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-C--CC---ccccce--eEEecC--eEEEEEEecCCC
Q 047020 22 ATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-H--PN---LVGLLG--FCLEKG--EQLLLLEYLANK 91 (266)
Q Consensus 22 ~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~--~~---i~~~~~--~~~~~~--~~~lv~e~~~~~ 91 (266)
.--.+|.+...+|.+ ++| +.... .....+..|+.++.-|. + +- +...-+ ...-++ ..+.+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLk-i~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILK-IYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEE-EecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445688888877777 444 44443 45566777888888774 1 11 222211 112233 778899999987
Q ss_pred chhh------------hhhhhc----CC---CCC---CCCHH----H---------HHHHHHHHHHHHHHHhhCC-----
Q 047020 92 SLFD------------RMHTYY----GQ---SLG---VLSWS----N---------RLSIALDIARALEYLHSQA----- 131 (266)
Q Consensus 92 ~L~~------------~~~~~~----~~---~~~---~~~~~----~---------~~~~~~~i~~~l~~Lh~~~----- 131 (266)
.+.. .+...+ +. ... ...+. . -.....++...+..+.+.=
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7762 111000 00 000 11111 0 0123344555555554331
Q ss_pred CCC--eecCCCCCCcEEEecCCc-eEEecccccc
Q 047020 132 DPP--IIHRDIKSSNILLIDDNH-AKLADFGLCK 162 (266)
Q Consensus 132 ~~~--i~H~dikp~nil~~~~~~-~~l~dfg~~~ 162 (266)
..+ +||+|+.|.||+++.+.. .-++||+-|.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 112 899999999999998875 7899999776
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.02 Score=47.85 Aligned_cols=30 Identities=13% Similarity=0.280 Sum_probs=27.3
Q ss_pred CeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 134 ~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
.+||+|+.+.|+++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 399999999999999988999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.005 Score=51.83 Aligned_cols=73 Identities=22% Similarity=0.257 Sum_probs=57.0
Q ss_pred cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEec
Q 047020 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLAD 157 (266)
Q Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~d 157 (266)
..+.|++|++- |+++. .+ ..-..+++..++++.+..+.-+.++ .++-||++.-.||+++ +|.+.|+|
T Consensus 298 ~~y~yl~~kdh-gt~is-~i--------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLID 364 (488)
T COG5072 298 TLYLYLHFKDH-GTPIS-II--------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLID 364 (488)
T ss_pred ceEEEEEEecC-Cceee-ee--------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEE
Confidence 33567777753 55653 22 2246778888999999888888874 4599999999999999 99999999
Q ss_pred cccccC
Q 047020 158 FGLCKL 163 (266)
Q Consensus 158 fg~~~~ 163 (266)
|-+++.
T Consensus 365 fklsRl 370 (488)
T COG5072 365 FKLSRL 370 (488)
T ss_pred eeeeec
Confidence 999985
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.0015 Score=64.13 Aligned_cols=159 Identities=15% Similarity=-0.045 Sum_probs=109.1
Q ss_pred HHHHHHhcCCCCCccccceeEEe--cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-
Q 047020 55 DEVSVLLRVSHPNLVGLLGFCLE--KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA- 131 (266)
Q Consensus 55 ~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~- 131 (266)
.|....+...|+++.....-..+ ....+..++++.+|.+.+.+.+.-. ...+.+..-+.....+......-+|++.
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e-e~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE-ESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc-cCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34444445678777665543322 2345778888889999998876311 1123333333333333355555555443
Q ss_pred -CCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHH
Q 047020 132 -DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLE 210 (266)
Q Consensus 132 -~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~ 210 (266)
+.--+|.++|+.|.++..+..++++++|+.+. .+......+...+++.|+.|+....-.++.++|+|..|+-+|.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKI----knp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKI----KNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccc----cCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 22457899999999999999999999999873 2233445567788888999998877788888999999999999
Q ss_pred HHhCCCCc
Q 047020 211 LITGLKSI 218 (266)
Q Consensus 211 l~~g~~pf 218 (266)
+..|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 98888877
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.22 Score=42.04 Aligned_cols=69 Identities=19% Similarity=0.161 Sum_probs=40.7
Q ss_pred cceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC---CCCccc--cce--eEEecCeEEEEEEecCCCc
Q 047020 23 TSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS---HPNLVG--LLG--FCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 23 ~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~--~~~--~~~~~~~~~lv~e~~~~~~ 92 (266)
--.||.+...+|..+++|... ........+..|.+++..|. -|-+.+ .-+ ....++..+.++++++|..
T Consensus 38 eN~vy~v~~~~~~~~vlKv~r-~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 38 ENRVYQFGDEDGRRVVAKFYR-PERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cceEEEEecCCCCEEEEEEcC-cccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 345888877677777777543 22224556667888877664 221111 111 2233456788999998754
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.14 Score=40.56 Aligned_cols=74 Identities=19% Similarity=0.221 Sum_probs=47.5
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC---CCCccccceeEEecCeEEEEEEecCCCch
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS---HPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
++..|.--..|.+..++..+ -||.= .......|..|+.-|+.+. .-.+.+.+.+-.++++.|+||+|++-+.+
T Consensus 23 ~v~gG~inea~~v~dg~~~~-FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRDGTDPF-FVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeecCCcce-EEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 45555555566665544333 33321 1223456777887777774 35677888888899999999999986554
Q ss_pred h
Q 047020 94 F 94 (266)
Q Consensus 94 ~ 94 (266)
.
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 3
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.014 Score=47.66 Aligned_cols=47 Identities=30% Similarity=0.379 Sum_probs=35.0
Q ss_pred HHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 116 IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 116 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
.+..+-..+.-.+.. +..+||+|+.|+|++.++.+.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 444444455555443 12489999999999999989999999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.37 Score=47.10 Aligned_cols=29 Identities=38% Similarity=0.546 Sum_probs=25.1
Q ss_pred eecCCCCCCcEEEecCC--ceE-EeccccccC
Q 047020 135 IIHRDIKSSNILLIDDN--HAK-LADFGLCKL 163 (266)
Q Consensus 135 i~H~dikp~nil~~~~~--~~~-l~dfg~~~~ 163 (266)
++|+|+++.||+++.++ ++. |+|||-+..
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 99999999999998775 565 999998764
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.013 Score=44.92 Aligned_cols=29 Identities=17% Similarity=0.319 Sum_probs=25.4
Q ss_pred CeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 134 ~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
..+|+|+.|.|+++++++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 479999999999998776 99999998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.038 Score=46.08 Aligned_cols=27 Identities=41% Similarity=0.666 Sum_probs=24.5
Q ss_pred eecCCCCCCcEEEecCCceEEecccccc
Q 047020 135 IIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 135 i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
++|+|+++.||+++. +.+.|+||+.+.
T Consensus 189 liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 189 FCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred eEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 999999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.23 Score=43.69 Aligned_cols=29 Identities=24% Similarity=0.432 Sum_probs=24.1
Q ss_pred CeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 134 ~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
.+||+|+.+.||+..++ .++++||..|..
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeeccccc
Confidence 48999999999987544 499999988763
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 266 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-39 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 3e-89
Identities = 97/273 (35%), Positives = 141/273 (51%), Gaps = 16/273 (5%)
Query: 1 TYALEELKMATNDFRIR--IGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVS 58
L +L+ ATN+F + IG G VY L DG A+KR E + F E+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 59 VLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL 118
L HP+LV L+GFC E+ E +L+ +Y+ N +L ++ ++ +SW RL I +
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM-SMSWEQRLEICI 146
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
AR L YLH+ IIHRD+KS NILL ++ K+ DFG+ K G + ++ T +
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGT--ELDQTHLSTVV 201
Query: 179 KGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSI-----QGSATLAEWTEECRR 233
KG+ GY+D Y G ++ KSDVYSFGV+L E++ +I + LAEW E
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 234 NKNVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266
N +E Q++DP L E LR +
Sbjct: 262 NGQLE---QIVDPNLADKIRPESLRKFGDTAVK 291
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 2e-85
Identities = 99/273 (36%), Positives = 150/273 (54%), Gaps = 17/273 (6%)
Query: 1 TYALEELKMATNDFRIR--IGVGATSFVYLAELGDGNFGAVKRVMEERG-GSRKIFLDEV 57
++L EL++A+++F + +G G VY L DG AVKR+ EER G F EV
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 58 SVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIA 117
++ H NL+ L GFC+ E+LL+ Y+AN S+ + L W R IA
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP-PLDWPKRQRIA 137
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
L AR L YLH DP IIHRD+K++NILL ++ A + DFGL KL + D + T+
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TA 194
Query: 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSI-------QGSATLAEWTEE 230
++G+ G++ YL+TG S K+DV+ +GV+LLELITG ++ L +W +
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 231 CRRNKNVEVWAQMLDPKLNGDANMEQLRVLIRI 263
+ K +E ++D L G+ E++ LI++
Sbjct: 255 LLKEKKLE---ALVDVDLQGNYKDEEVEQLIQV 284
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 8e-78
Identities = 88/287 (30%), Positives = 135/287 (47%), Gaps = 45/287 (15%)
Query: 1 TYALEELKMATNDFRIRIGVGATSFVYLAELGDGNFG------------AVKR-----VM 43
+++ ELK TN+F R + +G+G FG AVK+ +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNK-----MGEGGFGVVYKGYVNNTTVAVKKLAAMVDI 68
Query: 44 EERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQ 103
++ F E+ V+ + H NLV LLGF + + L+ Y+ N SL DR+ G
Sbjct: 69 TTEELKQQ-FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 104 SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163
LSW R IA A + +LH + IHRDIKS+NILL + AK++DFGL +
Sbjct: 128 P--PLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 164 GPFNDPNRPKRQ---TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSI-- 218
+ + I G+ Y+ L G ++ KSD+YSFGV+LLE+ITGL ++
Sbjct: 183 SEKFA-----QTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 219 -QGSATLAEWTEEC-RRNKNVEVWAQMLDPKLNGDANMEQLRVLIRI 263
+ L + EE K +E +D K+ DA+ + + +
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIE---DYIDKKM-NDADSTSVEAMYSV 279
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-56
Identities = 69/290 (23%), Positives = 108/290 (37%), Gaps = 39/290 (13%)
Query: 4 LEELKMATNDFRI--RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL 61
E L + ++ G V+ A+L + AVK + + EV L
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVK-IFPIQDKQSWQNEYEVYSLP 73
Query: 62 RVSHPNLVGLLGFCLE----KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIA 117
+ H N++ +G + L+ + SL D + V+SW+ IA
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIA 127
Query: 118 LDIARALEYLHSQAD-------PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170
+AR L YLH P I HRDIKS N+LL ++ A +ADFGL F
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK--FEAGK 185
Query: 171 RPKRQTSIKGSFGYVDTNYLNTGF-----VSTKSDVYSFGVLLLELITGLKSIQGSAT-- 223
G+ Y+ L + D+Y+ G++L EL + + G
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 224 LAEWTEECRRNKNVE-----VWAQMLDPKL----NGDANMEQLRVLIRIC 264
+ + EE ++ ++E V + P L A M L I C
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 8e-54
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 4 LEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV 63
+E+++ +G GA V A+ A+K++ E RK F+ E+ L RV
Sbjct: 7 YKEIEVEE-----VVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRV 58
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
+HPN+V L G CL L++EY SL++ +H + L + ++ +S L ++
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQG 114
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
+ YLHS +IHRD+K N+LL+ K+ DFG + T+ KGS
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------DIQTHMTNNKGSA 167
Query: 183 GY----VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ V S K DV+S+G++L E+IT
Sbjct: 168 AWMAPEV----FEGSNYSEKCDVFSWGIILWEVITR 199
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-52
Identities = 70/204 (34%), Positives = 111/204 (54%), Gaps = 18/204 (8%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKI--FLDEVSVLLRVSHPNLVGLLGF 74
+IG G+ V+ AE G+ AVK +ME+ + ++ FL EV+++ R+ HPN+V +G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP 134
+ ++ EYL+ SL+ +H + L RLS+A D+A+ + YLH++ +PP
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPP 159
Query: 135 IIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY----VDTNYL 190
I+HR++KS N+L+ K+ DFGL +L + S G+ + V L
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL----KASTFLSSKSAAGTPEWMAPEV----L 211
Query: 191 NTGFVSTKSDVYSFGVLLLELITG 214
+ KSDVYSFGV+L EL T
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATL 235
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-50
Identities = 45/219 (20%), Positives = 87/219 (39%), Gaps = 28/219 (12%)
Query: 4 LEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKI--FLDEVSVLL 61
++L T ++ + ++ GN VK + +RK F +E L
Sbjct: 9 FKQLNFLT-----KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLL--EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALD 119
SHPN++ +LG C L ++ SL++ +H V+ S + ALD
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFALD 119
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
+AR + +LH+ +P I + S ++++ +D A+++ + +
Sbjct: 120 MARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK---------FSFQSPGRM 169
Query: 180 GSFGY----VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ + +D++SF VLL EL+T
Sbjct: 170 YAPAWVAPEALQKKPEDTN-RRSADMWSFAVLLWELVTR 207
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-49
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 41/219 (18%)
Query: 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKI-------FLDEVSVLLRVSHPNL 68
+IG G V+ + D + A+K ++ F EV ++ ++HPN+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
V L G +++E++ L+ R+ + WS +L + LDIA +EY+
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGIEYMQ 139
Query: 129 SQADPPIIHRDIKSSNILLIDDN-----HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
+Q +PPI+HRD++S NI L + AK+ADFGL + + + G+F
Sbjct: 140 NQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSVSGLLGNFQ 191
Query: 184 YV--------DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
++ + +Y + K+D YSF ++L ++TG
Sbjct: 192 WMAPETIGAEEESY------TEKADTYSFAMILYTILTG 224
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 9e-49
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 39/217 (17%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRV----MEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
IG+G VY A G+ AVK E+ + + E + + HPN++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
G CL++ L++E+ L + + ++ A+ IAR + YLH +A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 133 PPIIHRDIKSSNILL--------IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
PIIHRD+KSSNIL+ + + K+ DFGL R +T+ + G
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA---------REWHRTTKMSAAG- 176
Query: 185 VDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
Y + S SDV+S+GVLL EL+TG
Sbjct: 177 ---AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-47
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 18/209 (8%)
Query: 17 RIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+G G G +K ++ +++ FL EV V+ + HPN++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
+ + EY+ +L + + Q WS R+S A DIA + YLHS I
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY------ 189
IHRD+ S N L+ ++ + +ADFGL +L ++ K T
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 190 ----LNTGFVSTKSDVYSFGVLLLELITG 214
+N K DV+SFG++L E+I
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGR 218
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-47
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 24/211 (11%)
Query: 17 RIGVGATSFVYLAEL-GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLG 73
IG G VY G+ A++ + ER K F EV + H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRWHGEV---AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
C+ ++ ++L+ + + VL + IA +I + + YLH++
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVR----DAKIVLDVNKTRQIAQEIVKGMGYLHAK--- 149
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKL-GPFNDPNRPKRQTSIKGSFGY-------- 184
I+H+D+KS N+ D+ + DFGL + G R + G +
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 185 -VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ S SDV++ G + EL
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-44
Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 36/238 (15%)
Query: 3 ALEELKMATNDFRI--RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSV- 59
A E + ++ ++ IG G VY L D AVK +R+ F++E ++
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIY 59
Query: 60 -LLRVSHPNLVGLLGFCLE-----KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNR 113
+ + H N+ + + E LL++EY N SL + + W +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSS 113
Query: 114 LSIALDIARALEYLHSQAD------PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
+A + R L YLH++ P I HRD+ S N+L+ +D ++DFGL N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 168 DPNRPKRQ----TSIKGSFGYV-------DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
RP + S G+ Y+ N + + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-44
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 30/203 (14%)
Query: 30 ELGDGNFG-----------AVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
+G G+FG AVK + + F +EV VL + H N++ +G+
Sbjct: 31 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 77 EKGEQLLLL-EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
QL ++ ++ SL+ +H + + IA AR ++YLH++ I
Sbjct: 91 A--PQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY----VDTNYLN 191
IHRD+KS+NI L +DN K+ DFGL + + + + GS + V +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEK--SRWSGSHQFEQLSGSILWMAPEV-IRMQD 198
Query: 192 TGFVSTKSDVYSFGVLLLELITG 214
+ S +SDVY+FG++L EL+TG
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTG 221
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-44
Identities = 49/215 (22%), Positives = 82/215 (38%), Gaps = 27/215 (12%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSV--LLRVSHPNLVGLLGF 74
+G G V+ G AVK K + E + + + H N++G +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 75 CLEKGEQ----LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS- 129
+ L+ Y SL+D + L + L I L IA L +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIE 124
Query: 130 ----QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
Q P I HRD+KS NIL+ + +AD GL + + G+ Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 186 ------DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+T ++ + D+++FG++L E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-41
Identities = 56/273 (20%), Positives = 102/273 (37%), Gaps = 33/273 (12%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
+IG G V++ + G AVK S E+ + + H N++G + +
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAADI 101
Query: 77 EKGEQ----LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS--- 129
+ L+ +Y N SL+D + + L + L +A L +LH+
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 130 --QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY--- 184
Q P I HRD+KS NIL+ + +AD GL + + G+ Y
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 185 ---VDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL-AEWTEECRRNKNVEVW 240
++ N +D+YSFG++L E+ S + + + + E
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 241 AQM---------LDPKLNGDANMEQLRVLIRIC 264
++ + + D + Q+ L+ C
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-41
Identities = 47/215 (21%), Positives = 82/215 (38%), Gaps = 27/215 (12%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSV--LLRVSHPNLVGLLGF 74
IG G V+ + G AVK + + E + + + H N++G +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 75 CLEKGEQ----LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS- 129
+ L+ +Y + SLFD ++ Y ++ + +AL A L +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHME 158
Query: 130 ----QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY- 184
Q P I HRD+KS NIL+ + +AD GL G+ Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 185 -----VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
D+ + ++D+Y+ G++ E+
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-36
Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 13 DFRIR--IGVGATSFVYLAE-LGDGNFGAVKRV----MEERGGSRKIFLDEVSVLLRVSH 65
+ +G G S+V L E L DG+F A+KR+ ++R +++ E + +H
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR----EADMHRLFNH 85
Query: 66 PNLVGLLGFCLEKGEQ----LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
PN++ L+ +CL + LLL + +L++ + L+ L + L I
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL-KDKGNFLTEDQILWLLLGIC 144
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT----- 176
R LE +H+ HRD+K +NILL D+ L D G + + T
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 177 SIKGSFGY----VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ + + Y + + + + ++DV+S G +L ++ G
Sbjct: 202 AQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFG 242
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-34
Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 31/214 (14%)
Query: 14 FRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKI--FLDEVSVLLRVSHPNLVG 70
F I IG G+ VY + A + + + + F +E +L + HPN+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 71 LLGFCL--EKGEQLL--LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
KG++ + + E + + +L + + V+ S I + L++
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQF 144
Query: 127 LHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY- 184
LH++ PPIIHRD+K NI + K+ D GL L R ++ G+ +
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL------KRASFAKAVIGTPEFM 197
Query: 185 ----VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ Y DVY+FG+ +LE+ T
Sbjct: 198 APEMYEEKY------DESVDVYAFGMCMLEMATS 225
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 62/218 (28%), Positives = 84/218 (38%), Gaps = 36/218 (16%)
Query: 13 DFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGS--RKIFLDEVSVLLRV-SHP 66
F+ R+G G+ V+ DG AVKR M G R L EV +V HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLG---VLSWSNRLSIALDIARA 123
V L E G L E SL + G SL V + D A
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAW-GASLPEAQVWGY------LRDTLLA 169
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
L +LHSQ ++H D+K +NI L KL DFGL + +G
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGE---VQEG--- 218
Query: 184 YVDTNY-----LNTGFVSTKSDVYSFGVLLLELITGLK 216
D Y L + T +DV+S G+ +LE+ ++
Sbjct: 219 --DPRYMAPELLQGSY-GTAADVFSLGLTILEVACNME 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-33
Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 52/223 (23%)
Query: 23 TSFVYLAELGDGNFG------------------AVKRVMEERGGSRKIFLDEVSVLLRVS 64
Y+++LG GNFG AVK++ ++ F E+ +L +
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 65 HPNLVGLLGFCLEKGEQLLLL--EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
+V G G Q L L EYL + L D + + + L S L + I +
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICK 138
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND---PNRPKRQTSIK 179
+EYL S+ +HRD+ + NIL+ + H K+ADFGL KL P + R Q+ I
Sbjct: 139 GMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 180 ---------GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
F S +SDV+SFGV+L EL T
Sbjct: 196 WYAPESLSDNIF-------------SRQSDVWSFGVVLYELFT 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-33
Identities = 62/218 (28%), Positives = 92/218 (42%), Gaps = 42/218 (19%)
Query: 23 TSFVYLAELGDGNFG------------------AVKRVMEERGGSRKIFLDEVSVLLRVS 64
+L +LG GNFG AVK++ + F E+ +L +
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 65 HPNLVGLLGFCLEKGEQLLLL--EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
H N+V G C G + L L EYL SL D + + + + L I +
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICK 125
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS---IK 179
+EYL ++ IHRD+ + NIL+ ++N K+ DFGL K+ P + ++ I
Sbjct: 126 GMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 180 ----GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
S L S SDV+SFGV+L EL T
Sbjct: 183 WYAPES--------LTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 42/218 (19%)
Query: 23 TSFVYLAELGDGNFG------------------AVKRVMEERGGSRKIFLDEVSVLLRVS 64
+L +LG GNFG AVK++ + F E+ +L +
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 65 HPNLVGLLGFCLEKGEQLLLL--EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
H N+V G C G + L L EYL SL D + + + + L I +
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICK 156
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN---RPKRQTSIK 179
+EYL ++ IHRD+ + NIL+ ++N K+ DFGL K+ P + + ++ I
Sbjct: 157 GMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 180 ----GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
S L S SDV+SFGV+L EL T
Sbjct: 214 WYAPES--------LTESKFSVASDVWSFGVVLYELFT 243
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 35/232 (15%)
Query: 11 TNDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPN 67
+DF +G GA V A D + A+K + L EV +L ++H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIK-KIRHTEEKLSTILSEVMLLASLNHQY 63
Query: 68 LVGLLGFCLEKGEQL-------------LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRL 114
+V LE+ + + +EY N +L+D +H+ W
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR--- 120
Query: 115 SIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174
+ I AL Y+HSQ IIHRD+K NI + + + K+ DFGL K +
Sbjct: 121 -LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 175 QTSIKGSFGYVDT-----NYL------NTGFVSTKSDVYSFGVLLLELITGL 215
++ GS + + Y+ TG + K D+YS G++ E+I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF 228
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 60/236 (25%), Positives = 91/236 (38%), Gaps = 50/236 (21%)
Query: 23 TSFVYLAELGDGNFG------------------AVKRVMEERGG-SRKIFLDEVSVLLRV 63
+ +LG+G+FG AVK + + G R + E+ +L +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 64 SHPNLVGLLGFCLEKGEQ--LLLLEYLANKSLFD--RMHTYYGQSLGVLSWSNRLSIALD 119
H +++ G C + G L++EY+ SL D H+ + + L A
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--------IGLAQLLLFAQQ 142
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS-- 177
I + YLH+Q IHRD+ + N+LL +D K+ DFGL K P R+
Sbjct: 143 ICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 178 -IK----GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEW 227
+ L SDV+SFGV L EL+T S E
Sbjct: 200 PVFWYAPEC--------LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 23 TSFVYLAELGDGNFG--------------AVKRVMEERGGS-RKIFLDEVSVLLRVSHPN 67
V ++G GNFG AVK E + FL E +L + SHPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+V L+G C +K +++E + + L L + D A +EYL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLT----FLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND--PNRPKRQTSIKG----S 181
S+ IHRD+ + N L+ + N K++DFG+ + + RQ +K +
Sbjct: 230 ESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
LN G S++SDV+SFG+LL E +
Sbjct: 287 --------LNYGRYSSESDVWSFGILLWETFS 310
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-31
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 27/212 (12%)
Query: 18 IGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKI--FLDEVSVLLRVSHPNL--VGLLG 73
IG G +S V+ A+K V E ++ + + +E++ L ++ + + L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+ + +++E N L + + R S ++ A+ +H
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG-- 175
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV------DT 187
I+H D+K +N L+ D KL DFG+ + + K S G+ Y+ D
Sbjct: 176 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK--DSQVGAVNYMPPEAIKDM 231
Query: 188 NYLNTGF-----VSTKSDVYSFGVLLLELITG 214
+ +S KSDV+S G +L + G
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 27/212 (12%)
Query: 18 IGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKI--FLDEVSVLLRVSHPNL--VGLLG 73
IG G +S V+ A+K V E ++ + + +E++ L ++ + + L
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+ + +++E N L + + R S ++ A+ +H
Sbjct: 96 YEITDQYIYMVMEC-GNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG-- 147
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV-------- 185
I+H D+K +N L+ D KL DFG+ + + K S G+ Y+
Sbjct: 148 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK--DSQVGTVNYMPPEAIKDM 203
Query: 186 ---DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
N + +S KSDV+S G +L + G
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 52/208 (25%), Positives = 79/208 (37%), Gaps = 30/208 (14%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
R+G G+ V+ + G AVK+V E ++E+ +S P +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAV 119
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
E + +E L SL + G L L LEYLH++ I
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---I 171
Query: 136 IHRDIKSSNILLIDD-NHAKLADFGLCK-LGPFNDPNRPKRQTSIKGSFGYVDTNY---- 189
+H D+K+ N+LL D + A L DFG L P I G T
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG------TETHMAP 225
Query: 190 ---LNTGFVSTKSDVYSFGVLLLELITG 214
+ K D++S ++L ++ G
Sbjct: 226 EVVMGKPC-DAKVDIWSSCCMMLHMLNG 252
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 31/221 (14%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFC 75
+ G +FVY A+ +G G A+KR++ + + EV + ++S HPN+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 76 LEKGEQ-------LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
E+ LLL L L + + + G LS L I RA++++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMH 153
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
Q PPIIHRD+K N+LL + KL DFG + P S + +
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSAT----TISHYPDYSWSAQRRALVEEEI 208
Query: 189 YLNT---------------GFVSTKSDVYSFGVLLLELITG 214
NT + K D+++ G +L L
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-31
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 43/219 (19%)
Query: 23 TSFVYLAELGDGNFG------------------AVKRVMEERGG-SRKIFLDEVSVLLRV 63
+ +LG+G+FG AVK + E GG E+ +L +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 64 SHPNLVGLLGFCLEKGEQLLLL--EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
H N+V G C E G + L E+L + SL + + + ++ +L A+ I
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQIC 136
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS---I 178
+ ++YL S+ +HRD+ + N+L+ ++ K+ DFGL K + + +
Sbjct: 137 KGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193
Query: 179 K----GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
L SDV+SFGV L EL+T
Sbjct: 194 FWYAPEC--------LMQSKFYIASDVWSFGVTLHELLT 224
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-31
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 41/232 (17%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPN 67
DF +G G V+ A+ D A+KR+ + R +R+ + EV L ++ HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 68 LVGLLGFCLEKGEQL------------LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS 115
+V LEK + ++ ++L D M+ S L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE--RERSVCLH 122
Query: 116 IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL--------GPFN 167
I L IA A+E+LHS+ ++HRD+K SNI D+ K+ DFGL
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 168 DPNRPKRQTSIKGSFGYV------DTNYLNTGFVSTKSDVYSFGVLLLELIT 213
R T G+ Y+ +Y S K D++S G++L EL+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSY------SHKVDIFSLGLILFELLY 225
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 27/212 (12%)
Query: 18 IGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKI--FLDEVSVLLRVSHPNL--VGLLG 73
IG G +S V+ A+K V E ++ + + +E++ L ++ + + L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+ + +++E N L + + R S ++ A+ +H
Sbjct: 77 YEITDQYIYMVMEC-GNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG-- 128
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV-------- 185
I+H D+K +N L+ D KL DFG+ + + K S G+ Y+
Sbjct: 129 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK--DSQVGTVNYMPPEAIKDM 184
Query: 186 ---DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
N + +S KSDV+S G +L + G
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 37/219 (16%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV----MEERGGSRKIFLDEVSVLLRVS 64
+ +IG G+ L + DG +K + M + R+ EV+VL +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK--EREESRREVAVLANMK 81
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLG---VLSWSNRLSIALDIA 121
HPN+V E G ++++Y LF R++ G +L W + I
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQIC 135
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
AL+++H + I+HRDIKS NI L D +L DFG+ ++ + + G+
Sbjct: 136 LALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARA-CIGT 188
Query: 182 FGYV------DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ + Y + KSD+++ G +L EL T
Sbjct: 189 PYYLSPEICENKPY------NNKSDIWALGCVLYELCTL 221
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 36/211 (17%)
Query: 23 TSFVYLAELGDGNFG--------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNL 68
T +LG G +G AVK ++E + FL E +V+ + HPNL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
V LLG C + ++ E++ +L D + Q +S L +A I+ A+EYL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLE 335
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN------DPNRPKRQTSIKGSF 182
+ IHR++ + N L+ +++ K+ADFGL +L + P + T+ +
Sbjct: 336 KKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES-- 390
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
L S KSDV++FGVLL E+ T
Sbjct: 391 -------LAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 23 TSFVYLAELGDGNFG------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVG 70
L +G G FG AVK + + + FL E SV+ ++ H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQ 250
Query: 71 LLGFCLEKGEQLLL-LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
LLG +E+ L + EY+A SL D + + L L +LD+ A+EYL
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLDVCEAMEYLEG 307
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR--PKRQTSIKGSFGYVDT 187
+HRD+ + N+L+ +DN AK++DFGL K P + T+ +
Sbjct: 308 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA------- 357
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELIT 213
L STKSDV+SFG+LL E+ +
Sbjct: 358 --LREKKFSTKSDVWSFGILLWEIYS 381
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-30
Identities = 46/268 (17%), Positives = 88/268 (32%), Gaps = 27/268 (10%)
Query: 5 EELKMATNDFRIR--IGVGATSFVYLAELGDGNFG------AVKRVMEERGGSRKIFLDE 56
E ++ + + +G GA + VY A GD N +K I
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 57 VSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI 116
+ L + L + +L+ E + +L + ++ Y V+ +S
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLID-----------DNHAKLADFGLCKLGP 165
A+ + +E +H IIH DIK N +L + L D G
Sbjct: 178 AMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA 225
T+ + G+ L+ + + D + + ++ G ++
Sbjct: 235 LFPKG--TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMKVKNEGG 291
Query: 226 EWTEEC--RRNKNVEVWAQMLDPKLNGD 251
E E RR ++++W + LN
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIP 319
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-30
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 51/221 (23%)
Query: 23 TSFVYLAELGDGNFGAVKR-VMEERGGSRKI------------------FLDEVSVLLRV 63
T F + LG G FG V + + G KI LDE V+ V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
+P++ LLG CL L+ + + L D + + + L+ + IA+
Sbjct: 75 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKG 129
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP--NRPKRQTSIK-- 179
+ YL + ++HRD+ + N+L+ H K+ DFGL KL + + + IK
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 180 -------GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ + +SDV+S+GV + EL+T
Sbjct: 187 ALESILHRIY-------------THQSDVWSYGVTVWELMT 214
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-30
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV-----MEERGGSRKIFLDEVSVLLRV 63
+FRI +IG G S VY A L DG A+K+V M+ + +R + E+ +L ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDLLKQL 89
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
+HPN++ +E E ++LE L + ++ + ++ + + A
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
LE++HS+ ++HRDIK +N+ + KL D GL + F+ S+ G+
Sbjct: 149 LEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAH--SLVGTPY 201
Query: 184 YV------DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ + Y + KSD++S G LL E+
Sbjct: 202 YMSPERIHENGY------NFKSDIWSLGCLLYEMAAL 232
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 52/233 (22%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL 68
DF+ IG G V+ A+ DG +KRV + + EV L ++ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNI 66
Query: 69 VGLLGFCLEKGEQL----------------LLLEYLANKSLFDRMHTYYGQSLG---VLS 109
V G + +E+ +L + G+ L L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 110 WSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169
I + ++Y+HS+ +I+RD+K SNI L+D K+ DFGL
Sbjct: 127 L------FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTS-----L 172
Query: 170 NRPKRQTSIKGSFGYV------DTNYLNTGFVSTKSDVYSFGVLLLELITGLK 216
++T KG+ Y+ +Y + D+Y+ G++L EL+
Sbjct: 173 KNDGKRTRSKGTLRYMSPEQISSQDY------GKEVDLYALGLILAELLHVCD 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 44/220 (20%)
Query: 26 VYLAELGDGNFG-------------------AVKRVMEERGGSRKI-FLDEVSVLLRVSH 65
ELG G+FG A+K V E +I FL+E SV+ +
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSLFD-----RMHTYYGQSLGVLSWSNRLSIALDI 120
++V LLG + L+++E + L R L S S + +A +I
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR-------PK 173
A + YL++ +HRD+ + N ++ +D K+ DFG+ + D R P
Sbjct: 148 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
R S + L G +T SDV+SFGV+L E+ T
Sbjct: 205 RWMSPES---------LKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 48/223 (21%), Positives = 84/223 (37%), Gaps = 32/223 (14%)
Query: 11 TNDFRI--RIGVGATSF--VYLA-ELGDGNFGAVKRV-MEERGGSR-KIFLDEVSVLLRV 63
+ + IG G V LA G + V+R+ +E E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL---DI 120
+HPN+V + E ++ ++A S D + T++ + N L+IA +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM------NELAIAYILQGV 137
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
+AL+Y+H +HR +K+S+IL+ D L+ + +++
Sbjct: 138 LKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN--LSMIS-HGQRQRVVHDF 191
Query: 181 SFGYVDTNY---------LNTGFVSTKSDVYSFGVLLLELITG 214
V G+ KSD+YS G+ EL G
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANG 233
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 36/210 (17%)
Query: 23 TSFVYLAELGDGNFG-------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
S +LG G FG A+K ++ S + FL E V+ ++ H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L E+ ++ EY++ SL D + G+ L + +A IA + Y+
Sbjct: 326 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIASGMAYVER 381
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR------PKRQTSIKGSFG 183
+HRD++++NIL+ ++ K+ADFGL +L N+ P + T+ +
Sbjct: 382 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--- 435
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
G + KSDV+SFG+LL EL T
Sbjct: 436 ------ALYGRFTIKSDVWSFGILLTELTT 459
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-29
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 23 TSFVYLAELGDGNFG------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVG 70
L +G G FG AVK + + + FL E SV+ ++ H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQ 78
Query: 71 LLGFCLEKGEQLLL-LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
LLG +E+ L + EY+A SL D + + L L +LD+ A+EYL
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLDVCEAMEYLEG 135
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR--PKRQTSIKGSFGYVDT 187
+HRD+ + N+L+ +DN AK++DFGL K P + T+ +
Sbjct: 136 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA------- 185
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELIT 213
L STKSDV+SFG+LL E+ +
Sbjct: 186 --LREKKFSTKSDVWSFGILLWEIYS 209
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-29
Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 49/220 (22%)
Query: 23 TSFVYLAELGDGNFG------------------AVKRVMEERGG-SRKIFLDEVSVLLRV 63
T L LG G FG +K + ++ G S + D + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
H ++V LLG C L+ +YL SL + Q G L L+ + IA+
Sbjct: 73 DHAHIVRLLGLCPGS-SLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT------- 176
+ YL ++HR++ + N+LL + ++ADFG+ L P +D +
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 177 ---SIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
SI + G + +SDV+S+GV + EL+T
Sbjct: 185 ALESI------------HFGKYTHQSDVWSYGVTVWELMT 212
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-29
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV----MEERGGSRKIFLDEVSVLLRVS 64
D+ + IG G+ DG K + M E +++ + EV++L +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELK 63
Query: 65 HPNLVGLLGFCLEKGEQLL--LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
HPN+V +++ L ++EY L + T + L L + +
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTL 122
Query: 123 ALEYLHSQADPP--IIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
AL+ H ++D ++HRD+K +N+ L + KL DFGL ++ + + +T + G
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTFV-G 178
Query: 181 SFGYV------DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ Y+ +Y + KSD++S G LL EL
Sbjct: 179 TPYYMSPEQMNRMSY------NEKSDIWSLGCLLYELCAL 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-29
Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 58/222 (26%)
Query: 23 TSFVYLAELGDGNFG--------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNL 68
T +LG G +G AVK ++E + FL E +V+ + HPNL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
V LLG C + ++ E++ +L D + Q +S L +A I+ A+EYL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLE 128
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
+ IHRD+ + N L+ +++ K+ADFGL +L
Sbjct: 129 KKN---FIHRDLAARNCLVGENHLVKVADFGLSRL--------------------MTGDT 165
Query: 189 Y-----------------LNTGFVSTKSDVYSFGVLLLELIT 213
Y L S KSDV++FGVLL E+ T
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-29
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 12 NDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPN 67
+D+ + IG GAT+ V A A+KR+ +E+ S L E+ + + HPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 68 LVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL---DIARA 123
+V ++L L+++ L+ S+ D + + + +IA ++
Sbjct: 75 IVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDPNR-PKRQTS---- 177
LEYLH IHRD+K+ NILL +D ++ADFG+ L D R R+T
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 178 -------IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
++ GY K+D++SFG+ +EL TG
Sbjct: 191 CWMAPEVMEQVRGY-----------DFKADIWSFGITAIELATG 223
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+IG G+T V LA E G AVK + + R++ +EV ++ H N+V +
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
L E +L+E+L +L D + L+ ++ + +AL YLH+Q +
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG---V 162
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDPNRPKRQTSIKGSFGYVDTNY----- 189
IHRDIKS +ILL D KL+DFG C ++ + PKR++ V T Y
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQI----SKDVPKRKS-------LVGTPYWMAPE 211
Query: 190 -LNTGFVSTKSDVYSFGVLLLELITG 214
++ +T+ D++S G++++E++ G
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 44/220 (20%)
Query: 26 VYLAELGDGNFG-------------------AVKRVMEERGGSRKI-FLDEVSVLLRVSH 65
+ LG G FG AVK + E ++ FL E ++ + +H
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSL--FDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
N+V +G L+ + +L+E +A L F R L+ + L +A DIA
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 124 LEYLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNR-------PK 173
+YL IHRDI + N LL AK+ DFG+ + R P
Sbjct: 153 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ + G ++K+D +SFGVLL E+ +
Sbjct: 210 KWMPPEA---------FMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 43/217 (19%)
Query: 23 TSFVYLAELGDGNFGAVKR-VMEERGGSRKI------------------FLDEVSVLLRV 63
T F + LG G FG V + + G KI LDE V+ V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
+P++ LLG CL L+ + + L D + + + L+ + IA+
Sbjct: 75 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKG 129
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR-------PKRQT 176
+ YL + ++HRD+ + N+L+ H K+ DFGL KL + P +
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 177 SIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+++ + + +SDV+S+GV + EL+T
Sbjct: 187 ALES---------ILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 56/224 (25%), Positives = 87/224 (38%), Gaps = 55/224 (24%)
Query: 23 TSFVYLAELGDGNFGAVKR---------------------VMEERGGSRKIFLDEVSVLL 61
L +LGDG+FG V+R V+ + F+ EV+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD-FIREVNAMH 76
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
+ H NL+ L G L +++ E SL DR+ + G A+ +A
Sbjct: 77 SLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVA 131
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN---RPKRQTSI 178
+ YL S+ IHRD+ + N+LL + K+ DFGL + P ND + + R+
Sbjct: 132 EGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 179 K---------GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+F S SD + FGV L E+ T
Sbjct: 189 AWCAPESLKTRTF-------------SHASDTWMFGVTLWEMFT 219
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 36/210 (17%)
Query: 23 TSFVYLAELGDGNFG-------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
S +LG G FG A+K ++ S + FL E V+ ++ H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L E+ ++ EY++ SL D + G+ L + +A IA + Y+
Sbjct: 243 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVER 298
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR------PKRQTSIKGSFG 183
+HRD++++NIL+ ++ K+ADFGL +L N+ P + T+ +
Sbjct: 299 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--- 352
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
G + KSDV+SFG+LL EL T
Sbjct: 353 ------ALYGRFTIKSDVWSFGILLTELTT 376
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 48/216 (22%)
Query: 23 TSFVYLAELGDGNFG-------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
+ ++ E+G G FG A+K + E S + F++E V++++SHP LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L G CLE+ L+ E++ + L D Y G+ + L + LD+ + YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSD----YLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS---IK------- 179
+IHRD+ + N L+ ++ K++DFG+ + D + +K
Sbjct: 123 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVF 177
Query: 180 --GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ S+KSDV+SFGVL+ E+ +
Sbjct: 178 SFSRY-------------SSKSDVWSFGVLMWEVFS 200
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 53/231 (22%)
Query: 24 SFVYLAELGDGNFG---------------------AVKRVMEERGGSRKI-FLDEVSVLL 61
LG+G FG AVK + ++ + E+ ++
Sbjct: 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 62 RV-SHPNLVGLLGFCLEKGEQLLLLEYLANKSL-----------FDRMHTYYGQSLGVLS 109
+ H N++ LLG C + G +++EY + +L + + ++
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 110 WSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169
+ + +S +AR +EYL SQ IHRD+ + N+L+ ++N K+ADFGL + D
Sbjct: 156 FKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212
Query: 170 NRPKRQ-------TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ + + L + +SDV+SFGVL+ E+ T
Sbjct: 213 YKKTTNGRLPVKWMAPEA---------LFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+IG GA+ VY A ++ G A++++ ++ +++ ++E+ V+ +PN+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
L E +++EYLA SL D + + ++ + +ALE+LHS +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---V 137
Query: 136 IHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDPNRPKRQTSIKGSFGYVDTNY----- 189
IHRDIKS NILL D KL DFG C ++ P + KR T V T Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRST-------MVGTPYWMAPE 186
Query: 190 -LNTGFVSTKSDVYSFGVLLLELITG 214
+ K D++S G++ +E+I G
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 49/220 (22%), Positives = 87/220 (39%), Gaps = 30/220 (13%)
Query: 18 IGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCL 76
+G G++ V G AVKR++ + I L E+ +L HPN++
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 77 EKGEQLLLLEYLANKSLFDRM--HTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP 134
+ LE N +L D + ++L + N +S+ IA + +LHS
Sbjct: 80 TDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--- 135
Query: 135 IIHRDIKSSNILL-------------IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
IIHRD+K NIL+ ++ ++DFGLCK + + G+
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 182 FGYV-------DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
G+ N ++ D++S G + +++
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-28
Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 46/223 (20%)
Query: 26 VYLAELGDGNFG-------------------AVKRVMEERGGSRKIFLDEVSVLLRVSHP 66
V ELG+G FG AVK + E +R+ F E +L + H
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSL--FDRMH--------TYYGQSLGVLSWSNRLSI 116
++V G C E L++ EY+ + L F R H + G L L++
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT 176
A +A + YL +HRD+ + N L+ K+ DFG+ + D R +T
Sbjct: 164 ASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 177 S--IKG----SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
I+ S Y +T+SDV+SFGV+L E+ T
Sbjct: 221 MLPIRWMPPESILY--------RKFTTESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-28
Identities = 64/224 (28%), Positives = 94/224 (41%), Gaps = 47/224 (20%)
Query: 26 VYLAELGDGNFG-------------------AVKRVMEERGGSRKIFLDEVSVLLRVSHP 66
V ELG+G FG AVK + + +RK F E +L + H
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSL--FDRMH---------TYYGQSLGVLSWSNRLS 115
++V G C + +++ EY+ + L F R H Q+ G L S L
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 116 IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175
IA IA + YL SQ +HRD+ + N L+ + K+ DFG+ + D R
Sbjct: 138 IASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 176 TS--IKG----SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
T I+ S Y +T+SDV+SFGV+L E+ T
Sbjct: 195 TMLPIRWMPPESIMY--------RKFTTESDVWSFGVILWEIFT 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-28
Identities = 57/220 (25%), Positives = 87/220 (39%), Gaps = 44/220 (20%)
Query: 26 VYLAELGDGNFG-------------------AVKRVMEERGGSRKI-FLDEVSVLLRVSH 65
+ LG G FG AVK + E ++ FL E ++ + +H
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSL--FDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
N+V +G L+ + +LLE +A L F R L+ + L +A DIA
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 124 LEYLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNR-------PK 173
+YL IHRDI + N LL AK+ DFG+ + R P
Sbjct: 194 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ + G ++K+D +SFGVLL E+ +
Sbjct: 251 KWMPPEA---------FMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-28
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
+G G VY +L + A+K + E + +E+++ + H N+V LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRL--SIALDIARALEYLHSQADPP 134
E G + +E + SL + + +G L + + I L+YLH
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGP----LKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 135 IIHRDIKSSNILLIDDN-HAKLADFGLCK-LGPFNDPNRPKRQTSIKGSFGY-----VDT 187
I+HRDIK N+L+ + K++DFG K L N + G+ Y +D
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-----CTETFTGTLQYMAPEIIDK 197
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITG 214
G+ +D++S G ++E+ TG
Sbjct: 198 G--PRGY-GKAADIWSLGCTIIEMATG 221
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-28
Identities = 62/236 (26%), Positives = 95/236 (40%), Gaps = 44/236 (18%)
Query: 5 EELKMATNDFRIRIGVGATSFVYLAELGDGNFG-----------------AVKRVMEERG 47
EL A I + + +G G+FG AVK +
Sbjct: 9 PELVQAVQHVVIGPS--SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 66
Query: 48 GS-RKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL-LLEYLANKSLFDRMHTYYGQSL 105
FL E ++ SHPN++ LLG CL L +L Y+ + L +
Sbjct: 67 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL----RNFIRNET 122
Query: 106 GVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165
+ + + L +A+ ++YL S+ +HRD+ + N +L + K+ADFGL +
Sbjct: 123 HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179
Query: 166 FNDPNRPKRQTSIK--------GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ +T K S L T +TKSDV+SFGVLL EL+T
Sbjct: 180 DKEYYSVHNKTGAKLPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-27
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 44/214 (20%)
Query: 23 TSFVYLAELGDGNFG-------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
+L ELG G FG A+K +++E S F++E V++ +SH LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L G C ++ ++ EY+AN L + Y + L + D+ A+EYL S
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLN----YLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR------PKRQT---SIK- 179
+ +HRD+ + N L+ D K++DFGL + ++ P R + +
Sbjct: 139 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
F S+KSD+++FGVL+ E+ +
Sbjct: 196 SKF-------------SSKSDIWAFGVLMWEIYS 216
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 53/229 (23%)
Query: 26 VYLAELGDGNFG---------------------AVKRVMEERGGSRKI-FLDEVSVLLRV 63
V LG+G FG AVK + + + E+ ++ +
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 64 -SHPNLVGLLGFCLEKGEQLLLLEYLANKSL-----------FDRMHTYYGQSLGVLSWS 111
H N++ LLG C + G +++EY + +L + + LS
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 112 NRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171
+ +S A +AR +EYL S+ IHRD+ + N+L+ +DN K+ADFGL + D +
Sbjct: 192 DLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 172 PKRQ-------TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ + L + +SDV+SFGVLL E+ T
Sbjct: 249 KTTNGRLPVKWMAPEA---------LFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-27
Identities = 48/213 (22%), Positives = 91/213 (42%), Gaps = 50/213 (23%)
Query: 30 ELGDGNFG----------------AVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLL 72
ELG GNFG A+K + + + + E ++ ++ +P +V L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
G C + +L++E L H + + SN + ++ ++YL +
Sbjct: 77 GVCQAE-ALMLVMEMAGGGPL----HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN- 130
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS---IK---------G 180
+HRD+ + N+LL++ ++AK++DFGL K +D R +K
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
F S++SDV+S+GV + E ++
Sbjct: 189 KF-------------SSRSDVWSYGVTMWEALS 208
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-27
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 23 TSFVYLAELGDGNFG-------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
+ + LG G FG AVK +++ S FL E +++ ++ H LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L ++ ++ EY+ N SL D + T G L + + L +A IA + ++
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKL---TINKLLDMAAQIAEGMAFIEE 127
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR------PKRQTSIKGSFG 183
+ IHRD++++NIL+ D K+ADFGL +L N+ P + T+ +
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA--- 181
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+N G + KSDV+SFG+LL E++T
Sbjct: 182 ------INYGTFTIKSDVWSFGILLTEIVT 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 53/231 (22%)
Query: 24 SFVYLAELGDGNFG---------------------AVKRVMEERGGSRKI-FLDEVSVLL 61
LG+G FG AVK + ++ + E+ ++
Sbjct: 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 141
Query: 62 RV-SHPNLVGLLGFCLEKGEQLLLLEYLANKSL-----------FDRMHTYYGQSLGVLS 109
+ H N++ LLG C + G +++EY + +L + + ++
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 110 WSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169
+ + +S +AR +EYL SQ IHRD+ + N+L+ ++N K+ADFGL + D
Sbjct: 202 FKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258
Query: 170 NRPKRQ-------TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ + + L + +SDV+SFGVL+ E+ T
Sbjct: 259 YKKTTNGRLPVKWMAPEA---------LFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 44/240 (18%), Positives = 81/240 (33%), Gaps = 58/240 (24%)
Query: 11 TNDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGS--RKIFLDEVSVLLRVS- 64
T +F +IG G V+ + DG A+KR + GS + L EV +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
H ++V E L+ EY SL D + + + + + + L + R L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNH-------------------AKLADFGLCKLGP 165
Y+HS + ++H DIK SNI + + K+ D G
Sbjct: 129 RYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-- 183
Query: 166 FNDPNRPKRQTS-----------IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Q ++ ++ + K+D+++ + ++
Sbjct: 184 -----ISSPQVEEGDSRFLANEVLQENYTH-----------LPKADIFALALTVVCAAGA 227
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 32/217 (14%)
Query: 17 RIGVGATSFVYLAELGDGNFG----AVKRVMEERGGSRKI--FLDEVSVLLRVSHPNLVG 70
+G G V A+L + AVK + + S I FL E + + HP++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 71 LLGFCLEKGEQ------LLLLEYLANKSL--FDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
L+G L + +++L ++ + L F L + +DIA
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP-FNLPLQTLVRFMVDIAC 148
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS--IKG 180
+EYL S+ IHRD+ + N +L +D +ADFGL + D R + +K
Sbjct: 149 GMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 181 ----SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
S L + SDV++FGV + E++T
Sbjct: 206 LALES--------LADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 42/211 (19%)
Query: 30 ELGDGNFG-----------------AVKRVMEERGGSRKI-FLDEVSVLLRVSHPNLVGL 71
+G G+FG A+K + + FL E ++ ++HPN++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 72 LGFCL-EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
+G L +G +LL Y+ + L + + + +S L +AR +EYL Q
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDL----LQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS----IKG----SF 182
+HRD+ + N +L + K+ADFGL + + ++ +K S
Sbjct: 144 K---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES- 199
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
L T +TKSDV+SFGVLL EL+T
Sbjct: 200 -------LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 66/240 (27%)
Query: 24 SFVYLAELGDGNFG-------------------AVKRVMEERGGSRKI-FLDEVSVLLRV 63
+ V LG+G FG AVK + E S L E +VL +V
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSL-------------------FDRMHTYYGQS 104
+HP+++ L G C + G LL++EY SL +
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 105 LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164
L+ + +S A I++ ++YL ++HRD+ + NIL+ + K++DFGL +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 165 PFNDPNRPKRQT----------SIK-GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
D + Q S+ + +T+SDV+SFGVLL E++T
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIY-------------TTQSDVWSFGVLLWEIVT 247
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 52/214 (24%)
Query: 30 ELGDGNFG----------------AVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGL 71
ELG GNFG AVK + E + L E +V+ ++ +P +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
+G C + +L++E L Y Q + N + + ++ ++YL
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNK-----YLQQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS---IK--------- 179
+HRD+ + N+LL+ ++AK++DFGL K ++ + +K
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
F S+KSDV+SFGVL+ E +
Sbjct: 195 YKF-------------SSKSDVWSFGVLMWEAFS 215
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 36/203 (17%)
Query: 30 ELGDGNFG-------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
+LG G FG AVK M+ S + FL E +V+ + H LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVK-TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPII 136
++ ++ E++A SL D + + G + + IA + ++ + I
Sbjct: 254 KEP-IYIITEFMAKGSLLDFLKSDEGSKQ---PLPKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 137 HRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR------PKRQTSIKGSFGYVDTNYL 190
HRD++++NIL+ K+ADFGL ++ N+ P + T+ + +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA---------I 357
Query: 191 NTGFVSTKSDVYSFGVLLLELIT 213
N G + KSDV+SFG+LL+E++T
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVT 380
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-27
Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 58/221 (26%)
Query: 23 TSFVYLAELGDGNFG-------------AVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
L ELG G FG AVK +++E S F E ++++SHP LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
G C ++ ++ EY++N L + Y L S L + D+ + +L S
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLN----YLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
IHRD+ + N L+ D K++DFG+ + + D Y
Sbjct: 123 HQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRY--------------VL------DDQY 159
Query: 190 -----------------LNTGFVSTKSDVYSFGVLLLELIT 213
+ S+KSDV++FG+L+ E+ +
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-27
Identities = 46/224 (20%), Positives = 86/224 (38%), Gaps = 56/224 (25%)
Query: 23 TSFVYLAELGDGNFG-----------------AVKRV----MEERGGSRKIFLDEVSVLL 61
+ +G G+ G A+K + E R+ FL E S++
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER---QRRDFLSEASIMG 105
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
+ HPN++ L G +++ EY+ N SL T+ G + + + +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL----DTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS---I 178
+ YL +HRD+ + N+L+ + K++DFGL ++ + I
Sbjct: 162 AGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 179 K---------GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ +F S+ SDV+SFGV++ E++
Sbjct: 219 RWTAPEAIAFRTF-------------SSASDVWSFGVVMWEVLA 249
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 7e-27
Identities = 48/213 (22%), Positives = 92/213 (43%), Gaps = 50/213 (23%)
Query: 30 ELGDGNFGAVKR-VMEERGG----------------SRKIFLDEVSVLLRVSHPNLVGLL 72
ELG GNFG+V++ V R + + E ++ ++ +P +V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
G C + +L++E L H + + SN + ++ ++YL +
Sbjct: 403 GVCQAE-ALMLVMEMAGGGPL----HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN- 456
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS---IK---------G 180
+HR++ + N+LL++ ++AK++DFGL K +D R +K
Sbjct: 457 --FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
F S++SDV+S+GV + E ++
Sbjct: 515 KF-------------SSRSDVWSYGVTMWEALS 534
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-27
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 18 IGVGATSFVYLAELGDGNFG----AVKRVMEERGGS-RKIFLDEVSVLLRVSHPNLVGLL 72
IG G VY L D + AVK + FL E ++ SHPN++ LL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 73 GFCLEKGEQLLL-LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
G CL L+ L Y+ + L + + + + L +A+ +++L S+
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDL----RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR---------PKRQTSIKGSF 182
+HRD+ + N +L + K+ADFGL + + + P + +++
Sbjct: 213 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES-- 267
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
L T +TKSDV+SFGVLL EL+T
Sbjct: 268 -------LQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-27
Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 52/224 (23%)
Query: 26 VYLAELGDGNFG-----------------AVKRVMEERGGSRKI--FLDEVSVLLRVSHP 66
+ LG+G FG AVK + + R+I FL E + + SHP
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 67 NLVGLLGFCLEKGEQ-----LLLLEYLANKSL--FDRMHTYYGQSLGVLSWSNRLSIALD 119
N++ LLG C+E Q +++L ++ L + + L +D
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP-KHIPLQTLLKFMVD 155
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT--- 176
IA +EYL ++ +HRD+ + N +L DD +ADFGL K D R R
Sbjct: 156 IALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 177 -------SIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
S L ++KSDV++FGV + E+ T
Sbjct: 213 VKWIAIES------------LADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-27
Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 52/230 (22%)
Query: 24 SFVYLAELGDGNFG-------------------AVKRVMEERGGSRKI-FLDEVSVLLRV 63
LG G FG AVK + E S + E+ +L+ +
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 64 -SHPNLVGLLGFCLEKGEQLLL-LEYLANKSL-----------FDRMHTYYGQSLGVLSW 110
H N+V LLG C + G L++ +E+ +L L+
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 111 SNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170
+ + + +A+ +E+L S+ IHRD+ + NILL + N K+ DFGL + +
Sbjct: 148 EHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 171 RPKRQ-------TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
K + + + + +SDV+SFGVLL E+ +
Sbjct: 205 VRKGDARLPLKWMAPET---------IFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 50/227 (22%), Positives = 91/227 (40%), Gaps = 61/227 (26%)
Query: 23 TSFVYLAELGDGNFG------------------AVKRV----MEERGGSRKIFLDEVSVL 60
+ +G G FG A+K + E+ R FL E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK---QRVDFLGEAGIM 100
Query: 61 LRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
+ SH N++ L G + +++ EY+ N +L + + G S + + I
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGAL----DKFLREKDGEFSVLQLVGMLRGI 156
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS--- 177
A ++YL + +HRD+ + NIL+ + K++DFGL ++ D TS
Sbjct: 157 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGK 211
Query: 178 --IK---------GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
I+ F ++ SDV+SFG+++ E++T
Sbjct: 212 IPIRWTAPEAISYRKF-------------TSASDVWSFGIVMWEVMT 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 52/231 (22%), Positives = 86/231 (37%), Gaps = 69/231 (29%)
Query: 30 ELGDGNFG-------------------AVKRVMEERGGSRKI-FLDEVSVLLRV-SHPNL 68
LG G FG AVK + K + E+ ++ + H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFD---------RMHTYYGQSLGVLSWSNRLSIALD 119
V LLG C G L++ EY L + + + S + L +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
+A+ + +L S+ IHRD+ + N+LL + + AK+ DFGL R
Sbjct: 173 VAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLA------------RDI--- 214
Query: 180 GSFGYVDTNY-----------------LNTGFVSTKSDVYSFGVLLLELIT 213
D+NY + + +SDV+S+G+LL E+ +
Sbjct: 215 ----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 17 RIGVGATSFVYLAELGDGNFG---AVKRVMEERGGSRKIFLD----EVSVLLRVSHPNLV 69
++G G S VYLAE D A+K + ++ L EV ++SH N+V
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
++ E L++EY+ +L + + ++ G LS ++ I +++ H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHD 129
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
I+HRDIK NIL+ + K+ DFG+ K + + G+ Y
Sbjct: 130 MR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSLTQTNHVLGTVQYFSPEQ 183
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
+D+YS G++L E++ G
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVG 208
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 51/231 (22%), Positives = 84/231 (36%), Gaps = 53/231 (22%)
Query: 24 SFVYLAELGDGNFG-------------------AVKRVMEERGGSRKI-FLDEVSVLLRV 63
+ LG G FG AVK + + + + E+ VL +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 64 -SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFD-------------RMHTYYGQSLGVLS 109
+H N+V LLG C G L++ EY L + L
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 110 WSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169
+ LS + +A+ + +L S+ IHRD+ + NILL K+ DFGL + +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 170 NRPKRQ-------TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
K + + + + +SDV+S+G+ L EL +
Sbjct: 201 YVVKGNARLPVKWMAPES---------IFNCVYTFESDVWSYGIFLWELFS 242
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 45/221 (20%)
Query: 26 VYLAELGDGNFG----------------AVKRVMEERGGS-RKIFLDEVSVLLRV-SHPN 67
+ +G+GNFG A+KR+ E + F E+ VL ++ HPN
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSL-----------FDRMHTYYGQSLGVLSWSNRLSI 116
++ LLG C +G L +EY + +L D + LS L
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR----P 172
A D+AR ++YL + IHRD+ + NIL+ ++ AK+ADFGL + P
Sbjct: 148 AADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
R +I+ LN +T SDV+S+GVLL E+++
Sbjct: 205 VRWMAIES---------LNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 43/233 (18%), Positives = 84/233 (36%), Gaps = 69/233 (29%)
Query: 23 TSFVYLAELGDGNFG---------------------AVKRVMEERGGSRKIFLDEVSVLL 61
++ LG G F +K + + + F + S++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
++SH +LV G C+ E +L+ E++ SL TY ++ ++ +L +A +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSL----DTYLKKNKNCINILWKLEVAKQLA 123
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLI--------DDNHAKLADFGLCKLGPFNDPNRPK 173
A+ +L +IH ++ + NILLI + KL+D G+
Sbjct: 124 AAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT---------- 170
Query: 174 RQTSIKGSFGYVDTNY-------------LNTGFVSTKSDVYSFGVLLLELIT 213
+ + N ++ +D +SFG L E+ +
Sbjct: 171 ----------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
+G GA VY A G A K + + + ++ E+ +L HP +V LLG
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG-A 84
Query: 76 LEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP 134
+L +++E+ ++ M + L+ + + AL +LHS+
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIML----ELDRGLTEPQIQVVCRQMLEALNFLHSKR--- 137
Query: 135 IIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG--Y------VD 186
IIHRD+K+ N+L+ + +LADFG+ N KR + I G Y V
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFI----GTPYWMAPEVVM 190
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ K+D++S G+ L+E+
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-26
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 8 KMATNDFRI--RIGVGATSF--VYLA-ELGDGNFGAVKRVME----ERGGSRKIFLDEVS 58
+ A DF I +G G F VYLA E A+K V+ E+ G EV
Sbjct: 5 QWALEDFEIGRPLGKG--KFGNVYLAREKQSKFILALK-VLFKAQLEKAGVEHQLRREVE 61
Query: 59 VLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL 118
+ + HPN++ L G+ + L+LEY +++ + Q L +
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 116
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
++A AL Y HS+ +IHRDIK N+LL K+ADFG P + +R
Sbjct: 117 ELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLC 168
Query: 179 KGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
G+ Y+ + K D++S GVL E + G
Sbjct: 169 -GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 58/244 (23%), Positives = 95/244 (38%), Gaps = 78/244 (31%)
Query: 26 VYLAELGDGNFG-------------------AVKRVMEERGGS-RKIFLDEVSVLLRV-S 64
+ LG G FG AVK + E+ S R+ + E+ ++ ++ S
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFD------------------RMHTYYGQSLG 106
H N+V LLG C G L+ EY L + + + L
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 107 VLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166
VL++ + L A +A+ +E+L ++ +HRD+ + N+L+ K+ DFGL
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLA----- 219
Query: 167 NDPNRPKRQTSIKGSFGYVDTNY-----------------LNTGFVSTKSDVYSFGVLLL 209
R D+NY L G + KSDV+S+G+LL
Sbjct: 220 -------RDI-------MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
Query: 210 ELIT 213
E+ +
Sbjct: 266 EIFS 269
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 56/233 (24%)
Query: 26 VYLAELGDGNFG-------------------AVKRVMEERGGS-RKIFLDEVSVLLRVSH 65
Y+ ++G+G FG AVK + EE + F E +++ +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSL--FDRMH-----------------TYYGQSLG 106
PN+V LLG C LL EY+A L F R
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 107 VLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166
LS + +L IA +A + YL + +HRD+ + N L+ ++ K+ADFGL +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 167 NDPNRPKRQTS--IKG----SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
D + + I+ S Y +T+SDV+++GV+L E+ +
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIFS 271
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 51/226 (22%), Positives = 86/226 (38%), Gaps = 63/226 (27%)
Query: 23 TSFVYLAELGDGNFG-----------------AVKRVMEE-RGGSRKIFLDEVSVLLRVS 64
V LG+G FG AVK ++ +++ F+ E ++ +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
HP++V L+G E+ +++E L Y ++ L + +L I +A+
Sbjct: 72 HPHIVKLIGIIEEE-PTWIIMELYPYGEL----GHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
YL S +HRDI NIL+ KL DFGL + I+
Sbjct: 127 AYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY--------------IE----- 164
Query: 185 VDTNY-----------------LNTGFVSTKSDVYSFGVLLLELIT 213
D +Y +N +T SDV+ F V + E+++
Sbjct: 165 -DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
+IG G+ V+ + A+K + +EE + E++VL + P + G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG- 87
Query: 75 CLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
K +L +++EYL S D + G L + +I +I + L+YLHS+
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK-- 139
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS-----------IKGSF 182
IHRDIK++N+LL + KLADFG+ + KR T IK S
Sbjct: 140 -KIHRDIKAANVLLSEHGEVKLADFGVAGQ---LTDTQIKRNTFVGTPFWMAPEVIKQS- 194
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y +K+D++S G+ +EL G
Sbjct: 195 AY-----------DSKADIWSLGITAIELARG 215
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 17 RIGVGATSFVYLAELGDGNFG---AVKRVMEERGGSRKIFLD----EVSVLLRVSHPNLV 69
+G G S V+LA D AVK V+ F E ++HP +V
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 70 GLLGFCLEKGEQL----LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE 125
+ + +++EY+ +L D +HT G ++ + + D +AL
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALN 130
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT-SIKGSFGY 184
+ H IIHRD+K +NI++ N K+ DFG+ + D QT ++ G+ Y
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQY 185
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ V +SDVYS G +L E++TG
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 50/227 (22%), Positives = 93/227 (40%), Gaps = 60/227 (26%)
Query: 22 ATSFVYLAELGDGNFG-----------------AVKRV----MEERGGSRKIFLDEVSVL 60
AT+ +G G FG A+K + E+ R+ FL E S++
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK---QRRDFLGEASIM 100
Query: 61 LRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
+ HPN++ L G + +++ EY+ N SL ++ + + + + I
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL----DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS--- 177
A ++YL +HRD+ + NIL+ + K++DFGL ++ D T
Sbjct: 157 ASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGK 211
Query: 178 --IK---------GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
I+ F ++ SDV+S+G++L E+++
Sbjct: 212 IPIRWTSPEAIAYRKF-------------TSASDVWSYGIVLWEVMS 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 47/226 (20%), Positives = 84/226 (37%), Gaps = 63/226 (27%)
Query: 23 TSFVYLAELGDGNFG-----------------AVKRVMEERGGSRKI-FLDEVSVLLRVS 64
+G+G FG A+K S + FL E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
HP++V L+G E +++E L ++ L ++ + A ++ AL
Sbjct: 75 HPHIVKLIGVITEN-PVWIIMELCTLGEL----RSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
YL S+ +HRDI + N+L+ ++ KL DFGL + ++
Sbjct: 130 AYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--------------ME----- 167
Query: 185 VDTNY-----------------LNTGFVSTKSDVYSFGVLLLELIT 213
D+ Y +N ++ SDV+ FGV + E++
Sbjct: 168 -DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 47/206 (22%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 18 IGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCL 76
+G GA + + D AVKR++ E EV +L HPN++
Sbjct: 32 LGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEK 88
Query: 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPII 136
++ Q + +E L +L + + +++ L +LHS I+
Sbjct: 89 DRQFQYIAIE-LCAATLQEYVEQKDFA----HLGLEPITLLQQTTSGLAHLHSLN---IV 140
Query: 137 HRDIKSSNILLIDDNH-----AKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
HRD+K NIL+ N A ++DFGLCK + R++ + G+ G++ L+
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA-VGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 192 TGFV---STKSDVYSFGVLLLELITG 214
+ D++S G + +I+
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-25
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 26/216 (12%)
Query: 8 KMATNDFRI--RIGVGATSF--VYLA-ELGDGNFGAVKRVME----ERGGSRKIFLDEVS 58
K +DF I +G G F VYLA E + A+K V+ E+ G E+
Sbjct: 10 KFTIDDFDIGRPLGKG--KFGNVYLAREKQNKFIMALK-VLFKSQLEKEGVEHQLRREIE 66
Query: 59 VLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL 118
+ + HPN++ + + ++ L+LE+ L+ + Q G +
Sbjct: 67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-----QKHGRFDEQRSATFME 121
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
++A AL Y H + +IHRDIK N+L+ K+ADFG P +R+T
Sbjct: 122 ELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMC 173
Query: 179 KGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
G+ Y+ + K D++ GVL E + G
Sbjct: 174 -GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 8e-25
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 42/220 (19%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLG- 73
+G G VY + G A+K VM+ G + E+++L + S H N+ G
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 74 ----FCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL---DIARALE 125
+QL L++E+ S+ D + G +L IA +I R L
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL------KEEWIAYICREILRGLS 143
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS---- 181
+LH +IHRDIK N+LL ++ KL DFG+ D +R T I G+
Sbjct: 144 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ---LDRTVGRRNTFI-GTPYWM 196
Query: 182 -------FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
D Y KSD++S G+ +E+ G
Sbjct: 197 APEVIACDENPDATY------DFKSDLWSLGITAIEMAEG 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 46/208 (22%), Positives = 85/208 (40%), Gaps = 41/208 (19%)
Query: 30 ELGDGNFG-----------------AVKRVMEERGGSRKI-FLDEVSVLLRVSHPNLVGL 71
+G+G FG A+K S + FL E + + HP++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
+G E +++E L ++ L ++ + A ++ AL YL S+
Sbjct: 457 IGVITEN-PVWIIMELCTLGEL----RSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR------PKRQTSIKGSFGYV 185
+HRDI + N+L+ ++ KL DFGL + + + P + + +
Sbjct: 512 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES----- 563
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+N ++ SDV+ FGV + E++
Sbjct: 564 ----INFRRFTSASDVWMFGVCMWEILM 587
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-24
Identities = 50/230 (21%), Positives = 90/230 (39%), Gaps = 58/230 (25%)
Query: 26 VYLAELGDGNFG-------------------AVKRVMEERGGSRKI-FLDEVSVLLRVSH 65
++ ELG+ FG A+K + ++ G + F E + R+ H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSL--FDRMH---------TYYGQSLGVLSWSNRL 114
PN+V LLG + ++ Y ++ L F M L + +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 115 SIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174
+ IA +EYL S ++H+D+ + N+L+ D + K++D GL + D +
Sbjct: 132 HLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 175 QT----------SIK-GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ +I G F S SD++S+GV+L E+ +
Sbjct: 189 NSLLPIRWMAPEAIMYGKF-------------SIDSDIWSYGVVLWEVFS 225
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-24
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 40/212 (18%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
++G G+ VY A G A+K+V +E + + E+S++ + P++V G
Sbjct: 36 KLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP 134
+ + +++EY S+ D + L+ +I + LEYLH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHFMR--- 145
Query: 135 IIHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDPNRPKRQTS-----------IKGSF 182
IHRDIK+ NILL + HAKLADFG+ +L KR T I+
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQL----TDTMAKRNTVIGTPFWMAPEVIQEI- 200
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
GY + +D++S G+ +E+ G
Sbjct: 201 GY-----------NCVADIWSLGITAIEMAEG 221
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-24
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 40/211 (18%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGS---------------RKIFLDEVSVLLRVSHPNLV 69
F ++ELG GN G V +V + G R + E+ VL + P +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
G G GE + +E++ SL + +L +++ + + L YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 149
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
+ I+HRD+K SNIL+ KL DFG+ G D S+ SF V T
Sbjct: 150 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID--------SMANSF--VGTRS 195
Query: 190 ------LNTGFVSTKSDVYSFGVLLLELITG 214
L S +SD++S G+ L+E+ G
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-24
Identities = 47/237 (19%), Positives = 93/237 (39%), Gaps = 53/237 (22%)
Query: 12 NDFRI--RIGVGATSFVYLAELGDGNFGAVK---------RVMEERGGSRKIFLD----- 55
ND+RI + G + + L E D F A+K + + + KI +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 56 ---EVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSN 112
E+ ++ + + + G E ++ EY+ N S+ + + VL +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK-----FDEYFFVLDKNY 144
Query: 113 RLSIALDIAR--------ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164
I + + + + Y+H++ + I HRD+K SNIL+ + KL+DFG +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 165 PFNDPNRPKRQTSIKGSFGYVDTNYL-------NTGFVSTKSDVYSFGVLLLELITG 214
K + S +G+ ++ + + K D++S G+ L +
Sbjct: 203 VDK-----KIKGS-RGT-----YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-24
Identities = 46/214 (21%), Positives = 82/214 (38%), Gaps = 26/214 (12%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
+G GAT+ V+ G+ A+K + + E VL +++H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 75 CLEKGEQL--LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
E + L++E+ SL+ + + L S L + D+ + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 133 PPIIHRDIKSSNILLI----DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV--- 185
I+HR+IK NI+ + + KL DFG + ++ S+ G+ Y+
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-----FVSLYGTEEYLHPD 185
Query: 186 -----DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ D++S GV TG
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-24
Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 13 DFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
F +G GA S V+L + G A+K + + +E++VL ++ H N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
L+++ ++ LFDR+ GV + + + + A++YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRI-----LERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 132 DPPIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
I+HRD+K N+L + +++ + DFGL K+ ++ G+ GYV
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ------NGIMSTACGTPGYVAPE 177
Query: 189 YLNTGFVSTKSDVYSFGVLL 208
L S D +S GV+
Sbjct: 178 VLAQKPYSKAVDCWSIGVIT 197
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 5e-24
Identities = 44/214 (20%), Positives = 80/214 (37%), Gaps = 44/214 (20%)
Query: 17 RIGVGATSFVYLAE---LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGL 71
I G ++YLA + +G +K + G ++ + + E L V HP++V +
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLK-GLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 72 LGFCLEKGEQL-----LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
F +++EY+ +SL L + ++ L+I AL Y
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSY 197
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS-IKGSFGY- 184
LHS +++ D+K NI ++ + KL D G + G+ G+
Sbjct: 198 LHSI---GLVYNDLKPENI-MLTEEQLKLIDLGAV---------SRINSFGYLYGTPGFQ 244
Query: 185 ----VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
V + +D+Y+ G L L
Sbjct: 245 APEIV------RTGPTVATDIYTVGRTLAALTLD 272
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 7e-24
Identities = 28/241 (11%), Positives = 61/241 (25%), Gaps = 54/241 (22%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVK--------------RVMEERGGSRKI--------- 52
+G A + G V ++ EE R +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 53 -----FLDEVSVLLRVSHPNLVGLLG-FCLEKGEQLLLLEYLANKSLFDRMHTY--YGQS 104
F+ ++ ++ + L +L + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 105 LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164
L RL + L + R L LH ++H ++ +I+L L F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 165 PFNDPNRPKRQTSIKGSFGYV-----------DTNYLNTGFVSTKSDVYSFGVLLLELIT 213
R + S G+ + ++ D ++ G+++ +
Sbjct: 255 ------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 214 G 214
Sbjct: 309 A 309
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-24
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 33/212 (15%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGS---------------RKIFLDEVSVLLRVS-HPNL 68
+ ELG G +G V+++ G +K L ++ + +R P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
V G +G+ + +E + + SL D+ + + IA+ I +ALE+LH
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDPNRPKRQTSIKGSFGY--- 184
S+ +IHRD+K SN+L+ K+ DFG+ L + + G Y
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV-----DDVAKDIDA-GCKPYMAP 178
Query: 185 --VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
++ G+ S KSD++S G+ ++EL
Sbjct: 179 ERINPELNQKGY-SVKSDIWSLGITMIELAIL 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 8e-24
Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 15/201 (7%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
+G GA V+ E GN A K VM ++ E+ + + HP LV L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPII 136
+ E +++ E+++ LF+++ +S + + + L ++H +
Sbjct: 225 DDNEMVMIYEFMSGGELFEKV----ADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 277
Query: 137 HRDIKSSNILLI--DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGF 194
H D+K NI+ N KL DFGL DP + G+ +
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPK--QSVKVTTGTAEFAAPEVAEGKP 332
Query: 195 VSTKSDVYSFGVLLLELITGL 215
V +D++S GVL L++GL
Sbjct: 333 VGYYTDMWSVGVLSYILLSGL 353
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 33/204 (16%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KI-------------FLDEVSVLLRVSHPNLVGLLG 73
+LG G +G V ++ KI L+EV+VL + HPN++ L
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
F +K L++E LFD + + + I + + YLH
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEI-----IHRMKFNEVDAAVIIKQVLSGVTYLHKHN-- 156
Query: 134 PIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
I+HRD+K N+LL D K+ DFGL + K+ G+ Y+ L
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQ--KKMKERLGTAYYIAPEVL 210
Query: 191 NTGFVSTKSDVYSFGVLLLELITG 214
K DV+S GV+L L+ G
Sbjct: 211 R-KKYDEKCDVWSIGVILFILLAG 233
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-23
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGS---------------RKIFLDEVSVLLRVS 64
A L E+G G +G+V +++ + G +K L ++ V++R S
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78
Query: 65 -HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
P +V G +G+ + +E ++ S Y V+ I L +A
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDPNRPKRQTSIKGSF 182
L +L IIHRDIK SNILL + KL DFG+ +L +T G
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDAGCR 189
Query: 183 GY-----VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y +D + G+ +SDV+S G+ L EL TG
Sbjct: 190 PYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATG 225
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-23
Identities = 45/214 (21%), Positives = 79/214 (36%), Gaps = 41/214 (19%)
Query: 31 LGDGNFGAVKRVMEERGGSR---KIF------------LDEVSVLLRVSHPNLVGLLGF- 74
LG G V R ++ G K+F + E VL +++H N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 75 -CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
++L++E+ SL+ + + L S L + D+ + +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 134 PIIHRDIKSSNILLI----DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV---- 185
I+HR+IK NI+ + + KL DFG + ++ S+ G+ Y+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-----FVSLYGTEEYLHPDM 186
Query: 186 -----DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ D++S GV TG
Sbjct: 187 YERAVLRKDHQKKY-GATVDLWSIGVTFYHAATG 219
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-23
Identities = 48/205 (23%), Positives = 82/205 (40%), Gaps = 21/205 (10%)
Query: 17 RIGVGATSFVYLAELGDGNFG---AVKRVMEERGGS----RKIFLDEVSVLLRVSHPNLV 69
+G G VY AE D A+K +M E S R E R+ P++V
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
+ F G+ + + + L + G L+ ++I I AL+ H+
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHA 152
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
HRD+K NIL+ D+ A L DFG+ + + + G+ Y+
Sbjct: 153 AG---ATHRDVKPENILVSADDFAYLVDFGIASAT---TDEKLTQLGNTVGTLYYMAPER 206
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
+ + ++D+Y+ +L E +TG
Sbjct: 207 FSESHATYRADIYALTCVLYECLTG 231
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-23
Identities = 56/248 (22%), Positives = 88/248 (35%), Gaps = 60/248 (24%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVK-----RVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
IG G+ V +A E A+K ++ + + EV ++ ++ HPN+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRL----------------- 114
++ L++E L D+++ + S G +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 115 ------------------SIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHA--K 154
+I I AL YLH+Q I HRDIK N L + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 155 LADFGLCKLGPFNDPNRPKRQTSIKGSFGYV--------DTNYLNTGFVSTKSDVYSFGV 206
L DFGL K + T+ G+ +V + +Y K D +S GV
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY------GPKCDAWSAGV 264
Query: 207 LLLELITG 214
LL L+ G
Sbjct: 265 LLHLLLMG 272
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-23
Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 37/210 (17%)
Query: 30 ELGDGNFGAVKRVME--------------------ERGGSRKIFLDEVSVLLRVSHPNLV 69
ELG G F V++ + RG SR+ EV++L + HPN++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L K + +L+LE ++ LFD + L+ I + YLHS
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 130 QADPPIIHRDIKSSNILLI----DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
+ I H D+K NI+L+ + KL DFG+ + +I G+ +V
Sbjct: 127 KR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAG--NEFKNIFGTPEFV 178
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELITGL 215
+N + ++D++S GV+ L++G
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGA 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-23
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 37/210 (17%)
Query: 30 ELGDGNFGAVKRVME--------------------ERGGSRKIFLDEVSVLLRVSHPNLV 69
ELG G F VK+ E RG SR+ EVS+L +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L + + +L+LE ++ LFD + LS S I + YLH+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 130 QADPPIIHRDIKSSNILLI----DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
+ I H D+K NI+L+ H KL DFGL + +I G+ +V
Sbjct: 134 KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDG--VEFKNIFGTPEFV 185
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELITGL 215
+N + ++D++S GV+ L++G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGA 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-23
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 34/205 (16%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KI--------------FLDEVSVLLRVSHPNLVGLL 72
LG G+FG V ++ G K+ L EV +L ++ HPN++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
F +KG L+ E LFD + S S + I + + Y+H
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEI-----ISRKRFSEVDAARIIRQVLSGITYMHKNK- 146
Query: 133 PPIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
I+HRD+K N+LL D + ++ DFGL + + K+ G+ Y+
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEAS--KKMKDKIGTAYYIAPEV 199
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
L+ G K DV+S GV+L L++G
Sbjct: 200 LH-GTYDEKCDVWSTGVILYILLSG 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-23
Identities = 62/223 (27%), Positives = 87/223 (39%), Gaps = 47/223 (21%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGSR----KIF--------------LDEVSVLL 61
F + LG+G+F V E SR KI E V+
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 62 RVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
R+ HP V L F + E+L L Y N L Y + +G
Sbjct: 86 RLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFD--------ETC 131
Query: 121 AR--------ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
R ALEYLH + IIHRD+K NILL +D H ++ DFG K+ ++
Sbjct: 132 TRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS--PESKQ 186
Query: 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGL 215
R S G+ YV L SD+++ G ++ +L+ GL
Sbjct: 187 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 7e-23
Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 37/212 (17%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV---MEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
IG G+ VY A ++ + A+K++ ++ + + EV L ++ HPN +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
G L + L++EY S D + + L ++ + L YLHS
Sbjct: 121 GCYLREHTAWLVMEYCLG-SASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHN- 174
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDPNRPKRQTSIKGS---------F 182
+IHRD+K+ NILL + KL DFG + + + G+
Sbjct: 175 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMA--------PANSFV-GTPYWMAPEVIL 223
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ Y K DV+S G+ +EL
Sbjct: 224 AMDEGQY------DGKVDVWSLGITCIELAER 249
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-23
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 37/210 (17%)
Query: 30 ELGDGNFGAVKRVME--------------------ERGGSRKIFLDEVSVLLRVSHPNLV 69
ELG G F VK+ E RG R+ EVS+L +V HPN++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L + + +L+LE ++ LFD + LS S I + YLH+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 130 QADPPIIHRDIKSSNILLI----DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
+ I H D+K NI+L+ H KL DFGL + +I G+ +V
Sbjct: 134 KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDG--VEFKNIFGTPEFV 185
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELITGL 215
+N + ++D++S GV+ L++G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGA 215
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 7e-23
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 40/208 (19%)
Query: 30 ELGDGNFGAVKRVME--------------ERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
ELG G FG V R +E + +E+S++ ++ HP L+ L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 76 LEKGEQLLLLEYLANKSLFDRM----HTYYGQSLGVLSWSNRLSIAL--DIARALEYLHS 129
+K E +L+LE+L+ LFDR+ + S I L+++H
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKM----------SEAEVINYMRQACEGLKHMHE 167
Query: 130 QADPPIIHRDIKSSNILLI--DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
+ I+H DIK NI+ + K+ DFGL +P+ + + +
Sbjct: 168 HS---IVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPD--EIVKVTTATAEFAAP 219
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITGL 215
++ V +D+++ GVL L++GL
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGL 247
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-23
Identities = 45/207 (21%), Positives = 84/207 (40%), Gaps = 39/207 (18%)
Query: 30 ELGDGNFGAVKRVME-------------ERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
+LG G FG V R +E +G + + E+S+L H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS------IALDIARALEYLHSQ 130
E +++ E+++ +F+R + + + L+ + AL++LHS
Sbjct: 72 SMEELVMIFEFISGLDIFER----------INTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 131 ADPPIIHRDIKSSNILLIDDNHA--KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
I H DI+ NI+ + K+ +FG + P + + Y
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPG--DNFRLLFTAPEYYAPE 173
Query: 189 YLNTGFVSTKSDVYSFGVLLLELITGL 215
VST +D++S G L+ L++G+
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 41/219 (18%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRV-------------MEERGGSRKIFLDEVSVLLRV 63
+G GA V L E + A+K + + + +E+S+L +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
HPN++ L +K L+ E+ LF+++ + + +I I
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-----INRHKFDECDAANIMKQILSG 158
Query: 124 LEYLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
+ YLH I+HRDIK NILL + K+ DFGL F + + G
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKD--YKLRDRLG 210
Query: 181 SFGYV-----DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ Y+ Y + K DV+S GV++ L+ G
Sbjct: 211 TAYYIAPEVLKKKY------NEKCDVWSCGVIMYILLCG 243
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 40/208 (19%)
Query: 30 ELGDGNFGAVKRVMEERGG--------------SRKIFLDEVSVLLRVSHPNLVGLLGFC 75
LG G FG V + E G ++ +E+SV+ ++ H NL+ L
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 76 LEKGEQLLLLEYLANKSLFDRM----HTYYGQSLGVLSWSNRLSIAL--DIARALEYLHS 129
K + +L++EY+ LFDR+ + + +I I + ++H
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNL----------TELDTILFMKQICEGIRHMHQ 205
Query: 130 QADPPIIHRDIKSSNILLI--DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
I+H D+K NIL + D K+ DFGL + P ++ G+ ++
Sbjct: 206 MY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPR--EKLKVNFGTPEFLAP 257
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITGL 215
+N FVS +D++S GV+ L++GL
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGL 285
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 43/209 (20%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KI-------------FLDEVSVLLRVSHPNLVGLLG 73
LG G+FG V + + K+ L EV +L ++ HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+ ++ E LFD + S + I + + Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEI-----IKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 134 PIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV----- 185
I+HRD+K NILL D K+ DFGL N + G+ Y+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQN--TKMKDRIGTAYYIAPEVL 195
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y K DV+S GV+L L++G
Sbjct: 196 RGTY------DEKCDVWSAGVILYILLSG 218
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-22
Identities = 57/204 (27%), Positives = 81/204 (39%), Gaps = 48/204 (23%)
Query: 30 ELGDGNFGAVKRVMEERGG------------SRKIFLDEVSVLLRVSHPNLVGLLGFCLE 77
ELG G V R ++ +KI E+ VLLR+SHPN++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 78 KGEQLLLLEYLANKSLFDRM--HTYYGQSLGVLSWSNR--LSIALDIARALEYLHSQADP 133
E L+LE + LFDR+ YY S R I A+ YLH
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKGYY---------SERDAADAVKQILEAVAYLHENG-- 168
Query: 134 PIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV----- 185
I+HRD+K N+L D K+ADFGL K + ++ G+ GY
Sbjct: 169 -IVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQ--VLMKTVCGTPGYCAPEIL 222
Query: 186 -DTNYLNTGFVSTKSDVYSFGVLL 208
Y + D++S G++
Sbjct: 223 RGCAY------GPEVDMWSVGIIT 240
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-22
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 37/210 (17%)
Query: 30 ELGDGNFGAVKRVME--------------------ERGGSRKIFLDEVSVLLRVSHPNLV 69
ELG G F VK+ E RG SR+ EVS+L + HPN++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L K + +L+LE +A LFD + L+ I + YLHS
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 130 QADPPIIHRDIKSSNILLI----DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
I H D+K NI+L+ K+ DFGL D +I G+ +V
Sbjct: 133 LQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFG--NEFKNIFGTPEFV 184
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELITGL 215
+N + ++D++S GV+ L++G
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGA 214
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-22
Identities = 49/203 (24%), Positives = 74/203 (36%), Gaps = 43/203 (21%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KI-------------FLDEVSVLLRVSHPNLVGLLG 73
LG G+FG V + + K+ L EV +L ++ HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+ ++ E LFD + S + I + + Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEI-----IKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 134 PIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV----- 185
I+HRD+K NILL D K+ DFGL N + G+ Y+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQN--TKMKDRIGTAYYIAPEVL 195
Query: 186 DTNYLNTGFVSTKSDVYSFGVLL 208
Y K DV+S GV+L
Sbjct: 196 RGTY------DEKCDVWSAGVIL 212
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 2e-22
Identities = 53/209 (25%), Positives = 80/209 (38%), Gaps = 34/209 (16%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KIF------------LDEVSVLLRVSHPNLVGLL-- 72
LG G FG V R + + G + K E+ ++ +++HPN+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 73 ----GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
LL +EY L ++ + ++ L ++ DI+ AL YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 129 SQADPPIIHRDIKSSNILLIDDNHA---KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
IIHRD+K NI+L K+ D G K + T G+ Y+
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-----CTEFVGTLQYL 190
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
L + D +SFG L E ITG
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITG 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 93.6 bits (232), Expect = 4e-22
Identities = 25/235 (10%), Positives = 54/235 (22%), Gaps = 43/235 (18%)
Query: 17 RIGVGATSFVYLAE-LGDGNFGAVK--------------RVMEERGGSRKI--------- 52
+G A G V ++ EE R +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 53 -----FLDEVSVLLRVSHPNLVGLLG-FCLEKGEQLLLLEYLANKSLFDRMHTY--YGQS 104
F+ ++ ++ + L +L + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 105 LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164
L RL + L + R L LH ++H ++ +I+L L F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 165 PFNDPNRPKRQTSIKGSFGYV-----DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ ++ D ++ G+ + +
Sbjct: 260 RDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-22
Identities = 48/201 (23%), Positives = 80/201 (39%), Gaps = 41/201 (20%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KI-----------FLDEVSVLLRVSHPNLVGLLGFC 75
+G G++G VK +++ R K F E+ ++ + HPN++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
+ + L++E LF+R+ V S+ I D+ A+ Y H +
Sbjct: 76 EDNTDIYLVMELCTGGELFERV-----VHKRVFRESDAARIMKDVLSAVAYCHKLN---V 127
Query: 136 IHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV-----DT 187
HRD+K N L + D+ KL DFGL P K + G+ YV +
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPG--KMMRTKVGTPYYVSPQVLEG 182
Query: 188 NYLNTGFVSTKSDVYSFGVLL 208
Y + D +S GV++
Sbjct: 183 LY------GPECDEWSAGVMM 197
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 4e-22
Identities = 29/231 (12%), Positives = 57/231 (24%), Gaps = 43/231 (18%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSR---KIFLDEVSVLLRVSHPNLVGLL 72
+ VG S V+L ++ A+K SR + + R+ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 73 GFC-------------------------LEKGEQLLLLEYLANKSLFDRMHT--YYGQSL 105
LLL A+ L T +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 106 GVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165
G + + R L S+ ++H N+ ++ D L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 166 FNDPNRPKRQTSIKGSFGYV--DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
R + Y + +T + + + G+ + +
Sbjct: 243 ----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-22
Identities = 52/219 (23%), Positives = 77/219 (35%), Gaps = 25/219 (11%)
Query: 7 LKMATNDFRIR--------IGVGATSFVYLA-ELGDGNFGAVK-----RVMEERGGSRKI 52
L MA +D IG G S V G AVK + G S +
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 53 FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSN 112
E S+ + HP++V LL G ++ E++ L + + V S +
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI-VKRADAGFVYSEAV 131
Query: 113 RLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHA--KLADFGLCKLGPFNDP 169
I AL Y H IIHRD+K +LL +N A KL FG+ +
Sbjct: 132 ASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGES 186
Query: 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLL 208
G+ ++ + DV+ GV+L
Sbjct: 187 G--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-22
Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 38/208 (18%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KI------------FLDEVSVLLRVSHPNLVGLLGF 74
+LG G FG V V E G K E+ VL + HPN++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPP 134
+ +++E L +R+ + + LS + + AL Y HSQ
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARG-KALSEGYVAELMKQMMNALAYFHSQH--- 144
Query: 135 IIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV-----D 186
++H+D+K NIL + K+ DFGL + + + T+ G+ Y+
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSD--EHSTNAAGTALYMAPEVFK 199
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ + K D++S GV++ L+TG
Sbjct: 200 RDV------TFKCDIWSAGVVMYFLLTG 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-22
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 39/219 (17%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGS---------------RKIFLDEVSVLLR-V 63
L E+G G G V ++ + G K L ++ V+L+
Sbjct: 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH 81
Query: 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLG--VLSWSNRLSIALDIA 121
P +V G + + + +E + + +++ + +L + + I
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMG--TCAEKLKKRMQGPIPERILG-----KMTVAIV 134
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDPNRPKRQTSIKG 180
+AL YL + +IHRD+K SNILL + KL DFG+ +L + + S G
Sbjct: 135 KALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-----DDKAKDRSA-G 186
Query: 181 SFGY-----VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y +D ++DV+S G+ L+EL TG
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 9e-22
Identities = 46/182 (25%), Positives = 71/182 (39%), Gaps = 25/182 (13%)
Query: 49 SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVL 108
++ + S N VG L K + ++ ++L D M+ SL
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN--RRCSLEDR 161
Query: 109 SWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL----- 163
L I + IA A+E+LHS+ ++HRD+K SNI D+ K+ DFGL
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218
Query: 164 ---GPFNDPNRPKRQTSIKGSFGYV------DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
T G+ Y+ NY S K D++S G++L EL+
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY------SHKVDIFSLGLILFELLYS 272
Query: 215 LK 216
Sbjct: 273 FS 274
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 56/227 (24%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGS-------RKIFL---DEV-------SVLLR 62
V F YL LG G FG V V E+ G +K + DEV VL
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 63 VSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI----- 116
HP L L + + ++L ++EY LF H LS S
Sbjct: 205 SRHPFLTALK-YSFQTHDRLCFVMEYANGGELF--FH---------LSRERVFSEDRARF 252
Query: 117 -ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175
+I AL+YLHS+ + +++RD+K N++L D H K+ DFGLCK G +
Sbjct: 253 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----ATM 306
Query: 176 TSIKGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
+ G+ Y+ D +Y ++ D + GV++ E++ G
Sbjct: 307 KTFCGTPEYLAPEVLEDNDY-------GRAVDWWGLGVVMYEMMCGR 346
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-21
Identities = 49/208 (23%), Positives = 76/208 (36%), Gaps = 42/208 (20%)
Query: 31 LGDGNFGAVKRVMEERGGSR---KIFLD---------------EVSVLLRVSHPNLVGLL 72
LG G+F V R G K+ +D EV + ++ HP+++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKM-IDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS------IALDIARALEY 126
+ + L+LE N + + S I + Y
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK----------PFSENEARHFMHQIITGMLY 127
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
LHS I+HRD+ SN+LL + + K+ADFGL K T G+ Y+
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH---EKHYTLC-GTPNYIS 180
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELITG 214
+SDV+S G + L+ G
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-21
Identities = 54/208 (25%), Positives = 81/208 (38%), Gaps = 30/208 (14%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVK---------RVMEERGGSRKIFLDEVSVLLRVS-HP 66
+G G +S V AVK EE R+ L EV +L +VS HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
N++ L L+ + + LFD + LS I + +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKIMRALLEVICA 139
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV- 185
LH I+HRD+K NILL DD + KL DFG DP ++ + G+ Y+
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPG--EKLREVCGTPSYLA 191
Query: 186 -----DTNYLNTGFVSTKSDVYSFGVLL 208
+ N + D++S GV++
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-21
Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 61/229 (26%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF------------LDEV-------SVL 60
V F YL LG G FG V ++ + + + DEV VL
Sbjct: 2 VTMNDFDYLKLLGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 61 LRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI--- 116
HP L L + + ++L ++EY LF H LS +
Sbjct: 60 QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELF--FH---------LSRERVFTEERA 107
Query: 117 ---ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173
+I ALEYLHS+ +++RDIK N++L D H K+ DFGLCK G +
Sbjct: 108 RFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----A 160
Query: 174 RQTSIKGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
+ G+ Y+ D +Y ++ D + GV++ E++ G
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDY-------GRAVDWWGLGVVMYEMMCGR 202
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 5e-21
Identities = 47/224 (20%), Positives = 80/224 (35%), Gaps = 47/224 (20%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVL 60
+G F+ LG G FG V + + K++ + E +L
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFAC--QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 61 LRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTY-YGQSLGVLSWSNRLSIAL 118
+V +V L + E L L++ + + H Y + +
Sbjct: 240 AKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIR--YHIYNVDEDNPGFQEPRAIFYTA 296
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
I LE+LH + II+RD+K N+LL DD + +++D GL +
Sbjct: 297 QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGY 349
Query: 179 KGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
G+ G++ Y S D ++ GV L E+I
Sbjct: 350 AGTPGFMAPELLLGEEY-------DFSVDYFALGVTLYEMIAAR 386
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-21
Identities = 50/204 (24%), Positives = 81/204 (39%), Gaps = 21/204 (10%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFC 75
+G GA + V L AVK + ++ G R EV +L + H N++ L+ F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
E+ L+ E + S+ + + + D+A AL++LH++ I
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHI-----HKRRHFNELEASVVVQDVASALDFLHNKG---I 132
Query: 136 IHRDIKSSNILLIDDNHA---KLADFGLCKLGPFNDPNRPKRQTSIK---GSFGYV---- 185
HRD+K NIL N K+ DF L N P + GS Y+
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 186 -DTNYLNTGFVSTKSDVYSFGVLL 208
+ + D++S GV+L
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-20
Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 58/221 (26%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KIF-------------------LDEVSVLLRVSHPN 67
LG G G VK E + + +I E+ +L +++HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDR--MHTYYGQSLGVLSWSNRLSIALDIARALE 125
++ + F + + ++LE + LFD+ + ++ L + A++
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-------YFYQMLLAVQ 253
Query: 126 YLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
YLH IIHRD+K N+LL +D K+ DFG K+ + + + T G+
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMR--TLC-GTP 305
Query: 183 GYV---------DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ Y + D +S GV+L ++G
Sbjct: 306 TYLAPEVLVSVGTAGY------NRAVDCWSLGVILFICLSG 340
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 50/224 (22%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF------------LDEV-------SVL 60
+ T F +L LG G+FG V ER G+ +++ D+V VL
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLS--ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 395
Query: 61 LRV-SHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL 118
P L L C + ++L ++EY+ L H Q +G + + A
Sbjct: 396 ALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM--YHI---QQVGRFKEPHAVFYAA 449
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
+IA L +L S+ II+RD+K N++L + H K+ADFG+CK ++ +
Sbjct: 450 EIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKTF 502
Query: 179 KGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
G+ Y+ Y KS D ++FGVLL E++ G
Sbjct: 503 CGTPDYIAPEIIAYQPY-------GKSVDWWAFGVLLYEMLAGQ 539
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 52/225 (23%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVL 60
V +F LG G FG V + + K++ L+E +L
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCAC--QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 61 LRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI--A 117
+V+ +V L + E + L L+L + L ++ +G + ++ A
Sbjct: 239 EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLK-----FHIYHMGQAGFPEARAVFYA 292
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
+I LE LH + I++RD+K NILL D H +++D GL P +
Sbjct: 293 AEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-----G 344
Query: 178 IKGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
G+ GY+ + Y T S D ++ G LL E+I G
Sbjct: 345 RVGTVGYMAPEVVKNERY-------TFSPDWWALGCLLYEMIAGQ 382
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 2e-20
Identities = 49/198 (24%), Positives = 80/198 (40%), Gaps = 32/198 (16%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KI-------------FLDEVSVLLRVSHPNLVGLLG 73
ELG G F V+R + + G KI E + ++ HPN+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
E+ L+ + + LF+ + + S ++ I ++ Y HS
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDI-----VAREFYSEADASHCIQQILESIAYCHSNG-- 125
Query: 134 PIIHRDIKSSNILLID-DNHA--KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
I+HR++K N+LL A KLADFGL + + + G+ GY+ L
Sbjct: 126 -IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDS--EAWHGFAGTPGYLSPEVL 179
Query: 191 NTGFVSTKSDVYSFGVLL 208
S D+++ GV+L
Sbjct: 180 KKDPYSKPVDIWACGVIL 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 45/200 (22%), Positives = 82/200 (41%), Gaps = 39/200 (19%)
Query: 30 ELGDGNFGAVKRVMEERGG----------SRKIFLDEVSVLLRVS-HPNLVGLLGFCLEK 78
++G G++ KR + + S++ +E+ +LLR HPN++ L +
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDG 88
Query: 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHR 138
++ E + L D++ S ++ I + +EYLH+Q ++HR
Sbjct: 89 KYVYVVTELMKGGELLDKI-----LRQKFFSEREASAVLFTITKTVEYLHAQG---VVHR 140
Query: 139 DIKSSNILLIDDNHA----KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV------DTN 188
D+K SNIL +D++ ++ DFG K N + + +V
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGL--LMTPCYTANFVAPEVLERQG 196
Query: 189 YLNTGFVSTKSDVYSFGVLL 208
Y D++S GVLL
Sbjct: 197 Y------DAACDIWSLGVLL 210
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-20
Identities = 45/201 (22%), Positives = 79/201 (39%), Gaps = 29/201 (14%)
Query: 31 LGDGNFGAVKRVMEERGGSR---KI--------------FLDEVSVLLRVSHPNLVGLLG 73
LG G F + + KI E+S+ ++H ++VG G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
F + ++LE +SL + + L+ I +YLH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLHRNR-- 161
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG 193
+IHRD+K N+ L +D K+ DFGL + + +++ G+ Y+ L+
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATK---VEYDGERKKVLC-GTPNYIAPEVLSKK 216
Query: 194 FVSTKSDVYSFGVLLLELITG 214
S + DV+S G ++ L+ G
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVG 237
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-20
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVL 60
V F L +G G+FG V V ++ ++K++ E+ ++
Sbjct: 12 VNFDHFEILRAIGKGSFGKVCIV--QKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 61 LRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLS-WSNRLSIAL 118
+ HP LV L + + E + ++++ L L Y+ Q + +L I
Sbjct: 70 QGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLR-----YHLQQNVHFKEETVKLFIC- 122
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
++ AL+YL +Q IIHRD+K NILL + H + DF + + P + T++
Sbjct: 123 ELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-----QITTM 174
Query: 179 KGSFGY----VDTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
G+ Y + ++ G+ + + D +S GV EL+ G
Sbjct: 175 AGTKPYMAPEMFSSRKGAGY--SFAVDWWSLGVTAYELLRGR 214
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 4e-20
Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 59/245 (24%)
Query: 4 LEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERG-GSRKIF--------- 53
++E+ + + + F L LG G+FG V V + G +R+++
Sbjct: 5 IKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT 64
Query: 54 ---------LDEVSVLLRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQ 103
E +L+ V+HP +V L + + +L L+L++L LF
Sbjct: 65 LKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLF--TR----- 116
Query: 104 SLGVLSWSNRLSI------ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLAD 157
LS + ++A AL++LHS II+RD+K NILL ++ H KL D
Sbjct: 117 ----LSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTD 169
Query: 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLE 210
FGL K ++ K+ S G+ Y+ + T+S D +SFGVL+ E
Sbjct: 170 FGLSKESIDHE----KKAYSFCGTVEYMAPEVVNRRGH-------TQSADWWSFGVLMFE 218
Query: 211 LITGL 215
++TG
Sbjct: 219 MLTGT 223
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-20
Identities = 45/201 (22%), Positives = 79/201 (39%), Gaps = 29/201 (14%)
Query: 31 LGDGNFGAVKRVMEERGGSR---KI--------------FLDEVSVLLRVSHPNLVGLLG 73
LG G F + + KI E+S+ ++H ++VG G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
F + ++LE +SL + + L+ I +YLH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLHRNR-- 135
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG 193
+IHRD+K N+ L +D K+ DFGL + + +++ G+ Y+ L+
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATK---VEYDGERKKVLC-GTPNYIAPEVLSKK 190
Query: 194 FVSTKSDVYSFGVLLLELITG 214
S + DV+S G ++ L+ G
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVG 211
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-20
Identities = 46/198 (23%), Positives = 75/198 (37%), Gaps = 31/198 (15%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KIFL-------------DEVSVLLRVSHPNLVGLLG 73
ELG G F V+R ++ G I E + + HPN+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
E+G L+ + + LF+ + + S ++ I A+ + H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDI-----VAREYYSEADASHCIQQILEAVLHCHQMG-- 130
Query: 134 PIIHRDIKSSNILLID-DNHA--KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
++HR++K N+LL A KLADFGL + G+ GY+ L
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQ--QAWFGFAGTPGYLSPEVL 185
Query: 191 NTGFVSTKSDVYSFGVLL 208
D+++ GV+L
Sbjct: 186 RKDPYGKPVDLWACGVIL 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-20
Identities = 48/198 (24%), Positives = 79/198 (39%), Gaps = 32/198 (16%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KI-------------FLDEVSVLLRVSHPNLVGLLG 73
ELG G F V+R + + G KI E + ++ HPN+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
E+ L+ + + LF+ + + S ++ I ++ Y HS
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDI-----VAREFYSEADASHCIQQILESIAYCHSNG-- 148
Query: 134 PIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
I+HR++K N+LL KLADFGL + + + G+ GY+ L
Sbjct: 149 -IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDS--EAWHGFAGTPGYLSPEVL 202
Query: 191 NTGFVSTKSDVYSFGVLL 208
S D+++ GV+L
Sbjct: 203 KKDPYSKPVDIWACGVIL 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-20
Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 61/231 (26%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERG-GSRKIF-------------LDEV-------S 58
+ F L LG G +G V +V + G + KIF + +
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 59 VLLRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI- 116
+L V HP +V L+ + + G +L L+LEYL+ LF M L
Sbjct: 74 ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELF--MQ---------LEREGIFMED 121
Query: 117 -----ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171
+I+ AL +LH + II+RD+K NI+L H KL DFGLCK +
Sbjct: 122 TACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--- 175
Query: 172 PKRQTSIKGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
+ G+ Y+ + + ++ D +S G L+ +++TG
Sbjct: 176 -TVTHTFCGTIEYMAPEILMRSGH-------NRAVDWWSLGALMYDMLTGA 218
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 9e-20
Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV-MEERGGSRKIF----LDEVSVLLRVSHPNLVG 70
+G G + VY A + A+K++ + R ++ L E+ +L +SHPN++G
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 71 LLGFCLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
LL K L+ +++ + + VL+ S+ + L + LEYLH
Sbjct: 77 LLDAFGHKSNISLVFDFMETDLEVIIKDNS-------LVLTPSHIKAYMLMTLQGLEYLH 129
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
I+HRD+K +N+LL ++ KLADFGL K F PNR
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRA 168
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 42/208 (20%)
Query: 30 ELGDGNFGAVKRVME----------------------ERGGSRKIFLDEVSVLLRVS-HP 66
+G G V+R + + R+ E +L +V+ HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
+++ L+ L+ + + LFD + LS SI + A+ +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYL-----TEKVALSEKETRSIMRSLLEAVSF 215
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV- 185
LH+ I+HRD+K NILL D+ +L+DFG +P ++ + G+ GY+
Sbjct: 216 LHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPG--EKLRELCGTPGYLA 267
Query: 186 -----DTNYLNTGFVSTKSDVYSFGVLL 208
+ + D+++ GV+L
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 31/206 (15%)
Query: 30 ELGDGNFGAVKRVMEERGG----------------SRKIFLDEVSVLLRVSH-PNLVGLL 72
ELG G F V++ + + G R L E++VL P ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
E +L+LEY A +F + ++S ++ + + I + YLH
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNN- 151
Query: 133 PPIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
I+H D+K NILL K+ DFG+ + I G+ Y+
Sbjct: 152 --IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHA--CELREIMGTPEYLAPEI 204
Query: 190 LNTGFVSTKSDVYSFGVLLLELITGL 215
LN ++T +D+++ G++ L+T
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTHT 230
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 45/194 (23%), Positives = 80/194 (41%), Gaps = 27/194 (13%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KIFLD--------EVSVLLRVS-HPNLVGLLGFCLE 77
LG+G+F ++ + ++ KI E++ L HPN+V L +
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD 77
Query: 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIH 137
+ L++E L LF+R+ + S + I + A+ ++H ++H
Sbjct: 78 QLHTFLVMELLNGGELFERI-----KKKKHFSETEASYIMRKLVSAVSHMHDVG---VVH 129
Query: 138 RDIKSSNILLIDDNHA---KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGF 194
RD+K N+L D+N K+ DFG + P+ +T + Y LN
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFAR---LKPPDNQPLKTPC-FTLHYAAPELLNQNG 185
Query: 195 VSTKSDVYSFGVLL 208
D++S GV+L
Sbjct: 186 YDESCDLWSLGVIL 199
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 16/160 (10%)
Query: 17 RIGVGATSFVYLAELGD-GNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
++G G + VY + N A+K + +E G+ + EVS+L + H N+V L
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 75 CLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
+ L+ EYL K D +++ N + R L Y H Q
Sbjct: 69 IHTEKSLTLVFEYLDKDLKQYLDDCG-------NIINMHNVKLFLFQLLRGLAYCHRQK- 120
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
++HRD+K N+L+ + KLADFGL + + P +
Sbjct: 121 --VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKT 156
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-19
Identities = 46/215 (21%), Positives = 79/215 (36%), Gaps = 58/215 (26%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KIF-------------------LDEVSVLLRVSHPN 67
LG G G VK E + + KI E+ +L +++HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDR--MHTYYGQSLGVLSWSNRLSIALDIARALE 125
++ + F + + ++LE + LFD+ + ++ + A++
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK-------LYFYQMLLAVQ 128
Query: 126 YLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
YLH IIHRD+K N+LL +D K+ DFG K ++ G+
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGET--SLMRTLCGTP 180
Query: 183 GYV---------DTNYLNTGFVSTKSDVYSFGVLL 208
Y+ Y + D +S GV+L
Sbjct: 181 TYLAPEVLVSVGTAGY------NRAVDCWSLGVIL 209
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-19
Identities = 26/204 (12%), Positives = 50/204 (24%), Gaps = 49/204 (24%)
Query: 17 RIGVGATSFVYLAELGDGNFG---AVKRVMEERGGSRKI---FLDEVSVLLRVSHPNLVG 70
G + A D A+ V + + L L R+ P +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
+L + L++ E++ SL + S + +A A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVAD-------TSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
+ S + + D LA +
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPAT--MPD------------------------- 178
Query: 191 NTGFVSTKSDVYSFGVLLLELITG 214
+ + D+ G L L+
Sbjct: 179 ----ANPQDDIRGIGASLYALLVN 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-19
Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 19/170 (11%)
Query: 15 RIRIGVGATSFVYLA---ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
++G G VY A + D A+K++ G E+++L + HPN++ L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISL 83
Query: 72 LGFCLEKGEQLLLL--EYLAN--KSLFDRMHTYYGQSLGV-LSWSNRLSIALDIARALEY 126
L ++ + L +Y + + V L S+ I + Y
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHA----KLADFGLCKLGPFNDPNRP 172
LH+ ++HRD+K +NIL++ + K+AD G +L FN P +P
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSPLKP 188
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-19
Identities = 39/160 (24%), Positives = 68/160 (42%), Gaps = 11/160 (6%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
++G G + VY G + A+K V ++ G+ + E+S++ + H N+V L
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 75 CLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
+ + L+ E++ N K D G + L + + + L + H
Sbjct: 72 IHTENKLTLVFEFMDNDLKKYMDSRTV--GNTPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
I+HRD+K N+L+ KL DFGL + F P
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARA--FGIPVNT 164
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-19
Identities = 51/200 (25%), Positives = 75/200 (37%), Gaps = 39/200 (19%)
Query: 31 LGDGNFGAVKRVMEERGGSR---KIFLD------EVSVLLRVS-HPNLVGLLGFCLEKGE 80
LG G G V R G + K+ D EV + S P++V +L
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHH 96
Query: 81 Q----LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNR--LSIALDIARALEYLHSQADPP 134
L+++E + LF R+ Q G +++ R I DI A+++LHS
Sbjct: 97 GKRCLLIIMECMEGGELFSRI-----QERGDQAFTEREAAEIMRDIGTAIQFLHSHN--- 148
Query: 135 IIHRDIKSSNILLIDDNHA---KLADFGLCKL---GPFNDPNRPKRQTSIKGSFGYVDTN 188
I HRD+K N+L KL DFG K P + YV
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP---------CYTPYYVAPE 199
Query: 189 YLNTGFVSTKSDVYSFGVLL 208
L D++S GV++
Sbjct: 200 VLGPEKYDKSCDMWSLGVIM 219
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-19
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 50/224 (22%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVL 60
+ T F +L LG G+FG V ER G+ +++ + E VL
Sbjct: 17 MKLTDFNFLMVLGKGSFGKVMLS--ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 74
Query: 61 LRV-SHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL 118
P L L C + ++L ++EY+ L H Q +G + + A
Sbjct: 75 ALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM--YHI---QQVGRFKEPHAVFYAA 128
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
+IA L +L S+ II+RD+K N++L + H K+ADFG+CK ++ +
Sbjct: 129 EIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKTF 181
Query: 179 KGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
G+ Y+ Y KS D ++FGVLL E++ G
Sbjct: 182 CGTPDYIAPEIIAYQPY-------GKSVDWWAFGVLLYEMLAGQ 218
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 6e-19
Identities = 50/220 (22%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVL 60
+ F +G G FG V + + K++ L+E +L
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 61 LRVS---HPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI 116
VS P +V + + ++L +L+ + L Y+ GV S ++
Sbjct: 244 SLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLH-----YHLSQHGVFSEADMRFY 297
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT 176
A +I LE++H++ +++RD+K +NILL + H +++D GL K+
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS------KKKPH 348
Query: 177 SIKGSFGYVDTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
+ G+ GY+ L G S D +S G +L +L+ G
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 8e-19
Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 16/161 (9%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV-ME-ERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
+IG G VY A G A+K++ ++ E G + E+S+L ++HPN+V LL
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 74 FCLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
+ + L+ E+L K D +L + S + + L + HS
Sbjct: 70 VIHTENKLYLVFEFLHQDLKKFMDAS------ALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
++HRD+K N+L+ + KLADFGL + F P R
Sbjct: 124 ---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRT 159
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 19 GVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF------------LDEV-------SV 59
+G +F ++ LG G+FG V ++ + ++ D+V +
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKV--MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRI 76
Query: 60 LLRV-SHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIA 117
L +HP L L C + ++L ++E++ L H Q + A
Sbjct: 77 LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLM--FHI---QKSRRFDEARARFYA 130
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
+I AL +LH + II+RD+K N+LL + H KLADFG+CK G N +
Sbjct: 131 AEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG----VTTAT 183
Query: 178 IKGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
G+ Y+ + Y + D ++ GVLL E++ G
Sbjct: 184 FCGTPDYIAPEILQEMLY-------GPAVDWWAMGVLLYEMLCGH 221
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 32/198 (16%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KIFLD------EVSVLLRVS-HPNLVGLLGFC---- 75
LG G G V ++ +R + K+ D EV + R S P++V ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY 128
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNR--LSIALDIARALEYLHSQADP 133
+ L+++E L LF R+ Q G +++ R I I A++YLHS
Sbjct: 129 AGRKCLLIVMECLDGGELFSRI-----QDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 181
Query: 134 PIIHRDIKSSNILLIDDNHA---KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL 190
I HRD+K N+L KL DFG K + T+ + YV L
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH--NSLTTPCYTPYYVAPEVL 235
Query: 191 NTGFVSTKSDVYSFGVLL 208
D++S GV++
Sbjct: 236 GPEKYDKSCDMWSLGVIM 253
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-18
Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 16/160 (10%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRV-ME-ERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
++G G VY A+ G A+KR+ ++ E G + E+S+L + HPN+V L+
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 75 CLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
+ L+ E++ K + D L S + R + + H
Sbjct: 88 IHSERCLTLVFEFMEKDLKKVLDENK-------TGLQDSQIKIYLYQLLRGVAHCHQHR- 139
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
I+HRD+K N+L+ D KLADFGL + F P R
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARA--FGIPVRS 175
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 50/242 (20%), Positives = 87/242 (35%), Gaps = 59/242 (24%)
Query: 4 LEELKMATNDFRIR--IGVGATSFVYLAEL-GDGNFGAV----KRVMEERGGSRKIFLDE 56
++++++ DF I IG GA V + +L A+ K M +R F +E
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA-ETACFREE 124
Query: 57 VSVLLRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS 115
VL+ + L + + L L+++Y L + + +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR------------ 171
Query: 116 IALDIAR--------ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
+ ++AR A++ +H +HRDIK NIL+ + H +LADFG C +
Sbjct: 172 LPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228
Query: 168 DPNRPKR-------------QTSIKGSFGYVDTNYLNTGFVSTKS-DVYSFGVLLLELIT 213
+ Q G Y D +S GV + E++
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRY------------GPECDWWSLGVCMYEMLY 276
Query: 214 GL 215
G
Sbjct: 277 GE 278
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-18
Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 17/161 (10%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV-ME-ERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
+IG G V+ A A+KRV ++ + G L E+ +L + H N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 74 FCLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
+ L+ E+ K FD + G L S + + L + HS+
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
++HRD+K N+L+ + KLA+FGL + F P R
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARA--FGIPVRC 157
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-18
Identities = 45/161 (27%), Positives = 68/161 (42%), Gaps = 17/161 (10%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVM--EERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
+IG G+ V+ G A+K+ + E+ +KI L E+ +L ++ HPNLV LL
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 74 FCLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
K L+ EY + DR + SI +A+ + H
Sbjct: 70 VFRRKRRLHLVFEYCDHTVLHELDRYQ-------RGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
IHRD+K NIL+ + KL DFG +L P+
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARL--LTGPSDY 158
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-18
Identities = 63/224 (28%), Positives = 90/224 (40%), Gaps = 50/224 (22%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF------------LDEV-------SVL 60
+ F+ LG G+FG V + E + + F D+V VL
Sbjct: 14 LKIEDFILHKMLGKGSFGKV--FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 61 LRV-SHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL 118
HP L + + E L ++EYL L H QS S A
Sbjct: 72 SLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLM--YHI---QSCHKFDLSRATFYAA 125
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
+I L++LHS+ I++RD+K NILL D H K+ADFG+CK D + +
Sbjct: 126 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----AKTNTF 178
Query: 179 KGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
G+ Y+ Y S D +SFGVLL E++ G
Sbjct: 179 CGTPDYIAPEILLGQKY-------NHSVDWWSFGVLLYEMLIGQ 215
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 52/226 (23%)
Query: 19 GVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSV 59
+G F L +G G++ V V + +I+ E V
Sbjct: 48 SLGLQDFDLLRVIGRGSYAKVLLV--RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV 105
Query: 60 LLRV-SHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSN-RLSI 116
+ +HP LVGL C + +L ++EY+ L ++ Q L + R
Sbjct: 106 FEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLM-----FHMQRQRKLPEEHARFYS 159
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT 176
A +I+ AL YLH + II+RD+K N+LL + H KL D+G+CK G +
Sbjct: 160 A-EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----DTTS 211
Query: 177 SIKGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
+ G+ Y+ +Y S D ++ GVL+ E++ G
Sbjct: 212 TFCGTPNYIAPEILRGEDY-------GFSVDWWALGVLMFEMMAGR 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-18
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 52/226 (23%)
Query: 19 GVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSV 59
+G F L +G G++ V ++ + +I+ E V
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKV--LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 60 LLRV-SHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSN-RLSI 116
+ +HP LVGL C + +L ++EY+ L ++ Q L + R
Sbjct: 63 FEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLM-----FHMQRQRKLPEEHARFYS 116
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT 176
A +I+ AL YLH + II+RD+K N+LL + H KL D+G+CK G +
Sbjct: 117 A-EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----DTTS 168
Query: 177 SIKGSFGYV------DTNYLNTGFVSTKS-DVYSFGVLLLELITGL 215
+ G+ Y+ +Y S D ++ GVL+ E++ G
Sbjct: 169 TFCGTPNYIAPEILRGEDY-------GFSVDWWALGVLMFEMMAGR 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-18
Identities = 44/172 (25%), Positives = 72/172 (41%), Gaps = 25/172 (14%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV-ME-ERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
+IG G V+ A G A+K+V ME E+ G L E+ +L + H N+V L+
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 74 FCLEKGEQL--------LLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARA 123
C K L+ ++ + L + + S + +
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-------KFTLSEIKRVMQMLLNG 136
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQ 175
L Y+H I+HRD+K++N+L+ D KLADFGL + F+ +
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR--AFSLAKNSQPN 183
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 50/219 (22%)
Query: 18 IGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE 77
IG G+ V+ A+L + + A+K+V++++ K E+ ++ V HPN+V L F
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDK--RFK--NRELQIMRIVKHPNVVDLKAFFYS 103
Query: 78 KGEQL------LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALD--------IARA 123
G++ L+LEY+ ++++ Y + ++ + + R+
Sbjct: 104 NGDKKDEVFLNLVLEYV-PETVYRASRHY---------AKLKQTMPMLLIKLYMYQLLRS 153
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHA-KLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
L Y+HS I HRDIK N+LL + KL DFG K+ +PN S
Sbjct: 154 LAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-----VS----- 200
Query: 183 GYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
Y+ + Y +T D++S G ++ EL+ G
Sbjct: 201 -YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 67/235 (28%), Positives = 96/235 (40%), Gaps = 65/235 (27%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERG-GSRKIF--------------------LDEVS 58
VG +F L LG G +G V V + G + K++ E
Sbjct: 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 59 VLLRVSH-PNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI 116
VL + P LV L + + +L L+L+Y+ LF H LS R +
Sbjct: 111 VLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELF--TH---------LSQRERFTE 158
Query: 117 ------ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170
+I ALE+LH II+RDIK NILL + H L DFGL K ++
Sbjct: 159 HEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 171 RPKRQTSIKGSF-GYVDTNYL--------NTGFVSTKS-DVYSFGVLLLELITGL 215
R F G ++ Y+ ++G K+ D +S GVL+ EL+TG
Sbjct: 216 R----AY---DFCGTIE--YMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 5e-18
Identities = 56/274 (20%), Positives = 94/274 (34%), Gaps = 89/274 (32%)
Query: 17 RIGVGATSFVYLAEL------GDGNFGAVKRVMEERGGS-RKIFLDEVSVLLRV-SHPNL 68
+G GA V A+ AVK + E S + + E+ +L+ + H N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 69 VGLLGFCLEKGEQLL----------LLEYLANK--------------------------- 91
V LLG C + G L+ L YL +K
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 92 -------------------------SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
S + L+ + + + +A+ +E+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR-------PKRQTSIK 179
L S+ IHRD+ + NILL + N K+ DFGL + + P + + +
Sbjct: 209 LASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ + +SDV+SFGVLL E+ +
Sbjct: 266 T---------IFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.2 bits (199), Expect = 6e-18
Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRV-ME-ERGGSRKIFLDEVSVLLRVSHPNLVGLLGF 74
+IG G VY A+ G A+K++ +E E G + E+S+L + H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 75 CLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
K +L+ E+L K L D G L S L + + Y H +
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
++HRD+K N+L+ + K+ADFGL + F P R
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARA--FGIPVRK 156
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 7e-18
Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 56/224 (25%)
Query: 23 TSFVYLAELGDGNFGAVKRVMEERGGSR----KIFLD------EVSVLLRVSHPNLVGLL 72
S+ +G+G+FG V + G K+ D E+ ++ ++ H N+V L
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 73 GFCLEKGEQL------LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALD------- 119
F GE+ L+L+Y+ ++++ Y + ++ +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHY---------SRAKQTLPVIYVKLYMY 163
Query: 120 -IARALEYLHSQADPPIIHRDIKSSNILLIDDNHA-KLADFGLCKLGPFNDPNRPKRQTS 177
+ R+L Y+HS I HRDIK N+LL D KL DFG K +PN S
Sbjct: 164 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-----VS 215
Query: 178 IKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
Y+ + Y ++ DV+S G +L EL+ G
Sbjct: 216 ------YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-18
Identities = 58/244 (23%), Positives = 90/244 (36%), Gaps = 61/244 (25%)
Query: 4 LEELKMATNDFRIR--IGVGATSFVYLAEL-GDGNFGAVK----RVMEERGGSRKIFLDE 56
L+E+++ +DF I IG GA S V + ++ G A+K M +RG F +E
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEV-SCFREE 111
Query: 57 VSVLLRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS 115
VL+ + L F + L L++EY L + + R+
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKF----------GERIP 160
Query: 116 IALDIAR--------ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
++AR A++ +H +HRDIK NILL H +LADFG C +
Sbjct: 161 --AEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215
Query: 168 DPNR------------P---KRQTSIKGSFGYVDTNYLNTGFVSTKS-DVYSFGVLLLEL 211
R P + G+ Y D ++ GV E+
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY------------GPECDWWALGVFAYEM 263
Query: 212 ITGL 215
G
Sbjct: 264 FYGQ 267
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 40/161 (24%), Positives = 64/161 (39%), Gaps = 17/161 (10%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVM--EERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
+G G+ V G A+K+ + ++ +KI + E+ +L ++ H NLV LL
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 74 FCLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
C +K L+ E++ + + L + I + + HS
Sbjct: 92 VCKKKKRWYLVFEFVDHTILDDLELFP-------NGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
IIHRDIK NIL+ KL DFG + P
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEV 180
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 55/239 (23%), Positives = 92/239 (38%), Gaps = 65/239 (27%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVK-----RVMEERGGSRKIFLD---------------- 55
IG G+ V LA D + A+K +++ + G R+
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 56 -----EVSVLLRVSHPNLVGLLGFCLE------KGEQLLLLEYLANKSLFDRMHTYYGQS 104
E+++L ++ HPN+V L+ E + ++ E + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPT------ 130
Query: 105 LGVLSWSNRLSIAL------DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158
LS D+ + +EYLH Q IIHRDIK SN+L+ +D H K+ADF
Sbjct: 131 ------LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADF 181
Query: 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVD---TNYLNTGFVSTKSDVYSFGVLLLELITG 214
G+ F + T G+ ++ + F DV++ GV L + G
Sbjct: 182 GVSNE--FKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 63/231 (27%), Positives = 91/231 (39%), Gaps = 64/231 (27%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF------------LDEV-------SVL 60
+ F +L +G G+FG V + E +VL
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLA--RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL 92
Query: 61 LR-VSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI-- 116
L+ V HP LVGL F + ++L +L+Y+ LF H L
Sbjct: 93 LKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELF--YH---------LQRERCFLEPR 140
Query: 117 ----ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
A +IA AL YLHS I++RD+K NILL H L DFGLCK ++
Sbjct: 141 ARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---- 193
Query: 173 KRQTSIKGSF-GYVDTNYL------NTGFVSTKS-DVYSFGVLLLELITGL 215
TS +F G + YL + ++ D + G +L E++ GL
Sbjct: 194 -STTS---TFCGTPE--YLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGL 236
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 36/215 (16%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEER-------GGSRKIFLDEVSVLLRVS----H 65
+G G V+ L D A+K + R S L EV++L +V H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGH 97
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLAN-KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
P ++ LL + + +L+LE + LFD Y G L + A+
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFD-----YITEKGPLGEGPSRCFFGQVVAAI 152
Query: 125 EYLHSQADPPIIHRDIKSSNILL-IDDNHAKLADFGLCKL---GPFNDPNRPKRQTSIKG 180
++ HS+ ++HRDIK NIL+ + AKL DFG L P+ D + G
Sbjct: 153 QHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---------G 200
Query: 181 SFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITG 214
+ Y +++ + + + V+S G+LL +++ G
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-17
Identities = 52/209 (24%), Positives = 79/209 (37%), Gaps = 26/209 (12%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVK---------RVMEERGGSRKIFLDEVSVLLRVSHPN 67
+G GA FV+ A VK E K+ L E+++L RV H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90
Query: 68 LVGLLGFCLEKGEQLLLLEYLAN-KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
++ +L +G L++E + LF + L I + A+ Y
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFA-----FIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
L + IIHRDIK NI++ +D KL DFG T G+ Y
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL----ERGKLFYTFC-GTIEYCA 197
Query: 187 TNYLN-TGFVSTKSDVYSFGVLLLELITG 214
L + + +++S GV L L+
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 27/150 (18%)
Query: 30 ELGDGNFGAVKRVMEERGGSR---KIFLD------EVSVLLRVS-HPNLVGLLGFC---- 75
LG G G V ++ +R + K+ D EV + R S P++V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY 84
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNR--LSIALDIARALEYLHSQADP 133
+ L+++E L LF R+ Q G +++ R I I A++YLHS
Sbjct: 85 AGRKCLLIVMECLDGGELFSRI-----QDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 137
Query: 134 PIIHRDIKSSNILLID-DNHA--KLADFGL 160
I HRD+K N+L +A KL DFG
Sbjct: 138 -IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 49/228 (21%), Positives = 80/228 (35%), Gaps = 62/228 (27%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVK-----RVMEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
+G G+ V AVK ++ G + E+ +L R+ H N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQL 71
Query: 72 -----------LGFCLE--KGEQLLLLEYLANKSLFDRM-HTYYGQSLGVLSWSNRLSIA 117
+ +E +L+ + K H Y+ Q
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ-------------- 117
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
+ LEYLHSQ I+H+DIK N+LL K++ G+ + + +TS
Sbjct: 118 --LIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD-TCRTS 171
Query: 178 -----------IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
G + +GF K D++S GV L + TG
Sbjct: 172 QGSPAFQPPEIANGLDTF-------SGF---KVDIWSAGVTLYNITTG 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 25/167 (14%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV-ME-ERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
++G G VY A + A+KR+ +E E G + EVS+L + H N++ L
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 74 FCLEKGEQLLLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
L+ EY N K D+ +S S + + + HS+
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKN--------PDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 132 DPPIIHRDIKSSNILLIDDNHA------KLADFGLCKLGPFNDPNRP 172
+HRD+K N LL+ + A K+ DFGL + F P R
Sbjct: 153 ---CLHRDLKPQN-LLLSVSDASETPVLKIGDFGLARA--FGIPIRQ 193
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-17
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 34/213 (15%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEER-------GGSRKIFLDEVSVLLRVSH--PN 67
+G G VY + D A+K V ++R ++ + EV +L +VS
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSG 109
Query: 68 LVGLLGFCLEKGEQLLLLEYLANK-SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
++ LL + +L+LE LFD + G L S + A+ +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFD-----FITERGALQEELARSFFWQVLEAVRH 164
Query: 127 LHSQADPPIIHRDIKSSNILL-IDDNHAKLADFGLCKL---GPFNDPNRPKRQTSIKGSF 182
H+ ++HRDIK NIL+ ++ KL DFG L + D + G+
Sbjct: 165 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---------GTR 212
Query: 183 GYVDTNYLN-TGFVSTKSDVYSFGVLLLELITG 214
Y ++ + + V+S G+LL +++ G
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-17
Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 44/209 (21%)
Query: 31 LGDGNFGAVKRVMEERGGSR---KIFLD-------------EVSVLLRVSHPNLVGLLGF 74
LG+G +G V+ + KI +D E+ + ++H N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR--------ALEY 126
E Q L LEY + LFDR + + A+ + Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDR-----------IEPDIGMPE--PDAQRFFHQLMAGVVY 120
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
LH I HRDIK N+LL + ++ K++DFGL + F NR + + G+ YV
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV--FRYNNRERLLNKMCGTLPYVA 175
Query: 187 TNYL-NTGFVSTKSDVYSFGVLLLELITG 214
L F + DV+S G++L ++ G
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-17
Identities = 61/231 (26%), Positives = 91/231 (39%), Gaps = 68/231 (29%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVM--EERGGSR----KIF--------------LDEVSV 59
F L LG G+FG RV R R K+ DE +
Sbjct: 3 YSLQDFQILRTLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM 59
Query: 60 LLRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI-- 116
L V+HP ++ + + +Q+ ++++Y+ LF L S R
Sbjct: 60 LSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELF--SL---------LRKSQRFPNPV 107
Query: 117 ----ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
A ++ ALEYLHS+ II+RD+K NILL + H K+ DFG K
Sbjct: 108 AKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK--------YV 156
Query: 173 KRQTSIKGSF-GYVDTNYL------NTGFVSTKS-DVYSFGVLLLELITGL 215
T + G D Y+ + KS D +SFG+L+ E++ G
Sbjct: 157 PDVTY---TLCGTPD--YIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGY 200
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-17
Identities = 54/207 (26%), Positives = 84/207 (40%), Gaps = 42/207 (20%)
Query: 31 LGDGNFGAVKRVMEERGGSR---KIFLD--------------EVSVLLRVSHPNLVGLLG 73
+G GNF VK G KI +D EV ++ ++HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKI-IDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADP 133
+ L++EY + +FD Y + G + S I A++Y H +
Sbjct: 82 VIETEKTLYLIMEYASGGEVFD-----YLVAHGRMKEKEARSKFRQIVSAVQYCHQKR-- 134
Query: 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY---- 189
I+HRD+K+ N+LL D + K+ADFG N + G Y
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFS--------NEFTVGGKLDAFCG--APPYAAPE 183
Query: 190 --LNTGFVSTKSDVYSFGVLLLELITG 214
+ + DV+S GV+L L++G
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 8e-17
Identities = 59/238 (24%), Positives = 90/238 (37%), Gaps = 54/238 (22%)
Query: 4 LEELKMATNDFRIR--IGVGATSFVYLA-ELGDGNFGAVK----RVMEERGGSRKIFLDE 56
+ +L+M D+ + IG GA V L A+K M +R S F +E
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS-AFFWEE 119
Query: 57 VSVLLRVSHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS 115
++ + P +V L + + L +++EY+ L + M Y +
Sbjct: 120 RDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNY------------DVP 166
Query: 116 IALDIAR--------ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
AR AL+ +HS IHRD+K N+LL H KLADFG C
Sbjct: 167 E--KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221
Query: 168 DPNRPKRQTSIKGSFGYVDT-NYL------NTGFVS--TKS-DVYSFGVLLLELITGL 215
R V T +Y+ + G + D +S GV L E++ G
Sbjct: 222 GMVR---------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-17
Identities = 53/214 (24%), Positives = 84/214 (39%), Gaps = 54/214 (25%)
Query: 31 LGDGNFGAVKRVMEERGGSR---KIFLD-------------EVSVLLRVSHPNLVGLLGF 74
LG+G +G V+ + KI +D E+ + ++H N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 75 CLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR--------ALEY 126
E Q L LEY + LFDR + + A+ + Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDR-----------IEPDIGMPE--PDAQRFFHQLMAGVVY 120
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
LH I HRDIK N+LL + ++ K++DFGL + F NR + + G+
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV--FRYNNRERLLNKMCGT----- 170
Query: 187 TNY------LNTGFVSTKSDVYSFGVLLLELITG 214
Y F + DV+S G++L ++ G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 51/222 (22%), Positives = 86/222 (38%), Gaps = 50/222 (22%)
Query: 20 VGATSFVYLAELGDGNFGAVKRVMEERGGSRKIF-------------------LDEVSVL 60
F + LG G+FG V V + S + L+E +L
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLV--KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 61 LRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
V+ P LV L + +++EY+A +F + + +G S + A I
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-----SHLRRIGRFSEPHARFYAAQI 150
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
EYLHS +I+RD+K N+L+ + ++ DFG K R ++ G
Sbjct: 151 VLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------KGRTWTLCG 200
Query: 181 SFGYVDTNYL------NTGFVSTKS-DVYSFGVLLLELITGL 215
+ L + G+ K+ D ++ GVL+ E+ G
Sbjct: 201 T-----PEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGY 235
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 52/210 (24%), Positives = 81/210 (38%), Gaps = 36/210 (17%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
IG G L AVK + + E+ + HPN+V L
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVIL 86
Query: 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR--------ALEYLH 128
+++EY + L++R + + R S D AR + Y H
Sbjct: 87 TPTHLAIIMEYASGGELYER-----------ICNAGRFSE--DEARFFFQQLLSGVSYCH 133
Query: 129 SQADPPIIHRDIKSSNILLIDDNHA---KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
S I HRD+K N LL D + A K+ DFG K ++PK +++ G+ Y+
Sbjct: 134 SMQ---ICHRDLKLENTLL-DGSPAPRLKICDFGYSKS--SVLHSQPK--STV-GTPAYI 184
Query: 186 DTNYL-NTGFVSTKSDVYSFGVLLLELITG 214
L + +DV+S GV L ++ G
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-16
Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 27/171 (15%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRV-ME-ERGGSRKI---FLDEVSVLLRVS---HPN 67
IGVGA VY A + G+F A+K V + GG + + EV++L R+ HPN
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 68 LVGLLGFCLEKGEQL-----LLLEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
+V L+ C L+ E++ ++ D+ L +
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG------LPAETIKDLMRQF 129
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171
R L++LH+ I+HRD+K NIL+ KLADFGL + ++
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMA 175
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-15
Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 66/226 (29%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVK----RVMEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
+GVG V + E G+ AVK + + KI E+ L HP+++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKLY 77
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR--------AL 124
+ +++EY++ LFD + R+ AR A+
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDY-----------ICKHGRVEE--MEARRLFQQILSAV 124
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
+Y H ++HRD+K N+LL +AK+ADFGL +
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------M 161
Query: 185 VDTNYLNT----------------GFVSTKSDVYSFGVLLLELITG 214
D +L T + + D++S GV+L L+ G
Sbjct: 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-14
Identities = 43/242 (17%), Positives = 87/242 (35%), Gaps = 63/242 (26%)
Query: 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
+G G+ V ++ G A+K+V+++ K E+ ++ + H N++ L+ +
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYK--NRELDIMKVLDHVNIIKLVDYFY 70
Query: 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNR-----LSIALD------------ 119
G++ + + N L++ ++
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 120 -------------------IARALEYLHSQADPPIIHRDIKSSNILLIDDNHA-KLADFG 159
+ RA+ ++HS I HRDIK N+L+ ++ KL DFG
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELI 212
K ++P+ + Y+ + + L + D++S G + ELI
Sbjct: 188 SAKKLIPSEPS-----VA------YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 213 TG 214
G
Sbjct: 237 LG 238
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 48/229 (20%), Positives = 85/229 (37%), Gaps = 58/229 (25%)
Query: 22 ATSFVYLAELGDGNFGAVKRVMEERGGSR----KIFLD---------EVSVLLRVSHPNL 68
F G G FG V+ E+ G K+ D + L + HPN+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 69 VGLLGFCLEKGEQ-------LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALD-- 119
V L + GE+ +++EY+ +L Y + +++
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNY---------YRRQVAPPPILI 131
Query: 120 ------IARALEYLHSQADPPIIHRDIKSSNILLIDDNHA-KLADFGLCKLGPFNDPNRP 172
+ R++ LH + + HRDIK N+L+ + + KL DFG K ++PN
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-- 188
Query: 173 KRQTSIKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
+ Y+ + Y +T D++S G + E++ G
Sbjct: 189 ---VA------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 49/226 (21%), Positives = 84/226 (37%), Gaps = 66/226 (29%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVK----RVMEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
+GVG V + + G+ AVK + + KI E+ L HP+++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKLY 82
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR--------AL 124
+ +++EY++ LFD + + RL +R +
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDY-----------ICKNGRLDE--KESRRLFQQILSGV 129
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
+Y H ++HRD+K N+LL +AK+ADFGL +
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------M 166
Query: 185 VDTNYLNT----------------GFVSTKSDVYSFGVLLLELITG 214
D +L T + + D++S GV+L L+ G
Sbjct: 167 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 51/226 (22%), Positives = 90/226 (39%), Gaps = 67/226 (29%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVK----RVMEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
+G G+ V LA A+K +++++ ++ E+S L + HP+++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKLY 75
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR--------AL 124
+ ++++EY A LFD + R++ D R A+
Sbjct: 76 DVITTPTDIVMVIEY-AGGELFDY-----------IVEKKRMTE--DEGRRFFQQIICAI 121
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
EY H I+HRD+K N+LL D+ + K+ADFGL +
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI--------------------M 158
Query: 185 VDTNYLNT----------------GFVSTKSDVYSFGVLLLELITG 214
D N+L T + + DV+S G++L ++ G
Sbjct: 159 TDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-14
Identities = 40/175 (22%), Positives = 73/175 (41%), Gaps = 38/175 (21%)
Query: 24 SFVYLAELGDGNFGAVKRVMEERGGSR-----KIFLD------------EVSVLL---RV 63
+ +AE+G+G +G V + + + G R ++ + EV+VL
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 64 SHPNLVGLL----GFCLEKGEQLLL-LEYLAN--KSLFDRMHTYYGQSLGVLSWSNRLSI 116
HPN+V L ++ +L L E++ + D++ + +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV------PEPGVPTETIKDM 125
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171
+ R L++LHS ++HRD+K NIL+ KLADFGL + ++
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMA 175
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 9e-13
Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 39/218 (17%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSR----KI--FLD---------EVSVLLRVSHPNLV 69
F + LG+G +G V + G KI F E+ +L H N++
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS------IALDIARA 123
+ + Y+ + M T L + + LS RA
Sbjct: 73 TIFNIQRPDSFENFNEVYII----QELMQT----DLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
++ LH ++ +IHRD+K SN+L+ + K+ DFGL ++ + + + G
Sbjct: 125 VKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 184 YVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
+V T + L + S DV+S G +L EL
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 45/223 (20%), Positives = 85/223 (38%), Gaps = 47/223 (21%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSR----KIFLD----------EVSVLLRVSHPNLVG 70
++ L LG G G V ++ R KI L E+ ++ R+ H N+V
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 71 LLGFCLEKGEQLLLLEYLANKS-----LFDRMHTYYGQSLGVLSWSNRLS------IALD 119
+ G QL + + + M T L + L
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEEHARLFMYQ 128
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLGPFNDPNRPKRQTSI 178
+ R L+Y+HS A+ ++HRD+K +N+ + ++ K+ DFGL + + +
Sbjct: 129 LLRGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLAR-IMDPHYSHKGHLS-- 182
Query: 179 KGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
+ T + L+ + D+++ G + E++TG
Sbjct: 183 ----EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 62/224 (27%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSR----KIF------------LDEVSVLLRVSHPNL 68
+ L+ +G G +G+V + + G R K+ E+ +L + H N+
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 69 VGLL-----GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS------IA 117
+GLL LE+ + YL M L + +L+ +
Sbjct: 91 IGLLDVFTPARSLEEFNDV----YLV----THLMGA----DLNNIVKCQKLTDDHVQFLI 138
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
I R L+Y+HS AD IIHRD+K SN+ + +D K+ DFGL R T+
Sbjct: 139 YQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLA------------RHTA 183
Query: 178 IKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
+ + GYV T + LN + D++S G ++ EL+TG
Sbjct: 184 DEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 46/218 (21%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSR----KI--FLD---------EVSVLLRVSHPNLV 69
+ L+ +G+G +G V + R KI F E+ +LLR H N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS------IALDIARA 123
G+ + + Y+ + D M T L L + LS I R
Sbjct: 89 GINDIIRAPTIEQMKDVYI----VQDLMET----DLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 124 LEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
L+Y+HS A+ ++HRD+K SN+LL K+ DFGL + D + T
Sbjct: 141 LKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLT------E 190
Query: 184 YVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
YV T + LN+ + D++S G +L E+++
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-12
Identities = 51/223 (22%), Positives = 81/223 (36%), Gaps = 48/223 (21%)
Query: 18 IGVGATSFVYLAELGDGNFGAVKRVME--ERGGSRKIFLD---------EVSVLLRVSHP 66
I G+ V +G A+KRV G + I D E+ +L HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALD------- 119
N++GL + E + YL + + M T L + R+ I+
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYL----VTELMRT----DLAQVIHDQRIVISPQHIQYFMY 141
Query: 120 -IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
I L LH A ++HRD+ NILL D+N + DF L + D N+
Sbjct: 142 HILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKT------ 191
Query: 179 KGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
YV + + + D++S G ++ E+
Sbjct: 192 ----HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-11
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 54/220 (24%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSR----KIF------------LDEVSVLLRVSHPNL 68
+ L +G G +GAV ++ R G++ K++ E+ +L + H N+
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 69 VGLLGFCLEKGEQLLLLE-YLANKSLFDRMHTYYGQSLGVLSWSNRLS------IALDIA 121
+GLL + YL + M T LG L +L + +
Sbjct: 87 IGLLDVFTPDETLDDFTDFYL----VMPFMGT----DLGKLMKHEKLGEDRIQFLVYQML 138
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
+ L Y+H+ A IIHRD+K N+ + +D K+ DFGL RQ + +
Sbjct: 139 KGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLA------------RQADSEMT 183
Query: 182 FGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
GYV T + LN + D++S G ++ E+ITG
Sbjct: 184 -GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 55/231 (23%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSR----KIF------------LDEVSVLLRVS-HPN 67
+ + +LG G +G V + ++ R G KIF E+ +L +S H N
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLS------IALDIA 121
+V LL ++ + YL FD M T L + +N L + +
Sbjct: 71 IVNLLNVLRADNDRDV---YLV----FDYMET----DLHAVIRANILEPVHKQYVVYQLI 119
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC-KLGPFNDPNRPKRQTSIKG 180
+ ++YLHS ++HRD+K SNILL + H K+ADFGL + +
Sbjct: 120 KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 181 SFGYVDTNYLNTGFVST-----------------KSDVYSFGVLLLELITG 214
+ + D + T +V+T D++S G +L E++ G
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-11
Identities = 51/220 (23%), Positives = 83/220 (37%), Gaps = 54/220 (24%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSR----KIF------------LDEVSVLLRVSHPNL 68
+ L +G G G V + K+ E+ ++ V+H N+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 69 VGLL-----GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL-DIAR 122
+ LL LE+ + + YL + M Q + + R+S L +
Sbjct: 124 ISLLNVFTPQKTLEEFQDV----YLV----MELMDANLCQVIQMELDHERMSYLLYQMLC 175
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
+++LHS A IIHRD+K SNI++ D K+ DFGL R
Sbjct: 176 GIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMM 220
Query: 183 -GYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
YV T Y L G+ D++S G ++ E++
Sbjct: 221 TPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRH 259
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-11
Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 51/220 (23%)
Query: 23 TSFVYLAELGDGNFGAVKRVMEERGGSR----KIF------------LDEVSVLLRVSHP 66
++V +G G +G+V +++R G + K+ E+ +L + H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 67 NLVGLL-----GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
N++GLL L L+ L G S + +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL----QKIMGLKF---SEEKIQYLVYQML 136
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
+ L+Y+HS A ++HRD+K N+ + +D K+ DFGL R + +
Sbjct: 137 KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLA------------RHADAEMT 181
Query: 182 FGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITG 214
GYV T + L+ + D++S G ++ E++TG
Sbjct: 182 -GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 44/257 (17%), Positives = 83/257 (32%), Gaps = 56/257 (21%)
Query: 8 KMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSR----KIF---------- 53
+ + +++ +G G++G V ++ K+
Sbjct: 16 FQGIKNVHV-----PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK 70
Query: 54 --LDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWS 111
L E+++L R+ ++ L + Y+ + + + +
Sbjct: 71 RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV----LEIADSDLKK---LFKTP 123
Query: 112 NRLS------IALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165
L+ I ++ ++H + IIHRD+K +N LL D K+ DFGL +
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 166 FNDPNRPKRQTSIKGSFGYVDTNYLN--TGFVST----------------KS-DVYSFGV 206
G + N T V T KS D++S G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240
Query: 207 LLLELITGLKSIQGSAT 223
+ EL+ L+S T
Sbjct: 241 IFAELLNMLQSHINDPT 257
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 44/212 (20%), Positives = 84/212 (39%), Gaps = 41/212 (19%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGF 74
++G G S V+ A + + VK + + +K E+ +L + PN++ L
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADI 99
Query: 75 CL--EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRL--SIALDIARALEYLHSQ 130
L+ E++ N Y Q+L ++ +I +AL+Y HS
Sbjct: 100 VKDPVSRTPALVFEHVNNTDF----KQLY-QTL-----TDYDIRFYMYEILKALDYCHSM 149
Query: 131 ADPPIIHRDIKSSNILLIDDNHA-KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
I+HRD+K N+++ ++ +L D+GL + F P + V + Y
Sbjct: 150 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYN--------VRVASRY 195
Query: 190 -------LNTGFVSTKSDVYSFGVLLLELITG 214
++ D++S G +L +I
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 52/233 (22%)
Query: 25 FVYLAELGDGNFGAVKRVMEERGGSR----KIF------------LDEVSVLLRVSHPNL 68
+ L +G G G V + K+ E+ ++ V+H N+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 69 VGLL-----GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL-DIAR 122
+GLL LE+ + + ++ L + +L L R+S L +
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDANL----CQVIQMEL----DHERMSYLLYQMLC 138
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
+++LHS A IIHRD+K SNI++ D K+ DFGL R + +
Sbjct: 139 GIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLA---------RTAGTSFMMT-- 184
Query: 183 GYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT 228
YV T Y L G+ D++S G ++ E+I G G+ + +W
Sbjct: 185 PYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 53/241 (21%), Positives = 84/241 (34%), Gaps = 48/241 (19%)
Query: 13 DFRIRIG-VGATSFVYLAELGDGNFGAVKRVMEERGGSR---KIF----------LDEVS 58
F + G + +F+ + ++GDG FG V K+ E
Sbjct: 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD 83
Query: 59 VL--LRVSHP---NLVGLLGFCLEKGEQLLLLEYLANKSLFD--RMHTYYGQSLGVLSWS 111
+L ++ N+V G + L+ E L SL++ + Y G + +
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLG-PSLYEIITRNNYNGFHIEDIK-- 140
Query: 112 NRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171
++I +AL YL + H D+K NILL D K
Sbjct: 141 ---LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 172 PKRQTSIK----GSFGYVD---TNYLNTGF-----V------STKSDVYSFGVLLLELIT 213
+ T IK G + + +NT V SD++SFG +L EL T
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
Query: 214 G 214
G
Sbjct: 255 G 255
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-10
Identities = 36/150 (24%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 17 RIGVGATSFVYLA-ELGDGNFGAVKRVME--ERGGSRKIFLDEVSVLLRVSHPNLVGLLG 73
IG G+ V A + + A+K+++ E K L E+++L R++H ++V +L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 74 FCLEKGEQLLLLEYLANKSLFDRMHT---YYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
+ K + Y+ + + ++ L+ + ++ ++ ++Y+HS
Sbjct: 120 IVIPKDVEKFDELYVV----LEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS- 174
Query: 131 ADPPIIHRDIKSSNILLIDDNHAKLADFGL 160
A I+HRD+K +N L+ D K+ DFGL
Sbjct: 175 AG--ILHRDLKPANCLVNQDCSVKVCDFGL 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 33/168 (19%), Positives = 64/168 (38%), Gaps = 24/168 (14%)
Query: 14 FRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVG 70
+ + +IG G +YLA A V E + +F E+ RV+ + +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIK 97
Query: 71 LLGFCLEKGEQLLLLEYLANKSLFDRMHTY-------YGQSLG-VLSWSNRLS------I 116
++ + L + + + + +Y G L + + +
Sbjct: 98 KW-IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILL--IDDNHAKLADFGLCK 162
+ + LEY+H +H DIK++N+LL + + LAD+GL
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 51/241 (21%), Positives = 92/241 (38%), Gaps = 56/241 (23%)
Query: 13 DFRIRIG-VGATSFVYLAELGDGNFGAVKRVMEERGGSR---KIF----------LDEVS 58
+ A + L +G G+FG V + + + K+ +E+
Sbjct: 86 SYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR 145
Query: 59 VL--LRVSHP----NLVGLLGFCLEKGEQLLLLEYLANKSLFD--RMHTYYGQSLGVLSW 110
+L LR N++ +L + + E L+ +L++ + + + G SL ++
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVR- 203
Query: 111 SNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHA--KLADFGL-CKLGPFN 167
A I + L+ LH IIH D+K NILL + K+ DFG C
Sbjct: 204 ----KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--- 253
Query: 168 DPNRPKRQTSIKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITGLKSIQG 220
+R + Y+ + + L + D++S G +L EL+TG + G
Sbjct: 254 -----QRVYT------YIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPG 301
Query: 221 S 221
Sbjct: 302 E 302
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-09
Identities = 26/163 (15%), Positives = 48/163 (29%), Gaps = 34/163 (20%)
Query: 31 LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV--SHPNLVGLLGFCLEKGEQLLLLEYL 88
N G + + + L++ L F + L + ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 89 ANKSL----FDRMHTY--------------YGQSLG-VLSWSNR--------LSIALDIA 121
S + G+SL L S + L +A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLL 169
Query: 122 RALEYLHSQADPPIIHRDIKSSNILL--IDDNHAKLADFGLCK 162
ALE+LH +H ++ + NI + D + LA +G
Sbjct: 170 DALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 54/241 (22%), Positives = 94/241 (39%), Gaps = 54/241 (22%)
Query: 13 DFRIRIG-VGATSFVYLAELGDGNFGAVKRVMEERGGSR---KIF----------LDEVS 58
D+ ++ G + + +G G+FG V + + KI EV
Sbjct: 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR 102
Query: 59 VL--LRVSHP----NLVGLLGFCLEKGEQLLLLEYLANKSLFD--RMHTYYGQSLGVLSW 110
+L + +V L + + L+ E L+ +L+D R + G SL +
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTR- 160
Query: 111 SNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHA--KLADFG-LCKLGPFN 167
A + AL +L + + IIH D+K NILL + + K+ DFG C+LG
Sbjct: 161 ----KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--- 212
Query: 168 DPNRPKRQTSIKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITGLKSIQG 220
+R Y+ + + L + D++S G +L+E+ TG G
Sbjct: 213 -----QRIYQ------YIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSG 260
Query: 221 S 221
+
Sbjct: 261 A 261
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 49/243 (20%), Positives = 85/243 (34%), Gaps = 56/243 (23%)
Query: 13 DFRIRIG-VGATSFVYLAELGDGNFGAVKRVMEERGGSR----KIF----------LDEV 57
RIG + + LG+G FG V ++ G KI E+
Sbjct: 8 HLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEI 67
Query: 58 SVL--LRVSHP----NLVGLLGFCLEKGEQLLLLEYLANKSLFD--RMHTYYGQSLGVLS 109
+VL ++ V + + G + E L K+ F+ + + + L +
Sbjct: 68 NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVR 126
Query: 110 WSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169
+A + AL +LH + + H D+K NIL ++ L + +
Sbjct: 127 -----HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK------SCE 172
Query: 170 NRPKRQTSIK----GSFGYVD---TNYLNTGF-----V------STKSDVYSFGVLLLEL 211
+ + TSI+ GS + T + T V + DV+S G +L E
Sbjct: 173 EKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232
Query: 212 ITG 214
G
Sbjct: 233 YRG 235
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 26/217 (11%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVL-LRVSHPN 67
+FR+ +IG G + L + L + A+K +E E S
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+ + F ++LE L SL D + S L IA+ + +EY+
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLG-PSLED----LFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 128 HSQADPPIIHRDIKSSNILL-----IDDNHAKLADFGLCKLGPFNDPN----RPKRQ-TS 177
HS+ +I+RD+K N L+ + DF L K + DP P R+ S
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK--EYIDPETKKHIPYREHKS 176
Query: 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ G+ Y+ N S + D+ + G + + + G
Sbjct: 177 LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPN 67
N FR+ +IG G+ +YL + A+K +E L E + +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTG 64
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+ + F +E +L+++ L SL D + LS L +A + +E++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLG-PSLED----LFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 128 HSQADPPIIHRDIKSSNILL---IDDNHAKLADFGLCKLGPFNDPN----RPKRQ-TSIK 179
HS++ +HRDIK N L+ N + DFGL K + D + P R+ ++
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK--KYRDTSTHQHIPYRENKNLT 174
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
G+ Y N S + D+ S G +L+ + G
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 5e-08
Identities = 32/195 (16%), Positives = 55/195 (28%), Gaps = 46/195 (23%)
Query: 9 MATNDFRI--RIGVGATSFVYLAELGDGNFGAVKRVM--------EERGGSRKIFLDEVS 58
+ T + +IG G V+ D A+K + + + L E+
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 59 VLLRV---------SHPNLVGLLGFCLEKGE--QLLLLEYLA----NKSLFDRMHTYYGQ 103
+ + +GL +G LLL + S DR +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 104 SL------------------GVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNI 145
L + S + SI + +L + HRD+ N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNV 193
Query: 146 LLIDDNHAKLADFGL 160
LL + KL
Sbjct: 194 LLKKTSLKKLHYTLN 208
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 5e-08
Identities = 21/73 (28%), Positives = 34/73 (46%), Gaps = 13/73 (17%)
Query: 100 YYGQSLG-VLSWSNR-------LSIALDIARALEYLHSQADPPIIHRDIKSSNILL--ID 149
+G L + + + L ++L I LEY+H +H DIK+SN+LL +
Sbjct: 133 RFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189
Query: 150 DNHAKLADFGLCK 162
+ L D+GL
Sbjct: 190 PDQVYLVDYGLAY 202
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 46/226 (20%), Positives = 87/226 (38%), Gaps = 32/226 (14%)
Query: 9 MATNDFRI--------RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSV 59
M+ + + RIG G+ ++ L + A+K E R DE
Sbjct: 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRT 58
Query: 60 L-LRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL 118
L + + F E +L+++ L SL D + G+ S A
Sbjct: 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGRKF---SVKTVAMAAK 113
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILL-----IDDNHAKLADFGLCKLGPFNDPN--- 170
+ ++ +H ++ +++RDIK N L+ + N + DFG+ K + DP
Sbjct: 114 QMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK--FYRDPVTKQ 168
Query: 171 -RPKRQ-TSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
P R+ ++ G+ Y+ N S + D+ + G + + + G
Sbjct: 169 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-08
Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 55/227 (24%)
Query: 28 LAELGDGNFGAVKRVMEERGGSR----KIF----------LDEVSVL--LRVSHP----N 67
+ LG+G FG V ++ + G R KI E+ VL L + P
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFD--RMHTYYGQSLGVLSWSNRLSIALDIARALE 125
V +L + G ++ E L S +D + + + L + +A I +++
Sbjct: 79 CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIR-----KMAYQICKSVN 132
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK----GS 181
+LH + H D+K NIL + ++ + + + R IK GS
Sbjct: 133 FLH---SNKLTHTDLKPENILFVQSDYTEAYNPKI------KRDERTLINPDIKVVDFGS 183
Query: 182 FGYVD---TNYLNTGF-----V------STKSDVYSFGVLLLELITG 214
Y D + ++T V S DV+S G +L+E G
Sbjct: 184 ATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-08
Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 24/215 (11%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH-PN 67
N +R+ +IG G+ +YL + G A+K +E E + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVG 66
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+ + E ++++E L SL D + S L +A + +EY+
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLG-PSLED----LFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 128 HSQADPPIIHRDIKSSNILL---IDDNHAKLADFGLCKLGPFNDPN----RPKRQ-TSIK 179
HS+ IHRD+K N L+ N + DFGL K + D P R+ ++
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRDARTHQHIPYRENKNLT 176
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
G+ Y N S + D+ S G +L+ G
Sbjct: 177 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 47/247 (19%), Positives = 87/247 (35%), Gaps = 67/247 (27%)
Query: 28 LAELGDGNFGAVKRVMEERGGSR---KIF----------LDEVSVLLRVS---------- 64
+ +LG G+F V + + KI DE+ +L RV+
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 65 -HPNLVGLLG---FCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRL--SIA 117
+++ LL G + ++ E L ++L + Y + + I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI-----PLIYVKQIS 137
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILL------IDDNHAKLADFGL-CKLGPFNDPN 170
+ L+Y+H + IIH DIK N+L+ + K+AD G C + D +
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEH 191
Query: 171 RPKRQTSIKGSFGYVDTNY-------LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT 223
+ T L + +D++S L+ ELITG +
Sbjct: 192 Y----------TNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 224 LAEWTEE 230
+ ++
Sbjct: 241 HSYTKDD 247
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 49/252 (19%), Positives = 78/252 (30%), Gaps = 62/252 (24%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-----SHPN---L 68
+G G S V+L+ + F A+K V++ + LDE+ +L V + PN +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 69 VGLLG-FCLE--KGE-QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
V LL F + G ++ E L L + Q L I + + L
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQ---GLPLPCVKKIIQQVLQGL 159
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
+YLH++ IIH DIK NILL + + P
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 185 VDTNYLNTGFV------------------------------------------STKSDVY 202
+ +T +D++
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277
Query: 203 SFGVLLLELITG 214
S + EL TG
Sbjct: 278 STACMAFELATG 289
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 266 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.78 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.72 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.65 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.47 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.38 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.27 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.11 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.01 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.72 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.65 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.64 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.59 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.54 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.51 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.31 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.29 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.17 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.58 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.47 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 95.3 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.04 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.49 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=368.48 Aligned_cols=235 Identities=25% Similarity=0.371 Sum_probs=205.1
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCC
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
|+...+||+|+||.||+| +..+|+.+|||++........+.+.+|+++++.++|||||++++++.+++..|+||||++|
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 555568999999999999 4567999999998766666677789999999999999999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
|+|.+++.. +.+++..+..++.|++.||.|||++| |+||||||+|||++.+|.+||+|||+|......
T Consensus 156 g~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 223 (346)
T 4fih_A 156 GALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 223 (346)
T ss_dssp EEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred CcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC---
Confidence 999999876 57999999999999999999999999 999999999999999999999999999854322
Q ss_pred CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc------------hh
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN------------VE 238 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------~~ 238 (266)
........||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.+....+..+....+. .+
T Consensus 224 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 -VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp -SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred -CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 22345678999999999999999999999999999999999999999988877776665543211 15
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
++.+|+..+|..|++.+++.+
T Consensus 303 li~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 678899999999999888753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-56 Score=364.77 Aligned_cols=237 Identities=25% Similarity=0.367 Sum_probs=206.7
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.|++.+.||+|+||.||+| +..+|+.+|||.+... .......+.+|++++++++||||+++++++++++..|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4667779999999999999 5667999999988643 23456788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|++||+|.+++... +.+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+|+....
T Consensus 113 y~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 113 YAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred cCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999875 78999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch---------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV--------- 237 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 237 (266)
.. .........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+.++.......
T Consensus 185 ~~--~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 262 (311)
T 4aw0_A 185 ES--KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKAR 262 (311)
T ss_dssp TT--TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHH
T ss_pred CC--CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHH
Confidence 22 2334556789999999999999999999999999999999999999999988877777776654322
Q ss_pred hhhhhhccCCCCCcchHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQL 257 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l 257 (266)
+++++|+..+|..|++.+++
T Consensus 263 dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGG
T ss_pred HHHHHHccCCHhHCcChHHH
Confidence 56788888999988887764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-56 Score=369.53 Aligned_cols=239 Identities=23% Similarity=0.286 Sum_probs=199.6
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+|++.++||+|+||.||++ +..+|+.+|||.+..... .....+.+|++++++++|||||++++++.+++..|+||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4566679999999999999 456799999998865432 2456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
++||+|.+++... ....+++..+..++.|++.||.|||++| |+||||||+|||++.+|.+||+|||+|+....
T Consensus 105 ~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~- 177 (350)
T 4b9d_A 105 CEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS- 177 (350)
T ss_dssp CTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH-
T ss_pred CCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC-
Confidence 9999999999763 2356799999999999999999999999 99999999999999999999999999985321
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc----------h
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN----------V 237 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~ 237 (266)
.........||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.+....+.++...... .
T Consensus 178 ---~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 254 (350)
T 4b9d_A 178 ---TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLR 254 (350)
T ss_dssp ---HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred ---CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 111234567999999999999999999999999999999999999999998888777777665322 1
Q ss_pred hhhhhhccCCCCCcchHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
+++.+|+..+|..||+.+++.+
T Consensus 255 ~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 255 SLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 5788999999999999988753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=369.84 Aligned_cols=235 Identities=25% Similarity=0.371 Sum_probs=205.9
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCC
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
|+...+||+|+||.||+| +..+|+.+|||++........+.+.+|+++|+.++|||||++++++.+.+..|+||||+.|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 555568999999999999 5567999999998776666677899999999999999999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
|+|.++++. +.+++..+..++.|++.||.|||++| |+||||||+|||++.+|.+||+|||+|......
T Consensus 233 G~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--- 300 (423)
T 4fie_A 233 GALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 300 (423)
T ss_dssp EEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS---
T ss_pred CcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC---
Confidence 999999876 57999999999999999999999999 999999999999999999999999999854322
Q ss_pred CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc------------hh
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN------------VE 238 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------~~ 238 (266)
........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+....+..+...... .+
T Consensus 301 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 301 -VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp -CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred -CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence 22345678999999999999999999999999999999999999999988877776665543211 25
Q ss_pred hhhhhccCCCCCcchHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~ 259 (266)
++.+|+..+|..|++.+++.+
T Consensus 380 li~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 678899999999999888753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=361.73 Aligned_cols=239 Identities=22% Similarity=0.218 Sum_probs=200.3
Q ss_pred hhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 14 FRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 14 ~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
..++||+|+||.||++ +..+|..+|||++..... ..+|+.+++.++|||||++++++.+.+..|+||||++||+
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 3447999999999999 456799999998865432 2469999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-ceEEeccccccCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~~~l~dfg~~~~~~~~~~~~ 171 (266)
|.++++.. +.+++..+..++.|++.||.|||+++ |+||||||+|||++.+| ++||+|||+|+.........
T Consensus 137 L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 137 LGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp HHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999875 67999999999999999999999999 99999999999999887 69999999998654332211
Q ss_pred C-CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc------------hh
Q 047020 172 P-KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN------------VE 238 (266)
Q Consensus 172 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------~~ 238 (266)
. .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+....+. .+
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 288 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHH
Confidence 1 2234467999999999999999999999999999999999999999887666655555553321 15
Q ss_pred hhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
++.+|+..+|..||+..+|.+.+..++
T Consensus 289 li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 289 AIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 688999999999999999988887764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=360.99 Aligned_cols=254 Identities=24% Similarity=0.310 Sum_probs=208.1
Q ss_pred HHHHhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecC
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG 79 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 79 (266)
+|....+.+.++||+|+||.||++.. .++..+|||++........+.+.+|++++++++|||||++++++.+.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 44555666777999999999999964 247789999987655556778999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhhhc--------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC
Q 047020 80 EQLLLLEYLANKSLFDRMHTYY--------GQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN 151 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~ 151 (266)
..++||||+++|+|.+++.... ......+++..+..++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCC
Confidence 9999999999999999997642 123357999999999999999999999999 99999999999999999
Q ss_pred ceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHH
Q 047020 152 HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEE 230 (266)
Q Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~ 230 (266)
.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.......+
T Consensus 166 ~~Ki~DFGla~~~~~~~--~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTD--YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp CEEECCCSCHHHHTGGG--CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred cEEECCcccceecCCCC--ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999997532211 1122334568999999999999999999999999999999998 89999887665555544
Q ss_pred HHhcC--c--------hhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 231 CRRNK--N--------VEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 231 ~~~~~--~--------~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
..... . .+++.+|+..+|..||+.++|...++..
T Consensus 244 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 244 TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 44321 1 1567899999999999999998888753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=348.97 Aligned_cols=236 Identities=22% Similarity=0.287 Sum_probs=190.0
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.+|++.+.||+|+||.||++. ..+|+.+|||.+.... .....++.+|++++++++||||+++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 456777799999999999994 5679999999886432 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+ +|+|.+++... +.+++..+..++.|++.||.|||++| |+||||||+||++++++++||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 998 68999999764 67999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
. ........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......
T Consensus 164 ~-----~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~ 238 (275)
T 3hyh_A 164 D-----GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPG 238 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred C-----CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 2 223345789999999999988876 57999999999999999999999988776666555554322
Q ss_pred -hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 -VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 -~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++++|+..+|..||+.+++.+
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHc
Confidence 25788999999999999988764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=349.84 Aligned_cols=234 Identities=23% Similarity=0.348 Sum_probs=193.8
Q ss_pred hhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEe----cCeEEEEE
Q 047020 13 DFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE----KGEQLLLL 85 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~ 85 (266)
+|..+||+|+||.||+| ...++..+++|++..... ...+++.+|++++++++|||||++++++.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45568999999999999 556788999998865432 235678999999999999999999999865 34689999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCceEEeccccccCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADFGLCKLG 164 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~~l~dfg~~~~~ 164 (266)
||++||+|.+++... +.+++..+..++.|++.||.|||+++ ++|+||||||+|||++. +|.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999875 67999999999999999999999874 45999999999999974 789999999999752
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
. ........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+........+.....
T Consensus 183 ~------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 255 (290)
T 3fpq_A 183 R------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp C------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred C------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccC
Confidence 1 233456789999999999875 5899999999999999999999999877666655554443211
Q ss_pred ----hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 ----VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ----~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++.+|+..+|..||+.+++.+
T Consensus 256 ~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 14677888888888888877653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=356.62 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=200.9
Q ss_pred hchhhhhccccccceEEEEEcC------CCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
...+.++||+|+||.||++... ++..+|||.+........+.|.+|++++++++|||||++++++.+.+..++|
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3444568999999999999642 5778999998765555677899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceE
Q 047020 85 LEYLANKSLFDRMHTYYG----------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAK 154 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~ 154 (266)
|||+++|+|.+++..... ...+++++..+..++.|++.||.|||+++ |+||||||+|||+++++.+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEE
Confidence 999999999999976422 12357899999999999999999999999 99999999999999999999
Q ss_pred EeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh
Q 047020 155 LADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~ 233 (266)
|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.......+...
T Consensus 199 i~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp ECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EcccccceeccCCCc--ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999985432221 223345679999999999999999999999999999999998 89999887766555554443
Q ss_pred cC--c--------hhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 234 NK--N--------VEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 234 ~~--~--------~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
.. . .+++.+|+..+|..||+.++|.+.|+..
T Consensus 277 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 277 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 21 1 1577899999999999999999888764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=356.78 Aligned_cols=255 Identities=21% Similarity=0.300 Sum_probs=209.4
Q ss_pred ChHHHHHhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeE
Q 047020 3 ALEELKMATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFC 75 (266)
Q Consensus 3 ~~~~i~~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 75 (266)
++.||..++.+|.++||+|+||.||+|.+ .++..||||++..... ...+.|.+|+.++++++|||||++++++
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 45566777888889999999999999964 3567899998865433 3457899999999999999999999999
Q ss_pred EecCeEEEEEEecCCCchhhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCc
Q 047020 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQ-----------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSN 144 (266)
Q Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~n 144 (266)
.+.+..++||||+++|||.+++...... ....+++..+..++.|++.||.|||+++ ++||||||+|
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~N 175 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRN 175 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccc
Confidence 9999999999999999999999753211 1246899999999999999999999999 9999999999
Q ss_pred EEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCch
Q 047020 145 ILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSAT 223 (266)
Q Consensus 145 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~ 223 (266)
||+++++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADY--YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGC--BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred eEECCCCCEEECCcccceeccCCCc--eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999975332211 223345679999999999999999999999999999999998 8999988766
Q ss_pred hHHHHHHHHhcCc----------hhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 224 LAEWTEECRRNKN----------VEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 224 ~~~~~~~~~~~~~----------~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
.+....+...... .+++.+|+..+|..||+..+|.+.|+
T Consensus 254 ~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 254 QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 5555444332211 15677899999999999999888876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=354.17 Aligned_cols=233 Identities=26% Similarity=0.347 Sum_probs=193.2
Q ss_pred hhchhhhhccccccceEEEEEc----CCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL----GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
..|++.+.||+|+||.||+|.. .+++.+|||.+.... .....++.+|++++++++||||+++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4577777999999999999953 357789999875432 2234567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||++||+|.+++... +.+++..+..++.|++.||.|||++| |+||||||+|||++.+|.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999875 67999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV------ 237 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 237 (266)
.... ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+.......
T Consensus 176 ~~~~----~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~ 251 (304)
T 3ubd_A 176 SIDH----EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSP 251 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred ccCC----CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCH
Confidence 3221 223445789999999999999999999999999999999999999999988877777766643321
Q ss_pred ---hhhhhhccCCCCCcchH
Q 047020 238 ---EVWAQMLDPKLNGDANM 254 (266)
Q Consensus 238 ---~~~~~~l~~~~~~~~~~ 254 (266)
+++++|+..+|..|++.
T Consensus 252 ~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 252 EAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HHHHHHHHHTCSSGGGSTTC
T ss_pred HHHHHHHHHcccCHHHCCCC
Confidence 56778888888888873
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=346.98 Aligned_cols=241 Identities=24% Similarity=0.329 Sum_probs=192.7
Q ss_pred hchhhhhccccccceEEEEEcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
...+.++||+|+||.||++.+.. .++||.+.... ....+.|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~ 113 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC 113 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence 34456689999999999998643 58888775432 2345678999999999999999999998754 5689999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
+||+|.+++... .+.+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 114 ~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 114 EGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp SSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999998652 256999999999999999999999999 9999999999999999999999999998643222
Q ss_pred CCCCCcccccccCCCccCcccccc---ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC----------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNT---GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---------- 235 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------- 235 (266)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.............
T Consensus 187 ~--~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 187 G--SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred c--ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 1 223455689999999999864 3588999999999999999999999988766555544443211
Q ss_pred -----chhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 236 -----NVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 236 -----~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
..+++.+|+..+|..||+..+|.+.++.
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1146788999999999999998877654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=336.83 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=183.8
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecC--------
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG-------- 79 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 79 (266)
..|++.+.||+|+||.||+| +..+|+.+|||++..... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 34667779999999999999 456789999998865433 23467889999999999999999999987554
Q ss_pred ----eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEE
Q 047020 80 ----EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKL 155 (266)
Q Consensus 80 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l 155 (266)
..|+||||+.||+|.+++... ......++..+..++.|++.||.|||++| |+||||||+|||++.++.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 368999999999999999764 22234456678899999999999999999 999999999999999999999
Q ss_pred eccccccCCCCCCCCC--------CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHH
Q 047020 156 ADFGLCKLGPFNDPNR--------PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW 227 (266)
Q Consensus 156 ~dfg~~~~~~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~ 227 (266)
+|||+|+......... ........||+.|+|||++.+..++.++||||+||++|+|++ ||.+.......
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 9999998654332211 112234579999999999999999999999999999999995 88765443332
Q ss_pred HHHHHhcC-----------chhhhhhhccCCCCCcchHHHHHH
Q 047020 228 TEECRRNK-----------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 228 ~~~~~~~~-----------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
........ ..+++.+|+..+|..||+..++.+
T Consensus 237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22222211 124678999999999999988754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=342.99 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=204.6
Q ss_pred HhhchhhhhccccccceEEEEEc-C-----CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCC-CCccccceeEEec-C
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL-G-----DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSH-PNLVGLLGFCLEK-G 79 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~-~-----~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~-~ 79 (266)
...+++.+.||+|+||.||+|.. + .++.++||.+..... .....+.+|++++.+++| ||||+++++|... +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 34556667999999999999953 2 235789998765433 235678899999999975 8999999998654 5
Q ss_pred eEEEEEEecCCCchhhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQ-----------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~ 148 (266)
..++||||+++|+|.++++..... ....+++..+..++.|++.||.|||+++ ++||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeC
Confidence 689999999999999999864321 1245899999999999999999999999 99999999999999
Q ss_pred cCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHH
Q 047020 149 DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEW 227 (266)
Q Consensus 149 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~ 227 (266)
+++.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+....+
T Consensus 220 ~~~~vKi~DFGlar~~~~~~--~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDP--DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCT--TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCCCEEECcchhhhhcccCC--CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999998643222 1233455678999999999999999999999999999999998 89999887655555
Q ss_pred HHHHHhcCc-----------hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 228 TEECRRNKN-----------VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 228 ~~~~~~~~~-----------~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...+..... .+++.+|+..+|..||+..+|.+.|+.++
T Consensus 298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 554443211 15678999999999999999998887764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=343.58 Aligned_cols=239 Identities=19% Similarity=0.231 Sum_probs=196.8
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEe------cCeE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE------KGEQ 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 81 (266)
.|++.+.||+|+||.||+| +..+|+.+|||++..... .....+.+|+++|+.++||||+++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 3566669999999999999 556899999999865432 234567899999999999999999998754 3578
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
|+||||+. |+|.+++... +.+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 135 ~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 99999995 6899988764 68999999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-----
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----- 235 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----- 235 (266)
+.................||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+...+...+.....
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 86544333334455667899999999998775 568999999999999999999999999988887766654211
Q ss_pred -----------------------------------chhhhhhhccCCCCCcchHHHHH
Q 047020 236 -----------------------------------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 -----------------------------------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++.+||..+|..|++.+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 343 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL 343 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 12467888999999999888764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=330.19 Aligned_cols=246 Identities=19% Similarity=0.231 Sum_probs=185.2
Q ss_pred hchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecC----eEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG----EQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e 86 (266)
++.+.++||+|+||.||++.. +|+.+|||++.... ........|+..+.+++||||+++++++.+.+ ..++|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 455566899999999999977 68899999875432 11222334555667789999999999987654 5799999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA-----DPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-----~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
|+++|+|.+++.. .++++..+..++.|++.||.|||++. .++|+||||||+|||++.++++||+|||++
T Consensus 82 y~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 82 YHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999976 56899999999999999999999871 112999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccc------cCCCcccchhHHHHHHHHHhCCCCcCCCc-------------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG------FVSTKSDVYSFGVLLLELITGLKSIQGSA------------- 222 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~i~~~l~~g~~pf~~~~------------- 222 (266)
+.................||+.|+|||++.+. .++.++|||||||++|||++|..||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 76433322222233456799999999998654 46779999999999999999987663221
Q ss_pred -hhHHHHHHHHhc-----------------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 223 -TLAEWTEECRRN-----------------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 223 -~~~~~~~~~~~~-----------------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
......+..... ...+++.+|+..+|..||+..+|.+.|+..
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 112222221110 012466788999999999999999888764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=328.58 Aligned_cols=204 Identities=25% Similarity=0.357 Sum_probs=167.6
Q ss_pred hchhhhhccccccceEEEEEc----CCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAEL----GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.|++.++||+|+||.||+|.. ++++.+|+|++... ....++.+|+++++.+ +||||+++++++.+.+..++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 456667999999999999943 45788999987543 3456688999999998 5999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC-CceEEeccccccCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD-NHAKLADFGLCKLG 164 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~~~l~dfg~~~~~ 164 (266)
||++|++|.++++ .+++..+..++.|++.||.|||++| |+||||||+|||++.+ +.+||+|||+|+..
T Consensus 100 E~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 100 PYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp ECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999884 3899999999999999999999999 9999999999999876 79999999999753
Q ss_pred CCCCC------------------------CCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcC
Q 047020 165 PFNDP------------------------NRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQ 219 (266)
Q Consensus 165 ~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~ 219 (266)
..... ..........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 32211 011123345799999999998765 58999999999999999999999995
Q ss_pred C-CchhHHH
Q 047020 220 G-SATLAEW 227 (266)
Q Consensus 220 ~-~~~~~~~ 227 (266)
+ .+...+.
T Consensus 249 ~~~~~~~~l 257 (361)
T 4f9c_A 249 KASDDLTAL 257 (361)
T ss_dssp CCSSHHHHH
T ss_pred CCCCHHHHH
Confidence 4 4444443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=346.89 Aligned_cols=238 Identities=22% Similarity=0.292 Sum_probs=205.7
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
..|++.+.||+|+||.||++ +..+|+.+|+|.+........+.+.+|+++|+.++||||+++++++.+.+..++||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 35667779999999999999 55679999999887655555677889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC--CceEEeccccccCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD--NHAKLADFGLCKLGPF 166 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~--~~~~l~dfg~~~~~~~ 166 (266)
.||+|.+++... .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 237 ~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 237 SGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred CCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999988642 257899999999999999999999999 9999999999999854 7899999999986422
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc----------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------- 236 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 236 (266)
........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..+......
T Consensus 310 -----~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 384 (573)
T 3uto_A 310 -----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 384 (573)
T ss_dssp -----TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSC
T ss_pred -----CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCC
Confidence 23345668999999999999999999999999999999999999999998887777666554321
Q ss_pred ---hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 ---VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ---~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++++||..+|..|++.+++.+
T Consensus 385 ~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 385 EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 15678899999999999888754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=341.57 Aligned_cols=230 Identities=21% Similarity=0.268 Sum_probs=185.9
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHH---HHHHHhcCCCCCccccceeEEecCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLD---EVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
..+++.+.||+|+||.||+| ...+|+.+|||.+.... ........+ ++++++.++||||++++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 34566679999999999999 55679999999885422 222333333 466777788999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+.||+|.+++... +.+++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|.
T Consensus 269 lVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999875 78999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccc-cccCCCcccchhHHHHHHHHHhCCCCcCCCchhH---HHHHHHHhcCc--
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLN-TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA---EWTEECRRNKN-- 236 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~---~~~~~~~~~~~-- 236 (266)
.... .......||+.|+|||++. +..|+.++||||+||++|+|++|..||.+.+... ....+......
T Consensus 341 ~~~~------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p 414 (689)
T 3v5w_A 341 DFSK------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414 (689)
T ss_dssp ECSS------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC
T ss_pred ecCC------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC
Confidence 5432 2234568999999999996 4689999999999999999999999997653322 22222222111
Q ss_pred -------hhhhhhhccCCCCCcch
Q 047020 237 -------VEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 237 -------~~~~~~~l~~~~~~~~~ 253 (266)
.+++.+++..+|..|++
T Consensus 415 ~~~S~~a~dLI~~lL~~dP~~Rl~ 438 (689)
T 3v5w_A 415 DSFSPELRSLLEGLLQRDVNRRLG 438 (689)
T ss_dssp TTSCHHHHHHHHHHTCSCGGGCTT
T ss_pred ccCCHHHHHHHHHHccCCHhHCCC
Confidence 14667777777777765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=303.72 Aligned_cols=236 Identities=25% Similarity=0.378 Sum_probs=203.5
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+|.....||+|+||.||++. ..+|+.+++|.+..........+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 45555689999999999994 56789999999877666677888999999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++.. ..+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++......
T Consensus 101 ~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 169 (297)
T 3fxz_A 101 GGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (297)
T ss_dssp TCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred CCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--
Confidence 9999999876 46899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC------------ch
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------------NV 237 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------------~~ 237 (266)
........||+.|+|||++.+..++.++||||+|+++|+|++|..||.+.+............. ..
T Consensus 170 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 170 --QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp --TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred --ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 2233456799999999999999999999999999999999999999988877666555443321 12
Q ss_pred hhhhhhccCCCCCcchHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
+++.+|+..+|..||+.+++.+
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHhh
Confidence 5688999999999999888753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=306.23 Aligned_cols=238 Identities=24% Similarity=0.310 Sum_probs=202.1
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
...+++.+.||+|+||.||++. ..+|+.+++|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4567777899999999999994 457899999988653 234566788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||++|++|.+++... +.+++..+..++.|++.||.|||++| |+||||||+||+++.+|.++|+|||++...
T Consensus 84 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999998764 67899999999999999999999999 999999999999999999999999998742
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
.. .........||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+......
T Consensus 156 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 231 (337)
T 1o6l_A 156 IS----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231 (337)
T ss_dssp CC----TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cc----CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 21 122344567999999999999999999999999999999999999999887766665555543221
Q ss_pred -hhhhhhhccCCCCCcc-----hHHHHH
Q 047020 237 -VEVWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 237 -~~~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
.+++.+|+..+|..|+ +.+++.
T Consensus 232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~ 259 (337)
T 1o6l_A 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVM 259 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHH
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHH
Confidence 2577899999999998 676664
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=306.93 Aligned_cols=236 Identities=24% Similarity=0.324 Sum_probs=201.3
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+|.+...||+|+||.||++. ..+|+.++||.+..... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 345666799999999999995 47899999998865432 235668899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... +.+++..++.++.|++.|+.|||++| ++||||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 95 YASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999775 67999999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCCCCCcccccccCCCccCccccccccCC-CcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVS-TKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN--------- 236 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 236 (266)
........||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..............
T Consensus 167 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 241 (328)
T 3fe3_A 167 -----GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 241 (328)
T ss_dssp -----SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred -----CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 2234456799999999999887765 7899999999999999999999988766666555543221
Q ss_pred hhhhhhhccCCCCCcchHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
.+++++|+..+|..||+.+++.
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil 263 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIM 263 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHT
T ss_pred HHHHHHHCCCChhHCcCHHHHh
Confidence 2678899999999999998875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=309.76 Aligned_cols=237 Identities=22% Similarity=0.328 Sum_probs=196.1
Q ss_pred HHHHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
.+...++++.+.||+|+||.||++. ..+|+.+++|.+... .......+.+|..+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 3555667777899999999999994 557899999988653 223456678899999988 69999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.++||||+.|++|.+++... +.+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||+
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccc
Confidence 99999999999999999875 67999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc----
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---- 236 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---- 236 (266)
+..... .........||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+....+..+......
T Consensus 171 a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 246 (353)
T 3txo_A 171 CKEGIC----NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW 246 (353)
T ss_dssp CBCSCC-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred eeeccc----CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 874221 122344567999999999999999999999999999999999999999988887777766664322
Q ss_pred -----hhhhhhhccCCCCCcchH
Q 047020 237 -----VEVWAQMLDPKLNGDANM 254 (266)
Q Consensus 237 -----~~~~~~~l~~~~~~~~~~ 254 (266)
.+++++|+..+|..|++.
T Consensus 247 ~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 247 LHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCHHHHHHHHHHhhhCHHHccCC
Confidence 256788888888888876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=304.64 Aligned_cols=236 Identities=25% Similarity=0.331 Sum_probs=201.1
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc------cHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
..|.+...||+|+||.||++. ..+|..+++|.+...... ....+.+|+.+++.++||||+++++++.+....+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 456677799999999999994 457889999988654332 3467899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC----ceEEecc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN----HAKLADF 158 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----~~~l~df 158 (266)
+||||+.|++|.+++... +.+++..+..++.|++.||.|||+.| ++|+||||+||+++.++ .++|+||
T Consensus 92 lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999763 67999999999999999999999999 99999999999998776 7999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--- 235 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 235 (266)
|++...... .......||+.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+....+..+.....
T Consensus 164 G~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 238 (361)
T 2yab_A 164 GLAHEIEDG-----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238 (361)
T ss_dssp SSCEECCTT-----CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred CCceEcCCC-----CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 999764322 223456799999999999998999999999999999999999999988776666555443221
Q ss_pred ----------chhhhhhhccCCCCCcchHHHHH
Q 047020 236 ----------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 ----------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++++|+..+|..||+.+++.
T Consensus 239 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred chhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 12578899999999999998875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=301.16 Aligned_cols=235 Identities=24% Similarity=0.374 Sum_probs=201.4
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
...+++...||+|+||.||++. ..+|+.+++|.+.... ......+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 4567777899999999999994 4578899999876532 23456778899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+.|++|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||+++.+|.++|+|||++...
T Consensus 85 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp ECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceec
Confidence 9999999999999864 67899999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
.. ......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+....+..+......
T Consensus 157 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 229 (318)
T 1fot_A 157 PD-------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229 (318)
T ss_dssp SS-------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CC-------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 21 233467899999999999999999999999999999999999999988877777666654321
Q ss_pred -hhhhhhhccCCCCCcc-----hHHHHH
Q 047020 237 -VEVWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 237 -~~~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
.+++++|+..+|..|+ +.+++.
T Consensus 230 ~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 230 VKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp HHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred HHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 2567889999999998 666654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=299.79 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=203.5
Q ss_pred HHHHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
++...+|.+...||+|+||.||++. ..++..+++|.+...... ....+.+|+.++++++||||+++++++.+.+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 3445567778899999999999994 567889999987553332 346788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||++|++|.+++... +++++..+..++.|++.||.|||+.| ++|+||||+||+++.+++++|+|||++
T Consensus 87 ~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp EEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred EEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCc
Confidence 9999999999999999875 67999999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------ 235 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------ 235 (266)
....... ........||+.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+.............
T Consensus 159 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T 4eqm_A 159 KALSETS---LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235 (294)
T ss_dssp TTC----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHH
T ss_pred ccccccc---ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchh
Confidence 7532211 1223446789999999999999999999999999999999999999988776655444333211
Q ss_pred --------chhhhhhhccCCCCCcc-hHHHHHHHHHHHh
Q 047020 236 --------NVEVWAQMLDPKLNGDA-NMEQLRVLIRICM 265 (266)
Q Consensus 236 --------~~~~~~~~l~~~~~~~~-~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..|| +.+++.+.++.++
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 12567899999999997 8888888877654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=298.21 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=207.0
Q ss_pred CChHHHHHhhch------------hhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCc
Q 047020 2 YALEELKMATND------------FRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL 68 (266)
Q Consensus 2 ~~~~~i~~~~~~------------~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i 68 (266)
|+.+++..++.. ....||+|+||.||++.. .+|+.++||.+..........+.+|+.+++.++||||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 104 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence 566777776643 234799999999999955 4799999998876666667889999999999999999
Q ss_pred cccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe
Q 047020 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~ 148 (266)
+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.| ++|+||||+||+++
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 9999999999999999999999999998865 56899999999999999999999999 99999999999999
Q ss_pred cCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHH
Q 047020 149 DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT 228 (266)
Q Consensus 149 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~ 228 (266)
.++.++|+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~ 251 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV----PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CCCcEEEeeeeeeeecccCc----cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999987543221 12345678999999999999899999999999999999999999998776655554
Q ss_pred HHHHhcC------------chhhhhhhccCCCCCcchHHHHHH
Q 047020 229 EECRRNK------------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 229 ~~~~~~~------------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....... ..+++.+|+..+|..||+.+++.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4433211 125678999999999999888754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=302.53 Aligned_cols=235 Identities=23% Similarity=0.356 Sum_probs=198.3
Q ss_pred HHHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeec---ccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 81 (266)
+....+++...||+|+||.||++.. .+|+.+++|.+... .......+..|..++..+ +||+|+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 4445667777999999999999954 45788999987653 223456788899999988 699999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||++|++|.+++... +.+++..++.++.|++.||.|||++| |+||||||+||+++.+|.++|+|||++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 9999999999999999875 67999999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-----
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN----- 236 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 236 (266)
..... .........||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+....+..+......
T Consensus 169 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 244 (353)
T 2i0e_A 169 KENIW----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 244 (353)
T ss_dssp BCCCC----TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred ccccc----CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Confidence 74221 122344567999999999999999999999999999999999999999988777666666554322
Q ss_pred ----hhhhhhhccCCCCCcch
Q 047020 237 ----VEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 237 ----~~~~~~~l~~~~~~~~~ 253 (266)
.+++.+|+..+|..|++
T Consensus 245 s~~~~~li~~lL~~dP~~R~~ 265 (353)
T 2i0e_A 245 SKEAVAICKGLMTKHPGKRLG 265 (353)
T ss_dssp CHHHHHHHHHHTCSCTTSCTT
T ss_pred CHHHHHHHHHHhhcCHHHcCC
Confidence 25778899999999984
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=304.08 Aligned_cols=237 Identities=25% Similarity=0.369 Sum_probs=196.9
Q ss_pred HHHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcC-CCCCccccceeEEecCeE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 81 (266)
+....+.+.+.||+|+||.||++.. .+|+.+++|.+.... ......+..|..+++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3445566667999999999999954 568899999886532 33456678899999876 899999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+.|++|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||+++.+|.++|+|||++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999875 67899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-----
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN----- 236 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 236 (266)
..... .........||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+....+..+......
T Consensus 166 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 241 (345)
T 1xjd_A 166 KENML----GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL 241 (345)
T ss_dssp BCCCC----TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred hhccc----CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 74221 122345567999999999999999999999999999999999999999988776666655543322
Q ss_pred ----hhhhhhhccCCCCCcchHH
Q 047020 237 ----VEVWAQMLDPKLNGDANME 255 (266)
Q Consensus 237 ----~~~~~~~l~~~~~~~~~~~ 255 (266)
.+++.+|+..+|..|++..
T Consensus 242 s~~~~~li~~lL~~dp~~R~~~~ 264 (345)
T 1xjd_A 242 EKEAKDLLVKLFVREPEKRLGVR 264 (345)
T ss_dssp CHHHHHHHHHHSCSSGGGSBTTB
T ss_pred CHHHHHHHHHHhcCCHhHcCCCh
Confidence 1456777777777777654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=296.34 Aligned_cols=238 Identities=25% Similarity=0.325 Sum_probs=200.9
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc------cHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
...|.+...||+|+||.||++. ..+|..+++|.+...... ....+.+|+++++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4567777799999999999994 457889999987654322 356788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC----ceEEec
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN----HAKLAD 157 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----~~~l~d 157 (266)
++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++ .++|+|
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999998753 67899999999999999999999999 99999999999998877 799999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-- 235 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 235 (266)
||++...... .......||+.|+|||++.+..++.++||||+|+++|+|++|..||.+.+.............
T Consensus 162 fg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (326)
T 2y0a_A 162 FGLAHKIDFG-----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236 (326)
T ss_dssp CTTCEECCTT-----SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred CCCCeECCCC-----CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence 9999764322 123345789999999999988999999999999999999999999988766555544433211
Q ss_pred -----------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 -----------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 -----------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++++|+..+|..||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 125788999999999999988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=307.65 Aligned_cols=240 Identities=20% Similarity=0.235 Sum_probs=201.5
Q ss_pred HHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
....|.+...||+|+||.||++ +..+|+.+++|.+..... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3456777789999999999999 556788999998765432 2345688999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe---cCCceEEeccccc
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLC 161 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~---~~~~~~l~dfg~~ 161 (266)
|||+.|++|.+.+... +.+++..+..++.|++.||.|||++| |+||||||+||+++ +++.+||+|||++
T Consensus 89 ~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp ECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999999874 67999999999999999999999999 99999999999998 4578999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------ 235 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------ 235 (266)
...... ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..+.....
T Consensus 161 ~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 161 IEVEGE----QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236 (444)
T ss_dssp BCCCTT----CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EEecCC----CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence 754322 2223446799999999999998999999999999999999999999988877666655554321
Q ss_pred -------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 -------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 -------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+..++.+
T Consensus 237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 237 WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 125788999999999999988754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=299.75 Aligned_cols=229 Identities=22% Similarity=0.286 Sum_probs=196.4
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
..+++...||+|+||.||++. ..+|+.+++|.+.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 345556689999999999995 4578999999875432 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||++|++|.+++... +.+++..++.++.|++.||.|||++| |+||||||+||+++.+|.++|+|||++....
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999875 67899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN--------- 236 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 236 (266)
. ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+....+..+......
T Consensus 193 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 265 (350)
T 1rdq_E 193 G-------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265 (350)
T ss_dssp S-------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHH
T ss_pred C-------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 1 223467999999999999999999999999999999999999999988776666665553221
Q ss_pred hhhhhhhccCCCCCcch
Q 047020 237 VEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~ 253 (266)
.+++.+|+..+|..|++
T Consensus 266 ~~li~~lL~~dp~~R~~ 282 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp HHHHHHHSCSCTTTCTT
T ss_pred HHHHHHHhhcCHHhccC
Confidence 25678889999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=296.56 Aligned_cols=248 Identities=29% Similarity=0.393 Sum_probs=197.1
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.++++...||+|+||.||++.. +|..++||.+...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 4555666899999999999976 5788999987654322 345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+++... .....+++..++.++.|++.||.|||+.| ++++||||||+||+++.++.++|+|||++......
T Consensus 116 ~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHST--THHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999999763 11134899999999999999999999874 56999999999999999999999999998753221
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-----------c
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-----------N 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------~ 236 (266)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+............. .
T Consensus 193 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 268 (309)
T 3p86_A 193 ----FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV 268 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred ----ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 1223456789999999999999999999999999999999999999988766555444322111 1
Q ss_pred hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.+++.+|+..+|..||+..++.+.++..+
T Consensus 269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 25788999999999999999999998765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=293.89 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=202.1
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..++.+...||+|+||.||++. ..+|..+++|.+..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 3456666799999999999994 456889999988665555677889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999763 256899999999999999999999999 999999999999999999999999999764332
Q ss_pred CCCCC----------CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH-----HHHHHHH
Q 047020 168 DPNRP----------KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA-----EWTEECR 232 (266)
Q Consensus 168 ~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~-----~~~~~~~ 232 (266)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 22110 11124579999999999999999999999999999999999999986532111 1111111
Q ss_pred h-------cCchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 233 R-------NKNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 233 ~-------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
. ....+++.+|+..+|..||+.+++.+.++..
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 1223678899999999999999999988764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=300.55 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=203.6
Q ss_pred HHHhhchhhhhccccccceEEEEEcC----CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELG----DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
+...++.+...||+|+||.||++... .+..++||.+..... .....+.+|+++++.++||||+++++++.+.+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 33455666679999999999999653 334589998765422 3356788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+.+++|.+++... .+.+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++
T Consensus 126 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EEEeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcc
Confidence 9999999999999998652 256899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-----
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----- 235 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----- 235 (266)
........ .........+|..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.............
T Consensus 199 ~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (325)
T 3kul_A 199 RVLEDDPD-AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM 277 (325)
T ss_dssp EECC-----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred cccccCcc-ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCC
Confidence 86433221 1122233456778999999998899999999999999999999 9999987766655544443211
Q ss_pred -----chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 -----NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 -----~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++.+.++.++
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 125788999999999999999999998765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=301.23 Aligned_cols=247 Identities=35% Similarity=0.547 Sum_probs=202.3
Q ss_pred hhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 13 DFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
+....||+|+||.||++...+|+.+++|+...........+.+|+++++.++||||+++++++.+.+..++||||+++++
T Consensus 42 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 121 (321)
T 2qkw_B 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121 (321)
T ss_dssp SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred CccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence 33448999999999999888899999998876665667789999999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.+++.... .....+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 122 L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 195 (321)
T 2qkw_B 122 LKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD--QT 195 (321)
T ss_dssp TGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSS--CC
T ss_pred HHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc--cc
Confidence 999986532 12246899999999999999999999999 9999999999999999999999999987532221 12
Q ss_pred CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH-----HHHHHHHh--------------
Q 047020 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA-----EWTEECRR-------------- 233 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~-----~~~~~~~~-------------- 233 (266)
.......||..|+|||++.+..++.++||||||+++|+|++|..||.+..... .+......
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD 275 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT
T ss_pred ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc
Confidence 22344568999999999988889999999999999999999999996543211 11111100
Q ss_pred -------cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 234 -------NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 234 -------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
....+++.+|+..+|..||+..++.+.++.++
T Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 01124567899999999999999999988764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=298.18 Aligned_cols=235 Identities=24% Similarity=0.348 Sum_probs=189.6
Q ss_pred HHHHhhchhhhhccccccceEEEEEc----CCCcEEEEEEeeecc----cccHHHHHHHHHHHhcCCCCCccccceeEEe
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAEL----GDGNFGAVKRVMEER----GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE 77 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 77 (266)
++....+++...||+|+||.||++.. .+|+.+++|.+.... ......+.+|+++++.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 34456677777999999999999965 578899999876532 2234567789999999999999999999999
Q ss_pred cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEec
Q 047020 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLAD 157 (266)
Q Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~d 157 (266)
.+..++||||+.+++|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEe
Confidence 99999999999999999999764 67899999999999999999999999 99999999999999999999999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN- 236 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 236 (266)
||++...... ........||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......+......
T Consensus 165 fg~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 240 (327)
T 3a62_A 165 FGLCKESIHD----GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240 (327)
T ss_dssp CSCC--------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred CCcccccccC----CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9998742211 12234567899999999999888999999999999999999999999988776666555543221
Q ss_pred --------hhhhhhhccCCCCCcc
Q 047020 237 --------VEVWAQMLDPKLNGDA 252 (266)
Q Consensus 237 --------~~~~~~~l~~~~~~~~ 252 (266)
.+++.+|+..+|..||
T Consensus 241 p~~~~~~~~~li~~~L~~dp~~R~ 264 (327)
T 3a62_A 241 PPYLTQEARDLLKKLLKRNAASRL 264 (327)
T ss_dssp CTTSCHHHHHHHHHHSCSCGGGST
T ss_pred CCCCCHHHHHHHHHHHhcCHhhcc
Confidence 2567888999998888
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=301.25 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=202.5
Q ss_pred hhchhhhhccccccceEEEEEc--------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEecC
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL--------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKG 79 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~--------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 79 (266)
..+.+.+.||+|+||.||++.. .++..++||.+..... .....+.+|+++++.+ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 3455556899999999999953 2345688888754432 2346788999999999 7999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQ-----------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~ 148 (266)
..++||||+.+++|.+++...... ....+++..+..++.|++.||.|||++| ++||||||+||+++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEEC
Confidence 999999999999999999874311 1245889999999999999999999999 99999999999999
Q ss_pred cCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHH
Q 047020 149 DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEW 227 (266)
Q Consensus 149 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~ 227 (266)
.++.+||+|||++........ ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.....
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCT--TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCEEEccccCCcccCcccc--eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999999975432221 122233456788999999999999999999999999999999 99999876554443
Q ss_pred HHHHHhc----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 228 TEECRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 228 ~~~~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
....... ...+++.+|+..+|..||+..++.+.++..+
T Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 3332221 1124788999999999999999999998765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=303.05 Aligned_cols=234 Identities=24% Similarity=0.328 Sum_probs=191.0
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 83 (266)
...+++.+.||+|+||.||++. ..+++.+++|.+..... .....+.+|..+++++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 3455666799999999999995 45678899998765432 2335578899999887 79999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+.|++|.+++... +.+++..+..++.|++.||.|||++| |+||||||+||+++.+|.+||+|||++..
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999999875 67999999999999999999999999 99999999999999999999999999974
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCch--------hH-HHHHHHHhc
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT--------LA-EWTEECRRN 234 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~--------~~-~~~~~~~~~ 234 (266)
.. ..........||+.|+|||++.+..++.++|+|||||++|+|++|..||.+... .. ....+....
T Consensus 203 ~~----~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 203 GL----RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp CC----CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred cc----cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence 21 112334567899999999999999999999999999999999999999964321 11 222222221
Q ss_pred C---------chhhhhhhccCCCCCcchH
Q 047020 235 K---------NVEVWAQMLDPKLNGDANM 254 (266)
Q Consensus 235 ~---------~~~~~~~~l~~~~~~~~~~ 254 (266)
. ..+++++|+..+|..|++.
T Consensus 279 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 1257889999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=298.37 Aligned_cols=238 Identities=22% Similarity=0.268 Sum_probs=199.0
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
...|.+...||+|+||.||++. ..+|..+++|.+..... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4566777799999999999994 45788999998865432 23466889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC---ceEEecccccc
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN---HAKLADFGLCK 162 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~~~l~dfg~~~ 162 (266)
||+.+++|.+.+... ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++ .+||+|||++.
T Consensus 108 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp CCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999988753 67899999999999999999999999 99999999999998654 59999999997
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------- 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 235 (266)
.... ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..+.....
T Consensus 180 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 254 (362)
T 2bdw_A 180 EVND-----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 254 (362)
T ss_dssp CCTT-----CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG
T ss_pred EecC-----CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 5432 1223346799999999999998999999999999999999999999988776665555444321
Q ss_pred ------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+..++.+
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 255 DTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 125778999999999999887653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=291.41 Aligned_cols=255 Identities=33% Similarity=0.498 Sum_probs=209.0
Q ss_pred CChHHHHHhhchhhh--------hccccccceEEEEEcCCCcEEEEEEeeecc----cccHHHHHHHHHHHhcCCCCCcc
Q 047020 2 YALEELKMATNDFRI--------RIGVGATSFVYLAELGDGNFGAVKRVMEER----GGSRKIFLDEVSVLLRVSHPNLV 69 (266)
Q Consensus 2 ~~~~~i~~~~~~~~~--------~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~ 69 (266)
|+.+++...+.+|.. .||+|+||.||++.. ++..+++|++.... ......+.+|++++++++||||+
T Consensus 15 ~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp CCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 788999999999885 499999999999976 67899999876532 22356788999999999999999
Q ss_pred ccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec
Q 047020 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID 149 (266)
Q Consensus 70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~ 149 (266)
++++++.+.+..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.| ++|+||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE 168 (307)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTG--GGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred EEEEEEecCCceEEEEEecCCCcHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence 9999999999999999999999999998754 22356899999999999999999999999 999999999999999
Q ss_pred CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH---H
Q 047020 150 DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA---E 226 (266)
Q Consensus 150 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~---~ 226 (266)
++.++|+|||++....... .........||+.|+|||.+.+ .++.++|+||||+++|+|++|..||.+..... .
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFA--QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCS--SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred CCcEEEeeccccccccccc--ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999987533211 1222334578999999998865 47889999999999999999999997654332 1
Q ss_pred HHHHHHh---------------------cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 227 WTEECRR---------------------NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 227 ~~~~~~~---------------------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+...... ....+++.+|+..+|..||+..++.+.++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111111 01225778999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=294.99 Aligned_cols=237 Identities=19% Similarity=0.233 Sum_probs=199.7
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+|.+...||+|+||.||++. ..+|..+++|.+... ......+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 456677799999999999994 456788888876543 334566889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec--CCceEEeccccccCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID--DNHAKLADFGLCKLGPF 166 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~--~~~~~l~dfg~~~~~~~ 166 (266)
+|++|.+++... ...+++..++.++.|++.||.|||+.| ++|+||||+||+++. ++.++|+|||++.....
T Consensus 84 ~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 84 SGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999998652 246899999999999999999999999 999999999999987 78999999999975322
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc----------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------- 236 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 236 (266)
........+|+.|+|||++.+..++.++||||+|+++|+|++|..||.+.+.......+......
T Consensus 157 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T 1tki_A 157 -----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp -----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred -----CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCC
Confidence 22334567899999999999888899999999999999999999999887766655555443211
Q ss_pred ---hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 ---VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ---~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++.+|+..+|..||+.+++.+
T Consensus 232 ~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 232 IEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 25788999999999999988764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=297.45 Aligned_cols=255 Identities=36% Similarity=0.587 Sum_probs=206.5
Q ss_pred CChHHHHHhhchhhh--hccccccceEEEEEcCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEec
Q 047020 2 YALEELKMATNDFRI--RIGVGATSFVYLAELGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK 78 (266)
Q Consensus 2 ~~~~~i~~~~~~~~~--~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 78 (266)
|+.+++...+.+|.. .||+|+||.||++...+|..++||.+..... .....+.+|+++++.++||||+++++++.+.
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 678888888888775 8999999999999877899999998865432 2334688999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---CCCCeecCCCCCCcEEEecCCceEE
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ---ADPPIIHRDIKSSNILLIDDNHAKL 155 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~---~~~~i~H~dikp~nil~~~~~~~~l 155 (266)
+..++||||+.+++|.+++.... .....+++..+..++.|++.||.|||+. | ++|+||||+||+++.++.++|
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999997642 2235689999999999999999999999 8 999999999999999999999
Q ss_pred eccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc-------hhHHHH
Q 047020 156 ADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA-------TLAEWT 228 (266)
Q Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~-------~~~~~~ 228 (266)
+|||++....... ........||+.|+|||++.+..++.++||||+|+++|+|++|..||.... ....+.
T Consensus 176 ~Dfg~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 176 GDFGLAKLMDYKD---THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp CCCSSCEECCSSS---SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred ccCccccccCccc---ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 9999997643221 223344568999999999988889999999999999999999999995211 011111
Q ss_pred HHHH---------------------hcCchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 229 EECR---------------------RNKNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 229 ~~~~---------------------~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
.... .....+++.+|+..+|..||+..++.+.++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000 0112356778999999999999999998864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=288.62 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=205.4
Q ss_pred HhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
..++++...||+|+||.||++...+++.+++|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35666777999999999999987788889999876533 34567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++... .+.+++..++.++.|++.|+.+||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 88 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp TTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999998652 246899999999999999999999999 9999999999999999999999999987532211
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------ch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------NV 237 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~~ 237 (266)
........++..|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+............. ..
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 161 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 237 (269)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred ---cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHH
Confidence 112234456778999999998899999999999999999999 9999988766555544443211 12
Q ss_pred hhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
+++.+|+..+|..||+..++.+.++..
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 578899999999999999999988765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=289.05 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=206.9
Q ss_pred HHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
+...++.+...||+|+||.||++...++..+++|.+.... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3456677777999999999999988888889998875533 345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... ...+++..++.++.|++.|+.+||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999999764 245899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK---------- 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~---------- 235 (266)
.. ........+|..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.............
T Consensus 157 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T 3sxs_A 157 DQ---YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT 233 (268)
T ss_dssp TC---EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred hh---hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHH
Confidence 21 122234456778999999998889999999999999999999 9999987766655544443221
Q ss_pred chhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
..+++.+|+..+|..||+..++.+.++..
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 12578899999999999999999888653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=295.69 Aligned_cols=234 Identities=24% Similarity=0.327 Sum_probs=191.9
Q ss_pred HhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc---cHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 83 (266)
...+++.+.||+|+||.||++.. .+|+.+++|.+...... ....+.+|..+++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 45667777999999999999954 56888999988654322 345678899999988 79999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+.|++|.+++... +.+++..++.++.|++.||.|||++| |+||||||+||+++.+++++|+|||++..
T Consensus 88 v~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 99999999999999765 67999999999999999999999999 99999999999999999999999999874
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC---------chhHHHHHHHHhc
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS---------ATLAEWTEECRRN 234 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~---------~~~~~~~~~~~~~ 234 (266)
... .........||+.|+|||++.+..++.++|+||+||++|+|++|..||... ........+....
T Consensus 160 ~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~ 235 (345)
T 3a8x_A 160 GLR----PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235 (345)
T ss_dssp SCC----TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC
T ss_pred ccC----CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC
Confidence 221 122344568999999999999999999999999999999999999999652 1111222222221
Q ss_pred C---------chhhhhhhccCCCCCcchH
Q 047020 235 K---------NVEVWAQMLDPKLNGDANM 254 (266)
Q Consensus 235 ~---------~~~~~~~~l~~~~~~~~~~ 254 (266)
. ..+++.+|+..+|..|++.
T Consensus 236 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1 1256788999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=304.83 Aligned_cols=236 Identities=21% Similarity=0.289 Sum_probs=191.0
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+++.+.||+|+||.||++. ..+++.+++|.+.... ......+.+|..+++.++||||+++++++.+....++|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34444589999999999995 4568889999875421 2234557889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|++||+|.+++.. ..+++..+..++.|++.||.|||++| |+||||||+||+++.+|.+||+|||++.....
T Consensus 150 ~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 150 YMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp CCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 9999999999876 46899999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCCCCCcccccccCCCccCcccccccc----CCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGF----VSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------- 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 235 (266)
.. ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+.++.....
T Consensus 221 ~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 221 EG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp TS---EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred CC---cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 11 12234568999999999997665 78899999999999999999999998887777666654210
Q ss_pred ------chhhhhhhccCCCCC--cchHHHHH
Q 047020 236 ------NVEVWAQMLDPKLNG--DANMEQLR 258 (266)
Q Consensus 236 ------~~~~~~~~l~~~~~~--~~~~~~l~ 258 (266)
..+++++|+..++.. |++.+++.
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~ 328 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIK 328 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHH
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHh
Confidence 113556666655544 66666554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=283.23 Aligned_cols=236 Identities=22% Similarity=0.253 Sum_probs=201.4
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..+|.+...||+|+||.||++ ...++..+++|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 345677779999999999999 4556788999988776666778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE---ecCCceEEeccccccCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL---IDDNHAKLADFGLCKLG 164 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~---~~~~~~~l~dfg~~~~~ 164 (266)
+.+++|.+++... ..+++..+..++.|++.|+.+||++| ++|+||||+||++ +.++.++|+|||++...
T Consensus 88 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 88 CTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999988764 67899999999999999999999999 9999999999999 77889999999998753
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--------- 235 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 235 (266)
.. ........+|+.|+|||++.+. ++.++|+||+|+++|+|++|..||.+.+.............
T Consensus 160 ~~-----~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T 3f3z_A 160 KP-----GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLN 233 (277)
T ss_dssp CT-----TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTT
T ss_pred cC-----ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhc
Confidence 32 2233456789999999998765 89999999999999999999999988776665555444321
Q ss_pred ----chhhhhhhccCCCCCcchHHHHH
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++.+|+..+|..||+..++.
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~s~~~~l 260 (277)
T 3f3z_A 234 VSPQAESLIRRLLTKSPKQRITSLQAL 260 (277)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 12578899999999999988875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=296.91 Aligned_cols=239 Identities=24% Similarity=0.340 Sum_probs=193.7
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.+|++...||+|+||.||++. ..+++.+++|.+..... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 456677799999999999994 45788999998754432 2345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 87 CSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999998753 57899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-----------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----------- 235 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----------- 235 (266)
. .........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.............
T Consensus 159 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (323)
T 3tki_A 159 N--RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236 (323)
T ss_dssp T--EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred C--cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCH
Confidence 1 1122345678999999999977765 7789999999999999999999987655433322222111
Q ss_pred -chhhhhhhccCCCCCcchHHHHH
Q 047020 236 -NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 -~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++.+|+..+|..||+.+++.
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HHHHHHHHHccCChhhCcCHHHHh
Confidence 12568899999999999988874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=300.53 Aligned_cols=235 Identities=27% Similarity=0.336 Sum_probs=190.4
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHH-HhcCCCCCccccceeEEecCeEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSV-LLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
....+++.+.||+|+||.||++. ..++..+++|.+..... .....+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 34556777799999999999995 45688899998865432 223445566666 56789999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+.|++|.+++... +.+++..++.++.|++.||.|||++| |+||||||+||+++.+|++||+|||++.
T Consensus 116 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 999999999999999774 67899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN------ 236 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 236 (266)
.... .........||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+....+..+......
T Consensus 188 ~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 263 (373)
T 2r5t_A 188 ENIE----HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263 (373)
T ss_dssp GGBC----CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSC
T ss_pred cccc----CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Confidence 4211 122345568999999999999999999999999999999999999999988877777766654221
Q ss_pred ---hhhhhhhccCCCCCcchH
Q 047020 237 ---VEVWAQMLDPKLNGDANM 254 (266)
Q Consensus 237 ---~~~~~~~l~~~~~~~~~~ 254 (266)
.+++.+++..++..|++.
T Consensus 264 ~~~~~li~~lL~~dp~~R~~~ 284 (373)
T 2r5t_A 264 NSARHLLEGLLQKDRTKRLGA 284 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSTTT
T ss_pred HHHHHHHHHHcccCHHhCCCC
Confidence 256778888888888876
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=291.99 Aligned_cols=238 Identities=24% Similarity=0.289 Sum_probs=193.7
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.+|++...||+|+||.||++...+|+.+++|++...... ....+.+|+++++.++||||+++++++.+....++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 456666799999999999998778999999988654322 346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+. ++|.+.+... ...+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++......
T Consensus 101 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 101 ME-KDLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CS-EEHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CC-CCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 96 4888877652 246899999999999999999999999 999999999999999999999999999753221
Q ss_pred CCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------------ 234 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------------ 234 (266)
........+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+............
T Consensus 173 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 ----VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp ----CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred ----cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 122334568999999999876 568999999999999999999999998766655544433210
Q ss_pred ---------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ---------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ---------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1125788999999999999888754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=300.01 Aligned_cols=239 Identities=20% Similarity=0.318 Sum_probs=195.1
Q ss_pred HHHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
+....+.+...||+|+||.||++ ...+|+.+++|.+.... ......+.+|+++++.++||||+++++++.+.+..+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34456777779999999999999 45668889999875432 234567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+.|++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+||+++.+|.++|+|||++.
T Consensus 92 lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp EEECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceee
Confidence 999999999999998764 67999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCCCCCcccccccCCCccCcccccc---ccCCCcccchhHHHHHHHHHhCCCCcCCCc--hhHHHHHHHHhcC--
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNT---GFVSTKSDVYSFGVLLLELITGLKSIQGSA--TLAEWTEECRRNK-- 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~i~~~l~~g~~pf~~~~--~~~~~~~~~~~~~-- 235 (266)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+ .............
T Consensus 164 ~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T 4fr4_A 164 MLPR-----ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT 238 (384)
T ss_dssp ECCT-----TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC
T ss_pred eccC-----CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC
Confidence 5432 223445679999999999863 458899999999999999999999997532 2222222222111
Q ss_pred --------chhhhhhhccCCCCCcch-HHHHH
Q 047020 236 --------NVEVWAQMLDPKLNGDAN-MEQLR 258 (266)
Q Consensus 236 --------~~~~~~~~l~~~~~~~~~-~~~l~ 258 (266)
..+++.+|+..+|..|++ .+++.
T Consensus 239 ~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 239 YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 125678899999999987 55554
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=299.95 Aligned_cols=237 Identities=21% Similarity=0.270 Sum_probs=199.0
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.|.+...||+|+||.||++. ..+|+.+++|.+..........+.+|+++++.++||||+++++++.+....++||||+.
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 45666689999999999994 45788889888765544455678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec--CCceEEeccccccCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID--DNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~--~~~~~l~dfg~~~~~~~~ 167 (266)
+++|.+++... ...+++..+..++.|++.||.|||+.| ++|+||||+||+++. .+.++|+|||++.....
T Consensus 132 gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~- 203 (387)
T 1kob_A 132 GGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 203 (387)
T ss_dssp CCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred CCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC-
Confidence 99999988652 246899999999999999999999999 999999999999974 46799999999985322
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC------------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------------ 235 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 235 (266)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.............
T Consensus 204 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 204 ----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ----TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ----CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 2223445799999999999998999999999999999999999999998876666555444221
Q ss_pred -chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 -NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 -~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhh
Confidence 125778999999999999888753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=295.47 Aligned_cols=243 Identities=21% Similarity=0.215 Sum_probs=197.5
Q ss_pred HHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc-----cccHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 8 KMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER-----GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
....|++...||+|+||.||++ ...+|+.++||.+.... ......+.+|+++++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3456777789999999999999 45678999999875421 12457789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc---eEEecc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH---AKLADF 158 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---~~l~df 158 (266)
++||||+.+++|.+.+..... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++. ++|+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecC
Confidence 999999999999988865321 2245899999999999999999999999 999999999999986554 999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc----
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN---- 234 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~---- 234 (266)
|++...... ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+... ..+..+....
T Consensus 178 g~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~ 252 (351)
T 3c0i_A 178 GVAIQLGES----GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMN 252 (351)
T ss_dssp TTCEECCTT----SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCC
T ss_pred cceeEecCC----CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCC
Confidence 999754321 1223456799999999999998999999999999999999999999987543 2222222211
Q ss_pred ---------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ---------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ---------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++++|+..+|..||+..++.+
T Consensus 253 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1125788999999999999888753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=299.61 Aligned_cols=236 Identities=22% Similarity=0.288 Sum_probs=195.0
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.+|.+.+.||+|+||.||++. ..+|+.+++|.+.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456677799999999999995 5778999999875432 233467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+ +++|.+++... +.+++..+..++.|++.|+.|||+.| ++||||||+||++++++.+||+|||++....
T Consensus 89 E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp CCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred ECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 999 78999988765 67999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH---------hcC
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR---------RNK 235 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~---------~~~ 235 (266)
. ........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+............ ...
T Consensus 160 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 234 (336)
T 3h4j_B 160 D-----GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPG 234 (336)
T ss_dssp T-----SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHH
T ss_pred C-----CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHH
Confidence 2 222345579999999999988776 6899999999999999999999976543332211111 011
Q ss_pred chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++++|+..+|..||+.+++.+
T Consensus 235 ~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 235 AQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHh
Confidence 225788999999999999988753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=289.59 Aligned_cols=236 Identities=24% Similarity=0.327 Sum_probs=192.5
Q ss_pred hchhhhhccccccceEEEEEcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+|.+...||+|+||.||++...+|+.+++|++..... .....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 5667779999999999999777899999998865432 23467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+ +|.+++... .+.+++..+..++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++......
T Consensus 83 ~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 153 (288)
T 1ob3_A 83 DQ-DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153 (288)
T ss_dssp SE-EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred CC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc-
Confidence 65 898887652 256899999999999999999999999 999999999999999999999999998753211
Q ss_pred CCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC------------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------------ 235 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 235 (266)
........+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.............
T Consensus 154 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 154 ---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 1122345689999999998654 589999999999999999999999988777666555443100
Q ss_pred --------------------------chhhhhhhccCCCCCcchHHHHH
Q 047020 236 --------------------------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 --------------------------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++.+|+..+|..||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 01577889999999999888765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=306.88 Aligned_cols=237 Identities=23% Similarity=0.304 Sum_probs=190.8
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
..+++...||+|+||.||++ ...+|..++||.+... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 34556668999999999999 4567899999988653 2233456778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .| |+||||||+||+++.++.++|+|||++...
T Consensus 228 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 228 EYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp CCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred eeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999998765 678999999999999999999998 99 999999999999999999999999998742
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 300 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 375 (446)
T 4ejn_A 300 IK----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 375 (446)
T ss_dssp CC---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cC----CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH
Confidence 21 122334567999999999999999999999999999999999999999887776666555443221
Q ss_pred -hhhhhhhccCCCCCcc-----hHHHHH
Q 047020 237 -VEVWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 237 -~~~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
.+++.+|+..+|..|+ +.+++.
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell 403 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIM 403 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHH
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHH
Confidence 2578899999999998 777765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=287.74 Aligned_cols=237 Identities=23% Similarity=0.328 Sum_probs=189.0
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--------------------------ccHHHHHHHHHHHh
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--------------------------GSRKIFLDEVSVLL 61 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--------------------------~~~~~~~~e~~~l~ 61 (266)
..+|.+...||+|+||.||++. ..+|+.++||.+..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4566777799999999999994 56788999998754321 11356889999999
Q ss_pred cCCCCCccccceeEEe--cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCC
Q 047020 62 RVSHPNLVGLLGFCLE--KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRD 139 (266)
Q Consensus 62 ~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~d 139 (266)
.++||||+++++++.+ ....++||||+++++|.+++.. ..+++..+..++.|++.||.|||++| ++|+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 9999999999999886 5688999999999999886543 57999999999999999999999999 99999
Q ss_pred CCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCcccccccc---CCCcccchhHHHHHHHHHhCCC
Q 047020 140 IKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGF---VSTKSDVYSFGVLLLELITGLK 216 (266)
Q Consensus 140 ikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~i~~~l~~g~~ 216 (266)
|||+||+++.++.++|+|||++...... ........||+.|+|||++.+.. ++.++||||||+++|+|++|..
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGS----DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSS----SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccc----cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999998753321 12234457899999999997654 3678999999999999999999
Q ss_pred CcCCCchhHHHHHHHHhcC-----------chhhhhhhccCCCCCcchHHHHH
Q 047020 217 SIQGSATLAEWTEECRRNK-----------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 217 pf~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
||.+.+............. ..+++.+|+..+|..||+.+++.
T Consensus 239 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 239 PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 9987765444433333211 12567889999999999888764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=289.56 Aligned_cols=243 Identities=25% Similarity=0.340 Sum_probs=195.5
Q ss_pred hHHHHHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-----ccHHHHHHHHHHHhcCC---CCCcccccee
Q 047020 4 LEELKMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-----GSRKIFLDEVSVLLRVS---HPNLVGLLGF 74 (266)
Q Consensus 4 ~~~i~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-----~~~~~~~~e~~~l~~l~---~~~i~~~~~~ 74 (266)
+.++...+|++...||+|+||.||++. ..+|+.+++|.+..... .....+.+|+++++.++ ||||++++++
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 456777888888899999999999995 46789999998864332 12346677888877775 9999999999
Q ss_pred EEecC-----eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec
Q 047020 75 CLEKG-----EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID 149 (266)
Q Consensus 75 ~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~ 149 (266)
+.... ..++|||++. ++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS 155 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECT
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcC
Confidence 87755 5799999996 5999998763 2244899999999999999999999999 999999999999999
Q ss_pred CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHH
Q 047020 150 DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE 229 (266)
Q Consensus 150 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~ 229 (266)
++.++|+|||++..... ........+|+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......
T Consensus 156 ~~~~kl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 230 (308)
T 3g33_A 156 GGTVKLADFGLARIYSY-----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 230 (308)
T ss_dssp TSCEEECSCSCTTTSTT-----CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH
T ss_pred CCCEEEeeCccccccCC-----CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999975322 2233456789999999999988999999999999999999999999998877776665
Q ss_pred HHHhcC------------------------------------chhhhhhhccCCCCCcchHHHHH
Q 047020 230 ECRRNK------------------------------------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 230 ~~~~~~------------------------------------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
+..... ..+++.+|+..+|..||+..++.
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 544210 12578899999999999988865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=307.21 Aligned_cols=233 Identities=20% Similarity=0.247 Sum_probs=189.0
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEec------CeE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK------GEQ 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~ 81 (266)
+|+..+.||+|+||.||++ +..+|+.++||++.... .....++.+|+.+++.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 4555668999999999999 56678999999886542 23456788999999999999999999998655 357
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+.+ ++.+.+.. .+++..+..++.|++.||.|||+.| |+||||||+||+++.++.+||+|||++
T Consensus 143 ~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred EEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 999999965 56666643 4899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------- 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------- 234 (266)
..... ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+...++..+....
T Consensus 212 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 212 RTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp ----------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eecCC-----CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 75321 223345678999999999999999999999999999999999999999988887776665421
Q ss_pred --------------------------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 --------------------------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 --------------------------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++.+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1235778888888888888887653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=299.59 Aligned_cols=213 Identities=21% Similarity=0.221 Sum_probs=177.0
Q ss_pred hhchhhhhcccc--ccceEEEEEc-CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 10 ATNDFRIRIGVG--ATSFVYLAEL-GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g--~~~~v~~~~~-~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
.+|++...||+| +||.||++.. .+|+.++||.+..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 345666799999 9999999954 5789999998865432 2346678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+.+++|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||.+...
T Consensus 105 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 105 TSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999998763 2356899999999999999999999999 999999999999999999999999987543
Q ss_pred CCCCC---CCCCcccccccCCCccCcccccc--ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHH
Q 047020 165 PFNDP---NRPKRQTSIKGSFGYVDTNYLNT--GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT 228 (266)
Q Consensus 165 ~~~~~---~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~ 228 (266)
..... ..........||..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+......
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 21111 11112233578899999999987 578999999999999999999999998765554443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=286.99 Aligned_cols=237 Identities=21% Similarity=0.253 Sum_probs=190.8
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+|++.+.||+|+||.||++. ..+|+.+++|.+...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 56677799999999999994 457889999988654332 346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+ ++.+.+... .+.+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 83 CDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred CCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 965 666665542 267899999999999999999999999 999999999999999999999999999753221
Q ss_pred CCCCCCcccccccCCCccCcccccccc-CCCcccchhHHHHHHHHHhCCCCc-CCCchhHHHHHHHHhc-----------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGF-VSTKSDVYSFGVLLLELITGLKSI-QGSATLAEWTEECRRN----------- 234 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~i~~~l~~g~~pf-~~~~~~~~~~~~~~~~----------- 234 (266)
........+|..|+|||++.+.. ++.++||||+||++|+|++|..|| .+.+............
T Consensus 155 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 155 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp ----CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ----cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 22234457899999999987665 799999999999999999887775 4544444444333210
Q ss_pred ---------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ---------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ---------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++++|+..+|..||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0125788899999999998887653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=299.31 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=202.5
Q ss_pred hhchhhhhccccccceEEEEE------cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEecC-e
Q 047020 10 ATNDFRIRIGVGATSFVYLAE------LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKG-E 80 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~------~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~-~ 80 (266)
.++.+...||+|+||.||++. ..+++.++||.+..... .....+.+|+++++++ +||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 344455589999999999994 34567899998865332 2345688999999999 6899999999987755 4
Q ss_pred EEEEEEecCCCchhhhhhhhcCCC--------------------------------------------------------
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQS-------------------------------------------------------- 104 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~-------------------------------------------------------- 104 (266)
.++||||+.+++|.+++.......
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 899999999999999998643210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccc
Q 047020 105 -----LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179 (266)
Q Consensus 105 -----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 179 (266)
...+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++....... .........
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~ 256 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP--DYVRKGDAR 256 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT--TCEEC--CE
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc--cchhccccC
Confidence 122899999999999999999999999 9999999999999999999999999998543221 123344567
Q ss_pred cCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-----------chhhhhhhccCC
Q 047020 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK-----------NVEVWAQMLDPK 247 (266)
Q Consensus 180 ~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~~ 247 (266)
+|..|+|||++.+..++.++||||||+++|+|++ |..||.+.+............. ..+++.+|+..+
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 336 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 336 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 8889999999998899999999999999999998 9999988765555444444321 125788999999
Q ss_pred CCCcchHHHHHHHHHHHh
Q 047020 248 LNGDANMEQLRVLIRICM 265 (266)
Q Consensus 248 ~~~~~~~~~l~~~~~~~~ 265 (266)
|..||+.+++.+.++..+
T Consensus 337 P~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 337 PSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHHH
Confidence 999999999999998765
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=293.84 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=190.8
Q ss_pred hchhhhhccccccceEEEEEcCCC-c---EEEEEEeeec--ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeE---
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDG-N---FGAVKRVMEE--RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ--- 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g-~---~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--- 81 (266)
++.+...||+|+||.||++..... + .++||.+... .......+.+|+++++.++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 455556899999999999965433 2 6889877554 233457788999999999999999999999876655
Q ss_pred ---EEEEEecCCCchhhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEec
Q 047020 82 ---LLLLEYLANKSLFDRMHTYYGQ-SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLAD 157 (266)
Q Consensus 82 ---~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~d 157 (266)
++||||+.+++|.+++...... ....+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEee
Confidence 9999999999999999764322 2236899999999999999999999999 99999999999999999999999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK- 235 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~- 235 (266)
||++........ ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.............
T Consensus 181 fg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 258 (323)
T 3qup_A 181 FGLSRKIYSGDY--YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL 258 (323)
T ss_dssp CCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred cccccccccccc--ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC
Confidence 999975432221 122234456788999999999899999999999999999999 9999988776665554443321
Q ss_pred ---------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 ---------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ---------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++.+.++.++
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 259 KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 125788999999999999999999988765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=288.66 Aligned_cols=214 Identities=23% Similarity=0.300 Sum_probs=167.2
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..++....||+|+||.||++.. .+|..+++|.+..... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 4566777999999999999954 5688999998865432 3446788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 88 LANKSLFDRMHTYYG-QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
+. ++|.+++..... .....+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 97 599998876432 22246899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~ 231 (266)
. ........+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus 161 ~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 222 (317)
T 2pmi_A 161 P----VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222 (317)
T ss_dssp C----CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred C----cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 1 112234578999999999876 468999999999999999999999998877666554443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=289.25 Aligned_cols=238 Identities=24% Similarity=0.312 Sum_probs=201.2
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc------cHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
...|.+...||+|+||.||++. ..+|..+++|.+...... ....+.+|+++++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4567777899999999999995 457889999988654332 356789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC----ceEEec
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN----HAKLAD 157 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----~~~l~d 157 (266)
++||||+.+++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||||+||+++.++ .++|+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999763 57899999999999999999999999 99999999999999887 799999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-- 235 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 235 (266)
||++...... .......||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.............
T Consensus 163 fg~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (321)
T 2a2a_A 163 FGLAHEIEDG-----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237 (321)
T ss_dssp CTTCEECCTT-----CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred CccceecCcc-----ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence 9998754322 222345689999999999988999999999999999999999999988766555544333211
Q ss_pred -----------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 -----------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 -----------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 238 DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 125788999999999999988764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=292.30 Aligned_cols=246 Identities=20% Similarity=0.214 Sum_probs=200.2
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.++.+...||+|+||.||++. ..+|+.++||.+.... ....+.+|+++++++ +||||+++++++......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 345666799999999999995 5778899999875443 234578999999999 899999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc-----eEEecccccc
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH-----AKLADFGLCK 162 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~-----~~l~dfg~~~ 162 (266)
+ +++|.+++... ...+++..+..++.|++.||.|||+.| ++||||||+||+++.++. ++|+|||++.
T Consensus 87 ~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 87 L-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp C-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred C-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 9 99999998763 257899999999999999999999999 999999999999998877 9999999998
Q ss_pred CCCCCCCCC---CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCch--h-HHHHHHHHh---
Q 047020 163 LGPFNDPNR---PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT--L-AEWTEECRR--- 233 (266)
Q Consensus 163 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~--~-~~~~~~~~~--- 233 (266)
......... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+. . ..+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 643322211 1123467899999999999999999999999999999999999999987422 2 222221110
Q ss_pred ----------cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 234 ----------NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 234 ----------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+...+++..|+..+|..||+.++|.++++..+
T Consensus 239 ~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 239 TPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp SCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 12235678999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=299.48 Aligned_cols=252 Identities=25% Similarity=0.313 Sum_probs=204.9
Q ss_pred HhhchhhhhccccccceEEEEEc--------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL--------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEK 78 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~--------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 78 (266)
..++.+.+.||+|+||.||++.. ..+..++||.+..... .....+.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 34556667899999999999953 2335788888765432 2346788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQ-----------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL 147 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~ 147 (266)
+..++||||+.+++|.+++...... ....+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 9999999999999999999875321 1246899999999999999999999999 9999999999999
Q ss_pred ecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHH
Q 047020 148 IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAE 226 (266)
Q Consensus 148 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~ 226 (266)
+.++.+||+|||++........ ........+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.+....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCT--TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred cCCCcEEEcccCcccccccccc--cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999985432221 122334567888999999999999999999999999999999 9999987765544
Q ss_pred HHHHHHhcC----------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 227 WTEECRRNK----------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 227 ~~~~~~~~~----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
......... ..+++.+|+..+|..||+.+++.+.++..+
T Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 433332211 125788999999999999999999998765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=304.13 Aligned_cols=237 Identities=22% Similarity=0.319 Sum_probs=201.1
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
..|.+...||+|+||.||++. ..+|+.++||.+.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456666799999999999995 4578999999886432 233567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+.+++|.+++... +.+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++....
T Consensus 96 E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999998753 67999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--------- 235 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 235 (266)
.. .......||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+......++.....
T Consensus 168 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 242 (476)
T 2y94_A 168 DG-----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPS 242 (476)
T ss_dssp TT-----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHH
T ss_pred cc-----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHH
Confidence 21 22345679999999999988765 6799999999999999999999988776666555544321
Q ss_pred chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++++|+..+|..||+.+++.+
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcCCCchhCcCHHHHHh
Confidence 125788999999999999998864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=297.16 Aligned_cols=236 Identities=21% Similarity=0.287 Sum_probs=184.9
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+|.+.+.||+|+||.||++. ..+|+.+++|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 456777799999999999994 4578899999875433 34467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc--eEEeccccccCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH--AKLADFGLCKLGPF 166 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~--~~l~dfg~~~~~~~ 166 (266)
.+++|.+++... +.+++..++.++.|++.||.|||++| ++||||||+||+++.++. +||+|||++....
T Consensus 99 ~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~- 169 (361)
T 3uc3_A 99 SGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 169 (361)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc-
Confidence 999999998764 67999999999999999999999999 999999999999987665 9999999987321
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCc-ccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH----hc-------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTK-SDVYSFGVLLLELITGLKSIQGSATLAEWTEECR----RN------- 234 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~----~~------- 234 (266)
.........||+.|+|||++.+..++.+ +||||+||++|+|++|..||.+.+....+..... ..
T Consensus 170 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (361)
T 3uc3_A 170 ----LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI 245 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTS
T ss_pred ----ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcC
Confidence 1222344579999999999988777655 8999999999999999999987544333222221 11
Q ss_pred ----CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ----KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ----~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++.+
T Consensus 246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 246 RISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1125788999999999999988754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=294.35 Aligned_cols=248 Identities=24% Similarity=0.282 Sum_probs=196.1
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeec-----ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEE-----RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
..+|++...||+|+||.||++ ...++..+++|.+... .......+.+|+++++.++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 345666679999999999999 4467888999987543 2334577889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCC-----------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 047020 83 LLLEYLANKSLFDRMHTYYGQS-----------------------------------LGVLSWSNRLSIALDIARALEYL 127 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~i~~~l~~L 127 (266)
+||||+++++|.+++....... ...+++..++.++.|++.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999886321110 12346778889999999999999
Q ss_pred hhCCCCCeecCCCCCCcEEEecCC--ceEEeccccccCCCCCCCCCCCcccccccCCCccCcccccc--ccCCCcccchh
Q 047020 128 HSQADPPIIHRDIKSSNILLIDDN--HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT--GFVSTKSDVYS 203 (266)
Q Consensus 128 h~~~~~~i~H~dikp~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~s 203 (266)
|+.+ ++|+||||+||+++.++ .++|+|||++..................||+.|+|||++.+ ..++.++||||
T Consensus 185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 9999 99999999999998766 89999999987543322222333456679999999999865 67889999999
Q ss_pred HHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-------------chhhhhhhccCCCCCcchHHHHHH
Q 047020 204 FGVLLLELITGLKSIQGSATLAEWTEECRRNK-------------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 204 lG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
||+++|+|++|..||.+.+............. ..+++.+|+..+|..||+..++.+
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999999988877766665554322 125778999999999999888754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=295.61 Aligned_cols=231 Identities=23% Similarity=0.284 Sum_probs=192.4
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchhh
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFD 95 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
.||+|+||.||++. ..+|..+++|.+..........+.+|++++++++||||+++++++.+.+..++||||+++++|.+
T Consensus 96 ~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~ 175 (373)
T 2x4f_A 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175 (373)
T ss_dssp ECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHH
T ss_pred EEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHH
Confidence 69999999999994 56788999998876554556788999999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE--ecCCceEEeccccccCCCCCCCCCCC
Q 047020 96 RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL--IDDNHAKLADFGLCKLGPFNDPNRPK 173 (266)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~ 173 (266)
++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++...... .
T Consensus 176 ~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-----~ 243 (373)
T 2x4f_A 176 RIIDE----SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-----E 243 (373)
T ss_dssp HHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-----C
T ss_pred HHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-----c
Confidence 88652 246899999999999999999999999 9999999999999 45678999999999864322 2
Q ss_pred cccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-------------chhhh
Q 047020 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-------------NVEVW 240 (266)
Q Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------~~~~~ 240 (266)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+..... ..+++
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 23345689999999999988899999999999999999999999998877766666554321 12578
Q ss_pred hhhccCCCCCcchHHHHHH
Q 047020 241 AQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 241 ~~~l~~~~~~~~~~~~l~~ 259 (266)
.+|+..+|..||+.+++.+
T Consensus 324 ~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhhCCCHHHHhc
Confidence 8999999999999988765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=302.30 Aligned_cols=254 Identities=23% Similarity=0.280 Sum_probs=204.7
Q ss_pred HHHhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecC
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG 79 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 79 (266)
+...++.+...||+|+||.||++.. .++..++||++..... .....+.+|+.++++++||||+++++++.+..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3345566667899999999999963 2466789998754322 23456889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC---ceE
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQ--SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN---HAK 154 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~~~ 154 (266)
..++||||+.+++|.+++...... ....+++..++.++.|++.||.|||++| ++||||||+||+++.++ .++
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 999999999999999999875322 2246899999999999999999999999 99999999999998555 499
Q ss_pred EeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh
Q 047020 155 LADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~ 233 (266)
|+|||++....... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...........
T Consensus 225 L~DFG~a~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 225 IGDFGMARDIYRAG--YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp ECCCHHHHHHHHHS--SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred ECCCcccccccccc--ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999986421111 1122334567889999999988899999999999999999998 99999887665555444432
Q ss_pred cC----------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 234 NK----------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 234 ~~----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.. ..+++.+|+..+|..||+..++.+.++.|.
T Consensus 303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 21 125788999999999999999999998774
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=291.18 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=191.7
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCe----
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE---- 80 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 80 (266)
..+|.+...||+|+||.||++. ..+++.++||.+...... ....+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4567777899999999999995 577889999988654332 23567899999999999999999998876543
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.++||||+++++|.+++... +.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 49999999999999999764 67899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc----
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---- 236 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---- 236 (266)
+........ .........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..............
T Consensus 163 a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 3ork_A 163 ARAIADSGN-SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 241 (311)
T ss_dssp C-------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH
T ss_pred ccccccccc-ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc
Confidence 875432211 112234457899999999999989999999999999999999999999887766655544443221
Q ss_pred ---------hhhhhhhccCCCCCcch-HHHHHHHHH
Q 047020 237 ---------VEVWAQMLDPKLNGDAN-MEQLRVLIR 262 (266)
Q Consensus 237 ---------~~~~~~~l~~~~~~~~~-~~~l~~~~~ 262 (266)
.+++.+|+..+|..||+ .+++..-+.
T Consensus 242 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 24678899999999974 444544443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=288.62 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=203.3
Q ss_pred HHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
...++.+.+.||+|+||.||++...++..+++|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 345566667999999999999988888889999876443 3457789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+++... ...+++..++.++.|++.||.+||++| ++|+||||+||+++.++.++|+|||++......
T Consensus 101 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 101 MANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred cCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999998753 246899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------c
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------N 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~ 236 (266)
. ........+|..|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+............. .
T Consensus 174 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 250 (283)
T 3gen_A 174 E---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 250 (283)
T ss_dssp H---HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred c---cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHH
Confidence 1 112233456778999999998889999999999999999998 9999987766555544443211 1
Q ss_pred hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.+++.+|+..+|..||+.+++.+.++..+
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 25788999999999999999999888754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=290.19 Aligned_cols=244 Identities=18% Similarity=0.268 Sum_probs=199.6
Q ss_pred HHHHhhchhhhhccccccceEEEEEcC-CC-------cEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEe
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAELG-DG-------NFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE 77 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~~-~g-------~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 77 (266)
+|...++.+...||+|+||.||++... ++ ..+++|.+........+.+.+|++++++++||||+++++++.+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 455667788889999999999999433 33 3588888766555667889999999999999999999999999
Q ss_pred cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc-----
Q 047020 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH----- 152 (266)
Q Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~----- 152 (266)
.+..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTB
T ss_pred CCCCEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccc
Confidence 99999999999999999999763 234899999999999999999999999 999999999999998877
Q ss_pred ---eEEeccccccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCC-CCcCCCchhHHH
Q 047020 153 ---AKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGL-KSIQGSATLAEW 227 (266)
Q Consensus 153 ---~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~-~pf~~~~~~~~~ 227 (266)
++|+|||++... .......++..|+|||++.+ ..++.++||||+|+++|+|++|. .||...+.. ..
T Consensus 157 ~~~~kl~Dfg~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~ 227 (289)
T 4fvq_A 157 PPFIKLSDPGISITV--------LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-RK 227 (289)
T ss_dssp CCEEEECCCCSCTTT--------SCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HH
T ss_pred cceeeeccCcccccc--------cCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-HH
Confidence 999999998632 22234568889999999987 67899999999999999999955 555443333 22
Q ss_pred HHHHHhc---------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 228 TEECRRN---------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 228 ~~~~~~~---------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
....... ...+++.+|+..+|..||+.+++.+.++..+
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 228 LQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred HHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2222221 1226789999999999999999999887654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=298.68 Aligned_cols=217 Identities=24% Similarity=0.382 Sum_probs=171.1
Q ss_pred HHHHHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCC-CCCccccceeEEecC-
Q 047020 5 EELKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKG- 79 (266)
Q Consensus 5 ~~i~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~- 79 (266)
++....+|.+...||+|+||.||++ +..+|+.++||++.... .....++.+|+.+++.+. ||||+++++++...+
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 4456677888889999999999999 55678999999885432 234566788999999997 999999999987544
Q ss_pred -eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 80 -EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 80 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
..++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+||
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF 153 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADF 153 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred CEEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCC
Confidence 6899999996 689988876 57899999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCC-----------------CCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCC
Q 047020 159 GLCKLGPFNDP-----------------NRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQG 220 (266)
Q Consensus 159 g~~~~~~~~~~-----------------~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~ 220 (266)
|+++....... ..........||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 99975432111 01122334579999999999876 6789999999999999999999999998
Q ss_pred CchhHHHHHHH
Q 047020 221 SATLAEWTEEC 231 (266)
Q Consensus 221 ~~~~~~~~~~~ 231 (266)
.+...++..+.
T Consensus 234 ~~~~~~~~~i~ 244 (388)
T 3oz6_A 234 SSTMNQLERII 244 (388)
T ss_dssp SSHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 88777665554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=293.96 Aligned_cols=242 Identities=25% Similarity=0.274 Sum_probs=193.6
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecC----eEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG----EQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~ 85 (266)
.++++...||+|+||.||++... ++.++||.+.... ........|+.++++++||||+++++++.... ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 45566679999999999999764 7889999875432 33445566888899999999999999987754 369999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCCeecCCCCCCcEEEecCCceEE
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ----------ADPPIIHRDIKSSNILLIDDNHAKL 155 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~----------~~~~i~H~dikp~nil~~~~~~~~l 155 (266)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.+||
T Consensus 102 e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 102 AFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp ECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred ecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 99999999999976 4689999999999999999999999 9 999999999999999999999
Q ss_pred eccccccCCCCCCCCCCCcccccccCCCccCcccccc-----ccCCCcccchhHHHHHHHHHhCCCCcCCCch-------
Q 047020 156 ADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-----GFVSTKSDVYSFGVLLLELITGLKSIQGSAT------- 223 (266)
Q Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~------- 223 (266)
+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 173 ~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 173 ADFGLALKFEAGKS--AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp CCCTTCEEECTTSC--CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred ccCCcccccccccC--ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 99999975433221 222344678999999999976 3566789999999999999999999976432
Q ss_pred --------hHHHHHHHHhc-----------------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 224 --------LAEWTEECRRN-----------------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 224 --------~~~~~~~~~~~-----------------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...+....... ...+++.+|+..+|..||+.+++.+.++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11121111110 023568899999999999999999988764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=296.64 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=203.3
Q ss_pred HhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeecc-cccHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
..++.+...||+|+||.||++.. +++..+++|.+.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 34556666899999999999964 345678999876432 23456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCC
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQ------------------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKS 142 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp 142 (266)
.++||||+++++|.+++...... ....+++..++.++.|++.||.|||+.| ++|+||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 99999999999999999764221 0134789999999999999999999999 99999999
Q ss_pred CcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCC
Q 047020 143 SNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGS 221 (266)
Q Consensus 143 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~ 221 (266)
+||+++.++.++|+|||++....... .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDS--NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCT--TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCc--cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999997533221 1223345567889999999988889999999999999999998 99999887
Q ss_pred chhHHHHHHHHhcC-----------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 222 ATLAEWTEECRRNK-----------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 222 ~~~~~~~~~~~~~~-----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.............. ..+++.+|+..+|..||+..++.+.++..+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 65555544444321 125788999999999999999999998765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=289.18 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=206.2
Q ss_pred HhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
..++.+...||+|+||.||++.. .++..+++|.+..... .....+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 34566667999999999999953 4567889988764432 2356788999999999 89999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQ-------------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL 147 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~ 147 (266)
.++||||+++++|.+++...... ....+++..++.++.|++.||.|||+.| ++|+||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 99999999999999999874221 1235899999999999999999999999 9999999999999
Q ss_pred ecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHH
Q 047020 148 IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAE 226 (266)
Q Consensus 148 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~ 226 (266)
+.++.++|+|||++....... .........+|..|+|||++.+..++.++||||||+++|+|++ |..||.+......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCT--TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cCCCCEEEccccccccccccc--cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999998643221 1222344567788999999988899999999999999999998 9999987665554
Q ss_pred HHHHHHhcC-----------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 227 WTEECRRNK-----------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 227 ~~~~~~~~~-----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
......... ..+++.+|+.++|..||+..++.+.++..+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 444443211 126788999999999999999999998865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=289.49 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=202.7
Q ss_pred hhchhhhhccccccceEEEEEc------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
.++.+.+.||+|+||.||++.. .++..+++|.+..... .....+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 4455556899999999999953 3457788888764332 23467889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCC
Q 047020 83 LLLEYLANKSLFDRMHTYYGQ-------------------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSS 143 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ 143 (266)
+||||+.+++|.+++...... ....+++..++.++.|++.||.|||++| ++|+||||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~ 179 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAAR 179 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccchh
Confidence 999999999999999874321 1234899999999999999999999999 999999999
Q ss_pred cEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCc
Q 047020 144 NILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSA 222 (266)
Q Consensus 144 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~ 222 (266)
||+++.++.++|+|||++........ ........++..|+|||++.+..++.++||||+|+++|+|++ |..||.+.+
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEEcCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999875432211 122234456788999999988889999999999999999999 999998765
Q ss_pred hhHHHHHHHHhc----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 223 TLAEWTEECRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 223 ~~~~~~~~~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
............ ...+++.+|+..+|..||+.+++.+.++..+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 258 PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 544433322211 1126788999999999999999999998765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=299.32 Aligned_cols=249 Identities=19% Similarity=0.257 Sum_probs=192.0
Q ss_pred HhhchhhhhccccccceEEEEEcC----CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAELG----DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
..++.+...||+|+||.||++... ++..++||.+..... .....+.+|++++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 345566678999999999999653 567799998764322 235678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 124 v~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999753 246899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc--------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN-------- 234 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~-------- 234 (266)
....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+............
T Consensus 197 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 275 (373)
T 2qol_A 197 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTC
T ss_pred cccCCcc-ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 4322111 111222345678999999998899999999999999999998 999998766544443333221
Q ss_pred --CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 235 --KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 235 --~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...+++.+|+..+|..||+.+++.+.++..+
T Consensus 276 ~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp BHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1125778999999999999999999988764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=285.99 Aligned_cols=243 Identities=27% Similarity=0.401 Sum_probs=192.9
Q ss_pred HHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeeccc----ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERG----GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
...++.+...||+|+||.||++.. .|..++||.+..... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 345667777999999999999976 478899998755332 234678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec--------CCceEE
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID--------DNHAKL 155 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~--------~~~~~l 155 (266)
||||+.+++|.+++.. ..+++..++.++.|++.|+.|||+++..+++|+||||+||+++. ++.++|
T Consensus 84 v~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999998864 57899999999999999999999997555789999999999986 677999
Q ss_pred eccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC
Q 047020 156 ADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK 235 (266)
Q Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (266)
+|||++..... .......||+.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.............
T Consensus 158 ~Dfg~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 231 (271)
T 3dtc_A 158 TDFGLAREWHR------TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231 (271)
T ss_dssp CCCCC-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC
T ss_pred ccCCccccccc------ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC
Confidence 99999875322 122345689999999999988899999999999999999999999988766555444433221
Q ss_pred -----------chhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 236 -----------NVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 236 -----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
..+++.+|+..+|..||+..++.+.++.
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1257889999999999999999988863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=304.80 Aligned_cols=211 Identities=21% Similarity=0.277 Sum_probs=177.7
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+++...||+|+||.||++.. .+++.+++|.+.... ......+.+|..++..++||||+++++++.+.+..++||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 34445899999999999955 457888999875421 12334478899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.||+|.+++... .+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 156 ~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 156 YVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp CTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999752 256899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCCCCCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
. ........||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+....+.++..
T Consensus 229 ~---~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 229 G---TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp S---CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred C---CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 1 22234467999999999986 45689999999999999999999999998887777666553
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=282.35 Aligned_cols=237 Identities=24% Similarity=0.408 Sum_probs=198.0
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
..+|.+...||+|+||.||++ ...++..+++|.+.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 345666779999999999999 45567789999875432 22356788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+++++|.+.+... ..+++..+..++.|++.|+.|||+.| ++|+||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999999775 67899999999999999999999999 999999999999999999999999988642
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
. ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+..............
T Consensus 160 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T 3fdn_A 160 P------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 233 (279)
T ss_dssp --------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred C------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHH
Confidence 2 12223457899999999999999999999999999999999999999887766665554443221
Q ss_pred -hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 -VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 -~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++.+|+..+|..||+.+++.+
T Consensus 234 ~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 234 ARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHhh
Confidence 25788999999999999888764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=289.47 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=199.9
Q ss_pred hHHHHHhhchhhhhccccccceEEEEE-----cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEe-
Q 047020 4 LEELKMATNDFRIRIGVGATSFVYLAE-----LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE- 77 (266)
Q Consensus 4 ~~~i~~~~~~~~~~ig~g~~~~v~~~~-----~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 77 (266)
.+++...++++.+.||+|+||.||++. ..+++.++||++..........+.+|++++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 355667788888899999999999996 34688999998876555556778999999999999999999998854
Q ss_pred -cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEe
Q 047020 78 -KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLA 156 (266)
Q Consensus 78 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~ 156 (266)
....++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.+++++|+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~ 156 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIG 156 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEEC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEc
Confidence 35689999999999999999763 235899999999999999999999999 9999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH-----------
Q 047020 157 DFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA----------- 225 (266)
Q Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~----------- 225 (266)
|||++........ .........++..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 157 Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 157 DFGLTKVLPQDKE-FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235 (295)
T ss_dssp CCCSCC--------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTH
T ss_pred cCcccccccCCcc-eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccc
Confidence 9999986433221 1122234457778999999999999999999999999999999999986432110
Q ss_pred ----HHHHHHHhc-----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 226 ----EWTEECRRN-----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 226 ----~~~~~~~~~-----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
......... ...+++.+|+..+|..||+..++.+.++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111111111 1125788999999999999999999888754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=287.55 Aligned_cols=242 Identities=21% Similarity=0.232 Sum_probs=194.2
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecC--eEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG--EQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~ 85 (266)
.+|.+...||+|+||.||++. ..+|+.++||.+.... ......+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 456667799999999999994 4568999999886533 234567889999999999999999999987665 789999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE----ecCCceEEeccccc
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL----IDDNHAKLADFGLC 161 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~----~~~~~~~l~dfg~~ 161 (266)
||+++++|.+++... .....+++..++.++.|++.||.|||+.| ++|+||||+||++ +..+.+||+|||++
T Consensus 89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 89 EFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp ECCTTCBHHHHHHSG--GGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred eCCCCCCHHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999864 22234899999999999999999999999 9999999999998 66777999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccc--------cccCCCcccchhHHHHHHHHHhCCCCcCCCc----hhHHHHH
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLN--------TGFVSTKSDVYSFGVLLLELITGLKSIQGSA----TLAEWTE 229 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~----~~~~~~~ 229 (266)
...... .......||..|+|||++. +..++.++|||||||++|+|++|..||.... ......+
T Consensus 164 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 164 RELEDD-----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp EECCTT-----CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred eecCCC-----CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 754322 2223456899999999986 4678899999999999999999999996432 2223333
Q ss_pred HHHhcC----------------------------------chhhhhhhccCCCCCcchHHHHHHHH
Q 047020 230 ECRRNK----------------------------------NVEVWAQMLDPKLNGDANMEQLRVLI 261 (266)
Q Consensus 230 ~~~~~~----------------------------------~~~~~~~~l~~~~~~~~~~~~l~~~~ 261 (266)
.....+ ..+++++|+..+|..|++.+++.+-.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 333221 12467899999999999998887644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=285.94 Aligned_cols=247 Identities=21% Similarity=0.267 Sum_probs=194.3
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
....|.+...||+|+||.||++. ..+++.+++|.+...... ....+.+|+++++.++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 34456677799999999999995 457888999987554322 24678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+++++|.+++... +.+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 112 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999875 57899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-------- 235 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 235 (266)
..... ........++..|+|||++.+..++.++|+||||+++|+|++|..||.+.+..... .......
T Consensus 184 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 259 (309)
T 2h34_A 184 TTDEK---LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-AHINQAIPRPSTVRP 259 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-HHHHSCCCCGGGTST
T ss_pred ccccc---cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-HHhccCCCCccccCC
Confidence 33221 12233456899999999999889999999999999999999999999876554322 2222111
Q ss_pred -----chhhhhhhccCCCCCcc-hHHHHHHHHHHHhC
Q 047020 236 -----NVEVWAQMLDPKLNGDA-NMEQLRVLIRICMA 266 (266)
Q Consensus 236 -----~~~~~~~~l~~~~~~~~-~~~~l~~~~~~~~~ 266 (266)
..+++.+|+..+|..|| +.+++.+.++.+++
T Consensus 260 ~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 260 GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 12578899999999998 99999999987753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=286.28 Aligned_cols=237 Identities=24% Similarity=0.329 Sum_probs=197.7
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..++.+...||+|+||.||++. ..+|+.+++|.+..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 4567777799999999999995 457889999988765444556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE---ecCCceEEeccccccCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL---IDDNHAKLADFGLCKLG 164 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~---~~~~~~~l~dfg~~~~~ 164 (266)
+++++|.+++... +.+++..+..++.|++.|+.+||+.| ++|+||||+||++ +.++.++|+|||++...
T Consensus 88 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 88 VSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred CCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999998764 67899999999999999999999999 9999999999999 67889999999998742
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--------- 235 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 235 (266)
. ........+++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+.............
T Consensus 160 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (304)
T 2jam_A 160 Q------NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDD 233 (304)
T ss_dssp C------CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTT
T ss_pred C------CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccccc
Confidence 1 2223445689999999999998999999999999999999999999988766555544443211
Q ss_pred ----chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 234 ISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 125778999999999999988754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=314.20 Aligned_cols=235 Identities=23% Similarity=0.355 Sum_probs=200.3
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 82 (266)
....+++...||+|+||.||++. ..+++.++||.+... .......+..|..++..+ +||+|+.+++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34456666789999999999994 567888999988643 233456778899999988 5999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+.|++|.+++... +.+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 419 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999875 67999999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN------ 236 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 236 (266)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+....+..+......
T Consensus 491 ~~~~~----~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 566 (674)
T 3pfq_A 491 ENIWD----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMS 566 (674)
T ss_dssp ECCCT----TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSC
T ss_pred ccccC----CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCC
Confidence 52211 22345578999999999999999999999999999999999999999998887777776664322
Q ss_pred ---hhhhhhhccCCCCCcchH
Q 047020 237 ---VEVWAQMLDPKLNGDANM 254 (266)
Q Consensus 237 ---~~~~~~~l~~~~~~~~~~ 254 (266)
.+++++++..+|..|++.
T Consensus 567 ~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 567 KEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HHHHHHHHHHSCSSSTTCTTC
T ss_pred HHHHHHHHHHccCCHHHCCCC
Confidence 257788999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=301.12 Aligned_cols=211 Identities=24% Similarity=0.296 Sum_probs=178.1
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+++.+.||+|+||.||++.. .+|+.+++|.+.... ......+.+|..++..++||||+++++++.+.+..++||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 34445899999999999954 578999999875421 12344578899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.|++|.+++... ...+++..++.++.|++.||.|||++| |+||||||+||+++.++++||+|||++......
T Consensus 143 ~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 143 YVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp CCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 9999999999764 136899999999999999999999999 999999999999999999999999999753321
Q ss_pred CCCCCCcccccccCCCccCccccc-------cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLN-------TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
. ........||+.|+|||++. ...++.++|+|||||++|+|++|..||.+.+....+.++..
T Consensus 216 ~---~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 216 G---TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp S---CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred C---ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 1 12233467999999999986 35689999999999999999999999998877776665553
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=294.09 Aligned_cols=251 Identities=24% Similarity=0.294 Sum_probs=202.3
Q ss_pred hhchhhhhccccccceEEEEEc------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
.++.+...||+|+||.||++.. .++..+++|.+..... .....+.+|++++++++||||+++++++.+.+..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 3455566899999999999954 2347889988765432 23567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCC
Q 047020 83 LLLEYLANKSLFDRMHTYYGQ-------------------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSS 143 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ 143 (266)
+||||+.+++|.+++...... ....+++..++.++.|++.||.|||++| ++|+||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcc
Confidence 999999999999999874211 1257899999999999999999999999 999999999
Q ss_pred cEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCc
Q 047020 144 NILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSA 222 (266)
Q Consensus 144 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~ 222 (266)
||+++.++.++|+|||++........ ........+|..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred eEEECCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 99999999999999999864321111 122334567889999999988889999999999999999999 999998776
Q ss_pred hhHHHHHHHHhcC----------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 223 TLAEWTEECRRNK----------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 223 ~~~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
............. ..+++.+|+..+|..||+..++.+.++...
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 5554443333211 125788999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=290.32 Aligned_cols=246 Identities=24% Similarity=0.317 Sum_probs=191.2
Q ss_pred HhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecC-------
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------- 79 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 79 (266)
..++++...||+|+||.||++.. .+|+.++||++..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 35667777999999999999955 4789999998865433 34577899999999999999999999885543
Q ss_pred --------------------------------------------------eEEEEEEecCCCchhhhhhhhcCCCCCCCC
Q 047020 80 --------------------------------------------------EQLLLLEYLANKSLFDRMHTYYGQSLGVLS 109 (266)
Q Consensus 80 --------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 109 (266)
..++||||+.+++|.+++... ......+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR--CSLEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC--CSGGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc--cCccchh
Confidence 379999999999999999864 2234556
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC--------CCcccccccC
Q 047020 110 WSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR--------PKRQTSIKGS 181 (266)
Q Consensus 110 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~t 181 (266)
+..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.......... ........||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 7778999999999999999999 9999999999999999999999999998654332111 1223445799
Q ss_pred CCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH--------HhcCchhhhhhhccCCCCCcch
Q 047020 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC--------RRNKNVEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 182 ~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~~~~~~~~ 253 (266)
+.|+|||++.+..++.++||||+|+++|+|++|..|+............. ......+++.+|+..+|..||+
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 99999999999999999999999999999999988774332211111000 0111235788999999999999
Q ss_pred HHHHHH
Q 047020 254 MEQLRV 259 (266)
Q Consensus 254 ~~~l~~ 259 (266)
.+++.+
T Consensus 320 ~~~~l~ 325 (332)
T 3qd2_B 320 ATDIIE 325 (332)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 888754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=292.18 Aligned_cols=246 Identities=20% Similarity=0.267 Sum_probs=193.0
Q ss_pred HHHHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhc--CCCCCccccceeEEe----c
Q 047020 5 EELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLR--VSHPNLVGLLGFCLE----K 78 (266)
Q Consensus 5 ~~i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~----~ 78 (266)
.++...++.+.+.||+|+||.||++.. +|+.++||.+... ....+..|.+++.. ++||||+++++++.. .
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 444566777888999999999999976 6889999987543 34555667777666 789999999998644 3
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeecCCCCCCcEEEecC
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH--------SQADPPIIHRDIKSSNILLIDD 150 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--------~~~~~~i~H~dikp~nil~~~~ 150 (266)
...++||||+.+++|.++++. ..+++..+..++.|++.||.||| +.+ ++||||||+||+++.+
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTT
T ss_pred ceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCC
Confidence 458999999999999999965 57899999999999999999999 888 9999999999999999
Q ss_pred CceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccc------cCCCcccchhHHHHHHHHHhC----------
Q 047020 151 NHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG------FVSTKSDVYSFGVLLLELITG---------- 214 (266)
Q Consensus 151 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~i~~~l~~g---------- 214 (266)
+.+||+|||++..................||+.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 9999999999865332222111223345799999999999776 455789999999999999999
Q ss_pred CCCcCCCc----hhHHHHHHHHh-----------------cCchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 215 LKSIQGSA----TLAEWTEECRR-----------------NKNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 215 ~~pf~~~~----~~~~~~~~~~~-----------------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
..||.+.. ........... ....+++.+|+..+|..||+.+++.+.++.
T Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 88885431 22222222110 112357889999999999999999998875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=281.83 Aligned_cols=241 Identities=24% Similarity=0.328 Sum_probs=193.8
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
..++.+...||+|+||.||++. ..+|..+++|.+..... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 3567777899999999999994 45688899998865443 346788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe---cCCceEEeccccccC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLCKL 163 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~---~~~~~~l~dfg~~~~ 163 (266)
|+.+++|.+.+...... ...+++..++.++.|++.||.|||+.| ++|+||||+||+++ .++.++|+|||++..
T Consensus 101 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 101 TCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred eCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999988653211 256899999999999999999999999 99999999999994 457899999999975
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-------- 235 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 235 (266)
... ........+|..|+|||++. ..++.++|+||+|+++|+|++|..||.+.+.............
T Consensus 177 ~~~-----~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (285)
T 3is5_A 177 FKS-----DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP 250 (285)
T ss_dssp ---------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CC
T ss_pred cCC-----cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCc
Confidence 322 12234566899999999986 4678899999999999999999999987765544433332211
Q ss_pred ----chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+..++.+
T Consensus 251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 251 LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 125788999999999999888753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=292.61 Aligned_cols=234 Identities=26% Similarity=0.355 Sum_probs=180.5
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.+.+...||+|+||.||++.. .+++.++||.+.... ..+.+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 355566899999999999954 568889999876543 34567889999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec---CCceEEeccccccCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID---DNHAKLADFGLCKLGPF 166 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~~~l~dfg~~~~~~~ 166 (266)
+++|.+++... +.+++..+..++.|++.||.|||+.| ++|+||||+||+++. ++.++|+|||++.....
T Consensus 132 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 132 GGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp SCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999998763 56899999999999999999999999 999999999999975 78899999999875321
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh-cC----------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR-NK---------- 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~-~~---------- 235 (266)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..........+.. ..
T Consensus 204 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 204 -----QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred -----ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 12234567899999999999989999999999999999999999999776554433322221 11
Q ss_pred ---chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ---NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ---~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++++|+..+|..||+..++.+
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 125788999999999999888754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=286.49 Aligned_cols=237 Identities=24% Similarity=0.300 Sum_probs=191.4
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+|++...||+|+||.||++. ..+|+.+++|++...... ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 456777799999999999995 456899999987654332 24567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... ..+++..+..++.|++.|+.|||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999998887653 56899999999999999999999999 99999999999999999999999999975332
Q ss_pred CCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-----------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----------- 234 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 234 (266)
. ........+|..|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.+............
T Consensus 155 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 155 P----SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred c----ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 1 122334578999999999876 567999999999999999999999998877666544332210
Q ss_pred -----------------------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 -----------------------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 -----------------------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 012478899999999999988875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=294.42 Aligned_cols=232 Identities=22% Similarity=0.276 Sum_probs=187.7
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecC------eE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------EQ 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~ 81 (266)
+|.....||+|+||.||++. ..+|+.++||++..... ....++.+|+++++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 45556689999999999994 56799999998854322 23467889999999999999999999987653 46
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++
T Consensus 106 ~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp EEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 9999999 8899998876 56899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------ 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------ 234 (266)
..... ......+|..|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+...++..+....
T Consensus 176 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 176 RQADS-------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp EECCS-------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccc-------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 85321 2334578999999999876 678999999999999999999999999888777666554311
Q ss_pred ----------------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ----------------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ----------------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 1125677899999999998887654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=291.46 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=203.1
Q ss_pred HhhchhhhhccccccceEEEEE-----cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEE--ecCeE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-----LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL--EKGEQ 81 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-----~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~ 81 (266)
..++++...||+|+||.||++. ..++..++||.+..........+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4566777799999999999996 3568889999887665555677899999999999999999999876 45578
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccc
Confidence 9999999999999999763 145899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh--------------HHH
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL--------------AEW 227 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~--------------~~~ 227 (266)
........ .........+|..|+|||++.+..++.++||||||+++|+|++|..||...... ...
T Consensus 175 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 175 KLLPLDKD-YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp EECCTTCS-EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred eecccCCc-cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 86432221 112233456788899999999888999999999999999999999999654332 111
Q ss_pred HHHHHhc-----------CchhhhhhhccCCCCCcchHHHHHHHHHHHhC
Q 047020 228 TEECRRN-----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 228 ~~~~~~~-----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~~ 266 (266)
....... ...+++.+|+.++|..||+.+++.+.++..|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 12267889999999999999999999988763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=285.77 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=206.3
Q ss_pred HHHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
+...++.+...||+|+||.||++.. .++..+++|.+.. .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 4455666667999999999999954 4578889987754 3345677889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+.+++|.+++... ....+++..+..++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp ECCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EcCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999763 3356899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC---------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK--------- 235 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~--------- 235 (266)
.. .........++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+.............
T Consensus 163 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 163 GD---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 239 (288)
T ss_dssp SS---SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred CC---ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCH
Confidence 22 1223344567888999999998899999999999999999999 9999987655443333222211
Q ss_pred -chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 -NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 -~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+.+++.+.++..+
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 126788999999999999999999988764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=293.56 Aligned_cols=206 Identities=24% Similarity=0.290 Sum_probs=174.4
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-----CCCccccceeEEecCeE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-----HPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~ 81 (266)
...+|.+..+||+|+||.||++. ..+++.++||.+... ......+..|+++++.++ ||||+++++++...+..
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 34456666799999999999994 467889999987532 234456778999999986 99999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec------------
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID------------ 149 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~------------ 149 (266)
++|||++ +++|.+++... ....+++..+..++.|++.||.|||+.| ++||||||+||+++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred EEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhc
Confidence 9999999 89999999863 2245899999999999999999999999 999999999999975
Q ss_pred -------------CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCC
Q 047020 150 -------------DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLK 216 (266)
Q Consensus 150 -------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~ 216 (266)
++.++|+|||++.... .......||+.|+|||++.+..++.++||||+||++|+|++|..
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKS-------DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETT-------SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccCCCCEEEEeccCceecC-------CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 7789999999997522 12235678999999999999999999999999999999999999
Q ss_pred CcCCCchhHHHH
Q 047020 217 SIQGSATLAEWT 228 (266)
Q Consensus 217 pf~~~~~~~~~~ 228 (266)
||.+.+......
T Consensus 258 pf~~~~~~~~~~ 269 (360)
T 3llt_A 258 LFRTHEHMEHLA 269 (360)
T ss_dssp SCCCSSHHHHHH
T ss_pred CCCCCcHHHHHH
Confidence 998776555443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=300.85 Aligned_cols=238 Identities=22% Similarity=0.266 Sum_probs=199.7
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
...+|++...||+|+||.||++. ..+|+.++||.+.... ......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 45677788899999999999994 4578899999875432 33567789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe---cCCceEEeccccc
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLC 161 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~---~~~~~~l~dfg~~ 161 (266)
|||+.+++|.+.+... +.+++..+..++.|++.||.|||++| |+||||||+||+++ .++.++|+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999988765 67999999999999999999999999 99999999999995 4557999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------ 235 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------ 235 (266)
..... ........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+.....
T Consensus 172 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (486)
T 3mwu_A 172 TCFQQ-----NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245 (486)
T ss_dssp TTBCC-----C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred eECCC-----CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 75322 223345679999999999876 488999999999999999999999998877666655554321
Q ss_pred -------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 -------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 -------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++++|+..+|..||+..++.+
T Consensus 246 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 125788999999999999988764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=280.44 Aligned_cols=239 Identities=25% Similarity=0.336 Sum_probs=198.7
Q ss_pred HHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc------cHHHHHHHHHHHhcCCCCCccccceeEEecCe
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 80 (266)
...+|.+...||+|+||.||++.. .+|+.+++|.+...... ....+.+|++++++++||||+++++++.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 456778888999999999999954 57889999987654321 35778999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC----ceEEe
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN----HAKLA 156 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----~~~l~ 156 (266)
.++||||+++++|.+++... ..+++..+..++.|++.||.+||+.| ++|+||||+||+++.++ .++|+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEE
Confidence 99999999999999999764 67899999999999999999999999 99999999999998776 79999
Q ss_pred ccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-
Q 047020 157 DFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK- 235 (266)
Q Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~- 235 (266)
|||.+...... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.............
T Consensus 155 dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (283)
T 3bhy_A 155 DFGIAHKIEAG-----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229 (283)
T ss_dssp CCTTCEECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred ecccceeccCC-----CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence 99998753221 122345689999999999988999999999999999999999999988766555443332211
Q ss_pred ------------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ------------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ------------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+..++.+
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 125788999999999999988765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=285.76 Aligned_cols=248 Identities=28% Similarity=0.370 Sum_probs=196.5
Q ss_pred hchhhhhccccccceEEEEEcCC----CcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeE-EecCeEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAELGD----GNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFC-LEKGEQLLL 84 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~----g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv 84 (266)
++++...||+|+||.||++.... +..+++|.+..... .....+.+|+.++++++||||+++++++ ...+..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 34555689999999999995432 22467776654322 2356788999999999999999999985 455678999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+.+++|.+++... ...+++..+..++.|++.||.+||++| ++|+||||+||+++.++.++|+|||++...
T Consensus 106 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999652 256799999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC--------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK-------- 235 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~-------- 235 (266)
...............+|+.|+|||.+.+..++.++|+||+|+++|+|++ +..||.+.+.............
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 258 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence 4333222333345567889999999998899999999999999999999 6677766655544444333221
Q ss_pred --chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 --NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 --~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+.++|..||+.+++.+.++..+
T Consensus 259 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 125788999999999999999999998875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=289.99 Aligned_cols=241 Identities=23% Similarity=0.323 Sum_probs=195.1
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEe--------c
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE--------K 78 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~ 78 (266)
.+|.+...||+|+||.||++.. .+|+.+++|++..... .....+.+|+++++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4566667999999999999954 6789999998755432 234577899999999999999999999876 3
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
+..++||||+.+ ++.+.+... ...+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCC-CHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 468999999965 777776542 256899999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh----
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR---- 233 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~---- 233 (266)
|++..................||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+...
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9998654443333444456678999999999876 46799999999999999999999999887766554443321
Q ss_pred -------------------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 -------------------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 -------------------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+..+|..||+.+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 310 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence 1122577889999999999888765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=279.46 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=198.7
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+|++...||+|+||.||++. ..+|..+++|.+...... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456677799999999999994 556889999987654322 34667899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc---eEEeccccccC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH---AKLADFGLCKL 163 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---~~l~dfg~~~~ 163 (266)
|+.+++|.+.+... ..+++..+..++.|++.|+.+||+.| ++|+||||+||+++.++. ++|+|||.+..
T Consensus 86 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 86 LVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred cCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999988765 67899999999999999999999999 999999999999986655 99999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-------- 235 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 235 (266)
... ........+|+.|+|||++.+..++.++||||+|+++|+|++|..||.+.+.............
T Consensus 158 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T 3kk8_A 158 VND-----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232 (284)
T ss_dssp CCS-----SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred ccc-----CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhc
Confidence 322 2222346789999999999999999999999999999999999999988766655554443221
Q ss_pred -----chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 -----NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 -----~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+.++|..||+.+++.+
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 125778999999999999988754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=282.70 Aligned_cols=237 Identities=21% Similarity=0.366 Sum_probs=199.6
Q ss_pred HhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
..++.+...||+|+||.||++.. .++..+++|.+.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 45566667999999999999954 567788999875432 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+++++|.+++... +.+++..+..++.|++.|+.+||+.| ++|+||||+||+++.++.++|+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999875 57899999999999999999999999 999999999999999999999999988643
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--------- 235 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 235 (266)
.. .......++..|+|||++.+..++.++|+||+|+++|+|++|..||.+.+.............
T Consensus 165 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 2vgo_A 165 PS------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDG 238 (284)
T ss_dssp SS------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHH
T ss_pred cc------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHH
Confidence 21 223345789999999999998899999999999999999999999988766655544443221
Q ss_pred chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 239 ~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 239 SKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhhcCHhhCCCHHHHhh
Confidence 125788999999999999988754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=298.76 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=198.9
Q ss_pred hhchhhhhccccccceEEEEEcC-CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG-DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..+.+...||+|+||.||++... ++..++||.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 34455568999999999999654 788999998764332 2235678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 194 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 194 VQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred CCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999763 245899999999999999999999999 999999999999999999999999998753211
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------Cc
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------KN 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~~ 236 (266)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+............ ..
T Consensus 267 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 344 (377)
T 3cbl_A 267 VY--AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV 344 (377)
T ss_dssp EE--ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred ce--eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 10 111122345678999999988889999999999999999998 999998765544333222211 11
Q ss_pred hhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
.+++.+|+..+|..||+.+++.+.++..
T Consensus 345 ~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 345 FRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 2577899999999999999999888764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=300.55 Aligned_cols=237 Identities=25% Similarity=0.323 Sum_probs=195.1
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
...|.+...||+|+||.||++. ..++..+++|.+.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3456777799999999999994 4578889999876543 234577889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC---CceEEecccccc
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD---NHAKLADFGLCK 162 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~~~l~dfg~~~ 162 (266)
||+.+++|.+.+... ..+++..+..++.|++.||.|||++| ++||||||+||+++.. +.+||+|||++.
T Consensus 116 e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 999999999988765 67899999999999999999999999 9999999999999764 459999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN------ 236 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 236 (266)
.... ........||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+......
T Consensus 188 ~~~~-----~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (494)
T 3lij_A 188 VFEN-----QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW 261 (494)
T ss_dssp ECBT-----TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGG
T ss_pred ECCC-----CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhc
Confidence 5322 22334567999999999986 45899999999999999999999999888776665555443211
Q ss_pred -------hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 -------VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 -------~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++++|+..+|..||+.+++.+
T Consensus 262 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 262 KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 25788999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=292.48 Aligned_cols=248 Identities=17% Similarity=0.239 Sum_probs=192.6
Q ss_pred hhchhhhhccccccceEEEEEcCC------CcEEEEEEeeeccccc-----------HHHHHHHHHHHhcCCCCCccccc
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGD------GNFGAVKRVMEERGGS-----------RKIFLDEVSVLLRVSHPNLVGLL 72 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~------g~~~~vk~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~i~~~~ 72 (266)
.+|.+...||+|+||.||++.... +..++||......... ......|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 456666799999999999996543 4778999775433211 12234566677788899999999
Q ss_pred eeEEec----CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe
Q 047020 73 GFCLEK----GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 73 ~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~ 148 (266)
+++... ...++||||+ |++|.+++... .+.+++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 988664 4589999999 99999998762 256899999999999999999999999 99999999999999
Q ss_pred --cCCceEEeccccccCCCCCCCCC---CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCch
Q 047020 149 --DDNHAKLADFGLCKLGPFNDPNR---PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT 223 (266)
Q Consensus 149 --~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~ 223 (266)
.++.++|+|||++.......... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999997643322111 1222345699999999999999999999999999999999999999986433
Q ss_pred hHHHHHHHH--------------------hcCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 224 LAEWTEECR--------------------RNKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 224 ~~~~~~~~~--------------------~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...+..... .....+++..|+..+|..||+.++|.++++.++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 322221111 011125678899999999999999999998875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=282.44 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=205.2
Q ss_pred HhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
..++.+...||+|+||.||++...+++.+++|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 35666777999999999999987778889999876543 34567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++... ...+++..+..++.|++.|+.+||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 86 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp TTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999763 246899999999999999999999999 9999999999999999999999999987532111
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------ch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------NV 237 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~~ 237 (266)
........++..|+|||++.+..++.++|+||+|+++|+|++ |..||.+.+............. ..
T Consensus 159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 235 (267)
T 3t9t_A 159 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 235 (267)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred ---ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHH
Confidence 112233456778999999988889999999999999999999 8999987765554444333211 12
Q ss_pred hhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 238 EVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+++.+|+..+|..||+..++.+.++...
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 5788999999999999999999988764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=284.21 Aligned_cols=247 Identities=20% Similarity=0.267 Sum_probs=189.8
Q ss_pred HHhhchhhhhccccccceEEEEEcC----CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELG----DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
...++++...||+|+||.||++... .+..+++|....... .....+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 3455666779999999999999543 234578877654322 23567889999999999999999999874 45789
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+.+++|.+++... ...+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 999999999999999753 246899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK------ 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~------ 235 (266)
...... ........+++.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+.............
T Consensus 165 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (281)
T 1mp8_A 165 YMEDST---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 241 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred ccCccc---ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCC
Confidence 543221 112233456778999999988889999999999999999996 9999987665554444333211
Q ss_pred ----chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++.+.++..+
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 125788999999999999999999988764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=293.22 Aligned_cols=247 Identities=17% Similarity=0.130 Sum_probs=193.8
Q ss_pred hchhhhhccccccceEEEE------EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC---CCCccccceeEEecCeE
Q 047020 11 TNDFRIRIGVGATSFVYLA------ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS---HPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~------~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~ 81 (266)
++.+...||+|+||.||++ ...+++.+++|.+... ....+..|.++++.++ |+||+++++++...+..
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 3445558999999999999 4567889999987543 3556778888888886 89999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-----------C
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-----------D 150 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-----------~ 150 (266)
++||||+.+++|.+++..........+++..+..++.|++.||.|||+.| |+||||||+||+++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccccc
Confidence 99999999999999998755445578999999999999999999999999 999999999999988 8
Q ss_pred CceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHH-HHH
Q 047020 151 NHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAE-WTE 229 (266)
Q Consensus 151 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~-~~~ 229 (266)
+.+||+|||++...... ..........||..|+|||++.+..++.++|||||||++|+|++|..||........ ...
T Consensus 220 ~~~kl~DFG~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 297 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLF--PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297 (365)
T ss_dssp TTEEECCCTTCEEGGGS--CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECS
T ss_pred CCEEEeeCchhhhhhcc--CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeech
Confidence 89999999999642211 112334556799999999999999999999999999999999999999954322110 000
Q ss_pred HHHhcC----chhhhhhhccCCCCCc-chHHHHHHHHHHHh
Q 047020 230 ECRRNK----NVEVWAQMLDPKLNGD-ANMEQLRVLIRICM 265 (266)
Q Consensus 230 ~~~~~~----~~~~~~~~l~~~~~~~-~~~~~l~~~~~~~~ 265 (266)
.....+ -.+++..++..++..| ++.+++++.++.++
T Consensus 298 ~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 298 LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp CCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred hccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 000111 1245567888888887 67777777776654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=284.20 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=202.1
Q ss_pred HHHHHhhchhhhhccccccceEEEEE-----cCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEec
Q 047020 5 EELKMATNDFRIRIGVGATSFVYLAE-----LGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK 78 (266)
Q Consensus 5 ~~i~~~~~~~~~~ig~g~~~~v~~~~-----~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 78 (266)
+.+....++..+.||+|+||.||++. ..+++.+++|.+.... ......+.+|+++++.++||||+++++++.+.
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 34445566777799999999999996 4578899999886443 23457789999999999999999999999776
Q ss_pred --CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEe
Q 047020 79 --GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLA 156 (266)
Q Consensus 79 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~ 156 (266)
...++||||+++++|.+++... ...+++..++.++.|++.||.+||+.| ++|+||||+||+++.++.++|+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEEC
Confidence 5689999999999999999653 246899999999999999999999999 9999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC--------------c
Q 047020 157 DFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS--------------A 222 (266)
Q Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~--------------~ 222 (266)
|||++........ .........+|..|+|||++.+..++.++|+||+|+++|+|++|..|+... .
T Consensus 169 Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 169 DFGLTKAIETDKE-YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247 (302)
T ss_dssp CCTTCEECCTTCC-EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG
T ss_pred cccccccccCCCc-ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc
Confidence 9999876433221 112234456788899999999888999999999999999999999886432 2
Q ss_pred hhHHHHHHHHhc-----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 223 TLAEWTEECRRN-----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 223 ~~~~~~~~~~~~-----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
............ ...+++.+|+..+|..||+.+++.+.++..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 222222222221 1226788999999999999999999998765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=280.96 Aligned_cols=248 Identities=17% Similarity=0.191 Sum_probs=201.8
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
...+|.+...||+|+||.||++. ..+|+.+++|.+.... ....+.+|+.+++.+ +|++++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 34556777799999999999995 5778899999775433 334578899999999 6999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc-----eEEecccc
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH-----AKLADFGL 160 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~-----~~l~dfg~ 160 (266)
||+ +++|.+++... ...+++..+..++.|++.||.|||++| ++|+||||+||+++.++. ++|+|||+
T Consensus 86 e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp ECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred Eec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 999 99999999763 245899999999999999999999999 999999999999987765 99999999
Q ss_pred ccCCCCCCCCC---CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc---hhHHHHHHHHh-
Q 047020 161 CKLGPFNDPNR---PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA---TLAEWTEECRR- 233 (266)
Q Consensus 161 ~~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~---~~~~~~~~~~~- 233 (266)
+.......... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+ ....+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 98654332211 122355679999999999999899999999999999999999999997742 22222211111
Q ss_pred --c-----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 234 --N-----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 234 --~-----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
. ...+++.+|+..+|..||+.++|.+.++.++
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 1 1225778999999999999999999998765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=287.36 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=195.1
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcE----EEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNF----GAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~----~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
..++..+.||+|+||.||++. ..+++. +++|.+.... ......+.+|+.+++.++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 455666789999999999995 455655 5666553332 223355678999999999999999999886 456899
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+.+++|.+++... .+.+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++..
T Consensus 92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999998752 257899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc--------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN-------- 234 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~-------- 234 (266)
...... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+..............
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
T 3kex_A 165 LPPDDK--QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQIC 242 (325)
T ss_dssp SCCCTT--CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTB
T ss_pred cCcccc--cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcC
Confidence 543322 223345667889999999998899999999999999999999 999998765444433333221
Q ss_pred --CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 235 --KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 235 --~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...+++.+|+..+|..||+..++.+.++..
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 243 TIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 123578899999999999999999988765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=282.47 Aligned_cols=246 Identities=26% Similarity=0.352 Sum_probs=202.5
Q ss_pred HhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
..++++...||+|+||.||++...++..+++|.+... ......+.+|+++++.++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 4566677799999999999998777788999887543 3356788999999999999999999998764 5689999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+++... ....+++..+..++.|++.||.+||++| ++|+||||+||++++++.++|+|||++.......
T Consensus 90 ~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 90 ENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp TTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999998753 1136899999999999999999999999 9999999999999999999999999987643221
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------Cch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------KNV 237 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~~~ 237 (266)
........++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+............ ...
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (279)
T 1qpc_A 164 ---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240 (279)
T ss_dssp ---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ---cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHH
Confidence 112233456778999999988889999999999999999999 999998766554443332221 112
Q ss_pred hhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 238 EVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+++.+|+..+|..||+.+++.+.++..+
T Consensus 241 ~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 241 QLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 5788999999999999999999998765
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=290.21 Aligned_cols=239 Identities=20% Similarity=0.243 Sum_probs=188.6
Q ss_pred HHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
...+|.+...||+|+||.||++ +..+|+.++||.+...... ....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3456667779999999999999 4667889999987544322 245677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe-----cCCceEEeccc
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI-----DDNHAKLADFG 159 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-----~~~~~~l~dfg 159 (266)
|||+. ++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++ ..+.++|+|||
T Consensus 112 ~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99996 5999998764 56899999999999999999999999 99999999999995 44559999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc----
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN---- 234 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~---- 234 (266)
++...... ........+|..|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+....
T Consensus 183 ~a~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 183 LARAFGIP----IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258 (329)
T ss_dssp HHHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CccccCCc----ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence 98753211 1223345679999999999764 58999999999999999999999999887777666554421
Q ss_pred -----------------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 -----------------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 -----------------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++.+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 1125778899999999998887653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=288.42 Aligned_cols=234 Identities=23% Similarity=0.350 Sum_probs=170.7
Q ss_pred hhchhh---hhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEE
Q 047020 10 ATNDFR---IRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 10 ~~~~~~---~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 84 (266)
..|++. +.||+|+||.||++. ..+|+.++||.+... ....+.+|+.+++.++ ||||+++++++.+....++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 344554 479999999999994 457889999987543 3466788999999997 99999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC---ceEEeccccc
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN---HAKLADFGLC 161 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~~~l~dfg~~ 161 (266)
|||+.+++|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||+++.++ .++|+|||++
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 85 MELLNGGELFERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp ECCCCSCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred EEccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 9999999999999874 67999999999999999999999999 99999999999998765 7999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh------HHHHHHHHh-c
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL------AEWTEECRR-N 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~------~~~~~~~~~-~ 234 (266)
...... ........+|+.|+|||++.+..++.++||||+|+++|+|++|..||.+.+.. ......+.. .
T Consensus 157 ~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~ 232 (325)
T 3kn6_A 157 RLKPPD----NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232 (325)
T ss_dssp EECCC--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC
T ss_pred eecCCC----CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC
Confidence 753221 22234556899999999999999999999999999999999999999764331 122222211 1
Q ss_pred -------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 -------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 -------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+.+++.
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 112467788888888888876653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=305.33 Aligned_cols=245 Identities=23% Similarity=0.328 Sum_probs=201.7
Q ss_pred HhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
...+.+.+.||+|+||.||++...++..++||.+... ....+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 3455566689999999999998888889999987653 345778999999999999999999999886 56789999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 265 ~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 265 AKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp TTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred CCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 9999999997531 135788999999999999999999999 9999999999999999999999999998532211
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------ch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------NV 237 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~~ 237 (266)
........++..|+|||++....++.++||||||+++|+|++ |..||.+.+............. ..
T Consensus 339 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 415 (454)
T 1qcf_A 339 ---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 415 (454)
T ss_dssp ---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred ---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 111223346778999999988889999999999999999999 9999988765554444333211 12
Q ss_pred hhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
+++.+|+..+|..||+.++|.+.++..
T Consensus 416 ~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 416 NIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 578899999999999999999988754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=278.06 Aligned_cols=241 Identities=23% Similarity=0.323 Sum_probs=196.2
Q ss_pred HhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
..++.+...||+|+||.||++.. .+|+.+++|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 35677777999999999999954 5788999998764432 345778899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++++|.+++... ..+++..+..++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||.+.....
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999988653 57899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-----------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN----------- 234 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 234 (266)
... ........++..|+|||++.+..+ +.++|+||+|+++|+|++|..||.+.+............
T Consensus 158 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (276)
T 2yex_A 158 NNR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235 (276)
T ss_dssp TTE--ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred Ccc--hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcC
Confidence 111 122344678999999999987665 778999999999999999999997765432222222110
Q ss_pred -CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 -KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 -~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++.+
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 236 SAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1125778999999999999888753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=303.27 Aligned_cols=237 Identities=22% Similarity=0.264 Sum_probs=194.0
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
++.+...||+|+||.||++. ..+|+.+++|.+... .......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 264 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 34455689999999999995 457899999988553 22345668899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.|++|.+++... ....+++..+..++.|++.||.|||++| |+||||||+||+++.+|.+||+|||++.....
T Consensus 265 y~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 265 LMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp CCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999988763 2245899999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCch---hHHHHHHHHhcC--------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT---LAEWTEECRRNK-------- 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~---~~~~~~~~~~~~-------- 235 (266)
. .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+. .......+...+
T Consensus 339 ~-----~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s 413 (576)
T 2acx_A 339 G-----QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS 413 (576)
T ss_dssp T-----CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred C-----ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCC
Confidence 1 122345799999999999998999999999999999999999999987542 222222222211
Q ss_pred --chhhhhhhccCCCCCcc-----hHHHHH
Q 047020 236 --NVEVWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 236 --~~~~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
..+++++|+..+|..|+ +.+++.
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil 443 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVK 443 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHH
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHH
Confidence 12567889999999998 666654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=300.33 Aligned_cols=239 Identities=30% Similarity=0.389 Sum_probs=196.0
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecC-eEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG-EQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~ 88 (266)
..+.+...||+|+||.||++... |..++||.+.... ..+.+.+|++++++++||||+++++++.... ..++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 44555668999999999999764 7789999876543 4577899999999999999999999987655 789999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 270 ~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 341 (450)
T 1k9a_A 270 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 341 (450)
T ss_dssp TTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc--
Confidence 999999999874 2234789999999999999999999999 99999999999999999999999999874221
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------Cch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------KNV 237 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~~~ 237 (266)
......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+............ ...
T Consensus 342 -----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 342 -----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 416 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred -----cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1122356788999999999999999999999999999998 999998765444333332221 112
Q ss_pred hhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
+++.+|+..+|..||+..++.+.++..
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 577899999999999999999888754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=282.76 Aligned_cols=241 Identities=23% Similarity=0.310 Sum_probs=189.7
Q ss_pred hchhh-hhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFR-IRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~-~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.|... ..||+|+||.||++. ..+|+.++||.+..........+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 44443 479999999999995 557899999998766656678899999999985 699999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc---eEEeccccccCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH---AKLADFGLCKLG 164 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---~~l~dfg~~~~~ 164 (266)
+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++. ++|+|||++...
T Consensus 93 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 93 MRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred CCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999875 67899999999999999999999999 999999999999987765 999999998754
Q ss_pred CCCCCC---CCCcccccccCCCccCcccccc-----ccCCCcccchhHHHHHHHHHhCCCCcCCCchh------------
Q 047020 165 PFNDPN---RPKRQTSIKGSFGYVDTNYLNT-----GFVSTKSDVYSFGVLLLELITGLKSIQGSATL------------ 224 (266)
Q Consensus 165 ~~~~~~---~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~------------ 224 (266)
...... .........||..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 322111 1112234568999999999865 56789999999999999999999999765321
Q ss_pred --HHH-HHHHHhc-------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 225 --AEW-TEECRRN-------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 225 --~~~-~~~~~~~-------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
... ....... ...+++.+|+..+|..||+.+++.+
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111 1111110 1126788999999999999988764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.39 Aligned_cols=236 Identities=24% Similarity=0.316 Sum_probs=195.8
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-------------ccHHHHHHHHHHHhcCCCCCccccceeE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-------------GSRKIFLDEVSVLLRVSHPNLVGLLGFC 75 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 75 (266)
..|.+..+||+|+||.||++. ..++..+++|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 456666799999999999994 45678899998764321 2356788999999999999999999999
Q ss_pred EecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC---c
Q 047020 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN---H 152 (266)
Q Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~ 152 (266)
.+....++||||+.+++|.+.+... +.+++..+..++.|++.||.|||+.| ++||||||+||+++.++ .
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999998765 67999999999999999999999999 99999999999998776 6
Q ss_pred eEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 153 AKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 153 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
++|+|||++..... ........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+..
T Consensus 188 ~kl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 188 IKIVDFGLSSFFSK-----DYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp EEECCCTTCEECCT-----TSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEEECCCCEEcCC-----CCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 99999999975332 223345679999999999874 589999999999999999999999998877666555544
Q ss_pred hcC-------------chhhhhhhccCCCCCcchHHHHHH
Q 047020 233 RNK-------------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 233 ~~~-------------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
... ..+++++|+..+|..||+.+++.+
T Consensus 262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 321 125788999999999999988753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=284.32 Aligned_cols=244 Identities=22% Similarity=0.278 Sum_probs=198.2
Q ss_pred hHHHHHhhchhh-hhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCC-CCCccccceeEEec
Q 047020 4 LEELKMATNDFR-IRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEK 78 (266)
Q Consensus 4 ~~~i~~~~~~~~-~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 78 (266)
..+.....|.+. +.||+|+||.||++ ...+|+.+++|.+..... .....+.+|+.+++.+. ||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344555556665 58999999999999 455789999998765332 34577889999999996 69999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec---CCceEE
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID---DNHAKL 155 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~~~l 155 (266)
+..++||||+.+++|.+++.. .....+++..++.++.|++.||.|||++| ++|+||||+||+++. .+.++|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred CeEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999998865 23367899999999999999999999999 999999999999987 789999
Q ss_pred eccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC
Q 047020 156 ADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK 235 (266)
Q Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (266)
+|||++..... ........||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......+.....
T Consensus 176 ~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 250 (327)
T 3lm5_A 176 VDFGMSRKIGH-----ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250 (327)
T ss_dssp CCGGGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred eeCccccccCC-----ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc
Confidence 99999985322 1223346789999999999999999999999999999999999999988777666555444221
Q ss_pred -------------chhhhhhhccCCCCCcchHHHHH
Q 047020 236 -------------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 -------------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++.+|+..+|..||+.+++.
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 12467889999999999988764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=302.81 Aligned_cols=239 Identities=24% Similarity=0.319 Sum_probs=201.7
Q ss_pred HHHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
+...+|.+...||+|+||.||++. ..+|+.++||.+.... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345667777899999999999994 4578999999875432 335677899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE---ecCCceEEeccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL---IDDNHAKLADFG 159 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~---~~~~~~~l~dfg 159 (266)
+||||+.+++|.+.+... +.+++..+..++.|++.||.|||++| ++||||||+||++ +.++.++|+|||
T Consensus 103 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp EEECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred EEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 999999999999988764 67899999999999999999999999 9999999999999 467889999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC----
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK---- 235 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~---- 235 (266)
++..... ........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+.....
T Consensus 175 ~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 175 LSTHFEA-----SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL 248 (484)
T ss_dssp HHHHBCC-----CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred eeEEccc-----ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9875321 223345679999999999876 689999999999999999999999998877766665554321
Q ss_pred ---------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ---------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ---------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++++|+..+|..||+.+++.+
T Consensus 249 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 125778999999999999888753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=279.83 Aligned_cols=244 Identities=18% Similarity=0.248 Sum_probs=201.9
Q ss_pred HHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEec--CeEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQL 82 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 82 (266)
+...++.+...||+|+||.||++... |..++||.+..... .....+.+|+.++++++||||+++++++.+. ...+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 34566777789999999999999764 88899998765432 2345788999999999999999999999877 7889
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++++|+||||+||+++.++.++|+|||+..
T Consensus 86 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEEECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eeecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEecccee
Confidence 999999999999999763 2236899999999999999999999874 569999999999999999999999888765
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCC---cccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVST---KSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN--- 236 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 236 (266)
. .......+|+.|+|||.+.+..++. ++||||||+++|+|++|..||.+.+..............
T Consensus 162 ~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3kmu_A 162 S---------FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232 (271)
T ss_dssp T---------TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred e---------ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC
Confidence 2 1223456789999999998765554 799999999999999999999887766665555443211
Q ss_pred --------hhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 237 --------VEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 237 --------~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
.+++.+|+..+|..||+.+++.+.++..
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 2578899999999999999999998865
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=281.02 Aligned_cols=237 Identities=21% Similarity=0.284 Sum_probs=196.4
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.+|.....||+|+||.||++.. .+++.+++|.+..... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 4556667999999999999954 4678888887755422 23567888999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+.+++|.+++... +.+++..+..++.|++.|+.+||+.| ++|+||||+||+++.++.++|+|||++....
T Consensus 95 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 95 ELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp ECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999988764 67899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN--------- 236 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 236 (266)
.. ........++..|+|||++.+..++.++|+||+|+++|+|++|..||.+.+....+.........
T Consensus 167 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 2rku_A 167 YD----GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA 242 (294)
T ss_dssp ST----TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred cC----ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHH
Confidence 22 12234467899999999999888999999999999999999999999887665555444332211
Q ss_pred hhhhhhhccCCCCCcchHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
.+++.+|+..+|..||+.+++.
T Consensus 243 ~~li~~~l~~~p~~Rps~~~ll 264 (294)
T 2rku_A 243 ASLIQKMLQTDPTARPTINELL 264 (294)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGG
T ss_pred HHHHHHHcccChhhCcCHHHHh
Confidence 2467788888888888877664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=288.37 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=191.6
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEE----EEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFG----AVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~----~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
...+++..+.||+|+||.||++. ..+|+.+ ++|.+.... ......+.+|+.++++++||||+++++++.+.. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 34556667799999999999995 4455544 666554322 234577899999999999999999999998764 7
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
+++++++.+++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 92 ~~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred EEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcce
Confidence 8899999999999998763 256899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-----
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----- 235 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----- 235 (266)
........ ........+|..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.............
T Consensus 165 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (327)
T 3poz_A 165 KLLGAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242 (327)
T ss_dssp HHHTTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred eEccCCcc--cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCc
Confidence 75432221 222234456889999999999999999999999999999999 9999987654433322222111
Q ss_pred -----chhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 236 -----NVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 236 -----~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
..+++.+|+..+|..||+..++.+.++..
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 243 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 12577899999999999999999888764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=286.85 Aligned_cols=231 Identities=23% Similarity=0.302 Sum_probs=192.2
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+.....||+|+||.||++. ..+|+.++||++...... ....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 4445589999999999995 567889999988654322 235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+. |++.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 136 ~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~-- 205 (348)
T 1u5q_A 136 CL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-- 205 (348)
T ss_dssp CS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS--
T ss_pred CC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC--
Confidence 96 6888887643 256899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCCCcccccccCCCccCccccc---cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLN---TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
......||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..............
T Consensus 206 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (348)
T 1u5q_A 206 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 279 (348)
T ss_dssp ------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred ------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Confidence 123457899999999984 567889999999999999999999999887766665555443211
Q ss_pred ---hhhhhhhccCCCCCcchHHHHH
Q 047020 237 ---VEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 237 ---~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
.+++.+|+..+|..||+.+++.
T Consensus 280 ~~l~~li~~~l~~dP~~Rps~~~ll 304 (348)
T 1u5q_A 280 EYFRNFVDSCLQKIPQDRPTSEVLL 304 (348)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHHcccChhhCcCHHHHh
Confidence 2567788999999999888765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=281.19 Aligned_cols=243 Identities=24% Similarity=0.298 Sum_probs=193.4
Q ss_pred hhccccccceEEEEEc-CCCc---EEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeE-EEEEEecC
Q 047020 16 IRIGVGATSFVYLAEL-GDGN---FGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ-LLLLEYLA 89 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~-~~g~---~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~lv~e~~~ 89 (266)
+.||+|+||.||++.. .++. .+++|.+..... .....+.+|+.+++.++||||+++++++.+.+.. +++|||+.
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~ 106 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC 106 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCT
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEeccc
Confidence 5799999999999953 3333 578887654332 2346788999999999999999999999766654 99999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++... ...+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++........
T Consensus 107 ~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 107 HGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp TCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred CCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999998752 256789999999999999999999999 99999999999999999999999999975433322
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCC-cCCCchhHHHHHHHHhcC----------chh
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKS-IQGSATLAEWTEECRRNK----------NVE 238 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~p-f~~~~~~~~~~~~~~~~~----------~~~ 238 (266)
..........++..|+|||.+.+..++.++|+||+|+++|+|++|..| |.+.+............. ..+
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 259 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHH
Confidence 223334456778899999999999999999999999999999995555 544443333222222211 125
Q ss_pred hhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
++.+|+..+|..||+.+++.+.++..+
T Consensus 260 li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 260 VMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 788999999999999999999988764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=281.09 Aligned_cols=247 Identities=19% Similarity=0.276 Sum_probs=199.9
Q ss_pred hhchhhh-hccccccceEEEEEc---CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 10 ATNDFRI-RIGVGATSFVYLAEL---GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 10 ~~~~~~~-~ig~g~~~~v~~~~~---~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
.++.... .||+|+||.||++.. .++..+++|.+..... .....+.+|+++++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3444444 899999999999953 3577889988765432 3456788999999999999999999998 45578999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+.+++|.+++... ...+++..++.++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999998642 256899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC--------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK-------- 235 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~-------- 235 (266)
...... ........+|..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+.............
T Consensus 161 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (287)
T 1u59_A 161 GADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 239 (287)
T ss_dssp TTCSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCcce-eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence 322211 112233456788999999988889999999999999999998 9999987665544433333211
Q ss_pred --chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 --NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 --~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++.+.++.++
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 125788999999999999999999999876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=286.18 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=198.9
Q ss_pred HHhhchhhhhccccccceEEEEEc-CCCcEE--EEEEeeecc-cccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL-GDGNFG--AVKRVMEER-GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~--~vk~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 82 (266)
...++.+...||+|+||.||++.. .+|..+ ++|.+.... ......+.+|+++++++ +||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 345667777999999999999954 455544 777765422 23456788999999999 8999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC
Q 047020 83 LLLEYLANKSLFDRMHTYY-----------GQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN 151 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~ 151 (266)
+||||+++++|.+++.... ......+++..++.++.|++.||.+||++| ++|+||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence 9999999999999997642 122357899999999999999999999999 99999999999999999
Q ss_pred ceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHH
Q 047020 152 HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEE 230 (266)
Q Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~ 230 (266)
.++|+|||++..... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+........
T Consensus 180 ~~kL~Dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 180 VAKIADFGLSRGQEV-----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp CEEECCTTCEESSCE-----ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred eEEEcccCcCccccc-----cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 999999999874211 112233456788999999988889999999999999999998 99999877655444332
Q ss_pred HHhc----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 231 CRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 231 ~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.... ...+++.+|+..+|..||+.+++.+.++..+
T Consensus 255 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 255 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2211 1125788999999999999999999888764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=291.15 Aligned_cols=206 Identities=23% Similarity=0.288 Sum_probs=166.2
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecC------e
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------E 80 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~ 80 (266)
.+|.+...||+|+||.||++ +..+|+.++||++..... .....+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 35566678999999999999 456788999998865322 23456789999999999999999999987655 7
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.++||||+. ++|.+.+. ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 899999996 57888775 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~ 231 (266)
+..... ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..+.
T Consensus 174 a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 239 (371)
T 2xrw_A 174 ARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239 (371)
T ss_dssp ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccc-----ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 875321 122344678999999999999899999999999999999999999999887776665544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=291.26 Aligned_cols=238 Identities=23% Similarity=0.248 Sum_probs=192.7
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc--------cHHHHHHHHHHHhcCCCCCccccceeEEecC
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG--------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG 79 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 79 (266)
..+|.+...||+|+||.||++. ..+|+.++||.+...... ....+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4456666789999999999994 667889999987654321 2345678999999999999999999999999
Q ss_pred eEEEEEEecCCC-chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 80 EQLLLLEYLANK-SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 80 ~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
..++|||++.++ +|.+++... ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 999999998666 999988764 57999999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH---hc
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR---RN 234 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~---~~ 234 (266)
|++..... ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+............ ..
T Consensus 175 g~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (335)
T 3dls_A 175 GSAAYLER-----GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSK 249 (335)
T ss_dssp TTCEECCT-----TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCH
T ss_pred ccceECCC-----CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCH
Confidence 99975332 222344678999999999988776 7889999999999999999999976433211100000 01
Q ss_pred CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+.++|..||+.+++.+
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 1225778999999999999887754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=280.37 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=195.6
Q ss_pred hchhhh-hccccccceEEEEEc---CCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 11 TNDFRI-RIGVGATSFVYLAEL---GDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 11 ~~~~~~-~ig~g~~~~v~~~~~---~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
++.+.. .||+|+||.||++.. ..+..++||.+...... ....+.+|+++++.++||||+++++++ ..+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 344445 899999999999932 34678899887654322 256788999999999999999999998 55678999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+.+++|.+++... +.+++..++.++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++...
T Consensus 96 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999864 56899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc---------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN--------- 234 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~--------- 234 (266)
...... ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+............
T Consensus 168 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (291)
T 1xbb_A 168 RADENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 246 (291)
T ss_dssp CTTCSE-EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCCCc-ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 322211 111223346688999999988888999999999999999999 999998766544433332221
Q ss_pred -CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 235 -KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 235 -~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...+++.+|+..+|..||+..++.+.++..+
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1126788999999999999999999998875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=298.64 Aligned_cols=203 Identities=24% Similarity=0.338 Sum_probs=154.8
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEec-----CeEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK-----GEQL 82 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 82 (266)
+|.+.+.||+|+||.||++ +..+|+.++||++..... ....++.+|+++++.++||||+++++++... ...+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4666679999999999999 455789999998865322 2346788999999999999999999998433 5689
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+|||++ +++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.
T Consensus 134 lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEECCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 999987 67999988763 67999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCCCC-----------------------CcccccccCCCccCcccc-ccccCCCcccchhHHHHHHHHHh-----
Q 047020 163 LGPFNDPNRP-----------------------KRQTSIKGSFGYVDTNYL-NTGFVSTKSDVYSFGVLLLELIT----- 213 (266)
Q Consensus 163 ~~~~~~~~~~-----------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~i~~~l~~----- 213 (266)
.......... .......||+.|+|||++ .+..++.++||||+||++|+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 6543221110 123445789999999986 56679999999999999999998
Q ss_pred ------CCCCcCCCc
Q 047020 214 ------GLKSIQGSA 222 (266)
Q Consensus 214 ------g~~pf~~~~ 222 (266)
|..+|.+.+
T Consensus 285 ~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 285 VAYHADRGPLFPGSS 299 (458)
T ss_dssp CSSGGGCCCSCC---
T ss_pred ccccccccccCCCCc
Confidence 677776644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=287.04 Aligned_cols=210 Identities=24% Similarity=0.335 Sum_probs=172.9
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.+|+....||+|+||.||++. ..+|+.+++|.+...... ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 455666699999999999994 456889999987654332 24557789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.++.... ..+++..+..++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 105 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99988888776543 56899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~ 231 (266)
. ........+|..|+|||++.+. .++.++||||+||++|+|++|..||.+.+.........
T Consensus 177 ~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 177 P----GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred C----ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 1 1223345689999999999775 68899999999999999999999998887766555443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=286.01 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=201.2
Q ss_pred HhhchhhhhccccccceEEEEEc--------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL--------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEK 78 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~--------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 78 (266)
..++.+.+.||+|+||.||++.. .++..+++|.+..... .....+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 34566667999999999999954 3567889998764432 2346788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQ-----------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL 147 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~ 147 (266)
+..++||||+.+++|.+++...... ....+++..++.++.|++.||.|||+.| ++|+||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999999864321 1235899999999999999999999999 9999999999999
Q ss_pred ecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHH
Q 047020 148 IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAE 226 (266)
Q Consensus 148 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~ 226 (266)
+.++.++|+|||++........ ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred cCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 9999999999999875432211 112233456788999999988889999999999999999999 9999987665444
Q ss_pred HHHHHHhc----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 227 WTEECRRN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 227 ~~~~~~~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
........ ...+++.+|+..+|..||+..++.+.++..+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 43333221 1125778999999999999999999988764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=286.12 Aligned_cols=237 Identities=21% Similarity=0.291 Sum_probs=196.9
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.+|.....||+|+||.||++. ..+++.+++|.+..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 345556689999999999995 45677888887755422 23567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+.+++|.+++... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++....
T Consensus 121 e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 121 ELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp CCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999988764 67899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN--------- 236 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 236 (266)
... .......+|..|+|||++.+..++.++||||||+++|+|++|..||.+.+....+.........
T Consensus 193 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
T 2owb_A 193 YDG----ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA 268 (335)
T ss_dssp STT----CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred cCc----ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHH
Confidence 221 2234467899999999999888999999999999999999999999887665555444433221
Q ss_pred hhhhhhhccCCCCCcchHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
.+++.+|+..++..||+.+++.
T Consensus 269 ~~li~~~l~~dp~~Rps~~ell 290 (335)
T 2owb_A 269 ASLIQKMLQTDPTARPTINELL 290 (335)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGG
T ss_pred HHHHHHHccCChhHCcCHHHHh
Confidence 2567788888888888877764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=291.72 Aligned_cols=247 Identities=19% Similarity=0.220 Sum_probs=189.8
Q ss_pred HHhhchhhhhccccccceEEEEEcC----CCcEEEEEEeeecccc-----------cHHHHHHHHHHHhcCCCCCccccc
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELG----DGNFGAVKRVMEERGG-----------SRKIFLDEVSVLLRVSHPNLVGLL 72 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~ 72 (266)
...+|.+...||+|+||.||++... ++..+++|........ ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3455667779999999999999553 5778888877654321 123356788899999999999999
Q ss_pred eeEEe----cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe
Q 047020 73 GFCLE----KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 73 ~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~ 148 (266)
+++.. ....++||||+ +++|.+++... +.+++..++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLG 185 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEc
Confidence 99877 67899999999 99999998764 47899999999999999999999999 99999999999999
Q ss_pred cCC--ceEEeccccccCCCCCCCC---CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCch
Q 047020 149 DDN--HAKLADFGLCKLGPFNDPN---RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT 223 (266)
Q Consensus 149 ~~~--~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~ 223 (266)
.++ .++|+|||++......... .........||..|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 877 9999999999764322211 12223456799999999999998899999999999999999999999965321
Q ss_pred hHH----HHHHHHhc----------------CchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 224 LAE----WTEECRRN----------------KNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 224 ~~~----~~~~~~~~----------------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
... ........ ...+++.+|+..+|..||+.++|.+.++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 266 DPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp CHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred ccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111 11111100 12356789999999999999999998864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=285.89 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=192.5
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEE----EEEEeeec-ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFG----AVKRVMEE-RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~----~vk~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
..+++..+.||+|+||.||++. ..+++.+ ++|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3456666799999999999995 4556554 55554332 2335678899999999999999999999988764 78
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
++++++.+++|.+++... ...+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 899999999999998763 256899999999999999999999999 9999999999999999999999999997
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK------ 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~------ 235 (266)
....... ........+|..|+|||++.+..++.++||||||+++|+|++ |..||.+...............
T Consensus 166 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 243 (327)
T 3lzb_A 166 LLGAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 243 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred EccCccc--cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 6432221 222234456788999999999999999999999999999999 9999987655443333222211
Q ss_pred ----chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+.+++.+.++...
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 125788999999999999999999988754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=301.92 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=197.6
Q ss_pred HhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
...+.+...||+|+||.||++....+..++||.+.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 34455566899999999999988777789999876433 345778999999999999999999999876 6789999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 261 ~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 261 SKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp TTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999753 1245899999999999999999999999 9999999999999999999999999997543211
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------ch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------NV 237 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~~ 237 (266)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+............. ..
T Consensus 335 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 411 (452)
T 1fmk_A 335 ---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 411 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred ---eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 112233456788999999988889999999999999999999 9999987765544433332211 12
Q ss_pred hhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 238 EVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+++.+|+..+|..||+.++|.+.++..+
T Consensus 412 ~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 412 DLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 5788999999999999999999987653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=284.08 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=193.3
Q ss_pred hHHHHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 4 LEELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 4 ~~~i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
..||...++.+..+||+|+||.||++.... .+++|.+..... .....+.+|++++++++||||++++++. .....
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 345566677778899999999999997643 588887754432 2346788999999999999999999964 55678
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 95 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred EEEEEecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceec
Confidence 9999999999999988642 256899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccc---cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLN---TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--- 235 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 235 (266)
....... .........||..|+|||++. +..++.++||||||+++|+|++|..||.+.+.............
T Consensus 168 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 168 TEKSRWS--GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred ccccccc--ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence 7533211 122234467899999999986 56678899999999999999999999988766665555443321
Q ss_pred ------------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 ------------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ------------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+.+++.+.++...
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 125678999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=288.95 Aligned_cols=236 Identities=24% Similarity=0.301 Sum_probs=186.5
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+|.+...||+|+||.||++. ..+++.+++|.+...... ....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 56677799999999999995 457889999987543322 1223457999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
. ++|.+++... ...+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 83 D-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp S-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred c-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 6 5898888763 246899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-------------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------------- 234 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------------- 234 (266)
........+|..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+............
T Consensus 154 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 154 ---TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 222334567999999999876 568999999999999999999999998877666554443310
Q ss_pred --------------------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 --------------------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 --------------------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 012677889999999999888764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=290.44 Aligned_cols=236 Identities=20% Similarity=0.270 Sum_probs=189.4
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEe----------
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE---------- 77 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------- 77 (266)
..+|.+...||+|+||.||++ +..+|+.+++|++...... ..+|+++++.++||||+++++++..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 345666679999999999999 5578999999988654322 2369999999999999999998843
Q ss_pred ----------------------------cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 047020 78 ----------------------------KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129 (266)
Q Consensus 78 ----------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 129 (266)
....++||||++ ++|.+.+..... ....+++..+..++.|++.||.|||+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ----------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 334889999997 588877765322 23678999999999999999999999
Q ss_pred CCCCCeecCCCCCCcEEEe-cCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHH
Q 047020 130 QADPPIIHRDIKSSNILLI-DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVL 207 (266)
Q Consensus 130 ~~~~~i~H~dikp~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i 207 (266)
.| ++||||||+||+++ .++.++|+|||++...... .......+|..|+|||++.+. .++.++||||+||+
T Consensus 160 ~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 160 LG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-----EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp TT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-----SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred Cc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-----CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99 99999999999998 6789999999999754222 223345678999999998765 58999999999999
Q ss_pred HHHHHhCCCCcCCCchhHHHHHHHHhcC--------------------------------------chhhhhhhccCCCC
Q 047020 208 LLELITGLKSIQGSATLAEWTEECRRNK--------------------------------------NVEVWAQMLDPKLN 249 (266)
Q Consensus 208 ~~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~l~~~~~ 249 (266)
+|+|++|..||.+.+..+....+..... ..+++.+|+..+|.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999999888777766654211 22567888888888
Q ss_pred CcchHHHHH
Q 047020 250 GDANMEQLR 258 (266)
Q Consensus 250 ~~~~~~~l~ 258 (266)
.||++.++.
T Consensus 312 ~R~t~~e~l 320 (383)
T 3eb0_A 312 LRINPYEAM 320 (383)
T ss_dssp GSCCHHHHH
T ss_pred hCCCHHHHh
Confidence 888887764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=291.29 Aligned_cols=231 Identities=24% Similarity=0.293 Sum_probs=175.0
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEec------CeE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK------GEQ 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~ 81 (266)
+|.....||+|+||.||++ +..+|+.++||++..... ....++.+|+++++.++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 4556668999999999999 466789999998755322 2356778999999999999999999998654 567
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++
T Consensus 110 ~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp EEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 9999988 7899888865 56899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------ 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------ 234 (266)
.... .......+|..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+...++..+....
T Consensus 180 ~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 180 RHTA-------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cccc-------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 7522 12334578999999999876 678999999999999999999999999888776665544311
Q ss_pred ----------------------------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 ----------------------------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 ----------------------------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+.+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L 310 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence 012567788888888888877764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=298.92 Aligned_cols=234 Identities=18% Similarity=0.215 Sum_probs=189.6
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+...+.||+|+||.||++.. .+|+.+++|.+.... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 34445799999999999954 578999999886432 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.|++|.+++.... .....+++..+..++.|++.||.|||++| |+||||||+||+++.+|.+||+|||++......
T Consensus 267 ~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 267 MNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp CTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 99999999887632 12357899999999999999999999999 999999999999999999999999999754322
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCch---hHHH-HHHHHhcC--------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT---LAEW-TEECRRNK-------- 235 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~---~~~~-~~~~~~~~-------- 235 (266)
. .......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+. .... ..+.....
T Consensus 343 ~----~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 343 Q----TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp C----CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C----cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 1 123345799999999999999999999999999999999999999977532 2222 22222211
Q ss_pred -chhhhhhhccCCCCCcch
Q 047020 236 -NVEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 236 -~~~~~~~~l~~~~~~~~~ 253 (266)
..+++++|+..+|..|++
T Consensus 419 ~~~~li~~lL~~dP~~R~~ 437 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLG 437 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHhccCCHhHCCC
Confidence 124667788888888874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=275.51 Aligned_cols=239 Identities=22% Similarity=0.306 Sum_probs=192.1
Q ss_pred HHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
...+|.+...||+|+||.||++.. .+|+.+++|.+.... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 345666777999999999999955 478899999875432 2345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+.+++|.+++... +.+++..+..++.|++.|+.+||+.| ++|+||||+||+++.++.++|+|||++..
T Consensus 89 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccc
Confidence 99999999999999775 57899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc--------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN-------- 234 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 234 (266)
.... .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.+.+............
T Consensus 161 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (276)
T 2h6d_A 161 MSDG-----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235 (276)
T ss_dssp CCC------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred cCCC-----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcC
Confidence 3321 22234568899999999987765 689999999999999999999998776555444433321
Q ss_pred -CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 -KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 -~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+.+++.+
T Consensus 236 ~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 236 RSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1125788999999999999998865
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=292.76 Aligned_cols=240 Identities=21% Similarity=0.282 Sum_probs=185.4
Q ss_pred HHHHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--------ccHHHHHHHHHHHhcCCCCCccccceeEE
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--------GSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 76 (266)
+.....|.+.+.||+|+||.||++ ...+++.++||.+..... .....+.+|++++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 344566777779999999999999 556789999998765321 11234778999999999999999999975
Q ss_pred ecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC---ce
Q 047020 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN---HA 153 (266)
Q Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~~ 153 (266)
. +..++||||+.+++|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++..+ .+
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCE
T ss_pred c-CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceE
Confidence 4 4689999999999999988653 67899999999999999999999999 99999999999997554 49
Q ss_pred EEeccccccCCCCCCCCCCCcccccccCCCccCcccccc---ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHH
Q 047020 154 KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT---GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE 230 (266)
Q Consensus 154 ~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~ 230 (266)
||+|||++..... ........||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+..........
T Consensus 282 kl~DFG~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~ 356 (419)
T 3i6u_A 282 KITDFGHSKILGE-----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 356 (419)
T ss_dssp EECCSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH
T ss_pred EEeecccceecCC-----CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH
Confidence 9999999985322 223345679999999999853 56788999999999999999999999765443333222
Q ss_pred HHh--------------cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 231 CRR--------------NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 231 ~~~--------------~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
... ....+++.+|+..+|..||+.+++.+
T Consensus 357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 221 11125788999999999999988654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=285.88 Aligned_cols=238 Identities=20% Similarity=0.275 Sum_probs=187.8
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCC--CCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSH--PNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~ 85 (266)
..|.+...||+|+||.||++...+++.++||.+...... ....+.+|+.+++.++| |||+++++++.+....++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 345666799999999999998888999999988654332 34668899999999986 99999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
|+ .+++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++ ++.++|+|||++....
T Consensus 89 e~-~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 89 EC-GNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp CC-CSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred eC-CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 94 588999999874 67899999999999999999999999 99999999999996 6789999999998543
Q ss_pred CCCCCCCCcccccccCCCccCcccccc-----------ccCCCcccchhHHHHHHHHHhCCCCcCCCchh-HHHHHHHHh
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNT-----------GFVSTKSDVYSFGVLLLELITGLKSIQGSATL-AEWTEECRR 233 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~-~~~~~~~~~ 233 (266)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .........
T Consensus 159 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 159 PDTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp -------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred cccc--cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 2211 122345679999999999865 56788999999999999999999999764333 233222221
Q ss_pred c-----------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 N-----------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 ~-----------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
. ...+++.+|+..+|..||+..++.+
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 1 1125788999999999999888753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=278.09 Aligned_cols=235 Identities=23% Similarity=0.295 Sum_probs=197.3
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+.....||+|+||.||++. ..+++.+++|.+.... ......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 4555689999999999994 5678899999876543 3346788999999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+++|.+++.. +.+++..+..++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++......
T Consensus 104 ~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 172 (303)
T 3a7i_A 104 GGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-- 172 (303)
T ss_dssp TEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT--
T ss_pred CCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc--
Confidence 9999998865 57899999999999999999999999 999999999999999999999999998753321
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC----------chhh
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----------NVEV 239 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~~~ 239 (266)
........++..|+|||++.+..++.++|+||||+++|+|++|..||...+............. ..++
T Consensus 173 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 173 --QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 250 (303)
T ss_dssp --BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHH
T ss_pred --ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHH
Confidence 1223456789999999999988999999999999999999999999987665544433332211 1257
Q ss_pred hhhhccCCCCCcchHHHHHH
Q 047020 240 WAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 240 ~~~~l~~~~~~~~~~~~l~~ 259 (266)
+.+|+.++|..||+.+++.+
T Consensus 251 i~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHcCCChhhCcCHHHHhh
Confidence 78999999999999888754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=303.07 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=202.8
Q ss_pred HHhhchhhhhccccccceEEEEEcC-CCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELG-DGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
....+.+...||+|+||.||++... ++..++||.+... ......+.+|++++++++||||+++++++......++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3445566678999999999999554 4788999987543 3356789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 297 ~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 297 FMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred ccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999763 2356899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------C
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------K 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~ 235 (266)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+............ .
T Consensus 371 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (495)
T 1opk_A 371 DT---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 447 (495)
T ss_dssp CC---EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred Cc---eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 11 112233456778999999988889999999999999999999 999998765443333222211 1
Q ss_pred chhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
..+++.+|+..+|..||+..+|.+.++..
T Consensus 448 l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 448 VYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 12578899999999999999999988754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=283.99 Aligned_cols=247 Identities=20% Similarity=0.278 Sum_probs=192.2
Q ss_pred HHHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcC--CCCCccccceeEEec----C
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV--SHPNLVGLLGFCLEK----G 79 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~----~ 79 (266)
+....++++.+.||+|+||.||++... |+.++||.+... .......|.+++... +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344567777789999999999999764 889999987543 234455666666655 899999999998877 6
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CCCCeecCCCCCCcEEEecCC
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ--------ADPPIIHRDIKSSNILLIDDN 151 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~--------~~~~i~H~dikp~nil~~~~~ 151 (266)
..++||||+.+++|.+++.. ..+++..++.++.|++.||.|||+. + ++|+||||+||+++.++
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG 179 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred ceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence 88999999999999999976 5689999999999999999999998 8 99999999999999999
Q ss_pred ceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCc------ccchhHHHHHHHHHhC----------C
Q 047020 152 HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTK------SDVYSFGVLLLELITG----------L 215 (266)
Q Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~------~Di~slG~i~~~l~~g----------~ 215 (266)
.+||+|||++..................||+.|+|||++.+...+.. +|||||||++|+|++| .
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997544333322233345679999999999987766655 9999999999999999 6
Q ss_pred CCcCCCc----hhHHHHHHHHh-----------------cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 216 KSIQGSA----TLAEWTEECRR-----------------NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 216 ~pf~~~~----~~~~~~~~~~~-----------------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.||.+.. ........... ....+++.+|+..+|..||+..++.+.++...
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 7775421 11122221110 01225788999999999999999999988753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=279.03 Aligned_cols=244 Identities=22% Similarity=0.304 Sum_probs=200.6
Q ss_pred ChHHHHHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEe----
Q 047020 3 ALEELKMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE---- 77 (266)
Q Consensus 3 ~~~~i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 77 (266)
++++.....+.....||+|+||.||++.. .+|+.+++|.+.... ..+.+|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp CCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred cccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 45666777888888999999999999955 478999999876543 346789999999999999999998754
Q ss_pred ------------cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcE
Q 047020 78 ------------KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNI 145 (266)
Q Consensus 78 ------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 145 (266)
....++||||+++++|.+++... ....+++..++.++.|++.||.+||+.| ++|+||||+||
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Ni 153 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNI 153 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHE
Confidence 34579999999999999999763 2256899999999999999999999999 99999999999
Q ss_pred EEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH
Q 047020 146 LLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA 225 (266)
Q Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~ 225 (266)
+++.++.++|+|||++...... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~- 227 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKND-----GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF- 227 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCC-----SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH-
T ss_pred EEcCCCCEEECcchhheecccc-----ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH-
Confidence 9999999999999998754322 1223456899999999999888999999999999999999999998643222
Q ss_pred HHHHHHHhcC--------chhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 226 EWTEECRRNK--------NVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 226 ~~~~~~~~~~--------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
........ ..+++.+|+..+|..||+..++.+.++..
T Consensus 228 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 228 --FTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp --HHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11222111 12568899999999999999999887653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=285.69 Aligned_cols=248 Identities=20% Similarity=0.248 Sum_probs=193.8
Q ss_pred hhchhhhhccccccceEEEEEcC-C----CcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG-D----GNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~-~----g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
.++...+.||+|+||.||++... + +..+++|.+..... .....+.+|+++++.++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 34455568999999999999543 2 23488887754332 234568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+.+++|.+++... ...+++..++.++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++..
T Consensus 124 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999998752 256899999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK------- 235 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~------- 235 (266)
....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.............
T Consensus 197 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 275 (333)
T 1mqb_A 197 LEDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 275 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred hcccccc-ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccC
Confidence 4322111 112223446778999999988889999999999999999998 9999987665544443332211
Q ss_pred ---chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 ---NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ---~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++.+.++..+
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 125788999999999999999999988764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.85 Aligned_cols=246 Identities=20% Similarity=0.220 Sum_probs=197.5
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecC--eEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG--EQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~ 85 (266)
.+|.+...||+|+||.||++. ..+|+.++||.+.... ......+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 456667799999999999994 4568999999886533 234567789999999999999999999987765 789999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE----ecCCceEEeccccc
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL----IDDNHAKLADFGLC 161 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~----~~~~~~~l~dfg~~ 161 (266)
||+.+++|.+++... .....+++..++.++.|++.||.|||+.| ++||||||+||++ +..+.+||+|||++
T Consensus 89 e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 89 EFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp CCCTTEEHHHHTTSG--GGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred ecCCCCCHHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999764 22234899999999999999999999999 9999999999998 66677999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCcccccc--------ccCCCcccchhHHHHHHHHHhCCCCcCCC----chhHHHHH
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT--------GFVSTKSDVYSFGVLLLELITGLKSIQGS----ATLAEWTE 229 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~i~~~l~~g~~pf~~~----~~~~~~~~ 229 (266)
..... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||... .......+
T Consensus 164 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 164 RELED-----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp EECCC-----GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred eEccC-----CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 75322 122334568999999999865 56788999999999999999999999642 22233333
Q ss_pred HHHhcC----------------------------------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 230 ECRRNK----------------------------------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 230 ~~~~~~----------------------------------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.....+ ..+++++|+..+|..|++.+++.+.++..+
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 333221 125678999999999999999888777654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=292.11 Aligned_cols=246 Identities=29% Similarity=0.396 Sum_probs=185.6
Q ss_pred hhhhhccccccceEEEEEcC--CC--cEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEE-ecCeEEEEEE
Q 047020 13 DFRIRIGVGATSFVYLAELG--DG--NFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCL-EKGEQLLLLE 86 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~--~g--~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e 86 (266)
.+...||+|+||.||++... ++ ..+++|.+..... .....+.+|+.++++++||||+++++++. .++..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 34568999999999999542 22 3567777654322 34567889999999999999999999864 4567899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... ...+++..+..++.|++.||.|||++| ++||||||+||+++.++.+||+|||++.....
T Consensus 172 ~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 172 YMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp CCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred CCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999752 245788999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK---------- 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~---------- 235 (266)
.............++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.............
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 324 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 22222222334567788999999998899999999999999999999 7888876654443333322211
Q ss_pred chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+.+++.+.++..+
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 125778999999999999999999988764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=286.63 Aligned_cols=233 Identities=23% Similarity=0.314 Sum_probs=188.2
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..|.+...||+|+||.||++. ..+|+.+++|.+...... ..+|++++.++ +||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 445666799999999999994 457889999987654322 34688888887 699999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC----CceEEeccccccC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD----NHAKLADFGLCKL 163 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~----~~~~l~dfg~~~~ 163 (266)
+.|++|.+.+... +.+++..+..++.|++.||.|||++| ++||||||+||++.+. +.++|+|||++..
T Consensus 98 ~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 98 MKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999998764 67899999999999999999999999 9999999999998543 3599999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC--chhHHHH-HHHHhcC-----
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS--ATLAEWT-EECRRNK----- 235 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~--~~~~~~~-~~~~~~~----- 235 (266)
.... ........+|+.|+|||++.+..++.++|+||+||++|+|++|..||.+. ....... .+.....
T Consensus 170 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 170 LRAE----NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp CBCT----TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred CcCC----CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 3322 12234567899999999998888999999999999999999999999753 2222222 2222111
Q ss_pred --------chhhhhhhccCCCCCcchHHHHH
Q 047020 236 --------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 --------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++++|+..+|..||+..++.
T Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il 276 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 12578899999999999988764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=287.88 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=202.0
Q ss_pred hhchhhhhccccccceEEEEEc-CCC-----cEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEecCeE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDG-----NFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g-----~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 81 (266)
.++.+...||+|+||.||++.. .++ ..+++|.+..... .....+.+|+++++.+ +||||+++++++.+.+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 3455556899999999999953 333 3688887755432 2356788999999999 899999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQ---------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH 152 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~ 152 (266)
++||||+.+++|.+++...... ....+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCe
Confidence 9999999999999999764211 1246799999999999999999999999 999999999999999999
Q ss_pred eEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHH
Q 047020 153 AKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 153 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~ 231 (266)
++|+|||++....... .........+|..|+|||++.+..++.++||||||+++|+|++ |..||.+...........
T Consensus 203 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDS--NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEBCCCGGGCCGGGCT--TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred EEECcccccccccccc--ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 9999999997532211 1222344567788999999988889999999999999999998 999998765555444443
Q ss_pred HhcC-----------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 232 RRNK-----------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 232 ~~~~-----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.... ..+++.+|+..+|..||+.+++.+.++...
T Consensus 281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 3221 125788999999999999999999988753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=278.16 Aligned_cols=239 Identities=21% Similarity=0.304 Sum_probs=174.2
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.++.+...||+|+||.||++. ..+|+.+++|.+.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 345666689999999999995 4678999999875432 223467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+++++|.+++... ...+++..++.++.|++.|+.|||+.| ++|+||||+||+++.++.++|+|||++....
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp ECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999998752 256899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh---------cCc
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR---------NKN 236 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~---------~~~ 236 (266)
... .......+|+.|+|||.+.+..++.++|+||+|+++|+|++|..||...+........... ...
T Consensus 164 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (278)
T 3cok_A 164 MPH----EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEA 239 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHH
T ss_pred CCC----CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHH
Confidence 211 1223456899999999999888999999999999999999999999765433322221111 111
Q ss_pred hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++.+|+..+|..||+.+++.+
T Consensus 240 ~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 240 KDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcccCHhhCCCHHHHhc
Confidence 25788999999999999888753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=284.70 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=201.9
Q ss_pred hhchhhhhccccccceEEEEE------cCCCcEEEEEEeeecccc-cHHHHHHHHHHHhcC-CCCCccccceeEEecC-e
Q 047020 10 ATNDFRIRIGVGATSFVYLAE------LGDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKG-E 80 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~------~~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~-~ 80 (266)
.++.+...||+|+||.||++. ..+++.++||.+...... ....+.+|+.+++++ +||||+++++++...+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 455556689999999999995 245678899987654332 345688999999999 6999999999987654 5
Q ss_pred EEEEEEecCCCchhhhhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQS-----------LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID 149 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~ 149 (266)
.++||||+.+++|.+++....... ...+++..++.++.|++.||.|||+.| ++|+||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECC
Confidence 899999999999999998642210 123789999999999999999999999 999999999999999
Q ss_pred CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHH
Q 047020 150 DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWT 228 (266)
Q Consensus 150 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~ 228 (266)
++.++|+|||++....... .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+........
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDP--DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGCEEECCCGGGSCTTTCT--TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCEEECCCccccccccCc--cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 9999999999997543221 1223345667889999999998899999999999999999998 999998766544444
Q ss_pred HHHHhcC-----------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 229 EECRRNK-----------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 229 ~~~~~~~-----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
....... ..+++.+|+..+|..||+..++.+.++..+
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 4333211 125778999999999999999999998765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=284.29 Aligned_cols=241 Identities=27% Similarity=0.287 Sum_probs=188.0
Q ss_pred HHHHHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc--cHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 5 EELKMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 5 ~~i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
+++...+++...+||+|+||.||++.. .+|..++||++...... .......|+..+..+ +||||+++++++.+.+.
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 345556677777999999999999954 47899999987553322 233444555555554 89999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTT
T ss_pred EEEEEecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEcccee
Confidence 99999999 67999888764 246899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHH-----HHh--
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE-----CRR-- 233 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~-----~~~-- 233 (266)
+..... ........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.......... ...
T Consensus 204 a~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (311)
T 3p1a_A 204 LVELGT-----AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL 277 (311)
T ss_dssp CEECC-----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTS
T ss_pred eeeccc-----CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCC
Confidence 875322 222344568999999999876 6899999999999999999998777655443332211 010
Q ss_pred -cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 -NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 -~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..||+.+++.+
T Consensus 278 ~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11226788999999999999988754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=284.39 Aligned_cols=237 Identities=23% Similarity=0.298 Sum_probs=196.9
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc--------cHHHHHHHHHHHhcC-CCCCccccceeEEecC
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG--------SRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKG 79 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~--------~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 79 (266)
..|+....||+|+||.||++.. .+|+.++||.+...... ....+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 3455556899999999999965 47899999987654321 145678899999999 7999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
..++||||+.|++|.+++... ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecC
Confidence 999999999999999999764 67899999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCcccccc------ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT------GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR 233 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (266)
++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 246 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~ 320 (365)
T 2y7j_A 246 FSCHLEPG-----EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320 (365)
T ss_dssp TCEECCTT-----CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cccccCCC-----cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 98754322 22345678999999999853 35788999999999999999999999887666555444332
Q ss_pred cC-------------chhhhhhhccCCCCCcchHHHHHH
Q 047020 234 NK-------------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 ~~-------------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.. ..+++.+|+..+|..||+.+++.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 321 QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 225778999999999999888754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=275.44 Aligned_cols=235 Identities=23% Similarity=0.337 Sum_probs=191.7
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEe----cCeEEEE
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE----KGEQLLL 84 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv 84 (266)
+.+...||+|+||.||++ ...++..+++|.+..... .....+.+|+.+++.++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 344457999999999999 556788889888765432 245678899999999999999999998865 3468999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe-cCCceEEeccccccC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI-DDNHAKLADFGLCKL 163 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~~~l~dfg~~~~ 163 (266)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++++|+||||+||+++ .++.++|+|||++..
T Consensus 108 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999875 67899999999999999999999874 4599999999999997 788999999999874
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-------- 235 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 235 (266)
.. ........||+.|+|||++.+ .++.++|+||+|+++|+|++|..||.+...............
T Consensus 182 ~~------~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 182 KR------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp CC------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred cc------ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence 22 223345678999999998865 488999999999999999999999988666665554444321
Q ss_pred ----chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 125678899999999998887653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=286.78 Aligned_cols=239 Identities=24% Similarity=0.272 Sum_probs=190.9
Q ss_pred HhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc-----cHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG-----SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
..+|.....||+|+||.||++.. .+|+.+++|.+...... ....+.+|+++++.++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 34556667999999999999955 46889999987643221 1346789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+.+ +|.+++... ...+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.
T Consensus 89 lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEECCSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEcCCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999965 888887652 246889999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------- 234 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------- 234 (266)
..... ........+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+....
T Consensus 161 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSP----NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSC----CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred eccCC----cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 54322 1223445789999999998654 57889999999999999999999999888777766655421
Q ss_pred ------------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ------------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ------------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++++|+..+|..||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1124677888888888888887653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=279.69 Aligned_cols=247 Identities=22% Similarity=0.305 Sum_probs=190.0
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.+|.+...||+|+||.||++. ..+|..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 456666799999999999994 5678999999886432 223567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+.+++|.+++..... ....+++..++.++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++....
T Consensus 112 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp ECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred ecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999875322 2256899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc-hhHHHHHHHHhc----------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA-TLAEWTEECRRN---------- 234 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~-~~~~~~~~~~~~---------- 234 (266)
.. ........++..|+|||++.+..++.++|+||||+++|+|++|..||.+.. ............
T Consensus 188 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 188 SK----TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred CC----CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence 21 122234568999999999998889999999999999999999999997643 222222222211
Q ss_pred --CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 235 --KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 235 --~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...+++.+|+..+|..||+.+++.+.++..
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 112567899999999999999999998865
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=288.49 Aligned_cols=244 Identities=16% Similarity=0.214 Sum_probs=194.6
Q ss_pred hhchhhhhccccccceEEEEEcC---------CCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccc----------
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG---------DGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVG---------- 70 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~---------~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~---------- 70 (266)
.+|.+...||+|+||.||++... .++.+++|..... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 45666679999999999999654 3788999987543 45788999999999999887
Q ss_pred -----cceeEEe-cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCc
Q 047020 71 -----LLGFCLE-KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSN 144 (266)
Q Consensus 71 -----~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~n 144 (266)
+++++.. ....++||||+ +++|.+++... ....+++..+..++.|++.||.|||++| ++|+||||+|
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 5666655 67889999999 99999999863 2357899999999999999999999999 9999999999
Q ss_pred EEEecCC--ceEEeccccccCCCCCCCC---CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcC
Q 047020 145 ILLIDDN--HAKLADFGLCKLGPFNDPN---RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQ 219 (266)
Q Consensus 145 il~~~~~--~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~ 219 (266)
|+++.++ .++|+|||++......... .........||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999988 8999999999764332211 1112244579999999999999899999999999999999999999997
Q ss_pred CCc-hhHHHHHHH---Hh----------------cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 220 GSA-TLAEWTEEC---RR----------------NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 220 ~~~-~~~~~~~~~---~~----------------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+.. ......... .. ....+++.+|+..+|..||+.+++.+.++.++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 654 222222111 11 11225788999999999999999999998875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=282.35 Aligned_cols=243 Identities=28% Similarity=0.401 Sum_probs=191.0
Q ss_pred HHHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
.|...++++...||+|+||.||++.. .++.+++|.+.. ......+.+|++++++++||||+++++++.+ ..++||
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 34456677778999999999999976 477889998753 2346778999999999999999999998764 479999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh---CCCCCeecCCCCCCcEEEecCCc-eEEeccccc
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS---QADPPIIHRDIKSSNILLIDDNH-AKLADFGLC 161 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~---~~~~~i~H~dikp~nil~~~~~~-~~l~dfg~~ 161 (266)
||+++++|.+++... .....++...+..++.|++.||.|||+ +| ++|+||||+||+++.++. +||+|||++
T Consensus 79 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 79 EYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp ECCTTCBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred EcCCCCCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccc
Confidence 999999999999763 222357889999999999999999999 78 999999999999998886 799999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH-HHHHHHHhc------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA-EWTEECRRN------ 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~-~~~~~~~~~------ 234 (266)
..... ......||..|+|||++.+..++.++||||||+++|+|++|..||....... .........
T Consensus 154 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (307)
T 2eva_A 154 CDIQT-------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226 (307)
T ss_dssp ------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCB
T ss_pred ccccc-------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcc
Confidence 74221 1233468999999999999899999999999999999999999997542221 111111111
Q ss_pred -----CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 235 -----KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 235 -----~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...+++.+|+..+|..||+.+++.+.++...
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1125788999999999999999999988653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=281.39 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=190.8
Q ss_pred hchhhhhccccccceEEEEEcC----CCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecC-----
Q 047020 11 TNDFRIRIGVGATSFVYLAELG----DGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG----- 79 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 79 (266)
.+.+...||+|+||.||++... ++..+++|.+..... .....+.+|+.++++++||||+++++++.+.+
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 3444458999999999999432 344789988754432 23466889999999999999999999987655
Q ss_pred eEEEEEEecCCCchhhhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYG-QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
..++||||+.+++|.+++..... .....+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeec
Confidence 35999999999999999854322 23367899999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC--
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK-- 235 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~-- 235 (266)
|++........ ........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+...............
T Consensus 192 g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 269 (313)
T 3brb_A 192 GLSKKIYSGDY--YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK 269 (313)
T ss_dssp SCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred Ccceecccccc--cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC
Confidence 99875432211 122234567788999999998899999999999999999999 8999987766555444433211
Q ss_pred --------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 --------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 --------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++.+.++..+
T Consensus 270 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 270 QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 125788999999999999999999988764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=274.55 Aligned_cols=242 Identities=24% Similarity=0.383 Sum_probs=194.0
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccccc-------HHHHHHHHHHHhcCCCCCccccceeEEecC
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGS-------RKIFLDEVSVLLRVSHPNLVGLLGFCLEKG 79 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 79 (266)
...++.+.+.||+|+||.||++. ..+++.+++|.+....... .+.+.+|+++++.++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 34566777799999999999995 4678899999875543321 167889999999999999999999886654
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc-----eE
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH-----AK 154 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~-----~~ 154 (266)
++||||+.+++|.+.+... ...+++..++.++.|++.|+.|||+.+ ++++|+||||+||+++.++. ++
T Consensus 97 --~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred --eEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEE
Confidence 7999999999999888652 257899999999999999999999874 56999999999999987776 99
Q ss_pred EeccccccCCCCCCCCCCCcccccccCCCccCcccc--ccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHH--HHHH
Q 047020 155 LADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL--NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAE--WTEE 230 (266)
Q Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~--~~~~ 230 (266)
|+|||++... ........+|+.|+|||++ ....++.++||||+|+++|+|++|..||.+.+.... ....
T Consensus 170 l~Dfg~~~~~-------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 170 VADFGLSQQS-------VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp ECCCTTCBCC-------SSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred eCCCCccccc-------cccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 9999998742 1223446789999999998 445678899999999999999999999976543222 2222
Q ss_pred HHhcC-----------chhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 231 CRRNK-----------NVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 231 ~~~~~-----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
..... ..+++.+|+..+|..||+.+++.+.++.
T Consensus 243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 22111 1257889999999999999999988864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=292.56 Aligned_cols=202 Identities=26% Similarity=0.356 Sum_probs=172.9
Q ss_pred HHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
...++.....||+|+||.||++.. .+|..+++|.+..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 345566667999999999999954 5788899998765432 33567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ-ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
||+++++|.+++... +.+++..+..++.|++.|+.|||+. | ++|+||||+||+++.++.++|+|||++...
T Consensus 111 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred ECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999875 5789999999999999999999996 8 999999999999999999999999988632
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCch
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT 223 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~ 223 (266)
. ........||+.|+|||++.+..++.++||||+||++|+|++|..||...+.
T Consensus 183 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 183 I------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp H------HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred c------cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 1122345789999999999999999999999999999999999999976543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=277.08 Aligned_cols=239 Identities=23% Similarity=0.283 Sum_probs=193.6
Q ss_pred HHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
....+.....||+|+||.||++.. .+|..+++|.+.... ....+.+|+++++.++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 344566667999999999999954 568899999876543 35678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... ...+++..++.++.|++.|+.+||+.| ++|+||||+||+++.++.++|+|||.+.....
T Consensus 105 ~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 105 YCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp CCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred cCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999998742 257899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-----------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----------- 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----------- 235 (266)
. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.............
T Consensus 178 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
T 3com_A 178 T----MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSD 253 (314)
T ss_dssp T----BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred h----ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCH
Confidence 1 1223345789999999999988899999999999999999999999987765554443333211
Q ss_pred -chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 -NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 -~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHHh
Confidence 125778999999999999888753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=285.48 Aligned_cols=251 Identities=23% Similarity=0.274 Sum_probs=201.4
Q ss_pred hhchhhhhccccccceEEEEEcC------CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
.++.+...||+|+||.||++... ++..+++|.+..... .....+.+|+++++.++||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 44555568999999999999542 467788888764332 23456889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEec
Q 047020 83 LLLEYLANKSLFDRMHTYYG-----QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLAD 157 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~d 157 (266)
+||||+.+++|.+++..... .....+++..+..++.|++.||.+||++| ++|+||||+||+++.++.++|+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECc
Confidence 99999999999999876421 11245789999999999999999999999 99999999999999999999999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK- 235 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~- 235 (266)
||++........ ........+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+.............
T Consensus 182 fg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 182 FGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259 (322)
T ss_dssp TTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred Cccccccccccc--cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC
Confidence 999874321111 112234456888999999988889999999999999999999 8999987765554443333211
Q ss_pred ---------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 ---------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ---------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++.+.++..+
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 125788999999999999999999887643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=287.68 Aligned_cols=236 Identities=20% Similarity=0.273 Sum_probs=187.9
Q ss_pred chhhhhccccccceEEEEEcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCC--CCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVS--HPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
|.+...||+|+||.||++...+++.++||.+..... .....+.+|+++++.++ ||||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 555668999999999999877799999998865432 23467889999999996 5999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++ ++.+||+|||++......
T Consensus 137 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 137 CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 5688999999874 57889999999999999999999999 99999999999995 578999999999864322
Q ss_pred CCCCCCcccccccCCCccCcccccc-----------ccCCCcccchhHHHHHHHHHhCCCCcCCCchh-HHHHHHHHhcC
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT-----------GFVSTKSDVYSFGVLLLELITGLKSIQGSATL-AEWTEECRRNK 235 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~-~~~~~~~~~~~ 235 (266)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ...........
T Consensus 208 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 208 TT--SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred Cc--cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence 11 122345679999999999865 36788999999999999999999999775433 33333222111
Q ss_pred -----------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 -----------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 -----------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 125788999999999999888753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=288.77 Aligned_cols=228 Identities=21% Similarity=0.255 Sum_probs=178.2
Q ss_pred hhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHh-cCCCCCccccceeEEe----cCeEEEEEEecC
Q 047020 16 IRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLL-RVSHPNLVGLLGFCLE----KGEQLLLLEYLA 89 (266)
Q Consensus 16 ~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~----~~~~~lv~e~~~ 89 (266)
..||+|+||.||++ ...+|+.++||.+.. ...+.+|++++. ..+||||+++++++.. ....++||||+.
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 47999999999999 455788999998753 245678888874 4579999999998865 567899999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec---CCceEEeccccccCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID---DNHAKLADFGLCKLGPF 166 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~~~l~dfg~~~~~~~ 166 (266)
|++|.+++... ....+++..+..++.|++.||.|||+.| |+||||||+||+++. ++.+||+|||++.....
T Consensus 143 gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 143 GGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp SEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999999763 2246899999999999999999999999 999999999999987 78899999999975322
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH----HHHHHHHhc--------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA----EWTEECRRN-------- 234 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~----~~~~~~~~~-------- 234 (266)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+... ....+....
T Consensus 217 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 291 (400)
T 1nxk_A 217 -----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291 (400)
T ss_dssp ---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTT
T ss_pred -----CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccc
Confidence 122345678999999999999999999999999999999999999997654322 111121111
Q ss_pred -----CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 -----KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 -----~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++++|+..+|..||+.+++.+
T Consensus 292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1125788999999999999888764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=285.53 Aligned_cols=238 Identities=22% Similarity=0.284 Sum_probs=192.3
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEec-----CeEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK-----GEQLL 83 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 83 (266)
+|.+...||+|+||.||++. ..++..+++|++..... .....+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 45556689999999999994 55788899998764332 2346788999999999999999999998654 36899
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
|||++. ++|.+++.. ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++..
T Consensus 108 v~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999986 599998876 56899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCCCCCcccccccCCCccCccccc-cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh---------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLN-TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR--------- 233 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~--------- 233 (266)
...... .........||+.|+|||++. +..++.++||||+||++|+|++|..||.+.+.......+...
T Consensus 178 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 178 ADPDHD-HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp CCGGGC-BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred cCCCCC-ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432211 111234457899999999865 445899999999999999999999999887766655544321
Q ss_pred -------------------------------cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 -------------------------------NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 -------------------------------~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..||+.+++.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11125788999999999998887753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=296.52 Aligned_cols=236 Identities=15% Similarity=0.087 Sum_probs=180.0
Q ss_pred chhhhhccccccceEEEEEc-CCCcEEEEEEeeec---ccccHHHHHHHHHH---HhcCCCCCccccc-------eeEEe
Q 047020 12 NDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEE---RGGSRKIFLDEVSV---LLRVSHPNLVGLL-------GFCLE 77 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~---~~~~~~~~~~e~~~---l~~l~~~~i~~~~-------~~~~~ 77 (266)
+.+...||+|+||.||++.. .+|+.++||.+... .....+.+.+|+++ ++.++||||++++ +++.+
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 34456899999999999964 56899999988643 23345778899954 4555799999998 66655
Q ss_pred cC-----------------eEEEEEEecCCCchhhhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecC
Q 047020 78 KG-----------------EQLLLLEYLANKSLFDRMHTYYGQS--LGVLSWSNRLSIALDIARALEYLHSQADPPIIHR 138 (266)
Q Consensus 78 ~~-----------------~~~lv~e~~~~~~L~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~ 138 (266)
.+ ..+++|||+ +|+|.+++....... ...+++..++.++.|++.||.|||++| |+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 43 278999999 679999998642111 122334888889999999999999999 9999
Q ss_pred CCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccc-----------cCCCcccchhHHHH
Q 047020 139 DIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-----------FVSTKSDVYSFGVL 207 (266)
Q Consensus 139 dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~Di~slG~i 207 (266)
||||+||+++.++.+||+|||++... ........| ..|+|||++.+. .++.++|||||||+
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~-------~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRD-------GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEET-------TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheec-------CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 99999999999999999999998742 122334566 899999999887 89999999999999
Q ss_pred HHHHHhCCCCcCCCchhHHHHHHHHh-----cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 208 LLELITGLKSIQGSATLAEWTEECRR-----NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 208 ~~~l~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
+|+|++|..||.+.+........... ....+++.+|+..+|..||+..++.+
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999776544333322221 11226788999999999999988754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=276.36 Aligned_cols=247 Identities=21% Similarity=0.251 Sum_probs=194.2
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeE-EecCeEEEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC-LEKGEQLLLLE 86 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e 86 (266)
..+|.+...||+|+||.||++. ..+++.++||....... ...+.+|+++++.++|++++..+..+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 3566777799999999999995 57788999997544332 34578899999999987777666655 66778899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE---ecCCceEEeccccccC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL---IDDNHAKLADFGLCKL 163 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~---~~~~~~~l~dfg~~~~ 163 (266)
|+ +++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++..
T Consensus 86 ~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp CC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred cc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 99 89999998742 256899999999999999999999999 9999999999999 7888999999999986
Q ss_pred CCCCCCCC---CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh---HHHHH---HHHh-
Q 047020 164 GPFNDPNR---PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL---AEWTE---ECRR- 233 (266)
Q Consensus 164 ~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~---~~~~~---~~~~- 233 (266)
........ ........||..|+|||++.+..++.++||||+||++|+|++|..||.+.+.. ..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 44332211 12334567999999999999999999999999999999999999999764321 11111 1111
Q ss_pred ----------cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 234 ----------NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 234 ----------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
....+++.+|+..+|..||+.+++.+.++..+
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 11236788999999999999999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=274.80 Aligned_cols=233 Identities=21% Similarity=0.275 Sum_probs=187.4
Q ss_pred hccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCchhh
Q 047020 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFD 95 (266)
Q Consensus 17 ~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
.||+|+||.||++. ..++..+++|.+..........+.+|+.+++.++||||+++++++...+..++||||+++++|.+
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (295)
T 2clq_A 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 108 (295)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHH
T ss_pred EEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHH
Confidence 79999999999994 56788999998876655566788999999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCceEEeccccccCCCCCCCCCCCc
Q 047020 96 RMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADFGLCKLGPFNDPNRPKR 174 (266)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~ 174 (266)
++... .....+++..++.++.|++.||.+||+.| ++|+||||+||+++. ++.++|+|||++...... ...
T Consensus 109 ~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~ 179 (295)
T 2clq_A 109 LLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI----NPC 179 (295)
T ss_dssp HHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--------
T ss_pred HHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC----CCc
Confidence 99764 22245678899999999999999999999 999999999999987 889999999998753321 112
Q ss_pred ccccccCCCccCccccccc--cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHH-HHHH-h-cC---------chhhh
Q 047020 175 QTSIKGSFGYVDTNYLNTG--FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT-EECR-R-NK---------NVEVW 240 (266)
Q Consensus 175 ~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~-~~~~-~-~~---------~~~~~ 240 (266)
.....|+..|+|||++.+. .++.++|+||||+++|+|++|..||.+........ .... . .+ ..+++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 3345789999999998664 37889999999999999999999997543332211 1111 1 00 12567
Q ss_pred hhhccCCCCCcchHHHHH
Q 047020 241 AQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 241 ~~~l~~~~~~~~~~~~l~ 258 (266)
.+|+..+|..||+.+++.
T Consensus 260 ~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLL 277 (295)
T ss_dssp HHTTCSSTTTSCCHHHHH
T ss_pred HHHccCChhhCCCHHHHh
Confidence 899999999999988864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=289.11 Aligned_cols=234 Identities=24% Similarity=0.318 Sum_probs=184.8
Q ss_pred hchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecC------eEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------EQLLL 84 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~~lv 84 (266)
+|...+.||+|+||.||++....++.+++|++...... ..+|+++++.++||||+++++++...+ ..++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 45666789999999999998777777999988654322 236999999999999999999985543 37899
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe-cCCceEEeccccccC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI-DDNHAKLADFGLCKL 163 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~~~l~dfg~~~~ 163 (266)
|||+.+ ++.+.+.... .....+++..++.++.|++.||.|||+.| ++||||||+||+++ .++.+||+|||++..
T Consensus 117 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 117 LEYVPE-TVYRASRHYA-KLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EECCSE-EHHHHHHHHH-HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eeccCc-cHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999966 4444443221 12367899999999999999999999999 99999999999999 789999999999975
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc--------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN-------- 234 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 234 (266)
..... ......+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+...+...+....
T Consensus 192 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGE-----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTC-----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCC-----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 42221 22345679999999998665 58999999999999999999999999988777766655421
Q ss_pred ------------------------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 ------------------------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 ------------------------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+..++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 112566777778888887777654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=274.76 Aligned_cols=246 Identities=20% Similarity=0.252 Sum_probs=195.3
Q ss_pred HhhchhhhhccccccceEEEEEcC----CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAELG----DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
..++.+...||+|+||.||++... ++..+++|.+..... .....+.+|+.+++.++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 345666679999999999999532 233578887755422 2456788999999999999999999987654 5689
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+.+++|.+++... ...+++..++.++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++..
T Consensus 90 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999763 245899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK------- 235 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~------- 235 (266)
..... ........++..|+|||++.+..++.++|+||||+++|+|++ |..||.................
T Consensus 163 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (281)
T 3cc6_A 163 IEDED---YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC 239 (281)
T ss_dssp C------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTC
T ss_pred ccccc---ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCC
Confidence 43221 112234556788999999988889999999999999999998 9999976544443333222211
Q ss_pred ---chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 ---NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ---~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++.+.++..+
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 126788999999999999999999988764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=284.67 Aligned_cols=243 Identities=22% Similarity=0.273 Sum_probs=188.6
Q ss_pred hHHHHHhhchhh--hhccccccceEEEEEcCCCcEEEEEEeeeccccc-----------HHHHHHHHHHHhcCCCCCccc
Q 047020 4 LEELKMATNDFR--IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGS-----------RKIFLDEVSVLLRVSHPNLVG 70 (266)
Q Consensus 4 ~~~i~~~~~~~~--~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~i~~ 70 (266)
+.++.....+|. ..||+|+||.||++...+|..++||++....... ...+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 345555445554 5899999999999977789999999886543321 267889999999999999999
Q ss_pred cceeEEe-----cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcE
Q 047020 71 LLGFCLE-----KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNI 145 (266)
Q Consensus 71 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 145 (266)
+++++.. ....++||||+. ++|.+.+... ...+++..+..++.|++.||.|||++| ++|+||||+||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999844 236799999996 6888887642 246899999999999999999999999 99999999999
Q ss_pred EEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchh
Q 047020 146 LLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATL 224 (266)
Q Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~ 224 (266)
+++.++.++|+|||++..... ........+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTA-----DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp EECTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EEcCCCCEEEEecCccccccc-----ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999874221 222344578899999999876 67899999999999999999999999887766
Q ss_pred HHHHHHHHhc-----------------------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 225 AEWTEECRRN-----------------------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 225 ~~~~~~~~~~-----------------------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.......... ...+++.+|+..+|..||+.+++.+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 6555443311 1225678899999999998887653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=277.18 Aligned_cols=240 Identities=31% Similarity=0.405 Sum_probs=191.0
Q ss_pred HhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEec-CeEEEEEEe
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK-GEQLLLLEY 87 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~ 87 (266)
..++++...||+|+||.||++.. +|..+++|.+... ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 35566667999999999999976 4788999987543 3457789999999999999999999986544 478999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++++|.+++... ....+++..+..++.|++.|+.+||++| ++|+||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~- 169 (278)
T 1byg_A 97 MAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 169 (278)
T ss_dssp CTTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc-
Confidence 9999999999763 1124789999999999999999999999 99999999999999999999999999874221
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------Cc
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------KN 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~~ 236 (266)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+............ ..
T Consensus 170 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 ------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred ------cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 1223456788999999988889999999999999999998 999998765444333322211 11
Q ss_pred hhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
.+++.+|+..+|..||+..++.+.++..
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 2578899999999999999999988764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=279.63 Aligned_cols=243 Identities=26% Similarity=0.341 Sum_probs=195.5
Q ss_pred hhhhhccccccceEEEEEc-----CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEec--CeEEEE
Q 047020 13 DFRIRIGVGATSFVYLAEL-----GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK--GEQLLL 84 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~-----~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 84 (266)
+....||+|+||.||++.. .+|+.++||.+..... .....+.+|+++++.++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 5667999999999988742 3678899998865432 2356788999999999999999999999874 578999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+++++|.+++.. ..+++..++.++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++...
T Consensus 114 ~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp ECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999976 45899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH--------------HHHHH
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA--------------EWTEE 230 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~--------------~~~~~ 230 (266)
..... .........++..|+|||++.+..++.++||||||+++|+|++|..||....... .....
T Consensus 185 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHE-YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCS-EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccc-ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 33211 0122334567888999999998889999999999999999999999997543211 11111
Q ss_pred HHhc-----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 231 CRRN-----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 231 ~~~~-----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.... ...+++++|+..+|..||+.+++.+.++...
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111 1225788999999999999999999988753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.42 Aligned_cols=240 Identities=19% Similarity=0.291 Sum_probs=193.6
Q ss_pred hccccccceEEEEEc---CCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLAEL---GDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~---~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||+|+||.||++.. +++..++||.+.... ......+.+|++++++++||||+++++++.. +..++||||+.+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 699999999999954 345678999876543 2356789999999999999999999999876 56899999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... .
T Consensus 422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~ 493 (613)
T 2ozo_A 422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-Y 493 (613)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce-e
Confidence 99998642 356899999999999999999999999 999999999999999999999999999864322211 1
Q ss_pred CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------chhhhh
Q 047020 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------NVEVWA 241 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~~~~~~ 241 (266)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+..... ..+++.
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 573 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS 573 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 12223345688999999998899999999999999999998 9999988766554444333211 125678
Q ss_pred hhccCCCCCcchHHHHHHHHHHHh
Q 047020 242 QMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 242 ~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+|+..+|..||+..++.+.|+.+|
T Consensus 574 ~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 574 DCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp HTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHHHHHHH
Confidence 999999999999999999998875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=284.27 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=194.3
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEE----ecCeEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL----EKGEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~lv 84 (266)
.+|.+...||+|+||.||++. ..+|+.+++|.+..........+.+|+++++.++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 456666799999999999995 4678999999887665556678899999999999999999999886 23478999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+.+++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 109 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999876432 2367899999999999999999999999 999999999999999999999999987642
Q ss_pred CCCCCCCC-----CcccccccCCCccCcccccccc---CCCcccchhHHHHHHHHHhCCCCcCCCc----hhHHHHHH-H
Q 047020 165 PFNDPNRP-----KRQTSIKGSFGYVDTNYLNTGF---VSTKSDVYSFGVLLLELITGLKSIQGSA----TLAEWTEE-C 231 (266)
Q Consensus 165 ~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~i~~~l~~g~~pf~~~~----~~~~~~~~-~ 231 (266)
........ .......||..|+|||++.+.. ++.++||||||+++|+|++|..||.... ........ .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 21100000 0012345689999999987553 6889999999999999999999995421 11111110 0
Q ss_pred Hh-------cCchhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 232 RR-------NKNVEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 232 ~~-------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
.. ....+++.+|+..+|..||+.+++.+.++.
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 303 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhh
Confidence 00 011257889999999999999999998875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=284.54 Aligned_cols=255 Identities=23% Similarity=0.275 Sum_probs=200.6
Q ss_pred HHHHhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEec
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK 78 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 78 (266)
++...++.+...||+|+||.||++.. .++..++||.+.... ......+.+|+.++++++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 44556777778999999999999963 356789999875432 23345788999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC---Cce
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQ--SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD---NHA 153 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~~ 153 (266)
...++||||+++++|.+++...... ....+++..++.++.|++.||.|||+.| ++|+||||+||+++.+ ..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999875321 1245899999999999999999999999 9999999999999844 459
Q ss_pred EEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHH
Q 047020 154 KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 154 ~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~ 232 (266)
+|+|||++........ ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..........
T Consensus 183 kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 183 KIGDFGMARDIYRASY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EECccccccccccccc--cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 9999999864221111 122344567889999999988889999999999999999998 9999987665444433332
Q ss_pred hc----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 233 RN----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 233 ~~----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.. ...+++.+|+..+|..||+..++.+.++.+.
T Consensus 261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 21 1126788999999999999999999888763
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=284.52 Aligned_cols=230 Identities=22% Similarity=0.314 Sum_probs=187.5
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeE------
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ------ 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~------ 81 (266)
+|.....||+|+||.||++ +..+|+.++||.+...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 4555568999999999999 4567889999988654322 346788999999999999999999999877654
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+. ++|.+.+. ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++
T Consensus 123 ~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp EEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred EEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999996 68877764 34899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh-------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR------- 233 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~------- 233 (266)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 192 ~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 192 RHAD-------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp ---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccc-------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 7432 22334568999999999877 67899999999999999999999999988766655554331
Q ss_pred ---------------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 ---------------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 ---------------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+..+|..||+.+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 322 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence 1123577889999999999888765
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=290.99 Aligned_cols=197 Identities=25% Similarity=0.311 Sum_probs=160.8
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEec-----CeE
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK-----GEQ 81 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 81 (266)
.+|.+...||+|+||.||++ ...+|+.++||++..... ....++.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 34566668999999999999 556788999998865322 2346788999999999999999999998766 578
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++|||++. ++|.+++... ..+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++
T Consensus 106 ~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 99999985 6999998763 56899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCCC------------------CCcccccccCCCccCcccc-ccccCCCcccchhHHHHHHHHHhCC
Q 047020 162 KLGPFNDPNR------------------PKRQTSIKGSFGYVDTNYL-NTGFVSTKSDVYSFGVLLLELITGL 215 (266)
Q Consensus 162 ~~~~~~~~~~------------------~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~i~~~l~~g~ 215 (266)
.......... ........||+.|+|||++ .+..++.++||||+||++|+|++|.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 8643322110 0123556789999999986 5667999999999999999999843
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=279.06 Aligned_cols=238 Identities=21% Similarity=0.299 Sum_probs=191.3
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
..+++...||+|+||.||++.. .+|..+++|.+..........+.+|+++++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 3455666899999999999955 468899999887666666788999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++++|.+++... ...+++..+..++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 99 ~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 169 (302)
T 2j7t_A 99 PGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-- 169 (302)
T ss_dssp TTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--
T ss_pred CCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999988653 256899999999999999999999999 99999999999999999999999998642100
Q ss_pred CCCCCcccccccCCCccCcccc-----ccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYL-----NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-------- 235 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 235 (266)
.........++..|+|||++ .+..++.++|+||||+++|+|++|..||.+.+.............
T Consensus 170 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T 2j7t_A 170 --TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK 247 (302)
T ss_dssp --HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred --cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccc
Confidence 01112335688999999998 356788899999999999999999999988766555544443321
Q ss_pred ----chhhhhhhccCCCCCcchHHHHH
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++.+|+..+|..||+.+++.
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll 274 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLL 274 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHT
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 12567899999999999988874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=278.59 Aligned_cols=239 Identities=21% Similarity=0.271 Sum_probs=186.0
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEE------------
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL------------ 76 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------------ 76 (266)
.+|...+.||+|+||.||++.. .+|+.+++|++..........+.+|+++++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 3455566899999999999954 468899999887655555677889999999999999999998873
Q ss_pred --ecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe-cCCce
Q 047020 77 --EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI-DDNHA 153 (266)
Q Consensus 77 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~~ 153 (266)
+....++||||+. ++|.+++.. +.+++..++.++.|++.||.|||++| ++|+||||+||+++ +++.+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 3467899999996 699998865 57899999999999999999999999 99999999999997 56789
Q ss_pred EEeccccccCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 154 KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 154 ~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
+|+|||++........ .........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..........
T Consensus 161 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYS-HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEccCccccccCCCcc-cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999986432211 1122344567889999998865 6788999999999999999999999988876665544433
Q ss_pred hc---------------------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 233 RN---------------------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 233 ~~---------------------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.. ...+++.+|+..+|..||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 21 1125678899999999998888753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=273.83 Aligned_cols=236 Identities=23% Similarity=0.260 Sum_probs=194.5
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc---------ccHHHHHHHHHHHhcCC-CCCccccceeEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG---------GSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEK 78 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~---------~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 78 (266)
.+|.....||+|+||.||++.. .+|+.++||.+..... .....+.+|+++++++. ||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 4556666899999999999954 5788899998764431 12456778999999996 99999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
...++||||+++++|.+++... ..+++..++.++.|++.||.+||+.| ++|+||+|+||+++.++.++|+||
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999874 67899999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccc------cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN------TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
|++..... ........++..|+|||++. ...++.++|+||||+++|+|++|..||.+.+..........
T Consensus 169 g~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 169 GFSCQLDP-----GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp TTCEECCT-----TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cchhhcCC-----CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 99875332 12234456899999999985 44678899999999999999999999987766555544443
Q ss_pred hcC-------------chhhhhhhccCCCCCcchHHHHH
Q 047020 233 RNK-------------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 233 ~~~-------------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
... ..+++.+|+..+|..||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (298)
T 1phk_A 244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 282 (298)
T ss_dssp TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred CCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 211 12567788888888898887764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=302.13 Aligned_cols=239 Identities=22% Similarity=0.304 Sum_probs=193.7
Q ss_pred hccccccceEEEEEc---CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAEL---GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~---~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
.||+|+||.||++.. ..+..++||.+..... .....+.+|++++++++||||+++++++.. +..++||||+.++
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g 454 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG 454 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCC
Confidence 699999999999933 3467889998765433 235778999999999999999999999865 4688999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 455 ~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~- 525 (635)
T 4fl3_A 455 PLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY- 525 (635)
T ss_dssp EHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc-
Confidence 999999764 67899999999999999999999999 999999999999999999999999999764332211
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------chhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------NVEVW 240 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~~~~~ 240 (266)
........+|..|+|||++.+..++.++||||||+++|+|++ |..||.+.+............. ..+++
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 605 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 122233456788999999999899999999999999999998 9999988766554443333211 12578
Q ss_pred hhhccCCCCCcchHHHHHHHHHHHh
Q 047020 241 AQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 241 ~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.+|+..+|..||+.++|.+.++.++
T Consensus 606 ~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 8999999999999999999998765
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=274.19 Aligned_cols=241 Identities=21% Similarity=0.238 Sum_probs=193.3
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc----cccHHHHHHHHHHHhcCCCCCccccceeE--EecCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER----GGSRKIFLDEVSVLLRVSHPNLVGLLGFC--LEKGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~ 82 (266)
.+|.+...||+|+||.||++.. .++..+++|.+.... ......+.+|+++++.++||||+++++++ .+....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 4677778999999999999954 568889999875532 23456788999999999999999999988 4455789
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+.++ +.+++... ....+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.
T Consensus 85 lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 999999765 77777653 2357899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCcccccccc--CCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-----
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGF--VSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----- 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----- 235 (266)
...... .........++..|+|||++.+.. .+.++||||||+++|+|++|..||.+.+.............
T Consensus 158 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 235 (305)
T 2wtk_C 158 ALHPFA--ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD 235 (305)
T ss_dssp ECCTTC--SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSS
T ss_pred ccCccc--cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCc
Confidence 543211 122334556899999999987643 36789999999999999999999988766555544433221
Q ss_pred ----chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ----NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ----~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 136788999999999999988864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=288.73 Aligned_cols=208 Identities=27% Similarity=0.353 Sum_probs=167.3
Q ss_pred hchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEec------CeEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK------GEQLL 83 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~l 83 (266)
.|...+.||+|+||.||++.. .+|+.++||++..... ...+|+++++.++||||+++++++... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 345556899999999999955 5689999998865332 234699999999999999999987432 24679
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC-CceEEecccccc
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD-NHAKLADFGLCK 162 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~~~l~dfg~~~ 162 (266)
||||+++ ++.+.+.... .....+++..++.++.|++.||.|||+.| |+||||||+||+++.+ +.+||+|||++.
T Consensus 131 v~e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred ehhcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 9999965 6766665421 12367899999999999999999999999 9999999999999955 568999999998
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
...... ......+|..|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+++.+++.
T Consensus 206 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 206 QLVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp ECCTTC-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred hcccCC-----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 543221 22345689999999998664 789999999999999999999999999887777666554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=303.83 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=201.1
Q ss_pred HhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
...+.+...||+|+||.||++....+..++||.+.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 34455566899999999999988777889999876533 345778999999999999999999999876 6789999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.+++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 344 ~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 344 SKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp TTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred cCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999753 1245899999999999999999999999 9999999999999999999999999997532110
Q ss_pred CCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------ch
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------NV 237 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~~ 237 (266)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.+............... ..
T Consensus 418 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 494 (535)
T 2h8h_A 418 ---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 494 (535)
T ss_dssp ---HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ---eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 111223446778999999988889999999999999999999 9999987665544433322211 12
Q ss_pred hhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 238 EVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+++.+|+..++..||+.++|.+.|+..+
T Consensus 495 ~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 495 DLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 5788999999999999999999887643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=282.21 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=180.5
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEE--------ecCe
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCL--------EKGE 80 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--------~~~~ 80 (266)
++++...||+|+||.||++. ..+|+.+++|.+..........+.+|+.+++++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 45666799999999999995 5678999999887665556677889999999996 999999999884 3345
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.+++|||+. ++|.+++.... ..+.+++..++.++.|++.||.|||+.+ ++++|+||||+||+++.++.++|+|||+
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 899999985 79999887642 2357999999999999999999999874 4599999999999999999999999999
Q ss_pred ccCCCCCCCCCC--------CcccccccCCCccCcccc---ccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHH
Q 047020 161 CKLGPFNDPNRP--------KRQTSIKGSFGYVDTNYL---NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE 229 (266)
Q Consensus 161 ~~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~---~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~ 229 (266)
+........... .......+|+.|+|||++ .+..++.++||||||+++|+|++|..||.+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 986433221110 111245689999999998 566788899999999999999999999976554433322
Q ss_pred HHHhc-------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 230 ECRRN-------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 230 ~~~~~-------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
..... ...+++.+|+..+|..||+.+++.+.++..
T Consensus 265 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 265 KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22111 122578899999999999999999988764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=279.95 Aligned_cols=239 Identities=22% Similarity=0.290 Sum_probs=190.1
Q ss_pred HHHHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--------ccHHHHHHHHHHHhcCCCCCccccceeEE
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--------GSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 76 (266)
......|.+...||+|+||.||++ ...+++.++||.+..... .....+.+|+++++.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 445677888889999999999999 455688999998754321 12345788999999999999999999987
Q ss_pred ecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc---e
Q 047020 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH---A 153 (266)
Q Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---~ 153 (266)
... .++||||+.+++|.+++... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++. +
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCE
T ss_pred CCc-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeE
Confidence 654 89999999999999988653 67899999999999999999999999 999999999999987654 9
Q ss_pred EEeccccccCCCCCCCCCCCcccccccCCCccCccccc---cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHH
Q 047020 154 KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN---TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEE 230 (266)
Q Consensus 154 ~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~ 230 (266)
+|+|||++..... ........||..|+|||++. ...++.++||||||+++|+|++|..||.+..........
T Consensus 157 kl~Dfg~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 231 (322)
T 2ycf_A 157 KITDFGHSKILGE-----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231 (322)
T ss_dssp EECCCTTCEECCC-----CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH
T ss_pred EEccCccceeccc-----ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH
Confidence 9999999875321 22233457899999999973 456889999999999999999999999765433222222
Q ss_pred HHh--------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 231 CRR--------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 231 ~~~--------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
... ....+++.+|+..+|..||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 211 1112678899999999999998875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=277.47 Aligned_cols=192 Identities=21% Similarity=0.298 Sum_probs=165.6
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEe--cCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLE--KGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~ 85 (266)
.+|.+.+.||+|+||.||++ ...+++.+++|.+.. .....+.+|+++++.++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 44566679999999999999 456788999998753 34577899999999997 9999999999987 66789999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-ceEEeccccccCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLG 164 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~~~l~dfg~~~~~ 164 (266)
||+.+++|.+++.. +++..+..++.|++.||.|||++| ++|+||||+||+++.++ .++|+|||++...
T Consensus 113 e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp ECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999888743 789999999999999999999999 99999999999999776 8999999999753
Q ss_pred CCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCC
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQG 220 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~ 220 (266)
... .......++..|+|||++.+ ..++.++||||+||++|+|++|..||..
T Consensus 182 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 182 HPG-----QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CTT-----CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCC-----CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 322 22344578889999999876 6789999999999999999999999943
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=271.10 Aligned_cols=241 Identities=22% Similarity=0.256 Sum_probs=199.7
Q ss_pred HHHHHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 5 EELKMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 5 ~~i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
.+....+|++...||+|+||.||++.. .+++.+++|.+.... ......+.+|++++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 345567788888999999999999954 578899999876533 23467788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC---CceEEecc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD---NHAKLADF 158 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~~~l~df 158 (266)
++|||++.+++|.+.+... ..+++..++.++.|++.||.+||+.| ++|+||||+||+++.+ +.++|+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999999988764 57899999999999999999999999 9999999999999754 46999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--- 235 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 235 (266)
|++..... ........++..|+|||.+.+. ++.++|+||||+++|+|++|..||.+.+.............
T Consensus 169 g~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T 2wei_A 169 GLSTCFQQ-----NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242 (287)
T ss_dssp TGGGTBCC-----CSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred CcceeecC-----CCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99875322 1222345688899999998764 88999999999999999999999988766555444433211
Q ss_pred ----------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ----------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ----------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+.++|..||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 125788999999999999988865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=271.73 Aligned_cols=246 Identities=21% Similarity=0.254 Sum_probs=195.9
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeE-EecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC-LEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~ 87 (266)
.+|.+...||+|+||.||++. ..+|+.+++|.+.... ....+.+|+.+++.++|++++..+..+ ......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 355666799999999999995 5778899999775543 335688999999999988776666655 666788999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe---cCCceEEeccccccCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLCKLG 164 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~---~~~~~~l~dfg~~~~~ 164 (266)
+ +++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++ .++.++|+|||++...
T Consensus 87 ~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 87 L-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp C-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred c-CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9 89999999742 256899999999999999999999999 99999999999994 7889999999999764
Q ss_pred CCCCCCC---CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh---HHHHHHH---Hhc-
Q 047020 165 PFNDPNR---PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL---AEWTEEC---RRN- 234 (266)
Q Consensus 165 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~---~~~~~~~---~~~- 234 (266)
....... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.. ..+.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 4332211 11234567999999999999989999999999999999999999999763221 1111111 111
Q ss_pred ----------CchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 235 ----------KNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 235 ----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
...+++.+|+..+|..||+.+++.+.++..+
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 1136788999999999999999999998765
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=274.61 Aligned_cols=238 Identities=20% Similarity=0.227 Sum_probs=188.8
Q ss_pred HhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 84 (266)
...+.+...||+|+||.||++.. .+++.+++|.+..... .....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 45566677999999999999954 5789999998765332 2456678899999998 899999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC--------------
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD-------------- 150 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-------------- 150 (266)
|||+++++|.+++..... ....+++..++.++.|++.||.|||++| ++|+||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999976422 1256899999999999999999999999 9999999999999844
Q ss_pred -----CceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchh
Q 047020 151 -----NHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATL 224 (266)
Q Consensus 151 -----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~ 224 (266)
..++|+|||.+..... .....+|..|+|||++.+. .++.++||||||+++|+|++|..|+......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISS--------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTC--------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred ccCCceEEEEcccccccccCC--------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 3789999999875322 1234589999999999765 5668999999999999999999887655433
Q ss_pred HHHHHHHHh-------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 225 AEWTEECRR-------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 225 ~~~~~~~~~-------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
......... ....+++.+|+.++|..||+..++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 322211000 0112567889999999999888765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=281.57 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=179.2
Q ss_pred HHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
...++.+...||+|+||.||++.. .+++.++||.+.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 344566667999999999999954 568899999875432 233566788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 86 EYLANKSLFDRMHTYYGQ---SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
||+++++|.+++...... ....+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998753211 2356899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCC-CCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-----
Q 047020 163 LGPFNDP-NRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----- 235 (266)
Q Consensus 163 ~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----- 235 (266)
....... ..........+|+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+...............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 5432211 11122344578999999999865 5688999999999999999999999987655544433332211
Q ss_pred --------------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 --------------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 --------------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+..++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 124677888889999988887753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=275.01 Aligned_cols=245 Identities=20% Similarity=0.262 Sum_probs=193.4
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEE--ecCeEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCL--EKGEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv 84 (266)
.+|++...||+|+||.||++. ..+|+.+++|.+..... ...+.+.+|++++++++||||+++++++. .....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 456666799999999999994 45788999998865432 23567889999999999999999999874 35688999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA--DPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
|||+++++|.+++..... ....+++..++.++.|++.||.+||+.+ ..+++|+||||+||+++.++.++|+|||.+.
T Consensus 86 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999976421 2245899999999999999999999875 2349999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------- 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 235 (266)
..... ........++..|+|||++.+..++.++|+||||+++|+|++|..||.+.+.............
T Consensus 165 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (279)
T 2w5a_A 165 ILNHD----TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240 (279)
T ss_dssp HC-------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeccc----cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCccc
Confidence 53211 1122345789999999999888899999999999999999999999987765544433333211
Q ss_pred ---chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ---NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ---~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 125678899999999998888754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=276.79 Aligned_cols=243 Identities=23% Similarity=0.272 Sum_probs=180.6
Q ss_pred HHHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
+...++++...||+|+||.||++. ..+|+.+++|.+...... ....+.++...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 345567777799999999999994 567889999988654322 22334455556788899999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ-ADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
||||++ ++|.+++..... ....+++..++.++.|++.|+.|||++ | ++|+||||+||+++.++.++|+|||++.
T Consensus 84 v~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999996 588887765322 226789999999999999999999998 9 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCcccc----ccccCCCcccchhHHHHHHHHHhCCCCcCCC-chhHHHHHHHHhcC--
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYL----NTGFVSTKSDVYSFGVLLLELITGLKSIQGS-ATLAEWTEECRRNK-- 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~-~~~~~~~~~~~~~~-- 235 (266)
.... ........+|+.|+|||++ .+..++.++|+||+|+++|+|++|..||... ..............
T Consensus 159 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 159 YLVD-----DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC
T ss_pred cccc-----cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC
Confidence 5322 1222344689999999996 5567888999999999999999999999763 33333333333211
Q ss_pred ---------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ---------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ---------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 124678899999999999888754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=275.95 Aligned_cols=248 Identities=26% Similarity=0.316 Sum_probs=192.1
Q ss_pred HhhchhhhhccccccceEEEEEc--CCCc--EEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL--GDGN--FGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~--~~g~--~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
..++++...||+|+||.||++.. .++. .+++|.+.... ......+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 45667777999999999999953 2333 57888765432 234567889999999999999999999987764 8
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++|+||+.+++|.+++... .+.+++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence 8999999999999998763 246899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC-----
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----- 235 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----- 235 (266)
........ .........++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+.............
T Consensus 169 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1u46_A 169 RALPQNDD-HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247 (291)
T ss_dssp EECCC-CC-EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred cccccccc-chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC
Confidence 76432211 1112234567778999999988888999999999999999999 9999988766555544433211
Q ss_pred ------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 ------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++.+.++...
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 126788999999999999999999988753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=281.15 Aligned_cols=240 Identities=18% Similarity=0.296 Sum_probs=194.3
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeeccccc-----------------HHHHHHHHHHHhcCCCCCccccc
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGS-----------------RKIFLDEVSVLLRVSHPNLVGLL 72 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~i~~~~ 72 (266)
.+|.+...||+|+||.||++.. +|+.+++|.+....... ...+.+|+++++.++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4566667899999999999977 89999999886533221 17889999999999999999999
Q ss_pred eeEEecCeEEEEEEecCCCchhhhhhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEe
Q 047020 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYY---GQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLI 148 (266)
Q Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~ 148 (266)
+++.+.+..++||||+++++|.+++.... ......+++..++.++.|++.|+.|||+ .| ++|+||||+||+++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEc
Confidence 99999999999999999999999833211 1224679999999999999999999999 99 99999999999999
Q ss_pred cCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccc-cCCC-cccchhHHHHHHHHHhCCCCcCCCchhHH
Q 047020 149 DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVST-KSDVYSFGVLLLELITGLKSIQGSATLAE 226 (266)
Q Consensus 149 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~~Di~slG~i~~~l~~g~~pf~~~~~~~~ 226 (266)
.++.++|+|||.+..... .......++..|+|||++.+. .++. ++|+||+|+++|+|++|..||.+.+....
T Consensus 187 ~~~~~kl~dfg~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVD------KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp TTSCEEECCCTTCEECBT------TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred CCCcEEEecccccccccc------ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999875321 133456789999999999877 5665 99999999999999999999987766333
Q ss_pred HHHHHHhc-----------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 227 WTEECRRN-----------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 227 ~~~~~~~~-----------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
........ ...+++.+|+..+|..||+.+++.+
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 33322211 1125677888888888888877653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=285.85 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=189.4
Q ss_pred hhchhhhhccccccceEEEEEc----CCCcEEEEEEeeecc----cccHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL----GDGNFGAVKRVMEER----GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
.++++...||+|+||.||++.. .+|+.++||.+.... ......+.+|+++++.+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4566667899999999999965 478899999875432 22345567899999999 59999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.++||||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.+++++|+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999875 57899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCcccccc--ccCCCcccchhHHHHHHHHHhCCCCcCCCch---hHHHHHHH-Hhc
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT--GFVSTKSDVYSFGVLLLELITGLKSIQGSAT---LAEWTEEC-RRN 234 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~---~~~~~~~~-~~~ 234 (266)
+....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ........ ...
T Consensus 206 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 206 SKEFVADE---TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282 (355)
T ss_dssp EEECCGGG---GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred CeecccCC---CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence 87532111 122334579999999999975 3578899999999999999999999965322 22222222 111
Q ss_pred C---------chhhhhhhccCCCCCcc-----hHHHHH
Q 047020 235 K---------NVEVWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 235 ~---------~~~~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
+ ..+++.+|+..+|..|| +.+++.
T Consensus 283 ~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell 320 (355)
T 1vzo_A 283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 320 (355)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHH
Confidence 1 12567899999999998 676664
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=286.06 Aligned_cols=205 Identities=22% Similarity=0.335 Sum_probs=153.3
Q ss_pred chhhh-hccccccceEEEEEcC---CCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEe--cCeEEEEE
Q 047020 12 NDFRI-RIGVGATSFVYLAELG---DGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE--KGEQLLLL 85 (266)
Q Consensus 12 ~~~~~-~ig~g~~~~v~~~~~~---~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 85 (266)
+++.. +||+|+||.||++... ++..+++|.+... .....+.+|+++++.++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 44433 7999999999999643 5788999987543 234568899999999999999999999854 66899999
Q ss_pred EecCCCchhhhhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE----ecCCceEEec
Q 047020 86 EYLANKSLFDRMHTYYG----QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL----IDDNHAKLAD 157 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~----~~~~~~~l~d 157 (266)
||+. ++|.+++..... .....+++..++.++.|++.||.|||+.| |+||||||+||++ +.++.++|+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9985 588888764321 12235899999999999999999999999 9999999999999 6678999999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCch
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSAT 223 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~ 223 (266)
||++........ .........||+.|+|||++.+. .++.++||||+||++|+|++|..||.+...
T Consensus 176 fg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 176 MGFARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp TTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCCceecCCCCc-ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 999986432111 11233456789999999998774 589999999999999999999999976543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=279.26 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=197.6
Q ss_pred HhhchhhhhccccccceEEEEE-----cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecC--eE
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-----LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG--EQ 81 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-----~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 81 (266)
...+++...||+|+||.||++. ..+|+.+++|.+..........+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 3456667799999999999996 3568899999887655555678899999999999999999999886544 78
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+++++|.+++... ...+++..++.++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++
T Consensus 120 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 9999999999999999763 245899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh---------------HH
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL---------------AE 226 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~---------------~~ 226 (266)
......... ........++..|+|||.+.+..++.++||||||+++|+|++|..||...... ..
T Consensus 193 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEY-YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSE-EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccc-cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 864322110 11123345677899999998888999999999999999999999998643110 01
Q ss_pred HHHHHHhc-----------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 227 WTEECRRN-----------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 227 ~~~~~~~~-----------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
........ ...+++.+|+..+|..||+..++.+.++..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111 112578899999999999999999888764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=275.47 Aligned_cols=237 Identities=25% Similarity=0.351 Sum_probs=191.3
Q ss_pred hhchhhhhccccccceEEEEEc--CCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcC---CCCCccccceeEE-----e
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL--GDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRV---SHPNLVGLLGFCL-----E 77 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~--~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~ 77 (266)
.+|.+...||+|+||.||++.. .+|..+++|.+..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 3455566999999999999965 4678889998765332 2233566777777766 7999999999986 5
Q ss_pred cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEec
Q 047020 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLAD 157 (266)
Q Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~d 157 (266)
....++||||+. ++|.+++... ....+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 567899999996 5999998763 2245899999999999999999999999 99999999999999999999999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-- 235 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 235 (266)
||++..... ........+|..|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.....
T Consensus 164 fg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSF-----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCG-----GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CcccccccC-----CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999875321 1223456789999999999988899999999999999999999999998877766655543210
Q ss_pred ----------------------------------chhhhhhhccCCCCCcchHHHHH
Q 047020 236 ----------------------------------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 ----------------------------------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++.+|+..+|..||+..++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 02567788999999999888765
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=286.19 Aligned_cols=206 Identities=23% Similarity=0.252 Sum_probs=173.2
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcC------CCCCccccceeEEecCeEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV------SHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~~l 83 (266)
+|++...||+|+||.||++ +..+++.++||.+... ......+.+|+.+++.+ .|+||+++++++......++
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 4566679999999999999 5566889999987543 23345677788888876 46799999999999999999
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc--eEEeccccc
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH--AKLADFGLC 161 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~--~~l~dfg~~ 161 (266)
|||++. ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++
T Consensus 177 v~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999995 6999998773 2245899999999999999999999999 999999999999998887 999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~ 231 (266)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 250 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~ 312 (429)
T 3kvw_A 250 CYEH-------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312 (429)
T ss_dssp EETT-------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eecC-------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7422 22334578999999999999999999999999999999999999999887766655444
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=278.36 Aligned_cols=215 Identities=25% Similarity=0.330 Sum_probs=162.6
Q ss_pred HHHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCe-----
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE----- 80 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----- 80 (266)
....++.+...||+|+||.||++.. .+|..++||++.... .......++++.+..++||||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 3445566667999999999999954 578899999875532 334566778888899999999999999865443
Q ss_pred --EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeecCCCCCCcEEEec-CCceEE
Q 047020 81 --QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH--SQADPPIIHRDIKSSNILLID-DNHAKL 155 (266)
Q Consensus 81 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--~~~~~~i~H~dikp~nil~~~-~~~~~l 155 (266)
.++||||+.+ ++.+.+.... .....+++..+..++.|++.|+.||| +.| ++|+||||+||+++. ++.++|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred eeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence 7899999976 5555544321 22367899999999999999999999 999 999999999999996 889999
Q ss_pred eccccccCCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 156 ADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
+|||++...... .......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..........
T Consensus 174 ~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 174 CDFGSAKKLSPS-----EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp CCCTTCBCCCTT-----SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeCCCceecCCC-----CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 999999854322 222345689999999998655 489999999999999999999999998877766655543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=280.35 Aligned_cols=247 Identities=19% Similarity=0.253 Sum_probs=197.4
Q ss_pred HHHHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhc--CCCCCccccceeEEecC---
Q 047020 5 EELKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLR--VSHPNLVGLLGFCLEKG--- 79 (266)
Q Consensus 5 ~~i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~--- 79 (266)
.+....++.+...||+|+||.||++.. +|+.++||.+... ....+.+|.++++. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 455567788888999999999999976 5889999987432 34567788888887 68999999999998776
Q ss_pred -eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeecCCCCCCcEEEecC
Q 047020 80 -EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH--------SQADPPIIHRDIKSSNILLIDD 150 (266)
Q Consensus 80 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--------~~~~~~i~H~dikp~nil~~~~ 150 (266)
..++||||+.+++|.+++.. ..+++..++.++.|++.||.||| +.+ ++|+||||+||+++.+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN 183 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred ceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence 78999999999999999976 46899999999999999999999 888 9999999999999999
Q ss_pred CceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccc------cCCCcccchhHHHHHHHHHhC----------
Q 047020 151 NHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG------FVSTKSDVYSFGVLLLELITG---------- 214 (266)
Q Consensus 151 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~i~~~l~~g---------- 214 (266)
++++|+|||++..................||..|+|||++.+. .++.++||||||+++|+|++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 9999999999875332221111123455789999999998765 334689999999999999999
Q ss_pred CCCcCCCc----hhHHHHHHHHhc-----------------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 215 LKSIQGSA----TLAEWTEECRRN-----------------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 215 ~~pf~~~~----~~~~~~~~~~~~-----------------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
..||.+.. ....+....... ...+++.+|+..+|..||+.+++.+.++..
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 78886532 222332222110 112467889999999999999999998865
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=287.62 Aligned_cols=202 Identities=25% Similarity=0.275 Sum_probs=167.7
Q ss_pred HHHHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC--------CCCccccceeEE
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS--------HPNLVGLLGFCL 76 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~ 76 (266)
++...+|.+...||+|+||.||++ +..+++.++||.+... ......+.+|+++++.++ |+||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 344456777779999999999999 4567888999987532 334567889999999985 778999999887
Q ss_pred ----ecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeecCCCCCCcEEEecCC
Q 047020 77 ----EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ-ADPPIIHRDIKSSNILLIDDN 151 (266)
Q Consensus 77 ----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~ 151 (266)
.....++||||+ ++++.+.+... ....+++..++.++.|++.||.|||++ | |+||||||+||+++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 556789999999 66777777652 235689999999999999999999998 9 99999999999998765
Q ss_pred -------------------------------------------------ceEEeccccccCCCCCCCCCCCcccccccCC
Q 047020 152 -------------------------------------------------HAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182 (266)
Q Consensus 152 -------------------------------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~ 182 (266)
.++|+|||++..... ......||.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-------~~~~~~gt~ 257 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-------HFTEDIQTR 257 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-------CSCSCCSCG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-------cCccCCCCC
Confidence 799999999975321 223456899
Q ss_pred CccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 183 ~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999899999999999999999999999997543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=285.33 Aligned_cols=246 Identities=23% Similarity=0.312 Sum_probs=186.6
Q ss_pred HHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHH--hcCCCCCccccceeEEe-----cC
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVL--LRVSHPNLVGLLGFCLE-----KG 79 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l--~~l~~~~i~~~~~~~~~-----~~ 79 (266)
+...++.+...||+|+||.||++.. +++.++||.+... ....+..|.+++ ..++||||+++++.+.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3445667777999999999999966 6889999987543 234444455554 45789999999975432 23
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------CCCCeecCCCCCCcEEEecC
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ---------ADPPIIHRDIKSSNILLIDD 150 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~---------~~~~i~H~dikp~nil~~~~ 150 (266)
..++||||+++++|.+++.. ...++..+..++.|++.||.|||+. + ++||||||+||+++.+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKND 156 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTT
T ss_pred eEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCC
Confidence 57899999999999999976 4558899999999999999999999 8 9999999999999999
Q ss_pred CceEEeccccccCCCCCCCC----CCCcccccccCCCccCcccccc-------ccCCCcccchhHHHHHHHHHhCCCCcC
Q 047020 151 NHAKLADFGLCKLGPFNDPN----RPKRQTSIKGSFGYVDTNYLNT-------GFVSTKSDVYSFGVLLLELITGLKSIQ 219 (266)
Q Consensus 151 ~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~i~~~l~~g~~pf~ 219 (266)
+.+||+|||++......... .........||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 99999999999764432211 1122234579999999999976 456778999999999999999977763
Q ss_pred CCchhH-----------------HHHHHHHh------------------cCchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 220 GSATLA-----------------EWTEECRR------------------NKNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 220 ~~~~~~-----------------~~~~~~~~------------------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...... ........ ....+++.+|+..+|..||+.+++.+.|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 322111 11111100 0133678899999999999999999998876
Q ss_pred h
Q 047020 265 M 265 (266)
Q Consensus 265 ~ 265 (266)
+
T Consensus 317 l 317 (336)
T 3g2f_A 317 M 317 (336)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=274.60 Aligned_cols=237 Identities=22% Similarity=0.292 Sum_probs=187.5
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEe------cCeEEE
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLE------KGEQLL 83 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~~~~l 83 (266)
+++...||+|+||.||++. ..+|+.+++|.+... ......+.+|+.+++++ +||||+++++++.. .+..++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 3445589999999999995 467889999987543 33457788999999999 79999999999876 467899
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+.+++|.+++... ....+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++..
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp EEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred EEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 99999999999999763 2356899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC---
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK--- 235 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 235 (266)
.... ........++..|+|||++. +..++.++|||||||++|+|++|..||.+.+.............
T Consensus 179 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (326)
T 2x7f_A 179 LDRT----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 254 (326)
T ss_dssp ----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred cCcC----ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC
Confidence 3221 11233457899999999986 55688999999999999999999999987766555544333211
Q ss_pred --------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 --------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 --------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 255 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 125778899999999999888754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=277.76 Aligned_cols=230 Identities=22% Similarity=0.306 Sum_probs=185.0
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCe------E
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE------Q 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------~ 81 (266)
+|.....||+|+||.||++. ..+|+.++||.+...... ....+.+|+.+++.++||||+++++++...+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 45555689999999999994 567889999988653322 34677899999999999999999999877654 4
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++
T Consensus 105 ~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp EEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 99999996 58877764 34899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------ 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------ 234 (266)
.... .......+|..|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.+....+..+....
T Consensus 174 ~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHAD-------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp TC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred cCCC-------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 7422 12234578999999999876 678999999999999999999999999877665554443310
Q ss_pred ----------------------------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 ----------------------------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 ----------------------------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 304 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 112567788888888888887764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=278.47 Aligned_cols=240 Identities=21% Similarity=0.240 Sum_probs=188.4
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEec-----CeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK-----GEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 82 (266)
.++.+...||+|+||.||++.. .+|+.++||.+..... .....+.+|+++++.++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 3556667999999999999954 5688999998854322 2345678999999999999999999987654 6789
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||+. ++|.+++.. +.+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.
T Consensus 91 lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 9999996 689988876 57899999999999999999999999 9999999999999999999999999997
Q ss_pred CCCCCCCCCC------CcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh--
Q 047020 163 LGPFNDPNRP------KRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR-- 233 (266)
Q Consensus 163 ~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~-- 233 (266)
.......... .......||..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 6433221111 11233578999999998754 67889999999999999999999999887655443322210
Q ss_pred ---------------------------------------cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 ---------------------------------------NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 ---------------------------------------~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00125678888899999988887653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=276.66 Aligned_cols=207 Identities=21% Similarity=0.295 Sum_probs=173.2
Q ss_pred HHHHHhhchhhhhccccccceEEEEEc--CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCC------CccccceeEE
Q 047020 5 EELKMATNDFRIRIGVGATSFVYLAEL--GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHP------NLVGLLGFCL 76 (266)
Q Consensus 5 ~~i~~~~~~~~~~ig~g~~~~v~~~~~--~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~ 76 (266)
+++...+|++...||+|+||.||++.. .+|..++||.+... ......+.+|+++++.++|+ +++++++++.
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 344456777888999999999999954 46778888877532 23456778899999988654 5999999999
Q ss_pred ecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-------
Q 047020 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID------- 149 (266)
Q Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~------- 149 (266)
+.+..++||||+ +++|.+++... ...++++..+..++.|++.||.|||++| ++|+||||+||+++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEE
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecccccccc
Confidence 999999999999 88999998763 2246899999999999999999999999 999999999999987
Q ss_pred ------------CCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCC
Q 047020 150 ------------DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKS 217 (266)
Q Consensus 150 ------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~p 217 (266)
++.++|+|||++.... .......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDD-------EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETT-------SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCccccccccccCCCceEeeCcccccCc-------cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 5679999999987522 122345789999999999998999999999999999999999999
Q ss_pred cCCCchhHH
Q 047020 218 IQGSATLAE 226 (266)
Q Consensus 218 f~~~~~~~~ 226 (266)
|.+.+....
T Consensus 234 f~~~~~~~~ 242 (339)
T 1z57_A 234 FPTHDSKEH 242 (339)
T ss_dssp CCCSCHHHH
T ss_pred CCCCChHHH
Confidence 987665443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=282.49 Aligned_cols=246 Identities=20% Similarity=0.269 Sum_probs=196.5
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCC-CCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH-PNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.+|.+...||+|+||.||++. ..+++.++||....... ...+.+|+++++.++| +++..+..++......++||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 456677799999999999995 56789999997654332 3457889999999986 5555666666778889999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE---ecCCceEEeccccccCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL---IDDNHAKLADFGLCKLG 164 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~---~~~~~~~l~dfg~~~~~ 164 (266)
+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 85 ~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 85 L-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp C-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred C-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 9 89999999752 256899999999999999999999999 9999999999999 57889999999999864
Q ss_pred CCCCCCC---CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCch---hHHHHHHHHh-----
Q 047020 165 PFNDPNR---PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT---LAEWTEECRR----- 233 (266)
Q Consensus 165 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~---~~~~~~~~~~----- 233 (266)
....... ........||..|+|||++.+..++.++|||||||++|+|++|..||.+... ...+.+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 4332211 1223367799999999999999999999999999999999999999976432 1222111111
Q ss_pred ---------cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 234 ---------NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 234 ---------~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
....+++..|+..++..||+.++|.++++.++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11235678999999999999999999998764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.62 Aligned_cols=208 Identities=23% Similarity=0.233 Sum_probs=171.5
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CC-----CccccceeEEecCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HP-----NLVGLLGFCLEKGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~~~~~~ 82 (266)
.+|.+...||+|+||.||++. ..+++.++||.+... ......+..|+.+++.++ |+ +|+++++++...+..+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 445556689999999999994 557888999987543 233456778888888885 54 4899999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeecCCCCCCcEEEe--cCCceEEecc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH--SQADPPIIHRDIKSSNILLI--DDNHAKLADF 158 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--~~~~~~i~H~dikp~nil~~--~~~~~~l~df 158 (266)
+||||+. ++|.+++... ....+++..+..++.|++.||.||| +.| |+||||||+||+++ .++.+||+||
T Consensus 133 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred EEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999995 5999998763 2246899999999999999999999 467 99999999999995 4678999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
|++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 206 G~a~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 206 GSSCQLGQ-------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp TTCEETTC-------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCceeccc-------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99975321 22345788999999999999999999999999999999999999998877766655443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=276.13 Aligned_cols=207 Identities=21% Similarity=0.292 Sum_probs=170.8
Q ss_pred HHHHHhhchhhhhccccccceEEEEEc-CCC-cEEEEEEeeecccccHHHHHHHHHHHhcCCCCC------ccccceeEE
Q 047020 5 EELKMATNDFRIRIGVGATSFVYLAEL-GDG-NFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPN------LVGLLGFCL 76 (266)
Q Consensus 5 ~~i~~~~~~~~~~ig~g~~~~v~~~~~-~~g-~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~ 76 (266)
+++...+|.+...||+|+||.||++.. .++ ..+++|.+.. .......+.+|+++++.++|++ ++.+++++.
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 344456777788999999999999954 445 5788887643 2334567788999999987654 888999999
Q ss_pred ecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE---------
Q 047020 77 EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL--------- 147 (266)
Q Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~--------- 147 (266)
..+..++||||+ ++++.+.+... ....+++..+..++.|++.||.|||++| ++|+||||+||++
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEE
T ss_pred eCCeEEEEEecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccc
Confidence 999999999999 66787777663 2246899999999999999999999999 9999999999999
Q ss_pred ----------ecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCC
Q 047020 148 ----------IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKS 217 (266)
Q Consensus 148 ----------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~p 217 (266)
+.++.++|+|||++.... .......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDH-------EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETT-------SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccCCCcEEEeecCcccccc-------ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence 567889999999987522 122345789999999999998999999999999999999999999
Q ss_pred cCCCchhHH
Q 047020 218 IQGSATLAE 226 (266)
Q Consensus 218 f~~~~~~~~ 226 (266)
|.+.+....
T Consensus 239 f~~~~~~~~ 247 (355)
T 2eu9_A 239 FQTHENREH 247 (355)
T ss_dssp CCCSSHHHH
T ss_pred CCCCCHHHH
Confidence 987665443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=296.06 Aligned_cols=245 Identities=20% Similarity=0.268 Sum_probs=195.7
Q ss_pred hhchhhhhccccccceEEEEEcC----CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG----DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~----~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
.++.+...||+|+||.||++... .+..+++|....... .....+.+|+.++++++||||+++++++. .+..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 44555668999999999999543 234678877654322 23467889999999999999999999885 4568999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+.+++|.+++... ...+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++...
T Consensus 469 ~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 469 MELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 9999999999999753 246899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC--------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK-------- 235 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~-------- 235 (266)
.... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+.....
T Consensus 542 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 618 (656)
T 2j0j_A 542 EDST---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 618 (656)
T ss_dssp CC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCC
T ss_pred CCCc---ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence 3221 122233456788999999988899999999999999999997 9999988766555544433221
Q ss_pred --chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 --NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 --~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..++.+.++..+
T Consensus 619 ~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 619 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 125788999999999999999999998765
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=266.23 Aligned_cols=240 Identities=26% Similarity=0.334 Sum_probs=183.4
Q ss_pred HhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEe----------
Q 047020 9 MATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE---------- 77 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------- 77 (266)
...+++...||+|+||.||++. ..+|+.+++|.+... ......+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 3456677799999999999995 467889999987543 2345678899999999999999999998754
Q ss_pred ---cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceE
Q 047020 78 ---KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAK 154 (266)
Q Consensus 78 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~ 154 (266)
.+..++||||+++++|.+++... ...+++..++.++.|++.|+.+||++| ++|+||||+||+++.++.++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 45689999999999999999752 245788999999999999999999999 99999999999999999999
Q ss_pred EeccccccCCCCCCC----------CCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCch
Q 047020 155 LADFGLCKLGPFNDP----------NRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSAT 223 (266)
Q Consensus 155 l~dfg~~~~~~~~~~----------~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~ 223 (266)
|+|||++........ ..........++..|+|||++.+. .++.++|+||+|+++|+|++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 999999875432110 001223345689999999999765 68899999999999999998 6654333
Q ss_pred hHHHHHHHHhcC--------------chhhhhhhccCCCCCcchHHHHHH
Q 047020 224 LAEWTEECRRNK--------------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 224 ~~~~~~~~~~~~--------------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
............ ..+++.+|+..+|..||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 333333322110 125678999999999999888754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=268.65 Aligned_cols=238 Identities=20% Similarity=0.267 Sum_probs=185.7
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCC--CCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVS--HPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~ 85 (266)
..|.+...||+|+||.||++...+++.+++|.+..... .....+.+|++++++++ ||||+++++++...+..++||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 34555669999999999999877899999998865432 23467889999999997 599999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
| +.+++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||++++ +.++|+|||++....
T Consensus 108 e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 108 E-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp C-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred e-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 9 5588999999864 57899999999999999999999999 999999999999964 899999999987543
Q ss_pred CCCCCCCCcccccccCCCccCcccccc-----------ccCCCcccchhHHHHHHHHHhCCCCcCCCchhH-HHHHHHHh
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNT-----------GFVSTKSDVYSFGVLLLELITGLKSIQGSATLA-EWTEECRR 233 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~-~~~~~~~~ 233 (266)
.... ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+..... ........
T Consensus 178 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (313)
T 3cek_A 178 PDTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred Cccc--cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence 2211 122334578999999999865 467889999999999999999999997653332 22222221
Q ss_pred cC-----------chhhhhhhccCCCCCcchHHHHHH
Q 047020 234 NK-----------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 ~~-----------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.. ..+++.+|+..+|..||+.+++.+
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11 125678899999999999888753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=275.70 Aligned_cols=245 Identities=19% Similarity=0.253 Sum_probs=192.1
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.++.+...||+|+||.||++.... .+++|.+..... .....+.+|+.++++++||||+++++++.+....++||||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 445566699999999999997643 478887654322 2345577899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+++|.+++... ...+++..++.++.|++.||.+||+.| ++|+||||+||+++ ++.++|+|||++......
T Consensus 111 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 111 CKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999998752 246899999999999999999999999 99999999999997 679999999998753221
Q ss_pred CC-CCCCcccccccCCCccCcccccc---------ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc---
Q 047020 168 DP-NRPKRQTSIKGSFGYVDTNYLNT---------GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN--- 234 (266)
Q Consensus 168 ~~-~~~~~~~~~~~t~~y~aPE~~~~---------~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~--- 234 (266)
.. ..........|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+.+............
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 11 11223344568999999999864 346889999999999999999999998766554443332211
Q ss_pred --------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 235 --------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 235 --------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
...+++.+|+..+|..||+.+++.+.++..
T Consensus 263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l 300 (319)
T 2y4i_B 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300 (319)
T ss_dssp CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 122678899999999999999999988653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=277.28 Aligned_cols=238 Identities=22% Similarity=0.269 Sum_probs=190.8
Q ss_pred HHhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc------cHHHHHHHHHHHhcCC--CCCccccceeEEec
Q 047020 8 KMATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG------SRKIFLDEVSVLLRVS--HPNLVGLLGFCLEK 78 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~ 78 (266)
...+|.+...||+|+||.||++ ...+|..++||.+...... ....+.+|+.++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 3455666779999999999999 4567889999988654322 2245667999999996 59999999999999
Q ss_pred CeEEEEEEecCC-CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe-cCCceEEe
Q 047020 79 GEQLLLLEYLAN-KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI-DDNHAKLA 156 (266)
Q Consensus 79 ~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~~~l~ 156 (266)
+..++|+|++.+ ++|.+++... +.+++..++.++.|++.||.|||+.+ ++|+||||+||+++ +++.++|+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred CcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 999999999876 8999998874 67899999999999999999999999 99999999999999 77899999
Q ss_pred ccccccCCCCCCCCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH---
Q 047020 157 DFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR--- 232 (266)
Q Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~--- 232 (266)
|||++..... .......||..|+|||++.+..+ +.++||||||+++|+|++|..||...+..........
T Consensus 193 Dfg~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 266 (320)
T 3a99_A 193 DFGSGALLKD------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266 (320)
T ss_dssp CCTTCEECCS------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCC
T ss_pred eCcccccccc------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccC
Confidence 9999875332 22334568999999999877665 6789999999999999999999976543211100000
Q ss_pred hcCchhhhhhhccCCCCCcchHHHHHH
Q 047020 233 RNKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 233 ~~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.....+++.+|+..+|..||+.+++.+
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011225778999999999999888754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=273.07 Aligned_cols=241 Identities=24% Similarity=0.247 Sum_probs=168.2
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccc-ccHHHHHHHHH-HHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERG-GSRKIFLDEVS-VLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~-~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.++.....||+|+||.||++.. .+|+.++||.+..... .....+..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 3455566899999999999954 5788999998865432 22344555665 6777899999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ-ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
|+.+ +|.+++..........+++..+..++.|++.|+.+||+. | ++|+||||+||+++.++.++|+|||++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9965 888887654333346789999999999999999999998 9 9999999999999999999999999987532
Q ss_pred CCCCCCCCcccccccCCCccCcccc----ccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHH-HHHHh-------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYL----NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT-EECRR------- 233 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~-~~~~~------- 233 (266)
.. .......||..|+|||++ .+..++.++||||||+++|+|++|..||.+.+...... .....
T Consensus 178 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 178 DS-----IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN 252 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred cc-----cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence 21 122334689999999998 45678899999999999999999999997644322111 11110
Q ss_pred -------cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 -------NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 -------~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..||+..++.+
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 01125677888888888888877643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=275.96 Aligned_cols=200 Identities=26% Similarity=0.293 Sum_probs=165.0
Q ss_pred HHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-----------CCCccccceeE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-----------HPNLVGLLGFC 75 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~ 75 (266)
...+|.+...||+|+||.||++. ..+|+.++||.+... ......+.+|+.++++++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 34567777899999999999995 467888999987532 234566788999999886 78999999998
Q ss_pred EecC----eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeecCCCCCCcEEEecC
Q 047020 76 LEKG----EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ-ADPPIIHRDIKSSNILLIDD 150 (266)
Q Consensus 76 ~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~ 150 (266)
...+ ..+++||++ +++|.+++... ....+++..+..++.|++.||.|||++ | ++|+||||+||+++..
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEecc
Confidence 7654 789999998 88999999863 224589999999999999999999998 9 9999999999999533
Q ss_pred ------CceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 151 ------NHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 151 ------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
+.++|+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDE-------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTB-------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CCCcCcceEEEcccccccccCC-------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3799999999875321 2234568999999999999899999999999999999999999997543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=273.74 Aligned_cols=240 Identities=25% Similarity=0.318 Sum_probs=183.5
Q ss_pred HHHHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc------cHHHHHHHHHHHhcC----CCCCcccccee
Q 047020 6 ELKMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG------SRKIFLDEVSVLLRV----SHPNLVGLLGF 74 (266)
Q Consensus 6 ~i~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l----~~~~i~~~~~~ 74 (266)
+....+|.+...||+|+||.||++. ..+|+.+++|.+...... ....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 4455667777899999999999994 457889999987554321 223345689988888 89999999999
Q ss_pred EEecCeEEEEEEe-cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe-cCCc
Q 047020 75 CLEKGEQLLLLEY-LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI-DDNH 152 (266)
Q Consensus 75 ~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~ 152 (266)
+...+..++|+|+ +.+++|.+++... +.+++..++.++.|++.||.|||+.| ++|+||||+||+++ .++.
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 9999999999999 7889999999874 57899999999999999999999999 99999999999999 7899
Q ss_pred eEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHH
Q 047020 153 AKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 153 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~ 231 (266)
++|+|||++..... .......++..|+|||++.+..+ +.++||||||+++|+|++|..||.+...........
T Consensus 179 ~kl~dfg~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 252 (312)
T 2iwi_A 179 AKLIDFGSGALLHD------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF 252 (312)
T ss_dssp EEECCCSSCEECCS------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCC
T ss_pred EEEEEcchhhhccc------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCC
Confidence 99999999875332 22334568999999999876665 458999999999999999999997653322110000
Q ss_pred H---hcCchhhhhhhccCCCCCcchHHHHHH
Q 047020 232 R---RNKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 232 ~---~~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
. .....+++.+|+..++..||+.+++.+
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011125788999999999999988764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=279.94 Aligned_cols=235 Identities=22% Similarity=0.269 Sum_probs=174.5
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCCCchh
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
+.||+|+||.||.+...+|+.++||++... ....+.+|+++++++ +||||+++++++.+.+..++||||+. ++|.
T Consensus 21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred CeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 479999999998887778999999987543 245678899999876 79999999999999999999999995 6999
Q ss_pred hhhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC-------------CceEEeccc
Q 047020 95 DRMHTYYGQSL--GVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD-------------NHAKLADFG 159 (266)
Q Consensus 95 ~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-------------~~~~l~dfg 159 (266)
+++........ ...++..++.++.|++.||.|||++| ++||||||+||+++.. +.++|+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 99976421110 11234456789999999999999999 9999999999999754 379999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCcccccc-------ccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHH
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-------GFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEEC 231 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~ 231 (266)
++..................||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+...... ...
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~i~ 251 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NII 251 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--HHH
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--HHh
Confidence 998654332221222345679999999999865 568899999999999999999 9999976543321 111
Q ss_pred Hh----------------cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 232 RR----------------NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 232 ~~----------------~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.. ....+++.+|+..+|..||+..++.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 11235678899999999998887753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=274.15 Aligned_cols=232 Identities=13% Similarity=0.098 Sum_probs=166.9
Q ss_pred chhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc---ccHHHHHHHHHHHhcC--CCCCccccc-------eeEEec
Q 047020 12 NDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG---GSRKIFLDEVSVLLRV--SHPNLVGLL-------GFCLEK 78 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~~~~~ 78 (266)
+.+...||+|+||.||++. ..+|+.++||.+..... .....+.+|+.+++.+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 4455689999999999995 55788999998876443 2345566775444444 699988755 444333
Q ss_pred -----------------CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCCe
Q 047020 79 -----------------GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNR------LSIALDIARALEYLHSQADPPI 135 (266)
Q Consensus 79 -----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~------~~~~~~i~~~l~~Lh~~~~~~i 135 (266)
...++||||++ ++|.+++.... ..+....+ ..++.|++.||.|||++| |
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 23799999997 89999998641 23444555 677799999999999999 9
Q ss_pred ecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCcccccc--ccCCCcccchhHHHHHHHHHh
Q 047020 136 IHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT--GFVSTKSDVYSFGVLLLELIT 213 (266)
Q Consensus 136 ~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~i~~~l~~ 213 (266)
+||||||+||+++.++.+||+|||++.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVG-------TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETT-------CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecC-------CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999999999999999999999998531 11224566799999999987 678999999999999999999
Q ss_pred CCCCcCCCchhH--HHHH---------H-------HHhcCchhhhhhhccCCCCCcchHHHHH
Q 047020 214 GLKSIQGSATLA--EWTE---------E-------CRRNKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 214 g~~pf~~~~~~~--~~~~---------~-------~~~~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
|..||.+..... .+.. . .......+++.+|+..+|..||+..++.
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 999997663211 0000 0 0001112577889999999999988764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=269.38 Aligned_cols=233 Identities=21% Similarity=0.274 Sum_probs=160.8
Q ss_pred hchhhh-hccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEe----cCeEEEE
Q 047020 11 TNDFRI-RIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE----KGEQLLL 84 (266)
Q Consensus 11 ~~~~~~-~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv 84 (266)
.|.+.. .||+|+||.||++.. .+|+.+++|.+... .....+....++.++||||+++++++.. ....++|
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 344433 599999999999954 57899999987542 1222233344566789999999999876 4458999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC---CceEEeccccc
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD---NHAKLADFGLC 161 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~~~l~dfg~~ 161 (266)
|||+.+++|.+++... ....+++..++.++.|++.||.|||++| ++|+||||+||+++.+ +.++|+|||++
T Consensus 105 ~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 105 MECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999863 2246899999999999999999999999 9999999999999764 45999999998
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHH---HHHHH------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW---TEECR------ 232 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~---~~~~~------ 232 (266)
.... ........+|+.|+|||++.+..++.++||||+|+++|+|++|..||.+....... .....
T Consensus 179 ~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 179 KETT------QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp EEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred eecc------ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 7532 12233456799999999998888999999999999999999999999655432211 10000
Q ss_pred --------hcCchhhhhhhccCCCCCcchHHHHHH
Q 047020 233 --------RNKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 233 --------~~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.....+++.+|+..+|..||+.+++.+
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001125778999999999999888765
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=260.95 Aligned_cols=237 Identities=22% Similarity=0.283 Sum_probs=170.6
Q ss_pred hhchhhhhccccccceEEEEEc-CCCcEEEEEEeeeccccc--HHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGS--RKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
..+.+...||+|+||.||++.. .+|+.++||.+....... ...+.++..+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 3455566899999999999954 578899999886543321 2334445557888899999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ-ADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
|+ ++.+..+.... ...+++..++.++.|++.||.|||++ | ++|+||||+||+++.++.++|+|||++....
T Consensus 105 ~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 98 55555554432 25689999999999999999999995 9 9999999999999999999999999987532
Q ss_pred CCCCCCCCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhCCCCcCCCchh-HHHHHHHHhcC----
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITGLKSIQGSATL-AEWTEECRRNK---- 235 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~-~~~~~~~~~~~---- 235 (266)
.. .......++..|+|||++. +..++.++||||||+++|+|++|..||.+.... ...........
T Consensus 177 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (318)
T 2dyl_A 177 DD-----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC
T ss_pred CC-----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence 21 1223456899999999984 456788999999999999999999999874333 33333333211
Q ss_pred --------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 --------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 --------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 125678999999999999887753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=274.85 Aligned_cols=235 Identities=21% Similarity=0.232 Sum_probs=176.2
Q ss_pred chhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEEEecCC
Q 047020 12 NDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
+.....||+|+||.|+.....+|+.++||++..... ..+.+|+++++.+ +||||+++++++.+....++|||++.
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 334458999999997766667899999998854322 2356799999999 79999999999999999999999995
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec---CC--ceEEeccccccCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID---DN--HAKLADFGLCKLGP 165 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~--~~~l~dfg~~~~~~ 165 (266)
++|.+++... .....+..+..++.|++.||.|||+.| |+||||||+||+++. ++ +++|+|||++....
T Consensus 102 g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 102 ATLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 5999998763 123455567899999999999999999 999999999999953 33 47799999998643
Q ss_pred CCCCCCCCcccccccCCCccCccccc---cccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHh--------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLN---TGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRR-------- 233 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~-------- 233 (266)
.... .........||+.|+|||++. ...++.++||||+||++|+|++ |..||.+.............
T Consensus 175 ~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (432)
T 3p23_A 175 VGRH-SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTT
T ss_pred CCCc-ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcc
Confidence 2221 112334567999999999997 4567789999999999999999 99999654333221111000
Q ss_pred ----cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 ----NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 ----~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++.+|+..+|..||+.+++.
T Consensus 254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 254 KHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp CHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 0023578899999999999988876
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=271.64 Aligned_cols=195 Identities=17% Similarity=0.148 Sum_probs=159.6
Q ss_pred HHHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeeccc--------ccHHHHHHHHHHHhcCC---------CCCcc
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERG--------GSRKIFLDEVSVLLRVS---------HPNLV 69 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~---------~~~i~ 69 (266)
+...+|.+...||+|+||.||++.. +|+.+|||.+..... .....+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3346677777999999999999976 789999999876532 23477889999998886 55554
Q ss_pred -----------------ccceeEEe-------------cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHH
Q 047020 70 -----------------GLLGFCLE-------------KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALD 119 (266)
Q Consensus 70 -----------------~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (266)
++++++.+ .+..++||||+.+|++.+.+.. ..+++..+..++.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQ 169 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHH
Confidence 44444443 6789999999999987777644 56899999999999
Q ss_pred HHHHHHHHh-hCCCCCeecCCCCCCcEEEecCC--------------------ceEEeccccccCCCCCCCCCCCccccc
Q 047020 120 IARALEYLH-SQADPPIIHRDIKSSNILLIDDN--------------------HAKLADFGLCKLGPFNDPNRPKRQTSI 178 (266)
Q Consensus 120 i~~~l~~Lh-~~~~~~i~H~dikp~nil~~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~ 178 (266)
++.||.||| +.+ |+||||||+|||++.++ .+||+|||+++... ....
T Consensus 170 i~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~---------~~~~ 237 (336)
T 2vuw_A 170 LTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER---------DGIV 237 (336)
T ss_dssp HHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE---------TTEE
T ss_pred HHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC---------CCcE
Confidence 999999999 999 99999999999999887 89999999998532 1245
Q ss_pred ccCCCccCccccccccCCCcccchhHHHH-HHHHHhCCCCcCCC
Q 047020 179 KGSFGYVDTNYLNTGFVSTKSDVYSFGVL-LLELITGLKSIQGS 221 (266)
Q Consensus 179 ~~t~~y~aPE~~~~~~~~~~~Di~slG~i-~~~l~~g~~pf~~~ 221 (266)
.||+.|+|||++.+.. +.++||||++++ .+++++|..||.+.
T Consensus 238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~ 280 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV 280 (336)
T ss_dssp ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH
T ss_pred EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch
Confidence 7999999999998776 889999998777 77889999999653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=286.37 Aligned_cols=211 Identities=26% Similarity=0.379 Sum_probs=173.6
Q ss_pred HHHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEe------c
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE------K 78 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 78 (266)
....+|.+...||+|+||.||++. ..+|..++||.+..... .....+.+|+++++.++||||+++++++.. .
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 344677888899999999999994 46788999998765322 335678899999999999999999988755 6
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCc---eEE
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNH---AKL 155 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---~~l 155 (266)
+..++||||+.|++|.+++... .....+++..++.++.|++.|+.|||+.| ++|+||||+||+++.++. ++|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEE
T ss_pred CeEEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEE
Confidence 6789999999999999999764 22346899999999999999999999999 999999999999997765 899
Q ss_pred eccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHH
Q 047020 156 ADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW 227 (266)
Q Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~ 227 (266)
+|||++...... .......||..|+|||.+.+..++.++|+||+|+++|+|++|..||.+......|
T Consensus 166 ~DFG~a~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~ 232 (676)
T 3qa8_A 166 IDLGYAKELDQG-----ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232 (676)
T ss_dssp CSCCCCCBTTSC-----CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHS
T ss_pred cccccccccccc-----cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhh
Confidence 999999864322 2234467899999999999999999999999999999999999999776554443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=287.00 Aligned_cols=237 Identities=22% Similarity=0.317 Sum_probs=184.7
Q ss_pred HHHhhchhhhhccccccceEEEEEcC--CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCe---
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELG--DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE--- 80 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~--~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 80 (266)
+...+|.+...||+|+||.||++... +|..++||.+..... .....+.+|++++++++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34456677779999999999999543 578899997754332 234567899999999999999999999987665
Q ss_pred --EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 81 --QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 81 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
.++||||++|++|.+.+.. .+++..+..++.|++.+|.|||++| |+||||||+||+++.+ .+||+||
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp EEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCC
T ss_pred ceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEec
Confidence 7999999999999876542 6899999999999999999999999 9999999999999875 8999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhH--HH-HHHHHhcC
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLA--EW-TEECRRNK 235 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~--~~-~~~~~~~~ 235 (266)
|++..... .....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+..... .. ........
T Consensus 226 G~a~~~~~--------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 296 (681)
T 2pzi_A 226 GAVSRINS--------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDS 296 (681)
T ss_dssp TTCEETTC--------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHH
T ss_pred ccchhccc--------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHH
Confidence 99875322 14567899999999986654 889999999999999999999986532111 00 00001122
Q ss_pred chhhhhhhccCCCCCcc-hHHHHHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDA-NMEQLRVLIRI 263 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~-~~~~l~~~~~~ 263 (266)
..+++.+|+.++|..|| +.+++..-+..
T Consensus 297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 33678899999999998 45666554443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=249.68 Aligned_cols=215 Identities=15% Similarity=0.066 Sum_probs=174.7
Q ss_pred HhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
..+|.+...||+|+||.||++.. .+|+.+++|.+...... ....+.+|+..+.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 34567777999999999999954 55889999988654332 236788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+.|++|.+++.. + .....+..++.|++.||.|||++| ++|+||||+||+++.+|.++|++++.
T Consensus 110 ~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~---- 175 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT---- 175 (286)
T ss_dssp EECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc----
Confidence 999999999999854 2 355678899999999999999999 99999999999999999999985542
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHH-------------HHHH
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW-------------TEEC 231 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~-------------~~~~ 231 (266)
++| ++.++|||||||++|+|++|..||.+.+..... ....
T Consensus 176 --------------------~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 176 --------------------MPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADI 228 (286)
T ss_dssp --------------------CTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHH
T ss_pred --------------------cCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhc
Confidence 222 578899999999999999999999875542211 0001
Q ss_pred Hh---cCchhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 232 RR---NKNVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 232 ~~---~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.. ....+++.+|+..+|..| +.+++.+.++.+-
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 00 112367889999999999 9999999988753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=264.95 Aligned_cols=231 Identities=15% Similarity=0.079 Sum_probs=171.6
Q ss_pred hhhccccccceEEEEE-cCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCC-CCccccc-----------------
Q 047020 15 RIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSH-PNLVGLL----------------- 72 (266)
Q Consensus 15 ~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~-~~i~~~~----------------- 72 (266)
...||+|+||.||++. ..+|+.++||.+...... ..+.+.+|+.+++.++| ++.....
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 3479999999999995 677999999987633222 35678899999999976 3221111
Q ss_pred ----eeEEe-----cCeEEEEEEecCCCchhhhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCC
Q 047020 73 ----GFCLE-----KGEQLLLLEYLANKSLFDRMHTYY--GQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIK 141 (266)
Q Consensus 73 ----~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dik 141 (266)
..+.. ....+++|+.. +++|.+++.... ......+++..+..++.|++.||.|||+++ |+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcc
Confidence 11111 12457777755 789999885321 122356788899999999999999999999 9999999
Q ss_pred CCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCcccc----------ccccCCCcccchhHHHHHHHH
Q 047020 142 SSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL----------NTGFVSTKSDVYSFGVLLLEL 211 (266)
Q Consensus 142 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~~Di~slG~i~~~l 211 (266)
|+||+++.++.+||+|||++.... .......| +.|+|||++ .+..++.++|||||||++|+|
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~-------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDG-------ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETT-------EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecC-------CccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999987522 12344566 899999999 555688899999999999999
Q ss_pred HhCCCCcCCCchhHHHHHHHHhc-----CchhhhhhhccCCCCCcchHHHH
Q 047020 212 ITGLKSIQGSATLAEWTEECRRN-----KNVEVWAQMLDPKLNGDANMEQL 257 (266)
Q Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~~~~~~~~~~~l 257 (266)
++|..||.+.+............ ...+++.+|+..+|..||+..++
T Consensus 311 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999998765544333322211 12257789999999999996554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=248.95 Aligned_cols=211 Identities=21% Similarity=0.268 Sum_probs=166.6
Q ss_pred chhh-hhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHH-hcCCCCCccccceeEEe----cCeEEEE
Q 047020 12 NDFR-IRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVL-LRVSHPNLVGLLGFCLE----KGEQLLL 84 (266)
Q Consensus 12 ~~~~-~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~~~~lv 84 (266)
|.+. +.||+|+||.||++ ...+|+.+++|.+.. ...+.+|++++ +..+||||+++++++.. ....++|
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 4444 46999999999999 456788999998743 24567888888 55689999999999876 6678999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec---CCceEEeccccc
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID---DNHAKLADFGLC 161 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~~~l~dfg~~ 161 (266)
|||+++++|.+++... ....+++..++.++.|++.||.|||+.| ++|+||||+||+++. ++.++|+|||++
T Consensus 94 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 94 MECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp ECCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999873 2246899999999999999999999999 999999999999997 788999999987
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHH------------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE------------ 229 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~------------ 229 (266)
.... +..++.++|+||+||++|+|++|..||.+.+.......
T Consensus 168 ~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 168 KETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221 (299)
T ss_dssp EECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS
T ss_pred cccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC
Confidence 6311 23467789999999999999999999966543221100
Q ss_pred --HH---HhcCchhhhhhhccCCCCCcchHHHHHH
Q 047020 230 --EC---RRNKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 230 --~~---~~~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.. ......+++.+|+..+|..||+.+++.+
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 0111225788999999999999888764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-33 Score=249.77 Aligned_cols=184 Identities=18% Similarity=0.112 Sum_probs=127.1
Q ss_pred ccccccceEEEE-EcCCCcEEEEEEeeeccc----------ccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEEE
Q 047020 18 IGVGATSFVYLA-ELGDGNFGAVKRVMEERG----------GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 18 ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~----------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
...|++|....+ ....|+.+++|.+..... .....+.+|+++|+++ +|+||+++++++++++..|+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 344444443332 222467788887754321 1245688999999999 5999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||++|++|.+++... +++++. +++.||+.||.|+|++| |+||||||+|||++++|++||+|||+|+...
T Consensus 322 Eyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp ECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred ecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999874 566654 57899999999999999 9999999999999999999999999998533
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCC
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKS 217 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~p 217 (266)
.. ........||+.|+|||++.+. +...+|+||+|++++++.++..+
T Consensus 391 ~~----~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QD----CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CC----CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 22 2334567899999999999765 56789999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=219.05 Aligned_cols=184 Identities=16% Similarity=0.165 Sum_probs=142.8
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeecccc--------cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGG--------SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+.||+|+||.||++.. .+..+++|+...+... ..+++.+|++++++++||||+++..++...+..++||||
T Consensus 342 ~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 342 HLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp ------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 4799999999999944 5677888876543321 134578999999999999999776666677788999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
++|++|.+++.. +..++.|++.+|.|||+++ |+||||||+||+++. ++||+|||+++.....
T Consensus 421 ~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 421 INGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp CCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred CCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999998864 4589999999999999999 999999999999998 9999999999863221
Q ss_pred CCCC---CCcccccccCCCccCcccccc--ccCCCcccchhHHHHHHHHHhCCCCc
Q 047020 168 DPNR---PKRQTSIKGSFGYVDTNYLNT--GFVSTKSDVYSFGVLLLELITGLKSI 218 (266)
Q Consensus 168 ~~~~---~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~i~~~l~~g~~pf 218 (266)
.... ........||+.|+|||++.. ..|+...|+|+..+-..+-..++-+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1000 001235689999999999987 56788899999998888877776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=176.22 Aligned_cols=140 Identities=16% Similarity=0.108 Sum_probs=112.5
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeecccc------------------cHHHHHHHHHHHhcCCCCCccccceeEEe
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGG------------------SRKIFLDEVSVLLRVSHPNLVGLLGFCLE 77 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~------------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 77 (266)
..||+|+||.||++...+|+.+++|.+...... ....+.+|++++++++ | +++.+++..
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~ 172 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW 172 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence 589999999999997777899999987543221 2456889999999999 5 667765544
Q ss_pred cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEec
Q 047020 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLAD 157 (266)
Q Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~d 157 (266)
+..++||||++|++|.+ +.. .....++.|++.|+.+||+.| ++|+||||+||+++ ++.++|+|
T Consensus 173 -~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 173 -EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp -ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECC
T ss_pred -cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEE
Confidence 45699999999999987 421 234579999999999999999 99999999999999 99999999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCcccccc
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT 192 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 192 (266)
||++.. +..+.|||++..
T Consensus 236 FG~a~~-----------------~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVE-----------------VGEEGWREILER 253 (282)
T ss_dssp CTTCEE-----------------TTSTTHHHHHHH
T ss_pred CCCCeE-----------------CCCCCHHHHHHH
Confidence 998862 234678888743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=151.77 Aligned_cols=133 Identities=22% Similarity=0.229 Sum_probs=100.7
Q ss_pred hhhhccccccceEEEEEc-CCCcE--EEEEEeeecccc------------------------cHHHHHHHHHHHhcCCCC
Q 047020 14 FRIRIGVGATSFVYLAEL-GDGNF--GAVKRVMEERGG------------------------SRKIFLDEVSVLLRVSHP 66 (266)
Q Consensus 14 ~~~~ig~g~~~~v~~~~~-~~g~~--~~vk~~~~~~~~------------------------~~~~~~~e~~~l~~l~~~ 66 (266)
+...||+|+||.||++.. .+|.. ++||........ ....+.+|+.+++.++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 445899999999999966 67888 999975432111 013678899999999887
Q ss_pred Cc--cccceeEEecCeEEEEEEecCC-C----chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeecC
Q 047020 67 NL--VGLLGFCLEKGEQLLLLEYLAN-K----SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH-SQADPPIIHR 138 (266)
Q Consensus 67 ~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~~~~i~H~ 138 (266)
++ +..+.. ...++||||+.+ | +|.+.... .++..+..++.|++.++.+|| +.| ++||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 54 333332 356899999942 4 45544322 235577899999999999999 999 9999
Q ss_pred CCCCCcEEEecCCceEEeccccccC
Q 047020 139 DIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 139 dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+|||+++ .++|+|||++..
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEE
T ss_pred CCCHHHEEEcC--cEEEEECccccc
Confidence 99999999988 899999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3.2e-17 Score=138.09 Aligned_cols=135 Identities=16% Similarity=0.158 Sum_probs=95.9
Q ss_pred chhhhhccccccceEEEEEcCCCcEEEEEEeeecccc--------------cH--------HHHHHHHHHHhcCCCCCcc
Q 047020 12 NDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGG--------------SR--------KIFLDEVSVLLRVSHPNLV 69 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~--------------~~--------~~~~~e~~~l~~l~~~~i~ 69 (266)
|.+...||+|++|.||+|...+|..+|||..+..... .. -....|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3445589999999999998888999999975421110 00 1123567777777554433
Q ss_pred ccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec
Q 047020 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID 149 (266)
Q Consensus 70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~ 149 (266)
...-+... ..++||||++|++|..+.. ......++.|++.++.+||+.| |+||||||.|||+++
T Consensus 177 vp~p~~~~--~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 177 VPEPIAQS--RHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp CCCEEEEE--TTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCeeeecc--CceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 22211122 2379999999888765421 1234678899999999999999 999999999999987
Q ss_pred CC----------ceEEecccccc
Q 047020 150 DN----------HAKLADFGLCK 162 (266)
Q Consensus 150 ~~----------~~~l~dfg~~~ 162 (266)
+| .+.|+||+-+.
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCcccccccccceEEEEeCCcc
Confidence 76 38999999664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=4e-13 Score=108.25 Aligned_cols=141 Identities=16% Similarity=0.073 Sum_probs=105.3
Q ss_pred hchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecC
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.+.+...++.|+.+.||++... |+.+++|............+.+|+++++.+. +..++++++++.+.+..++|||+++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 3444557788888899999754 6788888765432233446888999999885 6678889998888889999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA-------------------------------------- 131 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-------------------------------------- 131 (266)
|.++.+.+. +......++.++..++..||+..
T Consensus 94 G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 94 GVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp SEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred CeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 988876531 11223467888999999999810
Q ss_pred ------------------CCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 132 ------------------DPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 132 ------------------~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0238999999999999765445799999765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=9.1e-12 Score=99.92 Aligned_cols=129 Identities=19% Similarity=0.187 Sum_probs=91.9
Q ss_pred cc-ccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCC--ccccceeEEecCeEEEEEEecCCCchh
Q 047020 18 IG-VGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPN--LVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 18 ig-~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
++ .|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +++++.+....+..++||||++|.++.
T Consensus 27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 44 45568999998777777888875432 2345778999999886433 556788877777899999999998873
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------------
Q 047020 95 DRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA------------------------------------------- 131 (266)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------------------------------------------- 131 (266)
... .+ ...++.++...+..||+..
T Consensus 104 --~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 104 --SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp --TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred --cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 211 11 1245666667777777642
Q ss_pred ------------CCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 132 ------------DPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 132 ------------~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999776556699999765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.26 E-value=2.6e-11 Score=102.18 Aligned_cols=139 Identities=15% Similarity=0.266 Sum_probs=101.2
Q ss_pred hccccccceEEEEEcCCCcEEEEEEee--ecc-cccHHHHHHHHHHHhcCC--CCCccccceeEEec---CeEEEEEEec
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVM--EER-GGSRKIFLDEVSVLLRVS--HPNLVGLLGFCLEK---GEQLLLLEYL 88 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~--~~~-~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~---~~~~lv~e~~ 88 (266)
.++.|.+..+|++...+ +.+++|+.. ... ......+.+|..+++.+. +..+++++.++.+. +..++|||++
T Consensus 45 ~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 45 QFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp ECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 68999999999997754 566676554 211 112346778999999987 34577888887766 4589999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA------------------------------------- 131 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------------------------------------- 131 (266)
+|..+.+... ..++......++.++...|..||+..
T Consensus 124 ~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 124 SGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred CCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9887754221 34678888889999999999999731
Q ss_pred ------------------CCCeecCCCCCCcEEEecCC-c-eEEeccccccC
Q 047020 132 ------------------DPPIIHRDIKSSNILLIDDN-H-AKLADFGLCKL 163 (266)
Q Consensus 132 ------------------~~~i~H~dikp~nil~~~~~-~-~~l~dfg~~~~ 163 (266)
...++|+|++|.||+++.++ + +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 13499999999999998765 3 58999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.9e-10 Score=94.69 Aligned_cols=185 Identities=18% Similarity=0.162 Sum_probs=113.8
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCC--ccccceeEEecC---eEEEEEEecCC
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPN--LVGLLGFCLEKG---EQLLLLEYLAN 90 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv~e~~~~ 90 (266)
.++.|....+|++. +.+++|..... .....+.+|.++++.+. +.. +++.+......+ ..|+||++++|
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 57888888898874 45666654322 23567889999998874 332 334443333332 34889999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA--------------------------------------- 131 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--------------------------------------- 131 (266)
.++.+... ..++......++.+++..+..||+..
T Consensus 101 ~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 88865332 23566677777777777777777511
Q ss_pred ----------------CCCeecCCCCCCcEEEec--CCceEEeccccccCCCCCCCCCCCcccccccCCCccCcccccc-
Q 047020 132 ----------------DPPIIHRDIKSSNILLID--DNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT- 192 (266)
Q Consensus 132 ----------------~~~i~H~dikp~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 192 (266)
.+.++|+|++|.||++++ .+.+.|+||+.+....... ..........-..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-----Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-----DFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-----HHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-----HHHHHHhhccccCHHHHHHH
Confidence 124899999999999997 4457899999876421100 0000000000012221110
Q ss_pred ---c----------cCCCcccchhHHHHHHHHHhCCCCcC
Q 047020 193 ---G----------FVSTKSDVYSFGVLLLELITGLKSIQ 219 (266)
Q Consensus 193 ---~----------~~~~~~Di~slG~i~~~l~~g~~pf~ 219 (266)
. ......+.|+++.++|.+.+|..+|.
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0 01123578999999999999988883
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=1.4e-07 Score=75.95 Aligned_cols=133 Identities=19% Similarity=0.137 Sum_probs=91.8
Q ss_pred ccccccc-eEEEEEcCC-CcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecCCCchh
Q 047020 18 IGVGATS-FVYLAELGD-GNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 18 ig~g~~~-~v~~~~~~~-g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
+..|..+ .+|+..... +..+.+|.... .....+.+|...++.+. +-.+.+++.++.+.+..++||++++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3444444 588886654 44566665432 23456788999998885 334678888888889999999999998877
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------------
Q 047020 95 DRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA------------------------------------------- 131 (266)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------------------------------------------- 131 (266)
+.... .......+..++...+..||+..
T Consensus 109 ~~~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 109 QVLEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 65433 12233445566666666776431
Q ss_pred ------------CCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 132 ------------DPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 132 ------------~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
.+.++|+|++|.||++++.+.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0137999999999999876666799999765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=3.5e-07 Score=75.12 Aligned_cols=134 Identities=16% Similarity=0.182 Sum_probs=85.3
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCC---CccccceeEE-ecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHP---NLVGLLGFCL-EKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e~~~~~~ 92 (266)
.++.|....+|+. |+.+++|.. ........+.+|.++++.+.+. .+.+.+.+.. ..+..++||++++|.+
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 4677777788887 456667653 2223356788999999998742 3555565553 4456789999999987
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------------------
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ------------------------------------------ 130 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~------------------------------------------ 130 (266)
+.+..- ..++......+..++...+..||+.
T Consensus 100 l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 765211 1123333333333333333333322
Q ss_pred ---------------CCCCeecCCCCCCcEEEec---CCce-EEeccccccC
Q 047020 131 ---------------ADPPIIHRDIKSSNILLID---DNHA-KLADFGLCKL 163 (266)
Q Consensus 131 ---------------~~~~i~H~dikp~nil~~~---~~~~-~l~dfg~~~~ 163 (266)
..+.++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1223799999999999987 4565 7999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=5.9e-07 Score=75.26 Aligned_cols=79 Identities=10% Similarity=-0.004 Sum_probs=50.9
Q ss_pred hc-cccccceEEEEEcC-------CCcEEEEEEeeecc---cccHHHHHHHHHHHhcCC-C--CCccccceeEEec---C
Q 047020 17 RI-GVGATSFVYLAELG-------DGNFGAVKRVMEER---GGSRKIFLDEVSVLLRVS-H--PNLVGLLGFCLEK---G 79 (266)
Q Consensus 17 ~i-g~g~~~~v~~~~~~-------~g~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~---~ 79 (266)
.| +.|....+|++... +++.+++|...... ......+.+|..+++.+. + -.+.+++.+..+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 45 77888889988653 14556666543221 001245678899988885 3 2466777766554 3
Q ss_pred eEEEEEEecCCCchhh
Q 047020 80 EQLLLLEYLANKSLFD 95 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~ 95 (266)
..++|||+++|..+.+
T Consensus 107 ~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 107 TPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SCEEEEECCCCBCCCB
T ss_pred CceEEEEecCCCChhh
Confidence 5789999998876543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.38 E-value=4.1e-06 Score=69.49 Aligned_cols=29 Identities=21% Similarity=0.369 Sum_probs=26.2
Q ss_pred eecCCCCCCcEEEecCCceEEeccccccC
Q 047020 135 IIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 135 i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
++|+|+++.||+++.++.+.|+||+.+..
T Consensus 224 l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 224 LCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp EECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred eecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 99999999999998778899999997753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=5.3e-06 Score=70.55 Aligned_cols=73 Identities=16% Similarity=0.139 Sum_probs=46.9
Q ss_pred hccccccceEEEEEcC-CCcEEEEEEeeeccc-------ccHHHHHHHHHHHhcCCC--CC-ccccceeEEecCeEEEEE
Q 047020 17 RIGVGATSFVYLAELG-DGNFGAVKRVMEERG-------GSRKIFLDEVSVLLRVSH--PN-LVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~-~g~~~~vk~~~~~~~-------~~~~~~~~e~~~l~~l~~--~~-i~~~~~~~~~~~~~~lv~ 85 (266)
.||.|..+.+|++... .++.++||....... ....++..|.++++.+.. |. +++++.+ +.+..++||
T Consensus 37 ~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvm 114 (397)
T 2olc_A 37 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 114 (397)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred ECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEE
Confidence 6899999999999653 467788886543211 123556789999888742 33 3344433 344568999
Q ss_pred EecCCC
Q 047020 86 EYLANK 91 (266)
Q Consensus 86 e~~~~~ 91 (266)
|++.+.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.11 E-value=4.7e-05 Score=62.47 Aligned_cols=73 Identities=22% Similarity=0.200 Sum_probs=56.4
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC---CCCccccceeEEecCeEEEEEEecCCCch
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS---HPNLVGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
.|+.|....+|++... ++.+++|..... ....+..|...|+.+. ...+++.+.+....+..++|||+++|..+
T Consensus 43 ~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 43 KLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 6889999999999864 566677765432 3567888999998884 25677888888777889999999988654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.01 E-value=9.2e-05 Score=59.94 Aligned_cols=72 Identities=19% Similarity=0.274 Sum_probs=52.4
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-C-C-CccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-H-P-NLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~-~-~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
.+|.|..+.+|++++.+|+.+.+|+...........+..|...|+.+. . + .+++.+.+ + ..++|||++.++.
T Consensus 22 ~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 22 ERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred ecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 689999999999999999999998765544444556788999999885 2 2 33444443 2 3478999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00017 Score=61.66 Aligned_cols=32 Identities=22% Similarity=0.471 Sum_probs=27.3
Q ss_pred hhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 128 h~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
+... ++|||++|.||+++.++ +.++||+.+..
T Consensus 230 ~~~~---liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQA---LIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCE---EECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCe---EEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 4455 99999999999998776 99999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00025 Score=59.79 Aligned_cols=141 Identities=18% Similarity=0.207 Sum_probs=78.6
Q ss_pred hccccccceEEEEEcCC--------CcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEe
Q 047020 17 RIGVGATSFVYLAELGD--------GNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~--------g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.+..|....+|++...+ ++.+.++. ............+|..+++.+. +.-.++++..+.+ .+||+|
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~-~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRL-YGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEE-CC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEE-CCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 46667778899987642 35566654 3333334566778999999886 3333556655433 289999
Q ss_pred cCCCchhh--------------hhhhhcCCC---CCCCC--HHHHHHHHHHHHH-------------------HHH----
Q 047020 88 LANKSLFD--------------RMHTYYGQS---LGVLS--WSNRLSIALDIAR-------------------ALE---- 125 (266)
Q Consensus 88 ~~~~~L~~--------------~~~~~~~~~---~~~~~--~~~~~~~~~~i~~-------------------~l~---- 125 (266)
++|..+.. .++..+... ..... +.++.++..++.. .+.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 98855431 222222221 11111 2344444443321 122
Q ss_pred HHhhCC-CCCeecCCCCCCcEEEecC----CceEEecccccc
Q 047020 126 YLHSQA-DPPIIHRDIKSSNILLIDD----NHAKLADFGLCK 162 (266)
Q Consensus 126 ~Lh~~~-~~~i~H~dikp~nil~~~~----~~~~l~dfg~~~ 162 (266)
.|...+ ...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 232221 2258999999999999876 689999999775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00016 Score=58.97 Aligned_cols=139 Identities=12% Similarity=0.080 Sum_probs=71.3
Q ss_pred hhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCc-cccceeEEecCeEEEEEEec-CCCch
Q 047020 16 IRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL-VGLLGFCLEKGEQLLLLEYL-ANKSL 93 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~-~~~~L 93 (266)
..|+.|....+|++ +.+++|..... +.......+|..+++.+....+ .+++.. +.+..+++++|+ +|.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~-~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKG-TEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCC-ccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 35778888889988 34556544322 2111223568888887752222 345443 333457899999 66544
Q ss_pred hh---------------hhhhhcCCCC---CCCCH-HHHHHHHH--------------HHHHHH----HHHhh-CCCCCe
Q 047020 94 FD---------------RMHTYYGQSL---GVLSW-SNRLSIAL--------------DIARAL----EYLHS-QADPPI 135 (266)
Q Consensus 94 ~~---------------~~~~~~~~~~---~~~~~-~~~~~~~~--------------~i~~~l----~~Lh~-~~~~~i 135 (266)
.. .+...+.... ..++. ..+..+.. .+...+ ..+.. .....+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 21 1122222111 00111 11111100 011111 11111 112348
Q ss_pred ecCCCCCCcEEEecCCceEEeccccccC
Q 047020 136 IHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 136 ~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
+|+|+.|.||+ ..++.+.++||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 6677899999987764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00058 Score=56.37 Aligned_cols=30 Identities=30% Similarity=0.556 Sum_probs=26.0
Q ss_pred CeecCCCCCCcEEEecC----CceEEeccccccC
Q 047020 134 PIIHRDIKSSNILLIDD----NHAKLADFGLCKL 163 (266)
Q Consensus 134 ~i~H~dikp~nil~~~~----~~~~l~dfg~~~~ 163 (266)
.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 39999999999999864 6789999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.001 Score=54.47 Aligned_cols=143 Identities=15% Similarity=0.151 Sum_probs=73.2
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCC--ccccce------eEEecCeEEEEEEec
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPN--LVGLLG------FCLEKGEQLLLLEYL 88 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~------~~~~~~~~~lv~e~~ 88 (266)
.|+.|....+|++...+| .+++|...... ....+..|..+++.+.... +++++. +....+..+++++++
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 466677788999976555 45666554321 2234566777777664211 233331 122345678999999
Q ss_pred CCCchhh-----------hhhhhcCC--C--CC---CCCHHHHHH---------------HHHHHHHHHHHHhhC----C
Q 047020 89 ANKSLFD-----------RMHTYYGQ--S--LG---VLSWSNRLS---------------IALDIARALEYLHSQ----A 131 (266)
Q Consensus 89 ~~~~L~~-----------~~~~~~~~--~--~~---~~~~~~~~~---------------~~~~i~~~l~~Lh~~----~ 131 (266)
+|..+.. .+...+.. . .. ......... +...+...+..+... .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8865321 11111100 0 00 001000000 001133344444421 0
Q ss_pred CCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 132 ~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
...++|+|+++.||++++++.+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 1238999999999999876555799998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.002 Score=52.87 Aligned_cols=74 Identities=15% Similarity=0.133 Sum_probs=46.4
Q ss_pred ccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCC--Ccccccee-----EEecCeEEEEEEecCC
Q 047020 18 IGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHP--NLVGLLGF-----CLEKGEQLLLLEYLAN 90 (266)
Q Consensus 18 ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~-----~~~~~~~~lv~e~~~~ 90 (266)
++ |....+|++...+|+.+++|..... ......+..|..+++.+... .+++++.. ....+..++++++++|
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 55 7777899987766767788766422 12345667788888877421 13333332 2335567889999987
Q ss_pred Cch
Q 047020 91 KSL 93 (266)
Q Consensus 91 ~~L 93 (266)
..+
T Consensus 112 ~~~ 114 (328)
T 1zyl_A 112 RQF 114 (328)
T ss_dssp EEC
T ss_pred CCC
Confidence 543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00047 Score=59.16 Aligned_cols=71 Identities=23% Similarity=0.352 Sum_probs=44.1
Q ss_pred hccccccceEEEEEcCC--------CcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCc-cccceeEEecCeEEEEEEe
Q 047020 17 RIGVGATSFVYLAELGD--------GNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL-VGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~--------g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~ 87 (266)
.|+.|....+|++...+ ++.+.+|..... .....+..|..+++.+...++ +++++.+. + .+|++|
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~ 153 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 153 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence 57778788899997543 456666544221 112456689999998863333 45555443 2 289999
Q ss_pred cCCCch
Q 047020 88 LANKSL 93 (266)
Q Consensus 88 ~~~~~L 93 (266)
++|.++
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 987443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0014 Score=56.66 Aligned_cols=72 Identities=11% Similarity=-0.006 Sum_probs=42.1
Q ss_pred hccccccceEEEEEcCC-CcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCc-cccceeEEecCeEEEEEEecCCCch
Q 047020 17 RIGVGATSFVYLAELGD-GNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL-VGLLGFCLEKGEQLLLLEYLANKSL 93 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~-g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 93 (266)
.|+.|....+|++...+ +..+.++.. .......-...+|..+++.+...++ ++++..+. + .+|++|++|.++
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~-g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLY-GPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEE-CC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEEC-CCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 57778788899997654 355555543 3222211122578999998874444 45565542 2 259999987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00066 Score=56.92 Aligned_cols=72 Identities=17% Similarity=0.071 Sum_probs=39.6
Q ss_pred hccccccceEEEEEcCC---------CcEEEEEEeeecccccHHHHHHHHHHHhcCCCCC-ccccceeEEecCeEEEEEE
Q 047020 17 RIGVGATSFVYLAELGD---------GNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPN-LVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~---------g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e 86 (266)
.++.|..-.+|++...+ ++.+++|.. ............|..+++.+...+ .++++... . .++|++
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~-~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIY-GKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEEC-CTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEec-CCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 57777778899986543 245555543 322221122357888888886333 34555433 2 368999
Q ss_pred ecCCCch
Q 047020 87 YLANKSL 93 (266)
Q Consensus 87 ~~~~~~L 93 (266)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0029 Score=52.38 Aligned_cols=30 Identities=23% Similarity=0.385 Sum_probs=26.6
Q ss_pred CeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 134 PIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 134 ~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
.++|+|+.+.||++++++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 499999999999998878899999987664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.58 E-value=0.011 Score=45.34 Aligned_cols=104 Identities=13% Similarity=0.068 Sum_probs=66.8
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
.||.+.+... +.+++++++|.+++|.+.+|.-+-.+.. -...=+.|..|++..+|.+-+.+ ..+.
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc--------
Confidence 5788888764 3789999999999999999988732111 11233457889999998887764 1110
Q ss_pred CCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCc
Q 047020 171 RPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSI 218 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf 218 (266)
.....+.|||... ...+.+.-|||||+++|..+--..|=
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 1122356777652 33456778999999999988755554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.017 Score=49.37 Aligned_cols=72 Identities=13% Similarity=0.039 Sum_probs=43.3
Q ss_pred hccccccceEEEEEcCC--------CcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEe
Q 047020 17 RIGVGATSFVYLAELGD--------GNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~--------g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.+..|..-.+|++...+ ++.++++. ....+...-...+|..+++.+. +.-.+++++.+ . -+.|++|
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi-~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRI-YGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEE-CCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEE-CCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 56677778899987653 45555554 3332222223457888888885 33334555432 2 2789999
Q ss_pred cCCCch
Q 047020 88 LANKSL 93 (266)
Q Consensus 88 ~~~~~L 93 (266)
++|..+
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 988553
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=95.30 E-value=0.12 Score=39.53 Aligned_cols=141 Identities=13% Similarity=0.220 Sum_probs=85.9
Q ss_pred CCCCccccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCC
Q 047020 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSS 143 (266)
Q Consensus 64 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ 143 (266)
.+|+.++. .+-.+.+...+.++.-+.+--+..+ ...+....++++..++....++++ -+|--+.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i--------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI--------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG--------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH--------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 47777765 4555556555555533322222223 346888999999999998855554 458889999
Q ss_pred cEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccc-hhHHHHHHHHHhCCCCc----
Q 047020 144 NILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDV-YSFGVLLLELITGLKSI---- 218 (266)
Q Consensus 144 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~i~~~l~~g~~pf---- 218 (266)
|++++.++.+++.-.|+-.. ++|..+ ...|. -.+=|++..++++...|
T Consensus 109 NL~f~~~~~p~i~~RGik~~---------------------l~P~~~------~ee~fL~qyKAliiall~~K~~Fe~l~ 161 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNV---------------------VDPLPV------SEAEFLTRYKALVICAFNEKQSFDALV 161 (215)
T ss_dssp GEEECTTSCEEESCCEETTT---------------------BSCCCC------CHHHHHHHHHHHHHHHHCTTCCHHHHH
T ss_pred eEEEcCCCCEEEEEccCccC---------------------CCCCCC------CHHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence 99999999999998776432 222211 11222 35778888888888888
Q ss_pred CCCchh---HHHHHHHHhcCchhhhhhhcc
Q 047020 219 QGSATL---AEWTEECRRNKNVEVWAQMLD 245 (266)
Q Consensus 219 ~~~~~~---~~~~~~~~~~~~~~~~~~~l~ 245 (266)
.|..++ ..+.+.+......+.+...+.
T Consensus 162 ~G~lel~k~~~f~~~I~~a~tleeL~~~L~ 191 (215)
T 4ann_A 162 EGNLELHKGTPFETKVIEAATLDLLTAFLD 191 (215)
T ss_dssp HSCGGGCCCCHHHHHHHHCCSHHHHHHHHH
T ss_pred cChHhhccCCHHHHHHHccCCHHHHHHHHH
Confidence 233333 344444444444444444433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.04 E-value=0.76 Score=35.19 Aligned_cols=113 Identities=9% Similarity=0.111 Sum_probs=74.9
Q ss_pred CCCCccccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeecCCCCC
Q 047020 64 SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE-YLHSQADPPIIHRDIKS 142 (266)
Q Consensus 64 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~Lh~~~~~~i~H~dikp 142 (266)
.||++ -..+-.+.+...+.++.-+++--++.++ .++....++++..++.... ++++ -+|--+.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 46776 3334466666666666543433333443 3688889999999888777 5544 56788999
Q ss_pred CcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccc-hhHHHHHHHHHhCCCCc
Q 047020 143 SNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDV-YSFGVLLLELITGLKSI 218 (266)
Q Consensus 143 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~i~~~l~~g~~pf 218 (266)
+|++++.++.+++.-.|+-.. ++|..+. ..|. -.+=|++..++.+...|
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~---------------------lpP~e~~------ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKES---------------------LPPDEWD------DERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp GGEEECTTCCEEESCCEETTT---------------------BSSCSCC------HHHHHHHHHHHHHHHTTCSSCH
T ss_pred ceEEEeCCCcEEEEEcCCccc---------------------CCCCCCC------HHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999999998886432 3333211 1232 25677888888887777
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.49 E-value=0.095 Score=44.31 Aligned_cols=29 Identities=31% Similarity=0.537 Sum_probs=24.4
Q ss_pred eecCCCCCCcEEEe------cCCceEEeccccccC
Q 047020 135 IIHRDIKSSNILLI------DDNHAKLADFGLCKL 163 (266)
Q Consensus 135 i~H~dikp~nil~~------~~~~~~l~dfg~~~~ 163 (266)
+||+|+.+.||++. +.+.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 68999999999994 456799999998763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 266 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-17 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-55
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 17/212 (8%)
Query: 7 LKMATNDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLR 62
+++ +DF +G G V+ G A K + +E + R + E+ VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 63 VSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
+ P +VG G GE + +E++ SL + G + +++ + +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIK 115
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
L YL + I+HRD+K SNIL+ KL DFG+ S G+
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------DSMANSFVGTR 167
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ L S +SD++S G+ L+E+ G
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-54
Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 23/257 (8%)
Query: 12 NDFRI--RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
++ R+G G V++ AVK +++ S FL E +++ ++ H LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L + ++ EY+ N SL D + T G L + + L +A IA + ++
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL---TINKLLDMAAQIAEGMAFIEE 127
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
+ IHRD++++NIL+ D K+ADFGL +L N + K +
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEA 181
Query: 190 LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLN 249
+N G + KSDV+SFG+LL E++T + T E +N+E +M+ P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------QNLERGYRMVRP--- 232
Query: 250 GDANMEQLRVLIRICMA 266
D E+L L+R+C
Sbjct: 233 -DNCPEELYQLMRLCWK 248
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-52
Identities = 58/260 (22%), Positives = 107/260 (41%), Gaps = 21/260 (8%)
Query: 12 NDFRI--RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
+ RIG G+ VY + + V + F +EV VL + H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
+G+ + ++ ++ SL+ +H + + IA A+ ++YLH+
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHA 122
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
+ IIHRD+KS+NI L +D K+ DFGL + + + + + GS ++
Sbjct: 123 K---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV--KSRWSGSHQFEQLSGSILWMAPEV 177
Query: 190 L---NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDP 246
+ + S +SDVY+FG++L EL+TG + R D
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY------LSPDL 231
Query: 247 KLNGDANMEQLRVLIRICMA 266
+ ++ L+ C+
Sbjct: 232 SKVRSNCPKAMKRLMAECLK 251
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-49
Identities = 63/257 (24%), Positives = 117/257 (45%), Gaps = 23/257 (8%)
Query: 12 NDFRI--RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
++ IG G V+L + + A+K + E S + F++E V++++SHP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L G CLE+ L+ E++ + L D + T G + L + LD+ + YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLE- 118
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
+ +IHRD+ + N L+ ++ K++DFG+ + F ++ T K +
Sbjct: 119 --EACVIHRDLAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWASPEV 173
Query: 190 LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLN 249
+ S+KSDV+SFGVL+ E+ + K + + +E E+ ++ P+L
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------RLYKPRLA 227
Query: 250 GDANMEQLRVLIRICMA 266
+ ++ C
Sbjct: 228 S----THVYQIMNHCWK 240
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-48
Identities = 72/264 (27%), Positives = 117/264 (44%), Gaps = 31/264 (11%)
Query: 6 ELKMATNDFRI--RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRV 63
L M + ++ IG G V L + GN AVK + + + + FL E SV+ ++
Sbjct: 3 ALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQL 57
Query: 64 SHPNLVGLLGFCLEKGEQL-LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
H NLV LLG +E+ L ++ EY+A SL D + + + VL L +LD+
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCE 114
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
A+EYL +HRD+ + N+L+ +DN AK++DFGL K Q + K
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-------SSTQDTGKLPV 164
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQ 242
+ L STKSDV+SFG+LL E+ + + L + + ++
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 224
Query: 243 MLDPKLNGDANMEQLRVLIRICMA 266
+ +++ C
Sbjct: 225 C----------PPAVYEVMKNCWH 238
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-48
Identities = 51/269 (18%), Positives = 109/269 (40%), Gaps = 26/269 (9%)
Query: 5 EELKMATNDFRIR---IGVGATSFVYLAEL---GDGNFGAVKRV-MEERGGSRKIFLDEV 57
++L + ++ I +G G V A+K + + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 58 SVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIA 117
++ ++ +P +V L+G C + +L++E L + + + SN +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELL 115
Query: 118 LDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTS 177
++ ++YL + +HRD+ + N+LL++ ++AK++DFGL K +D R ++
Sbjct: 116 HQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR-SA 171
Query: 178 IKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV 237
K + +N S++SDV+S+GV + E ++ + E + K +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231
Query: 238 EVWAQMLDPKLNGDANMEQLRVLIRICMA 266
E + +L L+ C
Sbjct: 232 ECPPECP----------PELYALMSDCWI 250
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-47
Identities = 60/257 (23%), Positives = 105/257 (40%), Gaps = 23/257 (8%)
Query: 12 NDFRI--RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
R+ ++G G V++ A+K ++ S + FL E V+ ++ H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L + ++ EY++ SL D + G++ L + +A IA + Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
+HRD++++NIL+ ++ K+ADFGL +L N + K +
Sbjct: 132 M---NYVHRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEA 185
Query: 190 LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLN 249
G + KSDV+SFG+LL EL T + E ++ R + +
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------ 239
Query: 250 GDANMEQLRVLIRICMA 266
E L L+ C
Sbjct: 240 ----PESLHDLMCQCWR 252
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-47
Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 15/242 (6%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHPN 67
D+ + +G GA V LA AVK V M+ + E+ + ++H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+V G E Q L LEY + LFDR+ + + + + YL
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYL 119
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
H I HRDIK N+LL + ++ K++DFGL + F NR + + G+ YV
Sbjct: 120 HGI---GITHRDIKPENLLLDERDNLKISDFGLATV--FRYNNRERLLNKMCGTLPYVAP 174
Query: 188 NYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDP 246
L F + DV+S G++L ++ G + + + + K + +D
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 247 KL 248
Sbjct: 235 AP 236
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-47
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 19/212 (8%)
Query: 11 TNDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPN 67
+ + I +G GA VY A+ A K + + + ++ E+ +L HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+V LL + +L+E+ A ++ M L+ S + AL YL
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDALNYL 126
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
H IIHRD+K+ NIL D KLADFG+ + +R+ S G+ ++
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK----NTRTIQRRDSFIGTPYWMAP 179
Query: 188 NYL-----NTGFVSTKSDVYSFGVLLLELITG 214
+ K+DV+S G+ L+E+
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEI 211
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-47
Identities = 59/257 (22%), Positives = 105/257 (40%), Gaps = 23/257 (8%)
Query: 12 NDFRI--RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
D +G G V + A+K +++E S F++E V++ +SH LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L G C ++ ++ EY+AN L + + + L + D+ A+EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLE- 117
Query: 130 QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
+HRD+ + N L+ D K++DFGL + + K +
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWSPPEV 172
Query: 190 LNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLN 249
L S+KSD+++FGVL+ E+ + K T +E E + ++ P L
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLA 226
Query: 250 GDANMEQLRVLIRICMA 266
E++ ++ C
Sbjct: 227 S----EKVYTIMYSCWH 239
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-47
Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 14/211 (6%)
Query: 13 DFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPN 67
D+ + IG G+ DG K + +++ + EV++L + HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 68 LVGLLGFCLEKGEQLLLL--EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE 125
+V +++ L + EY L + + L L + + AL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG-TKERQYLDEEFVLRVMTQLTLALK 123
Query: 126 YLHSQAD--PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
H ++D ++HRD+K +N+ L + KL DFGL ++ + + G+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT----SFAKAFVGTPY 179
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ +N + KSD++S G LL EL
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 210
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-46
Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 22/220 (10%)
Query: 4 LEELKMA------TNDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFL 54
LE+L+ + +IG GA+ VY A ++ G A++++ ++ +++ +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 55 DEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRL 114
+E+ V+ +PN+V L L E +++EYLA SL D + +
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIA 119
Query: 115 SIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKR 174
++ + +ALE+LHS +IHRDIKS NILL D KL DFG C R
Sbjct: 120 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--- 173
Query: 175 QTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+++ G+ ++ + K D++S G++ +E+I G
Sbjct: 174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 2e-46
Identities = 62/291 (21%), Positives = 109/291 (37%), Gaps = 43/291 (14%)
Query: 4 LEELKMATNDFRI--RIGVGATSFVYLAEL------GDGNFGAVKRV-MEERGGSRKIFL 54
L L+ N+ IG GA V+ A AVK + E + F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 55 DEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLG-------- 106
E +++ +PN+V LLG C LL EY+A L + + + ++
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 107 -----------VLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKL 155
LS + +L IA +A + YL + +HRD+ + N L+ ++ K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 156 ADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGL 215
ADFGL + + K + ++ + +T+SDV+++GV+L E+ +
Sbjct: 182 ADFGLSRN--IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 216 KSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266
E R + +L L+R+C +
Sbjct: 240 LQPYYGMAHEEVIYYVRDGNILACPENC----------PLELYNLMRLCWS 280
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-46
Identities = 72/273 (26%), Positives = 116/273 (42%), Gaps = 36/273 (13%)
Query: 12 NDFRI--RIGVGATSFVYLAELGDGNFG---AVKRV-MEERGGSRKIFLDEVSVLLRVS- 64
ND + IG G V A + A+KR+ + F E+ VL ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYY-----------GQSLGVLSWSNR 113
HPN++ LLG C +G L +EY + +L D + + LS
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 114 LSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPK 173
L A D+AR ++YL IHRD+ + NIL+ ++ AK+ADFGL +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----- 181
Query: 174 RQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR 233
++T + ++ LN +T SDV+S+GVLL E+++ + T AE E+ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
Query: 234 NKNVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266
+E D ++ L+R C
Sbjct: 242 GYRLEKPLNCDD----------EVYDLMRQCWR 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-46
Identities = 54/261 (20%), Positives = 99/261 (37%), Gaps = 30/261 (11%)
Query: 14 FRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVG 70
F I IG G+ VY A + + + R+ F +E +L + HPN+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 71 LLGFCLEKGEQ----LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
+ +L+ E + + +L + + V+ S I + L++
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQF 127
Query: 127 LHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
LH++ PPIIHRD+K NI + K+ D GL L R ++ G+ ++
Sbjct: 128 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL------KRASFAKAVIGTPEFM 180
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLD 245
+ DVY+FG+ +LE+ T A+ + ++
Sbjct: 181 APEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 246 PKLNGDANMEQLRVLIRICMA 266
P +++ +I C+
Sbjct: 240 P---------EVKEIIEGCIR 251
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 5e-46
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 20/213 (9%)
Query: 8 KMATNDFRI--RIGVGATSFVYLAEL-GDGNFGAVKRV---MEERGGSRKIFLDEVSVLL 61
+ A DF I +G G VYLA A+K + E+ G EV +
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
+ HPN++ L G+ + L+LEY +++ + + ++A
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELA 116
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
AL Y HS+ +IHRDIK N+LL K+ADFG P R+T++ G+
Sbjct: 117 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP------SSRRTTLCGT 167
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ + K D++S GVL E + G
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 200
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-46
Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 27/274 (9%)
Query: 3 ALEELKMATNDFRIR----IGVGATSFVYLAELGDGN----FGAVKRVMEERG-GSRKIF 53
A++ + + + + IG G VY L D + AVK + G F
Sbjct: 16 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 54 LDEVSVLLRVSHPNLVGLLGFCLE-KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSN 112
L E ++ SHPN++ LLG CL +G L++L Y+ + L + + + +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN----FIRNETHNPTVKD 131
Query: 113 RLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172
+ L +A+ +++L +HRD+ + N +L + K+ADFGL + + +
Sbjct: 132 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188
Query: 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232
+T K ++ L T +TKSDV+SFGVLL EL+T + T
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248
Query: 233 RNKNVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266
+ + ++L P+ + L ++ C
Sbjct: 249 QGR------RLLQPEY----CPDPLYEVMLKCWH 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (385), Expect = 2e-45
Identities = 54/283 (19%), Positives = 107/283 (37%), Gaps = 34/283 (12%)
Query: 1 TYALEELKMATNDF-------RIR----IGVGATSFVYLAEL----GDGNFGAVKRVMEE 45
+ E+ A +F ++ IG G V L F A+K +
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 46 RG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQS 104
R+ FL E S++ + HPN++ L G + +++ E++ N SL + GQ
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 105 LGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164
+ + + IA ++YL D +HRD+ + NIL+ + K++DFGL +
Sbjct: 126 ----TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 165 PFNDPNRP-KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSAT 223
+ + K + + ++ SDV+S+G+++ E+++ + T
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 224 LAEWTEECRRNKNVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266
+ ++ + L L+ C
Sbjct: 239 NQDVINAIEQDYRLPPPMDC----------PSALHQLMLDCWQ 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-45
Identities = 59/278 (21%), Positives = 108/278 (38%), Gaps = 37/278 (13%)
Query: 12 NDFRI--RIGVGATSFVYLAEL------GDGNFGAVKRV-MEERGGSRKIFLDEVSVLLR 62
N +G GA V A AVK + R+ + E+ VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 63 VS-HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSL-------------GVL 108
+ H N+V LLG C G L++ EY L + + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 109 SWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168
+ LS + +A+ + +L S+ IHRD+ + NILL K+ DFGL + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARD--IKN 197
Query: 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT 228
+ + + + ++ + + +SDV+S+G+ L EL + GS+
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL-----GSSPYPGMP 252
Query: 229 EECRRNKNVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266
+ + K ++ +ML P + ++ +++ C
Sbjct: 253 VDSKFYKMIKEGFRMLSP----EHAPAEMYDIMKTCWD 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-45
Identities = 53/275 (19%), Positives = 95/275 (34%), Gaps = 33/275 (12%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
IG G V+ + G AVK + R E+ + + H N++G +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 77 EKGEQL----LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA- 131
+ L+ +Y + SLFD ++ Y ++ + +AL A L +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 132 ----DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
P I HRD+KS NIL+ + +AD GL G+ Y+
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 188 NYLNTGF------VSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVE--- 238
L+ ++D+Y+ G++ E+ + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 239 ---VWAQMLDPKLNGDAN----MEQLRVLIRICMA 266
V Q L P + + + ++R C
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (383), Expect = 3e-45
Identities = 68/258 (26%), Positives = 109/258 (42%), Gaps = 23/258 (8%)
Query: 12 NDFRI--RIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL 68
D + ++G G VY AVK ++E + FL E +V+ + HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
V LLG C + ++ E++ +L D + Q +S L +A I+ A+EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLE 132
Query: 129 SQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTN 188
IHRD+ + N L+ +++ K+ADFGL + + K +
Sbjct: 133 K---KNFIHRDLAARNCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWTAPE 186
Query: 189 YLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKL 248
L S KSDV++FGVLL E+ T S L++ E ++ +E
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC----- 241
Query: 249 NGDANMEQLRVLIRICMA 266
E++ L+R C
Sbjct: 242 -----PEKVYELMRACWQ 254
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 153 bits (387), Expect = 3e-45
Identities = 46/208 (22%), Positives = 85/208 (40%), Gaps = 17/208 (8%)
Query: 12 NDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL 68
+ + I +G GA V+ E GN A K VM ++ E+ + + HP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
V L + E +++ E+++ LF+++ + + +S + + + L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMH 141
Query: 129 SQADPPIIHRDIKSSNILLI--DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
+H D+K NI+ N KL DFGL + + G+ +
Sbjct: 142 EN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-----LDPKQSVKVTTGTAEFAA 193
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELITG 214
V +D++S GVL L++G
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSG 221
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 5e-45
Identities = 57/255 (22%), Positives = 103/255 (40%), Gaps = 25/255 (9%)
Query: 17 RIGVGATSFVYLAELGDGNFG---AVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGL 71
+G G V AVK + E + L E +V+ ++ +P +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
+G C E +L++E L + + N + + ++ ++YL
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEES- 126
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
+HRD+ + N+LL+ ++AK++DFGL K D N K QT K + +N
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWPVKWYAPECIN 183
Query: 192 TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLNGD 251
S+KSDV+SFGVL+ E + + +E T + + + A
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP------- 236
Query: 252 ANMEQLRVLIRICMA 266
++ L+ +C
Sbjct: 237 ---REMYDLMNLCWT 248
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-44
Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 16/213 (7%)
Query: 8 KMATNDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEERG---GSRKIFLDEVSVLL 61
K DF+ +G G+ S V LA EL A+K + + E V+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
R+ HP V L + + L Y N L + G + +I
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIV 118
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
ALEYLH IIHRD+K NILL +D H ++ DFG K+ + ++ R S G+
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV--LSPESKQARANSFVGT 173
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
YV L SD+++ G ++ +L+ G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-44
Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 12 NDFRI--RIGVGATSFVYLA------ELGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLR 62
+ +G GA V A + G AVK + E+ R+ + E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 63 V-SHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYG------------------Q 103
+ SH N+V LLG C G L+ EY L + + + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 104 SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163
L VL++ + L A +A+ +E+L + +HRD+ + N+L+ K+ DFGL +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ + + + ++ L G + KSDV+S+G+LL E+ +
Sbjct: 214 --IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (376), Expect = 6e-44
Identities = 54/257 (21%), Positives = 93/257 (36%), Gaps = 33/257 (12%)
Query: 17 RIGVGATSFVYLAE-LGDGNFGAVKRV---MEERGGSRKIFLDEVSVLLRVSHPNLVGLL 72
IG G+ VY A + + A+K++ ++ + + EV L ++ HPN +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 73 GFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQAD 132
G L + L++EY + L ++ + L YLHS
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH-- 134
Query: 133 PPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYL-- 190
+IHRD+K+ NILL + KL DFG + S G+ ++ +
Sbjct: 135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIM--------APANSFVGTPYWMAPEVILA 185
Query: 191 -NTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLN 249
+ G K DV+S G+ +EL + ++ + P L
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----------SPALQ 235
Query: 250 GDANMEQLRVLIRICMA 266
E R + C+
Sbjct: 236 SGHWSEYFRNFVDSCLQ 252
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 9e-43
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 18/211 (8%)
Query: 12 NDFRI--RIGVGATSFVYLAEL----GDGNFGAVKRV---MEERGGSRKIFLDEVSVLLR 62
D R+ ++G G+ V E G AVK + + + + F+ EV+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 63 VSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
+ H NL+ L G L ++ E SL DR+ + G A+ +A
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAE 122
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
+ YL S+ IHRD+ + N+LL + K+ DFGL + P ND + Q K F
Sbjct: 123 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY-VMQEHRKVPF 178
Query: 183 GYVDTNYLNTGFVSTKSDVYSFGVLLLELIT 213
+ L T S SD + FGV L E+ T
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 144 bits (365), Expect = 6e-42
Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 12 NDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL 68
+ + I +G GA V+ E G K + + +E+S++ ++ HP L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 69 VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLH 128
+ L +K E +L+LE+L+ LFDR+ + +S + ++ L+++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVINYMRQACEGLKHMH 144
Query: 129 SQADPPIIHRDIKSSNILL--IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
I+H DIK NI+ + K+ DFGL N + + +
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT-----KLNPDEIVKVTTATAEFAA 196
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELITG 214
++ V +D+++ GVL L++G
Sbjct: 197 PEIVDREPVGFYTDMWAIGVLGYVLLSG 224
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-41
Identities = 52/255 (20%), Positives = 101/255 (39%), Gaps = 24/255 (9%)
Query: 18 IGVGATSFVYLAELGDGNFG-----AVKRV-MEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
IG G VY L + A+K + R FL E ++ + SH N++ L
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
G + +++ EY+ N +L + G+ S + + IA ++YL +
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLAN-- 128
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
+HRD+ + NIL+ + K++DFGL ++ +DP + K + ++
Sbjct: 129 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 192 TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPKLNGD 251
++ SDV+SFG+++ E++T + + E + +
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-------- 238
Query: 252 ANMEQLRVLIRICMA 266
+ L+ C
Sbjct: 239 --PSAIYQLMMQCWQ 251
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-41
Identities = 45/207 (21%), Positives = 86/207 (41%), Gaps = 18/207 (8%)
Query: 13 DFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLV 69
+ I +G G V+ E K ++ +G + + E+S+L H N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 70 GLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS 129
L E +++ E+++ +F+R++T + L+ +S + AL++LHS
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVHQVCEALQFLHS 120
Query: 130 QADPPIIHRDIKSSNILLIDDN--HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
I H DI+ NI+ K+ +FG + D + + Y
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-----NFRLLFTAPEYYAP 172
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITG 214
VST +D++S G L+ L++G
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-41
Identities = 52/262 (19%), Positives = 100/262 (38%), Gaps = 28/262 (10%)
Query: 13 DFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVM-----EERGGSRKIFLDEVSVLLRVS 64
+F+ +G GA VY + +G + + + K LDE V+ V
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
+P++ LLG CL L+ + + L D + + L+ + IA+ +
Sbjct: 70 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGM 124
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
YL + ++HRD+ + N+L+ H K+ DFGL KL + K +
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVPIKW 179
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQML 244
+ + + +SDV+S+GV + EL+T +E + + + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC- 238
Query: 245 DPKLNGDANMEQLRVLIRICMA 266
+ +++ C
Sbjct: 239 ---------TIDVYMIMVKCWM 251
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 7e-40
Identities = 50/262 (19%), Positives = 95/262 (36%), Gaps = 28/262 (10%)
Query: 12 NDFRI--RIGVGATSFVYLAELGDGNFG----AVKRV-MEERGGSRKIFLDEVSVLLRVS 64
+ IG G V+ A+K R+ FL E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
HP++V L+G E +++E L + L ++ + A ++ AL
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTAL 121
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
YL S+ +HRDI + N+L+ ++ KL DFGL + + + + + + K +
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKW 175
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQML 244
+ +N ++ SDV+ FGV + E++ + + + +
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC- 234
Query: 245 DPKLNGDANMEQLRVLIRICMA 266
L L+ C A
Sbjct: 235 ---------PPTLYSLMTKCWA 247
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 8e-40
Identities = 59/279 (21%), Positives = 110/279 (39%), Gaps = 29/279 (10%)
Query: 2 YALEELKMATNDFRI--RIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKI 52
Y +E ++A + +G G+ VY A+K V E R
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 53 FLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYG-----QSLGV 107
FL+E SV+ + ++V LLG + L+++E + L + + L
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 108 LSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167
S S + +A +IA + YL++ +HRD+ + N ++ +D K+ DFG+ +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IY 184
Query: 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW 227
+ + ++ ++ L G +T SDV+SFGV+L E+ T + + +
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244
Query: 228 TEECRRNKNVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266
++ D L L+R+C
Sbjct: 245 LRFVMEGGLLDKPDNCPD----------MLFELMRMCWQ 273
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (345), Expect = 2e-39
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV---MEERGGSRKIFLDEVSVLLRVSH 65
DF+I +G G+ V+L +G + A+K + + R + DE +L V+H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE 125
P ++ + G + + ++++Y+ LF + A ++ ALE
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-----NPVAKFYAAEVCLALE 118
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
YLHS+ II+RD+K NILL + H K+ DFG K P ++ G+ Y+
Sbjct: 119 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-------PDVTYTLCGTPDYI 168
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS 221
++T + D +SFG+L+ E++ G S
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-39
Identities = 65/278 (23%), Positives = 117/278 (42%), Gaps = 38/278 (13%)
Query: 12 NDFRI--RIGVGATSFVYLAEL--------GDGNFGAVKRV-MEERGGSRKIFLDEVSVL 60
+ + +G GA V LAE AVK + + + E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 61 LRVS-HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSL-----------GVL 108
+ H N++ LLG C + G +++EY + +L + + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 109 SWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168
S + +S A +AR +EYL S IHRD+ + N+L+ +DN K+ADFGL + +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARD--IHH 187
Query: 169 PNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWT 228
+ K+ T+ + ++ L + +SDV+SFGVLL E+ T S + E
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 229 EECRRNKNVEVWAQMLDPKLNGDANMEQLRVLIRICMA 266
+ + ++ + +L +++R C
Sbjct: 248 KLLKEGHRMDKPSNC----------TNELYMMMRDCWH 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 2e-38
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 11 TNDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHP 66
+ + +G GA S V LAE A+K + + G +E++VL ++ HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
N+V L G L+++ ++ LFDR+ G + + + + A++Y
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKY 122
Query: 127 LHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
LH I+HRD+K N+L +D+ ++DFGL K+ + ++ G+ G
Sbjct: 123 LHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-----DPGSVLSTACGTPG 174
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
YV L S D +S GV+ L+ G
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 7e-38
Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGS---RKIFLDEVSVLLRV-S 64
DF + +G G+ V+LAE F A+K + ++ + + E VL
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 65 HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
HP L + K ++EYL L + S S A +I L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGL 116
Query: 125 EYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
++LHS+ I++RD+K NILL D H K+ADFG+CK D + + G+ Y
Sbjct: 117 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTPDY 169
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ L + D +SFGVLL E++ G
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 8e-38
Identities = 54/238 (22%), Positives = 102/238 (42%), Gaps = 27/238 (11%)
Query: 12 NDFRI--RIGVGATSFVYLA------ELGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLR 62
+ ++ +G GA V A + AVK + E + + E+ +L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 63 VSH-PNLVGLLGFCLEKGEQLLLL-EYLANKSLFDRMHTYYGQSL-----------GVLS 109
+ H N+V LLG C + G L+++ E+ +L + + + + L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 110 WSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169
+ + + +A+ +E+L S+ IHRD+ + NILL + N K+ DFGL +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD--IYKD 187
Query: 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW 227
R+ + ++ + + +SDV+SFGVLL E+ + S + E
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (331), Expect = 1e-37
Identities = 58/266 (21%), Positives = 110/266 (41%), Gaps = 27/266 (10%)
Query: 11 TNDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV---MEERGGSRKIFLDEVSVLLRVS 64
++ + + +G G S V+LA L AVK + + F E ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 65 HPNLVGLLGFCLEKGEQL----LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
HP +V + + +++EY+ +L D +HT G ++ + + D
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADA 120
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
+AL + H IIHRD+K +NI++ N K+ DFG+ + + N + ++ G
Sbjct: 121 CQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIG 176
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVW 240
+ Y+ V +SDVYS G +L E++TG G + ++ + R +
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP----- 231
Query: 241 AQMLDPKLNGDANMEQLRVLIRICMA 266
+ P + L ++ +A
Sbjct: 232 ---IPPSARHEGLSADLDAVVLKALA 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 129 bits (326), Expect = 6e-37
Identities = 54/216 (25%), Positives = 84/216 (38%), Gaps = 22/216 (10%)
Query: 13 DFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV---------MEERGGSRKIFLDEVSVL 60
++ +G G +S V AVK + EE R+ L EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 61 LRVS-HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALD 119
+VS HPN++ L L+ + + LFD + LS I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRA 118
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
+ + LH I+HRD+K NILL DD + KL DFG + R T
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175
Query: 180 GSFGYVDTN-YLNTGFVSTKSDVYSFGVLLLELITG 214
+ ++ + N + D++S GV++ L+ G
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-36
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 18 IGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL 76
IG G+ VY A+L G A+K+V++++ + E+ ++ ++ H N+V L F
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 77 EKGEQ------LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQ 130
GE+ L+L+Y+ H Y ++ L + R+L Y+HS
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 131 ADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNY 189
I HRDIK N+LL D KL DFG K +PN + I +
Sbjct: 142 ---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----VSYICSRYYRAPELI 194
Query: 190 LNTGFVSTKSDVYSFGVLLLELITG 214
++ DV+S G +L EL+ G
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLG 219
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 130 bits (327), Expect = 3e-36
Identities = 54/269 (20%), Positives = 104/269 (38%), Gaps = 35/269 (13%)
Query: 9 MATNDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV------MEERGGSRKIFLDEVSV 59
+ NDF + IG G VY G A+K + M++ +S+
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 60 LLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALD 119
+ P +V + + +L+ + L + + GV S ++ A +
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAE 115
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
I LE++H++ +++RD+K +NILL + H +++D GL K+ +
Sbjct: 116 IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD------FSKKKPHASV 166
Query: 180 GSFGYVDTNYLNTGF-VSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVE 238
G+ GY+ L G + +D +S G +L +L+ G + T E
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----------KDKHE 216
Query: 239 VWAQMLDPKLNGDANM-EQLRVLIRICMA 266
+ L + + +LR L+ +
Sbjct: 217 IDRMTLTMAVELPDSFSPELRSLLEGLLQ 245
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 7e-36
Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 18/215 (8%)
Query: 10 ATNDFRI--RIGVGATSFVYLAE--LGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRV 63
A + IG GA V+ A G F A+KRV + G G + EV+VL +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 64 S---HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQ-SLGVLSWSNRLSIALD 119
HPN+V L C L + + + TY + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 120 IARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
+ R L++LHS ++HRD+K NIL+ KLADFGL ++ + TS+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI-----YSFQMALTSVV 176
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ Y L +T D++S G + E+
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 211
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-35
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 11 TNDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRV-MEERGGSRKIFLDEVSVLLRVSHP 66
+ IG GA V A + + A+K++ E + L E+ +LLR H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 67 NLVGLLGFCLEKGEQ----LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
N++G+ + + L+ +L L+ + T LS + I R
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILR 120
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSF 182
L+Y+HS ++HRD+K SN+LL K+ DFGL ++ D + T +
Sbjct: 121 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYVATR 176
Query: 183 GYVDTNYLNTGFVSTKS-DVYSFGVLLLELITG 214
Y + TKS D++S G +L E+++
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (315), Expect = 3e-35
Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 15/207 (7%)
Query: 12 NDFRI--RIGVGATSFVYLAELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPN 67
+ +IG G VY A+ G A+K++ E+ G + E+S+L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+V L K +L+ E+L G L S L + + Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYC 116
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
H + ++HRD+K N+L+ + K+ADFGL + K I +
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLAR---AFGIPVRKYTHEIVTLWYRAPD 170
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITG 214
+ + ST D++S G + E++ G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-34
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 12 NDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRV------MEERGGSRKIFLDEVSVLLR 62
+ + +G G + V E G A K + RG SR+ EVS+L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 63 VSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
+ HPN++ L K + +L+LE +A LFD + L+ I
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILN 124
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDN----HAKLADFGLCKLGPFNDPNRPKRQTSI 178
+ YLHS I H D+K NI+L+D N K+ DFGL F + +I
Sbjct: 125 GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNI 176
Query: 179 KGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS 221
G+ +V +N + ++D++S GV+ L++G G
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-34
Identities = 63/271 (23%), Positives = 108/271 (39%), Gaps = 35/271 (12%)
Query: 18 IGVGATSFVYLAE-LGDGNFGAVKRV-----MEERGGSRKIFLDEVSVLLRVSHPNLVGL 71
+G G + VY A A+K++ E + G + L E+ +L +SHPN++GL
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 72 LGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA 131
L K L+ +++ VL+ S+ + L + LEYLH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 132 DPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLN 191
I+HRD+K +N+LL ++ KLADFGL K + + + T + Y L
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK----SFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 192 TGFV-STKSDVYSFGVLLLELITG---------------LKSIQGSATLAEWTEECRRNK 235
+ D+++ G +L EL+ + G+ T +W + C
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 236 NVEVWAQMLDPKLNGDANM-EQLRVLIRICM 265
V + P + + + L LI+
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLF 264
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 3e-34
Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 18/213 (8%)
Query: 8 KMATNDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKI---FLDEVSVLL 61
K+ NDF +G G V L G + A+K + +E ++ + E VL
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 62 RVSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
HP L L ++EY LF + + +I
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIV 115
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
ALEYLHS+ +++RDIK N++L D H K+ DFGLCK G + G+
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT----FCGT 168
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y+ L D + GV++ E++ G
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 5e-34
Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 22/217 (10%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVM--EERGGSRKIFLDEVSVLLRVSHP 66
+ + +IG G V+ A G A+K+V+ E+ G L E+ +L + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 67 NLVGLLGFCLE--------KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIAL 118
N+V L+ C KG L+ ++ + + L + S +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQ 124
Query: 119 DIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSI 178
+ L Y+H I+HRD+K++N+L+ D KLADFGL + ++P R T+
Sbjct: 125 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 179 KGSFGYVDTNYL-NTGFVSTKSDVYSFGVLLLELITG 214
+ Y L D++ G ++ E+ T
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (298), Expect = 1e-32
Identities = 55/270 (20%), Positives = 98/270 (36%), Gaps = 23/270 (8%)
Query: 6 ELKMATNDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLR 62
EL++ N +R+ +IG G+ +YL + G A+K + E +
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKM 58
Query: 63 VSHPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
+ + + +C +G+ +++ L SL D + + S L +A +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMIS 114
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLA---DFGLCKL---GPFNDPNRPKRQT 176
+EY+HS+ IHRD+K N L+ L DFGL K + +
Sbjct: 115 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 177 SIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN 236
++ G+ Y N S + D+ S G +L+ G Q L T+ + +
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ---GLKAATKRQKYERI 228
Query: 237 VEVWAQMLDPKLNGDANMEQLRVLIRICMA 266
E L E + C +
Sbjct: 229 SEKKMSTPIEVLCKGYPSE-FATYLNFCRS 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-32
Identities = 58/267 (21%), Positives = 98/267 (36%), Gaps = 32/267 (11%)
Query: 12 NDFRIR---IGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HP 66
+D+++ +G+G V A+K + + EV + R S P
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCP 65
Query: 67 NLVGLLGFC----LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIAR 122
++V ++ + L+++E L LF R+ Q+ + I I
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEIMKSIGE 122
Query: 123 ALEYLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
A++YLHS I HRD+K N+L + KL DFG K ++ T
Sbjct: 123 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT--- 176
Query: 180 GSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEV 239
YV L D++S GV++ L+ G + LA R +
Sbjct: 177 --PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--- 231
Query: 240 WAQMLDPKLNGDANMEQLRVLIRICMA 266
Q P E++++LIR +
Sbjct: 232 -GQYEFPNPEWSEVSEEVKMLIRNLLK 257
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-32
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 15/207 (7%)
Query: 13 DFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPN 67
+F+ +IG G VY A G A+K++ + G + E+S+L ++HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 68 LVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYL 127
+V LL + + L+ E+L + + S + + L +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG----IPLPLIKSYLFQLLQGLAFC 118
Query: 128 HSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDT 187
HS ++HRD+K N+L+ + KLADFGL + + +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEVVTLWYRAPE 172
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITG 214
L + ST D++S G + E++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTR 199
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 8e-32
Identities = 47/208 (22%), Positives = 78/208 (37%), Gaps = 16/208 (7%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRV--MEERGGSRKIFLDEVSVLLRVSHP 66
+ +IG G V+ A+ A+KRV ++ G L E+ +L + H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
N+V L + L+ E+ G L S + + L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGF 116
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
HS+ ++HRD+K N+L+ + KLA+FGL + F P R + +
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARA--FGIPVRCYSAE-VVTLWYRPP 170
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELITG 214
ST D++S G + EL
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANA 198
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 116 bits (292), Expect = 8e-32
Identities = 43/259 (16%), Positives = 91/259 (35%), Gaps = 22/259 (8%)
Query: 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFC 75
RIG G+ ++ L + A+K + DE ++ + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYF 69
Query: 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPI 135
++G +L+ L SL D + + S A + ++ +H + +
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHEK---SL 122
Query: 136 IHRDIKSSNILL-----IDDNHAKLADFGLCKLGPFNDPNRP---KRQTSIKGSFGYVDT 187
++RDIK N L+ + N + DFG+ K + + + ++ G+ Y+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 188 NYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNVEVWAQMLDPK 247
N S + D+ + G + + + G QG L T + + + E +
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG---LKAATNKQKYERIGEKKQSTPLRE 239
Query: 248 LNGDANMEQLRVLIRICMA 266
L E+ +
Sbjct: 240 LCAGFP-EEFYKYMHYARN 257
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (290), Expect = 5e-31
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 21/209 (10%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKI---FLDEVSVLLRVSH 65
+ F +G G+ V L + GN A+K + +++ K L+E +L V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 66 PNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE 125
P LV L + +++EY+A +F + +G S + A I E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFE 155
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYV 185
YLHS +I+RD+K N+L+ + ++ DFG K R ++ G+ +
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWTLCGTPEAL 205
Query: 186 DTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ + + D ++ GVL+ E+ G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 5e-31
Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 26/216 (12%)
Query: 12 NDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEER------GGSRKIFLDEVSVLLR 62
+ +++ +G G VY + D A+K V ++R + EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 63 VS--HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
VS ++ LL + +L+LE + G L S +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF----DFITERGALQEELARSFFWQV 119
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILL-IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIK 179
A+ + H+ ++HRDIK NIL+ ++ KL DFG L + T
Sbjct: 120 LEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTVYTDFD 170
Query: 180 GSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITG 214
G+ Y ++ + + V+S G+LL +++ G
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (270), Expect = 2e-28
Identities = 40/210 (19%), Positives = 86/210 (40%), Gaps = 25/210 (11%)
Query: 12 NDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPN 67
+D+++ ++G G S V+ A + + VK + + +K E+ +L + PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 68 LVGLLGFCLEKGEQL--LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALE 125
++ L + + L+ E++ N T L+ + +I +AL+
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALD 143
Query: 126 YLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGY 184
Y HS I+HRD+K N+++ ++ +L D+GL + + + +
Sbjct: 144 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS----RYFK 196
Query: 185 VDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
++ D++S G +L +I
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFR 226
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-28
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 24/220 (10%)
Query: 8 KMATNDFRI--RIGVGATSFVYLAEL----GDGNFGAVKRV----MEERGGSRKIFLDEV 57
K+ +F + +G GA V+L G A+K + + ++ + + E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 58 SVLLRVSH-PNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSI 116
VL + P LV L + + L+L+Y+ LF + +
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIY 134
Query: 117 ALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQT 176
+I ALE+LH II+RDIK NILL + H L DFGL + +R
Sbjct: 135 VGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS---KEFVADETERAY 188
Query: 177 SIKGSFGYVDTNYLNTGF--VSTKSDVYSFGVLLLELITG 214
G+ Y+ + + G D +S GVL+ EL+TG
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 6e-28
Identities = 43/208 (20%), Positives = 77/208 (37%), Gaps = 15/208 (7%)
Query: 12 NDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHP 66
+R +G GA V A + G A+K++ K E+ +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
N++GLL ++ + L + + + L Y
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRY 136
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVD 186
+H+ IIHRD+K N+ + +D K+ DFGL + + + +
Sbjct: 137 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR------QADSEMTGYVVTRWYRAP 187
Query: 187 TNYLNTGFVSTKSDVYSFGVLLLELITG 214
LN + D++S G ++ E+ITG
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITG 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-25
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 25/214 (11%)
Query: 11 TNDFRI--RIGVGATSFVYLAE-LGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSH 65
++ +G GA V A G AVK++ K E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 66 PNLVGLLGFC-----LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDI 120
N++GLL LE+ + L+ +L L + + L+ + + I
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQI 130
Query: 121 ARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKG 180
R L+Y+HS IIHRD+K SN+ + +D K+ DFGL + +
Sbjct: 131 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA------RHTDDEMTGYVAT 181
Query: 181 SFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
+ LN + D++S G ++ EL+TG
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 3e-24
Identities = 44/213 (20%), Positives = 82/213 (38%), Gaps = 25/213 (11%)
Query: 12 NDFRI--RIGVGATSFVYLA-ELGDGNFGAVKRV--MEERGGSRKIFLDEVSVLLRVSHP 66
++ IG GA V A + A+K++ + K E+ ++ V+H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 67 NLVGLLGFC-----LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIA 121
N++ LL LE+ + + L+ L + +L + + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQML 129
Query: 122 RALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGS 181
+++LHS IIHRD+K SNI++ D K+ DFGL + T +
Sbjct: 130 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTSFMMTPYVVT 181
Query: 182 FGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y + D++S G ++ E++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.7 bits (234), Expect = 4e-23
Identities = 44/211 (20%), Positives = 81/211 (38%), Gaps = 18/211 (8%)
Query: 17 RIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNL------- 68
++G G S V+LA+ + + A+K ++ + DE+ +L RV+ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 69 ----VGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARAL 124
+ LL KG + + + + + + I+ + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 125 EYLHSQADPPIIHRDIKSSNILL-IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFG 183
+Y+H + IIH DIK N+L+ I D+ L + LG + + +
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--IQTRE 194
Query: 184 YVDTNYLNTGFVSTKSDVYSFGVLLLELITG 214
Y L +D++S L+ ELITG
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITG 225
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 75.6 bits (185), Expect = 2e-17
Identities = 26/156 (16%), Positives = 44/156 (28%), Gaps = 22/156 (14%)
Query: 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKI----------FLDEVSVLLRVSHP 66
+G G S V+ VK +K+ F R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 67 NLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEY 126
L L G + K + N L M + L + N + I +
Sbjct: 67 ALQKLQGLAVPKV-----YAWEGNAVL---MELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 127 LHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162
+ + I+H D+ N+ L+ + + DF
Sbjct: 119 FYHR---GIVHGDLSQYNV-LVSEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 266 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.77 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.4 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.32 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 82.09 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=347.41 Aligned_cols=235 Identities=23% Similarity=0.402 Sum_probs=204.3
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.|++.+.||+|+||.||+|. ..+|+.+|+|.+... .......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 47778899999999999994 467889999987542 23456778899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++|+|.+++... +.+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.....
T Consensus 87 y~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 87 YAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred ecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999875 67999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------h
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------V 237 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~ 237 (266)
.......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..+...... .
T Consensus 159 ------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 232 (263)
T d2j4za1 159 ------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 232 (263)
T ss_dssp ------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHH
T ss_pred ------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHH
Confidence 2234567999999999999999999999999999999999999999888776666655553322 1
Q ss_pred hhhhhhccCCCCCcchHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
+++.+|+.++|..||+.+++.+
T Consensus 233 ~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 233 DLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCCHhHCcCHHHHHc
Confidence 5788999999999999988764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=349.58 Aligned_cols=236 Identities=25% Similarity=0.384 Sum_probs=205.0
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+|.+.++||+|+||.||+|. ..+|+.+|||.+........+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 45666689999999999994 56799999999876666667889999999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
||+|.+++.. +.+++..+..++.|++.||.|||++| |+||||||+|||++.++++||+|||++......
T Consensus 101 gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-- 169 (293)
T d1yhwa1 101 GGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (293)
T ss_dssp TCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred CCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--
Confidence 9999998765 57999999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc------------h
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN------------V 237 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------~ 237 (266)
........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+...... .
T Consensus 170 --~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 247 (293)
T d1yhwa1 170 --QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (293)
T ss_dssp --TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHH
T ss_pred --cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHH
Confidence 22334567999999999999999999999999999999999999999988877766655543211 1
Q ss_pred hhhhhhccCCCCCcchHHHHHH
Q 047020 238 EVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
+++.+|+.++|..||+.+++.+
T Consensus 248 ~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 248 DFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 5678999999999999988753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=345.22 Aligned_cols=239 Identities=24% Similarity=0.330 Sum_probs=196.6
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.|++.+.||+|+||.||+|. ..+|+.+|||.+..... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 46677799999999999994 56789999998865432 23456889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
++|+|.+++... +.+++..+..++.|++.||.|||++| |+||||||+||++++++.+||+|||+|.......
T Consensus 86 ~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 86 SGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp TTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999998753 67999999999999999999999999 9999999999999999999999999998643222
Q ss_pred CCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC------------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------------ 235 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 235 (266)
. ........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.............
T Consensus 158 ~--~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (271)
T d1nvra_ 158 R--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235 (271)
T ss_dssp E--ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred c--cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHH
Confidence 1 223345689999999999988775 6789999999999999999999977655444333333211
Q ss_pred chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++.+|+..+|..||+.+++.+
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHhc
Confidence 115788999999999999888743
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-53 Score=344.36 Aligned_cols=239 Identities=25% Similarity=0.365 Sum_probs=202.6
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
..|++.+.||+|+||.||+|. ..+|+.+|||.+... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 357777899999999999994 567999999987542 2345677899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||++||+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+||++++++.++|+|||+|....
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999998875 78999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch--------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV-------- 237 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 237 (266)
... .........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..+.......
T Consensus 160 ~~~--~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 237 (288)
T d1uu3a_ 160 PES--KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHH
T ss_pred cCC--cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHH
Confidence 222 1223345679999999999999999999999999999999999999999888777776666543322
Q ss_pred -hhhhhhccCCCCCcchHHHHH
Q 047020 238 -EVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 238 -~~~~~~l~~~~~~~~~~~~l~ 258 (266)
+++++|+..+|..||+.+++.
T Consensus 238 ~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 238 RDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp HHHHHTTSCSSGGGSTTSGGGT
T ss_pred HHHHHHHccCCHhHCcCHHHHc
Confidence 467889999999999888753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=335.40 Aligned_cols=234 Identities=23% Similarity=0.347 Sum_probs=193.3
Q ss_pred hhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEe----cCeEEEEE
Q 047020 13 DFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE----KGEQLLLL 85 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~ 85 (266)
+|..+||+|+||.||+| +..++..+++|.+..... ...+.+.+|++++++++||||+++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56668999999999999 456788999998865432 235678899999999999999999999865 34679999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe-cCCceEEeccccccCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI-DDNHAKLADFGLCKLG 164 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~~~l~dfg~~~~~ 164 (266)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||||+|||++ +++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999875 67899999999999999999999874 5599999999999996 5789999999999752
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
. ........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+..........+.....
T Consensus 166 ~------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (270)
T d1t4ha_ 166 R------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238 (270)
T ss_dssp C------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred c------CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccC
Confidence 1 223446689999999999876 5899999999999999999999999876655555444432211
Q ss_pred ----hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 ----VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ----~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++.+|+.++|..||+.+++.+
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 15678899999999998887753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=342.96 Aligned_cols=237 Identities=24% Similarity=0.292 Sum_probs=201.8
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCC
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLAN 90 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (266)
|++..+||+|+||.||+| +..+|..+|||.+........+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 556678999999999999 4567899999998776666677889999999999999999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCC
Q 047020 91 KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPN 170 (266)
Q Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (266)
|+|.+++... .+.+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 94 g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~---- 162 (288)
T d2jfla1 94 GAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---- 162 (288)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH----
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC----
Confidence 9999987653 256999999999999999999999999 99999999999999999999999999864211
Q ss_pred CCCcccccccCCCccCccccc-----cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------
Q 047020 171 RPKRQTSIKGSFGYVDTNYLN-----TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN--------- 236 (266)
Q Consensus 171 ~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 236 (266)
.........||+.|+|||++. +..++.++||||+||++|+|++|..||.+.+....+..+....+.
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 242 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSC
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCC
Confidence 112234567999999999983 456789999999999999999999999988777777666654211
Q ss_pred ---hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 ---VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ---~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++.+|+..+|..||+.+++.+
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 14678899999999999888754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-52 Score=341.40 Aligned_cols=237 Identities=25% Similarity=0.393 Sum_probs=188.4
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
..|++.+.||+|+||.||+|. ..+|+.+|||.+.... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 457788899999999999994 5678999999886543 23345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe---cCCceEEeccccccCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI---DDNHAKLADFGLCKLG 164 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~---~~~~~~l~dfg~~~~~ 164 (266)
++|++|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||++. +++.+||+|||++...
T Consensus 89 ~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 89 VSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred cCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999764 67999999999999999999999999 99999999999995 4688999999999753
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
.. ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..+......
T Consensus 161 ~~-----~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (307)
T d1a06a_ 161 DP-----GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTT
T ss_pred cC-----CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccC
Confidence 22 22234567999999999999999999999999999999999999999988777766666553221
Q ss_pred -----hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 -----VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 -----~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++.+|+..+|..||+.+++.+
T Consensus 236 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 15788999999999999988765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=340.43 Aligned_cols=233 Identities=24% Similarity=0.321 Sum_probs=202.1
Q ss_pred HhhchhhhhccccccceEEEE-EcCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
...|++.+.||+|+||.||+| +..+|+.+|||.+... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 456778889999999999999 4568999999988643 234567788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||++||+|.+++... +.+++..++.++.|++.||.|||++| |+||||||+||+++++|.+||+|||+++..
T Consensus 84 ~ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred eeccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999999999875 77899999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch-------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV------- 237 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 237 (266)
... ........||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+.......
T Consensus 156 ~~~----~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 231 (337)
T d1o6la_ 156 ISD----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231 (337)
T ss_dssp CCT----TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccC----CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHH
Confidence 221 223455789999999999999999999999999999999999999999988777666655543221
Q ss_pred --hhhhhhccCCCCCcch
Q 047020 238 --EVWAQMLDPKLNGDAN 253 (266)
Q Consensus 238 --~~~~~~l~~~~~~~~~ 253 (266)
+++++|+..+|..|++
T Consensus 232 ~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 232 AKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp HHHHHHHHTCSSTTTSTT
T ss_pred HHHHHHhhccCCchhhcc
Confidence 5778889999998874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=348.23 Aligned_cols=202 Identities=26% Similarity=0.361 Sum_probs=175.8
Q ss_pred HHHhhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
|....|+..++||+|+||.||+|. ..+|+.+|+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 344556666799999999999994 56789999998865433 3356788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
|||+.||+|.+++... +.+++..+..++.|++.||.|||+ +| |+||||||+||++++++++||+|||+|..
T Consensus 83 mEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 9999999999999875 679999999999999999999997 58 99999999999999999999999999875
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
.. ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus 155 ~~------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 155 LI------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HH------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cC------CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 122345689999999999999999999999999999999999999997654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.8e-52 Score=337.54 Aligned_cols=249 Identities=25% Similarity=0.320 Sum_probs=206.8
Q ss_pred HHHhhchhhhhccccccceEEEEEc-CCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAEL-GDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~-~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
|....+++.++||+|+||.||+|.. .+|..+|||++.. .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT-TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECC-ccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 3445566677999999999999954 5688899998754 3445678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+++|+|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 93 E~~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999998762 3367899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN--------- 236 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 236 (266)
.. .........|+..|+|||++.+..++.++|||||||++|+|++|..||.......+....+.....
T Consensus 167 ~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 167 GD---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243 (287)
T ss_dssp SS---SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CC---CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchH
Confidence 22 122334456889999999999999999999999999999999977776555555555554443221
Q ss_pred --hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 237 --VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 237 --~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.+++.+|+..+|..||+.+++.+.++..+
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 15678999999999999999988887643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=335.94 Aligned_cols=244 Identities=20% Similarity=0.274 Sum_probs=188.5
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEe--cCeEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLE--KGEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 84 (266)
..|++.+.||+|+||.||++ ...+|+.+|||.+..... ...+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 45677779999999999999 456789999998765432 235668899999999999999999998865 4568999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQA--DPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
|||+++|+|.+++..... ....+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 84 mEy~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999875321 2257999999999999999999999854 1249999999999999999999999999998
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN------ 236 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 236 (266)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 163 ~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 163 ILNHD----TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred ecccC----CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 64322 22234567899999999999999999999999999999999999999987776655555443221
Q ss_pred ----hhhhhhhccCCCCCcchHHHHH
Q 047020 237 ----VEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 237 ----~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
.+++++|+.++|..||+.+++.
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 1567788888888998888764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-51 Score=344.01 Aligned_cols=238 Identities=21% Similarity=0.287 Sum_probs=205.2
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.+|++.+.||+|+||.||+|. ..+|..+|||++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 457777899999999999994 5678999999987665556677889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec--CCceEEeccccccCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID--DNHAKLADFGLCKLGPF 166 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~--~~~~~l~dfg~~~~~~~ 166 (266)
+||+|.+++... .+.+++..+..++.||+.||.|||++| ++||||||+||+++. ++.+||+|||++.....
T Consensus 106 ~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 106 SGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999988542 256999999999999999999999999 999999999999964 57899999999985322
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc----------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------- 236 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 236 (266)
........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..+......
T Consensus 179 -----~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 253 (350)
T d1koaa2 179 -----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253 (350)
T ss_dssp -----TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCC
T ss_pred -----ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 23345678999999999999999999999999999999999999999988877777666553321
Q ss_pred ---hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 ---VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ---~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++++|+..+|..||+.+++.+
T Consensus 254 ~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 254 EDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 14688999999999999988764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-51 Score=335.36 Aligned_cols=232 Identities=22% Similarity=0.279 Sum_probs=197.0
Q ss_pred chhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 12 NDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 12 ~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
|+..++||+|+||.||+| ...+|..+|||.+...... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 555668999999999999 4567889999987654322 345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.++++..++... +++++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 97 ~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~-- 166 (309)
T d1u5ra_ 97 CLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-- 166 (309)
T ss_dssp CSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS--
T ss_pred cCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC--
Confidence 9998887666553 67999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCCCcccccccCCCccCcccccc---ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNT---GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-------- 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 236 (266)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 167 ------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 240 (309)
T d1u5ra_ 167 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240 (309)
T ss_dssp ------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSC
T ss_pred ------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCC
Confidence 2334679999999999854 35888999999999999999999999988877777666654221
Q ss_pred ---hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 ---VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 ---~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++.+|+..+|..||+.+++.+
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 15778899999999999988753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.7e-51 Score=336.27 Aligned_cols=234 Identities=24% Similarity=0.385 Sum_probs=201.8
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 85 (266)
..|++.+.||+|+||.||+|. ..+|+.+|||.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 347788899999999999995 467899999988643 2334677889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGP 165 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~ 165 (266)
||+.|+++.+.+... ..+++..+..++.|++.|+.|||++| |+||||||+|||++.+|.+||+|||++....
T Consensus 84 E~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec
Confidence 999999999988774 67889999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch--------
Q 047020 166 FNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV-------- 237 (266)
Q Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 237 (266)
. ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+......++.......
T Consensus 156 ~-------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 228 (316)
T d1fota_ 156 D-------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228 (316)
T ss_dssp S-------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred c-------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 2 2335689999999999999999999999999999999999999999988877777766643221
Q ss_pred -hhhhhhccCCCCCcc-----hHHHHH
Q 047020 238 -EVWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 238 -~~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
+++.+|+..+|..|+ +.+++.
T Consensus 229 ~~li~~~L~~dp~~R~~~~r~t~~~il 255 (316)
T d1fota_ 229 KDLLSRLITRDLSQRLGNLQNGTEDVK 255 (316)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred HHHHHHHhhhCHHhccccchhhHHHHH
Confidence 567888888888885 666654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.1e-51 Score=342.39 Aligned_cols=237 Identities=22% Similarity=0.280 Sum_probs=204.5
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
.|++.+.||+|+||.||+| +..+|+.+|||.+..........+.+|++++++++||||+++++++.+++..++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4667779999999999999 456799999998876555556678899999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEe--cCCceEEeccccccCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLI--DDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~--~~~~~~l~dfg~~~~~~~~ 167 (266)
||+|.+.+... ..++++..++.++.|++.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 110 gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~- 181 (352)
T d1koba_ 110 GGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 181 (352)
T ss_dssp CCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred CChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC-
Confidence 99999877642 246999999999999999999999999 99999999999997 568899999999986432
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-----------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN----------- 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------- 236 (266)
........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+......
T Consensus 182 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 182 ----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp ----TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ----CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 23345678999999999999999999999999999999999999999998877777666553221
Q ss_pred --hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 --VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 --~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++++|+..+|..||+.+++.+
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 25688999999999999988754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-51 Score=335.40 Aligned_cols=257 Identities=20% Similarity=0.304 Sum_probs=195.7
Q ss_pred CChHHHHHhhchhh-----------hhccccccceEEEEEcC-CCc---EEEEEEeeeccc-ccHHHHHHHHHHHhcCCC
Q 047020 2 YALEELKMATNDFR-----------IRIGVGATSFVYLAELG-DGN---FGAVKRVMEERG-GSRKIFLDEVSVLLRVSH 65 (266)
Q Consensus 2 ~~~~~i~~~~~~~~-----------~~ig~g~~~~v~~~~~~-~g~---~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~ 65 (266)
|+.+++..++.+|. ..||+|+||.||++... +|+ .++||++..... ...+.+.+|++++++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 44556666655553 47999999999999653 333 477777654332 345678999999999999
Q ss_pred CCccccceeEEecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcE
Q 047020 66 PNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNI 145 (266)
Q Consensus 66 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 145 (266)
|||+++++++.+.+..++||||+++|+|.+++... .+.+++..+..++.|++.||.|||+++ ++||||||+||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NI 159 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNI 159 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceE
Confidence 99999999999999999999999999999987652 256899999999999999999999999 99999999999
Q ss_pred EEecCCceEEeccccccCCCCCCCCC-CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCch
Q 047020 146 LLIDDNHAKLADFGLCKLGPFNDPNR-PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSAT 223 (266)
Q Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~ 223 (266)
|++.++++||+|||+++......... ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999998644322211 122223467899999999999999999999999999999998 8999988766
Q ss_pred hHHHHHHHHhcCc----------hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 224 LAEWTEECRRNKN----------VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 224 ~~~~~~~~~~~~~----------~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
......+...... .+++.+|+..+|..||+..+|.+.|++++
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 240 QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 5544443332111 25778999999999999999999888764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=332.21 Aligned_cols=244 Identities=25% Similarity=0.354 Sum_probs=195.4
Q ss_pred HhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
...+.+.+.||+|+||.||++..+ +.++||.+.... ....+.+.+|++++++++||||+++++++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 445667779999999999999864 358999875432 3345778899999999999999999998654 56899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 84 y~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999998652 256899999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCCCCCcccccccCCCccCccccccc---cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--------
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTG---FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-------- 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 235 (266)
.. .........||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..........+..
T Consensus 157 ~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 157 WS--GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cC--CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 21 12334456799999999998643 478899999999999999999999988766555544443211
Q ss_pred -------chhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 236 -------NVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 236 -------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
..+++.+|+..+|..||+.++|.+.++..
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12567899999999999999998887753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=330.97 Aligned_cols=237 Identities=25% Similarity=0.330 Sum_probs=202.9
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeeccc------ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERG------GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
..|++.+.||+|+||.||+|. ..+|+.+|||.+..... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 457777899999999999995 56799999998754322 13577899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC----ceEEecc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN----HAKLADF 158 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----~~~l~df 158 (266)
+||||++||+|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++.++ .+||+||
T Consensus 90 iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 999999999999999875 67999999999999999999999999 99999999999998766 4999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc--
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN-- 236 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 236 (266)
|++...... .......+|+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..+......
T Consensus 162 G~a~~~~~~-----~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 162 GLAHKIDFG-----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236 (293)
T ss_dssp TTCEECTTS-----CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred hhhhhcCCC-----ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 999754322 2334567899999999999999999999999999999999999999988776666554443211
Q ss_pred -----------hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 -----------VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 -----------~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++++|+..+|..||+.+++.+
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 25788999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=327.87 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=194.7
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+.+++.+.||+|+||.||++...+++.+|||++... ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 356777899999999999998888889999987643 3456789999999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+|+|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 84 ~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~- 155 (263)
T d1sm2a_ 84 HGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 155 (263)
T ss_dssp TCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC-
Confidence 99999988653 256789999999999999999999999 9999999999999999999999999997543222
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhC-CCCcCCCchhHHHHHHHHhcC----------chh
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG-LKSIQGSATLAEWTEECRRNK----------NVE 238 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g-~~pf~~~~~~~~~~~~~~~~~----------~~~ 238 (266)
........||..|+|||++.+..++.++|||||||++|||+++ .+||.+.+.......+..... ..+
T Consensus 156 --~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 233 (263)
T d1sm2a_ 156 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 233 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred --ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHH
Confidence 1223345789999999999999999999999999999999995 566655554444433333211 125
Q ss_pred hhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
++.+|+..+|..||+.+++.+.|++.
T Consensus 234 li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 234 IMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 67899999999999999999988764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=330.76 Aligned_cols=245 Identities=26% Similarity=0.343 Sum_probs=199.5
Q ss_pred HHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
....+++.++||+|+||.||+|.+.++..+|||++... ....+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 34566777799999999999998888888999987543 3456789999999999999999999998754 567999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+++|+|.+++... ...++++..+..++.|++.||.|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 89 ~~~g~L~~~~~~~---~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 89 MENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999977653 2245899999999999999999999999 999999999999999999999999999864332
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCC-cCCCchhHHHHHHHHhcC----------c
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKS-IQGSATLAEWTEECRRNK----------N 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~p-f~~~~~~~~~~~~~~~~~----------~ 236 (266)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..| |...+............. .
T Consensus 163 ~---~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 239 (272)
T d1qpca_ 163 E---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239 (272)
T ss_dssp C---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred c---cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHH
Confidence 1 2233456788999999999988999999999999999999996555 444444333333222111 1
Q ss_pred hhhhhhhccCCCCCcchHHHHHHHHHH
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
.+++.+|+..+|..||+.++|.+.|+.
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 257789999999999999999888775
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-50 Score=334.34 Aligned_cols=233 Identities=21% Similarity=0.300 Sum_probs=201.0
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeec---ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLE 86 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 86 (266)
.|++.+.||+|+||.||+|. ..+|+.+|||.+... .....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 45666699999999999994 567999999987542 22345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+|+|.+.+... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 122 ~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~- 192 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK- 192 (350)
T ss_dssp CCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS-
T ss_pred cccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc-
Confidence 99999999999875 67999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc---------h
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN---------V 237 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~ 237 (266)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...... .
T Consensus 193 ------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 266 (350)
T d1rdqe_ 193 ------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266 (350)
T ss_dssp ------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHH
T ss_pred ------cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHH
Confidence 2234568999999999999999999999999999999999999999988877777666664322 1
Q ss_pred hhhhhhccCCCCCcc-----hHHHHH
Q 047020 238 EVWAQMLDPKLNGDA-----NMEQLR 258 (266)
Q Consensus 238 ~~~~~~l~~~~~~~~-----~~~~l~ 258 (266)
+++++|+..+|..|+ +.+++.
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell 292 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIK 292 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred HHHHHHhhhCHHhccccccccHHHHH
Confidence 577888888888884 666654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=327.29 Aligned_cols=240 Identities=20% Similarity=0.294 Sum_probs=197.4
Q ss_pred hccccccceEEEEEc---CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCCc
Q 047020 17 RIGVGATSFVYLAEL---GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~---~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (266)
+||+|+||.||+|.. +++..+|||.+..... ...+.+.+|++++++++||||+++++++.+ +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 599999999999944 3445789998754332 345678999999999999999999999865 46899999999999
Q ss_pred hhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCCC
Q 047020 93 LFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNRP 172 (266)
Q Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 172 (266)
|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++........ .
T Consensus 95 L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~ 166 (285)
T d1u59a_ 95 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-Y 166 (285)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE-E
T ss_pred HHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccc-c
Confidence 99987542 256899999999999999999999999 999999999999999999999999999865433221 2
Q ss_pred CcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------chhhhh
Q 047020 173 KRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------NVEVWA 241 (266)
Q Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~~~~~~ 241 (266)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..... ..+++.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 246 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS 246 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 22334568899999999998899999999999999999998 8999987765544433333211 115788
Q ss_pred hhccCCCCCcchHHHHHHHHHHHh
Q 047020 242 QMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 242 ~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+|+..+|..||+..+|.+.|+.||
T Consensus 247 ~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 247 DCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999998876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=335.53 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=200.7
Q ss_pred HhhchhhhhccccccceEEEEEc-CCC-----cEEEEEEeeecc-cccHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL-GDG-----NFGAVKRVMEER-GGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~-~~g-----~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
...+++.+.||+|+||.||+|.. +.+ ..+++|.+.... ......+.+|+.++.++ +||||+++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 34566667999999999999954 222 257888775433 33456788999999998 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCC
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQ------------------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKS 142 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp 142 (266)
.++||||+++|+|.++++..... ....+++..+..++.|++.||.|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 99999999999999999764321 1245899999999999999999999999 99999999
Q ss_pred CcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCC
Q 047020 143 SNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGS 221 (266)
Q Consensus 143 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~ 221 (266)
+||+++.++.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDS--NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCT--TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hccccccCCeEEEeeccccccccCCC--ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999997533221 1223345678999999999999999999999999999999997 89999887
Q ss_pred chhHHHHHHHHhcCc-----------hhhhhhhccCCCCCcchHHHHHHHHH
Q 047020 222 ATLAEWTEECRRNKN-----------VEVWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 222 ~~~~~~~~~~~~~~~-----------~~~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
+......+....... .+++.+|+..+|..||+.++|.+.|.
T Consensus 271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 766666665554221 15788999999999999999988874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=324.65 Aligned_cols=237 Identities=22% Similarity=0.309 Sum_probs=191.1
Q ss_pred hccccccceEEEEEc---CCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecCCC
Q 047020 17 RIGVGATSFVYLAEL---GDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLANK 91 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~---~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (266)
+||+|+||.||+|.. +.++.+|||.+...... ..+.+.+|++++++++||||+++++++.++ ..++||||+++|
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g 92 (277)
T d1xbba_ 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELG 92 (277)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTE
T ss_pred CcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCC
Confidence 699999999999954 34567899987543322 356789999999999999999999998654 578999999999
Q ss_pred chhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCCCC
Q 047020 92 SLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDPNR 171 (266)
Q Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 171 (266)
+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+++....... .
T Consensus 93 ~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~-~ 163 (277)
T d1xbba_ 93 PLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-Y 163 (277)
T ss_dssp EHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS-E
T ss_pred cHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc-c
Confidence 999998764 67999999999999999999999999 99999999999999999999999999976433221 1
Q ss_pred CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC--c--------hhhh
Q 047020 172 PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK--N--------VEVW 240 (266)
Q Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~--~--------~~~~ 240 (266)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+..... . .+++
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li 243 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 243 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 122334578999999999999999999999999999999997 8999987665544333332211 1 1578
Q ss_pred hhhccCCCCCcchHHHHHHHHHH
Q 047020 241 AQMLDPKLNGDANMEQLRVLIRI 263 (266)
Q Consensus 241 ~~~l~~~~~~~~~~~~l~~~~~~ 263 (266)
.+|+..+|..||+.++|.+.++.
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhC
Confidence 89999999999999998877654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-49 Score=323.02 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=198.9
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc---cHHHHHHHHHHHhcCCCCCccccceeEEecC----eE
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG---SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG----EQ 81 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~ 81 (266)
.+|++.+.||+|+||.||+| +..+|+.+|||.+...... ....+.+|+++++.++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 35777779999999999999 4568999999988654332 3456889999999999999999999987654 37
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
|+||||++|++|.+++... +.+++..+..++.|++.||.|||++| ++||||||+||+++.++..+++|||.+
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 8999999999999988775 67999999999999999999999999 999999999999999999999999987
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-----
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN----- 236 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 236 (266)
....... ..........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+............+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T d1o6ya_ 159 RAIADSG-NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237 (277)
T ss_dssp EECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGT
T ss_pred hhhcccc-ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchh
Confidence 6432222 1223445668999999999999999999999999999999999999999988877777666654322
Q ss_pred --------hhhhhhhccCCCCCcc-hHHHHHHHHHHH
Q 047020 237 --------VEVWAQMLDPKLNGDA-NMEQLRVLIRIC 264 (266)
Q Consensus 237 --------~~~~~~~l~~~~~~~~-~~~~l~~~~~~~ 264 (266)
.+++++|+..+|..|| +.++|..-+.+.
T Consensus 238 ~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 2578899999999998 788887766654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=318.30 Aligned_cols=242 Identities=23% Similarity=0.330 Sum_probs=203.6
Q ss_pred hhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 10 ATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+.+++.++||+|+||.||++...++..+|||.+... ....+.+.+|++++++++||||+++++++.+++..++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 356777899999999999998888889999987653 3456789999999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
+|++.+++... ...+++..+..++.|++.||.|||+.| |+||||||+||++++++.+||+|||++.......
T Consensus 83 ~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 154 (258)
T d1k2pa_ 83 NGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 154 (258)
T ss_dssp TEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-
T ss_pred CCcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC-
Confidence 99999886543 256889999999999999999999999 9999999999999999999999999997543322
Q ss_pred CCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC----------chh
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK----------NVE 238 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~----------~~~ 238 (266)
........+|..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+.......+..... ..+
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 232 (258)
T d1k2pa_ 155 --YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 232 (258)
T ss_dssp --CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred --ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHH
Confidence 222334678999999999999999999999999999999998 8999988776655444443211 115
Q ss_pred hhhhhccCCCCCcchHHHHHHHHH
Q 047020 239 VWAQMLDPKLNGDANMEQLRVLIR 262 (266)
Q Consensus 239 ~~~~~l~~~~~~~~~~~~l~~~~~ 262 (266)
++++|+..+|..||+.+++.+.|.
T Consensus 233 li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 233 IMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHHhh
Confidence 778999999999999888877653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=325.60 Aligned_cols=234 Identities=24% Similarity=0.345 Sum_probs=197.6
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeec---ccccHHHHHHHHHHHh-cCCCCCccccceeEEecCeEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEE---RGGSRKIFLDEVSVLL-RVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~---~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
..|.+.+.||+|+||.||+| ...+|+.+|||.+... .......+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 35677889999999999999 5567999999988643 2334556677777665 68999999999999999999999
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
|||+++|+|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+|||+++++++||+|||++...
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999999875 67899999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCch-------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKNV------- 237 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 237 (266)
... ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....+..+....+..
T Consensus 154 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~ 229 (320)
T d1xjda_ 154 MLG----DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 229 (320)
T ss_dssp CCT----TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccc----cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHH
Confidence 322 233445689999999999999999999999999999999999999999888777666655543321
Q ss_pred --hhhhhhccCCCCCcchHH
Q 047020 238 --EVWAQMLDPKLNGDANME 255 (266)
Q Consensus 238 --~~~~~~l~~~~~~~~~~~ 255 (266)
+++++|+..+|..||+.+
T Consensus 230 ~~dli~~~L~~dP~~R~s~~ 249 (320)
T d1xjda_ 230 AKDLLVKLFVREPEKRLGVR 249 (320)
T ss_dssp HHHHHHHHSCSSGGGSBTTB
T ss_pred HHHHHHHhcccCCCCCcCHH
Confidence 457778888888887763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.8e-49 Score=319.67 Aligned_cols=236 Identities=24% Similarity=0.274 Sum_probs=199.6
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccc---------cHHHHHHHHHHHhcCC-CCCccccceeEEec
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG---------SRKIFLDEVSVLLRVS-HPNLVGLLGFCLEK 78 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~---------~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 78 (266)
..|++.+.||+|+||.||+|. ..+|+.+|||.+...... ..+++.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 356777799999999999994 467889999988654322 1346788999999997 99999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
+..++||||+++++|.+++... +++++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999875 68999999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCcccccc------ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT------GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR 232 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~ 232 (266)
|++..... ........||..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 155 G~a~~~~~-----~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 155 GFSCQLDP-----GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp TTCEECCT-----TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred hheeEccC-----CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence 99986432 222345679999999999853 3467899999999999999999999999887776666665
Q ss_pred hcCc-------------hhhhhhhccCCCCCcchHHHHH
Q 047020 233 RNKN-------------VEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 233 ~~~~-------------~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
.... .+++.+|+.++|..||+.+++.
T Consensus 230 ~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 230 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 4321 1567889999999999888764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=323.57 Aligned_cols=251 Identities=20% Similarity=0.230 Sum_probs=194.2
Q ss_pred HHHhhchhhhhccccccceEEEEEcCCC-----cEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCe
Q 047020 7 LKMATNDFRIRIGVGATSFVYLAELGDG-----NFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 7 i~~~~~~~~~~ig~g~~~~v~~~~~~~g-----~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 80 (266)
|.-+.+...+.||+|+||.||+|..... ..++||++...... ....+.+|++++++++||||+++++++.+.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 3445566667899999999999954332 36889987543332 34568899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccc
Q 047020 81 QLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGL 160 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~ 160 (266)
.++||||+.++++.+.+... ...+++..+..++.|++.|+.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccch
Confidence 99999999999998887653 256899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC-----
Q 047020 161 CKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK----- 235 (266)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~----- 235 (266)
++....... .........||+.|+|||++.+..++.++|||||||++|||+++..||.......+....+....
T Consensus 157 a~~~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~ 235 (283)
T d1mqba_ 157 SRVLEDDPE-ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235 (283)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred hhcccCCCc-cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc
Confidence 986433221 12223345689999999999999999999999999999999997665544444444444433221
Q ss_pred ------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 ------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+..+|.+.|++++
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 115788999999999999999999887653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=326.43 Aligned_cols=236 Identities=19% Similarity=0.234 Sum_probs=201.9
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+|.+.+.||+|+||.||+| +..+|+.+|||.+.... .....+.+|+++++.++||||+++++++.+++..|+||||+.
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 4677779999999999999 45678899999876543 344567899999999999999999999999999999999999
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecC--CceEEeccccccCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDD--NHAKLADFGLCKLGPFN 167 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~--~~~~l~dfg~~~~~~~~ 167 (266)
|++|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+||+++.+ ..++|+|||++....
T Consensus 85 gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~-- 155 (321)
T d1tkia_ 85 GLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-- 155 (321)
T ss_dssp CCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC--
T ss_pred CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc--
Confidence 99999998753 246899999999999999999999999 9999999999999854 479999999987532
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-----------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN----------- 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------- 236 (266)
.........+|+.|+|||...+..++.++||||+||++|+|++|..||.+.+....+..+......
T Consensus 156 ---~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 156 ---PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ---TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ---cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 223345677899999999999999999999999999999999999999988877766666553221
Q ss_pred --hhhhhhhccCCCCCcchHHHHHH
Q 047020 237 --VEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 237 --~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.+++.+|+..+|..||+.+++.+
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 25788999999999999998865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=323.84 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=195.9
Q ss_pred HHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
...++++...||+|+||.||++...+++.+|||++.. .....+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECc-ccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 3456777779999999999999887888899998753 34456789999999999999999999999854 567999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+|+|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++++||+|||+++.....
T Consensus 93 ~~~g~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 9999999888763 2246899999999999999999999999 999999999999999999999999999754322
Q ss_pred CCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcCc-----------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNKN----------- 236 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------- 236 (266)
. ........||+.|+|||++....++.++|||||||++|+|++|..||.......+....+.....
T Consensus 167 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 243 (285)
T d1fmka3 167 E---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred C---ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHH
Confidence 1 22334467899999999999999999999999999999999965555443333333333332111
Q ss_pred hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 237 VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 237 ~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.+++.+|+..+|..||+.++|.++++..+
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 15778999999999999999998887643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=321.72 Aligned_cols=232 Identities=24% Similarity=0.277 Sum_probs=190.3
Q ss_pred hhccccccceEEEEE-cCCCcEEEEEEeeecccc-----cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEecC
Q 047020 16 IRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGG-----SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYLA 89 (266)
Q Consensus 16 ~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (266)
+.||+|+||.||+|. ..+|+.+|||++...... ....+.+|++++++++||||+++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 479999999999995 457899999987543221 23568899999999999999999999999999999999998
Q ss_pred CCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCCC
Q 047020 90 NKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFNDP 169 (266)
Q Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~~ 169 (266)
++++...... ...+++..+..++.|++.||.|||++| ++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-- 153 (299)
T d1ua2a_ 84 TDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-- 153 (299)
T ss_dssp EEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--
T ss_pred chHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC--
Confidence 8777655543 267899999999999999999999999 999999999999999999999999999753322
Q ss_pred CCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc--------------
Q 047020 170 NRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN-------------- 234 (266)
Q Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~-------------- 234 (266)
........||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 154 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 154 --NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp --CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred --cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 222334578999999999864 467999999999999999999999999988877766654321
Q ss_pred -----------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 -----------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 -----------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..||+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 1124688999999999999988754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-48 Score=327.61 Aligned_cols=230 Identities=21% Similarity=0.275 Sum_probs=186.4
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc---cccHHHHHH---HHHHHhcCCCCCccccceeEEecCeEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER---GGSRKIFLD---EVSVLLRVSHPNLVGLLGFCLEKGEQL 82 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~---~~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (266)
..|++.+.||+|+||.||+|. ..+|+.+|||.+.... ......+.+ ++++++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 456777799999999999994 5679999999875422 122233333 467777888999999999999999999
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++| ++||||||+|||++.+|.+||+|||++.
T Consensus 84 ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999875 67899999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccc-cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHH--HHHHHh-cC---
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLN-TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEW--TEECRR-NK--- 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~--~~~~~~-~~--- 235 (266)
.... .......||+.|+|||++. +..++.++||||+||++|+|++|..||.+.+..... ...... ..
T Consensus 156 ~~~~------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (364)
T d1omwa3 156 DFSK------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 229 (364)
T ss_dssp ECSS------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCC
T ss_pred ecCC------CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCC
Confidence 5332 2234567999999999986 457899999999999999999999999765433222 111111 10
Q ss_pred ------chhhhhhhccCCCCCcch
Q 047020 236 ------NVEVWAQMLDPKLNGDAN 253 (266)
Q Consensus 236 ------~~~~~~~~l~~~~~~~~~ 253 (266)
..+++.+|+..+|..|++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t 253 (364)
T d1omwa3 230 DSFSPELRSLLEGLLQRDVNRRLG 253 (364)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSTT
T ss_pred CCCCHHHHHHHHHHcccCHHHhCC
Confidence 125678899999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=316.41 Aligned_cols=246 Identities=20% Similarity=0.266 Sum_probs=190.4
Q ss_pred HhhchhhhhccccccceEEEEEcC-C---CcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 9 MATNDFRIRIGVGATSFVYLAELG-D---GNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~~-~---g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
..++++.+.||+|+||.||+|... + +..++||.+..... .....+.+|++++++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 456777789999999999999542 2 33567776643322 23567899999999999999999999986 467899
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccC
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKL 163 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~ 163 (266)
||||+.+|++.+++... .+.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 85 v~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999887652 256899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcCc------
Q 047020 164 GPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNKN------ 236 (266)
Q Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~------ 236 (266)
..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..............
T Consensus 158 ~~~~~---~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (273)
T d1mp8a_ 158 MEDST---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred ccCCc---ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 43221 223345668899999999999999999999999999999998 89999877665555444433211
Q ss_pred ----hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 237 ----VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 237 ----~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.+++.+|+..+|..||+.++|.+.++..+
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 15788999999999999999998887643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=315.72 Aligned_cols=247 Identities=26% Similarity=0.322 Sum_probs=193.5
Q ss_pred HhhchhhhhccccccceEEEEEc--CCC--cEEEEEEeeecc---cccHHHHHHHHHHHhcCCCCCccccceeEEecCeE
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL--GDG--NFGAVKRVMEER---GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQ 81 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~--~~g--~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 81 (266)
...+++.+.||+|+||.||+|.. .++ ..+|||.+.... ....+.+.+|++++++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 34567777999999999999953 223 357888765432 2234678999999999999999999999966 467
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+.++++.+++... .+.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred heeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhh
Confidence 8999999999999887653 256899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcCch---
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNKNV--- 237 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~--- 237 (266)
+....... .........++..|+|||++.+..++.++||||||+++|||++ |..||.+.+.......+......+
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (273)
T d1u46a_ 159 RALPQNDD-HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237 (273)
T ss_dssp EECCC-CC-EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred hhcccCCC-cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc
Confidence 86433222 1223344567889999999999999999999999999999998 899998887777666555432211
Q ss_pred --------hhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 238 --------EVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 238 --------~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
+++.+|+.++|..||+..+|.++++.+
T Consensus 238 ~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 467899999999999999999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=316.35 Aligned_cols=238 Identities=24% Similarity=0.325 Sum_probs=194.8
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.|+..++||+|+||.||+| +..+|+.+|||.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 4566679999999999999 457799999998854332 2356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.+ ++.+++.. .....+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||.+.....
T Consensus 83 ~~~-~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~- 154 (298)
T d1gz8a_ 83 LHQ-DLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV- 154 (298)
T ss_dssp CSE-EHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-
T ss_pred cCC-chhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC-
Confidence 855 55555544 23367999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCCCCcccccccCCCccCcccccccc-CCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGF-VSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------------ 234 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------------ 234 (266)
.........||+.|+|||+..... ++.++|+||+||++|+|++|+.||.+.+.......+....
T Consensus 155 ---~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 155 ---PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp ---CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ---CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccc
Confidence 123344567999999999876655 5789999999999999999999999888777666554321
Q ss_pred --------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 --------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 --------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++++|+..+|..||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0124688999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=315.03 Aligned_cols=241 Identities=32% Similarity=0.411 Sum_probs=192.1
Q ss_pred HHhhchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEe-cCeEEEEEE
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE-KGEQLLLLE 86 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 86 (266)
....+++...||+|+||.||++.. +|..+|||++... ...+.+.+|++++++++||||+++++++.+ ++..++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 445677788999999999999987 5788999987543 345779999999999999999999998854 556899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+++|+|.+++... ....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 82 y~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~- 154 (262)
T d1byga_ 82 YMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS- 154 (262)
T ss_dssp CCTTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecC-
Confidence 99999999998753 1135899999999999999999999999 9999999999999999999999999987422
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhc----------C
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRN----------K 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~----------~ 235 (266)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.... .
T Consensus 155 ------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (262)
T d1byga_ 155 ------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred ------CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 22234567889999999998899999999999999999998 788887665444333332211 1
Q ss_pred chhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
..+++++|+..+|..||++.++.+.++..
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 12678899999999999999999988753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=321.77 Aligned_cols=234 Identities=21% Similarity=0.255 Sum_probs=188.7
Q ss_pred hhchhhh-hccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhc-CCCCCccccceeEEe----cCeEE
Q 047020 10 ATNDFRI-RIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLR-VSHPNLVGLLGFCLE----KGEQL 82 (266)
Q Consensus 10 ~~~~~~~-~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~----~~~~~ 82 (266)
..|.+.. .||+|+||.||+| +..+|+.+|||.+.. ...+.+|++++.+ .+||||+++++++.+ +...+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 3455554 5999999999999 557899999998743 3457789998765 479999999999865 45789
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec---CCceEEeccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID---DNHAKLADFG 159 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~~~l~dfg 159 (266)
+||||++||+|.+++... ....+++..+..++.|++.||.|||++| |+||||||+||+++. .+.+||+|||
T Consensus 86 ivmEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 999999999999999752 2257999999999999999999999999 999999999999975 4569999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH-------
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR------- 232 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~------- 232 (266)
++...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..........
T Consensus 160 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 160 FAKETTSH-----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp TCEECCCC-----CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred eeeeccCC-----CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence 99854322 233456799999999999999999999999999999999999999977654332221111
Q ss_pred ----------hcCchhhhhhhccCCCCCcchHHHHHH
Q 047020 233 ----------RNKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 233 ----------~~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
.....+++++|+..+|..||+.+++..
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111236788999999999999998865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=313.33 Aligned_cols=246 Identities=28% Similarity=0.359 Sum_probs=197.3
Q ss_pred hhhhhccccccceEEEEEcCC----CcEEEEEEeeec-ccccHHHHHHHHHHHhcCCCCCccccceeEEe-cCeEEEEEE
Q 047020 13 DFRIRIGVGATSFVYLAELGD----GNFGAVKRVMEE-RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE-KGEQLLLLE 86 (266)
Q Consensus 13 ~~~~~ig~g~~~~v~~~~~~~----g~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 86 (266)
+|..+||+|+||.||+|.+.. ...++||++... .....+++.+|++++++++||||+++++++.+ ++..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 445589999999999995432 235788887543 23345779999999999999999999998765 568899999
Q ss_pred ecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCC
Q 047020 87 YLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPF 166 (266)
Q Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~ 166 (266)
|+.+++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 110 ~~~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp CCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EeecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 99999999987652 245678889999999999999999999 99999999999999999999999999987655
Q ss_pred CCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-----------C
Q 047020 167 NDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN-----------K 235 (266)
Q Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~-----------~ 235 (266)
.............||..|+|||.+....++.++||||||+++|||++|..||.......++...+... .
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~ 262 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 262 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHH
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHH
Confidence 44444444455678999999999999999999999999999999999888886554444443333221 1
Q ss_pred chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++.+|+..+|..||+.+++.+.++.++
T Consensus 263 l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 263 LYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 125778999999999999999999988764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-48 Score=316.69 Aligned_cols=250 Identities=23% Similarity=0.271 Sum_probs=202.0
Q ss_pred hchhhhhccccccceEEEEEc------CCCcEEEEEEeeecccc-cHHHHHHHHHHHhcCCCCCccccceeEEecCeEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERGG-SRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLL 83 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 83 (266)
.+++.+.||+|+||.||+|.. .++..+|||++...... ...++.+|++++++++||||+++++++.+.+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 455566999999999999954 24568899987654332 35678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhhhcC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCc
Q 047020 84 LLEYLANKSLFDRMHTYYG-------------------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSN 144 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~n 144 (266)
+|||+.+++|.+++..... .....+++..+..++.|++.||.|||+++ ++||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccc
Confidence 9999999999999875321 12235789999999999999999999999 9999999999
Q ss_pred EEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCC-CCcCCCch
Q 047020 145 ILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGL-KSIQGSAT 223 (266)
Q Consensus 145 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~-~pf~~~~~ 223 (266)
|+++.++.+||+|||++....... .........+++.|+|||.+.+..++.++|||||||++|||++|. .||.+.+.
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSAD--YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGG--CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred eEECCCCcEEEccchhheeccCCc--cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999987533221 122334567889999999999999999999999999999999985 67877766
Q ss_pred hHHHHHHHHhcCc----------hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 224 LAEWTEECRRNKN----------VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 224 ~~~~~~~~~~~~~----------~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.+........... .+++.+|+..+|..||+..+|.+.|++.+
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6555443332111 15788999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=315.83 Aligned_cols=252 Identities=26% Similarity=0.334 Sum_probs=200.3
Q ss_pred HhhchhhhhccccccceEEEEEc-CC-------CcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEec
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL-GD-------GNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEK 78 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~-~~-------g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 78 (266)
...+++.+.||+|+||.||+|.. +. +..+|||++..... .....+.+|...+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 45667778999999999999953 22 23678888755433 2346778888888888 799999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYG-----------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL 147 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~ 147 (266)
...++||||+.+|+|.+++..... .....+++..+..++.|++.||.|||+.+ ++||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999976431 12246899999999999999999999999 9999999999999
Q ss_pred ecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHH
Q 047020 148 IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAE 226 (266)
Q Consensus 148 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~ 226 (266)
+.++.+||+|||++....... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHID--YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCC--TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred cCCCCeEeccchhhccccccc--cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 999999999999988543322 2233455678999999999999999999999999999999998 7888877665544
Q ss_pred HHHHHHhcCc-----------hhhhhhhccCCCCCcchHHHHHHHHHHHhC
Q 047020 227 WTEECRRNKN-----------VEVWAQMLDPKLNGDANMEQLRVLIRICMA 266 (266)
Q Consensus 227 ~~~~~~~~~~-----------~~~~~~~l~~~~~~~~~~~~l~~~~~~~~~ 266 (266)
+. .+..... .+++.+|+..+|..||+..+|.+.|++.+|
T Consensus 247 ~~-~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 FK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH-HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 33 3332211 257889999999999999999999998765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=314.43 Aligned_cols=244 Identities=23% Similarity=0.328 Sum_probs=190.2
Q ss_pred hchhhhhccccccceEEEEEc-CCCc----EEEEEEeeec-ccccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAEL-GDGN----FGAVKRVMEE-RGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~-~~g~----~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 84 (266)
.|+..+.||+|+||.||+|.. .+|+ .+++|++... .....+.+.+|++++++++||||+++++++.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 366667999999999999954 4554 4677776543 233567899999999999999999999998875 56788
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
++++.+++|.+.+... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999887753 357899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHHHHHHHHhcC--c-----
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAEWTEECRRNK--N----- 236 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~~~~~~~~~~--~----- 236 (266)
..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+............. .
T Consensus 162 ~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~ 239 (317)
T d1xkka_ 162 GAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239 (317)
T ss_dssp TTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBC
T ss_pred ccccc--cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence 43222 222334568999999999999999999999999999999998 7899977654443332222211 1
Q ss_pred ---hhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 237 ---VEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 237 ---~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
.+++.+|+..+|..||+..+|...+.+.
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1577899999999999999988776553
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=315.54 Aligned_cols=236 Identities=22% Similarity=0.276 Sum_probs=190.3
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc------cHHHHHHHHHHHhcCC--CCCccccceeEEecCe
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG------SRKIFLDEVSVLLRVS--HPNLVGLLGFCLEKGE 80 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 80 (266)
.+|++.+.||+|+||.||+| +..+|..+|||.+...... ...++.+|++++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 45677779999999999999 5567899999988643221 1234668999999986 8999999999999999
Q ss_pred EEEEEEecCC-CchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-CCceEEecc
Q 047020 81 QLLLLEYLAN-KSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-DNHAKLADF 158 (266)
Q Consensus 81 ~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~~~l~df 158 (266)
.++|||++.+ +++.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.+||+||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 9999999875 6788888764 67999999999999999999999999 999999999999985 478999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccccC-CCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh---c
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFV-STKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR---N 234 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~---~ 234 (266)
|++.... ........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+........... .
T Consensus 156 G~a~~~~------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~ 229 (273)
T d1xwsa_ 156 GSGALLK------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 229 (273)
T ss_dssp TTCEECC------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCH
T ss_pred ccceecc------cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCH
Confidence 9997532 223345679999999999987655 57799999999999999999999875432221100000 1
Q ss_pred CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++++|+..+|..||+.+++.+
T Consensus 230 ~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 230 ECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1126788999999999999988754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=314.38 Aligned_cols=259 Identities=21% Similarity=0.324 Sum_probs=196.2
Q ss_pred CChHHHH--HhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCcccc
Q 047020 2 YALEELK--MATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGL 71 (266)
Q Consensus 2 ~~~~~i~--~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~ 71 (266)
|..+++. ...+++.+.||+|+||.||+|.. .+++.+|||++..... .....+.+|...+.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 3444433 35667777999999999999953 2346789998754332 2345677788877776 58999999
Q ss_pred ceeEEec-CeEEEEEEecCCCchhhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCC
Q 047020 72 LGFCLEK-GEQLLLLEYLANKSLFDRMHTYYGQ-----------SLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRD 139 (266)
Q Consensus 72 ~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~d 139 (266)
++++... ...++||||+++|+|.+++...... ....+++..+..++.|++.||.|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9987654 4689999999999999999764321 1245899999999999999999999999 99999
Q ss_pred CCCCcEEEecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhC-CCCc
Q 047020 140 IKSSNILLIDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG-LKSI 218 (266)
Q Consensus 140 ikp~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g-~~pf 218 (266)
|||+||++++++.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|+++ ..||
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDP--DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCT--TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCccceeECCCCcEEEccCcchhhccccc--cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999997533222 22334456799999999999999999999999999999999986 5688
Q ss_pred CCCchhHHHHHHHHhcCc-----------hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 219 QGSATLAEWTEECRRNKN-----------VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.+.+....+...+..... .+++.+|+..+|..||+.+++.+.|+..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 238 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp TTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 776665555555443211 15788999999999999999999888754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.4e-47 Score=311.04 Aligned_cols=236 Identities=24% Similarity=0.298 Sum_probs=193.9
Q ss_pred hchhhhhccccccceEEEEEcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
+|+..++||+|+||.||+|...+|+.+|||++..... ....++.+|+.++++++||||+++++++.+.+..+++++++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 5666679999999999999878899999999865432 23578899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFND 168 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~~ 168 (266)
.++.+..+.... +.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+......
T Consensus 83 ~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~- 153 (286)
T d1ob3a_ 83 DQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153 (286)
T ss_dssp SEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred hhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC-
Confidence 776666555432 77999999999999999999999999 999999999999999999999999998753221
Q ss_pred CCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC------------
Q 047020 169 PNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------------ 235 (266)
Q Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 235 (266)
........+++.|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.+..+....+.....
T Consensus 154 ---~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 154 ---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 2233445689999999998654 568999999999999999999999998877776665443111
Q ss_pred --------------------------chhhhhhhccCCCCCcchHHHHH
Q 047020 236 --------------------------NVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 236 --------------------------~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
..+++++|+..+|..||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 01568899999999999998875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=314.90 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=207.1
Q ss_pred HhhchhhhhccccccceEEEEEc------CCCcEEEEEEeeeccc-ccHHHHHHHHHHHhcC-CCCCccccceeEEecCe
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL------GDGNFGAVKRVMEERG-GSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~------~~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 80 (266)
...+++.++||+|+||.||+|.. .++..+|||++..... .....+.+|+.+++++ +||||+++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 45666777999999999999953 3566889998764332 2455688999999999 69999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEE
Q 047020 81 QLLLLEYLANKSLFDRMHTYYG-------------QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILL 147 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~ 147 (266)
.++||||+++++|.+++..... .....+++..+..++.||+.|+.|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999876432 12246899999999999999999999999 9999999999999
Q ss_pred ecCCceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHh-CCCCcCCCchhHH
Q 047020 148 IDDNHAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELIT-GLKSIQGSATLAE 226 (266)
Q Consensus 148 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~-g~~pf~~~~~~~~ 226 (266)
+.++.++++|||.+....... .........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCT--TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccCcccccccchheeccCCC--cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999998644322 2334455788999999999999999999999999999999998 6666767666666
Q ss_pred HHHHHHhcCc-----------hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 227 WTEECRRNKN-----------VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 227 ~~~~~~~~~~-----------~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
+.+....... .+++.+|+..+|..||+.++|.++|++-+
T Consensus 257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 5555443211 16788999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=310.57 Aligned_cols=248 Identities=28% Similarity=0.397 Sum_probs=196.7
Q ss_pred hhchhhhhccccccceEEEEEcC-CCc--EEEEEEeeec-ccccHHHHHHHHHHHhcC-CCCCccccceeEEecCeEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLAELG-DGN--FGAVKRVMEE-RGGSRKIFLDEVSVLLRV-SHPNLVGLLGFCLEKGEQLLL 84 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~~-~g~--~~~vk~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 84 (266)
..+++.+.||+|+||.||+|... +|. .++||++... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 45566779999999999999553 444 3567766433 223456789999999998 699999999999999999999
Q ss_pred EEecCCCchhhhhhhhc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCce
Q 047020 85 LEYLANKSLFDRMHTYY-----------GQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHA 153 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~ 153 (266)
|||+++|+|.+++.... ......+++..+..++.|++.|+.|||+++ ++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999987531 233467899999999999999999999999 9999999999999999999
Q ss_pred EEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCC-CCcCCCchhHHHHHHHH
Q 047020 154 KLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGL-KSIQGSATLAEWTEECR 232 (266)
Q Consensus 154 ~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~-~pf~~~~~~~~~~~~~~ 232 (266)
||+|||++..... ........||..|+|||.+.+..++.++|||||||++|+|++|. .||.+.+.......+..
T Consensus 167 kl~DfG~a~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEV-----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp EECCTTCEESSCE-----ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred EEccccccccccc-----cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 9999999874221 12223456899999999999999999999999999999999975 56776655554443332
Q ss_pred hcC----------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 233 RNK----------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 233 ~~~----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
... ..+++.+|+..+|..||+.+++.+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 110 115788999999999999999999888764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=308.98 Aligned_cols=238 Identities=24% Similarity=0.308 Sum_probs=190.5
Q ss_pred hhchhhhhccccccceEEEEEc-CC-CcEEEEEEeeeccc--ccHHHHHHHHHHHhcC---CCCCccccceeEEe-----
Q 047020 10 ATNDFRIRIGVGATSFVYLAEL-GD-GNFGAVKRVMEERG--GSRKIFLDEVSVLLRV---SHPNLVGLLGFCLE----- 77 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~~-~~-g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~----- 77 (266)
.+|++..+||+|+||.||+|.. .+ ++.+|||++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 4566667999999999999954 45 56789998865432 2234566778777765 79999999998853
Q ss_pred cCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEec
Q 047020 78 KGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLAD 157 (266)
Q Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~d 157 (266)
....+++||++.++++..... .....+++..++.++.|++.||.|||+++ |+||||||+|||++..+.+||+|
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 346899999998766543322 22367899999999999999999999999 99999999999999999999999
Q ss_pred cccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC--
Q 047020 158 FGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK-- 235 (266)
Q Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 235 (266)
||++... ..........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 160 fg~~~~~-----~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIY-----SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp CCSCCCC-----CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhhhhhh-----cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 9998742 123344567899999999999999999999999999999999999999998887776666543200
Q ss_pred ----------------------------------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ----------------------------------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ----------------------------------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++++|+..+|..||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 124788999999999999988753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-46 Score=307.34 Aligned_cols=242 Identities=22% Similarity=0.295 Sum_probs=191.4
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecc--cccHHHHHHHHHHHhcCCCCCccccceeEEe--------c
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEER--GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLE--------K 78 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~ 78 (266)
.+|+...+||+|+||.||+|. ..+|+.+|||++.... .....++.+|++++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 567777799999999999994 5689999999875432 2345678899999999999999999998754 3
Q ss_pred CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecc
Q 047020 79 GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADF 158 (266)
Q Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~df 158 (266)
...+++||++.++.+...... ...+++..++.++.|++.||.|||++| |+||||||+||+++.++.++|+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 468999999977655544332 367899999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc---
Q 047020 159 GLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN--- 234 (266)
Q Consensus 159 g~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~--- 234 (266)
|++..................||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99976554443333444556799999999998665 68999999999999999999999998776655544332211
Q ss_pred --------------------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 --------------------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 --------------------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++.+|+..+|..|++++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0124688999999999999998764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=307.30 Aligned_cols=239 Identities=23% Similarity=0.293 Sum_probs=189.5
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecc-cccHHHHHHHHHHHhcCCCCCccccceeEEecC----eEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEER-GGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG----EQLLL 84 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv 84 (266)
+|+...+||+|+||.||+| +..+|+.+|||++.... ....+++.+|+++|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 4566679999999999999 56789999999886432 233567889999999999999999999986543 23444
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCC
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLG 164 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~ 164 (266)
++++.+++|.+++.. ..+++..+..++.|++.||.|||++| |+||||||+||++++++.+||+|||++...
T Consensus 89 ~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 556679999999976 57999999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCCCCCcccccccCCCccCccccc-cccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh----------
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLN-TGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR---------- 233 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~---------- 233 (266)
..... .........||+.|+|||++. +..++.++||||+||++|+|++|..||.+.+...........
T Consensus 160 ~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 160 DPDHD-HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CGGGC-BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred cCCCc-cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 33222 122345567999999999984 456788999999999999999999999887665544333221
Q ss_pred ------------------------------cCchhhhhhhccCCCCCcchHHHHHH
Q 047020 234 ------------------------------NKNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 234 ------------------------------~~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
....+++.+|+..+|..||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01235788999999999999988764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=308.64 Aligned_cols=232 Identities=22% Similarity=0.287 Sum_probs=185.9
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecC------eE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKG------EQ 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~ 81 (266)
+|+..++||+|+||.||+| +..+|+.+|||++..... ...+.+.+|+++|+.++||||+++++++...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 4555568999999999999 456799999999864322 23457889999999999999999999987654 57
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
++||||+ +.+|....+. ..+++..++.++.|++.||.|||++| |+||||||+|||++.++.++++|||++
T Consensus 99 ~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp EEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 9999998 6677777654 67999999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------ 234 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------ 234 (266)
.... .......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+............
T Consensus 169 ~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 169 RQAD-------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp EECC-------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eccC-------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 8532 22345678999999999865 456899999999999999999999998877666544332211
Q ss_pred ----------------------------------CchhhhhhhccCCCCCcchHHHHHH
Q 047020 235 ----------------------------------KNVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 235 ----------------------------------~~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
...+++++|+..+|..||+++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0125688999999999999998864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=303.79 Aligned_cols=241 Identities=20% Similarity=0.255 Sum_probs=185.3
Q ss_pred hchhhhhccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHH--HHHHHhcCCCCCccccceeEEecC----eEEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLD--EVSVLLRVSHPNLVGLLGFCLEKG----EQLLL 84 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~--e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv 84 (266)
++-+.+.||+|+||.||++.. +|..+|||++.... ...+.. |+..+.+++||||+++++++.+++ ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 344556899999999999976 68899999875432 233333 455556788999999999987654 57899
Q ss_pred EEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh--------CCCCCeecCCCCCCcEEEecCCceEEe
Q 047020 85 LEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS--------QADPPIIHRDIKSSNILLIDDNHAKLA 156 (266)
Q Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~--------~~~~~i~H~dikp~nil~~~~~~~~l~ 156 (266)
|||+.+|+|.++++. .++++..+..++.|++.|+.|||+ ++ |+||||||+||+++.++.+||+
T Consensus 80 ~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEE
Confidence 999999999999986 468999999999999999999997 47 9999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCcccccccCCCccCcccccccc------CCCcccchhHHHHHHHHHhCCCCcCCCc--------
Q 047020 157 DFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGF------VSTKSDVYSFGVLLLELITGLKSIQGSA-------- 222 (266)
Q Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------~~~~~Di~slG~i~~~l~~g~~pf~~~~-------- 222 (266)
|||++..................||+.|+|||++.+.. ++.++|||||||++|+|++|..||....
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 99999865444433333445678999999999987642 5678999999999999999988773211
Q ss_pred ------hhHHHHHHHHhc-----------------CchhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 223 ------TLAEWTEECRRN-----------------KNVEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 223 ------~~~~~~~~~~~~-----------------~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
............ ...+++.+|+..+|..||+..+|.+.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111111111110 012567789999999999999998888765
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=307.70 Aligned_cols=234 Identities=24% Similarity=0.292 Sum_probs=185.5
Q ss_pred hchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEEec------CeEEE
Q 047020 11 TNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCLEK------GEQLL 83 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~l 83 (266)
+|+..+.||+|+||.||+|. ..+|+.+|||++...... ..+|++++++++||||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 34555689999999999994 567999999988654322 34699999999999999999988432 35789
Q ss_pred EEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-ceEEecccccc
Q 047020 84 LLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCK 162 (266)
Q Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~~~l~dfg~~~ 162 (266)
||||++++ +.+.+... ......+++..++.++.|++.||.|||++| |+||||||+|||++.++ .+||+|||++.
T Consensus 97 v~Ey~~~~-~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEECCSEE-HHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEeccCCc-cHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence 99999654 44444321 122367999999999999999999999999 99999999999999775 79999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCcccccc-ccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhc-------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNT-GFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRN------- 234 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~------- 234 (266)
.... ........||..|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 172 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 172 QLVR-----GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp ECCT-----TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hccC-----CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 5432 223345679999999998765 578999999999999999999999999887777665554310
Q ss_pred -------------------------------CchhhhhhhccCCCCCcchHHHHH
Q 047020 235 -------------------------------KNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 235 -------------------------------~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
...+++.+|+..+|..||+++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 301 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 012467889999999999988875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=306.18 Aligned_cols=252 Identities=22% Similarity=0.259 Sum_probs=202.6
Q ss_pred HHhhchhhhhccccccceEEEEEcC------CCcEEEEEEeeeccc-ccHHHHHHHHHHHhcCCCCCccccceeEEecCe
Q 047020 8 KMATNDFRIRIGVGATSFVYLAELG------DGNFGAVKRVMEERG-GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGE 80 (266)
Q Consensus 8 ~~~~~~~~~~ig~g~~~~v~~~~~~------~g~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 80 (266)
....+...++||+|+||.||+|... ++..+|||++..... .....+.+|++++++++||||+++++++.....
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3355666678999999999999542 356889998764332 234568899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEE
Q 047020 81 QLLLLEYLANKSLFDRMHTYYG-----QSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKL 155 (266)
Q Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l 155 (266)
.++||||+.+|+|.+++..... .....+++..+..++.|++.||.|||+++ ++||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 9999999999999998875321 12235688999999999999999999999 999999999999999999999
Q ss_pred eccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhC-CCCcCCCchhHHHHHHHHhc
Q 047020 156 ADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITG-LKSIQGSATLAEWTEECRRN 234 (266)
Q Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g-~~pf~~~~~~~~~~~~~~~~ 234 (266)
+|||+++...... .........+|+.|+|||.+.+..++.++||||||+++|+|++| ..||.+.+....+.......
T Consensus 175 ~DFGla~~~~~~~--~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 175 GDFGMTRDIYETD--YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp CCTTCCCGGGGGG--CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred eecccceeccCCc--ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 9999987532221 12233445789999999999999999999999999999999998 57787766555444433321
Q ss_pred Cc----------hhhhhhhccCCCCCcchHHHHHHHHHHH
Q 047020 235 KN----------VEVWAQMLDPKLNGDANMEQLRVLIRIC 264 (266)
Q Consensus 235 ~~----------~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 264 (266)
.. .+++.+|+..+|..||+.++|.+.|++.
T Consensus 253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11 1567899999999999999999888764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=294.52 Aligned_cols=237 Identities=21% Similarity=0.220 Sum_probs=193.3
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeeccc--ccHHHHHHHHHHHhcCCCCCccccceeEEecCeEEEEEEe
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERG--GSRKIFLDEVSVLLRVSHPNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
+|+..++||+|+||.||+| +..+|+.+|||.+..... ....++.+|+.+++.++||||+++++++.+....++++++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 5666779999999999999 456889999998854432 2357788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccccCCCCC
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCKLGPFN 167 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~~~~~~ 167 (266)
+.++++..++... +.+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+......
T Consensus 83 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 83 CDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ccccccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9888888777654 67899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCCCCcccccccCCCccCcccccccc-CCCcccchhHHHHHHHHHhCCCCcCC-CchhHHHHHHHHhcC----------
Q 047020 168 DPNRPKRQTSIKGSFGYVDTNYLNTGF-VSTKSDVYSFGVLLLELITGLKSIQG-SATLAEWTEECRRNK---------- 235 (266)
Q Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~i~~~l~~g~~pf~~-~~~~~~~~~~~~~~~---------- 235 (266)
........++..|+|||.+.+.. ++.++||||+||++|+|++|..||.. .+.............
T Consensus 155 ----~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 155 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp ----CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ----CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh
Confidence 22233445778899999887654 68999999999999999999988644 444433333222111
Q ss_pred ----------------------------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ----------------------------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ----------------------------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++++|+..+|..||+++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 114688999999999999988753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-43 Score=290.88 Aligned_cols=246 Identities=17% Similarity=0.197 Sum_probs=194.8
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCC-CCccccceeEEecCeEEEEEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH-PNLVGLLGFCLEKGEQLLLLEY 87 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~ 87 (266)
.+|++.+.||+|+||.||+|. ..+|+.+|||...... ....+.+|++.++.++| +|++.+++++......++|||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 456777799999999999995 5678899999764433 23456789999999975 8999999999999999999999
Q ss_pred cCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec-----CCceEEecccccc
Q 047020 88 LANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID-----DNHAKLADFGLCK 162 (266)
Q Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-----~~~~~l~dfg~~~ 162 (266)
+ +++|.+++... ...++...+..++.|++.||.+||++| |+||||||+||+++. .+.++|+|||+++
T Consensus 83 ~-~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 83 L-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp C-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred c-CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 8 78999888653 246899999999999999999999999 999999999999974 5679999999998
Q ss_pred CCCCCCCCC---CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchh---HHHHHHHH--h-
Q 047020 163 LGPFNDPNR---PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATL---AEWTEECR--R- 233 (266)
Q Consensus 163 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~---~~~~~~~~--~- 233 (266)
......... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.... ........ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 654332211 12334567999999999999999999999999999999999999999754322 11111111 0
Q ss_pred cC-------c----hhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 234 NK-------N----VEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 234 ~~-------~----~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
.+ . .+++..+...++..||+.+.+.++++.++
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 10 1 13445677889999999999998888764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-43 Score=291.74 Aligned_cols=245 Identities=20% Similarity=0.217 Sum_probs=190.2
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccc-cceeEEecCeEEEEEEec
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVG-LLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~lv~e~~ 88 (266)
+|++.+.||+|+||.||+| +..+|+.+|||...... ....+..|+++++.++|++++. +..++.+.+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4667779999999999999 45678899999765433 2345788999999998766554 455667788899999998
Q ss_pred CCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEec---CCceEEeccccccCCC
Q 047020 89 ANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLID---DNHAKLADFGLCKLGP 165 (266)
Q Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~~~l~dfg~~~~~~ 165 (266)
++++.+.+... ...+++..+..++.|++.||.|||++| |+||||||+||+++. +..++|+|||++....
T Consensus 86 -~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 86 -GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred -CCchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 56776666542 257899999999999999999999999 999999999999863 4569999999998754
Q ss_pred CCCCCC---CCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHH------HHHhcC-
Q 047020 166 FNDPNR---PKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTE------ECRRNK- 235 (266)
Q Consensus 166 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~------~~~~~~- 235 (266)
...... ........||+.|+|||.+.+..++.++|||||||++|+|++|..||.+......... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 433222 2233456899999999999999999999999999999999999999976543322111 100000
Q ss_pred ----------chhhhhhhccCCCCCcchHHHHHHHHHHHh
Q 047020 236 ----------NVEVWAQMLDPKLNGDANMEQLRVLIRICM 265 (266)
Q Consensus 236 ----------~~~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 265 (266)
..+++..|+..+|..||+.+++.++++..|
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 125678999999999999999999888764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=299.98 Aligned_cols=232 Identities=20% Similarity=0.250 Sum_probs=181.7
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEe------cCeE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLE------KGEQ 81 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 81 (266)
+|+...+||+|+||.||+| +..+|+.+|||++...... ...++.+|+.++++++||||+++++++.. ....
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 4555569999999999999 4567999999998654332 34568899999999999999999999854 3688
Q ss_pred EEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccccc
Q 047020 82 LLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLC 161 (266)
Q Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~ 161 (266)
|+||||+.+ ++.+.+. ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.++++|||++
T Consensus 98 ~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 98 YLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 999999965 4544443 45899999999999999999999999 999999999999999999999999987
Q ss_pred cCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHh--------
Q 047020 162 KLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRR-------- 233 (266)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~-------- 233 (266)
.... .........+|+.|+|||++.+..++.++||||+||++|+|++|..||.+.+...........
T Consensus 167 ~~~~-----~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 167 RTAG-----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hccc-----cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence 7422 223334567899999999999999999999999999999999999999887766655443321
Q ss_pred -------------------------------------------cCchhhhhhhccCCCCCcchHHHHH
Q 047020 234 -------------------------------------------NKNVEVWAQMLDPKLNGDANMEQLR 258 (266)
Q Consensus 234 -------------------------------------------~~~~~~~~~~l~~~~~~~~~~~~l~ 258 (266)
....+++++|+..+|..||+++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 1123577899999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=300.40 Aligned_cols=233 Identities=24% Similarity=0.291 Sum_probs=188.7
Q ss_pred hchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccc--cHHHHHHHHHHHhcCCCCCccccceeEEec-----CeEE
Q 047020 11 TNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGG--SRKIFLDEVSVLLRVSHPNLVGLLGFCLEK-----GEQL 82 (266)
Q Consensus 11 ~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 82 (266)
+|+..++||+|+||.||+| +..+|+.+|||++...... ...++.+|+++++.++||||+++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 4555669999999999999 4678999999988654332 345688999999999999999999988533 3345
Q ss_pred EEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 83 LLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
++++++.+++|.+++.. +.+++..++.++.|++.||.|||++| |+||||||+||+++.++.++++|||.+.
T Consensus 99 ~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp EEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 66677889999998865 57999999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHHhcC------
Q 047020 163 LGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECRRNK------ 235 (266)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~~~~------ 235 (266)
.. ........|+..|+|||...+. .++.++||||+||++|+|++|..||.+.+.......+.....
T Consensus 170 ~~-------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 170 HT-------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp CC-------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cc-------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 42 3344557789999999987665 568899999999999999999999998877666555433211
Q ss_pred ----------------------------------chhhhhhhccCCCCCcchHHHHHH
Q 047020 236 ----------------------------------NVEVWAQMLDPKLNGDANMEQLRV 259 (266)
Q Consensus 236 ----------------------------------~~~~~~~~l~~~~~~~~~~~~l~~ 259 (266)
..+++++|+..+|..|++++++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 125688999999999999988764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=299.50 Aligned_cols=239 Identities=25% Similarity=0.321 Sum_probs=192.3
Q ss_pred HhhchhhhhccccccceEEEEEc----CCCcEEEEEEeeecc----cccHHHHHHHHHHHhcCCC-CCccccceeEEecC
Q 047020 9 MATNDFRIRIGVGATSFVYLAEL----GDGNFGAVKRVMEER----GGSRKIFLDEVSVLLRVSH-PNLVGLLGFCLEKG 79 (266)
Q Consensus 9 ~~~~~~~~~ig~g~~~~v~~~~~----~~g~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~ 79 (266)
...|++.+.||+|+||.||+|.. .+|+.+|||.+.... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 35577778999999999999943 357899999875422 2235667889999999976 89999999999999
Q ss_pred eEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEEeccc
Q 047020 80 EQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKLADFG 159 (266)
Q Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l~dfg 159 (266)
..+++|||+.+++|.+++... +.+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|||
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred ceeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeecc
Confidence 999999999999999999875 67889999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccccccCCCccCccccccc--cCCCcccchhHHHHHHHHHhCCCCcCCCchhHHHHHHHH---h-
Q 047020 160 LCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTG--FVSTKSDVYSFGVLLLELITGLKSIQGSATLAEWTEECR---R- 233 (266)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~i~~~l~~g~~pf~~~~~~~~~~~~~~---~- 233 (266)
++...... .........|++.|++||.+.+. .++.++||||+||++|+|++|..||.+.+.......+.. .
T Consensus 175 ~a~~~~~~---~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 175 LSKEFVAD---ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp EEEECCGG---GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred chhhhccc---ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 99754322 12334567899999999998654 467899999999999999999999977644433222222 1
Q ss_pred cC---------chhhhhhhccCCCCCcch-----HHHHH
Q 047020 234 NK---------NVEVWAQMLDPKLNGDAN-----MEQLR 258 (266)
Q Consensus 234 ~~---------~~~~~~~~l~~~~~~~~~-----~~~l~ 258 (266)
.. ..+++.+|+.++|..|++ .+++.
T Consensus 252 ~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 11 115778899999999984 56654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-43 Score=293.81 Aligned_cols=194 Identities=21% Similarity=0.280 Sum_probs=163.9
Q ss_pred hhchhhhhccccccceEEEE-EcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEec--CeEEEEE
Q 047020 10 ATNDFRIRIGVGATSFVYLA-ELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEK--GEQLLLL 85 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~-~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~ 85 (266)
.+|++.++||+|+||.||+| +..+|+.+|||.+.. ...+++.+|+++++.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 34566679999999999999 456789999998743 34577889999999996 99999999998744 4689999
Q ss_pred EecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCC-ceEEeccccccCC
Q 047020 86 EYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDN-HAKLADFGLCKLG 164 (266)
Q Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~~~l~dfg~~~~~ 164 (266)
||+.+++|.+.. +.+++..+..++.||+.||.|||++| |+||||||+|||++.++ .++|+|||++...
T Consensus 112 e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 112 EHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp ECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred eecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 999999987653 45899999999999999999999999 99999999999998655 6899999999753
Q ss_pred CCCCCCCCCcccccccCCCccCccccccc-cCCCcccchhHHHHHHHHHhCCCCcCCCc
Q 047020 165 PFNDPNRPKRQTSIKGSFGYVDTNYLNTG-FVSTKSDVYSFGVLLLELITGLKSIQGSA 222 (266)
Q Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i~~~l~~g~~pf~~~~ 222 (266)
... .......+|..|+|||.+.+. .++.++|+||+||++|+|++|..||...+
T Consensus 181 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 181 HPG-----QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CTT-----CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cCC-----CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 322 233456789999999998665 57999999999999999999999996543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-37 Score=258.04 Aligned_cols=199 Identities=23% Similarity=0.233 Sum_probs=156.3
Q ss_pred hhchhhhhccccccceEEEEE-cCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-----------CCCccccceeEEe
Q 047020 10 ATNDFRIRIGVGATSFVYLAE-LGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-----------HPNLVGLLGFCLE 77 (266)
Q Consensus 10 ~~~~~~~~ig~g~~~~v~~~~-~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~~ 77 (266)
.+|.+.++||+|+||.||+|. ..+|+.+|||++.... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 357788899999999999995 5679999999875432 23456778999888775 4789999988754
Q ss_pred c--CeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeecCCCCCCcEEEecCC---
Q 047020 78 K--GEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHS-QADPPIIHRDIKSSNILLIDDN--- 151 (266)
Q Consensus 78 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~--- 151 (266)
. ...++++.+............. .....+++..+..++.|++.|+.|||+ .| |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence 3 4566777765444332222221 334678999999999999999999997 88 99999999999998654
Q ss_pred ---ceEEeccccccCCCCCCCCCCCcccccccCCCccCccccccccCCCcccchhHHHHHHHHHhCCCCcCCC
Q 047020 152 ---HAKLADFGLCKLGPFNDPNRPKRQTSIKGSFGYVDTNYLNTGFVSTKSDVYSFGVLLLELITGLKSIQGS 221 (266)
Q Consensus 152 ---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i~~~l~~g~~pf~~~ 221 (266)
.++++|||.+... ........||+.|+|||++.+..++.++|+||+||++++|++|..||...
T Consensus 167 ~~~~~kl~dfg~s~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWY-------DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp TEEEEEECCCTTCEET-------TBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceeeEeeccccccc-------ccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 3899999998742 22334567999999999999999999999999999999999999999654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.3e-24 Score=164.59 Aligned_cols=130 Identities=16% Similarity=0.151 Sum_probs=101.7
Q ss_pred hhhhccccccceEEEEEcCCCcEEEEEEeeecccc------------------cHHHHHHHHHHHhcCCCCCccccceeE
Q 047020 14 FRIRIGVGATSFVYLAELGDGNFGAVKRVMEERGG------------------SRKIFLDEVSVLLRVSHPNLVGLLGFC 75 (266)
Q Consensus 14 ~~~~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~------------------~~~~~~~e~~~l~~l~~~~i~~~~~~~ 75 (266)
+..+||+|+||.||+|...+|+.+|||........ .......|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 34689999999999998788999999975421110 012345688899999999998877642
Q ss_pred EecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCCCCCCcEEEecCCceEE
Q 047020 76 LEKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRDIKSSNILLIDDNHAKL 155 (266)
Q Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~~~l 155 (266)
..+++||++++..+. .++...+..++.|++.++.+||+.| ++||||||+||+++++ .++|
T Consensus 84 ----~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 84 ----GNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp ----TTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ----CCEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 237999999775542 2455567789999999999999999 9999999999999865 5899
Q ss_pred eccccccC
Q 047020 156 ADFGLCKL 163 (266)
Q Consensus 156 ~dfg~~~~ 163 (266)
+|||.|..
T Consensus 144 iDFG~a~~ 151 (191)
T d1zara2 144 IDFPQSVE 151 (191)
T ss_dssp CCCTTCEE
T ss_pred EECCCccc
Confidence 99998864
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.77 E-value=4.6e-08 Score=76.46 Aligned_cols=131 Identities=18% Similarity=0.116 Sum_probs=87.4
Q ss_pred cccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEecCCCchhhhhhh
Q 047020 21 GATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYLANKSLFDRMHT 99 (266)
Q Consensus 21 g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 99 (266)
++.+.+|+... +++.+.+|+...........+.+|...+..+. +-.+.+++.+..+.+..++||++++|.++.+....
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 33467998865 45566777665544444555778888888775 33356777787888899999999988777554321
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------------------
Q 047020 100 YYGQSLGVLSWSNRLSIALDIARALEYLHSQA------------------------------------------------ 131 (266)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~------------------------------------------------ 131 (266)
......++.++...+..||+..
T Consensus 104 ----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 104 ----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp ----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred ----------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 1112233444555555555321
Q ss_pred --------CCCeecCCCCCCcEEEecCCceEEecccccc
Q 047020 132 --------DPPIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 132 --------~~~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
...++|+|+.|.||++++++..-|+||+.+.
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0137899999999999876556799999765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.43 E-value=1.9e-06 Score=66.54 Aligned_cols=74 Identities=19% Similarity=0.210 Sum_probs=51.2
Q ss_pred cccccc-ceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCC--CCccccceeEEecCeEEEEEEecCCCchh
Q 047020 18 IGVGAT-SFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH--PNLVGLLGFCLEKGEQLLLLEYLANKSLF 94 (266)
Q Consensus 18 ig~g~~-~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
+..|.. ..||++...++..+++|..... ....+..|...++.+.. -.+.+++.+..+.+..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344443 5689998877777777754332 23446778888877752 23566777778888899999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.20 E-value=8e-06 Score=67.37 Aligned_cols=75 Identities=16% Similarity=0.123 Sum_probs=47.3
Q ss_pred hccccccceEEEEEcCC-CcEEEEEEeeec-------ccccHHHHHHHHHHHhcCC--CC-CccccceeEEecCeEEEEE
Q 047020 17 RIGVGATSFVYLAELGD-GNFGAVKRVMEE-------RGGSRKIFLDEVSVLLRVS--HP-NLVGLLGFCLEKGEQLLLL 85 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~-g~~~~vk~~~~~-------~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv~ 85 (266)
.||.|..-.||++...+ ++.++||+.... ..-...+...|.+.++.+. .| .+++++.+ +.+..++||
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEE
Confidence 68999999999997655 567788865321 1112345667888887764 23 34455443 445668999
Q ss_pred EecCCCch
Q 047020 86 EYLANKSL 93 (266)
Q Consensus 86 e~~~~~~L 93 (266)
|++.+..+
T Consensus 111 E~L~~~~~ 118 (392)
T d2pula1 111 EDLSHLKI 118 (392)
T ss_dssp CCCTTSEE
T ss_pred eccCCccc
Confidence 99976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.61 E-value=0.00032 Score=55.92 Aligned_cols=67 Identities=16% Similarity=0.114 Sum_probs=43.9
Q ss_pred eEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCC---C--Cccccc--eeEEecCeEEEEEEecCCCc
Q 047020 25 FVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSH---P--NLVGLL--GFCLEKGEQLLLLEYLANKS 92 (266)
Q Consensus 25 ~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~---~--~i~~~~--~~~~~~~~~~lv~e~~~~~~ 92 (266)
.||++...+|..+++|.-.. .......+..|..++..|.. | ..+..- ..+...+..+.+++++.|..
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp EEEEECCTTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred eeEEEEcCCCCEEEEEEeCC-CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 69999888898888876433 22345667788888887742 2 111111 23455667889999987743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.40 E-value=0.00042 Score=56.73 Aligned_cols=72 Identities=21% Similarity=0.239 Sum_probs=45.0
Q ss_pred hccccccceEEEEEcCCCc-------EEEEEEeeecccccHHHHHHHHHHHhcCC-CCCccccceeEEecCeEEEEEEec
Q 047020 17 RIGVGATSFVYLAELGDGN-------FGAVKRVMEERGGSRKIFLDEVSVLLRVS-HPNLVGLLGFCLEKGEQLLLLEYL 88 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~-------~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~ 88 (266)
.|+.|..=.+|++....+. ...+.++... +.......+|..+++.+. +.-.++++.++.+ .+|++|+
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi 123 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 123 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence 5777777789998654432 2344444443 333445678999999886 4434466665532 5789999
Q ss_pred CCCch
Q 047020 89 ANKSL 93 (266)
Q Consensus 89 ~~~~L 93 (266)
+|..+
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.32 E-value=0.062 Score=41.66 Aligned_cols=29 Identities=28% Similarity=0.505 Sum_probs=25.5
Q ss_pred CeecCCCCCCcEEEecCCceEEecccccc
Q 047020 134 PIIHRDIKSSNILLIDDNHAKLADFGLCK 162 (266)
Q Consensus 134 ~i~H~dikp~nil~~~~~~~~l~dfg~~~ 162 (266)
.+||+|+.++||++++++..-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 38999999999999887666899999875
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=82.09 E-value=3.9 Score=31.16 Aligned_cols=137 Identities=16% Similarity=0.104 Sum_probs=74.5
Q ss_pred hccccccceEEEEEcCCCcEEEEEEeeecccccHHHHHHHHHHHhcCCCCCccccceeEE--------------------
Q 047020 17 RIGVGATSFVYLAELGDGNFGAVKRVMEERGGSRKIFLDEVSVLLRVSHPNLVGLLGFCL-------------------- 76 (266)
Q Consensus 17 ~ig~g~~~~v~~~~~~~g~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-------------------- 76 (266)
.+..+|.+-|+-+... ++.+++|.- .+...+.+..++...-.+..|...-+. .+.
T Consensus 75 ~~s~~Gs~Gv~FV~~e-~gaiVlK~s---~tta~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~e~d~~I 149 (342)
T d1cjaa_ 75 ERSEKGTEGLFFVETE-SGVFIVKRS---TNIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDKSFRVI 149 (342)
T ss_dssp EECCSTTSCEEEEEES-SCEEEEECC---TTHHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCSSSCHH
T ss_pred EEeecCCceEEEEEcC-CceEEEecC---CchHHHHHHHHHHHHhCCCCCceEEec-CCCHHHHHHHHHHhcCCChhHHH
Confidence 4666666666666553 445566642 234456677777777777777654332 110
Q ss_pred ---ecCeEEEEEEecCCCchhhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeecCC-CCCCcEEEecCC-
Q 047020 77 ---EKGEQLLLLEYLANKSLFDRMHTYYGQSLGVLSWSNRLSIALDIARALEYLHSQADPPIIHRD-IKSSNILLIDDN- 151 (266)
Q Consensus 77 ---~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~d-ikp~nil~~~~~- 151 (266)
-....+++|||.+|..+.+.-.... ...++...+..+ -.++..=.+++...-.|+.+++ =++.|++++.++
T Consensus 150 ~sel~~A~~liMeYvpG~~l~e~~~~~a---~~~fs~~~l~~L-GkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~ 225 (342)
T d1cjaa_ 150 TTLANQANILLMELVRGITLNKLTTTSA---PEVLTKSTMQQL-GSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGA 225 (342)
T ss_dssp HHHTTCSEEEEEECCCEEESTTCCSSSH---HHHSCHHHHHHH-HHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTT
T ss_pred HHHHhcccceeeeccCCccccccccccc---hhhhcHHHHHHh-hhHHHHHHHHcCCccccccccCCCCccceEEecCCc
Confidence 1235689999998877755432110 011222222221 1122222345544323566652 289999999877
Q ss_pred ceEEecccccc
Q 047020 152 HAKLADFGLCK 162 (266)
Q Consensus 152 ~~~l~dfg~~~ 162 (266)
.+..+|=+...
T Consensus 226 ~~~~IDs~i~~ 236 (342)
T d1cjaa_ 226 TVVPIDSKIIP 236 (342)
T ss_dssp CEEECSCCCCC
T ss_pred EEEEecCCccc
Confidence 57888855543
|